"Study ID","Author, Year (Study level)","Study Class","Study Publication Year","Treatment Focus (Study level)","Treatment Focus (Arm level)","Treatment Focus Subclass (Arm level)","Total N Randomized","Intervention Group","Arm N Randomized","Arm N Randomized Detail","Treatment Name","Standardized Treatment Name","Treatment Description","Psychotherapy","Psychotherapy Subclass","Pharmacotherapy","Pharmacotherapy Subclass","CIH","CIH Subclass","Nonpharmacologic Biologic","Nonpharmacologic Cognitive","Control","Other Study Class","Collaborative Care","Format","Delivery Method","Dose","Session Length","Frequency","Treatment Duration","Treatment Duration Detail","Completed Treatment Definition","Completed Treatment Percent","Completed Treatment Percent Detail","Participant Adherence Definition","Participants Adhered Percent","Participants Adhered Percent Detail","Psychotherapy Sessions Completed Mean","Psychotherapy Sessions Completed Standard deviation","Psychotherapy Sessions Completed Detail","Dose at Study End Point Mean","Dose at Study End Point Standard deviation","Dose at Study End Point Detail","Race/Ethnicity Reported (Study level)","Military Status (Study level)","Female Percent (Study level)","Trauma Type (Study level)","Trauma Detail (Study level)","Risk of Bias Rating (Study level)","Citation","PTSDpubs ID","Year Added to PTSD Repository"
"abdallah2022_A","abdallah2022","Pharmacotherapy","2022","PTSD","PTSD",,"158","A","51","53 randomized, 2 excluded ""never began"" treatment","Standard dose ketamine","Ketamine","Eight intravenous infusions of ketamine at a standard dose for treatment of depression, given over 40 minutes","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","0.5 mg/kg",,"Twice weekly","4",,,,,"completed 8 infusions","63%",,,,,,,,"Race and Ethnicity data reported","Mixed","23.42%",,,"High","Abdallah CG, Roache JD, Gueorguieva R, et al. Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial. Neuropsychopharmacology. 2022 Jul;47(8):1574-81. doi: 10.1038/s41386-022-01266-9. PMID: 35046508.","1586306","2023"
"abdallah2022_B","abdallah2022","Pharmacotherapy","2022","PTSD","Active Control",,"158","B","53","55 randomized, 2 excluded ""never began"" treatment","Low dose ketamine","Ketamine","Eight intravenous infusions of ketamine at a lower dose, given over 40 minutes; expected to act as either treatment or active control","No",,"Yes","Other pharmacotherapy","No",,"No","No","Yes","No","No","Individual","In Person","0.2 mg/kg",,"Twice weekly","4",,,,,"completed 8 infusions","72%",,,,,,,,"Race and Ethnicity data reported","Mixed","23.42%",,,"High","Abdallah CG, Roache JD, Gueorguieva R, et al. Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial. Neuropsychopharmacology. 2022 Jul;47(8):1574-81. doi: 10.1038/s41386-022-01266-9. PMID: 35046508.","1586306","2023"
"abdallah2022_C","abdallah2022","Pharmacotherapy","2022","PTSD","Inactive Control",,"158","C","54","55 randomized, 1 excluded ""never began"" treatment","Placebo","Placebo","Eight intravenous infusions of placebo (normal saline), given over 40 minutes","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Twice weekly","4",,,,,"completed 8 infusions","81%",,,,,,,,"Race and Ethnicity data reported","Mixed","23.42%",,,"High","Abdallah CG, Roache JD, Gueorguieva R, et al. Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial. Neuropsychopharmacology. 2022 Jul;47(8):1574-81. doi: 10.1038/s41386-022-01266-9. PMID: 35046508.","1586306","2023"
"abraham2022_A","abraham2022","Other study class","2022","PTSD","PTSD",,"29","A","12",,"Service dog training program","Animal Assisted","Participated in training service dogs for fellow veterans. Sessions with trainer and dog included grooming and bonding, educational lectures, dog training, and debrief.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","In Person",,"60 minutes","Three times weekly","2","6 sessions over 2 weeks","Completed all sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","28%",,,"High","Abraham PA, Kazman JB, Bonner JA, et al. Effects of training service dogs on service members with PTSD: A pilot-feasibility randomized study with mixed methods. Military Psychology. 2022;34(2):187-96. doi: 10.1080/08995605.2021.1984126.","1620165","2023"
"abraham2022_B","abraham2022","Other study class","2022","PTSD","Inactive Control",,"29","B","17",,"Waitlist","Waitlist","Waitlist","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"2",,,,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","28%",,,"High","Abraham PA, Kazman JB, Bonner JA, et al. Effects of training service dogs on service members with PTSD: A pilot-feasibility randomized study with mixed methods. Military Psychology. 2022;34(2):187-96. doi: 10.1080/08995605.2021.1984126.","1620165","2023"
"acarturk2016_A","acarturk2016","Psychotherapy","2016","PTSD","PTSD",,"98","A","49",,"EMDR Recent Traumatic Episode Protocol","Eye Movement Desensitization and Reprocessing (EMDR)","Patient asked to make eye movements or exposed to bilateral tones or tapping while recalling traumatic events, with focus on most recent traumatic events with an extended time perspective.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,,,"range of completed sessions was 2 to 7, indicating total of 7 sessions for treatment","completed full EMDR therapy",,,,,,"4.2","1.3",,,,,"Not reported","Community","74.49%","Terrorism/political violence/forced displacement",,"High","Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.","45262","2019"
"acarturk2016_B","acarturk2016","Psychotherapy","2016","PTSD","Inactive Control",,"98","B","49",,"Waitlist","Waitlist","Patients not allowed to receive any treatment, including through follow-up period (until assessment at 5 weeks posttreatment)","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Not reported","Community","74.49%","Terrorism/political violence/forced displacement",,"High","Acarturk C, Konuk E, Cetinkaya M, et al. The efficacy of eye movement desensitization and reprocessing for post-traumatic stress disorder and depression among Syrian refugees: results of a randomized controlled trial. Psychol Med. 2016 Sep;46(12):2583-93. doi: 10.1017/S0033291716001070. PMID: 27353367.","45262","2019"
"acierno2017_A","acierno2017","Psychotherapy","2017","PTSD","PTSD",,"150","A","76",,"PE delivered in-person","Prolonged Exposure (PE)","Trauma-focused CBT according to the manual by Foa, Hembree, & Rothbaum, 2007","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1.5 hours",,"12","10 to 12 sessions total","completed ≥6 treatment sessions",,,,,,"8.6","3.2",,,,,"Race and Ethnicity data reported","Veteran","3.79%","Combat-related",,"Some Concerns","Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.","45948","2019"
"acierno2017_B","acierno2017","Psychotherapy","2017","PTSD","PTSD",,"150","B","74",,"PE delivered via home-based telehealth","Prolonged Exposure (PE)","Trauma-focused CBT according to the manual by Foa, Hembree, & Rothbaum, 2007","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Video",,"1.5 hours",,"12","10 to12 sessions total","completed ≥6 treatment sessions",,,,,,"7.6","3.6",,,,,"Race and Ethnicity data reported","Veteran","3.79%","Combat-related",,"Some Concerns","Acierno RE, Knapp RG, Tuerk PW, et al. A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2017;89:57-65. doi: 10.1016/j.brat.2016.11.009. PMID: 27894058.","45948","2019"
"acierno2021_A","acierno2021","Psychotherapy","2021","PTSD","PTSD",,"136","A","69",,"Prolonged exposure therapy delivered via telehealth","Prolonged Exposure (PE)","Trauma-focused CBT according to the manual by Foa, Hembree, & Rothbaum, 2007, provided per PE protocol and delivered by home-based telemedicine.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Video",,"90 minutes","Weekly","12 to 15","12-15 sessions depending on patient progress","Completing 8 or more sessions",,,,,,"6.8","4.14",,,,,"Race and Ethnicity data reported","Veteran","100%","MST",,"Some Concerns","Acierno R, Jaffe AE, Gilmore AK, et al. A randomized clinical trial of in-person vs. home-based telemedicine delivery of prolonged exposure for PTSD in military sexual trauma survivors. J Anxiety Disord. 2021 Oct;83:102461. doi: 10.1016/j.janxdis.2021.102461. PMID: 34391978.","1575093","2023"
"acierno2021_B","acierno2021","Psychotherapy","2021","PTSD","Active Control",,"136","B","67",,"Prolonged exposure therapy delivered in person","Prolonged Exposure (PE)","Trauma-focused CBT according to the manual by Foa, Hembree, & Rothbaum, 2007, provided per PE protocol and delivered in-person.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Weekly","12 to 15","12-15 sessions depending on patient progress","Completing 8 or more sessions",,,,,,"6.28","4.33",,,,,"Race and Ethnicity data reported","Veteran","100%","MST",,"Some Concerns","Acierno R, Jaffe AE, Gilmore AK, et al. A randomized clinical trial of in-person vs. home-based telemedicine delivery of prolonged exposure for PTSD in military sexual trauma survivors. J Anxiety Disord. 2021 Oct;83:102461. doi: 10.1016/j.janxdis.2021.102461. PMID: 34391978.","1575093","2023"
"adenauer2011_A","adenauer2011","Psychotherapy","2011","PTSD","PTSD",,"34","A","16",,"NET","Narrative Exposure Therapy (NET)","Trauma-focused CBT with patients constructing a detailed chronological account of his/her biography, with particular attention on traumatic experiences. Therapy aims to reorganize fragmented report of traumatic experiences into a coherent narrative with details about current and past emotional, physiological, cognitive, and behavioral reactions.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"NR (session continues until trauma-related fear reaction shows a significant diminution; mean session length was 108 [SD 17.0] minutes)","Weekly or biweekly","6 to12","12 sessions total","did not drop out of treatment",,,,,,,,,,,,"Not reported","Community","44.12%","Terrorism/political violence/forced displacement",,"High","Adenauer H, Catani C, Gola H, et al. Narrative exposure therapy for PTSD increases top-down processing of aversive stimuli -- evidence from a randomized controlled treatment trial. BMC Neurosci. 2011 Dec 19;12:127. doi: 10.1186/1471-2202-12-127. PMID: 22182346.","37889","2019"
"adenauer2011_B","adenauer2011","Psychotherapy","2011","PTSD","Inactive Control",,"34","B","18",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"6 to12","""For the participants in the WLC group, the time spans between pre- and posttests were individually matched with the NET group""",,,,,,,,,,,,,"Not reported","Community","44.12%","Terrorism/political violence/forced displacement",,"High","Adenauer H, Catani C, Gola H, et al. Narrative exposure therapy for PTSD increases top-down processing of aversive stimuli -- evidence from a randomized controlled treatment trial. BMC Neurosci. 2011 Dec 19;12:127. doi: 10.1186/1471-2202-12-127. PMID: 22182346.","37889","2019"
"ahmadi2015_A","ahmadi2015","Other mixed","2015","PTSD","PTSD",,"48","A","16",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Sequences of large-magnitude, rhythmic saccadic eye movements while holding in mind the most salient aspect of a traumatic memory. (As described in: Shapiro F. Eye movement desensitization: a new treatment for post-traumatic stress disorder. J Behav Ther Exp Psychiatry. 1989 Sep;20(3):211-7. PubMed PMID: 2576656.)","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,,,,"See Detail",,"Study reports droout and exclusions, including participants who ""refused to continue the study to the end"" but unclear if treatment attrition or attrition from measurement",,,,,,,,,,"Not reported","Active Duty Military","0%","Combat-related",,"High","Ahmadi K, Hazrati M, Ahmadizadeh MJ, et al. REM desensitization as a new therapeutic method for post-traumatic stress disorder: a randomized controlled trial. Acta Med Indones. 2015 Apr;47(2):111-9.  PMID: 26260553.","46896","2019"
"ahmadi2015_B","ahmadi2015","Other mixed","2015","PTSD","PTSD",,"48","B","16",,"REM Desensitization","Rapid Eye Movement (REM) Desentization","Patients wore glasses during sleep that possess sensors with the ability to detect infrared waves that during the rapid eye movements (REM) period and which activates a musical instrument which delivers a light music","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person",,,,,,"See Detail",,"Study reports droout and exclusions, including participants who ""refused to continue the study to the end"" but unclear if treatment attrition or attrition from measurement",,,,,,,,,,"Not reported","Active Duty Military","0%","Combat-related",,"High","Ahmadi K, Hazrati M, Ahmadizadeh MJ, et al. REM desensitization as a new therapeutic method for post-traumatic stress disorder: a randomized controlled trial. Acta Med Indones. 2015 Apr;47(2):111-9.  PMID: 26260553.","46896","2019"
"ahmadi2015_C","ahmadi2015","Other mixed","2015","PTSD","Inactive Control",,"48","C","16",,"Control","Waitlist","Received no therapy","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Not reported","Active Duty Military","0%","Combat-related",,"High","Ahmadi K, Hazrati M, Ahmadizadeh MJ, et al. REM desensitization as a new therapeutic method for post-traumatic stress disorder: a randomized controlled trial. Acta Med Indones. 2015 Apr;47(2):111-9.  PMID: 26260553.","46896","2019"
"ahmadizadeh2018_A","ahmadizadeh2018","Nonpharmacologic biological","2018","PTSD","PTSD",,"65","A","22",,"Bilateral rTMS","Transcranial magnetic stimulation (TMS)","Stimulation applied to bilateral dorsolateral prefrontal cortex","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person",,"20 Hz for 2 seconds with inter-train interval of 28 seconds. Total train of 30, 1200 pulse per 15-minute session","Three times a week for first 2 weeks, then 2 times a week for 2 weeks","4",,"10 sessions of treatment",,,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"Some Concerns","Ahmadizadeh MJ, Rezaei M. Unilateral right and bilateral dorsolateral prefrontal cortex transcranial magnetic stimulation in treatment post-traumatic stress disorder: a randomized controlled study. Brain Res Bull. 2018;140:334-40. doi: 10.1016/j.brainresbull.2018.06.001. PMID: 29883597.","50480","2019"
"ahmadizadeh2018_B","ahmadizadeh2018","Nonpharmacologic biological","2018","PTSD","PTSD",,"65","B","21",,"Unilateral rTMS","Transcranial magnetic stimulation (TMS)","Stimulation applied to right dorsolateral prefrontal cortex","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person",,"20 Hz for 2 seconds with inter-train interval of 28 seconds. Total train of 60, 2400 pulse per 30-minute session","Three times a week for first 2 weeks, then 2 times a week for 2 weeks","4",,"10 sessions of treatmnt",,,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"Some Concerns","Ahmadizadeh MJ, Rezaei M. Unilateral right and bilateral dorsolateral prefrontal cortex transcranial magnetic stimulation in treatment post-traumatic stress disorder: a randomized controlled study. Brain Res Bull. 2018;140:334-40. doi: 10.1016/j.brainresbull.2018.06.001. PMID: 29883597.","50480","2019"
"ahmadizadeh2018_C","ahmadizadeh2018","Nonpharmacologic biological","2018","PTSD","Inactive Control",,"65","C","22",,"Sham rTMS","Sham","Participants received stimulation that induced a contraction of the abductor pollicis brevis muscle, then magnetic coil switched to a sham coil with identical looks and sounds but prevents magnetic energy from plastic shell","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Three times a week for first 2 weeks, then 2 times a week for 2 weeks","4",,"10 sessions of sham treatment",,,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"Some Concerns","Ahmadizadeh MJ, Rezaei M. Unilateral right and bilateral dorsolateral prefrontal cortex transcranial magnetic stimulation in treatment post-traumatic stress disorder: a randomized controlled study. Brain Res Bull. 2018;140:334-40. doi: 10.1016/j.brainresbull.2018.06.001. PMID: 29883597.","50480","2019"
"ahmadizadeh2019_A","ahmadizadeh2019","Nonpharmacologic biological","2019","PTSD","PTSD",,"40","A","20",,"Transcranial direct current stimulation (tDCS)","Transcranial direct current stimulation (tDCS)","Ten tDCS sessions delivered to the right (cathode) and left (anode) dorsolateral prefrontal cortex, with brain areas localized using EEG, over 10 consecutive weekdays","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person",,"20 minute treatment with 2mA delivered to scalp electrodes","5 days per week","2",,"Completed 10 sessions of treatment",,,,,,,,,,,,"Not reported","Community","65%",,,"High","Ahmadizadeh MJ, Rezaei M, Fitzgerald PB. Transcranial direct current stimulation (tDCS) for post-traumatic stress disorder (PTSD): a randomized, double-blinded, controlled trial. Brain research bulletin. 2019;153:273-8. PMID: 31560945.","1545324","2020"
"ahmadizadeh2019_B","ahmadizadeh2019","Nonpharmacologic biological","2019","PTSD","Inactive Control",,"40","B","20",,"Sham transcranial direct current stimulation","Sham","Ten sham treatment sessions, with scalp electrodes applied to the dorsolateral prefrontal cortex, over 10 consecutive weekdays.  Current ramped up for 30s and then ramped down.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"20 minute sham treatment","5 days per week","2",,"Completed the sham treatment",,,,,,,,,,,,"Not reported","Community","65%",,,"High","Ahmadizadeh MJ, Rezaei M, Fitzgerald PB. Transcranial direct current stimulation (tDCS) for post-traumatic stress disorder (PTSD): a randomized, double-blinded, controlled trial. Brain research bulletin. 2019;153:273-8. PMID: 31560945.","1545324","2020"
"ahmadpanah2014_A","ahmadpanah2014","Pharmacotherapy","2014","PTSD","PTSD",,"100","A","33",,"Prazosin","Prazosin","Alpha-1 receptor blocker; titrated over 10 days, then maintained at 15 mg for duration of study","No",,"Yes","Antiadrenergic","No",,"No","No","No","No","No","Individual","In Person","15 mg; titration: increased from 1 mg to 15 mg over first 10 days",,"Once Daily","8",,,,,,,,,,,,,,"Not reported","Community","28%","Mixed","combat-related, accidents, natural or manmade disasters, other (not specified)","Low","Ahmadpanah M, Sabzeiee P, Hosseini SM, et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology. 2014 Jul;69(4):235-42. doi: 10.1159/000362243. PMID: 24993832.","43996","2019"
"ahmadpanah2014_B","ahmadpanah2014","Pharmacotherapy","2014","PTSD","PTSD",,"100","B","34",,"Hydroxyzine","Hydroxyzine","Histamine H-1 blocker; increased from 10 mg over first 10 days to 100 mg, maintained at 100 mg for duration of study","No",,"Yes","Antianxiety: nonbenzodiazepine","No",,"No","No","No","No","No","Individual","In Person","Initiated at 10 mg, increased to 100 mg",,"Daily","8",,,,,,,,,,,,,,"Not reported","Community","28%","Mixed","combat-related, accidents, natural or manmade disasters, other (not specified)","Low","Ahmadpanah M, Sabzeiee P, Hosseini SM, et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology. 2014 Jul;69(4):235-42. doi: 10.1159/000362243. PMID: 24993832.","43996","2019"
"ahmadpanah2014_C","ahmadpanah2014","Pharmacotherapy","2014","PTSD","Inactive Control",,"100","C","33",,"Placebo","Placebo","Identical shape and color to prazosin and hydroxyzine","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","8",,,,,,,,,,,,,,"Not reported","Community","28%","Mixed","combat-related, accidents, natural or manmade disasters, other (not specified)","Low","Ahmadpanah M, Sabzeiee P, Hosseini SM, et al. Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology. 2014 Jul;69(4):235-42. doi: 10.1159/000362243. PMID: 24993832.","43996","2019"
"akbarian2015_A","akbarian2015","Psychotherapy & pharmacotherapy","2015","PTSD","PTSD",,"40","A","20",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Group sessions of CBT for PTSD based on Clark and Beck's method; all patients also received ""SSRIs, neuroleptics, or benzodiazepines""","Yes","Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Group","In Person",,"60 to 90 minutes","Weekly","10",,"Completed intervention",,"Received allocated intervention (n=14) minus discontinued intervention (n=0)",,,,,,,,,,"Not reported","Community","78.57%","Mixed","intimate partner violence, accidents, illness/medical procedure","High","Akbarian F, Bajoghli H, Haghighi M, et al. The effectiveness of cognitive behavioral therapy with respect to psychological symptoms and recovering autobiographical memory in patients suffering from post-traumatic stress disorder. Neuropsychiatr Dis Treat. 2015;11:395-404. doi: 10.2147/NDT.S79581. PMID: 25737635.","43629","2019"
"akbarian2015_B","akbarian2015","Psychotherapy & pharmacotherapy","2015","PTSD","Active Control",,"40","B","20",,"Control condition (psychopharmacologic treatment only)","Medication as usual","All patients received ""SSRIs, neuroleptics, or benzodiazepines;"" control patients visited treatment center for medical and medication check","No",,"Yes","Other pharmacotherapy","No",,"No","No","Yes","No","No","Individual","In Person",,,"Weekly","10",,"Completed intervention",,"Received allocated intervention (n=14) minus discontinued intervention (n=0)",,,,,,,,,,"Not reported","Community","78.57%","Mixed","intimate partner violence, accidents, illness/medical procedure","High","Akbarian F, Bajoghli H, Haghighi M, et al. The effectiveness of cognitive behavioral therapy with respect to psychological symptoms and recovering autobiographical memory in patients suffering from post-traumatic stress disorder. Neuropsychiatr Dis Treat. 2015;11:395-404. doi: 10.2147/NDT.S79581. PMID: 25737635.","43629","2019"
"akuchekian2004_A","akuchekian2004","Pharmacotherapy","2004","PTSD","PTSD",,"67","A","34",,"Topiramate augmentation","Topiramate augmentation","Anticonvulsant drug; augmentation of participant's existing pharmacotherapy (such as neuroleptics, TCAs, benzodiazepines, SSRIs, sodium valproate, or carbamazepine)","No",,"Yes","Mood Stabilizer","No",,"No","No","No","No","No","Individual","In Person","12.5 to 500 mg; titration: 12.5 or 25 mg initial dose, increased in increments of 25 to 50 mg every 3 to 4 days until clinical response up to maximum dose of 500 mg",,"Daily","12",,,,,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"High","Akuchekian S, Amanat S. The Comparison of Topiramate and Placebo in the Treatment of Posttraumatic Stress Disorder: A Randomized, Double- Blind Study. J Res Med Sci. 2004;9(5):240-4.","50403","2019"
"akuchekian2004_B","akuchekian2004","Pharmacotherapy","2004","PTSD","Active Control",,"67","B","33",,"Placebo augmentation","Placebo augmentation","Identical in appearance to topiramate 50 mg form; augmentation of participant's existing pharmacotherapy (such as neuroleptics, tricyclic antidepressants, benzodiazepines, SSRIs, sodium valproate, or carbamazepine).","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","Titration details NR (Topiramate group started at 12.5 or 25 mg with maximum dose of 500 mg)",,"Daily","12",,,,,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"High","Akuchekian S, Amanat S. The Comparison of Topiramate and Placebo in the Treatment of Posttraumatic Stress Disorder: A Randomized, Double- Blind Study. J Res Med Sci. 2004;9(5):240-4.","50403","2019"
"aldahadha2012_A","aldahadha2012","Psychotherapy","2012","PTSD","PTSD",,"51","A","25",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Patient asked to focus on traumatic memory, then therapist queries for salient negative and positive cognitions related to the targeted memory while patients move his/her eyes to the therapist's index finger","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Once every 3 weeks","6 to 9","2 to 3 sessions total",,,,,,,,,,,,,"Not reported","Community","52.94%","Accidents",,"High","Aldahadha B, Al-Harthy H, Sulaiman S. The Efficacy of Eye Movement Desensitization Reprocessing in Resolving the Trauma Caused by the Road Accidents in the Sultanate of Oman. Journal of Instructional Psychology. 2012;39(3/4):146-58.","1548482","2019"
"aldahadha2012_B","aldahadha2012","Psychotherapy","2012","PTSD","Inactive Control",,"51","B","26",,"Waitlist","Waitlist","No EMDR training","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Not reported","Community","52.94%","Accidents",,"High","Aldahadha B, Al-Harthy H, Sulaiman S. The Efficacy of Eye Movement Desensitization Reprocessing in Resolving the Trauma Caused by the Road Accidents in the Sultanate of Oman. Journal of Instructional Psychology. 2012;39(3/4):146-58.","1548482","2019"
"alghamdi2015_A","alghamdi2015","Psychotherapy","2015","PTSD","PTSD",,"34","A","17",,"NET","Narrative Exposure Therapy (NET)","Patients narrate their biography and encouraged to relive their trauma-related emotions until habituation was achieved","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 to 90 minutes","Every 2-4 days","3",,"Treatment completion",,"""All participants completed the treatment.""",,,,,,,,,,"Not reported","Community","0%",,,"High","Alghamdi M, Hunt NC, Thomas SA. The effectiveness of narrative exposure therapy with traumatised firefighters in Saudi Arabia: a randomized controlled study. Behav Res Ther. 2015 Mar;66:64-71. doi: 10.1016/j.brat.2015.01.008. PMID: 25701801.","46524","2020"
"alghamdi2015_B","alghamdi2015","Psychotherapy","2015","PTSD","Inactive Control",,"34","B","17",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"3",,,,,,,,,,,,,,"Not reported","Community","0%",,,"High","Alghamdi M, Hunt NC, Thomas SA. The effectiveness of narrative exposure therapy with traumatised firefighters in Saudi Arabia: a randomized controlled study. Behav Res Ther. 2015 Mar;66:64-71. doi: 10.1016/j.brat.2015.01.008. PMID: 25701801.","46524","2020"
"allen2022_A","allen2022","Other study class","2022","PTSD","PTSD",,"49","A","25",,"Internet-based CBT","Internet-based facilitated self-help","Internet-based CBT program with minimal therapeutic contact, adapted from cognitive processing therapy and prolonged exposure therapy. Lesson content included psychoeducation, writing and reading a trauma narrative, situational exposure, and tools including controlled breathing and progressive muscle relaxation. Therapist contact included response via phone or email to patient request or to symptom deterioration (mean 38 minutes spent per patient over 10 weeks). Participants also received automated email reminders.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology assisted",,"3-4 hours per week (recommended)",,"10","6 lessons over 10 weeks","Completed all 6 lessons",,"14 participants out of 25 randomized (21 participants started treatment)",,,,,,"Number of sessions completed per participant provided in publication",,,,"Not reported","Community","90%","Mixed","Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Illness/medical procedure; Other (severe human suffering; witnessed violent death; unexpected loss of others; harm/injury to others; other stressor)","High","Allen AR, Smith J, Hobbs MJ, et al. Internet-delivered cognitive behaviour therapy for post-traumatic stress disorder: a randomised controlled trial and outcomes in routine care. Behav Cogn Psychother. 2022 Nov;50(6):649-55. doi: 10.1017/S1352465822000285. PMID: 35924312.","1603004","2024"
"allen2022_B","allen2022","Other study class","2022","PTSD","Inactive Control",,"49","B","24",,"Waitlist","Waitlist","Waitlist","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"10",,,,,,,,,,,,,,"Not reported","Community","90%","Mixed","Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Illness/medical procedure; Other (severe human suffering; witnessed violent death; unexpected loss of others; harm/injury to others; other stressor)","High","Allen AR, Smith J, Hobbs MJ, et al. Internet-delivered cognitive behaviour therapy for post-traumatic stress disorder: a randomised controlled trial and outcomes in routine care. Behav Cogn Psychother. 2022 Nov;50(6):649-55. doi: 10.1017/S1352465822000285. PMID: 35924312.","1603004","2024"
"alon2022_A","alon2022","Nonpharmacologic cognitive","2022","PTSD","PTSD",,"60","A","30",,"Attention control training","Attention bias modification (ABM)","Remotely delivered training balancing attention between threatening and neutral stimuli. Two images of faces presented, one with neutral and one with angry expression, with arrowhead pointing right (‘>’) or left (‘<’) by one of the faces until response. Arrowhead appeared next to each image with equal probability.","No",,"No",,"No",,"No","Yes","No","No","No","Individual","Technology assisted",,,"Twice weekly","4","Eight sessions over 4 weeks","Completed all sessions",,,,,,,,,,,,"Not reported","Community","33.3%","Mixed","Combat-related; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Terrorism/political violence/forced displacement","Low","Alon Y, Azriel O, Pine DS, et al. A randomized controlled trial of supervised remotely-delivered attention bias modification for posttraumatic stress disorder. Psychol Med. 2022 Feb 8:1-10. doi: 10.1017/S003329172200023X. PMID: 35132952.","1587317","2023"
"alon2022_B","alon2022","Nonpharmacologic cognitive","2022","PTSD","Active Control",,"60","B","30",,"Attention bias modification","Attention bias modification (ABM)","Remotely delivered training directing attention away from threatening stimulus. Two images of faces presented, one with neutral and one with angry expression, with arrowhead pointing from angry to neutral face.","No",,"No",,"No",,"No","Yes","Yes","No","No","Individual","Technology assisted",,,"Twice weekly","4","Eight sessions over 4 weeks","Completed all sessions",,,,,,,,,,,,"Not reported","Community","33.3%","Mixed","Combat-related; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Terrorism/political violence/forced displacement","Low","Alon Y, Azriel O, Pine DS, et al. A randomized controlled trial of supervised remotely-delivered attention bias modification for posttraumatic stress disorder. Psychol Med. 2022 Feb 8:1-10. doi: 10.1017/S003329172200023X. PMID: 35132952.","1587317","2023"
"alsheikhali2020_A","alsheikhali2020","Psychotherapy","2020","PTSD","PTSD",,"40","A","20",,"Group counseling","Non-trauma-focused counseling","Group counseling program consisting of four domains: alienation; loss and grief; hope and hopelessness; psychological problems. Sessions targeted these domains and used psycho-education techniques and teaching coping strategies.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,,"Twice a week","6","""program was implemented for 1.5 months, two sessions per week""",,,,,,,,,,,,,"Not reported","Community","100%","Terrorism/political violence/forced displacement",,"High","Alsheikh Ali ASS. Efficiency of Intervention Counseling Program on the Enhanced Psychological Well-being and Reduced Post-traumatic Stress Disorder Symptoms Among Syrian Women Refugee Survivors. Clin Pract Epidemiol Ment Health. 2020 Jul 30;16(Suppl-1):134-141. doi: 10.2174/1745017902016010134. PMID: 33029190; PMCID: PMC7536727.","1558371","2022"
"alsheikhali2020_B","alsheikhali2020","Psychotherapy","2020","PTSD","Inactive Control",,"40","B","20",,"No treatment","No treatment","No psychological support or psychiatric medications","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"6",,,,,,,,,,,,,,"Not reported","Community","100%","Terrorism/political violence/forced displacement",,"High","Alsheikh Ali ASS. Efficiency of Intervention Counseling Program on the Enhanced Psychological Well-being and Reduced Post-traumatic Stress Disorder Symptoms Among Syrian Women Refugee Survivors. Clin Pract Epidemiol Ment Health. 2020 Jul 30;16(Suppl-1):134-141. doi: 10.2174/1745017902016010134. PMID: 33029190; PMCID: PMC7536727.","1558371","2022"
"angelakis2020_A","angelakis2020","Psychotherapy","2020","PTSD","Active Control",,"52","A","18",,"Cogntive Processing Therapy","Cognitive Processing Therapy (CPT)","Manualized therapy using 12-session protocol focused on teaching skills to identify and challenge trauma-related beliefs; up to 3 additional sessions offered based on clinical need to address residual symptoms.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"60 minutes",,,"12-15 sessions total","≥12 sessions attended",,,,,,"7.5","6.38",,,,,"Race data reported","Community","92%","Mixed","Accidents; Child physical abuse; Child sexual abuse; Rape/sexual assault; Community/school violence; Natural or manmade disasters; Terrorism/political violence/forced displacement; Other (traumatic loss)","Low","Angelakis S, Weber N, Nixon RDV. Comorbid posttraumatic stress disorder and major depressive disorder: The usefulness of a sequential treatment approach within a randomised design. J Anxiety Disord. 2020 Dec;76:102324. doi: 10.1016/j.janxdis.2020.102324. Epub 2020 Oct 20. PMID: 33137600.","1560706","2022"
"angelakis2020_B","angelakis2020","Psychotherapy","2020","PTSD","PTSD",,"52","B","17","18 allocated, 1 ""withdrawn due to medication status""","Behavioral Activation/Cognitive Processing Therapy","Behavioral activation (BA) followed by Cognitive Processing Therapy (CPT)","BA (5 sessions) followed by CPT (10 sessions). BA: manualized therapy for depression ""focused on the link between behavior and mood and involved psychoeducation, activity monitoring, and scheduling of mastery and pleasure tasks""; CPT: manualized therapy focused on teaching skills to identify and challenge trauma-related beliefs, content delivery was modified to fit content of 12-session protocol into 10 sessions.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60-90 minutes",,,"15 sessions total; 10 sessions CPT (12 hours total) + 5 sessions BA (5 hours total)","≥12 sessions attended",,,,,,"8.06","6.63",,,,,"Race data reported","Community","92%","Mixed","Accidents; Child physical abuse; Child sexual abuse; Rape/sexual assault; Community/school violence; Natural or manmade disasters; Terrorism/political violence/forced displacement; Other (traumatic loss)","Low","Angelakis S, Weber N, Nixon RDV. Comorbid posttraumatic stress disorder and major depressive disorder: The usefulness of a sequential treatment approach within a randomised design. J Anxiety Disord. 2020 Dec;76:102324. doi: 10.1016/j.janxdis.2020.102324. Epub 2020 Oct 20. PMID: 33137600.","1560706","2022"
"angelakis2020_C","angelakis2020","Psychotherapy","2020","PTSD","PTSD",,"52","C","17",,"Cognitive Processing Therapy/Behavioral Activation","Cognitive Processing Therapy (CPT) followed by Behavioral activation (BA)","CPT (10 sessions) followed by BA (5 sessions). Same content as arm B, in reverse order. CPT: manualized therapy focused on teaching skills to identify and challenge trauma-related beliefs, content delivery was modified to fit content of 12-session protocol into 10 sessions; BA: manualized therapy for depression ""focused on the link between behavior and mood and involved psychoeducation, activity monitoring, and scheduling of mastery and pleasure tasks"".","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60-90 minutes",,,"15 sessions total; 5 sessions BA (5 hours total) + 10 sessions CPT (12 hours total)","≥12 sessions attended",,,,,,"11.47","6.03",,,,,"Race data reported","Community","92%","Mixed","Accidents; Child physical abuse; Child sexual abuse; Rape/sexual assault; Community/school violence; Natural or manmade disasters; Terrorism/political violence/forced displacement; Other (traumatic loss)","Low","Angelakis S, Weber N, Nixon RDV. Comorbid posttraumatic stress disorder and major depressive disorder: The usefulness of a sequential treatment approach within a randomised design. J Anxiety Disord. 2020 Dec;76:102324. doi: 10.1016/j.janxdis.2020.102324. Epub 2020 Oct 20. PMID: 33137600.","1560706","2022"
"ardani2017_A","ardani2017","Pharmacotherapy","2017","PTSD","PTSD",,"36","A","12",,"Rivastigmine augmentation","Rivastigmine augmentation","Acetylcholinesterase inhibitor; augmentation of treatment with citalopram and valproate; randomized following 4-week run-in with citalopram and valproate; rivastigmine 3 mg (total daily dose) for 4 weeks then 6 mg (total daily dose) for 8 weeks.","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","3 mg (total daily dose 6 mg); titration: 1.5 mg for 4 weeks (total daily dose 3 mg) then 3 mg for 8 weeks (total daily dose 6 mg)",,"Twice Daily","12",,,,,"used ""Standard compliance checklist""",,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"Some Concerns","Ardani AR, Hosseini G, Bordbar MRF, et al. Effect of rivastigmine augmentation in treatment of male patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Clin Psychopharmacol. 2017 Feb;37(1):54-60. doi: 10.1097/jcp.0000000000000624. PMID: 27930500.","47465","2019"
"ardani2017_B","ardani2017","Pharmacotherapy","2017","PTSD","Active Control",,"36","B","12",,"Placebo augmentation","Placebo augmentation","Placebo identical to rivastigmine; after 4-week run-in with citalopram and valproate, randomized to placebo for 8 weeks in addition to treatment with citalopram and valproate.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"12",,,,,"used ""Standard compliance checklist""",,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"Some Concerns","Ardani AR, Hosseini G, Bordbar MRF, et al. Effect of rivastigmine augmentation in treatment of male patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Clin Psychopharmacol. 2017 Feb;37(1):54-60. doi: 10.1097/jcp.0000000000000624. PMID: 27930500.","47465","2019"
"ardani2017_C","ardani2017","Pharmacotherapy","2017","PTSD","Active Control",,"36","C","12",,"TAU","Treatment as usual (TAU)","After 4-week run-in with citalopram and valproate, randomized to no additional medications for 8 weeks, and continued routine medications (citalopram and valproate as established in run-in).","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"12",,,,,"used ""Standard compliance checklist""",,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"Some Concerns","Ardani AR, Hosseini G, Bordbar MRF, et al. Effect of rivastigmine augmentation in treatment of male patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Clin Psychopharmacol. 2017 Feb;37(1):54-60. doi: 10.1097/jcp.0000000000000624. PMID: 27930500.","47465","2019"
"arntz2007_A","arntz2007","Psychotherapy","2007","PTSD","PTSD",,"67","A","28",,"Imaginal Exposure + Imagery Rescripting","Imaginal exposure + imagery rescripting","Imaginal exposure portion based on program by Foa & Rothbaum (1989) with 60 minutes of imagery work each session; 3 sessions of imaginal exposure only, then 6 sessions focused on identifying and imagining reacting as they wished they had done, until a satisfying response could be used repetitively in imagery.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","10",,"completed ≥8 sessions",,,,,,,,,,,,"Not reported","Community","65.67%","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)","High","Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. J Behav Ther Exp Psychiatry. 2007 Dec;38(4):345-70. doi: 10.1016/j.jbtep.2007.10.006. PMID: 18005935.","30284","2019"
"arntz2007_B","arntz2007","Psychotherapy","2007","PTSD","Active Control",,"67","B","39",,"IE","Imaginal exposure","Based on the program by Foa & Rothbaum (1989) with 60 minutes of imagery exposure, but no in vivo exposure. Homework to listen to audiotaped exposure session 5 days per week and complete Standard Homework Diary Forms, which were reviewed at each therapy session.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Weekly","10",,"completed ≥8 sessions",,,,,,,,,,,,"Not reported","Community","65.67%","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)","High","Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. J Behav Ther Exp Psychiatry. 2007 Dec;38(4):345-70. doi: 10.1016/j.jbtep.2007.10.006. PMID: 18005935.","30284","2019"
"arntz2007_C","arntz2007","Psychotherapy","2007","PTSD","Inactive Control",,"67","C","21",,"Waitlist","Waitlist","Waitlist group created when waiting time to treatment increased ""to about 3 months"" at which time participants were informed they would start treatment after waiting period.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"10 to 15",,"completed treatment course",,,,,,,,,,,,"Not reported","Community","65.67%","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing trauma of others, unspecified childhood trauma)","High","Arntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. J Behav Ther Exp Psychiatry. 2007 Dec;38(4):345-70. doi: 10.1016/j.jbtep.2007.10.006. PMID: 18005935.","30284","2019"
"astillwright2023_A","astillwright2023","Psychotherapy","2023","PTSD","PTSD",,"40","A","20",,"Rewind psychotherapy protocol","Trauma-focused psychotherapy","Trauma-focused protocol targeting reconsolidation of traumatic memories; ""employs a 'rewinding' technique - where the participant imagines that they are in a cinema watching a film of her/his traumatic event, the participant then enters the screen and relives their trauma memory in reverse very quickly. It is theorised that this rewinding may utilise mechanisms such as exposure, extinction, and reconsolidation to alleviate PTSD symptoms""","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Video",,"60 minutes",,"8","Up to 3 sessions over 8 weeks, specific timing NR","Treatment completion",,"Not further described",,,,,,"Provided only for combined arms after waitlist received intervention",,,,"Race data reported","Community","57.5%","Mixed","Rape/sexual assault; Illness/medical procedure; Accidents; Community/school violence; Combat-related; Child physical abuse; Other (""serious injury, harm, or death you caused to someone else""; ""severe human suffering"", ""sudden violent death"", ""any other very stressful event or experience"")","High","Astill Wright L, Barawi K, Kitchiner N, et al. Rewind for posttraumatic stress disorder: a randomised controlled trial. Depress Anxiety. 2023;2023, Article ID 6279649:1-11. doi: 10.1155/2023/6279649.","1643768","2024"
"astillwright2023_B","astillwright2023","Psychotherapy","2023","PTSD","Inactive Control",,"40","B","20",,"Waitlist","Waitlist","Waitlist","No",,"No",,"No",,"No","No","Yes","No","No","Individual",,,,,"8",,,,,,,,,,,,,,"Race data reported","Community","57.5%","Mixed","Rape/sexual assault; Illness/medical procedure; Accidents; Community/school violence; Combat-related; Child physical abuse; Other (""serious injury, harm, or death you caused to someone else""; ""severe human suffering"", ""sudden violent death"", ""any other very stressful event or experience"")","High","Astill Wright L, Barawi K, Kitchiner N, et al. Rewind for posttraumatic stress disorder: a randomised controlled trial. Depress Anxiety. 2023;2023, Article ID 6279649:1-11. doi: 10.1155/2023/6279649.","1643768","2024"
"asukai2010_A","asukai2010","Psychotherapy","2010","PTSD","PTSD",,"24","A","12",,"PE + TAU","Prolonged Exposure (PE)","PE: manualized therapy consisting of psychoeducation, breathing retraining, in vivo exposure, imagery exposure, and processing; 2 introductory sessions and imagery exposure and processing during remaining sessions (6 to maximum of 13 sessions).







TAU: participants continued any treatment received before the study, including supportive counseling and medication; patients were asked to not change medication or dosages for duration of treatment.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","8 to 15",,,,,,,,,,,,,,"Not reported","Community","87.5%","Mixed","rape/sexual assault, accidents, community/school violence","Some Concerns","Asukai N, Saito A, Tsuruta N, et al. Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events: A randomized controlled study. J Trauma Stress. 2010 Dec;23(6):744-50. doi: 10.1002/jts.20589. PMID: 21171135.","84311","2019"
"asukai2010_B","asukai2010","Psychotherapy","2010","PTSD","Inactive Control",,"24","B","12",,"TAU","Treatment as usual (TAU)","TAU while on waitlist; continuation of any treatment received before the study, including supportive counseling and medication; patients were asked to not change medication or dosages for duration of treatment","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"10",,"completed treatment course",,,,,,,,,,,,"Not reported","Community","87.5%","Mixed","rape/sexual assault, accidents, community/school violence","Some Concerns","Asukai N, Saito A, Tsuruta N, et al. Efficacy of exposure therapy for Japanese patients with posttraumatic stress disorder due to mixed traumatic events: A randomized controlled study. J Trauma Stress. 2010 Dec;23(6):744-50. doi: 10.1002/jts.20589. PMID: 21171135.","84311","2019"
"back2019_A","back2019","Psychotherapy","2019","PTSD+SUD","PTSD+SUD","Integrated","81","A","54",,"COPE","Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE)","Integrates Prolonged Exposure and CBT for SUD; sessions include psychoeducation, in vivo exposure and imaginal exposure; abstinence is not required to participate but is strongly encouraged.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes",,"12","total 12 sessions; frequency and duration not stated specifically but end of treatment assessments done at week 12","attended 12 sessions",,,,,,"8.8","4.1",,,,,"Race and Ethnicity data reported","Veteran","9.1%","Mixed","Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)","High","Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.","51384","2020"
"back2019_B","back2019","Psychotherapy","2019","PTSD+SUD","Active Control","Not integrated","81","B","27",,"Relapse Prevention","Relapse Prevention","Manualized evidence-based treatment; ""teaches skills to help manage cravings and high-risk situations that commonly precipitate substance use.""","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes",,"12","total 12 sessions; frequency and duration not stated specifically but end of treatment assessments done at week 12","attended 12 sessions",,,,,,"7.4","5",,,,,"Race and Ethnicity data reported","Veteran","9.1%","Mixed","Combat-related, Rape/sexual assault, Accidents, Community/school violence, Natural or manmade disasters, Terrorism/policital violence/forced displacement; Other (physical assault, assault with a weapon, unwanted or uncomfortable sexual experience, captivity, severe human suffering, sudden violent death of someone close, sudden unexpected death of someone close, other very stressful event or experience)","High","Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019 Mar;90:369-77. doi: 10.1016/j.addbeh.2018.11.032. PMID: 30529244.","51384","2020"
"back2023_A","back2023","Pharmacotherapy","2023","PTSD+SUD","PTSD+SUD","Not integrated","141","A","70",,"Doxazosin","Doxazosin","Doxazosin immediate-release capsules formulated with 25 mg riboflavin to monitor adherence.","No",,"Yes","Antiadrenergic","No",,"No","No","No","No","No","Individual","In Person","16 mg; Titration: initiated at 1 mg/day and dose doubled every week (2 mg at week 2, 4 mg at week 3, 8 mg at week 4, 16 mg during weeks 5-12). Downward titration at the end of week 12: 8 mg on day 1, 6 mg on day 2, 4 mg on day 3, 2 mg on day 4, and 1 mg on day 5",,"Daily","12","Not counting downward titration after 12 weeks",,,,"Urine riboflavin level >900 ng/mL",,"75.5% (n/N NR, data missing for 9) with no difference between medication groups",,,,,,"overall 87.9% reached full dose of 16 mg, with no signficant differences by group","Race and Ethnicity data reported","Veteran","15.6%",,,"Some Concerns","Back S, Flanagan J, Mintz J, et al. A double-blind randomized controlled trial of doxazosin for co-occurring PTSD and alcohol use disorder in veterans. J Clin Psychiatry. 2023 Mar;84(2):21m14367. doi: 10.4088/JCP.21m14367. PMID: 36883885.","1617794","2024"
"back2023_B","back2023","Pharmacotherapy","2023","PTSD+SUD","Inactive Control",,"141","B","71",,"Placebo","Placebo","Capsules color-matched, opaque, and identically sized compared with doxazosin capsules.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","matched to active (doxasozin)",,"Daily","12","Not counting downward titration after 12 weeks",,,,"Urine riboflavin level >900 ng/mL",,"75.5% (n/N NR, data missing for 9) with no difference between medication groups",,,,,,"overall 87.9% reached full dose of 16 mg, with no signficant differences by group","Race and Ethnicity data reported","Veteran","15.6%",,,"Some Concerns","Back S, Flanagan J, Mintz J, et al. A double-blind randomized controlled trial of doxazosin for co-occurring PTSD and alcohol use disorder in veterans. J Clin Psychiatry. 2023 Mar;84(2):21m14367. doi: 10.4088/JCP.21m14367. PMID: 36883885.","1617794","2024"
"badurabrack2015a_A","badurabrack2015a","Nonpharmacologic cognitive","2015","PTSD","PTSD",,"52","A","27",,"Attention Bias Modification","Attention bias modification (ABM)","Computerized cognitive training strategies to alter biases in attention. Intervention utilized the dot-probe task to train attention bias away from threat","No",,"No",,"No",,"No","Yes","No","No","No","Individual","In Person",,"Each session consisted of 160 trials with 500 millisecond centrally-presented fixation cross, then replaced by a pair of words presented for 500 millisecond","Weekly","4",,"Did not discontinue training",,,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"Some Concerns","Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.","44617","2019"
"badurabrack2015a_B","badurabrack2015a","Nonpharmacologic cognitive","2015","PTSD","PTSD",,"52","B","25",,"Attention Control Training","Attention bias modification (ABM)","Repeated trials train patients to normalize fluctuations in threat-related attention bias","No",,"No",,"No",,"No","Yes","No","No","No","Individual","In Person",,"Each session consisted of 160 trials with 500 millisecond centrally-presented fixation cross, then replaced by a pair of words presented for 500 millisecond","Weekly","4",,"Did not discontinue training",,,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"Some Concerns","Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.","44617","2019"
"badurabrack2015b_A","badurabrack2015b","Nonpharmacologic cognitive","2015","PTSD","PTSD",,"46","A","22",,"Attention Bias Modification","Attention bias modification (ABM)","Computerized cognitive training strategies to alter biases in attention. Intervention utilized the dot-probe task with pairs of angry and neutral faces to train attention bias away from threat","No",,"No",,"No",,"No","Yes","No","No","No","Individual","In Person",,"Each session consisted of 120 trials with 500 millisecond centrally-presented fixation cross, followed by a face pair display for 500 millisecond","Twice weekly","4",,"Did not discontinue training",,,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"High","Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.","44617","2019"
"badurabrack2015b_B","badurabrack2015b","Nonpharmacologic cognitive","2015","PTSD","PTSD",,"46","B","24",,"Attention Control Training","Attention bias modification (ABM)","Repeated trials train patients to normalize fluctuations in threat-related attention bias","No",,"No",,"No",,"No","Yes","No","No","No","Individual","In Person",,"Each session consisted of 120 trials with 500 millisecond centrally-presented fixation cross, followed by a face pair display for 500 millisecond","Twice weekly","4",,"Did not discontinue training",,,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"High","Badura-Brack AS, Naim R, Ryan TJ, et al. Effect of attention training on attention bias variability and PTSD symptoms: randomized controlled trials in Israeli and U.S. combat veterans. Am J Psychiatry. 2015 Dec;172(12):1233-41. doi: 10.1176/appi.ajp.2015.14121578. PMID: 26206075.","44617","2019"
"baekkelund2021_A","baekkelund2021","Psychotherapy","2021","PTSD","PTSD",,"89","A","44",,"Stabilization group treatment","Skill building group","Manualized group treatment focused on psychoeducation and skill-building, to enable patients to cope with PTSD symptoms, strengthen emotional regulation, and improve interpersonal functioning. Each group included 9 participants and 2 therapists. Sessions included exercises, such as grounding, relaxation, or mindfulness. Homework between sessions. All patients also received adjunctive conventional individual treatment; individual treatment determined by therapist, not protocolled.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"90 minutes","Weekly","20","20 sessions total","Did not drop out",,,,,,,,,,,,"Not reported","Community","84.3%","Mixed","Child physical abuse; Child sexual abuse; Child other abuse","High","Baekkelund H, Karlsrud I, Hoffart A, et al. Stabilizing group treatment for childhood-abuse related PTSD: a randomized controlled trial. Eur J Psychotraumatol. 2021 Jan 22;12(1):1859079. doi: 10.1080/20008198.2020.1859079. PMID: 33537118.","1564973","2022"
"baekkelund2021_B","baekkelund2021","Psychotherapy","2021","PTSD","Active Control",,"89","B","45",,"Individual therapy only","Supportive counseling","All patients received adjunctive conventional individual treatment during the waiting period; individual treatment determined by therapist, not protocolled.. All patients in the control group were offered the experimental group treatment after the waiting period.","No",,"No",,"No",,"No","No","Yes","No","No",,"In Person",,,,"20","Duration of waiting period","Did not drop out (during waiting period)",,,,,,,,,,,,"Not reported","Community","84.3%","Mixed","Child physical abuse; Child sexual abuse; Child other abuse","High","Baekkelund H, Karlsrud I, Hoffart A, et al. Stabilizing group treatment for childhood-abuse related PTSD: a randomized controlled trial. Eur J Psychotraumatol. 2021 Jan 22;12(1):1859079. doi: 10.1080/20008198.2020.1859079. PMID: 33537118.","1564973","2022"
"baig2022_A","baig2022","Psychotherapy & pharmacotherapy","2022","PTSD","PTSD",,"20","A","10",,"Quetiapine + PE","Prolonged Exposure (PE) + quetiapine","Quetiapine monotherapy in addition to weekly PE therapy delivered as a standard of care in ten manualized 90-minute sessions following the model by Foa et al.  2-week dose reduction of current psychotropic medications followed by titration with flexible dosing of quetiapine starting at 25 mg and titrated up to 200 mg daily based on tolerability; quetiapine stabilization period of 2 weeks prior to starting PE therapy, with dose maintained throughout PE.","Yes","Trauma-focused","Yes","Antipsychotic","No",,"No","No","No","No","No","Individual","In Person","25 to 200 mg (flexible dosing starting at 25 mg and titrated up to 200 mg daily based on tolerability)","90 minutes","Quetiapine: daily

PE: Weekly","12","10 session weekly PE was preceded by 2 week run-in of pharmacotherapy","Completed until session 10 or therapist reported that patient completed treatment",,,,,,"8.7",,,,,,"Race and Ethnicity data reported","Veteran","5%","Combat-related",,"High","Baig MR, Wilson JL, Beck RD, et al. Quetiapine as an adjunct to enhance engagement in prolonged exposure therapy for PTSD in veterans: A randomized, pilot trial. Journal of Behavioral and Cognitive Therapy. 2022 doi: 10.1016/j.jbct.2022.04.001.","1620166","2023"
"baig2022_B","baig2022","Psychotherapy & pharmacotherapy","2022","PTSD","Active Control",,"20","B","10",,"TAU + PE","Prolonged Exposure (PE)","TAU medication management in addition to weekly PE therapy delivered as a standard of care in ten manualized 90-minute sessions following the model by Foa et al. TAU stabilized for 2-week period prior to starting PE, and maintained throughout PE.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Weekly","12","10 session weekly PE was preceded by 2 week run-in of TAU","Completed until session 10 or therapist reported that patient completed treatment",,,,,,"4.2",,,,,,"Race and Ethnicity data reported","Veteran","5%","Combat-related",,"High","Baig MR, Wilson JL, Beck RD, et al. Quetiapine as an adjunct to enhance engagement in prolonged exposure therapy for PTSD in veterans: A randomized, pilot trial. Journal of Behavioral and Cognitive Therapy. 2022 doi: 10.1016/j.jbct.2022.04.001.","1620166","2023"
"baker1995_A","baker1995","Pharmacotherapy","1995","PTSD","PTSD",,"118","A","56",,"Brofaromine","Brofaromine","Reversible MAOI with SSRI activity; flexible dose with titration","No",,"Yes","Antidepressant: MAOI","No",,"No","No","No","No","No","Individual","In Person","150 mg; flexible dosing, titration: starting dose NR, titrated up to 150 mg",,,"12",,,,,,,,,,,,,,"Not reported","Mixed","19.3%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)","High","Baker DG, Diamond BI, Gillette GM, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec;122(4):386-9. doi: 10.1007/BF02246271. PMID: 8657838.","06773","2019"
"baker1995_B","baker1995","Pharmacotherapy","1995","PTSD","Inactive Control",,"118","B","58",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"12",,,,,,,,,,,,,,"Not reported","Mixed","19.3%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)","High","Baker DG, Diamond BI, Gillette GM, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec;122(4):386-9. doi: 10.1007/BF02246271. PMID: 8657838.","06773","2019"
"baniasadi2014_A","baniasadi2014","Pharmacotherapy","2014","PTSD","PTSD",,"37","A","18",,"Pregabalin augmentation","Pregabalin","Anticonvulsant; augmentation of standard medications of SSRIs (citalopram 20 to 40 mg per day or sertraline 50 to 200 mg per day) and sodium valproate (1000 to 1800 mg per day)","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","150 mg (total daily dose 300 mg); titration: 75 mg per day for one week, then 75 mg twice daily for one week, then 150 mg twice daily",,"Twice Daily","6",,,,,"monitored using a compliance checkllist",,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"Some Concerns","Baniasadi M, Hosseini G, Fayyazi Bordbar MR, et al. Effect of pregabalin augmentation in treatment of patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Psychiatr Pract. 2014 Nov;20(6):419-27. doi: 10.1097/01.pra.0000456590.12998.41. PMID: 25406046.","44618","2019"
"baniasadi2014_B","baniasadi2014","Pharmacotherapy","2014","PTSD","Active Control",,"37","B","19",,"Placebo augmentation","Placebo augmentation","Placebo augmentation of standard medications of SSRIs (citalopram 20 to 40 mg per day or sertraline 50 to 200 mg per day) and sodium valproate (1000 to 1800 mg per day)","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"6",,,,,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"Some Concerns","Baniasadi M, Hosseini G, Fayyazi Bordbar MR, et al. Effect of pregabalin augmentation in treatment of patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Psychiatr Pract. 2014 Nov;20(6):419-27. doi: 10.1097/01.pra.0000456590.12998.41. PMID: 25406046.","44618","2019"
"basoglu2005_A","basoglu2005","Psychotherapy","2005","PTSD","PTSD",,"59","A","31",,"Modified behavioral treatment","Trauma-focused cognitive behavioral therapy (TF-CBT)","Shorter version of CBT with cognitive intervention limited to explanation of treatment rationale, focusing on reduction of fear and avoidance, and shifting focus from habituation to anxiogenic stimuli to enhancement of sense of control over traumatic stressor","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Once","0.14","Single session","See Detail",,"Unclear if dropout reported is from treatment or from measurement",,,,,,,,,,"Not reported","Community","84.75%","Natural or manmade disasters",,"Low","Basoglu M, Salcioglu E, Livanou M, et al. Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: a randomized waiting list controlled trial. J Trauma Stress. 2005;18(1):1-11. doi: 10.1002/jts.20011. PMID: 16281190.","18886","2019"
"basoglu2005_B","basoglu2005","Psychotherapy","2005","PTSD","Inactive Control",,"59","B","28",,"Waitlist","Waitlist","Participants completed a 6-week waiting period then were re-assessed","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"6",,,,,,,,,,,,,,"Not reported","Community","84.75%","Natural or manmade disasters",,"Low","Basoglu M, Salcioglu E, Livanou M, et al. Single-session behavioral treatment of earthquake-related posttraumatic stress disorder: a randomized waiting list controlled trial. J Trauma Stress. 2005;18(1):1-11. doi: 10.1002/jts.20011. PMID: 16281190.","18886","2019"
"basoglu2007_A","basoglu2007","Psychotherapy","2007","PTSD","PTSD",,"31","A","16",,"Behavioral treatment","Exposure therapy","Treatment rationale, treatment target setting, and self-exposure instructions provided in first session. Then patients were exposed to simulated earthquake tremors with ability to control intensity, and instructed to confront their fear until they felt in control","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 for first session, variable for simulation (mean 33 minutes, SD 18)","Once","0.14","Single session","See Detail",,"Unclear if dropout reported is from treatment or from measurement",,,,,,,,,,"Not reported","Community","87.1%","Natural or manmade disasters",,"High","Basoglu M, Salcioglu E, Livanou M. A randomized controlled study of single-session behavioural treatment of earthquake-related post-traumatic stress disorder using an earthquake simulator. Psychological Medicine. 2007;37(2):203-13. doi: 10.1017/S0033291706009123. PMID: 17254365.","29446","2020"
"basoglu2007_B","basoglu2007","Psychotherapy","2007","PTSD","Inactive Control",,"31","B","15",,"Repeated assessment","Waitlist","Participants assessed at week 4 and 8 after randomization, then received treatment","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"8",,,,,,,,,,,,,,"Not reported","Community","87.1%","Natural or manmade disasters",,"High","Basoglu M, Salcioglu E, Livanou M. A randomized controlled study of single-session behavioural treatment of earthquake-related post-traumatic stress disorder using an earthquake simulator. Psychological Medicine. 2007;37(2):203-13. doi: 10.1017/S0033291706009123. PMID: 17254365.","29446","2020"
"batki2014_A","batki2014","Pharmacotherapy","2014","PTSD+SUD","PTSD+SUD","Not integrated","30","A","14",,"Topiramate","Topiramate","Anticonvulsant medication + weekly medication management manualized counseling to promote adherence and reduce alcohol use","No",,"Yes","Mood stabilizer","No",,"No","No","No","No","No","Individual","In Person","25 to 300 mg per day flexible dosing determined by tolerability; titration schedule: 25 mg/day for 1 week, increased to 50 mg/day in week 2, then increased in 50 mg/day increments each week to maximum of 300 mg/day in week 6, final dose maintained weeks 6 through 11, then tapered and discontinued in week 12.",,"Daily in divided doses","12",,,,,"Self-report and pill count, medication adherence rate calculated as total dose reported taken/total dose prescribed x 100",,"mean medication adherence rate 63.1% (SD 20.3%)",,,,"286 mg","20 mg",,"Race and Ethnicity data reported","Veteran","6.67%","Mixed","combat-related, other (""civilian related trauma"")","Some Concerns","Batki SL, Pennington DL, Lasher B, et al. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial. Alcohol Clin Exp Res. 2014 Aug;38(8):2169-77. doi: 10.1111/acer.12496. PMID: 25092377.","42646","2020"
"batki2014_B","batki2014","Pharmacotherapy","2014","PTSD+SUD","Inactive Control","Not integrated","30","B","16",,"Placebo","Placebo","Placebo identical to topiramate","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","dose as topiramate-equivalent; 25 to 300 mg per day flexible dosing determined by tolerability; titration schedule: 25 mg/day for 1 week, increased to 50 mg/day in week 2, then increased in 50 mg/day increments each week to maximum of 300 mg/day in week 6, final dose maintained weeks 6 through 11, then tapered and discontinued in week 12.",,"Daily in divided doses","12",,,,,"Self-report and pill count, medication adherence rate calculated as total dose reported taken/total dose prescribed x 100",,"mean medication adherence rate 60.2% (SD 21.5%)",,,,"281 mg","45 mg",,"Race and Ethnicity data reported","Veteran","6.67%","Mixed","combat-related, other (""civilian related trauma"")","Some Concerns","Batki SL, Pennington DL, Lasher B, et al. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial. Alcohol Clin Exp Res. 2014 Aug;38(8):2169-77. doi: 10.1111/acer.12496. PMID: 25092377.","42646","2020"
"battaglia2016_A","battaglia2016","Other study class","2016","PTSD+SUD","PTSD+SUD","Not integrated","175","A","89",,"MI for smoking cessation + PTSD home telehealth care management program","Internet-based facilitated self-help","MI-based written smoking cessation curricula on home telehealth Health Buddy computer program and weekly telephone smoking cessation MI counseling by a nurse in addition to PTSD home telehealth care management program and nurse care manager. Mi-based smoking cessation curricula used MI material. A participant's response to a question dictated a different reply based on his or her stage of change. Nurse care managers used responses to promote identified health behavior change, and participants acquire a positive behavior (tobacco cessation)","No",,"No",,"No",,"No","No","No","Yes","Yes","Individual","Mixed",,"PTSD Health Buddy: 2 minutes;



MI counseling sessions: NR (average duration of call: 16.7 minutes)","PTSD Health Buddy: daily; MI counseling sessions: weekly","12",,"See Detail",,"n=87 described for mean number and duration of MI counseling calls, but treatment completion not defined; study/assessment completion reported",,,,,,"MI counseling sessions: 12.3 (5.5)",,,,"Race data reported","Veteran","13.71%",,,"High","Battaglia C, Peterson J, Whitfield E, et al. Integrating motivational interviewing into a home telehealth program for veterans with posttraumatic stress disorder who smoke: a randomized controlled trial. J Clin Psychol. 2016 Mar;72(3):194-206. doi: 10.1002/jclp.22252. PMID: 26783736.","49060","2020"
"battaglia2016_B","battaglia2016","Other study class","2016","PTSD+SUD","Active Control","Not integrated","175","B","86",,"PTSD home telehealth care management program","Internet-based facilitated self-help","PTSD home telehealth care management services with a device called the Health Buddy, designed to help those with PTSD self-monitor and self-manage. This computer-like device is 12x8x4 inches with a LCD screen. Patient read information and four large buttons for responding to questions. Patient responses transmitted overnight to a secure data center and the next day's curriculum was downloaded to device. Control nurse care managers read patients responses daily, monitored changes in health status, placed outreach phone calls to patients with urgent needs, and coordinated care with primary medical and/or mental health providers.","No",,"No",,"No",,"No","No","Yes","Yes","No","Individual","Technology assisted",,"PTSD Health Buddy sessions: 2 minutes","Daily","12","90 sessions",,,,,,,,,,,,,"Race data reported","Veteran","13.71%",,,"High","Battaglia C, Peterson J, Whitfield E, et al. Integrating motivational interviewing into a home telehealth program for veterans with posttraumatic stress disorder who smoke: a randomized controlled trial. J Clin Psychol. 2016 Mar;72(3):194-206. doi: 10.1002/jclp.22252. PMID: 26783736.","49060","2020"
"battersby2013_A","battersby2013","Collaborative care","2013","PTSD","PTSD",,"82","A","46",,"Flinders Program + Usual Care","Collaborative care","Multicomponent intervention consisting of Flinders Program, usual care, self-help materials, and optional participation in the Stanford Chronic Disease Self-Management group program.","No",,"No",,"No",,"No","No","No","No","Yes","Individual","Mixed",,,"Varied (RN visits at 1, 3, 6, 9 months with phone calls at 4.5 and 7.5 months; standard group weekly over 2.5 hours for 6 weeks)","36",,"completed intervention",,,,,,,,,,,,"Not reported","Veteran",,,,"High","Battersby MW, Beattie J, Pols RG, et al. A randomised controlled trial of the Flinders Program™ of chronic condition management in Vietnam veterans with co-morbid alcohol misuse, and psychiatric and medical conditions. Aust N Z J Psychiatry. 2013 May;47(5):451-62. doi: 10.1177/0004867412471977. PMID: 23307806.","1587974","2020"
"battersby2013_B","battersby2013","Collaborative care","2013","PTSD","Inactive Control",,"82","B","31",,"Usual care","Treatment as usual (TAU)","Services available included ""crisis intervention, alcohol-related education and counselling, pharmacological interventions, and cognitive behavioural and group pro- grams.""","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"36",,"completed per protocol",,,,,,,,,,,,"Not reported","Veteran",,,,"High","Battersby MW, Beattie J, Pols RG, et al. A randomised controlled trial of the Flinders Program™ of chronic condition management in Vietnam veterans with co-morbid alcohol misuse, and psychiatric and medical conditions. Aust N Z J Psychiatry. 2013 May;47(5):451-62. doi: 10.1177/0004867412471977. PMID: 23307806.","1587974","2020"
"beck2009_A","beck2009","Psychotherapy","2009","PTSD","PTSD",,"44","A","26",,"Group CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Based on Blanchard and Hickling's individual CBT with modifications: treatment extended; detailed manual developed to standardize treatment; imaginal exposure assigned as homework and exposure to target trauma (MVA) conducted in writing; emphasis placed on teaching the principles of extinction to facilitate exposure during homework; treatment delivered by two therapists. Included: psychoeducation; exposure; mindfulness meditation; progressive muscle relaxation; cognitive therapy interventions and assertion training; behavioral activation; and, relapse prevention training.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"2 hours","Weekly","14",,"attended ≥75% of sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Community","81.82%","Accidents",,"High","Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.","32054","2019"
"beck2009_B","beck2009","Psychotherapy","2009","PTSD","Inactive Control",,"44","B","18",,"Minimum contact","Minimal attention","Telephone contact by project coordinator using structured script to assess PTSD symptomatology and suicidality; minimal support provided; no active intervention administered.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Phone",,,"Every 4 weeks","14",,"completed treatment course",,,,,,,,,,,,"Race and Ethnicity data reported","Community","81.82%","Accidents",,"High","Beck JG, Coffey SF, Foy DW, et al. Group cognitive behavior therapy for chronic posttraumatic stress disorder: an initial randomized pilot study. Behav Ther. 2009 Mar;40(1):82-92. doi: 10.1016/j.beth.2008.01.003. PMID: 19187819.","32054","2019"
"beck2021_A","beck2021","Psychotherapy & CIH","2021","PTSD","PTSD",,"74","A","39",,"Trauma-focused psychotherapy with music and imagery","Trauma-focused psychotherapy + music therapy","Trauma-focused adapation of the Bonny Method of Guided Imagery and Music; focuses on spontaneous imagery stimulated by listening to music in an altered state of consciousness. Sessions included verbal communication and optional 5-20 minutes of music and imagery work, and were followed by verbal processing with the therapist. Also received standard therapy following best-practice guidelines for PTSD treatment; includes elements of trauma-focused CBT, psychodynamic, and narrative approaches","Yes","Trauma-focused","No",,"Yes","Creative therapies","No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","16","Supplemental treatment sessions allowed, up to 20 sessions total","Completing ≥12 sessions",,,,,,,,"Received 16 sessions: 68.4%



Received 17-20 sessions: 26.3%



Received 12-15 sessions: 0%",,,,"Not reported","Community","41.89%","Mixed","Terrorism/political violence/forced displacement; Other (child abuse, unspecified); Other (adult abuse, unspecified)","High","Beck BD, Meyer SL, Simonsen E, et al. Music therapy was noninferior to verbal standard treatment of traumatized refugees in mental health care: results from a randomized clinical trial. Eur J Psychotraumatol. 2021 Jul 6;12(1):1930960. doi: 10.1080/20008198.2021.1930960. PMID: 34285768.","1574199","2022"
"beck2021_B","beck2021","Psychotherapy & CIH","2021","PTSD","PTSD",,"74","B","35",,"Trauma-focused psychotherapy as usual","Trauma-focused psychotherapy","Standard therapy following best-practice guidelines for PTSD treatment; includes elements of trauma-focused CBT, psychodynamic, and narrative approaches","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","16","Supplemental treatment sessions allowed, up to 20 sessions total","Completing ≥12 sessions",,,,,,,,"Received 16 sessions: 17.1%



Received 17-20 sessions: 31.4%



Received 12-15 sessions: 14.3%",,,,"Not reported","Community","41.89%","Mixed","Terrorism/political violence/forced displacement; Other (child abuse, unspecified); Other (adult abuse, unspecified)","High","Beck BD, Meyer SL, Simonsen E, et al. Music therapy was noninferior to verbal standard treatment of traumatized refugees in mental health care: results from a randomized clinical trial. Eur J Psychotraumatol. 2021 Jul 6;12(1):1930960. doi: 10.1080/20008198.2021.1930960. PMID: 34285768.","1574199","2022"
"becker2007_A","becker2007","Pharmacotherapy","2007","PTSD","PTSD",,"30","A","18",,"Bupropion sustained release","Bupropion","Antidepressant with a monocyclic aminoketone structure and weak norepinephrine and dopamine reuptake inhibitor.","No",,"Yes","Antidepressant: Other","No",,"No","No","No","No","No","Individual","In Person","100 to 300 mg total daily dose; titration: 100 mg for first 2 weeks, then if indicated, dosing increased to 100 mg twice daily. At week 4, if indicated, dosing increased to 150 mg twice daily",,"Daily to twice daily","8",,,,,,,,,,,"300 mg for completers, 180 mg for noncompleters",,,"Race data reported","Mixed","21.43%","Mixed","combat-related, child sexual abuse, child physical abuse, intimate partner violence, rape/sexual assault, accidents, illness/medical procedure, other (homicide, death/suicide of a loved one)","Some Concerns","Becker ME, Hertzberg MA, Moore SD, et al. A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Apr;27(2):193-7. doi: 10.1097/JCP.0b013e318032eaed. PMID: 17414245.","31131","2019"
"becker2007_B","becker2007","Pharmacotherapy","2007","PTSD","Inactive Control",,"30","B","10",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily to twice daily","8",,,,,,,,,,,,,,"Race data reported","Mixed","21.43%","Mixed","combat-related, child sexual abuse, child physical abuse, intimate partner violence, rape/sexual assault, accidents, illness/medical procedure, other (homicide, death/suicide of a loved one)","Some Concerns","Becker ME, Hertzberg MA, Moore SD, et al. A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Apr;27(2):193-7. doi: 10.1097/JCP.0b013e318032eaed. PMID: 17414245.","31131","2019"
"beidel2011_A","beidel2011","Psychotherapy","2011","PTSD","PTSD",,"35","A","18",,"Trauma Management Therapy with Exposure Therapy","Trauma Management Therapy with exposure therapy","Intensive exposure therapy including imaginal and in vivo exposure. Social and emotional rehabilitation involves general social skills training with anger management skills","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Mixed","In Person",,"Individual exposure sessions: NR







Group social and emotional rehabilitation sessions: 90 minutes","Individual exposure sessions: 3 times weekly for 5 weeks







Group social and emotional rehabilitation sessions: twice weekly for 2 weeks, then once weekly for 10 weeks (14 total sessions)","16",,"completing all individual exposure sessions and 75% of group sessions",,,,,,,,,,,,"Race data reported","Veteran","0%","Combat-related",,"High","Beidel DC, Frueh BC, Uhde TW, et al. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2011 Mar;25(2):224-31. doi: 10.1016/j.janxdis.2010.09.006. PMID: 20951543.","35248","2019"
"beidel2011_B","beidel2011","Psychotherapy","2011","PTSD","Active Control",,"35","B","17",,"Exposure Therapy + psychoeducation","Exposure therapy","Intensive exposure therapy including imaginal and in vivo exposure, then therapist lead group psychoeducation and traditional ""rap"" group sessions where participants share experiences and garner support from other group members","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Mixed","In Person",,"Individual exposure sessions: NR







Group psychoeducation sessions: 90 minutes","Individual exposure sessions: 3 times weekly for 5 weeks







Group social and emotional rehabilitation sessions: twice weekly for 2 weeks, then once weekly for 10 weeks (14 total sessions)","16",,"completing all individual exposure sessions and 75% of group sessions",,,,,,,,,,,,"Race data reported","Veteran","0%","Combat-related",,"High","Beidel DC, Frueh BC, Uhde TW, et al. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2011 Mar;25(2):224-31. doi: 10.1016/j.janxdis.2010.09.006. PMID: 20951543.","35248","2019"
"bell2019_A","bell2019","Other mixed","2019","PTSD","PTSD",,"24","A","12",,"LORETA z-score neurofeedback","Neurofeedback","Training protocol individualized using NeuroGuide's Symptom Checklist-Neural Network Match method, with 3 networks and 5 metrics for each participant. Audiovisual feedback by participant watching a movie and the screen and volume zoom in/out based on physiological measures and set thresholds (used Zukor Media Player). Reward provision used Z-Tunes method with 2 selection criteria: 1) 70% of targeted metrics within set z-score range; 2) average of remaining 30% were moving in direction of z=0 (negative slope); z-score threshold adjusted during each session for reward rate of 24 to 36 rewards per minute.","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person",,"20 minutes","Twice a week","7.5","total 15 sessions","See Detail",,"Final sample includes only participants who completed the study, unclear if all participants completed treatment",,,,,,,,,,"Not reported","Community",,"Mixed","combat-related, rape/sexual assault, community/school violence, illness/medical procedure, natural or manmade disasters, child other abuse, other (""work-related trauma [e.g. first responders]"")","High","Bell AN, Moss D, Kallmeyer RJ. Healing the neurophysiological roots of trauma: a controlled study examining loreta z-score neurofeedback and HRV biofeedback for chronic PTSD. NeuroRegulation. 2019;6(2):54-70. doi: 10.15540/nr.6.2.54.","1515967","2020"
"bell2019_B","bell2019","Other mixed","2019","PTSD","Active Control",,"24","B","12",,"Heart rate variability biofeedback","Biofeedback","Participants guided to breathe at resonant frequency and increase heartrate variability metrics using audiovisual feedback (participant watching a movie and the screen and volume zoom in/out based on physiological measures and set thresholds, used Zukor Media Player) and breath pacer on training screen.","No",,"No",,"Yes","Relaxation","No","No","Yes","No","No","Individual","In Person",,"20 minutes","Twice a week","7.5","total 15 sessions","See Detail",,"Final sample includes only participants who completed the study, unclear if all participants completed treatment",,,,,,,,,,"Not reported","Community",,"Mixed","combat-related, rape/sexual assault, community/school violence, illness/medical procedure, natural or manmade disasters, child other abuse, other (""work-related trauma [e.g. first responders]"")","High","Bell AN, Moss D, Kallmeyer RJ. Healing the neurophysiological roots of trauma: a controlled study examining loreta z-score neurofeedback and HRV biofeedback for chronic PTSD. NeuroRegulation. 2019;6(2):54-70. doi: 10.15540/nr.6.2.54.","1515967","2020"
"bellehsen2021_A","bellehsen2021","CIH","2021","PTSD","PTSD",,"40","A","20",,"Transcendental meditation","Transcendental meditation","Taught in same format as offered in the community; no modifications to address PTSD symptoms specifically. Comprised of an introductory lecture, personal interview, 4 core instruction sessions (individual followed by 3 group sessions over 4 consecutive days), then weekly group sessions. Daily meditation at home encouraged.","No",,"No",,"Yes","Meditation","No","No","No","No","No","Mixed","In Person",,"60 minutes (group)","Daily for 5 days, then weekly","12","16 sessions total","Completed all core instructional sessions",,"additional information: 85% completed at least 3 additional refresher sessions (total of 8 TM sessions)",,,,,,"85% completed at least 8 sessions (not defined as treatment completion)",,,,"Race and Ethnicity data reported","Veteran","15%","Mixed","Combat-related; Rape/sexual assault; Illness/medical procedure; Natural or manmade disasters; Other (other traumatic event)","Low","Bellehsen M, Stoycheva V, Cohen BH, et al. A pilot randomized controlled trial of transcendental meditation as treatment for posttraumatic stress disorder in veterans. J Trauma Stress. 2021 Mar 18;18:18. doi: 10.1002/jts.22665. PMID: 33734493.","1554186","2022"
"bellehsen2021_B","bellehsen2021","CIH","2021","PTSD","Inactive Control",,"40","B","20",,"TAU","Treatment as usual (TAU)","Not described. Control group was offered an opportunity to learn transcendental mediation after study participation.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"12",,,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","15%","Mixed","Combat-related; Rape/sexual assault; Illness/medical procedure; Natural or manmade disasters; Other (other traumatic event)","Low","Bellehsen M, Stoycheva V, Cohen BH, et al. A pilot randomized controlled trial of transcendental meditation as treatment for posttraumatic stress disorder in veterans. J Trauma Stress. 2021 Mar 18;18:18. doi: 10.1002/jts.22665. PMID: 33734493.","1554186","2022"
"belleville2018_A","belleville2018","Psychotherapy","2018","PTSD","PTSD",,"42","A","22",,"Imagery rehearsal therapy + CBT","Imagery rehearsal training (IRT) + Trauma-focused cognitive behavioral therapy (TF-CBT)","Imagery rehearsal therapy sessions intended to alter the association between sleep and nightmares by rehearsing an alternate dream script in the daytime; followed by series of CBT sessions that included exposure to traumatic memories and to feared objects, activities and situations","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"Session length: 60 minutes for imagery rehearsal; 60 to 90 minutes for CBT","Weekly","20","5 for imagery rehearsal, 15 for CBT","completed entire 20-session treatment",,,,,,,,,,,,"Not reported","Community","88.1%","Mixed","child sexual abuse, rape/sexual assault","Some Concerns","Belleville G, Dube-Frenette M, Rousseau A. Efficacy of imagery rehearsal therapy and cognitive behavioral therapy in sexual assault victims with posttraumatic stress disorder: a randomized controlled trial. J Trauma Stress. 2018 Aug;31(4):591-601. doi: 10.1002/jts.22306. PMID: 30070398.","50883","2020"
"belleville2018_B","belleville2018","Psychotherapy","2018","PTSD","Active Control",,"42","B","20",,"CBT only","Trauma-focused cognitive behavioral therapy (TF-CBT)","CBT sessions included exposure to traumatic memories and to feared objects, activities and situations. Sessions followed a 5-week waiting period including weekly check-in phone calls of about 5 minutes' duration.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"60 to 90 minutes","Weekly","15",,"completed entire 15-session treatment",,,,,,,,,,,,"Not reported","Community","88.1%","Mixed","child sexual abuse, rape/sexual assault","Some Concerns","Belleville G, Dube-Frenette M, Rousseau A. Efficacy of imagery rehearsal therapy and cognitive behavioral therapy in sexual assault victims with posttraumatic stress disorder: a randomized controlled trial. J Trauma Stress. 2018 Aug;31(4):591-601. doi: 10.1002/jts.22306. PMID: 30070398.","50883","2020"
"bichescu2007_A","bichescu2007","Other mixed","2007","PTSD","PTSD",,"18","A","9",,"NET","Narrative Exposure Therapy (NET)","Therapist provided same psychoeducation as control group, explaining PTSD-related symptoms and dysfunctions that frequently occur. Patient, assisted by the therapist, construct a chronological report of his own biography with special focus on traumatic experience.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"120 minutes","Weekly or biweekly","10","5 sessions total","Completed NET",,"abstract and ""No refusals to participate or dropouts were recorded""",,,,,,,,,,"Not reported","Community","5.56%","Terrorism/political violence/forced displacement",,"High","Bichescu D, Neuner F, Schauer M, et al. Narrative exposure therapy for political imprisonment-related chronic posttraumatic stress disorder and depression. Behav Res Ther. 2007 Sep;45(9):2212-20. doi: 10.1016/j.brat.2006.12.006. PMID: 17288990.","29906","2019"
"bichescu2007_B","bichescu2007","Other mixed","2007","PTSD","Active Control",,"18","B","9",,"Psychoeducation","Psychoeducation","Therapist explain PTSD-related symptoms and dysfunctions that frequently occur, no further treatment offered","No",,"No",,"No",,"No","No","Yes","Yes","No","Individual","In Person",,,"Once","0.14","Single session; posttreatment assessment at 6 months","Completed psychoeducation",,"abstract and ""No refusals to participate or dropouts were recorded""",,,,,,,,,,"Not reported","Community","5.56%","Terrorism/political violence/forced displacement",,"High","Bichescu D, Neuner F, Schauer M, et al. Narrative exposure therapy for political imprisonment-related chronic posttraumatic stress disorder and depression. Behav Res Ther. 2007 Sep;45(9):2212-20. doi: 10.1016/j.brat.2006.12.006. PMID: 17288990.","29906","2019"
"bisson2020_A","bisson2020","Psychotherapy","2020","PTSD","PTSD",,"42","A","21",,"Multimodular motion-assisted memory desensitization and reconsolidation","Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR)","3MDR is ""based on known therapeutic principles of virtual reality exposure therapy and eye movement desensitization and reprocessing (EMDR), embedded in a novel context in which the patient walks on a treadmill whilst immersing in and interacting with a series of self-selected images that are displayed on a large screen""; study treatment protocol involved projection of purpose-built tunnels to walk in and projection of self-selected digital pictures integrated into the software used for treatment.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"Mean 63.3 (SD 14.5) minutes","Weekly","9","9 weekly sessions","Completed treatment",,"Received allocated intervention (n=21) minus discontinued intervention (n=11)",,,,,,,,,,"Race data reported","Veteran","0%","Mixed","Combat-related, Rape/sexual assault, Community/school violence, Other (""severe human suffering"", ""serious injury, harm or death you caused to someone"", ""fire or explosion"", ""exposure to a war zone, sudden violent death, sudden unexpected death of smoeone close to you"", ""captivity"")","Low","Bisson JI, van Deursen R, Hannigan B, Kitchiner N, Barawi K, Jones K, Pickles T, Skipper J, Young C, Abbott LR, van Gelderen M, Nijdam MJ, Vermetten E. Randomized controlled trial of multi-modular motion-assisted memory desensitization and reconsolidation (3MDR) for male military veterans with treatment-resistant post-traumatic stress disorder. Acta Psychiatr Scand. 2020 Aug;142(2):141-151. doi: 10.1111/acps.13200. Epub 2020 Jun 28. PMID: 32495381.","1554186","2022"
"bisson2020_B","bisson2020","Psychotherapy","2020","PTSD","Inactive Control",,"42","B","21",,"Waiting list","Waitlist","Waitlist for 12 weeks, then participants received experimental treatment (multimodular motion-assisted memory desensitization and reconsolidation)","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"12","12 week waiting period",,,,,,,,,,,,,"Race data reported","Veteran","0%","Mixed","Combat-related, Rape/sexual assault, Community/school violence, Other (""severe human suffering"", ""serious injury, harm or death you caused to someone"", ""fire or explosion"", ""exposure to a war zone, sudden violent death, sudden unexpected death of smoeone close to you"", ""captivity"")","Low","Bisson JI, van Deursen R, Hannigan B, Kitchiner N, Barawi K, Jones K, Pickles T, Skipper J, Young C, Abbott LR, van Gelderen M, Nijdam MJ, Vermetten E. Randomized controlled trial of multi-modular motion-assisted memory desensitization and reconsolidation (3MDR) for male military veterans with treatment-resistant post-traumatic stress disorder. Acta Psychiatr Scand. 2020 Aug;142(2):141-151. doi: 10.1111/acps.13200. Epub 2020 Jun 28. PMID: 32495381.","1554186","2022"
"bisson2022_A","bisson2022","Other mixed","2022","PTSD","PTSD",,"196","A","97",,"Guided internet-based TF-CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","8-step online guided self-help program (using Spring web-based program), including ""psychoeducation, grounding techniques, management of anxiety, behavioural activation, imaginal exposure, cognitive restructuring, in vivo exposure, and prevention of relapse."" Audio narrated with keywords and images displayed; interactive, user input determines feedback. Tools include building a fear ladder and writing a trauma narrative. Therapist meets with patient at start of treatment, with 4 subsequent meetings for guidance and review, usually in person. Four telephone or email contacts between sessions.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Mixed",,"1 hour for first session, 30 minutes for later sessions","Every 2 weeks","8","Guided internet program took ""about 8 weeks,"" with one session with therapist at the start and 4 subsequent sessions; end of treatment assessment at 16 weeks post-randomization to match arm B","Completing ≥3 sessions",,,,,,"5",,"""Average"" of 5 sessions, IQR 3 to 5; average 208.4 (SD 69.3) minutes of contact with therapist; 5 participants attended no sessions",,,,"Race data reported","Community","63.8%","Mixed","Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (""Serious incident not transportation; Sudden unexpected death of someone close; Sudden violent death; Life threatening injury; Captivity; Severe human suffering; Serious injury, harm, or death caused to someone; Other unwanted sexual experience; Any other stressful event or experience"")","Low","Bisson JI, Ariti C, Cullen K, et al. Guided, internet based, cognitive behavioural therapy for post-traumatic stress disorder: pragmatic, multicentre, randomised controlled non-inferiority trial (RAPID). BMJ. 2022;377:e069405. doi: 10.1136/bmj-2021-069405. PMID: 35710124.","1594681","2023"
"bisson2022_B","bisson2022","Other mixed","2022","PTSD","PTSD",,"196","B","99",,"CBT with trauma focus (CBT-TF)","Trauma-focused cognitive behavioral therapy (TF-CBT)","Cognitive therapy for PTSD; up to 12 sessions, with assignments between sessions, including modifying negative appraisals, discussing trauma memories, stopping unhelpful behaviors and cognitive strategies, and ""when possible, visiting the site of the trauma with the therapist to update the trauma memory.""","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 to 90 minutes","Weekly","up to 12","Up to 12 weekly sessions; end of treatment assessment at 16 weeks post-randomization (allowing  extra time for participants to complete sessions)","Completing ≥8 sessions or judged to need <8 sessions",,,,,,"9",,"""Average"" of 9 sessions, IQR 6 to 12; average 767.0 (SD 278.2) minutes of contact with therapist; 3 participants attended no sessions",,,,"Race data reported","Community","63.8%","Mixed","Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (""Serious incident not transportation; Sudden unexpected death of someone close; Sudden violent death; Life threatening injury; Captivity; Severe human suffering; Serious injury, harm, or death caused to someone; Other unwanted sexual experience; Any other stressful event or experience"")","Low","Bisson JI, Ariti C, Cullen K, et al. Guided, internet based, cognitive behavioural therapy for post-traumatic stress disorder: pragmatic, multicentre, randomised controlled non-inferiority trial (RAPID). BMJ. 2022;377:e069405. doi: 10.1136/bmj-2021-069405. PMID: 35710124.","1594681","2023"
"bizouerne2023_A","bizouerne2023","Psychotherapy","2023","PTSD","PTSD",,"110","A","57","78 allocated to intervention after psychoeducation session; 21 excluded due to not meeting IES-R criteria (no assessment done or score <33)","Group traumatic episode protocol (G-TEP)","Eye Movement Desensitization and Reprocessing (EMDR)","Group traumatic episode protocol (G-TEP); uses bilateral stimulation and ""aims to treat a traumatic episode in order to reduce traumatic stress, promote adaptive treatment, build resilience and prevent post-traumatic complications"". Based on the Adaptive
Information Processing theoretical model and the 8 phases of EMDR processing.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"70-120 minutes",,,"6 sessions, timing NR","Completing session 1 and session 6",,"denominator is N allocated and not excluded for IES score (N=57)",,,,"5.4","0.955",,,,,"Not reported","Community","46.5%",,,"High","Bizouerne C, Dozio E, Dlasso E, et al. Randomized controlled trial: Comparing the effectiveness of brief group cognitive behavioural therapy and group eye movement desensitisation and reprocessing interventions for PTSD in internally displaced persons, administered by paraprofessionals in Northern Iraq. Eur J Trauma Dissociation. 2023;7(4) doi: 10.1016/j.ejtd.2023.100362.","1631250","2024"
"bizouerne2023_B","bizouerne2023","Psychotherapy","2023","PTSD","PTSD",,"110","B","53","77 allocated to intervention after psychoeducation session; 24 excluded due to not meeting IES-R criteria (no assessment done or score <33)","Trauma-focused cognitive behavioral therapy (TF-CBT)","Trauma-focused cognitive behavioral therapy (TF-CBT)","Group-based, trauma-focused cognitive behavior therapy adapted to the cultural and contextual specificities of Kurdistan","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"90-120 minutes",,,"6 sessions, timing NR","Completing session 1 and session 6",,"denominator is N allocated and not excluded for IES score (N=53)",,,,"5.57","0.807",,,,,"Not reported","Community","46.5%",,,"High","Bizouerne C, Dozio E, Dlasso E, et al. Randomized controlled trial: Comparing the effectiveness of brief group cognitive behavioural therapy and group eye movement desensitisation and reprocessing interventions for PTSD in internally displaced persons, administered by paraprofessionals in Northern Iraq. Eur J Trauma Dissociation. 2023;7(4) doi: 10.1016/j.ejtd.2023.100362.","1631250","2024"
"blanchard2003_A","blanchard2003","Psychotherapy","2003","PTSD","PTSD",,"98","A","37",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Manualized treatment with emphasis on helping the patient understand PTSD as a reaction to trauma and to normalize patient's view of his/her symptoms. Treatment included progressive muscle relaxation, reading aloud description of the MVA, in vivo exposure, and behavioral activation to counteract the numbing symptoms","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Weekly","8 to 12","planned 8 to 12 sessions total with an expected mode of 10","Treatment completion",,,,,,"9.8","1.2",,,,,"Race data reported","Community","73.47%","Accidents",,"High","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_B","blanchard2003","Psychotherapy","2003","PTSD","Active Control",,"98","B","36",,"Supportive psychotherapy","Psychotherapy","Manualized treatment with emphasis on helping the patient understand PTSD as a reaction to trauma and to normalize patient's view of his/her symptoms. Therapist provided support on issues raised, including interpersonal or relationship issues, work issues, etc.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Weekly","8 to12","planned 8 to 12 sessions total with an expected mode of 10","Treatment completion",,,,,,"10","1.2",,,,,"Race data reported","Community","73.47%","Accidents",,"High","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"blanchard2003_C","blanchard2003","Psychotherapy","2003","PTSD","Inactive Control",,"98","C","25",,"Waitlist","Waitlist","Waitlist","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Race data reported","Community","73.47%","Accidents",,"High","Blanchard EB, Hickling EJ, Devineni T, et al. A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors. Behav Res Ther. 2003 Jan;41(1):79-96.  PMID: 12488121.","25272","2019"
"boals2015_A","boals2015","Other study class","2015","PTSD","PTSD",,"70","A","26",,"ACT analog","Acceptance and Commitment Therapy (ACT) + expressive writing","Participants listened to audio recording that included an acceptance-based rationale and a guided mindfulness exercise. Participants then completed 2 expressive writing exercises","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Mixed",,"Audio: 10 minutes







Writing sessions: 20 minutes",,"1","writing sessions completed within 1 weeks",,,,"Score ≥2 on following writing direction","59.26%",,,,,,,,"Race and Ethnicity data reported","Community",,,,"Some Concerns","Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.","1548485","2019"
"boals2015_B","boals2015","Other study class","2015","PTSD","PTSD",,"70","B","20",,"CBT analog","Cognitive behavioral therapy (CBT) + expressive writing","Participants listened to audio recording that included CBT rationale and a guided imagery exercise. Participants then completed 2 expressive writing exercises","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Mixed",,"Audio: 10 minutes







Writing sessions: 20 minutes",,"1","writing sessions completed within 1 weeks",,,,"Score ≥2 on following writing direction","50%",,,,,,,,"Race and Ethnicity data reported","Community",,,,"Some Concerns","Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.","1548485","2019"
"boals2015_C","boals2015","Other study class","2015","PTSD","Inactive Control",,"70","C","23",,"Neutral script and writing","Control writing","Participants listened to audio recording on history of baseball then completed 2 writing sessions about time management","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Mixed",,"Audio: 10 minutes







Writing sessions: 20 minutes",,"1","writing sessions completed within 1 weeks",,,,"Score ≥2 on following writing direction","95.65%",,,,,,,,"Race and Ethnicity data reported","Community",,,,"Some Concerns","Boals A, Murrell AR, Berntsen D, et al. Experimentally reducing event centrality using a modified expressive writing intervention. J Contextual Behav Sci. 2015 Oct;4(4):269-76. doi: 10.1016/j.jcbs.2015.10.001.","1548485","2019"
"boggio2010_A","boggio2010","Nonpharmacologic biological","2010","PTSD","PTSD",,"30","A","10",,"High-frequency left rTMS","Transcranial magnetic stimulation (TMS)","Magnetic stimulation applied to the left Dorsolateral Pre-frontal Cortex","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person","20 Hz at 80% of patient's motor threshold; 1600 pulses per session",,"Once daily on weekdays","2","10 sessions total","Completed treatment",,"Study reports on dropouts, states all dropouts were due to travel difficulty for treatments; remainder appear to be treatment completers",,,,,,,,,,"Not reported","Community","70%","Mixed","rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)","Some Concerns","Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.","33726","2019"
"boggio2010_B","boggio2010","Nonpharmacologic biological","2010","PTSD","PTSD",,"30","B","10",,"High-frequency Right rTMS","Transcranial magnetic stimulation (TMS)","Magnetic stimulation applied to the right dorsolateral prefrontal cortex","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person","21 Hz at 80% of patient's motor threshold; 1600 pulses per session",,"Once daily on weekdays","2","10 sessions total","Completed treatment",,"Study reports on dropouts, states all dropouts were due to travel difficulty for treatments; remainder appear to be treatment completers",,,,,,,,,,"Not reported","Community","70%","Mixed","rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)","Some Concerns","Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.","33726","2019"
"boggio2010_C","boggio2010","Nonpharmacologic biological","2010","PTSD","Inactive Control",,"30","C","10",,"Sham rTMS","Sham","Administered the same TMS methodology as intervention groups only without magnetic stimulation from the coil. The sham TMS had a small electrical stimulator to mimic scalp sensation.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Once daily on weekdays","2","10 sessions total","Completed treatment",,"Study reports on dropouts, states all dropouts were due to travel difficulty for treatments; remainder appear to be treatment completers",,,,,,,,,,"Not reported","Community","70%","Mixed","rape/sexual assault, community/school violence, other (death or severe disease of relative, perceived physical harm/psychological distress)","Some Concerns","Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010 Aug;71(8):992-9. doi: 10.4088/JCP.08m04638blu. PMID: 20051219.","33726","2019"
"bohus2013_A","bohus2013","Psychotherapy","2013","PTSD","PTSD",,"82","A","43",,"DBT-PTSD","Dialectical Behavior Therapy (DBT) + Trauma-focused cognitive behavioral therapy (TF-CBT)","Integrated trauma-focused cognitive and exposure-based interventions described by Foa et al (2007) and Ehlers & Clark (2000). Intervention included individual exposure-based treatment plus the following weekly group treatments: skills training, self-esteem intervention, mindfulness sessions, PTSD-specific psychoeducation, and non-specific group interventions (music therapy, art therapy)","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Mixed","In Person",,"Individual sessions: 45 minutes







Group sessions: 90 minutes skills training, 60 minutes self-esteem intervention, 25 minutes mindfulness, 60 minutes PTSD-specific psychoeducation, and 90 minutes non-specific interventions","Individual sessions: twice weekly







Group sessions: weekly","12",,"Treatment completion",,"flow diagram in supplemental materials",,,,"25",,,,,,"Not reported","Community","100%","Child sexual abuse",,"Some Concerns","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2013_B","bohus2013","Psychotherapy","2013","PTSD","Inactive Control",,"82","B","39",,"TAU waitlist","Treatment as usual (TAU)","Participants received 6 months of any treatment of their choice except DBT-PTSD","No",,"No",,"No",,"No","No","Yes","No","No",,"In Person",,,,"12",,,,,,,,,,,,,,"Not reported","Community","100%","Child sexual abuse",,"Some Concerns","Bohus MJ, Dyer AS, Priebe K, et al. Dialectical behaviour therapy for post-traumatic stress disorder after childhood sexual abuse in patients with and without borderline personality disorder: a randomised controlled trial. Psychother Psychosom. 2013 Jun;82(4):221-33. doi: 10.1159/000348451. PMID: 23712109.","41533","2019"
"bohus2020_A","bohus2020","Psychotherapy","2020","PTSD","PTSD",,"193","A","98","103 randomized but 5 later found ineligible and excluded","DBT-PTSD","Dialectical Behavior Therapy (DBT) + Trauma-focused cognitive behavioral therapy (TF-CBT)","DBT for PTSD based on standard DBT with additional trauma-focused cognitive-behavioral interventions, and techniques drawn from compassion-focused therapy and acceptance and commitment therapy. Includes identifying patients' typical escape strategies in response to trauma-related stimuli, skills-assisted exposure to traumatic memories, and exercises on acceptance of the past and grief. Individual therapy, plus homework and telephone consultation as needed. Up to 45 weekly sessions over a year, followed by a booster phase of 3 monthly sessions.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Weekly for a year then monthly for 3 months","65",,"Completed intervention and follow-up",,"n=24 discontinued intervention, n=1 lost to follow-up before receiving intervention",,,,,,,,,,"Not reported","Community","100%","Mixed","Child physical abuse, Child sexual abuse","Some Concerns","Bohus M, Kleindienst N, Hahn C, et al. Dialectical behavior therapy for posttraumatic stress disorder (DBT-PTSD) compared with cognitive processing therapy (CPT) in complex presentations of PTSD in women survivors of childhood abuse: a randomized clinical trial. JAMA Psychiatry. 2020 Jul 22;22:22. doi: 10.1001/jamapsychiatry.2020.2148. PMID: 32697288.","1556502","2022"
"bohus2020_B","bohus2020","Psychotherapy","2020","PTSD","Active Control",,"193","B","95","97 randomized but 2 later found ineligible and excluded","CPT","Cognitive Processing Therapy (CPT)","Trauma-focused cognitive therapy attempting to challenge dysfunctional trauma-associated cognitions and emotion. Follows a session by session protocol including original 12 CPT sessions and exploring themes such as trust, safety, and guilt. Later sessions identify and challenge ""stuck points"" not resolved in previous sessions. Individual therapy, plus homework and telephone consultation as needed. Up to 45 weekly sessions over a year, followed by a booster phase of 3 monthly sessions.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Weekly for a year then monthly for 3 months","65",,"Completed intervention and follow-up",,"n=32 discontinued intervention, n=5 lost to follow-up before receiving intervention",,,,,,,,,,"Not reported","Community","100%","Mixed","Child physical abuse, Child sexual abuse","Some Concerns","Bohus M, Kleindienst N, Hahn C, et al. Dialectical behavior therapy for posttraumatic stress disorder (DBT-PTSD) compared with cognitive processing therapy (CPT) in complex presentations of PTSD in women survivors of childhood abuse: a randomized clinical trial. JAMA Psychiatry. 2020 Jul 22;22:22. doi: 10.1001/jamapsychiatry.2020.2148. PMID: 32697288.","1556502","2022"
"bomyea2015_A","bomyea2015","Nonpharmacologic cognitive","2015","PTSD","PTSD",,"42","A","22",,"High Interference Control Training","Interference control training","Computerized cognitive training designed to prevent interfering thoughts from entering consciousness and removing them once they come to mind by improving cognitive performance on a working memory capacity test involving testing of sentence accuracy and memory under a condition of high proactive interference with item memoranda that were words for all trials; 3 blocks of training (45 trials) completed per session.","No",,"No",,"No",,"No","Yes","No","No","No","Individual","In Person",,"30 minutes","Twice weekly","4",,"Received intervention and did not discontinue intervention",,"Flow diagram; study also reports for completer sample but this appears to be assessment/measure completion",,,,,,,,,,"Race data reported","Community","100%","Rape/sexual assault",,"High","Bomyea J, Stein MB, Lang AJ. Interference control training for PTSD: A randomized controlled trial of a novel computer-based intervention. J Anxiety Disord. 2015 Aug;34:33-42. doi: 10.1016/j.janxdis.2015.05.010. PMID: 26114901.","44517","2019"
"bomyea2015_B","bomyea2015","Nonpharmacologic cognitive","2015","PTSD","Active Control",,"42","B","20",,"Low Interference Control Training","Interference control training","Computerized cognitive training designed to prevent interfering thoughts from entering consciousness and removing them once they come to mind by improving cognitive performance on a working memory capacity test involving testing of sentence accuracy and memory under a condition of low proactive interference with item memoranda that alternated between words and numbers every 3 trials; 3 blocks of training (45 trials) completed per session.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"30 minutes","Twice weekly","4",,"Received intervention and did not discontinue intervention",,"Flow diagram; study also reports for completer sample but this appears to be assessment/measure completion",,,,,,,,,,"Race data reported","Community","100%","Rape/sexual assault",,"High","Bomyea J, Stein MB, Lang AJ. Interference control training for PTSD: A randomized controlled trial of a novel computer-based intervention. J Anxiety Disord. 2015 Aug;34:33-42. doi: 10.1016/j.janxdis.2015.05.010. PMID: 26114901.","44517","2019"
"bomyea2025_A","bomyea2025","Nonpharmacologic cognitive","2025","PTSD","PTSD",,"81","A","42",,"High interference control (HIC) working memory training (WMT)","Interference control training","Reading span task which requires participants to remember item stimuli presented while doing a secondary problem solving or processing task. All items to be remembered were from the same category, requiring higher interference control but the same amount of overall working memory capacity. All stimuli were affectively neutral. Participants completed 45 self-paced trials each visit.","No",,"No",,"No",,"No","Yes","No","No","No","Individual","Technology alone",,"30 minutes","Twice a week","8",,"Completed all 16 sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","34.6%",,,"Low","Bomyea J, Caudle MM, Bartolovich AL, Simmons AN, Jak AJ, Golshan S. Randomized controlled trial of computerized working memory training for Veterans with PTSD. J Psychiatr Res. 2025 Jan;181:350-357. doi: 10.1016/j.jpsychires.2024.11.072. Epub 2024 Nov 29. PMID: 39642474.","1642154","2025"
"bomyea2025_B","bomyea2025","Nonpharmacologic cognitive","2025","PTSD","Active Control",,"81","B","39",,"Low interference control (LIC) working memory training (WMT)","Interference control training","Reading span task which requires participants to remember item stimuli presented while doing a secondary problem solving or processing task. All items to be remembered alternated categories every three trials, requiring less interference control but the same amount of overall working memory capacity. All stimuli were affectively neutral. Participants completed 45 self-paced trials each visit.","No",,"No",,"No",,"No","Yes","Yes","No","No","Individual","Technology alone",,"30 minutes","Twice a week","8",,"Completed all 16 sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","34.6%",,,"Low","Bomyea J, Caudle MM, Bartolovich AL, Simmons AN, Jak AJ, Golshan S. Randomized controlled trial of computerized working memory training for Veterans with PTSD. J Psychiatr Res. 2025 Jan;181:350-357. doi: 10.1016/j.jpsychires.2024.11.072. Epub 2024 Nov 29. PMID: 39642474.","1642154","2025"
"bonnmiller2021_A","bonnmiller2021","Pharmacotherapy","2021","PTSD","PTSD",,"80","A","20","Stage 1 randomization","High THC","High Delta-9-tetrahydrocannabinol (THC) and low Cannabidiol (CBD)","THC 12% and CBD <0.05%; independent testing showed THC 9% instead. Participants provided with 37.8 grams (1.8 grams/day) for the three-week ad libitum treatment period along with a metal pipe for treatment delivery (smoked). Unused drug returned to clinic weekly for measurement, with option for patients to use it in an open-label Stage 3.","No",,"Yes","Phytocannabinoid","No",,"No","No","No","No","No","Individual","In Person","Ad libitum self-administration (smoked) up to maximum 1.8 g/day",,"Daily","3",,,,,,,,,,,"14.6 g/3 weeks","10.4","mean amount used in total over the 3-week treatment period","Race data reported","Veteran","10%","Mixed","combat-related, other (not specified)","High","Bonn-Miller MO, Sisley S, Riggs P, et al. The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial. PLoS One. 2021;16(3):e0246990. doi: 10.1371/journal.pone.0246990. PMID: 33730032.","1566890","2022"
"bonnmiller2021_B","bonnmiller2021","Pharmacotherapy","2021","PTSD","PTSD",,"80","B","20","Stage 1 randomization","High CBD","High Cannabidiol (CBD) and low Delta-9-tetrahydrocannabinol (THC)","CBD 11% and THC 0.50%. Participants provided with 37.8 grams (1.8 grams/day) for the three-week ad libitum treatment period along with a metal pipe for treatment delivery (smoked). Unused drug returned to clinic weekly for measurement, with option for patients to use it in an open-label Stage 3.","No",,"Yes","Phytocannabinoid","No",,"No","No","No","No","No","Individual","In Person","Ad libitum self-administration (smoked) up to maximum 1.8 g/day",,"Daily","3",,,,,,,,,,,"14.3 g/3 weeks","13.0","mean amount used in total over the 3-week treatment period","Race data reported","Veteran","10%","Mixed","combat-related, other (not specified)","High","Bonn-Miller MO, Sisley S, Riggs P, et al. The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial. PLoS One. 2021;16(3):e0246990. doi: 10.1371/journal.pone.0246990. PMID: 33730032.","1566890","2022"
"bonnmiller2021_C","bonnmiller2021","Pharmacotherapy","2021","PTSD","PTSD",,"80","C","20","Stage 1 randomization","THC+CBD","Delta-9-tetrahydrocannabinol (THC) + Cannabidiol (CBD)","THC 7.9% and CBD 8.1%. Participants provided with 37.8 grams (1.8 grams/day) for the three-week ad libitum treatment period along with a metal pipe for treatment delivery (smoked). Unused drug returned to clinic weekly for measurement, with option for patients to use it in an open-label Stage 3.","No",,"Yes","Phytocannabinoid","No",,"No","No","No","No","No","Individual","In Person","Ad libitum self-administration (smoked) up to maximum 1.8 g/day",,"Daily","3",,,,,,,,,,,"8.2 g/3 weeks","6.8","mean amount used in total over the 3-week treatment period","Race data reported","Veteran","10%","Mixed","combat-related, other (not specified)","High","Bonn-Miller MO, Sisley S, Riggs P, et al. The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial. PLoS One. 2021;16(3):e0246990. doi: 10.1371/journal.pone.0246990. PMID: 33730032.","1566890","2022"
"bonnmiller2021_D","bonnmiller2021","Pharmacotherapy","2021","PTSD","Inactive Control",,"80","D","20","Stage 1 randomization","Placebo","Low Delta-9-tetrahydrocannabinol (THC) + low Cannabidiol (CBD)","THC <0.03% and CBD <0.01%. Participants provided with 37.8 grams (1.8 grams/day) for the three-week ad libitum treatment period along with a metal pipe for treatment delivery (smoked). Unused drug returned to clinic weekly for measurement, with option for patients to use it in an open-label Stage 3.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","Ad libitum self-administration (smoked) up to maximum 1.8 g/day",,"Daily","3",,,,,,,,,,,"8.4 g/3 weeks","10.1","mean amount used in total over the 3-week treatment period","Race data reported","Veteran","10%","Mixed","combat-related, other (not specified)","High","Bonn-Miller MO, Sisley S, Riggs P, et al. The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial. PLoS One. 2021;16(3):e0246990. doi: 10.1371/journal.pone.0246990. PMID: 33730032.","1566890","2022"
"bormann2008_A","bormann2008","CIH","2008","PTSD","PTSD",,"29","A","14",,"Mantram","Mantram Repetition","Education on PTSD symptoms and skills on how to choose and silently repeat a mantram - a word or phrase with spiritual associations chosen by the participant from a provided list. Repetition on Mantram is intended to train attention. Includes concepts of ""slowing down"" and ""one-pointed attention"". Used as a ""pause button"" for the mind to decrease reactivity to stress.","No",,"No",,"Yes","Meditation","No","No","No","No","No","Group","In Person",,"90 minutes","Weekly","6",,"See Detail",,"Provided for overall sample only, and unclear if delayed treatment group was considered as completers for waiting period or after receipt of intervention following waiting period; n/N not reported. ""Eighty-six percent of participants, including the controls, completed the intervention and rated the program with “moderate to high” satisfaction."" Study/assessment completion reported.",,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Combat-related",,"Some Concerns","Bormann JE, Thorp S, Wetherell JL, et al. A spiritually based group intervention for combat veterans with posttraumatic stress disorder: feasibility study. J Holist Nurs. 2008 Jun;26(2):109-16. doi: 10.1177/0898010107311276. PMID: 18356284.","30929","2019"
"bormann2008_B","bormann2008","CIH","2008","PTSD","Inactive Control",,"29","B","15",,"Usual care delayed-treatment","Treatment as usual (TAU)","Usual medical care with weekly or monthly case manager and/or primary care provider visits and medication management.","No",,"No",,"No",,"No","No","Yes","No","No",,"In Person",,,"Weekly or monthly","6",,"See Detail",,"Provided for overall sample only, and unclear if delayed treatment group was considered as completers for waiting period or after receipt of intervention following waiting period; n/N not reported. ""Eighty-six percent of participants, including the controls, completed the intervention and rated the program with “moderate to high” satisfaction."" Study/assessment completion reported.",,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Combat-related",,"Some Concerns","Bormann JE, Thorp S, Wetherell JL, et al. A spiritually based group intervention for combat veterans with posttraumatic stress disorder: feasibility study. J Holist Nurs. 2008 Jun;26(2):109-16. doi: 10.1177/0898010107311276. PMID: 18356284.","30929","2019"
"bormann2013_A","bormann2013","CIH","2013","PTSD","PTSD",,"146","A","71",,"Mantram Repetition Program + TAU","Mantram Repetition","Mantram Repetition Program is a portable, meditation-based intervention that teaches concentrative meditation, slowing down, and one-pointed attention for training attention and regulating emotion; group sessions contained lectures, discussion, sharing, questions and answers, and homework.







TAU consisted of case management as needed to evaluate mental health status and to monitor treatments","No",,"No",,"Yes","Meditation","No","No","No","No","No","Group","In Person",,"90 minutes","Weekly","6",,"See Detail",,"Reports study drop out only (did not complete assessments), also referred to as just ""drop out"" in text and unclear if this is also treatment drop out; drop out rate 7.04% (7/51)",,,,,,,,,,"Race and Ethnicity data reported","Veteran","2.74%","Combat-related",,"Low","Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.","38465","2019"
"bormann2013_B","bormann2013","CIH","2013","PTSD","Inactive Control",,"146","B","75",,"TAU","Treatment as usual (TAU)","Case management as needed to evaluate mental health status and to monitor treatments","No",,"No",,"No",,"No","No","Yes","No","No",,"In Person",,"As needed","As needed","6",,,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","2.74%","Combat-related",,"Low","Bormann JE, Thorp SR, Wetherell JL, et al. Meditation-based mantram intervention for veterans with posttraumatic stress disorder: A randomized trial. Psychol Trauma. 2013 May;5(3):259-67. doi: 10.1037/a0027522.","38465","2019"
"bormann2018_A","bormann2018","Psychotherapy & CIH","2018","PTSD","PTSD",,"173","A","89",,"Mantram repetition","Mantram Repetition","Education on choosing a mantram (word or phrase with a spiritual meaning), slowing down thoughts, one-pointed attention for emotional self-regulation and relaxation. Instructions and in-session and out-of-session experiential homework. Applying skills for emotional self-regulation and symptom management (putting space between reactivity and behaviors). Discussion, storytelling, weekly assignments. Discuss obstacles to practicing and develop methods to sustain practicing.","No",,"No",,"Yes","Meditation","No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","8",,"Attend ≥6 treatment sessions",,,,,,"7.8",,"among study completers",,,,"Race and Ethnicity data reported","Veteran","15.03%","Other","""related to military service""","Low","Bormann JE, Thorp SR, Smith E, et al. Individual treatment of posttraumatic stress disorder using mantram repetition: a randomized clinical trial. Am J Psychiatry. 2018 Oct 1;175(10):979-88. doi: 10.1176/appi.ajp.2018.17060611. PMID: 29921143.","50584","2022"
"bormann2018_B","bormann2018","Psychotherapy & CIH","2018","PTSD","PTSD",,"173","B","84",,"PCT","Present-Centered Therapy (PCT)","Supportive, present-focused, nondirective psychotherapy; manualized treatment. Discuss current problems and use problem-solving techniques. Record daily stressors in diary to use for discussion during sessions. Set goals for current and future treatment.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","8",,"Attend ≥6 treatment sessions",,,,,,"7.75",,"among study completers",,,,"Race and Ethnicity data reported","Veteran","15.03%","Other","""related to military service""","Low","Bormann JE, Thorp SR, Smith E, et al. Individual treatment of posttraumatic stress disorder using mantram repetition: a randomized clinical trial. Am J Psychiatry. 2018 Oct 1;175(10):979-88. doi: 10.1176/appi.ajp.2018.17060611. PMID: 29921143.","50584","2022"
"boterhovendehaan2020_A","boterhovendehaan2020","Psychotherapy","2020","PTSD","PTSD",,"155","A","74",,"Imagery rescripting","Imagery rescripting","Phased protocol: phase 1, patient recalls a trauma memory and is guided to imagine a different ending, such as someone intervening to stop the abuse; phase 2, patient as adult imagined as intervening; phase 3, patient re-experiences event as a child with adult intervening.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Twice a week","6","6 weeks, with 8 weeks permitted; stopping before 6 weeks allowed if site coordinator agreed treatment no longer necessary","Completed treatment",,"completed imagery rescripting condition within 8 weeks",,,,,,,,,,"Race data reported","Community","76.8%","Mixed","Child physical abuse; Child sexual abuse; Child other abuse; Intimate partner violence; Other (""serious injury/death""); Other (not described)","Low","Boterhoven de Haan KL, Lee CW, Fassbinder E, et al. Imagery rescripting and eye movement desensitisation and reprocessing as treatment for adults with post-traumatic stress disorder from childhood trauma: randomised clinical trial. Br J Psychiatry. 2020 11;217(5):609-15. doi: 10.1192/bjp.2020.158. PMID: 32892758.","1558454","2022"
"boterhovendehaan2020_B","boterhovendehaan2020","Psychotherapy","2020","PTSD","PTSD",,"155","B","81",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Phased protocol including identifying key memory components of trauma to be processed, active trauma processing, and assessment of current triggers and anticipatory anxiety","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Twice a week","6","6 weeks, with 8 weeks permitted; stopping before 6 weeks allowed if site coordinator agreed treatment no longer necessary","Completed treatment",,"completed EMDR condition within 8 weeks",,,,,,,,,,"Race data reported","Community","76.8%","Mixed","Child physical abuse; Child sexual abuse; Child other abuse; Intimate partner violence; Other (""serious injury/death""); Other (not described)","Low","Boterhoven de Haan KL, Lee CW, Fassbinder E, et al. Imagery rescripting and eye movement desensitisation and reprocessing as treatment for adults with post-traumatic stress disorder from childhood trauma: randomised clinical trial. Br J Psychiatry. 2020 11;217(5):609-15. doi: 10.1192/bjp.2020.158. PMID: 32892758.","1558454","2022"
"bottche2021_A","bottche2021","Other study class","2021","PTSD","PTSD",,"224","A","110",,"Internet-based CBT (regular length)","Internet-based facilitated self-help","Standard-length internet-based cognitive behavioral intervention guided by a therapist. Three components with 10 structured writing assignments: written imaginal exposure, describing traumatic event in detail (4 assignments); cognitive restructuring, reflecting on guilt, automatic cognitions, and unrealistic assumptions (4 assignments); and cognitive processing, including reflecting on the meaning of the trauma and social sharing (writing a supportive letter to oneself at the time of trauma) (2 assignments). Therapists (with experience in psychosocial counselling or bachelor's degree in psychology) gave instructions and written feedback on assignments, and were available by telephone for technical problems and emergencies.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Mixed",,"45 minutes","Twice a week","5",,"10 writing assignments",,"Of N=110 randomized



Of N=83 who started treatment, 77.1% completed ≥6 writing assignments",,,,,,,,,,"Not reported","Community","67.4%","Mixed","Rape/sexual assault; Other (sexual intercourse before age 18 with someone 5 years older; proximity to death); Other (NR)","High","Bottche M, Wagner B, Vohringer M, et al. Is only one cognitive technique also effective? Results from a randomized controlled trial of two different versions of an internet-based cognitive behavioural intervention for post-traumatic stress disorder in Arabic-speaking countries. Eur J Psychotraumatol. 2021 Jul 15;12(1):1943870. doi: 10.1080/20008198.2021.1943870. PMID: 34345377.","1574907","2022"
"bottche2021_B","bottche2021","Other study class","2021","PTSD","PTSD",,"224","B","114",,"Brief internet-based CBT","Internet-based facilitated self-help","Shorter internet-based cognitive behavioral intervention guided by a therapist. Two components with 6 structured writing assignments, excluding cognitive restructuring: written imaginal exposure, describing traumatic event in detail (4 assignments); and cognitive processing, including reflecting on the meaning of the trauma and social sharing (writing a supportive letter to oneself at the time of trauma) (2 assignments). Therapists (with experience in psychosocial counselling or bachelor's degree in psychology) gave instructions and written feedback on assignments, and were available by telephone for technical problems and emergencies.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Mixed",,"45 minutes","Twice a week","3",,"6 writing assignments",,"Of N=112 randomized



Of N=92 who started treatment, 82.6% completed 6 writing assignments",,,,,,,,,,"Not reported","Community","67.4%","Mixed","Rape/sexual assault; Other (sexual intercourse before age 18 with someone 5 years older; proximity to death); Other (NR)","High","Bottche M, Wagner B, Vohringer M, et al. Is only one cognitive technique also effective? Results from a randomized controlled trial of two different versions of an internet-based cognitive behavioural intervention for post-traumatic stress disorder in Arabic-speaking countries. Eur J Psychotraumatol. 2021 Jul 15;12(1):1943870. doi: 10.1080/20008198.2021.1943870. PMID: 34345377.","1574907","2022"
"bradshaw2014_A","bradshaw2014","Psychotherapy","2014","PTSD","PTSD",,"10","A","5",,"Observed and  Experiential Integration - Switching component","Observed and  Experiential Integration - Switching component","Participant instructed to close his/her eyes and envision the traumatic incident. When patient experiences physical or emotional signs of distress, instruction is given to uncover the nondominant eye and cover the dominant eye. Dominant/nondominant eye is alternatingly covered or both uncovered.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes",,"2","3 sessions total","See Detail",,"Study did not provide specific information on treatment completion; there is no indication of any treatment dropouts, all participants included in analysis",,,,,,,,,,"Race data reported","Community","80%","Mixed","rape/sexual assault, intimate partner violence, accidents, community/school violence","High","Bradshaw RA, McDonald MJ, Grace R, et al. A randomized clinical trial of Observed and Experiential Integration (OEI): a simple, innovative intervention for affect regulation in clients with PTSD. Traumatology (Tallahass Fla). 2014 Sep;20(3):161-71. doi: 10.1037/h0099401.","45231","2019"
"bradshaw2014_B","bradshaw2014","Psychotherapy","2014","PTSD","Inactive Control",,"10","B","5",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"2",,,,,,,,,,,,,,"Race data reported","Community","80%","Mixed","rape/sexual assault, intimate partner violence, accidents, community/school violence","High","Bradshaw RA, McDonald MJ, Grace R, et al. A randomized clinical trial of Observed and Experiential Integration (OEI): a simple, innovative intervention for affect regulation in clients with PTSD. Traumatology (Tallahass Fla). 2014 Sep;20(3):161-71. doi: 10.1037/h0099401.","45231","2019"
"brady2000_A","brady2000","Pharmacotherapy","2000","PTSD","PTSD",,"187","A","94",,"Sertraline","Sertraline","SSRI; flexible dosing titrated in 50-mg increments based on clinical response and tolerability at no less than weekly intervals. Followed a 2-week single-blind placebo run-in period.","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","50 to 200 mg; titration: 25 mg for 1 week then increased to 50 mg, further increases in 50-mg increments with maximum 200 mg dose",,"Daily","12",,,,,"compliance monitored by counts of returned medication",,,,,,"133.3 mg","59.2",,"Race data reported","Community","73.3%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)","Some Concerns","Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.","22232","2019"
"brady2000_B","brady2000","Pharmacotherapy","2000","PTSD","Inactive Control",,"187","B","93",,"Placebo","Placebo","Matched placebo. Followed a 2-week single-blind placebo run-in period.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,"compliance monitored by counts of returned medication",,,,,,,,,"Race data reported","Community","73.3%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (seeing someone hurt or die, kidnapping)","Some Concerns","Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000 Apr;283(14):1837-44. doi: 10.1001/jama.283.14.1837. PMID: 10770145.","22232","2019"
"brady2005_A","brady2005","Psychotherapy & pharmacotherapy","2005","PTSD+SUD","PTSD+SUD","Not integrated","94","A","49",,"Sertraline + CBT for alcohol dependence","Cognitive behavioral therapy (CBT) for alcohol use + sertraline","SSR; 50 mg tablets. Also received weekly CBT targeting alcohol dependence.","Yes","Non-Trauma-focused","Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","150 mg; titration: 50 mg for 2 days, 100 mg for 2 days, then 150 mg for the rest of the study",,"Daily","12",,"Treatment completion",,,"100 mg riboflavin tablets given with study drugs; also monitored by pill count",,,,,,"150 mg",,,"Race and Ethnicity data reported","Community","45.7%","Mixed","rape/sexual assault, accidents, community/school violence, other (childhood trauma not specified)","Some Concerns","Brady KT, Sonne SC, Anton RF, et al. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005 Mar;29(3):395-401. doi: 10.1097/01.ALC.0000156129.98265.57. PMID: 15770115.","27416","2020"
"brady2005_B","brady2005","Psychotherapy & pharmacotherapy","2005","PTSD+SUD","Active Control","Not integrated","94","B","45",,"Placebo + CBT for alcohol dependence","Cognitive behavioral therapy (CBT) for alcohol use","Placebo tablets matched sertraline tablets. Also received weekly CBT targeting alcohol dependence.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,"Treatment completion",,,"100 mg riboflavin tablets given with study drugs; also monitored by pill count",,,,,,,,,"Race and Ethnicity data reported","Community","45.7%","Mixed","rape/sexual assault, accidents, community/school violence, other (childhood trauma not specified)","Some Concerns","Brady KT, Sonne SC, Anton RF, et al. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005 Mar;29(3):395-401. doi: 10.1097/01.ALC.0000156129.98265.57. PMID: 15770115.","27416","2020"
"brady2021_A","brady2021","Psychotherapy","2021","PTSD","PTSD",,"25","A","15",,"Narrative exposure therapy","Narrative Exposure Therapy (NET)","Detailed narration of traumatic experiences that processes and contextualises traumatic memories and helps individuals to establish a coherent autobiographical narrative of their experiences. Three sessions of psychoeducation delivered prior to NET. Allowed up to 4 additional non-NET sessions to address urgent or risk issues arising during treatment. Goal of up to 20 sessions of NET.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90-120 minutes","Weekly","31.5","mean timeframe for NET session delivery (220.6 days, SD 65.27)

maximum 20 sessions (range 13-26 sessions)","Completed NET",,,,,,"17","4.07",,,,,"Not reported","Community","76%","Terrorism/political violence/forced displacement",,"High","Brady F, Chisholm A, Walsh E, et al. Narrative exposure therapy for survivors of human trafficking: feasibility randomised controlled trial. BJPsych Open. 2021 Nov;7(6):e196. doi: 10.1192/bjo.2021.1029.","1585372","2023"
"brady2021_B","brady2021","Psychotherapy","2021","PTSD","Active Control",,"25","B","10",,"Waitlist with psychoeducation","Psychoeducation","Psychoeducation and waitlist. Three sessions of psychoeducation delivered by therapist or trained assistant psychologists prior to 5-month waitlist period.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No",,,,,,"21.7","5 months waiting period;  psychoeducation sessions before waiting period started",,,,,,,,,,,,,"Not reported","Community","76%","Terrorism/political violence/forced displacement",,"High","Brady F, Chisholm A, Walsh E, et al. Narrative exposure therapy for survivors of human trafficking: feasibility randomised controlled trial. BJPsych Open. 2021 Nov;7(6):e196. doi: 10.1192/bjo.2021.1029.","1585372","2023"
"braun1990_A","braun1990","Pharmacotherapy","1990","PTSD","PTSD",,"16","A","16","7 assigned to alprazolam in first treatment period","Alprazolam","Alprazolam","Benzodiazepine; titration over 2 weeks then steady dose for 3 weeks, followed by 2-week taper for patients taking alprazolam in first period (not included in treatment period)","No",,"Yes","Antianxiety: benzodiazepine","No",,"No","No","No","No","No","Individual","In Person","1.5 to 6 mg; titration: initiated at 1.5 mg, titrated over 2 weeks to maximum 6 mg",,"Daily (divided doses)","5",,,,,,,,,,,"4 mg/day",,,"Not reported","Community",,"Mixed","combat-related, accidents, terrorism/political violence/forced displacement","High","Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J. Clin. Psychiatry. 1990 Jun;51(6):236-8.  PMID: 2189869.","02466","2019"
"braun1990_B","braun1990","Pharmacotherapy","1990","PTSD","Inactive Control",,"16","B","16","9 assigned to placebo in first treatment period","Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily (divided doses)","5",,,,,,,,,,,,,,"Not reported","Community",,"Mixed","combat-related, accidents, terrorism/political violence/forced displacement","High","Braun P, Greenberg D, Dasberg H, et al. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J. Clin. Psychiatry. 1990 Jun;51(6):236-8.  PMID: 2189869.","02466","2019"
"bremner2017_A","bremner2017","Psychotherapy & CIH","2017","PTSD","PTSD",,"26","A","17",,"MBSR","Mindfulness-based stress reduction (MBSR)","Mindfulness-based Stress Reduction based on Kabat-Zinn approach tailored to PTSD and veterans. Elements include body scan meditation, sitting meditation, hatha yoga via group sessions and home practice","No",,"No",,"Yes","Meditation","No","No","No","No","No","Group","In Person",,"2.5 hour sessions plus one 6-hour session during week 6","Weekly","8",,"completed the group and study procedures",,,,,,,,,,,,"Race data reported","Veteran","0%","Combat-related",,"High","Bremner JD, Mishra S, Campanella C, et al. A pilot study of the effects of mindfulness-based stress reduction on post-traumatic stress disorder symptoms and brain response to traumatic reminders of combat in Operation Enduring Freedom/Operation Iraqi Freedom combat veterans with post-traumatic stress disorder. Front Psychiatry. 2017 Aug 25;8:157. doi: 10.3389/fpsyt.2017.00157. PMID: 28890702.","49077","2019"
"bremner2017_B","bremner2017","Psychotherapy & CIH","2017","PTSD","Active Control",,"26","B","9",,"Group PCT","Present-Centered Therapy (PCT)","Psychoeducation and group support","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Group","In Person",,"NR (same total number of hours as Mindfulness-based Stress Reduction group)","Weekly","8",,"completed the group and study procedures",,,,,,,,,,,,"Race data reported","Veteran","0%","Combat-related",,"High","Bremner JD, Mishra S, Campanella C, et al. A pilot study of the effects of mindfulness-based stress reduction on post-traumatic stress disorder symptoms and brain response to traumatic reminders of combat in Operation Enduring Freedom/Operation Iraqi Freedom combat veterans with post-traumatic stress disorder. Front Psychiatry. 2017 Aug 25;8:157. doi: 10.3389/fpsyt.2017.00157. PMID: 28890702.","49077","2019"
"bremner2021_A","bremner2021","Nonpharmacologic biological","2021","PTSD","PTSD",,"20","A","9",,"Transcutaneous cervical vagal nerve stimulation","Transcutaneous cervical vagal nerve stimulation","Transcutaneous vagus nerve stimulation on both sides using handheld VNS device applied to skin over cervical part of nerve, identified by palpation of carotid artery. Initial 3 days of treatment given by researcher and paired with exposure; exposure comprised of patient-made voice recordings retelling traumatic experiences. Day 1 included neutral and trauma scripts and VNS; Days 2 & 3 included mental stress (public speaking and mental arithmetic) and VNS. Patients self-administered treatment at home twice daily for 3 months with the addition of traumatic script twice a week.","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person","5kHz sine bursts, repeated at frequency 25 Hz; peak output 0 to 30V, increased to maximum tolerable without pain","5 minutes (2 minutes per side, 1 minute rest interval)","Twice daily","13.4","3 days initial treatment + 3 months self-treatment",,,,,,,,,,,,,"Race data reported",,"65%","Mixed","Combat-related; Child sexual abuse; Rape/sexual assault; Community/school violence; Other (""injury or death of someone close to them; ""husband left for hockey game, never returned""; failed suicide; ""mother attempted suicide multiple times in childhood"")","Low","Bremner JD, Wittbrodt MT, Gurel NZ, et al. Transcutaneous cervical vagal nerve stimulation in patients with posttraumatic stress disorder (PTSD): a pilot study of effects on PTSD symptoms and interleukin-6 response to stress. J Affect Disord Rep. 2021 Dec;6:100190. doi: 10.1016/j.jadr.2021.100190. PMID: 34778863.","1583895","2023"
"bremner2021_B","bremner2021","Nonpharmacologic biological","2021","PTSD","Inactive Control",,"20","B","11",,"Sham transcutaneous cervical vagal nerve stimulation","Sham","Sham transcutaneous vagus nerve stimulation on both sides using handheld VNS device applied to skin over cervical part of nerve, identified by palpation of carotid artery. Initial 3 days of treatment given by researcher and paired with exposure; exposure comprised of patient-made voice recordings retelling traumatic experiences. Day 1 included neutral and trauma scripts and sham VNS; Days 2 & 3 included mental stress (public speaking and mental arithmetic) and sham VNS. Patients self-administered sham treatment at home twice daily for 3 months with the addition of traumatic script twice a week.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","0.2 Hz pulses producing a mild sensation; peak output 0 to 14V","5 minutes (2 minutes per side, 1 minute rest interval)","Twice daily","13.4","3 days initial treatment + 3 months self-treatment",,,,,,,,,,,,,"Race data reported",,"65%","Mixed","Combat-related; Child sexual abuse; Rape/sexual assault; Community/school violence; Other (""injury or death of someone close to them; ""husband left for hockey game, never returned""; failed suicide; ""mother attempted suicide multiple times in childhood"")","Low","Bremner JD, Wittbrodt MT, Gurel NZ, et al. Transcutaneous cervical vagal nerve stimulation in patients with posttraumatic stress disorder (PTSD): a pilot study of effects on PTSD symptoms and interleukin-6 response to stress. J Affect Disord Rep. 2021 Dec;6:100190. doi: 10.1016/j.jadr.2021.100190. PMID: 34778863.","1583895","2023"
"brocker2024_A","brocker2024","Other study class","2024","PTSD","PTSD",,"62","A","32",,"Counsellor-supported PTSD Coach","Internet-based facilitated self-help","Sessions with counsellor and using the PTSD Coach app. ""The registered counsellor was trained in a standard support method (assisting with language and technology difficulties and not providing therapeutic support)."" Sessions included review of the past week and homework, accessing and using selected portions of the application, and homework assignment. Participants were encouraged to use the app outside of sessions and to review material covered in the session. PTSD Coach app: free mobile application includes psychoeducation, symptom monitoring and management with 21 symptom management tools (e.g. mindfulness and stress management exercises), and encouragement to seek treatment if indicated.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Mixed",,"30 to 40 minutes","Weekly","4",,"Received full intervention (all 4 sessions)",,,,,,"3.81","0.535","4 sessions: 87.50% (28/32)
3 sessions: 6.25% (2/32)
2 sessions:  6.25% (2/32)
PTSD Coach app usage ranged from 70 to 86% for any use during past week (assessed and reported for each session separately)",,,,"Race data reported","Community","89%","Mixed","Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Other (""traumatic loss of loved one""; ""life-threatening injury"")","Low","Brocker E, Olff M, Suliman S, et al. A counsellor-supported 'PTSD Coach' intervention versus enhanced Treatment-as-Usual in a resource-constrained setting: A randomised controlled trial. Glob Ment Health (Camb). 2024;11:e7. doi: 10.1017/gmh.2023.92. PMID: 38283877.","1629857","2024"
"brocker2024_B","brocker2024","Other study class","2024","PTSD","Inactive Control",,"62","B","30",,"Enhanced TAU","Treatment as usual (TAU)","Detailed referral letter provided for psychological support in primary care setting. Counsellor contacted clinics and arranged appointments, followed up with participants on treatment accessed, and tracked symptoms including suicidality.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Weekly","4",,,,"After 4 week intervention period, 27% had received support or had scheduled appointments, 47% were still waiting for linkages to care at their local clinic and 23% were lost to follow-up",,,,,,,,,,"Race data reported","Community","89%","Mixed","Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Other (""traumatic loss of loved one""; ""life-threatening injury"")","Low","Brocker E, Olff M, Suliman S, et al. A counsellor-supported 'PTSD Coach' intervention versus enhanced Treatment-as-Usual in a resource-constrained setting: A randomised controlled trial. Glob Ment Health (Camb). 2024;11:e7. doi: 10.1017/gmh.2023.92. PMID: 38283877.","1629857","2024"
"brom1989_A","brom1989","Psychotherapy & CIH","1989","PTSD","PTSD",,"112","A","31",,"Trauma Desensitization","Exposure therapy","After the patient has learned relaxation techniques, they are encouraged to re-experience the traumatic event. The patient is then confronted with the previously avoided stimuli, which beforehand are categorized in hierarchies, and learns skills to strengthen the feeling of control.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,,,,,,,,,,"15","2.9",,,,,"Not reported","Community","79%","Mixed","accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)","High","Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.","03090","2019"
"brom1989_B","brom1989","Psychotherapy & CIH","1989","PTSD","PTSD",,"112","B","29",,"Hypnotherapy","Hypnotherapy","Treatment goal was to bring the patient in contact with the reality of the traumatic event and to bring about a decrease in the conditioned responses triggered by the event","No",,"No",,"Yes","Clinical hypnosis","No","No","No","No","No","Individual","In Person",,,,,,,,,,,,"14.4","1.4",,,,,"Not reported","Community","79%","Mixed","accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)","High","Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.","03090","2019"
"brom1989_C","brom1989","Psychotherapy & CIH","1989","PTSD","PTSD",,"112","C","29",,"Psychodynamic therapy","Psychodynamic psychotherapy","Aim of this therapy is limited to the solving of the intrapsychic conflicts resulting from the traumatic experience, with the therapist playing an active role.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,,,,,,,,,,"18.8","2.6",,,,,"Not reported","Community","79%","Mixed","accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)","High","Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.","03090","2019"
"brom1989_D","brom1989","Psychotherapy & CIH","1989","PTSD","Inactive Control",,"112","D","23",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"16",,,,,,,,,,,,,,"Not reported","Community","79%","Mixed","accidents, community/school violence, illness/medical procedure, other (loss of loved one, undefined)","High","Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol. 1989;57(5):607-12.  PMID: 2571625.","03090","2019"
"brom2017_A","brom2017","CIH","2017","PTSD","PTSD",,"63","A","33",,"Somatic Experiencing","Somatic Experiencing","Body awareness with psychotherapy","No",,"No",,"Yes","Other CIH","No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","15",,"Completed treatment",,"""completed the process""; n=5 discontinued during treatment period",,,,,,,,,,"Not reported","Community","50.7%","Mixed","combat-related, accidents, illness/medical procedure, community/school violence terrorism/political violence/forced displacement, other (death or injury of family member, threat)","Some Concerns","Brom D, Stokar Y, Lawi C, et al. Somatic experiencing for posttraumatic stress disorder: a randomized controlled outcome study. J Trauma Stress. 2017 Jun;30(3):304-12. doi: 10.1002/jts.22189. PMID: 28585761.","48274","2019"
"brom2017_B","brom2017","CIH","2017","PTSD","Inactive Control",,"63","B","30",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"15",,,,,,,,,,,,,,"Not reported","Community","50.7%","Mixed","combat-related, accidents, illness/medical procedure, community/school violence terrorism/political violence/forced displacement, other (death or injury of family member, threat)","Some Concerns","Brom D, Stokar Y, Lawi C, et al. Somatic experiencing for posttraumatic stress disorder: a randomized controlled outcome study. J Trauma Stress. 2017 Jun;30(3):304-12. doi: 10.1002/jts.22189. PMID: 28585761.","48274","2019"
"brunet2018_A","brunet2018","Other mixed","2018","PTSD","PTSD",,"61","A","30",,"Propranolol + traumatic memory reactivation","Propranolol + imaginal exposure (experimental paradigm)","Beta blocker taken 90 minutes prior to trauma reactivation; all patients in study underwent trauma reactivation, writing a trauma narrative at the first visit which they read aloud at each visit.","No",,"Yes","Antiadrenergic","No",,"No","No","No","Yes","No","Individual","In Person","1.67 mg/kg: 0.67 mg/kg short-acting plus 1.0 mg/kg long-acting",,"Weekly","6",,"completed ≥ 5 sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Community","58.33%","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Some Concerns","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"brunet2018_B","brunet2018","Other mixed","2018","PTSD","Active Control",,"61","B","31",,"Placebo + traumatic memory reactivation","Imaginal exposure (experimental paradigm) + placebo","All patients in study underwent trauma reactivation, writing a trauma narrative at the first visit which they read aloud at each visit 90 minutes after receiving medication.","No",,"No",,"No",,"No","No","Yes","Yes","No","Individual","In Person",,,"Weekly","6",,"completed ≥ 5 sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Community","58.33%","Mixed","combat-related. rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (war zone, captivity, life threat, sudden unexpected death, other trauma not specified)","Some Concerns","Brunet A, Saumier D, Liu A, et al. Reduction of PTSD Symptoms with pre-reactivation propranolol therapy: a randomized controlled trial. Am J Psychiatry. 2018 May 1doi: 10.1176/appi.ajp.2017.17050481. PMID: 29325446.","49661","2019"
"bryant2003_A","bryant2003","Psychotherapy","2003","PTSD","PTSD",,"58","A","20",,"Prolonged Imaginal Exposure with Cognitive Restructuring","Trauma-focused cognitive behavioral therapy (TF-CBT)","Psychoeducation and education about cognitive restructuring (first session); 6 sessions consisted of 25 minutes of cognitive restructuring including monitoring of thoughts and affective states, modifying thoughts, and identification and modification of underlying beliefs, followed by 45 minutes of imaginal exposure with patient-provided narrative of trauma experience, and homework included daily exercise of imaginal exposure; the final session focused om relapse prevention using both IE and CR strategies.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","8",,"completed treatment course",,,,,,,,,,,,"Not reported","Community","52%","Mixed","accidents, community/school violence","Some Concerns","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2003_B","bryant2003","Psychotherapy","2003","PTSD","Active Control",,"58","B","20",,"Imaginal Exposure","Imaginal exposure","Psychoeducation and trauma narrative (first session); 6 sessions consisted of 45 minutes of imaginal exposure with patient-provided narrative of trauma experience,25 minutes of supportive counseling, and monitored homework included daily exercise of imaginal exposure; the final session focused om relapse prevention using exposure-based strategies. Cognitive restructuring was not provided in any sessions.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Weekly","8",,"completed treatment course",,,,,,,,,,,,"Not reported","Community","52%","Mixed","accidents, community/school violence","Some Concerns","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2003_C","bryant2003","Psychotherapy","2003","PTSD","Active Control",,"58","C","18",,"Supportive Counseling","Supportive counseling","Therapy in unconditionally supportive role with trauma education and general problem-solving skills; homework to keep diary of current problems and mood states. Cognitive restructuring and imaginal exposure techniques were specifically avoided.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Weekly","8",,,,,,,,,,,,,,"Not reported","Community","52%","Mixed","accidents, community/school violence","Some Concerns","Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003 Aug;71(4):706.  PMID: 12924676.","25807","2019"
"bryant2008_A","bryant2008","Psychotherapy","2008","PTSD","Active Control",,"118","A","31",,"Imaginal Exposure","Imaginal exposure","Exposure to traumatic memories using personal narrative of trauma, discussion of exposure experience, and homework for daily repetition of exposure exercise with monitoring; relapse prevention using imaginal exposure-based strategies. Each session was comprised of: 40 minutes of imaginal exposure, 50 minutes of supportive counseling, and 10 minutes of homework assignments.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"100 minutes","Weekly","8",,"completed treatment course",,,,,,,,,,,,"Race data reported","Community",,"Mixed","accidents, community/school violence","High","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_B","bryant2008","Psychotherapy","2008","PTSD","Active Control",,"118","B","28",,"In vivo exposure","In vivo exposure","Hierarchy of feared situations, in vivo exercises during sessions when appropriate, and daily homework assignments for approaching and remaining in feared situations until anxiety decreased by 50%; relapse prevention using in vivo exposure-based strategies. Each session comprised of: 25 minutes in vivo exposure instructions, 65 minutes of supportive counseling, and 10 minutes of homework assignments.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"100 minutes","Weekly","8",,"completed treatment course",,,,,,,,,,,,"Race data reported","Community",,"Mixed","accidents, community/school violence","High","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_C","bryant2008","Psychotherapy","2008","PTSD","Active Control",,"118","C","31",,"Imaginal exposure + In vivo exposure","Trauma-focused cognitive behavioral therapy (TF-CBT)","Development of hierarchy of feared situations, imaginal exposure to traumatic memories, in vivo exposure exercises (in vivo exercises during sessions when appropriate, homework assignments for approaching and remaining in feared situations until anxiety decreased by 50%), and relapse prevention using both imaginal exposure and in vivo exposure strategies. Each session comprised of: 40 minutes of imaginal exposure, 25 minutes of in vivo exposure, 25 minutes of supportive counseling, and 10 minutes of homework assignments.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"100 minutes","Weekly","8",,"completed treatment course",,,,,,,,,,,,"Race data reported","Community",,"Mixed","accidents, community/school violence","High","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2008_D","bryant2008","Psychotherapy","2008","PTSD","PTSD",,"118","D","28",,"Imaginal exposure + In vivo exposure + Cognitive restructuring","Trauma-focused cognitive behavioral therapy (TF-CBT)","Sessions comprised of 25 minutes cognitive restructuring, 40 minutes of imaginal exposure, 25 minutes of in vivo exposure, and 10 minutes of homework assignments. Final session for relapse prevention using strategies from all 3 approaches.







Imaginal exposure: exposure to traumatic memories using personal narrative of trauma, discussion of exposure experience.







In vivo exposure: hierarchy of feared situations, in vivo exercises during sessions when appropriate, assignments to approaching and remaining in feared situations until anxiety decreased by 50%.







Cognitive restructuring: identification and monitoring of dysfunctional, unrealistic, and catastrophic thoughts, and affect states and use of Socratic questioning, probabilistic reasoning and evidence-based thinking to modify thoughts.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"100 minutes","Weekly","8",,"completed treatment course",,,,,,,,,,,,"Race data reported","Community",,"Mixed","accidents, community/school violence","High","Bryant RA, Moulds ML, Guthrie RM, et al. A randomized controlled trial of exposure therapy and cognitive restructuring for posttraumatic stress disorder. J Consult Clin Psychol. 2008 Aug;76(4):695-703. doi: 10.1037/a0012616. PMID: 18665697.","31196","2019"
"bryant2011_A","bryant2011","Psychotherapy","2011","PTSD","PTSD",,"28","A","16",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Individual sessions including education about trauma reactions, anxiety management techniques (including Thai meditation), prolonged imaginal exposure, in vivo exposure to avoided situations, cognitive restructuring (modified to recognize ongoing and realistic threat of terrorist attacks), and relapse prevention.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","8",,"Completed treatment",,"no treatment drop-outs",,,,"6.6","1",,,,,"Not reported","Community","96.43%","Terrorism/political violence/forced displacement",,"Some Concerns","Bryant RA, Ekassawin S, Chakkraband MLS, et al. A randomized controlled effectiveness trial of cognitive behavior therapy for post-traumatic stress disorder in terrorist-affected people in Thailand. World Psychiatry. 2011 Oct;10(3):205-9.  PMID: 21991280.","37395","2019"
"bryant2011_B","bryant2011","Psychotherapy","2011","PTSD","Active Control",,"28","B","12",,"TAU","Supportive counseling","Supportive counseling without anxiety management, exposure, or cognitive restructuring.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"60 minutes","Weekly","8",,"Completed treatment",,"no treatment drop-outs",,,,"5.5","2.5",,,,,"Not reported","Community","96.43%","Terrorism/political violence/forced displacement",,"Some Concerns","Bryant RA, Ekassawin S, Chakkraband MLS, et al. A randomized controlled effectiveness trial of cognitive behavior therapy for post-traumatic stress disorder in terrorist-affected people in Thailand. World Psychiatry. 2011 Oct;10(3):205-9.  PMID: 21991280.","37395","2019"
"bryant2013_A","bryant2013","Psychotherapy","2013","PTSD","PTSD",,"70","A","36",,"Emotion Regulation Training + CBT","Emotion Regulation Training followed by Trauma-focused cognitive behavioral therapy (TF-CBT)","Emotion regulation training (4 sessions) followed by CBT (7 sessions), with one introductory session for psychoeducation.







Emotion regulation training: individualized strategies with emotion tolerance skills, breathing retraining, or progressive muscle relaxation.







CBT: cognitive restructuring, imaginal exposure, in vivo exposure, hierarchy of feared events, and relapse prevention.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12",,"completed treatment",,,,,,,,"Emotion regulation training: 3.12 (1.26); CBT: 5.97 (3.00)",,,,"Race data reported","Community","54.29%","Mixed","accidents, community/school violence","High","Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.","40045","2019"
"bryant2013_B","bryant2013","Psychotherapy","2013","PTSD","Active Control",,"70","B","34",,"Supportive counseling + CBT","Supportive counseling followed by Trauma-focused cognitive behavioral therapy (TF-CBT)","Supportive counseling (4 sessions) followed by CBT (7 sessions), with one introductory session for psychoeducation.







Supportive counseling: non-directive with patient-led approach; avoided specific strategies and components of emotional regulation.







CBT: cognitive restructuring, imaginal exposure, in vivo exposure, hierarchy of feared events, and relapse prevention.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Weekly","12",,"completed treatment",,,,,,,,"Supportive counseling sessions: 2.98 (1.22)



CBT sessions: 4.24 (2.96)",,,,"Race data reported","Community","54.29%","Mixed","accidents, community/school violence","High","Bryant RA, Mastrodomenico JA, Hopwood S, et al. Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153-60. doi: 10.1017/S0033291713000068. PMID: 23406821.","40045","2019"
"bryant2019_A","bryant2019","Psychotherapy","2019","PTSD","PTSD",,"100","A","33",,"CBT with prolonged exposure","Trauma-focused cognitive behavioral therapy (TF-CBT)","CBT included psychoeducation, CBT skills building, prolonged imaginal exposure, in vivo exposure, cognitive restructuring and relapse prevention.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes with 40 minutes of imaginal exposure","Weekly","12",,"See Detail",,"Study reports treatment sessions attended but only for group including waitlist participants who received treatment after waiting period; stduy/asssessment completion reported (27/33 completed 3-month assessment)",,,,,,,,,,"Race data reported","Community","23%","Other","emergency service personnel including police, firefighters, and paramedics; exposure to fatality","Low","Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.","51039","2020"
"bryant2019_B","bryant2019","Psychotherapy","2019","PTSD","PTSD",,"100","B","33",,"CBT with brief exposure","Trauma-focused cognitive behavioral therapy (TF-CBT)","CBT included psychoeducation, CBT skills building, brief imaginal exposure, in vivo exposure, cognitive restructuring and relapse prevention.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes with 10 minutes of imaginal exposure","Weekly","12",,"See Detail",,"Study reports treatment sessions attended but only for group including waitlist participants who received treatment after waiting period; stduy/asssessment completion reported (29/33 completed 3-month assessment)",,,,,,,,,,"Race data reported","Community","23%","Other","emergency service personnel including police, firefighters, and paramedics; exposure to fatality","Low","Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.","51039","2020"
"bryant2019_C","bryant2019","Psychotherapy","2019","PTSD","Inactive Control",,"100","C","34",,"Waitlist","Waitlist","WL participants underwent a 3-month waiting period while CBT patients received treatment; WL patients then randomized to active treatment.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"12",,,,,,,,,,,,,,"Race data reported","Community","23%","Other","emergency service personnel including police, firefighters, and paramedics; exposure to fatality","Low","Bryant RA, Kenny L, Rawson N, et al. Efficacy of exposure-based cognitive behaviour therapy for post-traumatic stress disorder in emergency service personnel: a randomised clinical trial. Psychol Med. 2019 Jul;49(9):1565-73. doi: 10.1017/S0033291718002234. PMID: 30149825.","51039","2020"
"bryant2023_A","bryant2023","Other mixed","2023","PTSD","PTSD",,"130","A","65",,"Exposure therapy with aerobic exercise","Trauma-focused cognitive behavioral therapy (TF-CBT) + exercise","Sessions included psychoeducation (1st session), cognitive reframing with weekly homework (sessions 2-9), exposure therapy consisting of 20 minutes reliving the trauma memory (sessions 3-8), and in vivo exposure (sessions 4-9, not further described). Following each therapy session, therapist supervised participants in 20 minutes of aerobic exercise on a high-stepper exercise platform (about 10 minutes to achieve target heart rate and 10 minutes sustaining this exertion level).","Yes","Trauma-focused","No",,"No",,"No","No","No","Yes","No","Individual","In Person",,"110 minutes","Weekly","9","Each session 90 minutes exposure therapy + 20 minutes exercise","attended at least 8 sessions",,,,,,,,"Mean 8.1 (SD 2.1) attended across both groups",,,,"Race data reported","Community","61%","Mixed","Accidents; Community/school violence","Low","Bryant RA, Dawson KS, Azevedo S, et al. Augmenting trauma-focused psychotherapy for post-traumatic stress disorder with brief aerobic exercise in Australia: a randomised clinical trial. Lancet Psychiatry. 2023;10(1):21-9. doi: 10.1016/S2215-0366(22)00368-6. PMID: 36436532.","1609320","2023"
"bryant2023_B","bryant2023","Other mixed","2023","PTSD","Active Control",,"130","B","65",,"Exposure therapy with passive stretching","Trauma-focused cognitive behavioral therapy (TF-CBT) + stretching","Sessions included psychoeducation (1st session), cognitive reframing with weekly homework (sessions 2-9), exposure therapy consisting of 20 minutes reliving the trauma memory (sessions 3-8), and in vivo exposure (sessions 4-9, not further described). Following each therapy session, therapist instructed participants in 20 minutes of non-strenuous stretching of limbs.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"110 minutes","Weekly","9","Each session 90 minutes exposure therapy + 20 minutes stretching","attended at least 8 sessions",,,,,,,,"Mean 8.1 (SD 2.1) attended across both groups",,,,"Race data reported","Community","61%","Mixed","Accidents; Community/school violence","Low","Bryant RA, Dawson KS, Azevedo S, et al. Augmenting trauma-focused psychotherapy for post-traumatic stress disorder with brief aerobic exercise in Australia: a randomised clinical trial. Lancet Psychiatry. 2023;10(1):21-9. doi: 10.1016/S2215-0366(22)00368-6. PMID: 36436532.","1609320","2023"
"bryant2025_A","bryant2025","Psychotherapy","2025","PTSD","PTSD",,"100","A","50",,"TF-CBT + memory specificity training","Trauma-focused cognitive behavioral therapy (TF-CBT) + memory specificity training","Manualized therapy modeled on previous TF-CBT programs for first responders. Inlcuded psychoeducation about PTSD, training retrieval of specific memories, cognitive reframing, challenging maladaptive trauma-related thoughts, skills training to assist with specific problems (e.g. anger, panic, depression, sleep difficulties), in vivo exposure to avoided situations; imaginal exposure to the trauma memory, and relapse prevention. Participants were given a workbook to practice retrieval of positive memories between sessions.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12","total 12 sessions","See Detail",,"Study reports completion of study assessments/measurement, no information on treatment completion",,,,"10.2","3.4",,,,,"Race data reported","Community","29%",,,"Low","Bryant RA, Dawson KS, Yadav S, Tran J, Choi-Christou J, Rawson N, Tockar J, Stech E, Garber B, Broomfield C, Harrison A, Keyan D, Azevedo S. Augmenting trauma-focused cognitive behavior therapy for post-traumatic stress disorder with memory specificity training: a randomized controlled trial. World Psychiatry. 2025 Feb;24(1):113-119. doi: 10.1002/wps.21280. PMID: 39810665.","1643672","2025"
"bryant2025_B","bryant2025","Psychotherapy","2025","PTSD","Active Control",,"100","B","50",,"TF-CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","TF-CBT was the same as for TF-CBT + memory specificity group except participants received non-directive counseling instead of memory specificity training; no workbook for memory retrieval.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Weekly","12","total 12 sessions","See Detail",,"Study reports completion of study assessments/measurement, no information on treatment completion",,,,"10.6","2.7",,,,,"Race data reported","Community","29%",,,"Low","Bryant RA, Dawson KS, Yadav S, Tran J, Choi-Christou J, Rawson N, Tockar J, Stech E, Garber B, Broomfield C, Harrison A, Keyan D, Azevedo S. Augmenting trauma-focused cognitive behavior therapy for post-traumatic stress disorder with memory specificity training: a randomized controlled trial. World Psychiatry. 2025 Feb;24(1):113-119. doi: 10.1002/wps.21280. PMID: 39810665.","1643672","2025"
"buhmann2016_A","buhmann2016","Psychotherapy & pharmacotherapy","2016","PTSD","PTSD",,"280","A","71",,"CBT + sertraline and/or mianserin","Trauma-focused cognitive behavioral therapy (TF-CBT) + sertraline and/or mianserin","Manualized CBT including methods from acceptance and commitment therapy, mindfulness exercises, and in vivo and visualized exposure. Doctor adjusts SSRI and provides psychoeducation at each consultation, which was manualized and cover the illness, treatment, sleep, lifestyle, physical activity and social relations, pain, cognitive function, and influence of illness on the family. Patients have weekly consultation with doctor for first 2 months, then monthly consultation for 4 months. Participants reporting sleeping problems were supplemented with mianserin (atypical antipsychotic). Participants with too many side effects from sertraline were switched to mianserin.","Yes","Trauma-focused","Yes","Mixed","No",,"No","No","No","No","No","Individual","In Person","Sertraline: 25 to 200mg; titration: initial dose 2 mg, increased in 25 to 50 mg increments every 1 to 2 weeks with maximum dose of 200 mg



Mianserin: 10 to 30 mg",,"Psychotherapy: weekly







Sertraline/mianserin: daily","24","Psychotherapy: 16, Sertraline/mianserin: 24","Completed treatment",,"""completers"" reported in text, sum reported across arms matches number completed treatment reported in abstract results",,,,"11","3",,"Sertraline: 93.3 mg/day



Mianserin: 14.4 mg/day","Sertraline: 48



Mianserin: 7",,"Not reported","Community","41.01%","Terrorism/political violence/forced displacement",,"High","Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.","46863","2019"
"buhmann2016_B","buhmann2016","Psychotherapy & pharmacotherapy","2016","PTSD","PTSD",,"280","B","70",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Manualized CBT including methods from acceptance and commitment therapy, mindfulness exercises, and in vivo and visualized exposure.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,,"24","16 total sessions","Completed treatment",,"""completers"" reported in text, sum reported across arms matches number completed treatment reported in abstract results",,,,"13","3",,,,,"Not reported","Community","41.01%","Terrorism/political violence/forced displacement",,"High","Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.","46863","2019"
"buhmann2016_C","buhmann2016","Psychotherapy & pharmacotherapy","2016","PTSD","PTSD",,"280","C","71",,"Sertraline and/or mianserin","Sertraline and/or mianserin","Doctor adjusts SSRI and provides psychoeducation at each consultation, which was manualized and cover the illness, treatment, sleep, lifestyle, physical activity and social relations, pain, cognitive function, and influence of illness on the family. Patients have weekly consultation with doctor for first 2 months, then monthly consultation for 4 months. Participants reporting sleeping problems were supplemented with mianserin (atypical antipsychotic). Participants with too many side effects from sertraline were switched to mianserin","No",,"Yes","Mixed","No",,"No","No","No","No","No","Individual","In Person","Sertraline: 25 to 200mg; titration: initial dose 2 mg, increased in 25 to 50 mg increments every 1 to 2 weeks with maximum dose of 200 mg



Mianserin: 10 to 30 mg",,"Daily","24",,"Completed treatment",,"""completers"" reported in text, sum reported across arms matches number completed treatment reported in abstract results",,,,,,,"Sertraline: 95.2 mg



Mianserin: 14.4 mg","Sertraline: 58



Mianserin: 8",,"Not reported","Community","41.01%","Terrorism/political violence/forced displacement",,"High","Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.","46863","2019"
"buhmann2016_D","buhmann2016","Psychotherapy & pharmacotherapy","2016","PTSD","Inactive Control",,"280","D","68",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"24",,"Completed treatment",,"""completers"" reported in text, sum reported across arms matches number completed treatment reported in abstract results",,,,,,,,,,"Not reported","Community","41.01%","Terrorism/political violence/forced displacement",,"High","Buhmann CB, Nordentoft M, Ekstrom M, et al. The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016 Mar;208(3):252-9. doi: 10.1192/bjp.bp.114.150961. PMID: 26541687.","46863","2019"
"butler2018_A","butler2018","Psychotherapy & CIH","2018","PTSD","PTSD",,"20","A","11",,"EMDR + PMR + group psychoeducation","Eye Movement Desensitization and Reprocessing (EMDR) + progressive muscle relaxation (PMR) + group psychoeducation","Individual trauma-specific therapy sessions using EMDR, plus relaxation therapy using PMR, and group psychoeducation sessions. Participants also had occupational therapy (100 minutes per day), sports therapy (50 minutes per day), and physiotherapy (100 minutes per week).","Yes","Trauma-focused","No",,"Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"EMDR: 120 minutes;



PMR: 50 minutes;



Group psychoeducation: NR (total 250 minutes per week)","EMDR: twice per week; PMR: daily; Group psychoeducation: NR (total 250 minutes per week)","6",,"completed therapy",,,,,,,,,,,,"Not reported","Active Duty Military","0%","Combat-related",,"High","Butler O, Willmund G, Gleich T, et al. Hippocampal gray matter increases following multimodal psychological treatment for combat-related post-traumatic stress disorder. Brain Behav. 2018 May;8(5):e00956. doi: 10.1002/brb3.956. PMID: 29761009.","1508056","2020"
"butler2018_B","butler2018","Psychotherapy & CIH","2018","PTSD","Inactive Control",,"20","B","9",,"Waitlist","Waitlist","Waiting list control group","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"6",,,,,,,,,,,,,,"Not reported","Active Duty Military","0%","Combat-related",,"High","Butler O, Willmund G, Gleich T, et al. Hippocampal gray matter increases following multimodal psychological treatment for combat-related post-traumatic stress disorder. Brain Behav. 2018 May;8(5):e00956. doi: 10.1002/brb3.956. PMID: 29761009.","1508056","2020"
"butollo2016_A","butollo2016","Psychotherapy","2016","PTSD","PTSD",,"141","A","74",,"Dialogical Exposure Therapy","Dialogical Exposure Therapy","Based on gestalt therapy and consisted of 4 phases (safety, stability, confrontation, and integration). Therapist help patients identify and resolve the disruptions of contact so patient will be able to experience continuity of self and regain ability to shape interactions with the environment. Therapy includes exposure to traumatic event (confrontation phase)","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Flexible treatment frequency","27.8","mean 6.42 [SD 3.10] months, maximum 24 sessions","Completed treatment",,"4.1% did not start treatment, 8.1% dropped out of treatment",,,,"20.15","6.99","up to 24",,,,"Not reported","Community","65.96%","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","Some Concerns","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butollo2016_B","butollo2016","Psychotherapy","2016","PTSD","PTSD",,"141","B","67","74 randomized to CPT, excluded 7 patients treated as pilot case","CPT","Cognitive Processing Therapy (CPT)","CBT targeting dysfunctional cognitions about the traumatic event, includes written exposure component.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Flexible treatment frequency","27.6","mean 6.37 [SD 2.36] months, maximum 24 sessions","Completed treatment",,"6.0% declined treatment, 9.0% dropped out of treatment",,,,"20.39","6.8",,,,,"Not reported","Community","65.96%","Mixed","accidents, illness/medical procedure, other (""interpersonal"", ""loss"", not specified)","Some Concerns","Butollo WH, Karl R, König J, et al. A randomized controlled clinical trial of dialogical exposure therapy versus cognitive processing therapy for adult outpatients suffering from PTSD after type I trauma in adulthood. Psychother Psychosom. 2016 Jan;85(1):16-26. doi: 10.1159/000440726. PMID: 26610167.","45076","2020"
"butterfield2001_A","butterfield2001","Pharmacotherapy","2001","PTSD","PTSD",,"15","A","10",,"Olanzapine","Olanzapine","Atypical antipsychotic; binds to serotonin receptor subtypes with substantial affinities greater than its dopamine affinities. Effective serotonin receptor antagonist.","No",,"Yes","Antipsychotic","No",,"No","No","No","No","No","Individual","In Person","5 to 20 mg; titration: initial dose of 5 mg for 1 week, then 10 mg for 3 weeks, 15 mg for 2 weeks, up to potential maximum dose of 20 mg",,"Daily","10",,,,,,,,,,,"14.1 mg/day (mean peak daily dosage during study)",,,"Race data reported","Veteran","93.33%","Mixed","MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])","Some Concerns","Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.","23547","2019"
"butterfield2001_B","butterfield2001","Pharmacotherapy","2001","PTSD","Inactive Control",,"15","B","5",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Once daily","10",,,,,,,,,,,"13.9 mg (mean peak daily dosage during study)",,,"Race data reported","Veteran","93.33%","Mixed","MST, child physical abuse, rape/sexual assault, intimate partner violence, community/school violence, other (military harassment, ""nurse in Vietnam"", ""Persian Gulf"" [non-combat trauma])","Some Concerns","Butterfield M, Becker M, Connor K, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16(4):197-203.  PMID: 11459333.","23547","2019"
"capezzani2013_A","capezzani2013","Psychotherapy","2013","PTSD","PTSD",,"21","A","11",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Follows standard EMDR protocol (Shapiro 2001) including 8 stages. Goals include stabilization through psychoeducation, with resources including a ""safe place"" technique; identification and reprocessing of disturbing memories; and integration of resources into daily life.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Weekly","8",,"Did not drop out from treatment",,"""We did not have any patient dropouts from the treatment.""",,,,,,,,,,"Not reported","Community","90.48%","Illness/medical procedure",,"High","Capezzani L, Ostacoli L, Cavallo M, et al. EMDR and CBT for cancer patients: comparative study of effects on PTSD, anxiety, and depression. J EMDR Prac Res. 2013;7(3):134-43. doi: 10.1891/1933-3196.7.3.134.","87730","2025"
"capezzani2013_B","capezzani2013","Psychotherapy","2013","PTSD","Active Control",,"21","B","10",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Techniques/therapeutic approaches used according to symptoms, phase of psychotherapy: Rational Emotive Imagery (Ellis 1994), prolonged exposure (in vivo or imaginative), progressive relaxation with breathing exercises, homework, and diary entries. Goals include stabilization through psychoeducation; shifting attention from intrusive thoughts; and cognitive restructuring of negative thoughts.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Weekly","8",,"Did not drop out from treatment",,"""We did not have any patient dropouts from the treatment.""",,,,,,,,,,"Not reported","Community","90.48%","Illness/medical procedure",,"High","Capezzani L, Ostacoli L, Cavallo M, et al. EMDR and CBT for cancer patients: comparative study of effects on PTSD, anxiety, and depression. J EMDR Prac Res. 2013;7(3):134-43. doi: 10.1891/1933-3196.7.3.134.","87730","2025"
"capone2018_A","capone2018","Psychotherapy","2018","PTSD+SUD","PTSD+SUD","Integrated","44","A","21",,"Integrated CBT","Integrated Cognitive Behavioral Therapy (ICBT)","Manual-guided intervention designed to improve both PTSD and substance use, adapted for veterans and delivered in both individual and group format (sessions 1-4 delivered individually and sessions 5-12 in group format).","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,,,"total 12 sessions","attended ≥8 sessions",,,,,,"5.48",,,,,,"Race and Ethnicity data reported","Veteran","4.55%","Mixed","MST, combat-related, child sexual abuse, rape/sexual assault","High","Capone C, Presseau C, Saunders E, et al. Is integrated CBT effective in reducing PTSD symptoms and substance use in Iraq and Afghanistan veterans? Results from a randomized clinical trial. Cognit Ther Res. 2018;42(6):735-46. doi: 10.1007/s10608-018-9931-8.","50582","2020"
"capone2018_B","capone2018","Psychotherapy","2018","PTSD+SUD","Inactive Control","Not integrated","44","B","23",,"TAU","Treatment as usual (TAU)","Continuation of ""usual VA care, such as medication management and individual or group psychotherapy in the substance use treatment program or PTSD clinics…""; trauma-focused treatments were not prohibited but more often treatments included skills training or supportive therapy.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,,,,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","4.55%","Mixed","MST, combat-related, child sexual abuse, rape/sexual assault","High","Capone C, Presseau C, Saunders E, et al. Is integrated CBT effective in reducing PTSD symptoms and substance use in Iraq and Afghanistan veterans? Results from a randomized clinical trial. Cognit Ther Res. 2018;42(6):735-46. doi: 10.1007/s10608-018-9931-8.","50582","2020"
"carey2012_A","carey2012","Pharmacotherapy","2012","PTSD","PTSD",,"34","A",,,"Olanzapine","Olanzapine","Second-generation antipsychotic","No",,"Yes","Antipsychotic","No",,"No","No","No","No","No","Individual","In Person","10 to 15 mg; titration: 5 mg for first week, 7.5 mg for second week, then 10 mg for 2 weeks, dose maintained for next 4 weeks or titrated up to 15 mg",,"Daily","8",,,,,,,,,,,,,,"Not reported","Community","60.71%","Mixed","intimate partner violence, community/school violence","High","Carey P, Suliman S, Ganesan K, et al. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2012 Jul;27(4):386-91. doi: 10.1002/hup.2238. PMID: 22730105.","38996","2019"
"carey2012_B","carey2012","Pharmacotherapy","2012","PTSD","Inactive Control",,"34","B",,,"Placebo","Placebo","Matching placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","8",,,,,,,,,,,,,,"Not reported","Community","60.71%","Mixed","intimate partner violence, community/school violence","High","Carey P, Suliman S, Ganesan K, et al. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2012 Jul;27(4):386-91. doi: 10.1002/hup.2238. PMID: 22730105.","38996","2019"
"carlson1998_A","carlson1998","Psychotherapy & CIH","1998","PTSD","PTSD",,"35","A","10",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Manual-based intervention according to Shapiro 1995. Each session included 20 to 28 back-and-forth motions while participants listened to traumatic scripts and focused on related images, negative cognitions and bodily sensations, and finally on the positive cognition","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 to 75 minutes","Twice weekly","6",,"See Detail",,"study reports no participants dropped out after randomization and prior to posttreatment assessment, but unclear if dropout from treatment or from measurement",,,,,,,,,,"Race data reported","Veteran","0%","Combat-related",,"Some Concerns","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_B","carlson1998","Psychotherapy & CIH","1998","PTSD","PTSD",,"35","B","13",,"Biofeedback-assisted relaxation","Biofeedback-assisted relaxation","Electromyographic electrode placement and feedback administration followed manualized protocol by Carlson, Basilio, & Heaukulani 1983. Biofeedback included a pure tone on the  headphones. Participants were also given a recorded cassette containing modified progressive relaxation instructions and written instructions for daily home use","No",,"No",,"Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"40 minutes","Twice weekly","6",,"See Detail",,"n=1 participant dropped out after randomization and prior to posttreatment assessment, but unclear if dropout from treatment or from measurement",,,,,,,,,,"Race data reported","Veteran","0%","Combat-related",,"Some Concerns","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlson1998_C","carlson1998","Psychotherapy & CIH","1998","PTSD","Inactive Control",,"35","C","12",,"TAU waitlist","Treatment as usual (TAU)",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"6",,"See Detail",,"no participants dropped out after randomization and prior to posttreatment assessment, but unclear if dropout from treatment or from measurement",,,,,,,,,,"Race data reported","Veteran","0%","Combat-related",,"Some Concerns","Carlson JG, Chemtob CM, Rusnak K, et al. Eye Movement Desensitization and Reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder. J Trauma Stress. 1998 Jan;11(1):3-24. doi: 10.1023/A:1024448814268. PMID: 9479673.","13921","2019"
"carlsson2018_A","carlsson2018","Psychotherapy","2018","PTSD","PTSD",,"135","A","70","70 randomized, 62 with pretreatment data included for ITT sample","SIT","Stress Inoculation Training (SIT)","Manualized program including relaxation, attention diversion, and behavioral activation. Participants in both groups also received 10 sessions with a medical doctor for psychoeducation and pharmacotherapy.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"45 to 60 minutes",,"24","16 psychotherapy sessions total, mean duration 6.8 (SD 1.60) months (inclusive of the additional 10 sessions with medical doctor); treatment program aimed to last 6-7 months","completed ≥8 sessions",,"of n=70 randomized",,,,"11.3","4.14",,,,,"Not reported","Community","43.65%","Terrorism/political violence/forced displacement",,"Some Concerns","Carlsson J, Sonne C, Vindbjerg E, et al. Stress management versus cognitive restructuring in trauma-affected refugees - A pragmatic randomised study. Psychiatry Res. 2018 Aug;266:116-23. doi: 10.1016/j.psychres.2018.05.015. PMID: 29859498","1519484","2019"
"carlsson2018_B","carlsson2018","Psychotherapy","2018","PTSD","Active Control",,"135","B","70","70 randomized, 64 with pretreatment data included for ITT sample","CR","Trauma-focused cognitive behavioral therapy (TF-CBT)","Manualized intervention consisting of psychoeducation and cognitive restructuring of negative thoughts resulting from traumatic experiences and exposure. Participants in both groups also received 10 sessions with a medical doctor for psychoeducation and pharmacotherapy.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"45 to 60 minutes",,"24","16 psychotherapy sessions total, mean duration 6.8 (SD 1.84) months (inclusive of the additional 10 sessions with medical doctor); treatment program aimed to last 6-7 months","completed ≥8 sessions",,"of n=70 randomized",,,,"11.2","4.36",,,,,"Not reported","Community","43.65%","Terrorism/political violence/forced displacement",,"Some Concerns","Carlsson J, Sonne C, Vindbjerg E, et al. Stress management versus cognitive restructuring in trauma-affected refugees - A pragmatic randomised study. Psychiatry Res. 2018 Aug;266:116-23. doi: 10.1016/j.psychres.2018.05.015. PMID: 29859498","1519484","2019"
"carr2012_A","carr2012","CIH","2012","PTSD","PTSD",,"17","A","9",,"Music Therapy","Music therapy","Manualized group music therapy employing methods used in psychodynamic music therapy, combination of active and receptive activities and emphasis on free improvisation. Patients were introduced to instruments and encouraged to improvise and therapists gave improvised instrumental support; verbal reflection on thoughts and feelings was encouraged; therapists used supportive psychotherapeutic interventions; personal statements about symptoms were highlighted and made relevant to the whole group.","No",,"No",,"Yes","Creative therapies","No","No","No","No","No","Group","In Person",,"1 hour","Weekly","10",,"attended ≥7 sessions",,,,,,"7",,"range 2 to 9",,,,"Race data reported","Community","56.25%","Mixed","child sexual abuse, rape/sexual assault, community/school violence, terrorism/political violence/forced displacement, other (torture)","High","Carr C, D'Ardenne P, Sloboda A, et al. Group music therapy for patients with persistent post-traumatic stress disorder -- an exploratory randomized controlled trial with mixed methods evaluation. Psychol Psychother. 2012 Jun;85(2):179-202. doi: 10.1111/j.2044-8341.2011.02026.x. PMID: 22903909.","39454","2019"
"carr2012_B","carr2012","CIH","2012","PTSD","Inactive Control",,"17","B","8",,"Waitlist","Waitlist","Maintained on clinic caseload with access to mental health care; assessments conducted by telephone. Received music therapy intervention after waiting period and completion of end of evaluation assessment.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"10",,,,,,,,,,,,,,"Race data reported","Community","56.25%","Mixed","child sexual abuse, rape/sexual assault, community/school violence, terrorism/political violence/forced displacement, other (torture)","High","Carr C, D'Ardenne P, Sloboda A, et al. Group music therapy for patients with persistent post-traumatic stress disorder -- an exploratory randomized controlled trial with mixed methods evaluation. Psychol Psychother. 2012 Jun;85(2):179-202. doi: 10.1111/j.2044-8341.2011.02026.x. PMID: 22903909.","39454","2019"
"carter2013_A","carter2013","CIH","2013","PTSD","PTSD",,"31","A","16",,"Sudarshan Kriya Yoga","Yoga","Comprised of 3 rounds of cyclical breathing. Treatment also includes psychoeducation about stress reduction and group processes. Intervention consisted of a week-long workshop, followed by weekly group sessions for the first month and monthly group session for the next 5 months","No",,"No",,"Yes","Yoga","No","No","No","No","No","Group","In Person",,"22 hours total during weeklong workshop, 2 hours subsequent group session","Daily during weeklong workshop, weekly for subsequent 1 month, then monthly for next 5 months","24",,"Completed treatment",,"of n=16 randomized, n=1 withdrew before or during intervention; another n=1 refused post-intervention testing (considering this participant as completed treatment)",,,,,,,,,,"Not reported","Veteran","0%",,,"Some Concerns","Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.","46976","2019"
"carter2013_B","carter2013","CIH","2013","PTSD","Inactive Control",,"31","B","15",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"24",,,,,,,,,,,,,,"Not reported","Veteran","0%",,,"Some Concerns","Carter JJ, Gerbarg PL, Brown RP, et al. Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. J Trauma Stress Disord Treat. 2013 Jul 31;2(3)doi: 10.4172/2324-8947.1000108.","46976","2019"
"castillo2016_A","castillo2016","Psychotherapy","2016","PTSD","PTSD",,"86","A","44",,"Group-delivered Cognitive/Exposure Therapy","Trauma-focused cognitive behavioral therapy (TF-CBT)","Three-module treatment including imaginal exposure (trauma narrative writing and identification of coping strategies), cognitive restructuring (from CPT), and behavioral skills development","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"90 minutes",,"16",,"Treatment completion",,"flow diagram reports ""did not receive full tx"" (n=12) and ""received tx"" (n=32); treatment completion = ""received tx""",,,,,,,,,,"Race and Ethnicity data reported","Veteran","100%","Mixed","MST, combat-related, other (not specified)","Some Concerns","Castillo DT, Chee CL, Nason E, et al. Group-delivered cognitive/exposure therapy for PTSD in women veterans: a randomized controlled trial. Psychol Trauma. 2016 May;8(3):404-12. doi: 10.1037/tra0000111. PMID: 26854355.","44771","2019"
"castillo2016_B","castillo2016","Psychotherapy","2016","PTSD","Active Control",,"86","B","42",,"Waitlist with minimal intervention","Supportive counseling","Unstructured, nondirective individual support, which excluded treatment such as trauma review, cognitive restructuring, or behavioral treatment techniques","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","Mixed",,"60 minutes","Bimonthly","16",,,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","100%","Mixed","MST, combat-related, other (not specified)","Some Concerns","Castillo DT, Chee CL, Nason E, et al. Group-delivered cognitive/exposure therapy for PTSD in women veterans: a randomized controlled trial. Psychol Trauma. 2016 May;8(3):404-12. doi: 10.1037/tra0000111. PMID: 26854355.","44771","2019"
"celik2011_A","celik2011","Pharmacotherapy","2011","PTSD","PTSD",,"50","A","25",,"Paroxetine","Paroxetine","SSRI","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","60 mg; titration: initiated at 10 mg/day, increased by 10 mg every 2 weeks until 60 mg, then maintained for weeks 8 through 12 if tolerated and clinically indicated",,"Daily","12",,,,,,,,,,,,,,"Not reported","Community",,"Combat-related",,"High","Celik C, Ozdemir B, Ozmenler KN, et al. Efficacy of paroxetine and amitriptyline in posttraumatic stress disorder: an open-label comparative study. Klinik Psikofarmakol Bülteni. 2011 Sep;21(3):179-85. doi: 10.5455/bcp.20110627111141.","1519639","2019"
"celik2011_B","celik2011","Pharmacotherapy","2011","PTSD","PTSD",,"50","B","25",,"Amitriptyline","Amitriptyline","TCA","No",,"Yes","Antidepressant: TCA","No",,"No","No","No","No","No","Individual","In Person","Initiated at 25 mg/day for first 3 days, followed by 50 mg/day on days 4 to 7, then 75 mg/day for following 2 weeks. Dose could be increased to 100 mg/day as necessary for weeks 3 and 4, then to 200 mg/day at end of week 5",,"Daily","12",,,,,,,,,,,,,,"Not reported","Community",,"Combat-related",,"High","Celik C, Ozdemir B, Ozmenler KN, et al. Efficacy of paroxetine and amitriptyline in posttraumatic stress disorder: an open-label comparative study. Klinik Psikofarmakol Bülteni. 2011 Sep;21(3):179-85. doi: 10.5455/bcp.20110627111141.","1519639","2019"
"chard2005_A","chard2005","Psychotherapy","2005","PTSD","PTSD",,"71","A","36",,"CPT for sexual abuse survivor","Cognitive Processing Therapy (CPT)","Adapted from Resick & Schnicke's (1993) CPT manual to include schema-discrepant and schema-congruent beliefs, and a session on assertiveness/communications, sexual intimacy, and social support. Intervention included weekly group sessions and individual therapy session in the first 9 and last week of intervention","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Mixed","In Person",,"Group session: 90 minutes







Individual session: 60 minutes","Weekly","17",,"Treatment completion",,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Child sexual abuse",,"Some Concerns","Chard KM. An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J Consult Clin Psychol. 2005 Oct;73(5):965-71. doi: 10.1037/0022-006X.73.5.965. PMID: 16287396.","27944","2019"
"chard2005_B","chard2005","Psychotherapy","2005","PTSD","Inactive Control",,"71","B","35",,"Minimal attention waitlist","Minimal attention","Telephone call to assess current emotional state and give supportive, nondirective, brief counseling if experiencing a crisis","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Phone",,"5 to 10 minutes","Weekly","17",,,,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Child sexual abuse",,"Some Concerns","Chard KM. An evaluation of cognitive processing therapy for the treatment of posttraumatic stress disorder related to childhood sexual abuse. J Consult Clin Psychol. 2005 Oct;73(5):965-71. doi: 10.1037/0022-006X.73.5.965. PMID: 16287396.","27944","2019"
"chung2004_A","chung2004","Pharmacotherapy","2004","PTSD","PTSD",,"113","A",,,"Mirtazapine","Mirtazapine","Atypical antidepressant (alpha-2 agonist); dose could be adjusted after 1, 2, and 6 weeks of treatment","No",,"Yes","Antidepressant: Other","No",,"No","No","No","No","No","Individual","In Person","Initiated at 15 mg; maximum dose NR",,"Daily","6",,,,,,,,,,,"38.5 mg/day","12.1",,"Not reported","Veteran","0%","Combat-related",,"High","Chung MY, Min KH, Jun YJ, et al. Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial. Hum Psychopharmacol. 2004 Oct;19(7):489-94. doi: 10.1002/hup.615. PMID: 15378676.","26712","2019"
"chung2004_B","chung2004","Pharmacotherapy","2004","PTSD","PTSD",,"113","B",,,"Sertraline","Sertraline","SSRI; dose could be adjusted after 1, 2, and 6 weeks' therapy, maximum dose NR","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","Initiated at 50 mg; maximum dose NR",,"Daily","6",,,,,,,,,,,"115.3 mg/day","36.02",,"Not reported","Veteran","0%","Combat-related",,"High","Chung MY, Min KH, Jun YJ, et al. Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial. Hum Psychopharmacol. 2004 Oct;19(7):489-94. doi: 10.1002/hup.615. PMID: 15378676.","26712","2019"
"church2013_A","church2013","CIH","2013","PTSD","PTSD",,"59","A","30",,"Emotional Freedom Technique","Emotional Freedom Technique (EFT)","Brief exposure therapy with a somatic and cognitive component. The subject pairs the traumatic memory with a self-acceptance statement, then taps a sequence of points on his/her body repeatedly until subjective units of distress decreases to 0. All subjects also received the standard of care at VA.","No",,"No",,"Yes","Energy therapies","No","No","No","No","No","Individual","In Person",,"1 hour",,"4","6 sessions total","Completed intervention",,"Flow diagram notes n=1 dropped out after 3 sessions, remainder ""received EFT intervention"" (no other treatment dropouts noted)",,,,,,,,,,"Not reported","Veteran","10.17%",,,"High","Church D, Hawk C, Brooks AJ, et al. Psychological trauma symptom improvement in veterans using Emotional Freedom Techniques. J Nerv Ment Dis. 2013 Feb;201(2):153-60. doi: 10.1097/NMD.0b013e31827f6351. PMID: 23364126.","40000","2019"
"church2013_B","church2013","CIH","2013","PTSD","Inactive Control",,"59","B","29",,"Standard of care","Treatment as usual (TAU)",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"4",,,,"86.21% completed WL period",,,,,,,,,,"Not reported","Veteran","10.17%",,,"High","Church D, Hawk C, Brooks AJ, et al. Psychological trauma symptom improvement in veterans using Emotional Freedom Techniques. J Nerv Ment Dis. 2013 Feb;201(2):153-60. doi: 10.1097/NMD.0b013e31827f6351. PMID: 23364126.","40000","2019"
"classen2001_A","classen2001","Psychotherapy","2001","PTSD","PTSD",,"58","A",,,"Trauma-focused or Present-focused group therapy","Trauma-focused cognitive behavioral therapy (TF-CBT)","Both treatment groups combined for analysis.







Trauma-focused group therapy: goal of treatment is to help survivors work through and integrate their traumatic abuse experiences; involves: reconstructing traumatic experiences; integrating the affect associated with the trauma; modifying negative views of self which arose due to the abuse; integration of traumatic history into conscious awareness of self and others.







Present-focused group therapy: goal to help survivors identify and modify maladaptive patterns of behavior which had arisen as a result of their traumatic past; treatment assumption that by focusing on the present, survivors can alter their current functioning and thereby address the impact of their abuse history.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"90 minutes","Weekly","24",,,,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Child sexual abuse",,"High","Classen CC, Koopman C, Nevill-Manning K, et al. A preliminary report comparing trauma-focused and present-focused group therapy against a wait-listed condition among childhood sexual abuse survivors with PTSD. J Aggress Maltreat Trauma. 2001 Jun;4(2):265-88. doi: 10.1300/J146v04n02_12.","16145","2019"
"classen2001_B","classen2001","Psychotherapy","2001","PTSD","Inactive Control",,"58","B",,,"Waitlist","Waitlist",,"Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Group","In Person",,,,"24",,,,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Child sexual abuse",,"High","Classen CC, Koopman C, Nevill-Manning K, et al. A preliminary report comparing trauma-focused and present-focused group therapy against a wait-listed condition among childhood sexual abuse survivors with PTSD. J Aggress Maltreat Trauma. 2001 Jun;4(2):265-88. doi: 10.1300/J146v04n02_12.","16145","2019"
"cloitre2002_A","cloitre2002","Psychotherapy","2002","PTSD","PTSD",,"58","A","31",,"STAIR + modified PE","Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy","STAIR is CBT targeting development of emotion management and interpersonal skills. Topics include labeling and identifying feelings, emotion management, distress tolerance, acceptance of feelings, identification of trauma-based interpersonal schemas and conflict between trauma-generated feelings and current interpersonal goals, and role play related to issue of power and control. PE followed technique described by Foa & Rothbaum (1998), except in vivo exposure to rape-related cues was eliminated, while postexposure stabilization check, postexposure emotion-focused processing, and identification of negative interpersonal schemas and addressed with skills from STAIR.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"STAIR: 1 hour; Modified PE: 1.5 hour","STAIR: weekly; Modified PE: twice weekly","12",,,,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Mixed","child physical abuse, child sexual abuse","Some Concerns","Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.","24762","2019"
"cloitre2002_B","cloitre2002","Psychotherapy","2002","PTSD","Inactive Control",,"58","B","27",,"Minimal attention","Minimal attention","Study coordinator monitored participants through phone session","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Phone",,"15 minutes","Weekly","12",,,,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Mixed","child physical abuse, child sexual abuse","Some Concerns","Cloitre M, Koenen KC, Cohen LR, et al. Skills training in affective and interpersonal regulation followed by exposure: a phase-based treatment for PTSD related to childhood abuse. J Consult Clin Psychol. 2002 Oct;70(5):1067-74. doi: 10.1037//0022-006X.70.5.1067. PMID: 12362957.","24762","2019"
"cloitre2010_A","cloitre2010","Psychotherapy","2010","PTSD","PTSD",,"104","A","33",,"STAIR + Exposure Treatment","Skills Training in Affect and Interpersonal Regulation (STAIR) + exposure therapy","STAIR (8 sessions) followed by exposure treatment (8 sessions). Exposure treatment was modified from prolonged exposure protocol with interpersonal skills practice instead of in vivo exposure to trauma stimuli, and meaning analysis introduced after the exposure.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Weekly","16",,"completed treatment course",,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","High","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_B","cloitre2010","Psychotherapy","2010","PTSD","Active Control",,"104","B","38",,"STAIR + Supportive Counseling","Skills Training in Affect and Interpersonal Regulation (STAIR) + supportive therapy","STAIR (8 sessions) followed by supportive counseling (8 sessions). Supportive counseling with client-directed discussion of abuse history-related life problems.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Weekly","16",,"completed treatment course",,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","High","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2010_C","cloitre2010","Psychotherapy","2010","PTSD","Active Control",,"104","C","33",,"Supportive Counseling + Exposure Treatment","Supportive counseling + exposure","Supportive counseling (8 sessions) and exposure treatment (8 sessions). Supportive counseling with client-directed discussion of abuse history-related life problems. Exposure treatment was modified from prolonged exposure protocol with interpersonal skills practice instead of in vivo exposure to trauma stimuli, and meaning analysis introduced after the exposure.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Weekly","16",,"completed treatment course",,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Mixed","child physical abuse, child sexual abuse, child other abuse, intimate partner violence, rape/sexual assault, community/school violence, other (""other interpersonal victimization"")","High","Cloitre M, Stovall-McClough KC, Nooner K, et al. Treatment for PTSD related to childhood abuse: a randomized controlled trial. Am J Psychiatry. 2010 Aug;167(8):915-24. doi: 10.1176/appi.ajp.2010.09081247. PMID: 20595411.","34562","2020"
"cloitre2024_A","cloitre2024","Psychotherapy","2024","PTSD","PTSD",,"161","A","79","86 in Supplemental Table, unclear reason for discrepancy","STAIR","Skills Training in Affect and Interpersonal Regulation (STAIR)","Manualized, strengths-based treatment that ""focuses on
improving emotion management skills, interpersonal skills, and
social cognition."" Delivered virtually via videoconferencing. Five sessions on awareness and management of emotions; seven on interpersonal problems, including identifying & changing maladaptive relationship patterns, resolving conflict, and increasing intimacy; final session includes exercises in compassion for self and others. Homework includes practicing skills and tracking life events.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Video",,,"Weekly","12",,"""treatment completion"" (not further defined)",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","100%","MST",,"Low","Cloitre M, Morabito D, Macia K, et al. A home-based telehealth randomized controlled trial of skills training in affective and interpersonal regulation versus present-centered therapy for women veterans who have experienced military sexual trauma. J Consult Clin Psychol. 2024 Jan 15;15:15. doi: 10.1037/ccp0000872. PMID: 38227462.","1629715","2024"
"cloitre2024_B","cloitre2024","Psychotherapy","2024","PTSD","Active Control",,"161","B","82","88 in Supplemental Table, unclear reason for discrepancy","PCT","Present-Centered Therapy (PCT)","Treatment delivered virtually via videoconferencing; includes psychoeducation and discussion of client-initiated subjects, with clinician practicing active listening, reflection, and ""informal problem solving."" Homework included diary of daily activities.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","Video",,,"Weekly","12","""number and length of the sessions are adapted to be compatible with the
treatment being studied""","""treatment completion"" (not further defined)",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","100%","MST",,"Low","Cloitre M, Morabito D, Macia K, et al. A home-based telehealth randomized controlled trial of skills training in affective and interpersonal regulation versus present-centered therapy for women veterans who have experienced military sexual trauma. J Consult Clin Psychol. 2024 Jan 15;15:15. doi: 10.1037/ccp0000872. PMID: 38227462.","1629715","2024"
"coffey2006_A","coffey2006","Psychotherapy & CIH","2006","PTSD+SUD","PTSD+SUD",,"43","A",,,"Imaginal Exposure","Imaginal exposure","Manualized intervention according to Foa & Rothbaum 1998. Intervention includes participants repeatedly describe their trauma. All participants were required to be in alcohol addition treatment, not delivered as part of the study. Treatment at the centers from which participants were recruited was delivered outpatient and included three times per week group coping-skills-based therapy for addiction and once every 1 or 2 weeks individual treatment for addiction.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes",,,"6 sessions total","attending all laboratory and clinical sessions",,,,,,,,,,,,"Race data reported","Community","67.44%","Mixed","child physical abuse, child sexual abuse","High","Coffey SF, Stasiewicz PR, Hughes PM, et al. Trauma-focused imaginal exposure for individuals with comorbid posttraumatic stress disorder and alcohol dependence: revealing mechanisms of alcohol craving in a cue reactivity paradigm. Psychol Addict Behav. 2006 Dec;20(4):425-35. doi: 10.1037/0893-164X.20.4.425. PMID: 17176177.","34482","2019"
"coffey2006_B","coffey2006","Psychotherapy & CIH","2006","PTSD+SUD","Active Control",,"43","B",,,"Relaxation","Relaxation","Participants listened to an imagery-based relaxation audiotape during treatment session. All participants were required to be in alcohol addition treatment, not delivered as part of the study. Treatment at the centers from which participants were recruited was delivered outpatient and included three times per week group coping-skills-based therapy for addiction and once every 1 or 2 weeks individual treatment for addiction.","No",,"No",,"Yes","Relaxation","No","No","Yes","No","No","Individual","In Person",,"60 minutes",,,"6 sessions total","attending all laboratory and clinical sessions",,,,,,,,,,,,"Race data reported","Community","67.44%","Mixed","child physical abuse, child sexual abuse","High","Coffey SF, Stasiewicz PR, Hughes PM, et al. Trauma-focused imaginal exposure for individuals with comorbid posttraumatic stress disorder and alcohol dependence: revealing mechanisms of alcohol craving in a cue reactivity paradigm. Psychol Addict Behav. 2006 Dec;20(4):425-35. doi: 10.1037/0893-164X.20.4.425. PMID: 17176177.","34482","2019"
"coffey2016_A","coffey2016","Psychotherapy","2016","PTSD+SUD","PTSD+SUD","Not integrated","126","A","40",,"Modified PE with trauma-focused motivational enhancement session, plus standard SUD TAU","Motivational enhancement session followed by Prolonged Exposure (PE) + Treatment as usual (TAU) for substance use","Prior to first PE session, participants received a 90-minute motivational enhancement therapy consisting of eliciting/developing discrepancy, presenting feedback, and future directions. Traditional PE according to Foa et al. (2007) consisting of imaginal and in vivo exposure techniques, psychoeducation about PTSD and its relationship with SUD, and breathing retraining. If participant's PTSD symptoms did not decrease by 70% by the end of 9 sessions, additional 3 sessions were offered. Standard SUD treatment consisted of daily group therapy for 3 hours, daily recreation therapy, Alcohol Anonymous and Narcotics Anonymous meetings, individual drug counseling sessions, and completion of drug counseling homework.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Twice weekly","5 to 8",,"completed ≥8 sessions",,,,,,,,,,,,"Race data reported","Community","46.03%","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters","Some Concerns","Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.","48230","2019"
"coffey2016_B","coffey2016","Psychotherapy","2016","PTSD+SUD","PTSD+SUD","Not integrated","126","B","45",,"Modified PE plus standard SUD TAU","Prolonged Exposure (PE)","Prior to first PE session, participants received a 60-minute relaxation session. Traditional PE according to Foa et al. (2007) consisting of imaginal and in vivo exposure techniques, psychoeducation about PTSD and its relationship with SUD, and breathing retraining. If participant's PTSD symptoms did not decrease by 70% by the end of 9 sessions, additional 3 sessions were offered. Standard SUD treatment consisted of daily group therapy for 3 hours, daily recreation therapy, Alcohol Anonymous and Narcotics Anonymous meetings, individual drug counseling sessions, and completion of drug counseling homework.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Twice weekly","5 to 8",,"completed ≥8 sessions",,,,,,,,,,,,"Race data reported","Community","46.03%","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters","Some Concerns","Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.","48230","2019"
"coffey2016_C","coffey2016","Psychotherapy","2016","PTSD+SUD","Active Control","Not integrated","126","C","41",,"Healthy lifestyle sessions plus standard SUD TAU","Healthy lifetsyle session +  Treatment as usual (TAU) for substance use","Prior to first education session, participants received a 60-minute relaxation session. Education on health-related topics included sleep hygiene, progressive muscle relaxation, starting/maintaining an exercise program, personal role identification, healthy eating and nutrition, diabetes, monitoring goals and values, cancer, and HIV. If participant's PTSD symptoms did not decrease by 70% by the end of Session 9, additional 3 sessions were offered. Standard SUD treatment consisted of daily group therapy for 3 hours, daily recreation therapy, Alcohol Anonymous and Narcotics Anonymous meetings, individual drug counseling sessions, and completion of drug counseling homework.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"60 minutes","Twice weekly","5 to 8",,"completed ≥8 sessions",,,,,,,,,,,,"Race data reported","Community","46.03%","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, accidents, natural or manmade disasters","Some Concerns","Coffey SF, Schumacher JA, Nosen E, et al. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: a randomized controlled trial. Psychol. Addict Behav. 2016 Nov;30(7):778-90. doi: 10.1037/adb0000201. PMID: 27786516.","48230","2019"
"cohen2004_A","cohen2004","Nonpharmacologic biological","2004","PTSD","PTSD",,"29","A","10",,"Low frequency rTMS","Transcranial magnetic stimulation (TMS)","rTMS performed with Magstim stimulator with 9-cm diameter. Motor threshold was determined in each subject once which was defined as lowest stimulation intensity capable of inducing a visible movement at least five times out of 10. 







Treatment was administered over the right dorsolateral prefrontal cortex (defined as 5 cm anterior to the motor cortex - following a parasagittal line)







Stimulus intensity was 80% of subject's motor threshold intensity","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person","1 Hz for 5 seconds with intertrain interval of 55 seconds","20 minutes","Once daily on weekdays","2",,"Completed 10 TMS sessions",,,,,,,,,,,,"Not reported","Community","29%","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_B","cohen2004","Nonpharmacologic biological","2004","PTSD","PTSD",,"29","B","11",,"High frequency rTMS","Transcranial magnetic stimulation (TMS)","rTMS performed with Magstim stimulator with 9-cm diameter. Motor threshold was determined in each subject once which was defined as lowest stimulation intensity capable of inducing a visible movement at least five times out of 10. 







Treatment was administered over the right dorsolateral prefrontal cortex (defined as 5 cm anterior to the motor cortex - following a parasagittal line)







Stimulus intensity was 80% of subject's motor threshold intensity.","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person","1 Hz for 2 seconds per train with intertrain interval of 55 seconds","Session length: 20 minutes","Once daily on weekdays","2",,"Completed 10 TMS sessions",,,,,,,,,,,,"Not reported","Community","29%","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"cohen2004_C","cohen2004","Nonpharmacologic biological","2004","PTSD","Inactive Control",,"29","C","8",,"Sham rTMS","Sham","Sham rTMS","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"20 minutes","Once daily on weekdays","2",,"Completed 10 sham TMS sessions",,,,,,,,,,,,"Not reported","Community","29%","Mixed","combat-related, accidents, rape/sexual assault, community/school violence, other (occupational, unexpected death of relative)","High","Cohen H, Kaplan Z, Kotler M, et al. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2004 Mar;161(3):515-24. doi: 10.1176/appi.ajp.161.3.515. PMID: 14992978.","26291","2019"
"connor1999_A","connor1999","Pharmacotherapy","1999","PTSD","PTSD",,"54","A","27",,"Fluoxetine","Fluoxetine","SSRI; increased by 10 mg per week to maximum 60 mg/day based on response and tolerability","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","10 to 60 mg; titration: initiated at 10 mg, increased by 10 mg per week to maximum 60 mg",,"Daily","12",,,,,"Pill counts",,"95-99% for both groups",,,,,,"Median 30 mg (IQR 20 to 40 mg)","Race data reported","Community","91%","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters. other (traumatic bereavement, father in intensive care unit, witnessed emotional abuse)","High","Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999 Jul;175:17-22.  PMID: 10621763.","21108","2019"
"connor1999_B","connor1999","Pharmacotherapy","1999","PTSD","Inactive Control",,"54","B","27",,"Placebo","Placebo","Capsules matched fluoxetine and titration schedule the same","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","Initiated at 10 mg, titrated to maximum 60 mg",,"Daily","12",,,,,"Pill counts",,"95-99% for both groups",,,,,,"Median 40 mg equivalent (IQR 20 to 50 mg)","Race data reported","Community","91%","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters. other (traumatic bereavement, father in intensive care unit, witnessed emotional abuse)","High","Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999 Jul;175:17-22.  PMID: 10621763.","21108","2019"
"connor2006_A","connor2006","Pharmacotherapy","2006","PTSD","PTSD",,"18","A","10",,"Tiagabine","Tiagabine","Selective GABA reuptake inhibitor; initial 12-week open-label tiagabine treatment for all patients, those with at least minimal response or better on CGI-I scale randomized for continuation at same dose","No",,"Yes","Mood Stabilizer","No",,"No","No","No","No","No","Individual","In Person","2 to 16 mg; continued dose established in open-label phase (open-label phase titration: 2 mg for 1 week then increased by 4 mg increments per week with maximum 16 mg)",,"Daily","12",,,,,,,,,,,"10.8 mg/day",,,"Race data reported","Community","73.08%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)","High","Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.","29324","2019"
"connor2006_B","connor2006","Pharmacotherapy","2006","PTSD","Inactive Control",,"18","B","8",,"Placebo","Placebo","Matched placebo. Followed 12-week open-label tiagabine period, with those randomized to placebo tapered off tiagabine by 2 mg every 3 days.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,"10.5 mg tiagabine equivalent",,,"Race data reported","Community","73.08%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death of or threat of harm to a loved one; unwanted therapeutic abortion)","High","Connor KM, Davidson JRT, Weisler RH, et al. Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. Psychopharmacology (Berl). 2006 Jan;184(1):21-5. doi: 10.1007/s00213-005-0265-3. PMID: 16341846.","29324","2019"
"cook2010_A","cook2010","Psychotherapy","2010","PTSD","PTSD",,"124","A","61",,"Imagery Rehearsal","Imagery Rehearsal Training (IRT)","Veterans chose a repetitive nightmare related to their war-zone experiences, alter the nightmare script during waking hours using imagery techniques, and mentally research the revised script daily","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","6",,"completed 5 out of 6 sessions",,,,,,"4.1","2.29",,,,,"Race data reported","Veteran","0%","Combat-related",,"High","Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.","84153","2019"
"cook2010_B","cook2010","Psychotherapy","2010","PTSD","Active Control",,"124","B","63",,"Sleep and nightmare management","Sleep and nightmare management","Contains psychoeducation about PTSD nightmares and sleep disturbances and elements of CBT for insomnia","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Weekly","6",,"completed 5 out of 6 sessions",,,,,,"5.05","1.66",,,,,"Race data reported","Veteran","0%","Combat-related",,"High","Cook JM, Harb GC, Gehrman PR, et al. Imagery rehearsal for posttraumatic nightmares: a randomized controlled trial. J Trauma Stress. 2010 Oct;23(5):553-63. doi: 10.1002/jts.20569. PMID: 20839311.","84153","2019"
"cottraux2008_A","cottraux2008","Psychotherapy","2008","PTSD","PTSD",,"60","A","31",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Standard therapy including imaginal or in vivo exposure, relaxation techniques, and cognitive therapy targeting anxious cognitions, automatic thoughts, dysfunctional beliefs, vulnerability schemas and emotions related to the trauma","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 to 2 hours",,"16","10 to 16 sessions total","Completed treatment",,,,,,,,,,,,"Not reported","Community","76.19%","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)","High","Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.","30573","2019"
"cottraux2008_B","cottraux2008","Psychotherapy","2008","PTSD","Active Control",,"60","B","29",,"Rogerian supportive therapy","Supportive counseling","Therapy does not include any active component of CBT (e.g., relaxation, exposure advice, structured cognitive therapy). Therapist used active listening with an empathic attitude, and had unconditionally positive regard for the patients. Therapist reassured patients when they expressed anxiety and emphasize the importance to ventilate problems verbally","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"1 hour","Weekly","16",,"Completed treatment",,,,,,,,,,,,"Not reported","Community","76.19%","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (not specified)","High","Cottraux J, Note I, Yao S-N, et al. Randomized controlled comparison of cognitive behavior therapy with Rogerian supportive therapy in chronic post-traumatic stress disorder: a 2-year follow-up. Psychother Psychosom. 2008 Jan;77(2):101-10. doi: 10.1159/000112887. PMID: 18230943.","30573","2019"
"crespo2024_B","crespo2024","Psychotherapy","2024","PTSD","PTSD",,"91","A","44",,"Cognitive behavioral therapy with positive memory evocation (CBT-M+)","Trauma-focused cognitive behavioral therapy (TF-CBT) + positive memory evocation","Manualiized, multicomponent trauma-focused CBT with positive memory evocation. CBT included the following components: psychoeducation about IPV; breathing control training exercises; activity scheduling; techniques to improve self-esteem and re-evaluated biased cognitions; imaginal exposure; and, relapse prevention. Positive memory evocation task with positive autobiographical memories in sessions 4-7 after exposure to trauma memories, using breath control training to facilitate transition between tasks.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"100 to 145 minutes","Weekly","8","8 weekly sessions","Completed at least 5 of 8 sessions",,,,,,,,,,,,,"Community","100%","Intimate partner violence",,"High","Crespo M, Hernández-Lloreda MJ, Hornillos C, Miguel-Alvaro A, Sánchez-Ferrer S, Antón AA. Evocation of positive memories as complement to trauma-focused cognitive-behavioural therapy for intimate partner violence against women. Eur J Psychotraumatol. 2024;15(1):2419699. doi: 10.1080/20008066.2024.2419699. Epub 2024 Nov 12. PMID: 39529598.","1641191","2025"
"crespo2024_A","crespo2024","Psychotherapy","2024","PTSD","Active Control",,"91","B","35",,"Cognitive behavioral therapy (CBT) + placebo evocation task","Trauma-focused cognitive behavioral therapy (TF-CBT) + placebo","Manualiized, multicomponent trauma-focused CBT including the following components: psychoeducation about IPV; breathing control training exercises; activity scheduling; techniques to improve self-esteem and re-evaluated biased cognitions; imaginal exposure; and, relapse prevention. Also included a placebo task consisting of evocation of neutral images matching timing and duration for positive memory evocation task in CBT-M+ group.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Group","In Person",,"100 to 145 minutes","Weekly","8","8 weekly sessions","Completed at least 5 of 8 sessions",,,,,,,,,,,,,"Community","100%","Intimate partner violence",,"High","Crespo M, Hernández-Lloreda MJ, Hornillos C, Miguel-Alvaro A, Sánchez-Ferrer S, Antón AA. Evocation of positive memories as complement to trauma-focused cognitive-behavioural therapy for intimate partner violence against women. Eur J Psychotraumatol. 2024;15(1):2419699. doi: 10.1080/20008066.2024.2419699. Epub 2024 Nov 12. PMID: 39529598.","1641191","2025"
"crespo2024_C","crespo2024","Psychotherapy","2024","PTSD","Inactive Control",,"91","C","12",,"Waitlist","Waitlist","Waitlist","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"8",,,,,,,,,,,,,,,"Community","100%","Intimate partner violence",,"High","Crespo M, Hernández-Lloreda MJ, Hornillos C, Miguel-Alvaro A, Sánchez-Ferrer S, Antón AA. Evocation of positive memories as complement to trauma-focused cognitive-behavioural therapy for intimate partner violence against women. Eur J Psychotraumatol. 2024;15(1):2419699. doi: 10.1080/20008066.2024.2419699. Epub 2024 Nov 12. PMID: 39529598.","1641191","2025"
"dadabayev2020_A","dadabayev2020","Pharmacotherapy","2020","PTSD","PTSD",,"21","A","11",,"Ketamine","Ketamine","Single IV infusion of ketamine hydrochloride given over 40 minutes. 4 mg IV ondansetron given to all patients to prevent nausea and vomiting, a known side effect of ketamine.","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","0.5 mg/kg IV infusion",,"Once","0.14","single infusion; 0.5 mg/kg IV infusion given over 40 minutes",,,,,,"Single dose given",,,,,,"Single dose given","Race data reported","Veteran","38.1%","Other","""related to military service""","Low","Dadabayev AR, Joshi SA, Reda MH, et al. Low dose ketamine infusion for comorbid posttraumatic stress disorder and chronic pain: a randomized double-blind clinical trial. Chronic Stress (Thousand Oaks). 2020 Jan-Dec;4:2470547020981670. doi: 10.1177/2470547020981670. PMID: 33426410","1563929","2022"
"dadabayev2020_B","dadabayev2020","Pharmacotherapy","2020","PTSD","Active Control",,"21","B","10",,"Ketorolac","Ketorolac","Ketorolac reconstituted in 500 cc of normal saline and given over 40 minutes.  4 mg IV ondansetron given to all patients to prevent unblinding.","No",,"Yes","Other pharmacotherapy","No",,"No","No","Yes","No","No","Individual","In Person","15 mg IV infusion",,"Once","0.14","single infusion; 15 mg in 500 mL saline given over 40 minutes",,,,,,"Single dose given",,,,,,"Single dose given","Race data reported","Veteran","38.1%","Other","""related to military service""","Low","Dadabayev AR, Joshi SA, Reda MH, et al. Low dose ketamine infusion for comorbid posttraumatic stress disorder and chronic pain: a randomized double-blind clinical trial. Chronic Stress (Thousand Oaks). 2020 Jan-Dec;4:2470547020981670. doi: 10.1177/2470547020981670. PMID: 33426410","1563929","2022"
"darvish2019_A","darvish2019","Other study class","2019","PTSD","PTSD",,"66","A","33",,"Text messaging-based psychiatric nursing program","Text message-based facilitated self-help","Text messaging program for PTSD self-care. Contents included psychoeducation; addressing anxiety, intrusive thoughts, insomnia, and other PTSD symptoms; preventing thoughts of suicide; diet; substance use; relaxation and breathing exercises, and meditation. Contact information for psychiatric providers given to participants for direct communication as needed, and clinical psychiatry nurse also contacted participants monthly. Participants allowed to freely visit physician/psychiatrist.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology alone",,,,"26",,"See Detail",,"Unclear, reports loss to follow-up/intervention (n=4) but does not provide information on timing (if did not receive text intervention or only to post-treatment assessment)",,,,,,,,,,"Not reported","Veteran",,,,"High","Darvish A, Khodadadi-Hassankiadeh N, Abdoosti S, Ghapandar Kashani M. Effect of text messaging-based psychiatric nursing program on quality of life in veterans with post-traumatic stress disorder: a randomized controlled trial. Int J Community Based Nurs Midwifery. 2019 Jan;7(1):52-62. doi: 10.30476/IJCBNM.2019.40846. PMID: 30643833.","52052","2024"
"darvish2019_B","darvish2019","Other study class","2019","PTSD","Inactive Control",,"66","B","33",,"TAU","Treatment as usual (TAU)","Routine psychiatric care including mental support and initial treatment (e.g. medication, education, anger management, relaxation, and effective social relationship); able to freely visit physician/psychiatrist.","No",,"No",,"No",,"No","No","Yes","No","No","Individual",,,,,"26",,,,,,,,,,,,,,"Not reported","Veteran",,,,"High","Darvish A, Khodadadi-Hassankiadeh N, Abdoosti S, Ghapandar Kashani M. Effect of text messaging-based psychiatric nursing program on quality of life in veterans with post-traumatic stress disorder: a randomized controlled trial. Int J Community Based Nurs Midwifery. 2019 Jan;7(1):52-62. doi: 10.30476/IJCBNM.2019.40846. PMID: 30643833.","52052","2024"
"davidson1990_A","davidson1990","Pharmacotherapy","1990","PTSD","PTSD",,"46","A","25",,"Amitriptyline","Amitriptyline","TCA; variable dose with initial titration over 2 weeks followed by increase if necessary and tolerated; both groups received supportive therapy and medication management","No",,"Yes","Antidepressant: TCA","No",,"No","No","No","No","No","Individual","In Person","50 to 300 mg variable dose; titration: 50 mg increased in 25 mg increments to 100 mg over 1 week, by 50 mg increments to 200 mg over the following week, then increased if necessary as tolerated",,"Daily","8",,,,,,,,,,,"169 mg/day",,,"Not reported","Veteran",,"Combat-related",,"High","Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.","00912","2019"
"davidson1990_B","davidson1990","Pharmacotherapy","1990","PTSD","Inactive Control",,"46","B","21",,"Placebo","Placebo","Placebo; both groups received supportive therapy and medication management","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","8",,,,,,,,,,,"237 mg amitriptyline equivalent",,,"Not reported","Veteran",,"Combat-related",,"High","Davidson J, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990 Mar;47(3):259-66. PMID: 2407208.","00912","2019"
"davidson2001_A","davidson2001","Pharmacotherapy","2001","PTSD","PTSD",,"208","A","100",,"Sertraline","Sertraline","Flexible dose sertraline based on clinical response and tolerability with 1 week run-in period at 25 mg dose.","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","50 to 200 mg; titration: 1 week run-in at 25 mg",,"Daily","12",,,,,"pill counts of returned medication",,,,,,"146 mg/day","49.3",,"Race data reported","Community","77.88%","Mixed","accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")","Some Concerns","Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.","23358","2019"
"davidson2001_B","davidson2001","Pharmacotherapy","2001","PTSD","Inactive Control",,"208","B","108",,"Placebo","Placebo","Matched placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,"pill counts of returned medication",,,,,,,,,"Race data reported","Community","77.88%","Mixed","accidents, rape/sexual assault, combat-related, natural or manmade disasters, community/school violence, other (""seeing someone hurt or die"", ""other event"")","Some Concerns","Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001 May;58(5):485-92. PMID: 11343529.","23358","2019"
"davidson2003_A","davidson2003","Pharmacotherapy","2003","PTSD","PTSD",,"29","A","17",,"Mirtazapine","Mirtazapine","Atypical antidepressant","No",,"Yes","Antidepressant: Other","No",,"No","No","No","No","No","Individual","In Person","45 mg; titration: 15 mg starting dose titrated weekly up to 45 mg",,"Once daily","8",,,,,,,,,,,"38.82 mg/day",,,"Not reported","Community","65%","Mixed","child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)","High","Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.","25290","2019"
"davidson2003_B","davidson2003","Pharmacotherapy","2003","PTSD","Inactive Control",,"29","B","9",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Once daily","8",,,,,,,,,,,,,,"Not reported","Community","65%","Mixed","child sexual abuse, community/school violence, combat-related, accidents, other (non-specified)","High","Davidson JR, Weisler RH, Butterfield MI, et al. Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. Biol Psychiatry. 2003 Jan 15;53(2):188-91. PMID: 12547477.","25290","2019"
"davidson2006a_A","davidson2006a","Pharmacotherapy","2006","PTSD","PTSD",,"329","A","161",,"Venlafaxine extended release","Venlafaxine","Extended release SNRI; flexible dosing based on tolerability titrated to achieve remission (CAPS-SX17 ≤ 20)","No",,"Yes","Antidepressant: SNRI","No",,"No","No","No","No","No","Individual","In Person","75 to 300 mg flexible dosing; titration: lead-in dose 37.5 mg increased to maximum doses of 75 mg at day 5, 150 mg at day 14, 225 mg at day 28, and 300 mg at day 42",,"Daily","24",,,,,,,,,,,"Mean average daily: 181.7 mg/day



Mean maximum: 221.5 mg/day",,,"Not reported","Community","54.1%","Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, natural or manmade disasters, other (nonsexual abuse, witnessing unexpected death)","High","Davidson JRT, Baldwin DV, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006 Oct;63(10):1158-65. doi: 10.1001/archpsyc.63.10.1158. PMID: 17015818.","28838","2019"
"davidson2006a_B","davidson2006a","Pharmacotherapy","2006","PTSD","Inactive Control",,"329","B","168",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","24",,,,,,,,,,,,,,"Not reported","Community","54.1%","Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, natural or manmade disasters, other (nonsexual abuse, witnessing unexpected death)","High","Davidson JRT, Baldwin DV, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006 Oct;63(10):1158-65. doi: 10.1001/archpsyc.63.10.1158. PMID: 17015818.","28838","2019"
"davidson2006b_A","davidson2006b","Pharmacotherapy","2006","PTSD","PTSD",,"538","A","179",,"Venlafaxine extended release","Venlafaxine","Extended release SNRI; flexible dosing 75 to 300 mg based on efficacy and tolerability to achieve remission (CAPS-SX17 score ≤20)","No",,"Yes","Antidepressant: SNRI","No",,"No","No","No","No","No","Individual","In Person","75 to 300 mg; titration: 37.5 mg lead-in dose, increased to maximum daily dose of 75 mg at day 5, 150 mg at day 14, 225 mg at day 28, and 300 mg at day 42.",,"Daily","12",,,,,,,,,,,"Mean average daily: 164.4 mg/day



Mean maximum: 224.6 mg/day",,,"Not reported","Community",,"Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (""unexpected death"")","High","Davidson JRT, Rothbaum BO, Tucker PM, et al. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006 Jun 1;26(3):259-67. doi: 10.1097/01.jcp.0000222514.71390.c1. PMID: 16702890.","28788","2019"
"davidson2006b_B","davidson2006b","Pharmacotherapy","2006","PTSD","PTSD",,"538","B","173",,"Sertraline","Sertraline","SSRI; flexible dose following within-label dosing guidelines for sertraline for PTSD; lead-in dose of 25 mg/day, increased based on efficacy and tolerability to achieve remission (CAPS-SX17 score ≤20) with maximum doses of 50 mg/day at day 5, 100 mg/day at day 14, 150 mg/day at day 28, and 200 mg/d at day 42.","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","50 to 200 mg; titration: 25 mg lead-in dose, increased to maximum daily dose of 50mg at day 5, 100 mg at day 14, 150 mg at day 28, and 200 mg at day 42.",,"Daily","12",,,,,,,,,,,"Mean average daily: 110.2 mg/day



Mean maximum: 151.4 mg/day",,,"Not reported","Community",,"Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (""unexpected death"")","High","Davidson JRT, Rothbaum BO, Tucker PM, et al. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006 Jun 1;26(3):259-67. doi: 10.1097/01.jcp.0000222514.71390.c1. PMID: 16702890.","28788","2019"
"davidson2006b_C","davidson2006b","Pharmacotherapy","2006","PTSD","Inactive Control",,"538","C","179",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,,,,"Not reported","Community",,"Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (""unexpected death"")","High","Davidson JRT, Rothbaum BO, Tucker PM, et al. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006 Jun 1;26(3):259-67. doi: 10.1097/01.jcp.0000222514.71390.c1. PMID: 16702890.","28788","2019"
"davidson2007_A","davidson2007","Pharmacotherapy","2007","PTSD","PTSD",,"232","A","116",,"Tiagabine","Tiagabine","Anticonvulsant; during titration, doses were increased unless medication adverse events, not expected to increase efficacy, or not desired by the patient.","No",,"Yes","Mood Stabilizer","No",,"No","No","No","No","No","Individual","In Person","16 mg; titration: 4 mg/day for 1 week, individually titrated in up to 4 mg increments weekly to maximum of 16 mg, no dose increases after week 6",,"Twice daily","12",,,,,,,,,,,"11.2 mg/day",,,"Not reported","Community","66%","Mixed","rape/sexual assault, community/school violence, accidents, combat-related, natural or manmade disasters, other (non-specified)","High","Davidson JR, Brady K, Mellman TA, et al. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. J Clin Psychopharmacol. 2007 Feb;27(1):85-8. doi: 10.1097/JCP.0b013e31802e5115. PMID: 17224720.","29658","2019"
"davidson2007_B","davidson2007","Pharmacotherapy","2007","PTSD","Inactive Control",,"232","B","116",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Twice daily","12",,,,,,,,,,,"11.8 mg/day equivalent",,,"Not reported","Community","66%","Mixed","rape/sexual assault, community/school violence, accidents, combat-related, natural or manmade disasters, other (non-specified)","High","Davidson JR, Brady K, Mellman TA, et al. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. J Clin Psychopharmacol. 2007 Feb;27(1):85-8. doi: 10.1097/JCP.0b013e31802e5115. PMID: 17224720.","29658","2019"
"davis2004_A","davis2004","Pharmacotherapy","2004","PTSD","PTSD",,"42","A","27",,"Nefazodone","Nefazodone","Phenylpiperazine derivative; presynaptic serotonin reuptake inhibitor, postsynaptic 5-hydroxytryptamine 2A receptor antagonist, with modest norepinephrine uptake inhibition","No",,"Yes","Antidepressant: Other","No",,"No","No","No","No","No","Individual","In Person","200 to 600 mg total daily dose; initial dose 200 mg titrated in increments of 100 mg every 4 days as tolerated to maximum therapeutic benefit, with a maximum dose of 600 mg",,"Twice daily","12",,,,,,,,,,,"435 mg/day",,,"Race data reported","Mixed","2.38%","Mixed","combat-related, rape/sexual assault","Some Concerns","Davis LL, Jewell ME, Ambrose S, et al. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol. 2004;24(3):291-7.  PMID: 15118483.","26401","2019"
"davis2004_B","davis2004","Pharmacotherapy","2004","PTSD","Inactive Control",,"42","B","15",,"Placebo","Placebo","Look-a-like placebo capsules","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Twice daily","12",,,,,,,,,,,,,,"Race data reported","Mixed","2.38%","Mixed","combat-related, rape/sexual assault","Some Concerns","Davis LL, Jewell ME, Ambrose S, et al. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study. J Clin Psychopharmacol. 2004;24(3):291-7.  PMID: 15118483.","26401","2019"
"davis2008a_A","davis2008a","Pharmacotherapy","2008","PTSD","PTSD",,"36","A","18",,"Guanfacine","Guanfacine","Centrally-acting alpha-2 agonist; increased from 1 to 2 mg based on symptoms and side effects, as tolerated","No",,"Yes","Antiadrenergic","No",,"No","No","No","No","No","Individual","In Person","1 to 2 mg",,"Daily","8",,,,,,,,,,,"2 mg",,,"Race data reported","Veteran","5.71%","Combat-related",,"Some Concerns","Davis LL, Ward C, Rasmusson A, et al. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull. 2008;41(1):8-18.  PMID: 18362867.","34102","2019"
"davis2008a_B","davis2008a","Pharmacotherapy","2008","PTSD","Inactive Control",,"36","B","18",,"Placebo","Placebo","Placebo intervention not described;  trial reported as double-blind","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","8",,,,,,,,,,,,,,"Race data reported","Veteran","5.71%","Combat-related",,"Some Concerns","Davis LL, Ward C, Rasmusson A, et al. A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. Psychopharmacol Bull. 2008;41(1):8-18.  PMID: 18362867.","34102","2019"
"davis2008b_A","davis2008b","Pharmacotherapy","2008","PTSD","PTSD",,"85","A","44",,"Divalproex","Divalproex","Increases GABA levels in brain; enteric-coated, delayed release; dose increased as tolerated to maximum benefit","No",,"Yes","Mood Stabilizer","No",,"No","No","No","No","No","Individual","In Person","1000 to 3000 mg total daily dose; titration: initial dose 500 mg twice a day, increased in 500-mg increments with maximum dose 3000 mg/day",,"Daily (2 divided doses)","8",,,,,"Blinded serum valproic acid morning trough levels",,"serum level 82.9 (30.1) mg/L at week 8 (authors conclude that ""compliance may have been variable"")",,,,"2309 mg daily","508",,"Not reported","Veteran","2.44%","Mixed","combat-related, other (non-specified)","Low","Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347","30463","2019"
"davis2008b_B","davis2008b","Pharmacotherapy","2008","PTSD","Inactive Control",,"85","B","44",,"Placebo","Placebo","Visually identical to divalproex tablets","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Twice daily","8",,,,,"Technician provided sham reports for morning trough levels for placebo group",,,,,,,,,"Not reported","Veteran","2.44%","Mixed","combat-related, other (non-specified)","Low","Davis LL, Davidson JR, Ward LC, et al. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol. 2008 Feb;28(1):84-8. doi: 10.1097/JCP.0b013e318160f83b. PMID: 18204347","30463","2019"
"davis2018_A","davis2018","Psychotherapy & CIH","2018","PTSD","PTSD",,"214","A","107",,"MBSR","Mindfulness-based stress reduction (MBSR)","MBSR sessions included body scan meditation, sitting meditation, and mindful stretching. Six-hour retreat prior to week 6 included extended practices and mindful walking and eating. Participants given two guided meditation CDs to practice at home.","No",,"No",,"Yes","Meditation","No","No","No","No","No","Group","In Person",,"Sessions: 90 minutes; Retreat: 6 hours","Sessions: weekly; Retreat: once","8",,"completed all 8 sessions",,,,,,,,,,,,"Race data reported","Veteran","16.2%","Mixed","Combat-related; Rape/sexual assault; Other (noncombat military, civilian)","Some Concerns","Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..","51046","2020"
"davis2018_B","davis2018","Psychotherapy & CIH","2018","PTSD","Active Control",,"214","B","107",,"Present-centered group therapy","Present-Centered Therapy (PCT)","Therapy was psycho-educational and addressed symptoms of PTSD and the effects of PTSD on daily life. Allowed shared support and positive experiences with other veterans. The groups had a present focus that avoided discussion of traumas. Participants were assigned to keep a journal and had a lunch gathering to partially control for the MBSR retreat.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Group","In Person",,"Sessions: 90 minutes; Lunch: 2 hours","Sessions: weekly; Lunch: once","8",,"completed all 8 sessions",,,,,,,,,,,,"Race data reported","Veteran","16.2%","Mixed","Combat-related; Rape/sexual assault; Other (noncombat military, civilian)","Some Concerns","Davis LL, Whetsell C, Hamner MB, et al. A multisite randomized controlled trial of mindfulness-based stress reduction in the treatment of posttraumatic stress disorder. Psychiatric Research and Clinical Practice. 2018b Nov 5;1(2):39-48. doi: 10.1176/appi.prcp.20180002..","51046","2020"
"davis2020a_A","davis2020a","Other mixed","2020","PTSD","PTSD",,"212","A","108",,"Holistic yoga program","Yoga","Yoga instruction including components of Hatha Yoga: postures (asanas), breathing practices (pranayama), and relaxation. Home practice support included instructional DVD and audio device, handout with figures depicting sequence of poses, and a yoga mat and eye pillow.","No",,"No",,"Yes","Yoga","No","No","No","No","No","Mixed","In Person",,"Session (class) length: 90 minutes","Weekly","16",,"Completed 8 or more sessions",,"also reports number that completed 7 or fewer sessions (n=44), and those that did not receive any yoga (n=10)",,,,,,,,,,"Race data reported","Mixed","34%","Mixed","MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)","High","Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.","1552693","2020"
"davis2020a_B","davis2020a","Other mixed","2020","PTSD","Active Control",,"212","B","101",,"Wellness lifestyle program","Wellness lifestyle program","Designed primarily as an attention control, but in order for the program to be perceived as a credible treatment, it matched the physical activity of the yoga program with low intensity walking in addition to didactics and discussion of wellness topics","No",,"No",,"No",,"No","No","Yes","Yes","No","Mixed","In Person",,"Session (class) length: 90 minutes","Weekly","16",,"Completed 8 or more sessions",,"flow diagram (supplemental materials); also reports number that completed 7 or fewer sessions (n=44), and those that did not receive any wellness sessions (n=10)",,,,,,,,,,"Race data reported","Mixed","34%","Mixed","MST; Combat-related; Rape/sexual assault; Other (childhood, not specified; other adult, not specified)","High","Davis LW, Schmid AA, Daggy JK, et al. Symptoms improve after a yoga program designed for PTSD in a randomized controlled trial with veterans and civilians. Psychol Trauma. 2020 Apr 20 doi: https://dx.doi.org/10.1037/tra0000564. PMID: 32309986.","1552693","2020"
"davis2020b_A","davis2020b","Pharmacotherapy","2020","PTSD","PTSD",,"78","A","39",,"Mirtazapine","Mirtazapine","Mirtazapine, minimum target dose 30 mg/day; initiated at 15 mg for one week, increased by 15 mg each week as tolerated to a maximum of 45 mg daily.","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","Dose: 15 to 45 mg/day



Titration: initiated at 15 mg/day, increased weekly by 15 mg to maximum 45 mg/day; minimum target dose 30 mg/day",,"Daily","8",,,,,"compliance monitored by pill count",,,,,,"38.5 mg/day","10.5",,"Race and Ethnicity data reported","Veteran","6.4%","Mixed","Combat-related, Other (not specified)","Low","Davis LL, Pilkinton P, Lin C, et al. A randomized, placebo-controlled trial of mirtazapine for the treatment of posttraumatic stress disorder in veterans. J Clin Psychiatry. 2020 10 20;81(6):20. doi: 10.4088/JCP.20m13267. PMID: 33084254","1560536","2022"
"davis2020b_B","davis2020b","Pharmacotherapy","2020","PTSD","Inactive Control",,"78","B","39",,"Placebo","Placebo","Placebo matched in appearance and following same dosing (titration, maximum dosing) as mirtazapine","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","8",,,,,"compliance monitored by pill count",,,,,,,,,"Race and Ethnicity data reported","Veteran","6.4%","Mixed","Combat-related, Other (not specified)","Low","Davis LL, Pilkinton P, Lin C, et al. A randomized, placebo-controlled trial of mirtazapine for the treatment of posttraumatic stress disorder in veterans. J Clin Psychiatry. 2020 10 20;81(6):20. doi: 10.4088/JCP.20m13267. PMID: 33084254","1560536","2022"
"davis2021_A","davis2021","Psychotherapy","2021","PTSD","PTSD",,"92","A","46","23 couples","Mindfulness-based CBCT","Cognitive Behavioral Conjoint Therapy (CBCT)","Manualized mindfulness-based adaptation of CBCT for couples, with Phases 1 and 2 given via multicouple group therapy during weekend retreats (7 sessions), followed by 9 individual couple sessions including Phase 3 of CBCT. Phases 1 and 2 include awareness training, and education about PTSD and relationships, communication, anger, conflict management, and approaching rather than avoiding trauma-related issues. Phase 3 facilitates making meaning of the trauma and challenging trauma-related cognitions. Mindfulness integrated throughout CBCT protocol.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Mixed","In Person",,"Phase 1 & 2: NR for sessions, 2 days for retreat



Post-retreat: 90 minutes (total 13.5 hours, 9 sessions)","Phase 1 & 2: 7 sessions over 2 days



Phase 3: weekly","10",,"completed treatment",,,,,,,,,,,,"Race data reported","Veteran","10.87%","Mixed","Combat-related; Other (TBI)","High","Davis LW, Luedtke BL, Monson C, et al. Testing adaptations of cognitive-behavioral conjoint therapy for PTSD: a randomized controlled pilot study with veterans. Couple Family Psychol. 2021 Jun;10(2):71-86. doi: 10.1037/cfp0000148.","1571223","2022"
"davis2021_B","davis2021","Psychotherapy","2021","PTSD","Active Control",,"92","B","46","23 couples","CBCT with communication skills training","Cognitive Behavioral Conjoint Therapy (CBCT)","Modified version of CBCT for couples, including communication skills training from Phases 1 and 2 given via multicouple group therapy during weekend retreats (7 sessions), followed by two more multicouple group sessions reviewing communication skills. No PTSD-specific or mindfulness interventions.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Mixed","In Person",,"Phase 1 & 2: NR for sessions, 2 days for retreat



Follow-up sessions: 90 minutes","Phase 1 & 2: 7 sessions over 2 days



Follow-up: 2 sessions 1 month apart","8","retreat followed by 2 monthly sessions","completed treatment",,,,,,,,,,,,"Race data reported","Veteran","10.87%","Mixed","Combat-related; Other (TBI)","High","Davis LW, Luedtke BL, Monson C, et al. Testing adaptations of cognitive-behavioral conjoint therapy for PTSD: a randomized controlled pilot study with veterans. Couple Family Psychol. 2021 Jun;10(2):71-86. doi: 10.1037/cfp0000148.","1571223","2022"
"davis2024_A","davis2024","Pharmacotherapy","2024","PTSD","PTSD",,"416","A","214","n=148 in efficacy sample analyzed","Sertraline + brexpiprazole","Sertraline + brexpiprazole","One week placebo run-in period (placebo + placebo) followed by sertraline + brexpiprazole. 
Brexpiprazole: atypical antipscyhotic, flexibly dosed at 2-3 mg per day taken orally at same time as sertraline. Titration: week 1, 0.5 mg/day; week 2, 1.0 mg/day; week 3, 2 mg/day; week 4, option to stay at 2 mg/day or increase to 3 mg/day (both for remainder of trial) based on efficacy and tolerability; a one-time dose decrease to 2 mg/day was permissible up to the Week 6 visit.
Sertraline: SSRI, 150 mg per day taken orally at same time as brexpiprazole. Titration: week 1, 50 mg/day; week 2, 100 mg/day; week 3 on, 150 mg/day.
Washout for prohibited medications (including psychotropic agents) during screening period.","No",,"Yes","Other (atypical antipsychotic) + Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","Brexpiprazole: 2 to 3 mg/day. Titration: week 1, 0.5 mg/day; week 2, 1.0 mg/day; week 3, 2 mg/day; week 4, option to stay at 2 mg/day or increase to 3 mg/day based on efficacy and tolerability
Sertraline: 150 mg/day. Titration: week 1, 50 mg/day; week 2, 100 mg/day; week 3 on, 150 mg/day.",,"Daily","9","Total treatment duration for evaluation of primary endpoint is 9 weeks (week 1 to week 10). Study duration total 12 weeks, includes 1 week placebo run-in, 9 weeks active treatment start to blinded endpoint, plus 2 weeks treatment from blinded endpoint to study end.",,,,,,,,,,"Brexpiprazole: 2.2 mg","Brexpiprazole: 0.6 mg","for n=205 treated","Race and Ethnicity data reported","Community","74.5%","Mixed","Rape/sexual assault; Accidents; Community/school violence; Other (exposure to sudden death; 'other')","Some Concerns","Davis LL, Behl S, Lee D, et al. Brexpiprazole and Sertraline Combination Treatment in Posttraumatic Stress Disorder: A Phase 3 Randomized Clinical Trial. JAMA Psychiatry. 2024 Dec 18;18:18. doi: 10.1001/jamapsychiatry.2024.3996. PMID: 39693081.","1643008","2025"
"davis2024_B","davis2024","Pharmacotherapy","2024","PTSD","Active Control",,"416","B","202","n=134 in efficacy sample analyzed","Sertraline + placebo","Sertraline + placebo","One week placebo run-in period (placebo + placebo) followed by sertraline + placebo. 
Placebo: matching placebo
Sertraline: SSRI, 150 mg per day taken orally at same time as brexpiprazole. Titration: week 1, 50 mg/day; week 2, 100 mg/day; week 3 on, 150 mg/day.
Washout for prohibited medications (including psychotropic agents) during screening period.","No",,"Yes","Antidepressant: SSRI","No",,"No","No","Yes","No","No","Individual","In Person","150 mg/day. Titration: week 1, 50 mg/day; week 2, 100 mg/day; week 3 on, 150 mg/day.",,"Daily","9","Total treatment duration for evaluation of primary endpoint is 9 weeks (week 1 to week 10). Study duration total 12 weeks, includes 1 week placebo run-in, 9 weeks active treatment start to blinded endpoint, plus 2 weeks treatment from blinded endpoint to study end.",,,,,,,,,,,,,"Race and Ethnicity data reported","Community","74.5%","Mixed","Rape/sexual assault; Accidents; Community/school violence; Other (exposure to sudden death; 'other')","Some Concerns","Davis LL, Behl S, Lee D, et al. Brexpiprazole and Sertraline Combination Treatment in Posttraumatic Stress Disorder: A Phase 3 Randomized Clinical Trial. JAMA Psychiatry. 2024 Dec 18;18:18. doi: 10.1001/jamapsychiatry.2024.3996. PMID: 39693081.","1643008","2025"
"davis2025_A","davis2025","Other study class","2025","PTSD+SUD","PTSD+SUD","Integrated","201","A","101",,"Mind Guide mindfulness app","Mindfulness","Mindfulness-based mobile application, expands Mindfulness Coach app by adding mindfulness-based relapse prevention content, for a total of 16 modules. App contains a self-guided training program with psychoeducation on topics related to mindfulness, audio-guided mindfulness exercises, self-assessments, journals, goal setting and customizable reminders, and access to support and crisis resources. Participants asked to complete 2 modules per week, and received text/email reminders to use the app every other week from the program coordinator.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology alone",,"ad libitum","ad libitum","8",,"Completing 75% or more of the modules",,"Also reports number completing different percentages of modules (less than 25% of modules, 25-49%, and 50-74% of modules) and average number of times participants logged into app",,,,,,,,,,"Race and Ethnicity data reported","Veteran","16.4%",,,"Some Concerns","Davis JP, Pedersen ER, Borsari B, Bowen S, Owen JE, Sedano A, Tran DD, Saba S, Fitzke RE, Delacruz J, Canning L. Effects of a mobile mindfulness smartphone app on posttraumatic stress disorder symptoms and alcohol use problems for veterans: A pilot randomized controlled trial. J Consult Clin Psychol. 2025 Feb;93(2):96-109. doi: 10.1037/ccp0000940. PMID: 39913485.","1644458","2025"
"davis2025_B","davis2025","Other study class","2025","PTSD+SUD","Active Control",,"201","B","100",,"Stress management program","Psychoeducation","Participants received stress management content, with no mindfulness components, via link sent weekly. Designed as an active control condition in mindfulness-based intervention trials. Content topics included effects of stress on physiology, sleep, and the immune system; psychoeducation for time management, nutrition, and developing an exercise routine.","No",,"No",,"No",,"No","No","Yes","Yes","No","Individual","Technology alone",,"ad libitum","ad libitum","8",,,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","16.4%",,,"Some Concerns","Davis JP, Pedersen ER, Borsari B, Bowen S, Owen JE, Sedano A, Tran DD, Saba S, Fitzke RE, Delacruz J, Canning L. Effects of a mobile mindfulness smartphone app on posttraumatic stress disorder symptoms and alcohol use problems for veterans: A pilot randomized controlled trial. J Consult Clin Psychol. 2025 Feb;93(2):96-109. doi: 10.1037/ccp0000940. PMID: 39913485.","1644458","2025"
"dawson2024_A","dawson2024","Psychotherapy","2024","PTSD","PTSD",,"83","A","28",,"Cognitive Reprocessing Writing","Trauma-focused psychotherapy","Trauma-focused writing using exposure and cognitive reprocessing, considered a form of tauma reprocessing. Participants instructed to write about the traumatic experience they felt was contributing the most to their current symptoms; some instructions adapted from 'Interapy' protocol. Sessions included check-in, 20 minutes of writing, and debrief; supportive nondirective counseling during check-in and debrief.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Technology alone",,"Session 1: 60-90 minutes
Sessions 2-3: 40-60 minutes
Writing portion: 20 minutes each session","Weekly","3","3 sessions total","Completed all treatment sessions",,"did not drop out before or during intervention",,,,,,"Gives number that dropped out prior to given session numbers, but for overall sample only (not by arm)",,,,"Not Reported","Community","86.75%","Mixed","Accidents; Combat-related; Community/school violence; Illness/medical procedure; Intimate partner violence; Natural or manmade disasters;  Rape/sexual assault; Other (""war zone"", child abuse [not further specified], ""vicarious trauma"", ""witnessing traumatic death of other/tramatic loss"", ""adoption trauma"", ""other"")","Some Concerns","Dawson RL, Nixon RDV, Calear AL, Sivanathan D, O'Kearney R. Efficacy of two brief trauma-focussed writing interventions in comparison to positive experiences writing: A randomized controlled trial. J Affect Disord. 2024 Aug 1;358:449-457. doi: 10.1016/j.jad.2024.05.014. Epub 2024 May 10. PMID: 38734242.","1634790","2025"
"dawson2024_B","dawson2024","Psychotherapy","2024","PTSD","PTSD",,"83","B","28",,"Written Recounting","Written narrative exposure","Trauma-focused writing, with instructions adapted from disclosure and written exposure therapy protocols, theorized to be a form of repeated exposure to the trauma. Participants instructed to write in depth about their thoughts, feelings and sensations related to a traumatic event that they felt  contributed the most to current symptoms. Sessions included check-in, 20 minutes of writing, and debrief; supportive nondirective counseling during check-in and debrief.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Technology alone",,"Session 1: 60-90 minutes
Sessions 2-3: 40-60 minutes
Writing portion: 20 minutes each session","Weekly","3","3 sessions total","Completed all treatment sessions",,"did not drop out before or during intervention",,,,,,"Gives number that dropped out prior to given session numbers, but for overall sample only (not by arm)",,,,"Not Reported","Community","86.75%","Mixed","Accidents; Combat-related; Community/school violence; Illness/medical procedure; Intimate partner violence; Natural or manmade disasters;  Rape/sexual assault; Other (""war zone"", child abuse [not further specified], ""vicarious trauma"", ""witnessing traumatic death of other/tramatic loss"", ""adoption trauma"", ""other"")","Some Concerns","Dawson RL, Nixon RDV, Calear AL, Sivanathan D, O'Kearney R. Efficacy of two brief trauma-focussed writing interventions in comparison to positive experiences writing: A randomized controlled trial. J Affect Disord. 2024 Aug 1;358:449-457. doi: 10.1016/j.jad.2024.05.014. Epub 2024 May 10. PMID: 38734242.","1634790","2025"
"dawson2024_C","dawson2024","Psychotherapy","2024","PTSD","Active Control",,"83","C","27",,"Positive Experience Writing","Control writing","Non-trauma focused writing. Participants instructed to write in depth about a past positive experience, and encouraged to imagine themselves in the event and to reexperience the thoughts and feelings that occurred during the event; instructions from Intensely Positive Experiences writing protocol. Participants given the same instructions given each session. Sessions included check-in, 20 minutes of writing, and debrief; supportive nondirective counseling during check-in and debrief.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","Technology alone",,"Session 1: 60-90 minutes
Sessions 2-3: 40-60 minutes
Writing portion: 20 minutes each session","Weekly","3","3 sessions total","Completed all treatment sessions",,"did not drop out before or during intervention",,,,,,"Gives number that dropped out prior to given session numbers, but for overall sample only (not by arm)",,,,"Not Reported","Community","86.75%","Mixed","Accidents; Combat-related; Community/school violence; Illness/medical procedure; Intimate partner violence; Natural or manmade disasters;  Rape/sexual assault; Other (""war zone"", child abuse [not further specified], ""vicarious trauma"", ""witnessing traumatic death of other/tramatic loss"", ""adoption trauma"", ""other"")","Some Concerns","Dawson RL, Nixon RDV, Calear AL, Sivanathan D, O'Kearney R. Efficacy of two brief trauma-focussed writing interventions in comparison to positive experiences writing: A randomized controlled trial. J Affect Disord. 2024 Aug 1;358:449-457. doi: 10.1016/j.jad.2024.05.014. Epub 2024 May 10. PMID: 38734242.","1634790","2025"
"decker2018_A","decker2018","Psychotherapy & CIH","2018","PTSD","PTSD",,"38","A","19",,"Art therapy + CPT","Art therapy + Cognitive Processing Therapy (CPT)","Concurrent individual CPT and art therapy.
CPT: sessions 1 through 8 of manualized treatment (Resick, Monson, & Chard, 2007) ""designed to challenge negative cognitions associated with trauma"" .
Art therapy: followed protocol by Campbell (2014) and involving ""psychoeducation, goal setting, creating a sense of safety, creating and processing one’s visual trauma narrative, identifying and addressing symptoms and triggers, integrating the trauma with the rest of their experiences, identifying grief and loss caused by combat trauma, reconstructing worldviews and self-concept, and reviewing artworks and recovery-oriented goals... participants were given six directives to construct the visual trauma narrative: 1) Create an image of a time before the trauma that you felt peaceful and safe—a positive memory; 2) Create an image of the last moment you remember directly before the trauma; 3) Create an image of what happened during the trauma; 4) Create an image of a moment you can remember right after the trauma; 5) Create an image of a time when you were safe from the physical threats of war; 6) Create an image of a time when you tried to self-soothe.""","Yes","Trauma-focused","No",,"Yes","Creative therapies","No","No","No","No","No","Individual","In Person",,"60 minutes",,,"8 sessions CPT + 8 sessions art therapy","Did not discontinue intervention prematurely",,"flow diagram, also described as study completers",,,,,,,,,,"Race data reported","Veteran","3.23%","Combat-related",,"High","Decker KP, Deaver SP, Abbey V, et al. Quantitatively improved treatment outcomes for combat-associated PTSD with adjunctive art therapy: randomized controlled trial. Art Therapy. 2018;35(4):184-94. doi: 10.1080/07421656.2018.1540822.","1587975","2020"
"decker2018_B","decker2018","Psychotherapy & CIH","2018","PTSD","Active Control",,"38","B","19",,"Supportive psychotherapy + CPT","Supportive psychotherapy + Cognitive Processing Therapy (CPT)","Concurrent individual CPT and supportive psychotherapy.



CPT: sessions 1 through 8 of manualized treatment (Resick, Monson, & Chard, 2007) ""designed to challenge negative cognitions associated with trauma"".



Supportive psychotherapy: ""focused on present-centered concerns, with the goal of reinforcing healthy and adaptive patterns of thoughts and behaviors to reduce symptoms of PTSD and depression""","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"60 minutes",,,"8 sessions CPT + 8 sessions supportive psychotherapy","Did not discontinue intervention prematurely",,"flow diagram, also described as study completers",,,,,,,,,,"Race data reported","Veteran","3.23%","Combat-related",,"High","Decker KP, Deaver SP, Abbey V, et al. Quantitatively improved treatment outcomes for combat-associated PTSD with adjunctive art therapy: randomized controlled trial. Art Therapy. 2018;35(4):184-94. doi: 10.1080/07421656.2018.1540822.","1587975","2020"
"dedert2019_A","dedert2019","Psychotherapy","2019","PTSD+SUD","PTSD+SUD","Integrated","40","A","15",,"CPT + smoking cessation","Cognitive Processing Therapy (CPT) + smoking cessation","Combined CPT and smoking cessation; ""smoking was conceptualized and integrated into treatment as an avoidance behavior that interferes with processing PTSD symptoms"". Participants taught to apply cognitive restructuring skills from CPT to smoking cessation. Smoking cessation content followed Integrated Care for Smoking Cessation treatment manual, and was identical to that of the Present-focused smoking cessation arm except for use of cognitive restructuring skills in the CPT arm.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"CPT: 60 minutes



Smoking cessation: 25 minutes","Twice a week","6",,"attended all 12 sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","82.5%",,,"High","Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.","1556168","2020"
"dedert2019_B","dedert2019","Psychotherapy","2019","PTSD+SUD","Active Control","Not integrated","40","B","25",,"Present-focused smoking cessation","Smoking cessation","Cognitive behavioral smoking cessation treatment following the Integrated Care for Smoking Cessation manual; treatment is present-focused. ""The smoking cessation treatment in this arm was identical to the smoking cessation component of the [combined CPT + smoking cessation] group, except that the [present-focused smoking cessation] arm did not utilize formal cognitive restructuring to address smoking triggers.""","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"25 minutes","Twice weekly","6",,"attended all 12 sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","82.5%",,,"High","Dedert EA, Resick PA, Dennis PA, et al. Pilot trial of a combined cognitive processing therapy and smoking cessation treatment. J Addict Med. 2019 Jul/Aug;13(4):322-30. doi: 10.1097/ADM.0000000000000502. PMID: 30664539.","1556168","2020"
"dekleine2012_A","dekleine2012","Psychotherapy & pharmacotherapy","2012","PTSD","PTSD",,"75","A","33",,"PE + D-cycloserine","Prolonged Exposure (PE) + D-cycloserine","D-cycloserine prior to PE sessions







PE: standardized program including prolonged imaginal exposure (30 minutes each session), in vivo exposure assignments and homework of exposure using recorded session audiotape.







D-cycloserine: glutamatergic N-methyl-D-aspartate receptor partial agonist, taken 1 hour prior to start of each PE session","Yes","Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","50 mg","30 minutes","Weekly","up to 10",,">8 sessions",,,,,,,,,,,,"Not reported","Community","80.6%","Mixed","combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")","Some Concerns","de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.","38434","2019"
"dekleine2012_B","dekleine2012","Psychotherapy & pharmacotherapy","2012","PTSD","Active Control",,"75","B","34",,"PE + placebo","Prolonged Exposure (PE) + placebo","Placebo prior to PE sessions







PE: standardized program including prolonged imaginal exposure (30 minutes each session), in vivo exposure assignments and homework of exposure using recorded session audiotape.







Placebo: identical in appearance to D-cycloserine, taken 1 hour prior to start of each PE session","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"30 minutes","Weekly","up to 10",,">8 sessions",,,,,,,,,,,,"Not reported","Community","80.6%","Mixed","combat-related, rape/sexual assault, accidents, other (violent nonsexual assault; ""miscellaneous"")","Some Concerns","de Kleine RA, Hendriks GJ, Kusters WJ, et al. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. PMID: 22480663.","38434","2019"
"dekleine2019_A","dekleine2019","Nonpharmacologic cognitive","2019","PTSD","PTSD",,"107","A","49",,"Cognitive Bias Modification","Cognitive Bias Modification (CBM)","Online CBM training completed at home. Participant responded to a series of 40 scripted vignettes representing domains of the PTCI. Sentence completion format: two sentences, with second sentence including a word fragment to be completed. Participant typed a missing letter which gave the sentence a positive meaning.","No",,"No",,"No",,"No","Yes","No","No","No","Individual","Technology alone",,"6 minutes (median)","Four times weekly","1",,"Completing all 4 sessions",,,,,,,,,,,,"Not reported","Community","81.3%","Mixed","Child physical abuse; Child sexual abuse; Child other abuse; Rape/sexual assault; Intimate partner violence; Community/school violence","Low","de Kleine RA, Woud ML, Ferentzi H, et al. Appraisal-based cognitive bias modification in patients with posttraumatic stress disorder: a randomised clinical trial. Eur J Psychotraumatol. 2019 Jul 8;10(1):1625690. doi: 10.1080/20008198.2019.1625690. PMID: 31448063.","52213","2024"
"dekleine2019_B","dekleine2019","Nonpharmacologic cognitive","2019","PTSD","Inactive Control",,"107","B","58",,"Control Training","Attention control","Online control training completed at home. Pesponded to a series of 40 scripted vignettes representing domains of the PTCI. Sentence completion format: two sentences, with second sentence including a word fragment to be completed. Participant typed a missing letter which gave the sentence a neutral meaning.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Technology alone",,"6 minutes (median)","Four times weekly","1",,"Completing all 4 sessions",,,,,,,,,,,,"Not reported","Community","81.3%","Mixed","Child physical abuse; Child sexual abuse; Child other abuse; Rape/sexual assault; Intimate partner violence; Community/school violence","Low","de Kleine RA, Woud ML, Ferentzi H, et al. Appraisal-based cognitive bias modification in patients with posttraumatic stress disorder: a randomised clinical trial. Eur J Psychotraumatol. 2019 Jul 8;10(1):1625690. doi: 10.1080/20008198.2019.1625690. PMID: 31448063.","52213","2024"
"dell2022_A","dell2022","Psychotherapy","2022","PTSD","PTSD",,"138","A","65",,"Massed Prolonged Exposure","Prolonged Exposure (PE)","Therapy with in vivo homework, using fear extinction through engaging with the traumatic memory. Identical to standard therapy but sessions delivered over 2 weeks. Intervention adapted during COVID-19 restrictions to include telehealth treatment (same format and duration of therapy but using online video platforms)","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Mixed",,"90 minutes","Daily","2","Reported as both 2 weeks and 10 days (may be weekdays only)","Attended ≥7 sessions",,,,,,,,,,,,"Not reported","Mixed","11.94%","Mixed","Combat-related; Other (trauma occurring during military service but not required to be specific to deployment)","High","Dell L, Sbisa AM, Forbes A, et al. Effect of massed v. standard prolonged exposure therapy on PTSD in military personnel and veterans: a non-inferiority randomised controlled trial. Psychol Med. 2022 Apr 20:1-8. doi: 10.1017/S0033291722000927. PMID: 35440345.","1592061","2023"
"dell2022_B","dell2022","Psychotherapy","2022","PTSD","PTSD",,"138","B","73",,"Standard Prolonged Exposure","Prolonged Exposure (PE)","Standard manualised therapy with in vivo homework, using fear extinction through engaging with the traumatic memory. Delivered over 10 weeks. Intervention adapted during COVID-19 restrictions to include telehealth treatment (same format and duration of therapy but using online video platforms)","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Mixed",,"90 minutes","Weekly","10",,"Attended ≥7 sessions",,,,,,,,,,,,"Not reported","Mixed","11.94%","Mixed","Combat-related; Other (trauma occurring during military service but not required to be specific to deployment)","High","Dell L, Sbisa AM, Forbes A, et al. Effect of massed v. standard prolonged exposure therapy on PTSD in military personnel and veterans: a non-inferiority randomised controlled trial. Psychol Med. 2022 Apr 20:1-8. doi: 10.1017/S0033291722000927. PMID: 35440345.","1592061","2023"
"devilly1998_A","devilly1998","Psychotherapy","1998","PTSD","PTSD",,"51","A","19",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Participants track extreme hand movements while holding in mind a representative picture of the traumatic event. On average, 24 back-and-forth sweeps were given for each set until subjective units of distress decrease to 0. Eye movement desensitization repeated until no more imaginal picture arises","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","2",,"Received 2nd (final) treatment session",,,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"High","Devilly GJ, Spence SH, Rapee RM. Statistical and reliable change with eye movement desensitization and reprocessing: treating trauma within a veteran population. Behav. Ther. 1998 Summer;29(3):435-55. doi: 10.1016/S0005-7894(98)80042-7.","20740","2019"
"devilly1998_B","devilly1998","Psychotherapy","1998","PTSD","PTSD",,"51","B","16",,"Reactive Eye Dilation Desensitization and Reprocessing","Eye Movement Desensitization and Reprocessing (EMDR)","Participant concentrates on the imaginal picture and accompanying body sensation while concentrating on a black box emitting flashing light at rate of 4 flashes per second.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","2",,"Received 2nd (final) treatment session",,,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"High","Devilly GJ, Spence SH, Rapee RM. Statistical and reliable change with eye movement desensitization and reprocessing: treating trauma within a veteran population. Behav. Ther. 1998 Summer;29(3):435-55. doi: 10.1016/S0005-7894(98)80042-7.","20740","2019"
"devilly1998_C","devilly1998","Psychotherapy","1998","PTSD","Inactive Control",,"51","C","16",,"Standard Psychiatric Support","Treatment as usual (TAU)","Participants continued their usual treatment without additional support from research therapist","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"5","post-treatment assessment at 5 weeks",,,,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"High","Devilly GJ, Spence SH, Rapee RM. Statistical and reliable change with eye movement desensitization and reprocessing: treating trauma within a veteran population. Behav. Ther. 1998 Summer;29(3):435-55. doi: 10.1016/S0005-7894(98)80042-7.","20740","2019"
"devilly1999_A","devilly1999","Psychotherapy","1999","PTSD","PTSD",,"23","A","12","15 randomized, 12 completers analyzed","Trauma Treatment Protocol","Trauma-focused cognitive behavioral therapy (TF-CBT)","Variant of CBT utilizing components from SIT (stress inoculation training), PE (prolonged exposure) and in-depth cognitive therapy","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90-120 minutes",,,"9 sessions, frequency NR; unclear treatment duration; arm C (control) had post-treatment assessment at 5 weeks","Completed treatment",,"2 participants completed 8 sessions (implies remaining 10 participants completed 9 sessions)",,,,,,,,,,"Not reported","Community","65.2%","Mixed","Accidents; Natural or manmade disasters; Rape/sexual assault; Community/school violence; Other (""war zone"")","High","Devilly GJ, Spence C. The relative efficacy and treatment distress of EMDR and a cognitive-behavior trauma treatment protocol in the amelioration of posttraumatic stress disorder. J Anxiety Disord. 1999 2016-09-15;13(1-2):131-57. doi: 10.1016/S0887-6185(98)00044-9. PMID: 10225505.","14687","2023"
"devilly1999_B","devilly1999","Psychotherapy","1999","PTSD","PTSD",,"23","B","11","17 randomized, 11 completers analyzed","Eye Movement Desensitization and Reproccessing","Eye Movement Desensitization and Reprocessing (EMDR)","Protocol using EMDR and exploring associated trauma and personal history","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90-120 minutes",,,"8 sessions, frequency NR; unclear treatment duration; arm C (control) had post-treatment assessment at 5 weeks","Completed treatment",,"2 participants completed 7 sessions (implies remaining 9 participants completed 8 sessions)",,,,,,,,,,"Not reported","Community","65.2%","Mixed","Accidents; Natural or manmade disasters; Rape/sexual assault; Community/school violence; Other (""war zone"")","High","Devilly GJ, Spence C. The relative efficacy and treatment distress of EMDR and a cognitive-behavior trauma treatment protocol in the amelioration of posttraumatic stress disorder. J Anxiety Disord. 1999 2016-09-15;13(1-2):131-57. doi: 10.1016/S0887-6185(98)00044-9. PMID: 10225505.","14687","2023"
"difede2014_A","difede2014","Psychotherapy & pharmacotherapy","2014","PTSD","PTSD",,"25","A","13",,"Exposure therapy with virtual reality plus D-cycloserine","Virtual reality exposure therapy (VRET) + D-cycloserine","Participants recounted their trauma while wearing a virtual reality helmet with a computer simulation of the September 11th attacks. Graded scenarios increased in intensity and detail, target of 45 minutes ""in the virtual world"". D-cycloserine: antibiotic, also used as a cognitive enhancer, given 90 minutes before sessions beginning with session 2.","Yes","Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","100 mg","90 minutes","Weekly","12",,"Completed treatment",,"reports number completed the intervention; none dropped out from this arm","verbal inquiry about medication ingestion before session",,,"11","1",,,,,"Race and Ethnicity data reported","Community","24%","Terrorism/political violence/forced displacement",,"Low","Difede J, Cukor J, Wyka KE, et al. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology. 2014 Apr;39(5):1052-108. doi: 10.1038/npp.2013.317. PMID: 24217129.","41641","2019"
"difede2014_B","difede2014","Psychotherapy & pharmacotherapy","2014","PTSD","Active Control",,"25","B","12",,"Exposure therapy with virtual reality plus placebo","Virtual reality exposure therapy (VRET) + placebo","Participants recounted their trauma while wearing a virtual reality helmet with a computer simulation of the September 11th attacks. Graded scenarios increased in intensity and detail, goal 45 minutes ""in the virtual world"". Matched placebo given 90 minutes prior to start of therapy beginning at session 2.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Weekly","12",,"Completed treatment",,"reports number completed the intervention; from this arm, n=3 dropped out (after sessions 3, 6 and 7)","verbal inquiry about medication ingestion before session",,,"9.33","3.34",,,,,"Race and Ethnicity data reported","Community","24%","Terrorism/political violence/forced displacement",,"Low","Difede J, Cukor J, Wyka KE, et al. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology. 2014 Apr;39(5):1052-108. doi: 10.1038/npp.2013.317. PMID: 24217129.","41641","2019"
"difede2022_A","difede2022","Psychotherapy & pharmacotherapy","2022","PTSD","PTSD",,"192","A","47","See Study Comments","Virtual Reality Exposure (VRE) + D-cycloserine (DCS)","Virtual reality exposure therapy (VRET) + D-cycloserine","VRE: first 2 sessions, therapists collected information, explained PTSD, gave rationale for treatment, and taught breathing retraining. Following 7 sessions included exposure using VR equipment that allowed movement through a virtual environment, and simulated settings and  sounds, visual stimuli, and tactile stimuli (e.g. vibration). Patient recounted trauma and therapist adjusted setting and stimuli to simulate the traumatic memory. 

DCS: partial NMDA agonist mediating learning, memory, and fear extinction; given when patient arrived, 30 minutes before session, starting at session 3","Yes","Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","9",,"""completed treatment""",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","10.4%","Combat-related",,"Low","Difede J, Rothbaum BO, Rizzo AA, et al. Enhancing exposure therapy for posttraumatic stress disorder (PTSD): a randomized clinical trial of virtual reality and imaginal exposure with a cognitive enhancer. Translational psychiatry. 2022;12(1):299. doi: 10.1038/s41398-022-02066-x. PMID: 35896533.","1597237","2023"
"difede2022_B","difede2022","Psychotherapy & pharmacotherapy","2022","PTSD","Active Control",,"192","B","50","See Study Comments","Virtual Reality Exposure (VRE) + placebo","Virtual reality exposure therapy (VRET) + placebo","VRE: first 2 sessions, therapists collected information, explained PTSD, gave rationale for treatment, and taught breathing retraining. Following 7 sessions included exposure using VR equipment that allowed movement through a virtual environment, and simulated settings and  sounds, visual stimuli, and tactile stimuli (e.g. vibration). Patient recounted trauma and therapist adjusted setting and stimuli to simulate the traumatic memory. 

Placebo: given when patient arrived, 30 minutes before session, starting at session 3","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Weekly","9",,"""completed treatment""",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","10.4%","Combat-related",,"Low","Difede J, Rothbaum BO, Rizzo AA, et al. Enhancing exposure therapy for posttraumatic stress disorder (PTSD): a randomized clinical trial of virtual reality and imaginal exposure with a cognitive enhancer. Translational psychiatry. 2022;12(1):299. doi: 10.1038/s41398-022-02066-x. PMID: 35896533.","1597237","2023"
"difede2022_C","difede2022","Psychotherapy & pharmacotherapy","2022","PTSD","Active Control",,"192","C","48","See Study Comments","Prolonged Exposure (PE) + DCS","Prolonged Exposure (PE) + D-cycloserine","PE: first 2 sessions, therapists collected information, explained PTSD, gave rationale for treatment, and taught breathing retraining; in remaining 7 sessions, patients ""instructed to close their

eyes, imagine the scene of their trauma, and repeatedly recount the

trauma vividly, aloud, and in the present tense.""

DCS: partial NMDA agonist mediating learning, memory, and fear extinction; given when patient arrived, 30 minutes before session, starting at session 3","Yes","Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Weekly","9",,"""completed treatment""",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","10.4%","Combat-related",,"Low","Difede J, Rothbaum BO, Rizzo AA, et al. Enhancing exposure therapy for posttraumatic stress disorder (PTSD): a randomized clinical trial of virtual reality and imaginal exposure with a cognitive enhancer. Translational psychiatry. 2022;12(1):299. doi: 10.1038/s41398-022-02066-x. PMID: 35896533.","1597237","2023"
"difede2022_D","difede2022","Psychotherapy & pharmacotherapy","2022","PTSD","Active Control",,"192","D","47","See Study Comments","Prolonged Exposure (PE) + placebo","Prolonged Exposure (PE) + placebo","PE: first 2 sessions, therapists collected information, explained PTSD, gave rationale for treatment, and taught breathing retraining; in remaining 7 sessions, patients ""instructed to close their

eyes, imagine the scene of their trauma, and repeatedly recount the

trauma vividly, aloud, and in the present tense.""

Placebo: given when patient arrived, 30 minutes before session, starting at session 3","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Weekly","9",,"""completed treatment""",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","10.4%","Combat-related",,"Low","Difede J, Rothbaum BO, Rizzo AA, et al. Enhancing exposure therapy for posttraumatic stress disorder (PTSD): a randomized clinical trial of virtual reality and imaginal exposure with a cognitive enhancer. Translational psychiatry. 2022;12(1):299. doi: 10.1038/s41398-022-02066-x. PMID: 35896533.","1597237","2023"
"doenyasbarak2022_A","doenyasbarak2022","Nonpharmacologic biological","2022","PTSD","PTSD",,"35","A","18",,"Hyperbaric oxygen therapy","Hyperbaric oxygen therapy (HBOT)","HBOT administered in a multiplace chamber (HAUX-Life-Support GmbH). Exposure to 100% oxygen at 2 atmospheres absolute (ATA), with 5-minute air breaks every 20 minutes. Continued baseline psychotherapy and pharmacotherapy; no additional psychotherapy given.","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person",,"90 minutes","Daily on weekdays","12","Total 60 sessions","Completed HBOT protocol",,"n=1 stopped after 20 sessions, n=3 had frequent interruptions due to illness",,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"High","Doenyas-Barak K, Catalogna M, Kutz I, et al. Hyperbaric oxygen therapy improves symptoms, brain's microstructure and functionality in veterans with treatment resistant post-traumatic stress disorder: a prospective, randomized, controlled trial. PLoS One. 2022 Feb 22;17(2):e0264161. doi: 10.1371/journal.pone.0264161. PMID: 35192645.","1587823","2023"
"doenyasbarak2022_B","doenyasbarak2022","Nonpharmacologic biological","2022","PTSD","Inactive Control",,"35","B","17",,"TAU","Treatment as usual (TAU)","No intervention; continued baseline psychotherapy and pharmacotherapy.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,,,"See Detail",,"n=15 completed control protocol",,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"High","Doenyas-Barak K, Catalogna M, Kutz I, et al. Hyperbaric oxygen therapy improves symptoms, brain's microstructure and functionality in veterans with treatment resistant post-traumatic stress disorder: a prospective, randomized, controlled trial. PLoS One. 2022 Feb 22;17(2):e0264161. doi: 10.1371/journal.pone.0264161. PMID: 35192645.","1587823","2023"
"doenyasbarak2024_A","doenyasbarak2024","Nonpharmacologic biological","2024","PTSD","PTSD",,"63","A","34","n=34 randomized, 28 analyzed; 2 withdrawn for illicit substance/alcohol use during trial, 4 withdrew consent","Hyperbaric oxygen treatment (HBOT)","Hyperbaric oxygen therapy (HBOT)","Hyperbaric oxygen treatment; 60 daily sessions, with 90 minutes of exposure to 100% oxygen at 2 atmospheres absolute (ATA) with 5-minute air breaks every 20 minutes. Groups of 4-6 participants, since HBOT chambers accommodate up to 6 subjects.","No",,"No",,"No",,"Yes","No","No","No","No","Group","In Person","100% oxygen at 2 atmospheres absolute","90 minutes","Daily","up to 14","60 sessions within 14 weeks","Completed at least 50 sessions",,"n=28 included in analysis, ""all participants except 8 patients in the sham group completed at least 50 sessions""; so using n=28 for completers (n=28 analyzed minus n=0 [all noncompleters in sham group]); completers 82.35% (28/34)",,,,"59.92",,"range 58 to 60",,,,,"Veteran","0%","Combat-related",,"High","Doenyas-Barak K, Kutz I, Lang E, Assouline A, Hadanny A, Aberg KC, Levi G, Beberashvili I, Mayo A, Efrati S. Hyperbaric Oxygen Therapy for Veterans With Combat-Associated Posttraumatic Stress Disorder: A Randomized, Sham-Controlled Clinical Trial. J Clin Psychiatry. 2024 Nov 10;85(4):24m15464. doi: 10.4088/JCP.24m15464. PMID: 39566051.","1641595","2025"
"doenyasbarak2024_B","doenyasbarak2024","Nonpharmacologic biological","2024","PTSD","Inactive Control",,"63","B","29","n=29 randomized, 28 analyzed; 1  withdrew consent","Sham hyperbaric oxygen treatment","Sham","Sham hyperbaric oxygen treatment; 60 daily sessions, with 90 minutes of exposure to 21% oxygen at 1.02 atmospheres absolute (ATA). Compression to 1.2 ATA was performed for the first 5 minutes to achieve blinding and have subjects perform pressure equalization, this was followed by slow decompression to 1.02 ATA in the next 5 minutes (minimum pressure required to keep chanber door closed). Groups of 4-6 participants, since HBOT chambers accommodate up to 6 subjects.","No",,"No",,"No",,"No","No","Yes","No","No","Group","In Person","21% oxygen at 1.02 atmospheres absolute","90 minutes","Daily","up to 14","60 sessions within 14 weeks","Completed at least 50 sessions",,"n=28 included in analysis, ""all participants except 8 patients in the sham group completed at least 50 sessions""; so using n=20 for completers (n=28 analyzed minus n=8); completers 68.97% (20/29)",,,,"52.42",,"range 20 to 60",,,,,"Veteran","0%","Combat-related",,"High","Doenyas-Barak K, Kutz I, Lang E, Assouline A, Hadanny A, Aberg KC, Levi G, Beberashvili I, Mayo A, Efrati S. Hyperbaric Oxygen Therapy for Veterans With Combat-Associated Posttraumatic Stress Disorder: A Randomized, Sham-Controlled Clinical Trial. J Clin Psychiatry. 2024 Nov 10;85(4):24m15464. doi: 10.4088/JCP.24m15464. PMID: 39566051.","1641595","2025"
"dorrepaal2012_A","dorrepaal2012","Psychotherapy","2012","PTSD","PTSD",,"71","A","38",,"Group CBT","Cognitive behavioral therapy (CBT) without a trauma focus","Participants received individual treatment as usual by a psychotherapist, psychiatric nurse, or psychiatrist. In addition, participants received a stabilizing group CBT program based on manual by Zlotnick et al. (1997). Group session included psychoeducation aimed at attaining a sense of cognitive mastery, cognitive behavioral skills focused on identifying and modifying dysfunctional behavior, thoughts, and beliefs about the trauma. Treatment focused on the present, positive reinforcement, and empowerment, and avoided sharing individual trauma histories","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"2 hours","Weekly","20",,"See Detail",,"Study reports attrition from measurement and completer analysis, no information specifically for treatment completion",,,,,,,,,,"Not reported","Community","100%","Mixed","child sexual abuse, child physical abuse","High","Dorrepaal E, Thomaes K, Smit JH, et al. Stabilizing group treatment for complex posttraumatic stress disorder related to child abuse based on psychoeducation and cognitive behavioural therapy: a multisite randomized controlled trial. Psychother Psychosom. 2012;81(4):217-25. doi: 10.1159/000335044. PMID: 22585094.","39141","2019"
"dorrepaal2012_B","dorrepaal2012","Psychotherapy","2012","PTSD","Active Control",,"71","B","33",,"TAU","Supportive counseling","Participants received individual treatment by a psychotherapist, psychiatric nurse, or psychiatrist","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"20",,"See Detail",,"Study reports attrition from measurement and completer analysis, no information specifically for treatment completion",,,,,,,,,,"Not reported","Community","100%","Mixed","child sexual abuse, child physical abuse","High","Dorrepaal E, Thomaes K, Smit JH, et al. Stabilizing group treatment for complex posttraumatic stress disorder related to child abuse based on psychoeducation and cognitive behavioural therapy: a multisite randomized controlled trial. Psychother Psychosom. 2012;81(4):217-25. doi: 10.1159/000335044. PMID: 22585094.","39141","2019"
"douglas2024_A","douglas2024","Psychotherapy","2024","PTSD","PTSD",,"30","A","16",,"Prolonged exposure (PE)","Prolonged Exposure (PE)","Manualized therapy delivered in person or by secure video chat. Comprised of ""education about common reactions to trauma, breathing retraining, prolonged (repeated) imaginal exposure to trauma memories, repeated in vivo exposure to situations that participants are avoiding due to trauma-related fear, and discussion of thoughts and feelings related to the trauma."" ""Treatment also entails processing, consisting of a discussion following imaginal exposure,which aims to address participants’ unrealistic beliefs about themselves, the world, and other people and to “make sense” of the trauma."" In vivo exposure practice was limited by mobility and environmental factors during inpatient hospitalization; exercises included ""listening to audio clips of repeated gunshots or ambulance sirens, watching videos or looking at pictures of automobile accidents, and practicing sitting in or transferring into a car shell that was on the therapy floor of the hospital.""","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Mixed",,"60 minutes","1-3 sessions per week",,"Total 12 to 13 sessions.","Completed allocated number of sessions (all planned sessions)",,,,,,,,"All participants completed at least one PE session; 50% (8) participants received at least 3 PE sessions (at least one session with exposure)",,,,"Race and Ethnicity data reported","Mixed","44.8%","Other","Spinal cord injury (traumatic or nontraumatic)","High","Douglas ME, Bennett M, Jones KA, Pogue JR, Chauvette GV, Sikka S, Driver S, Hamilton R, Curcio N, Patel S, Wierzchowski A, Adams M, Thomas EV, Turner E, Leonard K, Carl E, Foreman M, Warren AM, Powers MB. Prolonged exposure for posttraumatic stress disorder following spinal cord injury: A randomized controlled trial. Rehabil Psychol. 2024 Aug 29. doi: 10.1037/rep0000580. Epub ahead of print. PMID: 39207423.","1638176","2025"
"douglas2024_B","douglas2024","Psychotherapy","2024","PTSD","Inactive Control",,"30","B","14","14 randomized, 13 analyzed","Treatment as usual (TAU)","Treatment as usual (TAU)","Standard clinical treatment for spinal cord injury inpatients at the rehabilitation hopsital; ""includes an evaluation by a licensed clinical psychologist or master’s level therapist and continued follow-up treatment as needed. The content of individual therapy sessions varies, but typical inpatient mental health sessions predominantly address psychological adjustment to disability and management of mood and anxiety. TAU did not include PE or other exposure-based therapies.""","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,,,,,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","44.8%","Other","Spinal cord injury (traumatic or nontraumatic)","High","Douglas ME, Bennett M, Jones KA, Pogue JR, Chauvette GV, Sikka S, Driver S, Hamilton R, Curcio N, Patel S, Wierzchowski A, Adams M, Thomas EV, Turner E, Leonard K, Carl E, Foreman M, Warren AM, Powers MB. Prolonged exposure for posttraumatic stress disorder following spinal cord injury: A randomized controlled trial. Rehabil Psychol. 2024 Aug 29. doi: 10.1037/rep0000580. Epub ahead of print. PMID: 39207423.","1638176","2025"
"dowd2020_A","dowd2020","Pharmacotherapy","2020","PTSD","PTSD",,"25","A","13",,"Eszopiclone","Eszopiclone","Gamma-aminobutyric acid (GABA) alpha receptor agonist indicated for the treatment of sleep, given at bedtime","No",,"Yes","Antianxiety: nonbenzodiazepine","No",,"No","No","No","No","No","Individual","In Person","3 mg",,"Daily","12",,,,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","40%","Mixed","Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (observed violence to or death of a loved one)","High","Dowd SM, Zalta AK, Burgess HJ, et al. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World J Psychiatry. 2020 Mar 19;10(3):21-8. doi: 10.5498/wjp.v10.i3.21. PMID: 32257848.","1552152","2020"
"dowd2020_B","dowd2020","Pharmacotherapy","2020","PTSD","Inactive Control",,"25","B","12",,"Placebo","Placebo",,"No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","40%","Mixed","Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (observed violence to or death of a loved one)","High","Dowd SM, Zalta AK, Burgess HJ, et al. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World J Psychiatry. 2020 Mar 19;10(3):21-8. doi: 10.5498/wjp.v10.i3.21. PMID: 32257848.","1552152","2020"
"duberstein2018_A","duberstein2018","Psychotherapy","2018","PTSD","PTSD",,"161","A","83",,"IPT-T","Interpersonal Psychotherapy (IPT)","Individual psychotherapy adapted from IPT to address needs of depressed women with childhood sexual abuse histories in the community health setting. The 4 adaptations to the IPT protocol are: 1) expanded treatment period to 16 sessions over 32 weeks; 2) used engagement analysis to ""help patients identify and problem-solve social, practical, and psychological barriers to treatment participation""; 3) used a sociocultural formulation ""to help patients identify ways in which cultural and economic influences (e.g., family beliefs, ethnic identities, religious practices, racism, and poverty) may affect their interpersonal problems and depression""; 4) an ""interpersonal-patterns"" problem area replaced the ""interpersonal deficits"" problem  area, ""the interpersonal-patterns problem area is used to help patients recognize longstanding patterns of behavior and emotion commonly seen among individuals with trauma histories that could undermine social health""","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,,"32","total 16 sessions","See Detail",,"Study reports attrition from measurement and completer analysis, no information specifically for treatment completion",,,,"10.6","5.8",,,,,"Race and Ethnicity data reported","Community","100%","Child sexual abuse",,"High","Duberstein PR, Ward EA, Chaudron LH, et al. Effectiveness of interpersonal psychotherapy-trauma for depressed women with childhood abuse histories. J Consult Clin Psychol. 2018 Oct;86(10):868-78. doi: 10.1037/ccp0000335. PMID: 30265045.","51365","2020"
"duberstein2018_B","duberstein2018","Psychotherapy","2018","PTSD","Active Control",,"161","B","78",,"Clinic Psychotherapy","Supportive counseling","Clinician choice of psychotherapy among treatments typically used in a community mental health clinic; therapists were not restricted from ""reasonable therapeutic activities or interventions""","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"32","total 16 sessions","See Detail",,"reports asssessment/study completion only",,,,"5.7","4.2",,,,,"Race and Ethnicity data reported","Community","100%","Child sexual abuse",,"High","Duberstein PR, Ward EA, Chaudron LH, et al. Effectiveness of interpersonal psychotherapy-trauma for depressed women with childhood abuse histories. J Consult Clin Psychol. 2018 Oct;86(10):868-78. doi: 10.1037/ccp0000335. PMID: 30265045.","51365","2020"
"duek2023_A","duek2023","Psychotherapy & pharmacotherapy","2023","PTSD","PTSD",,"28","A","14",,"Ketamine + PE","Prolonged Exposure (PE) + ketamine","Single ketamine infusion followed by 4 sessions of PE.
Ketamine: single infusion over 40 minutes
PE: initial session (prior to ketamine) included information on the disorder and building exposure hierarchy; 4 sessions of exposure therapy following ketamine (started one day after ketamine infusion) included imaginal exposure, recall and reconsolidation of the traumatic memory, and in vivo exposure (for a total of 5 sessions).","Yes","Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","0.5 mg/kg, single infusion over 40 minutes","90 to 120 minutes","Ketamine: single infusion
PE: daily","0.71","Ketamine: single infusion
PE: 5 consecutive days","Completed therapy",,"flow diagram, n=14 randomized minus n=2 did not complete therapy",,,,,,,,,,"Race and Ethnicity data reported","Veteran","37.04%","Mixed","Combat-related; Rape/sexual assault; Community/school violence; Other (not specified)","Low","Duek O, Korem N, Li Y, et al. Long term structural and functional neural changes following a single infusion of Ketamine in PTSD. Neuropsychopharmacology. 2023 Jun 03;03:03. doi: 10.1038/s41386-023-01606-3. PMID: 37270621.","1621519","2024"
"duek2023_B","duek2023","Psychotherapy & pharmacotherapy","2023","PTSD","Active Control",,"28","B","14",,"Midazolam + PE","Prolonged Exposure (PE) + midazolam","Single midazolam infusion followed by 4 sessions of PE.
Midazolam: single infusion over 40 minutes
PE: initial session (prior to midazolam) included information on the disorder and building exposure hierarchy; 4 sessions of exposure therapy following midazolam (started one day after midazolam infusion) included imaginal exposure, recall and reconsolidation of the traumatic memory, and in vivo exposure (for a total of 5 sessions).","Yes","Trauma-focused","Yes","Antianxiety: benzodiazepine","No",,"No","No","Yes","No","No","Individual","In Person","0.045 mg/kg, single infusion over 40 minutes","90 to 120 minutes","Midazolam: single infusion
PE: daily","0.71","Midazolam: single infusion
PE: 5 consecutive days","Completed therapy",,"flow diagram, n=14 randomized minus n=1 did not complete therapy",,,,,,,,,,"Race and Ethnicity data reported","Veteran","37.04%","Mixed","Combat-related; Rape/sexual assault; Community/school violence; Other (not specified)","Low","Duek O, Korem N, Li Y, et al. Long term structural and functional neural changes following a single infusion of Ketamine in PTSD. Neuropsychopharmacology. 2023 Jun 03;03:03. doi: 10.1038/s41386-023-01606-3. PMID: 37270621.","1621519","2024"
"duffy2007_A","duffy2007","Psychotherapy","2007","PTSD","PTSD",,"58","A","29",,"Cognitive Therapy","Cognitive Therapy for PTSD (CT-PTSD)","Based on Ehlers and Clark's model that addresses excessively negative appraisals of the traumatic event or its sequelae, disturbance in autobiographical memory, and dysfunctional cognitive and behavioral strategies. Includes behavioral activation early in therapy.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Up to weekly","12",,"completed ≥6 sessions or ended therapy earlier as agreed by the therapist because of noticeable improvement",,,,,,"5.9","2.5","patients received additional average 2.0 [SD 3.2] sessions after 12-week period for a total of 7.8 [SD 5.1] sessions",,,,"Not reported","Community","39.66%","Mixed","terrorism/political violence/forced displacement, community/school violence, accidents","High","Duffy M, Gillespie K, Clark DM. Post-traumatic stress disorder in the context of terrorism and other civil conflict in Northern Ireland: randomised controlled trial. BMJ. 2007 Jun 2;334(7604):1147-50. doi: 10.1136/bmj.39021.846852.BE. PMID: 17495988.","29736","2019"
"duffy2007_B","duffy2007","Psychotherapy","2007","PTSD","Inactive Control",,"58","B","29",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"12",,,,,,,,,,,,,,"Not reported","Community","39.66%","Mixed","terrorism/political violence/forced displacement, community/school violence, accidents","High","Duffy M, Gillespie K, Clark DM. Post-traumatic stress disorder in the context of terrorism and other civil conflict in Northern Ireland: randomised controlled trial. BMJ. 2007 Jun 2;334(7604):1147-50. doi: 10.1136/bmj.39021.846852.BE. PMID: 17495988.","29736","2019"
"dunlop2017_A","dunlop2017","Pharmacotherapy","2017","PTSD","PTSD",,"128","A","63",,"GSK561679 investigational drug","GSK561679 investigational drug","Orally active selective CRF1 receptor antagonist that suppressed ACTH response to stress, reduced anxiety","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","350 mg",,"Daily at bedtime","6",,,,,"completed treatment and complied with medication regimen (daily dosing diary and verification by serum levels)","66.67%",,,,,"923 ng/mL (mean concentration at 6 weeks among compliant patients)","603",,"Race and Ethnicity data reported",,"100%","Mixed","combat-related, other (unspecified child abuse, unspecified)","Low","Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974","49315","2019"
"dunlop2017_B","dunlop2017","Pharmacotherapy","2017","PTSD","Inactive Control",,"128","B","65",,"Placebo","Placebo","Matching placebo tablet","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","6",,,,,"completed treatment and complied with medication regimen (daily dosing diary)","75.38%",,,,,,,,"Race and Ethnicity data reported",,"100%","Mixed","combat-related, other (unspecified child abuse, unspecified)","Low","Dunlop BW, Binder EB, Iosifescu D, et al. Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017 Dec;82(12):866-74. doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974","49315","2019"
"dunlop2021_A","dunlop2021","Pharmacotherapy","2021","PTSD","PTSD",,"41","A","20",,"Vortioxetine","Vortioxetine","Vortioxetine 10-20 mg/day. Initiated at 10 mg/day for 4 weeks, then optional increase to 20 mg/day at discretion of study psychiatrist based on effectiveness and tolerability; dose reductions allowed for intolerabe adverse effects.","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","10-20 mg/day; initial dose 10 mg/day for 4 weeks, then optional increase to 20 mg/day",,"Daily","12",,,,,,,"Patients recorded daily administration in a diary which was reviewed by treatment team to assess adherence.",,,,"16.5 mg/day",,,"Race and Ethnicity data reported","Community","68%","Mixed","Combat-related; Child sexual abuse; Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Other (imprisonment, torture, other not specified)","Low","Dunlop BW, Rakofsky JJ, Newport DJ, et al. Efficacy of vortioxetine monotherapy for posttraumatic stress disorder: a randomized, placebo-controlled trial. J Clin Psychopharmacol. 2021 Mar-Apr 01;41(2):172-9. doi: 10.1097/JCP.0000000000001363. PMID: 33587394","1565688","2022"
"dunlop2021_B","dunlop2021","Pharmacotherapy","2021","PTSD","Inactive Control",,"41","B","21",,"Placebo","Placebo","Matching placebo capsule","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","Equivalent dose 10-20 mg/day, matched to vortioxetine",,"Daily","12",,,,,,,"Patients recorded daily administration in a diary which was reviewed by treatment team to assess adherence.",,,,"18.0 mg/day",,"placebo equivalent dose","Race and Ethnicity data reported","Community","68%","Mixed","Combat-related; Child sexual abuse; Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Other (imprisonment, torture, other not specified)","Low","Dunlop BW, Rakofsky JJ, Newport DJ, et al. Efficacy of vortioxetine monotherapy for posttraumatic stress disorder: a randomized, placebo-controlled trial. J Clin Psychopharmacol. 2021 Mar-Apr 01;41(2):172-9. doi: 10.1097/JCP.0000000000001363. PMID: 33587394","1565688","2022"
"dunn2007_A","dunn2007","Psychotherapy","2007","PTSD","PTSD",,"101","A","51","55 randomized, 4 declined to enter treatment and were excluded from analysis; data reported for n=51 randomized and entered treatment","Self-management group therapy","Psychotherapy","Manualized therapy with education on depression (including effects of activity and thoughts on mood, attributions for positive and negative events, goal setting, and self-reinforcement for gains), group discussion, and homework including self-monitoring positive activities and mood. All participants also received Trauma Recovery Program care prior to and throughout the course of the study, includes PTSD education and anger management, and medication as indicated.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"90 minutes","Weekly","14",,"Attending ≥7 sessions and the posttest interview",,"Percent completed of participants randomized and entered treatment (34/51)",,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Combat-related",,"High","Dunn NJ, Rehm LP, Schillaci J, et al. A randomized trial of self-management and psychoeducational group therapies for comorbid chronic posttraumatic stress disorder and depressive disorder. J Trauma Stress. 2007 Jun;20(3):221-37. doi: 10.1002/jts.20214. PMID: 17598141.","80924","2024"
"dunn2007_B","dunn2007","Psychotherapy","2007","PTSD","Active Control",,"101","B","50","56 randomized, 6 declined to enter treatment and were excluded from analysis; data reported for n=50 randomized and entered treatment","Psychoeducational group therapy","Psychoeducation","Manualized therapy with education on PTSD and depression, but no instruction on behavior change. Weekly homework, session feedback, and self-assessment. All participants also received Trauma Recovery Program care prior to and throughout the course of the study, includes PTSD education and anger management, and medication as indicated.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Group","In Person",,"90 minutes","Weekly","14",,"Attending ≥7 sessions and the posttest interview",,"Percent completed of participants randomized and entered treatment (44/50)",,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Combat-related",,"High","Dunn NJ, Rehm LP, Schillaci J, et al. A randomized trial of self-management and psychoeducational group therapies for comorbid chronic posttraumatic stress disorder and depressive disorder. J Trauma Stress. 2007 Jun;20(3):221-37. doi: 10.1002/jts.20214. PMID: 17598141.","80924","2024"
"dunne2012_A","dunne2012","Psychotherapy","2012","PTSD","PTSD",,"26","A","13",,"Trauma-focused CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Treatment according to the Australian Guidelines for the treatment of Adult with Acute Stress Disorder for PTSD (Australian Centre for Posttraumatic Mental Health. Australian Guidelines for the Treatment of Adults with Acute Stress Disorder and Post-traumatic Stress Disorder. Melbourne, VIC: ACPMH; 2007). Treatment included psychoeducation, anxiety management by deep breathing and progressive muscle relaxation, cognitive restructuring, imaginal exposure, graded in vivo exposure, and relapse prevention.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","10",,"Completed all 10 sessions",,"completed all 10 sessions by posttreatment assessment; another n=1 completed treatment between posttreatment assessment and 6 month follow-up (not included in entered value)",,,,"9.38","1.71",,,,,"Not reported","Community","50%","Accidents",,"High","Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.","39572","2019"
"dunne2012_B","dunne2012","Psychotherapy","2012","PTSD","Inactive Control",,"26","B","13",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"10",,,,,,,,,,,,,,"Not reported","Community","50%","Accidents",,"High","Dunne RL, Kenardy JA, Sterling M. A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash. Clin J Pain. 2012 Nov-Dec;28(9):755-65. doi: 10.1097/AJP.0b013e318243e16b. PMID: 22209798.","39572","2019"
"duran2020_A","duran2020","Psychotherapy","2020","PTSD","Active Control",,"95","A","51",,"PE","Prolonged Exposure (PE)","Manualized protocol founded on prolonged imaginal exposure techniques using a hierarchy of feared situations from those eliciting the least anxiety or discomfort to those that are the most difficult","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"1 hour","Weekly","13","13 total sessions",,,,,,,,,,,,,"Not reported","Community","80%",,,"High","Duran EP, Corchs F, Vianna A, et al. A randomized clinical trial to assess the efficacy of trial-based cognitive therapy compared to prolonged exposure for post-traumatic stress disorder: preliminary findings. CNS Spectr. 2020 May 26:1-8. doi: 10.1017/S1092852920001455. PMID: 32450928.","1553709","2022"
"duran2020_B","duran2020","Psychotherapy","2020","PTSD","PTSD",,"95","B","44",,"TBCT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Manualized CBT","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","13","13 total sessions",,,,,,,,,,,,,"Not reported","Community","80%",,,"High","Duran EP, Corchs F, Vianna A, et al. A randomized clinical trial to assess the efficacy of trial-based cognitive therapy compared to prolonged exposure for post-traumatic stress disorder: preliminary findings. CNS Spectr. 2020 May 26:1-8. doi: 10.1017/S1092852920001455. PMID: 32450928.","1553709","2022"
"echeburua1996_A","echeburua1996","Psychotherapy & CIH","1996","PTSD","PTSD",,"20","A","10",,"Cognitive Restructuring and coping-skills training","Cognitive restructuring and coping-skills training","Treatment seeks to modify negative thoughts associated with rape. Coping skills training includes progressive muscular relaxation, thought-stopping, cognitive distractions, and instruction in gradual exposure","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","5",,"Treatment completion",,"""There were no refusals of treatment or dropouts from the program. """,,,,,,,,,,"Not reported","Community","100%","Rape/sexual assault",,"Some Concerns","Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.","07521","2019"
"echeburua1996_B","echeburua1996","Psychotherapy & CIH","1996","PTSD","PTSD",,"20","B","10",,"Progressive muscular relaxation","Relaxation","Progressive muscular relaxation training according to Bernstein & Borkovec (1973)","No",,"No",,"Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","5",,"Treatment completion",,"""There were no refusals of treatment or dropouts from the program. """,,,,,,,,,,"Not reported","Community","100%","Rape/sexual assault",,"Some Concerns","Echeburua E, de Corral P, Sarasua B, et al. Treatment of acute posttraumatic stress disorder in rape victims: an experimental study. J Anxiety Disord. 1996 May-Jun;10(3):185-99. doi: 10.1016/0887-6185(96)89842-2.","07521","2019"
"echiverricohen2021_A","echiverricohen2021","Nonpharmacologic cognitive","2021","PTSD","PTSD",,"49","A","24",,"Response inhibition training","Response inhibition training","A behavioral intervention that promotes behavioral and neural changes in response inhibition; ""computerized training program that randomizes visual stimuli (letters: E, A, M, O, S, T, colors: Blue, Cyan, Green, Red, White) as Go and No-Go stimuli in which participants are instructed to respond as fast as possible to a set of stimuli (Go) while withholding their responses to another set of stimuli (No-Go)"".","No",,"No",,"No",,"No","Yes","No","No","No","Individual","Technology assisted",,"3 hours","Daily","0.3","3 hour trainings held over 2 days","See Detail",,"study reports on study completers only, not stated if these participants also completed treatment sessions (""training and waitlist groups of this study consisted of individuals who completed pre- and -post training sessions""",,,,,,,,,,"Race data reported","Community","74.5%",,,"High","Echiverri-Cohen A, Spierer L, Perez M, et al. Randomized-controlled trial of response inhibition training for individuals with PTSD and impaired response inhibition. Behav Res Ther. 2021 Aug;143:103885. doi: 10.1016/j.brat.2021.103885. PMID: 34089923.","1571015","2023"
"echiverricohen2021_B","echiverricohen2021","Nonpharmacologic cognitive","2021","PTSD","Inactive Control",,"49","B","25",,"Waitlist","Waitlist","Waitlist","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Race data reported","Community","74.5%",,,"High","Echiverri-Cohen A, Spierer L, Perez M, et al. Randomized-controlled trial of response inhibition training for individuals with PTSD and impaired response inhibition. Behav Res Ther. 2021 Aug;143:103885. doi: 10.1016/j.brat.2021.103885. PMID: 34089923.","1571015","2023"
"efendi2020_A","efendi2020","Psychotherapy","2020","PTSD","PTSD",,"90","A","45",,"Trauma-focused Cognitive Behavioral Therapy","Trauma-focused cognitive behavioral therapy (TF-CBT)","TF-CBT include psychoeducation, relaxation, social problem solving, cognitive restructuring, real life exposure and the development of the trauma narrative","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Twice a week","6",,,,,,,,,,,,,,"Not reported","Community","74.4%","Natural or manmade disasters",,"High","Efendi F, Indarwati R, Aurizki GE. Effect of trauma-focused cognitive behavior therapy on depression and the quality of life of the elderly in Indonesia. Work Older People. 2020;24(3):149-57. doi: 10.1108/WWOP-02-2020-0004.","1587976","2022"
"efendi2020_B","efendi2020","Psychotherapy","2020","PTSD","Inactive Control",,"90","B","45",,"Waitlist","Waitlist","Waitlist; received intervention after post-test assessment","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Not reported","Community","74.4%","Natural or manmade disasters",,"High","Efendi F, Indarwati R, Aurizki GE. Effect of trauma-focused cognitive behavior therapy on depression and the quality of life of the elderly in Indonesia. Work Older People. 2020;24(3):149-57. doi: 10.1108/WWOP-02-2020-0004.","1587976","2022"
"ehlers2003_A","ehlers2003","Psychotherapy","2003","PTSD","PTSD",,"85","A","28",,"Cognitive Therapy","Cognitive Therapy for PTSD (CT-PTSD)","Manualized treatment; goal is to modify excessively negative appraisals, correct the autobiographical memory disturbance, and remove the problematic behavior and cognitive responses.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 to 90 minutes","Weekly for 3 months, followed by up to 3 monthly booster sessions","12 to 26","3 months (weekly sessions), plus up to 3 months (booster sessions)","Completed intervention phase",,"intervention phase is first 3 months with weekly sessions",,,,,,"Weekly: 9.0/12; Boosters: 2.4/3",,,,"Not reported","Community",,"Accidents",,"Some Concerns","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_B","ehlers2003","Psychotherapy","2003","PTSD","Active Control",,"85","B","28",,"Self-help booklet","Self-help booklet","Participants were given a 64-page booklet providing cognitive behavioral principles for the treatment of PTSD (Understanding Your Reactions to Trauma) and an additional 4-page sheet which focused on common avoidance behaviors and safety-seeking behaviors after motor vehicle accidents; one meeting with a clinician to explain use of the booklet and provide motivation to follow advice in the booklet.","No",,"No",,"No",,"No","No","Yes","No","No",,,,"Clinician session: 40 minutes","Clinician session: once","0.14","single session","Completed intervention phase",,"intervention phase is first 3 months",,,,,,,,,,"Not reported","Community",,"Accidents",,"Some Concerns","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2003_C","ehlers2003","Psychotherapy","2003","PTSD","Inactive Control",,"85","C","29",,"Repeated assessments","Assessment","Single meeting with clinician covering rationale and protocol for assessments and monitoring; regular monitoring with the same assessments and timing as other arms.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"Clinician session: 20 minutes","Clinician: once","0.14","single session","Completed intervention phase",,"intervention phase is first 3 months",,,,,,,,,,"Not reported","Community",,"Accidents",,"Some Concerns","Ehlers A, Clark DM, Hackmann A, et al. A randomized controlled trial of cognitive therapy, a self-help booklet, and repeated assessments as early interventions for posttraumatic stress disorder. Arch Gen Psychiatry. 2003;60(10):1024-32. doi: 10.1001/archpsyc.60.10.1024. PMID: 14557148.","25861","2019"
"ehlers2005_A","ehlers2005","Psychotherapy","2005","PTSD","PTSD",,"28","A","14",,"Cogntive therapy","Cognitive Therapy for PTSD (CT-PTSD)","Individualized version of the model developed for each participant, with up to 12 sessions and up to 3 monthly booster sessions; ""cognitive therapy for PTSD aims to modify excessively negative appraisals, correct the autobiographical memory disturbance, and remove the problematic behavioural and cognitive strategies."" Techniques utilized include imaginal reliving, cognitive restructuring, stimulus discrimination procedures, and imagery transformation.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes (first session) and 60 minutes (subsequent sessions)","Weekly","13","12 sessions could be completed within 13 weeks","Treatment completion",,"no patient dropped out",,,,"10","2.9","weekly sessions: mean 10 (SD 2.9); monthly booster sessions: mean 2.4 (SD 1.1)",,,,"Race data reported","Community","53.6%","Mixed","Accidents; Community/school violence; Other (""witness death"")","High","Ehlers A, Clark DM, Hackmann A, McManus F, Fennell M. Cognitive therapy for post-traumatic stress disorder: development and evaluation. Behav Res Ther. 2005 Apr;43(4):413-31. doi: 10.1016/j.brat.2004.03.006. PMID: 15701354.","26999","2023"
"ehlers2005_B","ehlers2005","Psychotherapy","2005","PTSD","Inactive Control",,"28","B","14",,"Waitlist","Waitlist","Waitlist, offered active intervention after completion of waitlist period; contact information provided for emergencies.","No",,"No",,"No",,"No","No","Yes","No","No","Individual",,,,,,,"Treatment completion",,"no patient dropped out",,,,,,,,,,"Race data reported","Community","53.6%","Mixed","Accidents; Community/school violence; Other (""witness death"")","High","Ehlers A, Clark DM, Hackmann A, McManus F, Fennell M. Cognitive therapy for post-traumatic stress disorder: development and evaluation. Behav Res Ther. 2005 Apr;43(4):413-31. doi: 10.1016/j.brat.2004.03.006. PMID: 15701354.","26999","2023"
"ehlers2014_A","ehlers2014","Psychotherapy","2014","PTSD","PTSD",,"121","A","30",,"Intensive Cognitive Therapy","Cognitive Therapy for PTSD (CT-PTSD)","Intensive delivery (5 to 7 days) of Ehlers and Clark’s model of cognitive therapy aimed at reducing the patient’s sense of current threat by identifying and modifying excessively negative appraisals of the trauma, elaborating the trauma memory and discriminating triggers of intrusive re-experiencing, and reducing the use of cognitive strategies and behaviors that maintain the problem. Up to 2 sessions one week and one month after intensive period and up to 3 optional monthly booster sessions.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes to 2 hours","2 sessions per day","1","5-7 days","Treatment completion",,"Dropouts were defined as attending fewer than eight sessions unless earlier completion was agreed with the therapist",,,,,,"10.13 (2.18) regular sessions and 1.90 (0.80) booster sessions",,,,"Race data reported","Community","58.68%","Mixed","child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)","Some Concerns","Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.","41886","2019"
"ehlers2014_B","ehlers2014","Psychotherapy","2014","PTSD","PTSD",,"121","B","31",,"Standard Cognitive Therapy","Cognitive Therapy for PTSD (CT-PTSD)","Standard delivery of Ehlers and Clark’s model of cognitive therapy aimed at reducing the patient’s sense of current threat by identifying and modifying excessively negative appraisals of the trauma, elaborating the trauma memory and discriminating triggers of intrusive re-experiencing, and reducing the use of cognitive strategies and behaviors that maintain the problem.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes, 60 minutes for booster sessions","Weekly","12","plus optional monthly booster session for 3 months","Treatment completion",,"Dropouts were defined as attending fewer than eight sessions unless earlier completion was agreed with the therapist",,,,,,"10.10 (3.26) regular sessions; 2.07 (1.46) booster sessions",,,,"Race data reported","Community","58.68%","Mixed","child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)","Some Concerns","Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.","41886","2019"
"ehlers2014_C","ehlers2014","Psychotherapy","2014","PTSD","Active Control",,"121","C","30",,"Emotion-focused supportive therapy","Supportive counseling","Therapy focused on patients’ emotional reactions rather than their cognitions; designed to provide a credible therapeutic alternative to control for nonspecific therapeutic factors","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes, 60 minutes for booster sessions","Weekly","12","plus optional monthly booster session for 3 months","Treatment completion",,"Dropouts were defined as attending fewer than eight sessions unless earlier completion was agreed with the therapist",,,,,,"10.27 (3.21) regular sessions and 2.20 (1.32) booster sessions",,,,"Race data reported","Community","58.68%","Mixed","child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)","Some Concerns","Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.","41886","2019"
"ehlers2014_D","ehlers2014","Psychotherapy","2014","PTSD","Inactive Control",,"121","D","30",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"14",,,,,,,,,,,,,,"Race data reported","Community","58.68%","Mixed","child other abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (traumatic death of others, not specified)","Some Concerns","Ehlers A, Hackmann A, Grey N, et al. A randomized controlled trial of 7-day intensive and standard weekly cognitive therapy for PTSD and emotion-focused supportive therapy. Am J Psychiatry. 2014 Mar;171(3):294-304. doi: 10.1176/appi.ajp.2013.13040552. PMID: 24480899.","41886","2019"
"ehlers2023_A","ehlers2023","Psychotherapy","2023","PTSD","PTSD",,"217","A","92",,"Internet-delivered cognitive therapy for PTSD (iCT-PTSD)","Cognitive Therapy for PTSD (CT-PTSD)","Series of trauma-focused online therapy modules with therapist support through online and text messages and weekly phone calls (weekly during first 12 weeks [weekly treatment phase] then 3 monthly phone calls over the next 3 months [booster phase]. Includes changing problematic appraisals, updating trauma memories, identifying triggers, and changing unhelpful behaviors. No stress reduction training. Therapists released 2-3 modules each week; 18 modules released to all participants, and another 16 optional modules released by the therapist on per-participant basis.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Technology assisted",,"Therapist phone calls and messages: weekly during first 12 weeks [weekly treatment phase] then 3 monthly phone calls over the next 3 months [booster phase]","Weekly phone calls","13","12 weekly calls, assessment at 13 weeks","Completed weekly treatment (not further defined)",,"Received minimum treatment dose, defined as completing core procedures relating to (1) rationale and psychoeducation, (2) activities in everyday life, and (3) at least one core technique addressing trauma memories: 90.2%",,,,"9.44","2.4","mean number of weekly phone calls with therapist during 3 months of weekly calls
also reported-
total therapist time (phone calls and messages), weekly treatment and booster phases: mean 6.7 (SD 3.0) hours
total time patient logged in, weekly treatment and booster phases: mean 24.1 (SD 23.1) hours",,,,"Race data reported","Community","73%","Mixed","Combat-related; Child physical abuse; Child sexual abuse; Child other abuse; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (death, severe illness, or harm of significant other; professionals witnessing harm to others)","Low","Ehlers A, Wild J, Warnock-Parkes E, et al. Therapist-assisted online psychological therapies differing in trauma focus for post-traumatic stress disorder (STOP-PTSD): a UK-based, single-blind, randomised controlled trial. Lancet Psychiatry. 2023 Aug;10(8):608-22. doi: 10.1016/S2215-0366(23)00181-5. PMID: 37479341.","1623154","2024"
"ehlers2023_B","ehlers2023","Psychotherapy","2023","PTSD","Active Control",,"217","B","93",,"Internet-delivered stress management therapy for PTSD (iStress-PTSD)","Stress management therapy for PTSD","Stress-management therapy program adapted for the study for PTSD, with therapist support through online and text messages and weekly phone calls (weekly during first 12 weeks [weekly treatment phase] then 3 monthly phone calls over the next 3 months [booster phase].  Includes psychoeducation, coping skills, problem-solving, applied relaxation training, challenging irrational thoughts, mindfullness, sleep improvement, and in vivo exposure; however, does not specifically address trauma appraisal and memories. Therapists released 2-3 modules each week; 18 modules released to all participants, and can choose from an additional 5 challenge areas with 3-4 modules each.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","Technology assisted",,"Therapist phone calls and messages: weekly during first 12 weeks [weekly treatment phase] then 3 monthly phone calls over the next 3 months [booster phase]","Weekly phone calls","13","12 weekly calls, assessment at 13 weeks","Completed weekly treatment (not further defined)",,"Received minimum treatment dose, defined as completing core procedures relating to (1) rationale and psychoeducation, (2) activities in everyday life, and (3) at least one core stress-management technique: 94.6%",,,,"9.66","3.36","mean number of weekly phone calls with therapist during 3 months of weekly calls
also reported-
total therapist time (phone calls and messages), weekly treatment and booster phases: mean 5.7 (SD 2.1) hours
total time patient logged in, weekly treatment and booster phases: mean 16.2 (SD 14.3) hours",,,,"Race data reported","Community","73%","Mixed","Combat-related; Child physical abuse; Child sexual abuse; Child other abuse; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (death, severe illness, or harm of significant other; professionals witnessing harm to others)","Low","Ehlers A, Wild J, Warnock-Parkes E, et al. Therapist-assisted online psychological therapies differing in trauma focus for post-traumatic stress disorder (STOP-PTSD): a UK-based, single-blind, randomised controlled trial. Lancet Psychiatry. 2023 Aug;10(8):608-22. doi: 10.1016/S2215-0366(23)00181-5. PMID: 37479341.","1623154","2024"
"ehlers2023_C","ehlers2023","Psychotherapy","2023","PTSD","Inactive Control",,"217","C","32",,"Waitlist with TAU","Treatment as usual (TAU)","Waitlist with usual National Health Service clinical care, described as ""general practitioner and other treating NHS services, eg, a stable dose of psychotropic medication, and treatment for pain and comorbid medical problems.""","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"13",,"Completed waiting list",,,,,,,,,,,,"Race data reported","Community","73%","Mixed","Combat-related; Child physical abuse; Child sexual abuse; Child other abuse; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (death, severe illness, or harm of significant other; professionals witnessing harm to others)","Low","Ehlers A, Wild J, Warnock-Parkes E, et al. Therapist-assisted online psychological therapies differing in trauma focus for post-traumatic stress disorder (STOP-PTSD): a UK-based, single-blind, randomised controlled trial. Lancet Psychiatry. 2023 Aug;10(8):608-22. doi: 10.1016/S2215-0366(23)00181-5. PMID: 37479341.","1623154","2024"
"elbarazi2022_A","elbarazi2022","Psychotherapy & pharmacotherapy","2022","PTSD+SUD","PTSD+SUD",,"150","A","50",,"CPT","Cognitive Processing Therapy (CPT)","Manual-guided cognitive therapy consisting of weekly 45-50 minute sessions for 12 week. Study evaluates treatment for comorbid PTSD+SUD, stating that therapy teaches individuals with co-occurring PTSD and substance use disorders practical self-help techniques that are developed to immediately improve quality of life.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"45-50 minutes","Weekly","12",,"Attended at least 6 therapy sessions",,"""All patients in the CPT group attended at least six therapy sessions""",,,,,,,,,,"Not reported","Community","4.67%","Mixed","Accidents; Community/school violence; Rape/sexual assault; Other (war, threatened physical assault, threatened sexual violence)","Some Concerns","ElBarazi A, Badary OA, Elmazar MM, et al. Cognitive Processing Therapy versus medication for the treatment of comorbid substance use disorder and post-traumatic stress disorder in Egyptian patients (randomized clinical trial). Journal of Evidence-Based Psychotherapies. 2022;22(2):63-90. doi: 10.24193/jebp.2022.2.13.","1620168","2023"
"elbarazi2022_B","elbarazi2022","Psychotherapy & pharmacotherapy","2022","PTSD+SUD","PTSD+SUD",,"150","B","50",,"Sertraline","Sertraline","Sertraline 200 mg daily; gradual titration over 2 weeks from starting dose of 50 mg to 200 mg, dose held at 200 mg once daily for remainder of trial. Study evaluates treatment for comorbid PTSD+SUD, as it is used to treat both disorders separately.","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","200 mg; titration: 50 mg increased to 200 mg over 2 weeks, 200 mg dose maintained through 12 month assessment",,"Daily","12","medication continued throughout follow-up period (to 12 months post-randomization); end of treatment assessment at 3 months post-randomization",,,,"Riboflavin detection rate","45%","Attended at least 6 medication visits: 70%",,,,,,,"Not reported","Community","4.67%","Mixed","Accidents; Community/school violence; Rape/sexual assault; Other (war, threatened physical assault, threatened sexual violence)","Some Concerns","ElBarazi A, Badary OA, Elmazar MM, et al. Cognitive Processing Therapy versus medication for the treatment of comorbid substance use disorder and post-traumatic stress disorder in Egyptian patients (randomized clinical trial). Journal of Evidence-Based Psychotherapies. 2022;22(2):63-90. doi: 10.24193/jebp.2022.2.13.","1620168","2023"
"elbarazi2022_C","elbarazi2022","Psychotherapy & pharmacotherapy","2022","PTSD+SUD","Inactive Control",,"150","C","50",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","12","placebo continued throughout follow-up period (to 12 months post-randomization); end of treatment assessment at 3 months post-randomization",,,,"Riboflavin detection rate","40%","Attended at least 6 medication visits: 78%",,,,,,,"Not reported","Community","4.67%","Mixed","Accidents; Community/school violence; Rape/sexual assault; Other (war, threatened physical assault, threatened sexual violence)","Some Concerns","ElBarazi A, Badary OA, Elmazar MM, et al. Cognitive Processing Therapy versus medication for the treatment of comorbid substance use disorder and post-traumatic stress disorder in Egyptian patients (randomized clinical trial). Journal of Evidence-Based Psychotherapies. 2022;22(2):63-90. doi: 10.24193/jebp.2022.2.13.","1620168","2023"
"elbogen2019_A","elbogen2019","Other mixed","2019","PTSD","PTSD",,"112","A","57",,"Cognitive Applications for Life Management","Cognitive Applications for Life Management","Cognitive rehabilitation combining ""[goal management training], content-free cueing, and the n-back task, delivers these via a mobile device, and involves support of a family member or friend."" Three home visits by a clinical facilitator; mobile applications (""Mind Jogger"" for cueing, and ""IQ Boost"" for n-back task). Family member/friend attended home visits, were given goal management training educational materials, and instructed to provide support and encouragement to veteran participant.","No",,"No",,"No",,"No","Yes","No","No","No","Individual","Mixed",,"Home visits: 60 to 90 minutes
Cognitive and goal management training: NR","Home visits: every 2 months; Cognitive and goal management training: daily","24",,,,,,,,,,"Home visits: 2.73 (0.54)/3 (both arms combined);



Cognitive and goal management training, executive reviews: 188.60 (202.20);



Cognitive and goal management training, n-back application: 73.05 (84.15);",,,,"Race data reported","Veteran","9.8%",,,"Some Concerns","Elbogen EB, Dennis PA, Van Voorhees EE, et al. Cognitive rehabilitation with mobile technology and social support for veterans with TBI and PTSD: a randomized clinical trial. J Head Trauma Rehabil. 2019 Jan/Feb;34(1):1-10. doi: 10.1097/HTR.0000000000000435. PMID: 30169439.","51118","2020"
"elbogen2019_B","elbogen2019","Other mixed","2019","PTSD","Active Control",,"112","B","55",,"Control","Psychoeducation","Psychoeducation on TBI and visual memory training using mobile device. Three home visits by a clinical facilitator; mobile application ""Unotan Memory"" for visual memory exercises. Family member/friend attended home visits, were given psychoeducational materials on TBI and brain functioning, and instructed to provide support and encouragement to veteran participant.","No",,"No",,"No",,"No","No","Yes","Yes","No","Individual","Mixed",,"Home visits: 60 to 90 minutes
Visual memory training: NR","Home visits: every 2 months; Visual memory training: daily","24",,,,,,,,,,"Home visits: 2.73 (0.54) (both arms combined);



Visual memory training: 90.77 (57.27);",,,,"Race data reported","Veteran","9.8%",,,"Some Concerns","Elbogen EB, Dennis PA, Van Voorhees EE, et al. Cognitive rehabilitation with mobile technology and social support for veterans with TBI and PTSD: a randomized clinical trial. J Head Trauma Rehabil. 2019 Jan/Feb;34(1):1-10. doi: 10.1097/HTR.0000000000000435. PMID: 30169439.","51118","2020"
"engel2014_A","engel2014","CIH","2014","PTSD","PTSD",,"55","A","28",,"Acupuncture + Usual PTSD care","Acupuncture","Acupuncture: Hair-thin, solid needles manually inserted into subcutaneous tissue or muscle at specified points. Acupoints include: Urinary Bladder, Liver, Large Intestine, Kidney, Heart, Pericardium, Ren, Du, Ear Shenmen, and Yingtang. 







Usual PTSD care: care as outlined in the VA/DoD Clinical Practice Guideline for Management of Post-Traumatic Stress.","No",,"No",,"Yes","Acupuncture","No","No","No","No","No","Individual","In Person",,"60 minutes","Twice weekly","4",,"Completion of full protocol",,,,,,,,,,,,"Race data reported","Active Duty Military","30.9%",,,"Low","Engel CC, Cordova EH, Benedek DM, et al. Randomized effectiveness trial of a brief course of acupuncture for posttraumatic stress disorder. Med Care. 2014 Dec;52(12 Suppl 5):S57-64. doi: 10.1097/mlr.0000000000000237. PMID: 25397825.","43160","2019"
"engel2014_B","engel2014","CIH","2014","PTSD","Inactive Control",,"55","B","27",,"Usual Care","Treatment as usual (TAU)","Medications and psychotherapy as guided by existing standards, outlined in VA/DoD Clinical Practice Guideline for Management of Post-Traumatic Stress.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,"Twice weekly","4",,"completed treatment course",,,,,,,,,,,,"Race data reported","Active Duty Military","30.9%",,,"Low","Engel CC, Cordova EH, Benedek DM, et al. Randomized effectiveness trial of a brief course of acupuncture for posttraumatic stress disorder. Med Care. 2014 Dec;52(12 Suppl 5):S57-64. doi: 10.1097/mlr.0000000000000237. PMID: 25397825.","43160","2019"
"engel2015_A","engel2015","Other study class","2015","PTSD","PTSD",,"80","A","43",,"Delivery of Self Training and Education for Stressful Situations-Primary Care version","Internet-based facilitated self-help","Online CBT-based and stress inoculation training approach in a Nurse-guided format.







Includes online educational information about PTSD, stress, and trauma. Homework activities on strategies to manage stress and anger, and to promote better sleep hygiene. Training in cognitive reframing techniques.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology assisted",,"15 to 30 minutes","Three times weekly","6",,"Completed all 18 logins",,"Treatment completion not defined; reports by number of logins completed (also reported: n=28 completed at least 6 logins, and n=18 at least 12 logins)",,,,,,,,,,"Race data reported","Mixed","18.75%","Mixed","combat-related, MST","Some Concerns","Engel CC, Litz B, Magruder KM, et al. Delivery of self training and education for stressful situations (DESTRESS-PC): a randomized trial of nurse assisted online self-management for PTSD in primary care. Gen Hosp Psychiatry. 2015 Jul-Aug;37(4):323-8. doi: 10.1016/j.genhosppsych.2015.04.007. PMID: 25929985.","44647","2019"
"engel2015_B","engel2015","Other study class","2015","PTSD","Active Control",,"80","B","37",,"Optimized usual PTSD care","Treatment as usual (TAU)","Consists of usual primary care PTSD treatment augmented with low intensity care management, feedback to the primary care provider, and training of the clinic providers in management of PTSD.","No",,"No",,"No",,"No","No","Yes","No","No",,,,"15 minutes","Once every two weeks","6",,"See Detail",,"Reports drop out from measurement only",,,,,,,,,,"Race data reported","Mixed","18.75%","Mixed","combat-related, MST","Some Concerns","Engel CC, Litz B, Magruder KM, et al. Delivery of self training and education for stressful situations (DESTRESS-PC): a randomized trial of nurse assisted online self-management for PTSD in primary care. Gen Hosp Psychiatry. 2015 Jul-Aug;37(4):323-8. doi: 10.1016/j.genhosppsych.2015.04.007. PMID: 25929985.","44647","2019"
"engel2016_A","engel2016","Collaborative care","2016","PTSD","PTSD",,"666","A","332",,"Centrally assisted collaborative telecare","Collaborative care","Integrated, collaborative care for PTSD and depression with telecare central specialist support/services. Nurse care managers provided basic psychosocial support, monitored/encouraged medication and psychotherapy adherence, connected participants to specialty services, and helped participants make evidence-based treatment decisions; stepped pharmacologic and specialty mental health services with online cognitive-behavioral self-management, CBT by telephone with psychologist, and site therapists for face-to-face psychotherapy; central symptom registry for identification of those in need of treatment change; central specialist/services with psychiatrist for treatment monitoring and suggestions to primary care provider, psychologist delivering CBT by telephone and training/coaching care managers, and care manager to support other care managers and participants who moved, left the military, etc.","No",,"No",,"No",,"No","No","No","No","Yes","Individual","Phone",,,,"52",,"See Detail",,"No treatment completion defined or reported, only study/assessment completion; process of care outcomes also reported",,,,,,"Study reports patient-reported mental health service use (Table 4): individual therapy visits, telephone contacts, depression medication use, and PTSD medication use, as mean (SE) for each by time period (3 mo prior to enrollment; 0-3 mo; 3-6 mo; 6-12 mo.)",,,,"Race and Ethnicity data reported","Active Duty Military","19.07%",,,"Some Concerns","Engel CC, Jaycox LH, Freed MC, et al. Centrally assisted collaborative telecare for posttraumatic stress disorder and depression among military personnel attending primary care: a randomized clinical trial. JAMA Intern Med. 2016 Jul 1;176(7):948-56. doi: 10.1001/jamainternmed.2016.2402. PMID: 27294447.","45003","2019"
"engel2016_B","engel2016","Collaborative care","2016","PTSD","Active Control",,"666","B","334",,"Re-Engineering Systems of Primary Care Treatment in the Military","Treatment as usual (TAU)","Treatment as usual with the RESPECT-Mil program. Integrated mental health for PTSD and depression using 3-component model: 1) screening at each clinic visit and use of symptom severity tools for diagnosis and assessment; 2) monthly contact by nurse care managers, who provided symptom status to the primary care clinician; 3) increased access to non-primary care clinic-based mental health specialists.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"52",,,,,,,,,,"Study reports patient-reported mental health service use (Table 4): individual therapy visits, telephone contacts, depression medication use, and PTSD medication use, as mean (SE) for each by time period (3 mo prior to enrollment; 0-3 mo; 3-6 mo; 6-12 mo.)",,,,"Race and Ethnicity data reported","Active Duty Military","19.07%",,,"Some Concerns","Engel CC, Jaycox LH, Freed MC, et al. Centrally assisted collaborative telecare for posttraumatic stress disorder and depression among military personnel attending primary care: a randomized clinical trial. JAMA Intern Med. 2016 Jul 1;176(7):948-56. doi: 10.1001/jamainternmed.2016.2402. PMID: 27294447.","45003","2019"
"everypalmer2024_A","everypalmer2024","Psychotherapy","2024","PTSD","PTSD",,"24","A","12",,"EMDR + TAU","Eye Movement Desensitization and Reprocessing (EMDR)","EMDR following Shapiro's eight-phase standard protocol; no stabilization period. Session 1: ""therapist and patient developed a standardized case conceptualization""; sessions 2-9: ""memories processed with eye movements applied as the dual-attention stimulus"". All participants received TAU at discretion of their clinical team including treatment for psychotic disorders; treatment could include antipsychotic medication and multidisciplinary treatment by psychiatrists, psychologists, social workers, occupational therapists, nurses, and cultural worker.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","9","9 sessions","Completing 6 or more sessions of fulfilling criteria for early completion",,,,,,,,,,,,"Race data reported","Community","33%","Mixed","Rape/sexual assault; Community/school violence; Other (""index offense"" [not further specified], childhood abuse [not further specified], unspecified Other)","Low","Every-Palmer S, Flewett T, Dean S, et al. Eye movement desensitization and reprocessing (EMDR) therapy compared to usual treatment for posttraumatic stress disorder in adults with psychosis in forensic settings: Randomized controlled trial. Psychol Trauma. 2024 Jan 15;15:15. doi: 10.1037/tra0001643. PMID: 38227442.","30661","2024"
"everypalmer2024_B","everypalmer2024","Psychotherapy","2024","PTSD","Inactive Control",,"24","B","12",,"TAU","Treatment as usual (TAU)","TAU at discretion of their clinical team including treatment for psychotic disorders; treatment could include antipsychotic medication and multidisciplinary treatment by psychiatrists, psychologists, social workers, occupational therapists, nurses, and cultural worker.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,,,,,,,,,,,,,,,"Race data reported","Community","33%","Mixed","Rape/sexual assault; Community/school violence; Other (""index offense"" [not further specified], childhood abuse [not further specified], unspecified Other)","Low","Every-Palmer S, Flewett T, Dean S, et al. Eye movement desensitization and reprocessing (EMDR) therapy compared to usual treatment for posttraumatic stress disorder in adults with psychosis in forensic settings: Randomized controlled trial. Psychol Trauma. 2024 Jan 15;15:15. doi: 10.1037/tra0001643. PMID: 38227442.","30661","2024"
"falsetti2008_A","falsetti2008","Psychotherapy","2008","PTSD","PTSD",,"60","A","29",,"Multiple Channel Exposure Therapy","Exposure therapy","Treatment followed the ""Patient Manual and Therapy Manual"" by Falsetti and Resnick. Treatment included components of CPT adapted from Resick & Schnicke (1993) and ""Mastery of Your Anxiety and Panic"" by Barlow & Craske (1988, 1994). Participants were presented with cognitive-behavioral models of PTSD and panic, and participated in exposures directed at physiological, cognitive, and behavioral channels of anxiety.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12",,"Completed treatment",,"n=7 did not attend a single treatment session and excluded from analysis, n=8 dropped out, remainder (n=14) described as completer sample",,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Mixed","child sexual abuse, rape/sexual assault, community/school violence, natural or manmade disasters","High","Falsetti SA, Resnick HS, Davis JL. Multiple channel exposure therapy for women with PTSD and comorbid panic attacks. Cogn Behav Ther. 2008;37(2):117-30. doi: 10.1080/16506070801969088. PMID: 18470742.","82073","2019"
"falsetti2008_B","falsetti2008","Psychotherapy","2008","PTSD","Inactive Control",,"60","B","31",,"Waitlist","Minimal attention","Participants were contacted by phone every 2 weeks and offered supportive counseling","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Phone",,,,"12",,,,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Mixed","child sexual abuse, rape/sexual assault, community/school violence, natural or manmade disasters","High","Falsetti SA, Resnick HS, Davis JL. Multiple channel exposure therapy for women with PTSD and comorbid panic attacks. Cogn Behav Ther. 2008;37(2):117-30. doi: 10.1080/16506070801969088. PMID: 18470742.","82073","2019"
"fani2009_A","fani2009","Pharmacotherapy","2009","PTSD","PTSD",,"43","A",,,"Paroxetine controlled release","Paroxetine","SSRI; titrated in 12.5 mg increments (1 capsule) to maximum of 5 capsules as tolerated over 8-week medication adjustment period","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","12.5 to 62.5 mg; titration: initiated at 12.5 mg, titrated to maximum 62.5 mg over 8 weeks",,"Daily","12",,,,,,,,,,,,,,"Race data reported","Community","55.6%","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, other (witnessing trauma)","High","Fani N, Kitayama N, Ashraf A, et al. Neuropsychological functioning in patients with posttraumatic stress disorder following short-term paroxetine treatment. Psychopharmacol Bull. 2009 Jan 1;42(1):53-68.  PMID: 19204651.","47120","2019"
"fani2009_B","fani2009","Pharmacotherapy","2009","PTSD","Inactive Control",,"43","B",,,"Placebo","Placebo","Placebo started at 1 capsule per day, increased by 1 capsule per study visit as tolerated, up to 5 capsules per day during 8 week medication adjustment period.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","1 to 5 capsules (paroxetine equivalent 12.5 to 62.5 mg); titration: initiated at 1 capsule increased as tolerated to maximum of 5 capsules over 8 weeks",,"Daily","12",,,,,,,,,,,,,,"Race data reported","Community","55.6%","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, other (witnessing trauma)","High","Fani N, Kitayama N, Ashraf A, et al. Neuropsychological functioning in patients with posttraumatic stress disorder following short-term paroxetine treatment. Psychopharmacol Bull. 2009 Jan 1;42(1):53-68.  PMID: 19204651.","47120","2019"
"farahimanesh2021_A","farahimanesh2021","Nonpharmacologic cognitive","2021","PTSD","PTSD",,"60","A","30",,"Competitive Memory Training","Competitive Memory Training","Aims to make positive self-representations in long-term memory more accessible through the constant activation of these self-representations, leading to strengthened positive self-representations and inhibition of negative memory representations.","No",,"No",,"No",,"No","Yes","No","No","No","Individual","In Person",,"60 minutes","Weekly","7",,"Completing all sessions",,,,,,,,,,,,"Not reported","Community","68%",,,"Some Concerns","Farahimanesh S, Moradi A, Sadeghi M, et al. Comparing the efficacy of competitive memory training (COMET) and memory specificity training (MEST) on posttraumatic stress disorder among newly diagnosed cancer patients. Cognit Ther Res. 2021;45(5):918-28. doi: 10.1007/s10608-020-10175-4.","1561688","2022"
"farahimanesh2021_B","farahimanesh2021","Nonpharmacologic cognitive","2021","PTSD","PTSD",,"60","B","30",,"Memory Specificity Training","Memory specificity training","Focuses on developing memory specificity and reducing overgeneral memories; improving the precision of retrieving specific personal events from autobiographical memory","No",,"No",,"No",,"No","Yes","No","No","No","Individual","In Person",,"60 minutes","Weekly","6",,"Completing all sessions",,,,,,,,,,,,"Not reported","Community","68%",,,"Some Concerns","Farahimanesh S, Moradi A, Sadeghi M, et al. Comparing the efficacy of competitive memory training (COMET) and memory specificity training (MEST) on posttraumatic stress disorder among newly diagnosed cancer patients. Cognit Ther Res. 2021;45(5):918-28. doi: 10.1007/s10608-020-10175-4.","1561688","2022"
"fecteau1999_A","fecteau1999","Psychotherapy","1999","PTSD","PTSD",,"23","A","12",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Treatment included education about post-trauma reactions, relaxation training, imaginal exposure therapy with cognitive restructuring, instruction for self-directed graduated in-vivo behavior practice.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"2 hours","Weekly","4",,"completed all 4 sessions",,,,,,,,,,,,"Not reported","Community","70%","Accidents",,"High","Fecteau GW, Nicki RM. Cognitive behavioural treatment of post traumatic stress disorder after motor vehicle accident. Behav. Cogn. Psychother. 1999 Jul;27(3):201-14.","21968","2019"
"fecteau1999_B","fecteau1999","Psychotherapy","1999","PTSD","Inactive Control",,"23","B","11",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"4",,"completed treatment course",,,,,,,,,,,,"Not reported","Community","70%","Accidents",,"High","Fecteau GW, Nicki RM. Cognitive behavioural treatment of post traumatic stress disorder after motor vehicle accident. Behav. Cogn. Psychother. 1999 Jul;27(3):201-14.","21968","2019"
"feder2014_A","feder2014","Pharmacotherapy","2014","PTSD","PTSD",,"41","A","22",,"Ketamine hydrochloride","Ketamine","Antagonist of glutamate NMDA receptor; single intravenous infusion given over 40 minutes","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","0.5 mg/kg",,"Once (single dose)","0.14","single dose",,,,,,,,,,,,,"Race and Ethnicity data reported","Community","46.34%","Mixed","combat-related. rape/sexual assault, accidents, community/school violence, other (fire, witnessed assault or death, witnessed 9/11 attacks)","Low","Feder A, Parides MK, Murrough JW, et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2014 Jun;71(6):681-8. doi: 10.1001/jamapsychiatry.2014.62. PMID: 24740528.","42218","2019"
"feder2014_B","feder2014","Pharmacotherapy","2014","PTSD","Active Control",,"41","B","19",,"Midazolam","Midazolam","Benzodiazepine; single intravenous infusion given over 40 minutes","No",,"Yes","Antianxiety: benzodiazepine","No",,"No","No","Yes","No","No","Individual","In Person","0.045 mg/kg",,"Single dose","0.14","single dose",,,,,,,,,,,,,"Race and Ethnicity data reported","Community","46.34%","Mixed","combat-related. rape/sexual assault, accidents, community/school violence, other (fire, witnessed assault or death, witnessed 9/11 attacks)","Low","Feder A, Parides MK, Murrough JW, et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2014 Jun;71(6):681-8. doi: 10.1001/jamapsychiatry.2014.62. PMID: 24740528.","42218","2019"
"feder2021_A","feder2021","Pharmacotherapy","2021","PTSD","PTSD",,"30","A","15",,"Ketamine","Ketamine","Intravenous infusions of ketamine given over 40 minutes, with 6 infusions over 2 weeks","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","0.5 mg/kg IV infusion over 40 minutes",,"3 times weekly","2",,,,,"Completed all infusions","93.33%",,,,,,,,"Race and Ethnicity data reported","Community","76.67%","Mixed","Combat-related; Rape/sexual assault; Accidents; Community/school violence; Terrorism/political violence/forced displacement; Other (""witnessed violent assault or death"")","Low","Feder A, Costi S, Rutter SB, et al. A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder. Am J Psychiatry. 2021 02 01;178(2):193-202. doi: 10.1176/appi.ajp.2020.20050596. PMID: 33397139.","1563573","2022"
"feder2021_B","feder2021","Pharmacotherapy","2021","PTSD","Active Control",,"30","B","15",,"Placebo","Midazolam","Midazolam 0.045 mg/kg given as a psychoactive placebo control; Intravenous infusions given over 40 minutes, with 6 infusions over 2 weeks","No",,"Yes","Antianxiety: benzodiazepine","No",,"No","No","Yes","No","No","Individual","In Person","0.045 mg/kg IV infusion over 40 minutes",,"3 times weekly","2",,,,,"Completed all infusions","100%",,,,,,,,"Race and Ethnicity data reported","Community","76.67%","Mixed","Combat-related; Rape/sexual assault; Accidents; Community/school violence; Terrorism/political violence/forced displacement; Other (""witnessed violent assault or death"")","Low","Feder A, Costi S, Rutter SB, et al. A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder. Am J Psychiatry. 2021 02 01;178(2):193-202. doi: 10.1176/appi.ajp.2020.20050596. PMID: 33397139.","1563573","2022"
"feder2023_A","feder2023","Pharmacotherapy","2023","PTSD","PTSD",,"30","A","15",,"Ketamine","Ketamine","Ketamine given intravenously with an infusion pump","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","0.5 mg/kg","Infused over 40 minutes","Approximately 3 times weekly","2","6 infusions over 2 weeks",,,,"Completing all 6 infusions","93.33%",,,,,,,,"Race and Ethnicity data reported","Community","76.67%","Mixed","Combat-related; Rape/sexual assault; Accidents; Community/school violence; Terrorism/political violence/forced displacement; Other (witnessed violent assault or death)","Low","Feder A, Costi S, Rutter SB, et al. A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder. Focus. 2023 Jul;21(3):296-305. doi: 10.1176/appi.focus.23021014. PMID: 37404970.","1622760","2024"
"feder2023_B","feder2023","Pharmacotherapy","2023","PTSD","Active Control",,"30","B","15",,"Midazolam","Midazolam","Midazolam given intravenously with an infusion pump","No",,"Yes","Antianxiety: benzodiazepine","No",,"No","No","Yes","No","No","Individual","In Person","0.045 mg/kg","Infused over 40 minutes","Approximately 3 times weekly","2","6 infusions over 2 weeks",,,,"Completing all 6 infusions","100%",,,,,,,,"Race and Ethnicity data reported","Community","76.67%","Mixed","Combat-related; Rape/sexual assault; Accidents; Community/school violence; Terrorism/political violence/forced displacement; Other (witnessed violent assault or death)","Low","Feder A, Costi S, Rutter SB, et al. A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder. Focus. 2023 Jul;21(3):296-305. doi: 10.1176/appi.focus.23021014. PMID: 37404970.","1622760","2024"
"feng2019_A","feng2019","Other mixed","2019","PTSD","Active Control",,"240","A","60",,"Sertraline + simulated TEAS","Sertraline + simulated transcutaneous electrical acupoint stimulation","SSRI + adhesive electrode pads placed 1 cm radial to Nei-Guan (PC6) with minimum stimulation fro 30 seconds then ramped off over next 15 seconds","No",,"Yes","Antidepressant: SSRI","No",,"No","No","Yes","No","No","Individual","In Person","Sertraline initiated at 25 mg/day titrated up to 100 mg/d over 7 days",,"TEAS: weekly; Sertraline: daily","12",,"Completed the full 12 weeks of treatment and assessment",,,"pill counted daily",,"reported 95% across all groups",,,,,,"median 96.4 mg/d","Not reported","Community","70.42%","Mixed","rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)","Low","Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.","51941","2020"
"feng2019_B","feng2019","Other mixed","2019","PTSD","Active Control",,"240","B","60",,"CBT + simulated TEAS","Trauma-focused cognitive behavioral therapy (TF-CBT) + simulated transcutaneous electrical acupoint stimulation","Trauma-focused CBT+ adhesive electrode pads placed 1 cm radial to Nei-Guan (PC6) with minimum stimulation fro 30 seconds then ramped off over next 15 seconds","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"CBT session length: 45 minutes;



TEAS session length: NR","Weekly","12",,"Completed the full 12 weeks of treatment/full CBT sessions and assessment",,,,,,,,,,,,"Not reported","Community","70.42%","Mixed","rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)","Low","Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.","51941","2020"
"feng2019_C","feng2019","Other mixed","2019","PTSD","PTSD",,"240","C","60",,"CBT + active TEAS","Trauma-focused cognitive behavioral therapy (TF-CBT) + active transcutaneous electrical acupoint stimulation","Trauma-focused CBT + TEAS delivered to bilateral Nei-Guan (PC6) point on anterior forearm. Battery-drive TEAS (Shenzhen Ryan Medical Device model SNH-138) simulated at 50 Hz with pulse width of 50 microseconds and amplitude 0 to 100 mA titrated to strong but comfortable level","Yes","Trauma-focused","No",,"Yes","Acupuncture","No","No","No","No","No","Individual","In Person",,"CBT session length: 45 minutes;



TEAS session length: NR","Weekly","12",,"Completed the full 12 weeks of treatment/full CBT sessions and assessment",,,,,,,,,,,,"Not reported","Community","70.42%","Mixed","rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)","Low","Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.","51941","2020"
"feng2019_D","feng2019","Other mixed","2019","PTSD","PTSD",,"240","D","60",,"Sertraline + CBT + active TEAS","Sertraline + Trauma-focused cognitive behavioral therapy (TF-CBT) + active transcutaneous electrical acupoint stimulation","SSRI + trauma-focused CBT +TEAS delivered to bilateral Nei-Guan (PC6) point on anterior forearm. Battery-drive TEAS (Shenzhen Ryan Medical Device model SNH-138) simulated at 50 Hz with pulse width of 50 microseconds and amplitude 0 to 100 mA titrated to strong but comfortable level","Yes","Trauma-focused","Yes","Antidepressant: SSRI","Yes","Acupuncture","No","No","No","No","No","Individual","In Person","Sertraline initiated at 25 mg/day titrated up to 100 mg/d over 7 days","CBT session length: 45 minutes;



TEAS session length: NR","CBT and TEAS: weekly; Sertraline: daily","12",,"Completed the full 12 weeks of treatment/full CBT sessions and assessment",,,"pill counted daily",,"reported 95% across all groups",,,,,,"median 96.4 mg/day","Not reported","Community","70.42%","Mixed","rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (death of family members)","Low","Feng B, Zhang Y, Luo LY, et al. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: assessor-blinded, randomized controlled study. Psychiatry Clin Neurosci. 2019 Apr;73(4):179-86. doi: 10.1111/pcn.12810. PMID: 30565342.","51941","2020"
"feske2008_A","feske2008","Psychotherapy","2008","PTSD","PTSD",,"27","A","13",,"PE","Prolonged Exposure (PE)","Treatment adhered to manual by Foa, Hearst-Ikeda, Dancu, Hembree & Jaycox (1997), which included breathing retraining, and imaginal and in vivo exposure. In session 8, participants with <70% improvement on PTSD outcome were encouraged to participate in additional 3 PE sessions","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","9 to 12",,"Completed at least 9 treatment protocol sessions",,,,,,"9.3","1",,,,,"Race data reported","Community","100%","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, community/school violence","High","Feske U. Treating low-income and minority women with posttraumatic stress disorder: a pilot study comparing prolonged exposure and treatment as usual conducted by community therapists. J Interpers Violence. 2008 Aug;23(8):1027-40. doi: 10.1177/0886260507313967. PMID: 18292398.","82117","2019"
"feske2008_B","feske2008","Psychotherapy","2008","PTSD","Active Control",,"27","B","14",,"TAU","Supportive counseling","Individual counseling session and group treatment session (e.g., anger management)","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Mixed","In Person",,"Individual session: 60 minutes







Group session: 90 minutes","Weekly","9 to 12",,"Completed at least 9 treatment protocol sessions",,,,,,"9.5","1",,,,,"Race data reported","Community","100%","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, community/school violence","High","Feske U. Treating low-income and minority women with posttraumatic stress disorder: a pilot study comparing prolonged exposure and treatment as usual conducted by community therapists. J Interpers Violence. 2008 Aug;23(8):1027-40. doi: 10.1177/0886260507313967. PMID: 18292398.","82117","2019"
"fine2023_A","fine2023","Other mixed","2023","PTSD","PTSD",,"55","A","40",,"Trauma-focused intensive therapy + amygdala electrical finger print neurofeedback","Neurofeedback","Intensive trauma-focused therapy plus neurofeedback (concurrent)
Intensive trauma-focused therapy: included weekly individual psychotherapy, skills group, and psychotropic medication; incorporated skills from DBT including psychoeducation, emotion regulation training, and trauma processing.
Neurofeedback: training sessions to down-regulate amygdala-related activity through feedback via 3D audiovisual animated scenario","Yes","Trauma-focused","No",,"No",,"Yes","No","No","No","No","Mixed","In Person",,"Psychotherapy: NR
Neurofeedback: 50 minutes","Psychotherapy: weekly
Neurofeedback: twice a week for 2 weeks, then weekly for 6 weeks","8","Neurofeedback: total 10 sessions","Completed at least 6 of 10 neurofeedback sessions",,,,,,,,,,,,"Not reported","Community","100%","Child sexual abuse",,"Some Concerns","Fine NB, Helpman L, Armon DB, et al. Amygdala-related EEG Neuro-Feedback as an add-on Therapy for treatment-resistant Childhood Sexual Abuse PTSD: feasibility Study. Psychiatry Clin Neurosci. 2023 doi: 10.1111/pcn.13591. PMID: 37615935.","1624527","2024"
"fine2023_B","fine2023","Other mixed","2023","PTSD","Active Control",,"55","B","15",,"Trauma-focused intensive therapy","Treatment as usual (TAU)","Intensive trauma-focused therapy: included weekly individual psychotherapy, skills group, and psychotropic medication; incorporated skills from DBT including psychoeducation, emotion regulation training, and trauma processing.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Mixed","In Person",,,"Weekly","8",,,,,,,,,,,,,,"Not reported","Community","100%","Child sexual abuse",,"Some Concerns","Fine NB, Helpman L, Armon DB, et al. Amygdala-related EEG Neuro-Feedback as an add-on Therapy for treatment-resistant Childhood Sexual Abuse PTSD: feasibility Study. Psychiatry Clin Neurosci. 2023 doi: 10.1111/pcn.13591. PMID: 37615935.","1624527","2024"
"flanagan2018_A","flanagan2018","Psychotherapy & pharmacotherapy","2018","PTSD","PTSD",,"17","A","8",,"PE + oxytocin","Prolonged Exposure (PE) + oxytocin","PE augmented with oxytocin







PE: individual, manualized, trauma-focused CBT







Oxytocin: hypothalamic neuropeptide; self-administered intranasal spray 45 minutes prior to PE therapy (sessions 2 through 9)","Yes","Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","40 IU","90 minutes","Weekly","10","PE: 10, Oxytocin: 8","completed all 10 PE sessions",,,"medication administration observed by research staff","100%",,,,,,,,"Race data reported","Mixed","17.7%","Mixed","combat-related, rape/sexual assault, accidents, terrorism/political violence/forced displacement, other (assault)","Low","Flanagan JC, Sippel LM, Wahlquist A, et al. Augmenting prolonged exposure therapy for PTSD with intranasal oxytocin: a randomized, placebo-controlled pilot trial. J Psychiatr Res. 2018 Mar;98:64-9. doi: 10.1016/j.jpsychires.2017.12.014. PMID: 29294429.","49583","2019"
"flanagan2018_B","flanagan2018","Psychotherapy & pharmacotherapy","2018","PTSD","Active Control",,"17","B","9",,"PE + placebo","Prolonged Exposure (PE) + placebo","PE with placebo augmentation







PE: individual, manualized, trauma-focused CBT







Placebo: matching placebo 45 minutes prior to PE therapy (sessions 2 through 9)","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","PE: weekly







Placebo: weekly","10","PE: 10, Placebo: 8","completed all 10 PE sessions","77.78%",,"medication administration observed by research staff","100%",,,,,,,,"Race data reported","Mixed","17.7%","Mixed","combat-related, rape/sexual assault, accidents, terrorism/political violence/forced displacement, other (assault)","Low","Flanagan JC, Sippel LM, Wahlquist A, et al. Augmenting prolonged exposure therapy for PTSD with intranasal oxytocin: a randomized, placebo-controlled pilot trial. J Psychiatr Res. 2018 Mar;98:64-9. doi: 10.1016/j.jpsychires.2017.12.014. PMID: 29294429.","49583","2019"
"foa1991_A","foa1991","Psychotherapy","1991","PTSD","PTSD",,"55","A","17",,"SIT","Stress Inoculation Training (SIT)","Individual sessions with female therapist. Two sessions devoted to information gathering, description of treatment method and rationale, and explanation for origin of fear and anxiety. Seven sessions comprised of breathing exercises, deep muscle relaxation, thought stopping to counter ruminative or obsessive thinking, cognitive restructuring, guided self-dialogue, covert modeling, and role-playing.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Twice weekly","4.5",,"Treatment completion",,"analyzed/described sample limited to participants who started treatment, n=3 dropped out, remainder described as completers",,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Rape/sexual assault",,"High","Foa EB, Rothbaum BO, Riggs DS, et al. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991 Oct;59(5):715-23.  PMID: 1955605.","02437","2019"
"foa1991_B","foa1991","Psychotherapy","1991","PTSD","PTSD",,"55","B","14",,"PE","Prolonged Exposure (PE)","Individual sessions with female therapist. Two sessions devoted to information gathering, explanation of treatment rationale and treatment planning. Seven sessions comprised of imaginal exposure in which participants were instructed to imagine reliving the assault in vivid detail while describing it aloud, using present tense, and repeating for approximately 60 minutes of the session. Homework as at least once daily listening to tape-recorded narrative, with additional homework including in vivo exposure.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Twice weekly","4.5",,"Treatment completion",,"analyzed/described sample limited to participants who started treatment, n=4 dropped out, remainder described as completers",,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Rape/sexual assault",,"High","Foa EB, Rothbaum BO, Riggs DS, et al. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991 Oct;59(5):715-23.  PMID: 1955605.","02437","2019"
"foa1991_C","foa1991","Psychotherapy","1991","PTSD","Active Control",,"55","C","14",,"Supportive Counseling","Supportive counseling","Individual sessions with female therapist. Two sessions devoted to information gathering, explanation of treatment rationale and treatment planning. Seven sessions in which participants were taught a general problem-solving technique with therapists in unconditionally supportive role. Homework with diary-keeping of daily problems and attempts at problem solving. Participants were immediately redirected to focus on current daily problems if discussion of assault occurred.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Twice weekly","4.5",,"Treatment completion",,"analyzed/described sample limited to participants who started treatment, n=3 dropped out, remainder described as completers",,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Rape/sexual assault",,"High","Foa EB, Rothbaum BO, Riggs DS, et al. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991 Oct;59(5):715-23.  PMID: 1955605.","02437","2019"
"foa1991_D","foa1991","Psychotherapy","1991","PTSD","Inactive Control",,"55","D","10",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"5",,,,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Rape/sexual assault",,"High","Foa EB, Rothbaum BO, Riggs DS, et al. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991 Oct;59(5):715-23.  PMID: 1955605.","02437","2019"
"foa1999_A","foa1999","Psychotherapy","1999","PTSD","Active Control",,"96","A","25",,"PE","Prolonged Exposure (PE)","Individual treatment following manual; 2 sessions included information gathering, treatment rationale, construction of in vivo exposure hierarchy, and in vivo homework; remaining sessions included homework review, imaginal exposure, and homework assignment; homework to listen to tape recordings of imaginal exposure from sessions, and in vivo exposure.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"120 minutes for 2 sessions



90 minutes for 7 sessions","Twice weekly","5",,"did not drop out of treatment",,,,,,,,,,,,"Race data reported","Community","100%","Mixed","rape/sexual assault, community/school violence","Some Concerns","Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.","09724","2019"
"foa1999_B","foa1999","Psychotherapy","1999","PTSD","Active Control",,"96","B","26",,"SIT","Stress Inoculation Training (SIT)","Individual treatment following manual, program adapted from Veronen and Kilpatrick (1983); 2 sessions included information gathering, breathing retraining, and treatment rationale and planning; remaining 7 sessions focused on coping skills for management of assault-related anxiety and postassault problems; coping skills included: deep muscle relaxation, cue-controlled and differential relaxation, thought stopping, cognitive restructuring, guided self-dialogue, covert modeling, and role-play. Homework to practice the coping skills to manage anxiety and fear in daily activities. Explicit in vivo homework instructions were omitted.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"120 minutes for 2 sessions



90 minutes for 7 sessions","Twice weekly","5",,"did not drop out of treatment",,,,,,,,,,,,"Race data reported","Community","100%","Mixed","rape/sexual assault, community/school violence","Some Concerns","Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.","09724","2019"
"foa1999_C","foa1999","Psychotherapy","1999","PTSD","PTSD",,"96","C","30",,"PE + SIT","Prolonged Exposure (PE) + Stress Inoculation Training (SIT)","Individual treatment following manual; combination of PE and SIT included education, training on SIT coping skills, in vivo exposure, and imaginal exposure; homework assigned for exposure and coping skill practice","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"120 minutes for first 2 sessions, 90 minutes for remaining 7 sessions","Twice weekly","5",,"did not drop out of treatment",,,,,,,,,,,,"Race data reported","Community","100%","Mixed","rape/sexual assault, community/school violence","Some Concerns","Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.","09724","2019"
"foa1999_D","foa1999","Psychotherapy","1999","PTSD","Inactive Control",,"96","D","15",,"Waitlist","Waitlist","Waitlist participant were instructed to call if experiencing any problems; contacted once during the waiting period by a therapist to determine their current status.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"5",,,,,,,,,,,,,,"Race data reported","Community","100%","Mixed","rape/sexual assault, community/school violence","Some Concerns","Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999;67(2):194.  PMID: 10224729.","09724","2019"
"foa2005_A","foa2005","Psychotherapy","2005","PTSD","PTSD",,"104","A","74",,"PE + CR","Trauma-focused cognitive behavioral therapy (TF-CBT)","Sessions involved imaginal exposure and participants were taught to identify and challenge erroneous beliefs","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"≥90 minutes","Once a week","9 to 12",,"Attended ≥8 therapy sessions and completed a posttreatment assessment",,,,,,,,,,,,"Race data reported","Community","100%","Mixed","rape/sexual assault, intimate partner violence, child sexual abuse","High","Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.","27946","2019"
"foa2005_B","foa2005","Psychotherapy","2005","PTSD","Active Control",,"104","B","79",,"PE","Prolonged Exposure (PE)","Each session began with reviewing homework and ended with assigning homework. Sessions involved imaginal exposure","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"≥90 minutes","Once weekly","9 to 12",,"Attended ≥ 8 therapy sessions and completed a posttreatment assessment",,,,,,,,,,,,"Race data reported","Community","100%","Mixed","rape/sexual assault, intimate partner violence, child sexual abuse","High","Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.","27946","2019"
"foa2005_C","foa2005","Psychotherapy","2005","PTSD","Inactive Control",,"104","C","26",,"Waitlist","Waitlist","Participants informed their treatment will begin in 9 weeks","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"9",,,,,,,,,,,,,,"Race data reported","Community","100%","Mixed","rape/sexual assault, intimate partner violence, child sexual abuse","High","Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73(5):953. doi: 10.1037/0022-006X.73.5.953. PMID: 16287395.","27946","2019"
"foa2013_A","foa2013","Psychotherapy & pharmacotherapy","2013","PTSD+SUD","PTSD+SUD","Not integrated","165","A","40",,"PE + naltrexone","Prolonged Exposure (PE) + naltrexone","Prolonged exposure with repeated imaginal exposures, processing the memory, and homework including in vivo exposure. Naltrexone starting dose given for a minimum of 3 days and titrated up within 1 week. All patients also received supportive counseling including medication management, adherence monitoring, and education about alcohol dependency.","Yes","Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","Start at 50 mg up to 100 mg","PE 90 minutes, counseling 30 to 45 minutes","Psychotherapy: weekly for 12 weeks then biweekly; Naltrexone: daily","24",,"See Detail",,"not reported for PE sessions (see treatment adherence for supportive counseling completion); 35% dropped out of the study prior to end of treatment period","≥80% adherence to medication and attendance at supportive counseling. Naltrexone given with 100 mg riboflavin, and urine riboflavin tests were used to monitor medication compliance; pill counts also used","85%",,,"6.18","3.86",,,,"Race and Ethnicity data reported","Mixed","34.55%","Mixed","Combat-related; Rape/sexual assault; Community/school violence; Other (not specified)","Some Concerns","Foa EB, Yusko DA, McLean CP, et al. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013 Aug 7;310(5):488-95. doi: 10.1001/jama.2013.8268. PMID: 23925619.","40905","2020"
"foa2013_B","foa2013","Psychotherapy & pharmacotherapy","2013","PTSD+SUD","Active Control","Not integrated","165","B","40",,"PE + placebo","Prolonged Exposure (PE) + placebo","Prolonged exposure with repeated imaginal exposures, processing the memory, and homework including in vivo exposure. Placebo identical to naltrexone given at starting dose for a minimum of 3 days and titrated up within 1 week. All patients also received supportive counseling including medication management, adherence monitoring, and education about alcohol dependency.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person","Start with placebo tablet identical to 50 mg naltrexone, titrate up to 100 mg","PE 90 minutes, counseling 30 to 45 minutes","Psychotherapy: weekly for 12 weeks then biweekly; Placebo: daily","24",,"See Detail",,"not reported for PE sessions (see treatment adherence for supportive counseling completion); 38% dropped out of the study prior to end of treatment period","≥80% adherence to medication and attendance at supportive counseling. Placebo given with 100 mg riboflavin, and urine riboflavin tests were used to monitor medication compliance; pill counts also used","85%",,,"6.48","3.49",,,,"Race and Ethnicity data reported","Mixed","34.55%","Mixed","Combat-related; Rape/sexual assault; Community/school violence; Other (not specified)","Some Concerns","Foa EB, Yusko DA, McLean CP, et al. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013 Aug 7;310(5):488-95. doi: 10.1001/jama.2013.8268. PMID: 23925619.","40905","2020"
"foa2013_C","foa2013","Psychotherapy & pharmacotherapy","2013","PTSD+SUD","Active Control","Not integrated","165","C","42",,"Supportive counseling + naltrexone","Supportive counseling + naltrexone","Naltrexone starting dose given for a minimum of 3 days and titrated up within 1 week. All patients also received supportive counseling including medication management, adherence monitoring, and education about alcohol dependency.","Yes","Non-Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","Yes","No","No","Individual","In Person","Start at 50 mg up to 100 mg","30 to 45 minutes","Psychotherapy: weekly for 12 weeks then biweekly; Naltrexone: daily","24",,"See Detail",,"see treatment adherence; 31% dropped out of the study prior to end of treatment period","≥80% adherence to medication and attendance at supportive counseling. Naltrexone given with 100 mg riboflavin, and urine riboflavin tests were used to monitor medication compliance; pill counts also used","85.71%",,,,,,,,"Race and Ethnicity data reported","Mixed","34.55%","Mixed","Combat-related; Rape/sexual assault; Community/school violence; Other (not specified)","Some Concerns","Foa EB, Yusko DA, McLean CP, et al. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013 Aug 7;310(5):488-95. doi: 10.1001/jama.2013.8268. PMID: 23925619.","40905","2020"
"foa2013_D","foa2013","Psychotherapy & pharmacotherapy","2013","PTSD+SUD","Active Control","Not integrated","165","D","43",,"Supportive counseling + placebo","Supportive counseling + placebo","Placebo identical to naltrexone starting dose given for a minimum of 3 days and titrated up within 1 week. All patients also received supportive counseling including medication management, adherence monitoring, and education about alcohol dependency.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person","Start with placebo tablet identical to 50 mg naltrexone, titrate up to 100 mg","Counseling 30 to 45 minutes","Psychotherapy: weekly for 12 weeks then biweekly; Placebo: daily","24",,"See Detail",,"see treatment adherence; 26% dropped out of the study prior to end of treatment period","≥80% adherence to medication and attendance at supportive counseling. Placebo given with 100 mg riboflavin, and urine riboflavin tests were used to monitor medication compliance; pill counts also used","86.05%",,,,,,,,"Race and Ethnicity data reported","Mixed","34.55%","Mixed","Combat-related; Rape/sexual assault; Community/school violence; Other (not specified)","Some Concerns","Foa EB, Yusko DA, McLean CP, et al. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013 Aug 7;310(5):488-95. doi: 10.1001/jama.2013.8268. PMID: 23925619.","40905","2020"
"foa2017_A","foa2017","Psychotherapy & pharmacotherapy","2017","PTSD+SUD","PTSD+SUD","Integrated","142","A","72",,"PE + smoking cessation counseling + varenicline","Prolonged Exposure (PE) + smoking cessation counseling + varenicline","Smoking cessation counseling (20 to 30 minutes) followed by PE (90 minutes) including imaginal exposure and in vivo exposure with weekly homework. Varenicline dose titrated, with 0.5 mg/day for 3 days, 1.0 mg/day for 4 days, then 2.0 mg/day through day 84. Medication initiated at baseline, and smoking quit date planned about one week later.","Yes","Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","Dose: 1.0 mg (after titration)","Session length: 110 to 120 minutes","Psychotherapy: weekly; Varenicline: twice daily","12",,"See Detail",,"Study reports loss to follow-up; no data on treatment completion specifically","percent of prescribed number of pills taken, verified by pill count and Timeline Follow Back Interview","94.5%",,"8.3","3.5",,,,,"Race and Ethnicity data reported","Community","39.44%","Mixed","Combat-related; Child sexual abuse; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (imprisonment, torture, other)","Some Concerns","Foa EB, Asnaani A, Rosenfield D, et al. Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: a randomized controlled trial. J Consult Clin Psychol. 2017 Sep;85(9):862-72. doi: 10.1037/ccp0000213. PMID: 28569519.","48569","2020"
"foa2017_B","foa2017","Psychotherapy & pharmacotherapy","2017","PTSD+SUD","Active Control","Not integrated","142","B","70",,"Smoking cessation counseling + varenicline","Smoking cessation counseling + varenicline","Smoking cessation counseling plus varenicline, dose titrated with 0.5 mg/day for 3 days, 1.0 mg/day for 4 days, then 2.0 mg/day through day 84. Medication initiated at baseline and smoking quit date planned about one week later.","Yes","Non-Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","Yes","No","No","Individual","In Person","Dose: 1.0 mg (after titration)","Session length: 20 to 30 minutes","Psychotherapy: weekly; Varenicline: twice daily","12",,"See Detail",,"Study reports loss to follow-up; no data on treatment completion specifically","percent of prescribed number of pills taken, verified by pill count and Timeline Follow Back Interview","95.1%",,"9.2","3.71",,,,,"Race and Ethnicity data reported","Community","39.44%","Mixed","Combat-related; Child sexual abuse; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (imprisonment, torture, other)","Some Concerns","Foa EB, Asnaani A, Rosenfield D, et al. Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: a randomized controlled trial. J Consult Clin Psychol. 2017 Sep;85(9):862-72. doi: 10.1037/ccp0000213. PMID: 28569519.","48569","2020"
"foa2018_A","foa2018","Psychotherapy","2018","PTSD","PTSD",,"370","A","110",,"Massed PE Therapy","Prolonged Exposure (PE)","CBT consisting of imaginal exposure followed by processing thoughts and feelings related to the imaginal exposure, in-vivo exposure, psychoeducation about PTSD, and controlled breathing training.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Once daily on weekdays","2",,"Received full intervention",,,,,,"9.04","2.6",,,,,"Race and Ethnicity data reported",,"12.02%","Mixed","combat-related, other (not specified)","Low","Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.","49595","2020"
"foa2018_B","foa2018","Psychotherapy","2018","PTSD","PTSD",,"370","B","110",,"Spaced PE Therapy","Prolonged Exposure (PE)","CBT consisting of imaginal exposure followed by processing thoughts and feelings related to the imaginal exposure, in-vivo exposure, psychoeducation about PTSD, and controlled breathing training","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Twice weekly for first and last weeks, once weekly for other weeks","8",,"Received full intervention",,,,,,"8.59","2.68",,,,,"Race and Ethnicity data reported",,"12.02%","Mixed","combat-related, other (not specified)","Low","Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.","49595","2020"
"foa2018_C","foa2018","Psychotherapy","2018","PTSD","Active Control",,"370","C","110",,"PCT","Present-Centered Therapy (PCT)","Non-trauma-focused treatment focusing on current life problems that may or may not be PTSD-related.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Twice weekly for first and last weeks, once weekly for other weeks","8",,"Received full intervention",,,,,,"9.1","2.53",,,,,"Race and Ethnicity data reported",,"12.02%","Mixed","combat-related, other (not specified)","Low","Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.","49595","2020"
"foa2018_D","foa2018","Psychotherapy","2018","PTSD","Inactive Control",,"370","D","40",,"Minimal contact","Minimal attention","Therapist call participants to ask about well-being, offer support as needed, and received contact information in case symptoms worsened.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Phone",,"10 to 15 minutes","Once weekly","4",,"received minimal contact",,"all participants also completed postassessment",,,,"3.54",,,,,,"Race and Ethnicity data reported",,"12.02%","Mixed","combat-related, other (not specified)","Low","Foa EB, McLean CP, Zang Y, et al. Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018 Jan 23;319(4):354-64. doi: 10.1001/jama.2017.21242. PMID: 29362795.","49595","2020"
"foa2022_A","foa2022","Psychotherapy","2022","PTSD","PTSD",,"160","A","80",,"60-minute PE","Prolonged Exposure (PE)","Therapy followed published PE manual; treatment followed same protocol as 90-minute PE intervention with the following changes: imaginal exposure length reduced from 40 to 20 minutes and session length reduced from 90 to 60 minutes; content was abridged but no content was omitted.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Mixed",,"60 minutes","Once weekly","8 to 15","up to 15 sessions, treatment could end earlier if participant scored ≤19 on PCL-5","≥8 sessions or PCL-5 score ≤19",,,,,,"8.34","4.17",,,,,"Race and Ethnicity data reported","Active Duty Military","28.1%","Mixed","Combat-related; Rape/sexual assault; Other (not specified)","Low","Foa EB, Bredemeier K, Acierno R, et al. The efficacy of 90-min versus 60-min sessions of prolonged exposure for PTSD: A randomized controlled trial in active-duty military personnel. J Consult Clin Psychol. 2022;90(6):503-12. doi: 10.1037/ccp0000739. PMID: 35771512.","1595676","2023"
"foa2022_B","foa2022","Psychotherapy","2022","PTSD","PTSD",,"160","B","80",,"90-minute PE","Prolonged Exposure (PE)","Therapy followed published PE manual; treatment consisting of psychoeducation about PTSD, in vivo exposure, and 40 minutes of imaginal exposure, followed by processing thoughts and feelings related to the imaginal experience.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Mixed",,"90 minutes","Once weekly","8 to 15","up to 15 sessions, treatment could end earlier if participant scored ≤19 on PCL-5","≥8 sessions or PCL-5 score ≤19",,,,,,"8.84","4.01",,,,,"Race and Ethnicity data reported","Active Duty Military","28.1%","Mixed","Combat-related; Rape/sexual assault; Other (not specified)","Low","Foa EB, Bredemeier K, Acierno R, et al. The efficacy of 90-min versus 60-min sessions of prolonged exposure for PTSD: A randomized controlled trial in active-duty military personnel. J Consult Clin Psychol. 2022;90(6):503-12. doi: 10.1037/ccp0000739. PMID: 35771512.","1595676","2023"
"fonzo2017_A","fonzo2017","Psychotherapy","2017","PTSD","PTSD",,"66","A","36",,"PE","Prolonged Exposure (PE)","Manualized procedures according to Foa, Hembree, & Rothbaum 2007. Participants with adequate response to treatment, defined as <30% of PCL-C score at baseline (i.e. 70% reduction from baseline), were given the option to terminate treatment after Session 9. Nonresponders continued through Session 12","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Once or twice weekly","4.5 to 12","9 to 12 sessions total","completed treatment",,"n=24 completed treatment, of those, n=16 completed 12 sessions",,,,,,,,,,"Not reported",,"65.15%","Mixed","combat-related, illness/medical procedure, community/school violence, natural or manmade disasters, rape/sexual assault","High","Fonzo GA, Goodkind MS, Oathes DJ, et al. PTSD psychotherapy outcome predicted by brain activation during emotional reactivity and regulation. Am J Psychiatry. 2017 Dec 1;174(12):1163-74. doi: 10.1176/appi.ajp.2017.16091072. PMID: 28715908.","48700","2019"
"fonzo2017_B","fonzo2017","Psychotherapy","2017","PTSD","Inactive Control",,"66","B","30",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"10",,,,,,,,,,,,,,"Not reported",,"65.15%","Mixed","combat-related, illness/medical procedure, community/school violence, natural or manmade disasters, rape/sexual assault","High","Fonzo GA, Goodkind MS, Oathes DJ, et al. PTSD psychotherapy outcome predicted by brain activation during emotional reactivity and regulation. Am J Psychiatry. 2017 Dec 1;174(12):1163-74. doi: 10.1176/appi.ajp.2017.16091072. PMID: 28715908.","48700","2019"
"fonzo2019_A","fonzo2019","Other study class","2019","PTSD","PTSD",,"84","A","48",,"Cognitive/affective remediation training","Attention bias modification (ABM)","Computerized training on 11 cogntiive/affective remediation training tasks, accessed via website; participants instructed to train on each of the tasks for 3-4 minutes, for a total of 35045 minutes per day.Tasks trained: selective attention, working memory, task shifting, processing speed, positive emotion recognition/resisting negative emotion distraction, attention towards positive affective stimuli, identification of emotional faces, and identification of complex emotional stimuli.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology alone",,"45 minutes","Daily","6.43","45 days","completing 30 or more training days of 30 minutes each",,"proportion of randomized sample; 77% completed out of N=31 that completed posttreatment assessment",,,,"40.29","5.51","Mean sessions completed",,,,"Race data reported","Mixed","52.4%",,,"High","Fonzo GA, Fine NB, Wright RN, et al. Internet-delivered computerized cognitive & affective remediation training for the treatment of acute and chronic posttraumatic stress disorder: two randomized clinical trials. J Psychiatr Res. 2019 sept 2019;115:82-9. doi: 10.1016/j.jpsychires.2019.05.007. PMID: 31125916.","52284","2024"
"fonzo2019_B","fonzo2019","Other study class","2019","PTSD","Inactive Control",,"84","B","36",,"Attention control","Attention control","Engaging computer games for attention control, accessed via website; administration was the same as for active intervention; games did not train any cognitive of affective functions.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Technology alone",,"45 minutes","Daily","6.43","45 days","completing 30 or more sessions of 30 minutes each",,"proportion of randomized sample; 75% completed out of N=24 that completed posttreatment assessment",,,,"39.94","4.3","Mean sessions completed",,,,"Race data reported","Mixed","52.4%",,,"High","Fonzo GA, Fine NB, Wright RN, et al. Internet-delivered computerized cognitive & affective remediation training for the treatment of acute and chronic posttraumatic stress disorder: two randomized clinical trials. J Psychiatr Res. 2019 sept 2019;115:82-9. doi: 10.1016/j.jpsychires.2019.05.007. PMID: 31125916.","52284","2024"
"forbes2012_A","forbes2012","Psychotherapy","2012","PTSD","PTSD",,"59","A","30",,"CPT","Cognitive Processing Therapy (CPT)","Manualized treatment addressing key themes including safety, trust, power and control, self-esteem, and intimacy with cognitive therapy and written exposure","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"Session 1: 90 minutes



Sessions 2 to 12: 60  minutes","Biweekly","6","12 sessions total","received allocated intervention",,"reported value is equal to n randomized minus those who did not complete allocated intervention",,,,"10.27","4.93",,,,,"Race data reported","Veteran","3.39%","Other","""military-related""","Some Concerns","Forbes D, Lloyd D, Nixon RDV, et al. A multisite randomized controlled effectiveness trial of cognitive processing therapy for military-related posttraumatic stress disorder. J Anxiety Disord. 2012 Apr;26(3):442-52. doi: 10.1016/j.janxdis.2012.01.006. PMID: 22366446..","38353","2019"
"forbes2012_B","forbes2012","Psychotherapy","2012","PTSD","PTSD",,"59","B","29",,"TAU","Psychotherapy as usual","Varied according to therapist: 14% psychoeducation and supportive counseling; 52% nontrauma-focused symptom management interventions; 34% CBT which included elements of exposure","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No",,"In Person",,,,"6",,"received allocated intervention",,"reported value is equal to n randomized minus those who did not complete allocated intervention",,,,"6.31","4.68",,,,,"Race data reported","Veteran","3.39%","Other","""military-related""","Some Concerns","Forbes D, Lloyd D, Nixon RDV, et al. A multisite randomized controlled effectiveness trial of cognitive processing therapy for military-related posttraumatic stress disorder. J Anxiety Disord. 2012 Apr;26(3):442-52. doi: 10.1016/j.janxdis.2012.01.006. PMID: 22366446..","38353","2019"
"ford2018_A","ford2018","Psychotherapy","2018","PTSD","PTSD",,"31","A","17",,"Trauma Affect Regulation: Guide for Education and Therapy","Trauma Affect Regulation: Guide for Education and Therapy","Manualized therapy (Ford, 2015) including psychoeducation, eliciting day triggers for PTSD alarm reactions and teaching skills to inhibit impulsive emotional and behavioral reactions. Intervention teaches the ""Slow down, Orient Self-check"" skill and other skills to replace alarm reaction with emotional self-regulation.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"75 to 90 minutes","Weekly","10",,"complete 80% of treatment sessions",,,,,,"7.65",,,,,,"Race and Ethnicity data reported","Mixed","0%","Combat-related",,"High","Ford JD, Grasso DJ, Greene CA, et al. Randomized clinical trial pilot study of prolonged exposure versus present centred affect regulation therapy for PTSD and anger problems with male military combat veterans. Clin Psychol Psychother. 2018 Sep;25(5):641-9. doi: 10.1002/cpp.2194. PMID: 29687524.","50258","2019"
"ford2018_B","ford2018","Psychotherapy","2018","PTSD","PTSD",,"31","B","14",,"PE","Prolonged Exposure (PE)","Intervention according to manualized guidelines (Foa, Hembree, & Rothbaum, 2007), including psychoeducation, breathing retraining, imaginal and in vivo exposure","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"75 to 90 minutes","Weekly","10",,"complete 80% of treatment sessions",,,,,,"4.71",,,,,,"Race and Ethnicity data reported","Mixed","0%","Combat-related",,"High","Ford JD, Grasso DJ, Greene CA, et al. Randomized clinical trial pilot study of prolonged exposure versus present centred affect regulation therapy for PTSD and anger problems with male military combat veterans. Clin Psychol Psychother. 2018 Sep;25(5):641-9. doi: 10.1002/cpp.2194. PMID: 29687524.","50258","2019"
"fortney2015_A","fortney2015","Collaborative care","2015","PTSD","PTSD",,"265","A","133",,"Telemedicine Outreach for PTSD","Collaborative care","Off-site PTSD care team used telemedicine technology to support the PTSD treatment delivered by clinic providers. Specific components: Home-based telephone nurse care manager (e.g., symptom monitoring, education, medication adherence) and telephone pharmacist; clinic-based telepsychology and telepsychiatry service","No",,"No",,"No",,"No","No","No","No","Yes","Individual","Phone",,,,"52","total followup 52 weeks","See Detail",,"No treatment completion defined or reported. Study evaluated and reports results for process of care outcomes, including proportion prescribed medications, psychiatry encounters, and CPT attendance.","Pharmacologic component: patient self-report ≥80% adherence







Nonpharmacologic component: attended ≥8 CPT sessions",,"Pharmacologic: 59.41% first 6 months; 57.43% second 6 months; Nonpharmacologic: 27.1%",,,"CPT: 4.2 (5.4); Case manager encounters: 14.4 (NR)",,,,"Race and Ethnicity data reported","Veteran","10.2%","Combat-related",,"High","Fortney JC, Pyne JM, Kimbrell TA, et al. Telemedicine-based collaborative care for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Jan;72(1):58-67. doi: 10.1001/jamapsychiatry.2014.1575. PMID: 25409287.","43084","2019"
"fortney2015_B","fortney2015","Collaborative care","2015","PTSD","Inactive Control",,"265","B","132",,"Usual care","Treatment as usual (TAU)","Care received at distant VA and local community-based outpatient clinic with no home-based or telemedicine support","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"52","total followup 52 weeks","See Detail",,"No treatment completion defined or reported. Study evaluated and reports results for process of care outcomes, including proportion prescribed medications, psychiatry encounters, and CPT attendance.","Pharmacologic component: patient self-report ≥80% adherence



Nonpharmacologic component: attended ≥8 CPT sessions",,"Pharmacologic: 67.01% first 6 months; 67.37% second 6 months; Nonpharmacologic: 5.3%","0.8","2.6",,,,,"Race and Ethnicity data reported","Veteran","10.2%","Combat-related",,"High","Fortney JC, Pyne JM, Kimbrell TA, et al. Telemedicine-based collaborative care for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Jan;72(1):58-67. doi: 10.1001/jamapsychiatry.2014.1575. PMID: 25409287.","43084","2019"
"franklin2017_A","franklin2017","Psychotherapy","2017","PTSD","PTSD",,"27","A","12",,"Telehealth PE","Prolonged Exposure (PE)","PE therapy delivered via streaming-video calls using Tango (free application downloaded to the phone which uses the 3G network); no changes made to PE treatment other than mode of delivery. Participants loaned an iPhone 4 with service plans for duration of treatment.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Video",,,"Weekly","12","10 sessions total","completed 10 sessions within 12 weeks",,,,,,,,,,,,"Race data reported","Veteran","7.4%",,,"High","Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.","50424","2019"
"franklin2017_B","franklin2017","Psychotherapy","2017","PTSD","PTSD",,"27","B","7",,"PE delivered via computer-based teleconferencing","Prolonged Exposure (PE)","PE therapy delivered via computer-based teleconferencing equipment at rural VA community-based outpatient clinics; no changes made to PE treatment other than mode of delivery.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Video",,,"Weekly","12","10 sessions total","completed 10 sessions within 12 weeks",,,,,,,,,,,,"Race data reported","Veteran","7.4%",,,"High","Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.","50424","2019"
"franklin2017_C","franklin2017","Psychotherapy","2017","PTSD","Active Control",,"27","C","8",,"TAU","Treatment as usual (TAU)","Treatment offered through the study. This could be referring clinician's choice of therapy, excluding evidence-based psychotherapy for PTSD; therapies which occurred: supportive psychotherapy or medication management, typically provided by psychiatrists, masters'-level social workers, psychology interns/fellows, and psychologists at the community clinic.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"12",,"remained in treatment for 12-week duration of the study",,,,,,,,,,,,"Race data reported","Veteran","7.4%",,,"High","Franklin CL, Cuccurullo LA, Walton JL, et al. Face to face but not in the same place: a pilot study of prolonged exposure therapy. J Trauma Dissociation. 2017 Jan-Feb;18(1):116-30. doi: 10.1080/15299732.2016.1205704. PMID: 27348462.","50424","2019"
"friedman2007_A","friedman2007","Pharmacotherapy","2007","PTSD","PTSD",,"169","A","86",,"Sertraline","Sertraline","SSRI; started at 25 mg/day for 1 week, increased to 50 mg/day in week 2, weekly increases of 50 mg/day based on response and tolerability","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","Initiated at 25 mg, titrated to maximum 200 mg",,"Daily","12",,,,,,,,,,,"135 mg/day","61.9",,"Race data reported","Veteran","22.82%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (injury, fire, seeing someone hurt or die, ""miscellaneous"")","Some Concerns","Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007 May;68(5):711-20. PMID: 17503980.","29522","2019"
"friedman2007_B","friedman2007","Pharmacotherapy","2007","PTSD","Inactive Control",,"169","B","83",,"Placebo","Placebo","Placebo matched sertraline","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,"172 mg/day equivalent","49.6",,"Race data reported","Veteran","22.82%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (injury, fire, seeing someone hurt or die, ""miscellaneous"")","Some Concerns","Friedman MJ, Marmar CR, Baker DG, et al. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry. 2007 May;68(5):711-20. PMID: 17503980.","29522","2019"
"frommberger2004_A","frommberger2004","Psychotherapy & pharmacotherapy","2004","PTSD","PTSD",,"21","A","11",,"Paroxetine","Paroxetine","SSRI; dose increased according to response and tolerability","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","20 to 50 mg; titration: 10 mg for 1 week then increased weekly in 10-mg increments",,"Daily","12",,,,,,,,,,,"28 mg/day",,,"Not reported","Community","57.14%","Mixed","rape/sexual assault, accidents, community/school violence","High","Frommberger UH, Stieglitz R-D, Nyberg E, et al. Comparison between paroxetine and behaviour therapy in patients with posttraumatic stress disorder (PTSD): a pilot study. Int. J. Psychiatry Clin. Pract. 2004;8(1):19-24. doi: 10.1080/13651500310004803. PMID: 24937579.","27144","2019"
"frommberger2004_B","frommberger2004","Psychotherapy & pharmacotherapy","2004","PTSD","PTSD",,"21","B","10",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","CBT comprised psychoeducation,



behavioral assessment, relaxation training, stress inoculation training, exposure in sensu (prolonged exposure) and in vivo and cognitive restructuring. Methods and training provided by Edna Foa.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Weekly","12",,,,,,,,,,,,,,"Not reported","Community","57.14%","Mixed","rape/sexual assault, accidents, community/school violence","High","Frommberger UH, Stieglitz R-D, Nyberg E, et al. Comparison between paroxetine and behaviour therapy in patients with posttraumatic stress disorder (PTSD): a pilot study. Int. J. Psychiatry Clin. Pract. 2004;8(1):19-24. doi: 10.1080/13651500310004803. PMID: 24937579.","27144","2019"
"fruchtmansteinbok2021_A","fruchtmansteinbok2021","Nonpharmacologic biological","2021","PTSD","PTSD",,"59","A","20",,"Trauma-focused neurofeedback","Neurofeedback","Neurofeedback  interface consisting of an individually-tailored audio script of the personal traumatic narrative; first 5 sessions using neutral interface; ""upon reaching a predetermined neuromodulation success criterion, NF training was further guided by a pre-recorded edited script of the personal traumatic experience including trauma hot-spots, thoughts, emotions, and physical sensations. Successful down-regulation of AmygEFP was reflected by the reduced sound volume of the traumatic script","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person",,"40 minutes","Twice weekly for 2 weeks and then once per week","13","15 sessions over 13 weeks","Completed the trial",,,,,,,,,,,,"Not reported","Community","45%","Mixed","Accidents; Combat-related; Community/school violence; Terrorism/political violence/forced displacement; Other (""life threatening injury"", ""witness trauma"", ""traumatic grief"", ""repeated exposure"")","Some Concerns","Fruchtman-Steinbok T, Keynan JN, Cohen A, et al. Amygdala electrical-finger-print (AmygEFP) neurofeedback guided by individually-tailored trauma script for post-traumatic stress disorder: proof-of-concept. Neuroimage Clin. 2021 Oct 15;32:102859. doi: 10.1016/j.nicl.2021.102859. PMID: 34689055.","1581869","2023"
"fruchtmansteinbok2021_B","fruchtmansteinbok2021","Nonpharmacologic biological","2021","PTSD","Active Control",,"59","B","19",,"Neutral neurofeedback","Neurofeedback","Neutral neurofeedback interface; ""neurofeedback guided by a non-trauma-related interace (interleaved audiovisual animated scenario) and neutral auditory feedback""","No",,"No",,"No",,"Yes","No","Yes","No","No","Individual","In Person",,"40 minutes","Twice weekly for 2 weeks and then once per week","13","15 sessions over 13 weeks","Completed the trial",,,,,,,,,,,,"Not reported","Community","45%","Mixed","Accidents; Combat-related; Community/school violence; Terrorism/political violence/forced displacement; Other (""life threatening injury"", ""witness trauma"", ""traumatic grief"", ""repeated exposure"")","Some Concerns","Fruchtman-Steinbok T, Keynan JN, Cohen A, et al. Amygdala electrical-finger-print (AmygEFP) neurofeedback guided by individually-tailored trauma script for post-traumatic stress disorder: proof-of-concept. Neuroimage Clin. 2021 Oct 15;32:102859. doi: 10.1016/j.nicl.2021.102859. PMID: 34689055.","1581869","2023"
"fruchtmansteinbok2021_C","fruchtmansteinbok2021","Nonpharmacologic biological","2021","PTSD","Inactive Control",,"59","C","20",,"Control","Control","No neurofeedback","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"40 minutes","Twice weekly for 2 weeks and then once per week","13","15 sessions over 13 weeks","Completed the trial",,,,,,,,,,,,"Not reported","Community","45%","Mixed","Accidents; Combat-related; Community/school violence; Terrorism/political violence/forced displacement; Other (""life threatening injury"", ""witness trauma"", ""traumatic grief"", ""repeated exposure"")","Some Concerns","Fruchtman-Steinbok T, Keynan JN, Cohen A, et al. Amygdala electrical-finger-print (AmygEFP) neurofeedback guided by individually-tailored trauma script for post-traumatic stress disorder: proof-of-concept. Neuroimage Clin. 2021 Oct 15;32:102859. doi: 10.1016/j.nicl.2021.102859. PMID: 34689055.","1581869","2023"
"frueh2007_A","frueh2007","Psychotherapy","2007","PTSD","PTSD",,"38","A","17",,"Telehealth CBT","Cognitive behavioral therapy (CBT) without a trauma focus","Treatment specifically targeted social skills training (e.g., assertion, social communication, anger management), and activities to increase social participation","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Video",,"90 minutes","Weekly","14",,"Completed active treatment phase",,,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"High","Frueh BC, Monnier J, Yim E, et al. A randomized trial of telepsychiatry for post-traumatic stress disorder. J. Telemed. Telecare. 2007 Apr 1;13(3):142-7. doi: 10.1258/135763307780677604. PMID: 17519056.","29644","2019"
"frueh2007_B","frueh2007","Psychotherapy","2007","PTSD","PTSD",,"38","B","21",,"CBT in-person","Cognitive behavioral therapy (CBT) without a trauma focus","Treatment specifically targeted social skills training (e.g., assertion, social communication, anger management), and activities to increase social participation","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","14",,"Completed active treatment phase",,,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"High","Frueh BC, Monnier J, Yim E, et al. A randomized trial of telepsychiatry for post-traumatic stress disorder. J. Telemed. Telecare. 2007 Apr 1;13(3):142-7. doi: 10.1258/135763307780677604. PMID: 17519056.","29644","2019"
"gallegos2020_A","gallegos2020","Other mixed","2020","PTSD","PTSD",,"29","A","19",,"MBSR","Mindfulness-based stress reduction (MBSR)","Mindfulness taught in group format and included four practices: sitting meditation, walking meditation, movement similar to hatha yoga, and a body scan. Eight sessions plus ""intensive retreat,"" not further described.","No",,"No",,"Yes","Meditation","No","No","No","No","No","Group","In Person",,"2 hours","Weekly","8",,"Attended all 8 sessions and the intensive retreat",,,,,,,,"52% attended at least half of the classes",,,,"Race and Ethnicity data reported","Community","100%","Intimate partner violence",,"High","Gallegos AM, Heffner KL, Cerulli C, et al. Effects of mindfulness training on posttraumatic stress symptoms from a community-based pilot clinical trial among survivors of intimate partner violence. Psychol Trauma. 2020 Nov;12(8):859-68. doi: 10.1037/tra0000975. PMID: 32969703.","1558890","2022"
"gallegos2020_B","gallegos2020","Other mixed","2020","PTSD","Active Control",,"29","B","10",,"Wellness Control","Psychoeducation","Participants given health education manual including information on diet, exercise, sleep, stress management, and communication, with phone check-ins with a research assistant.","No",,"No",,"No",,"No","No","Yes","Yes","No","Individual","Phone",,"15 minutes","Weekly","8",,"Completed all sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Intimate partner violence",,"High","Gallegos AM, Heffner KL, Cerulli C, et al. Effects of mindfulness training on posttraumatic stress symptoms from a community-based pilot clinical trial among survivors of intimate partner violence. Psychol Trauma. 2020 Nov;12(8):859-68. doi: 10.1037/tra0000975. PMID: 32969703.","1558890","2022"
"galovski2012_A","galovski2012","Psychotherapy","2012","PTSD","PTSD",,"100","A","53",,"Modified CPT","Cognitive Processing Therapy (CPT)","Modified application of traditional CPT (Resick, Monson, & Chard, 2008); primary modifications: length of intervention individually tailored with conclusion based on predefined specified end-state criterion (4 to 18 possible sessions); up to 2 optional ""stressor sessions"" offered when a participant experienced a significant psychosocial stressor or emergency during the course of therapy, and participant's choice whether to use the stressor session.



End-state criterion for termination of treatment: PDS ≤20, BDI ≤18, agreement between the therapist and participant that treatment goals had been attained, and negative PTSD status on CAPS by blind rater.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,,,"4 to 18 sessions total","reached end-state criterion",,,,,,,,,,,,"Race and Ethnicity data reported","Community","69%","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence","Low","Galovski TE, Blain LM, Mott JM, et al. Manualized therapy for PTSD: flexing the structure of cognitive processing therapy. J Consult Clin Psychol. 2012 Dec;80(6):968-81. doi: 10.1037/a0030600. PMID: 23106761.","39611","2019"
"galovski2012_B","galovski2012","Psychotherapy","2012","PTSD","Inactive Control",,"100","B","47",,"Symptom monitoring","Symptom monitoring","Daily monitoring of PTSD and depressive symptoms; 3 phone interviews for CAPS administration and inquiry into progress on symptom monitoring, overall symptom severity, and general distress but without cognitive therapy or other trauma-focused intervention.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"10","10 weeks symptom monitoring, then crossed over to active treatment (modified CPT; data for crossover not entered)","completed treatment course",,,,,,,,,,,,"Race and Ethnicity data reported","Community","69%","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence","Low","Galovski TE, Blain LM, Mott JM, et al. Manualized therapy for PTSD: flexing the structure of cognitive processing therapy. J Consult Clin Psychol. 2012 Dec;80(6):968-81. doi: 10.1037/a0030600. PMID: 23106761.","39611","2019"
"galovski2016_A","galovski2016","Psychotherapy & CIH","2016","PTSD","PTSD",,"92","A","44",,"Sleep-directed hypnosis + CPT","Sleep-directed hypnosis followed by Cognitive Processing Therapy (CPT)","Sleep-directed hypnosis for 3 weeks followed by 12 weeks of CPT.







Scripted hypnosis targeting sleep impairment (no trauma-related material) with focus on sleep onset difficulty and mid-sleep awakening and inability to fall back to sleep; utilized psychoeducation, hypnotic trance using eye fixation technique, guided imagery and redirection of mental activity. Participants instructed to practice daily using audiotape of hypnosis session.







CPT targeting interpretations of the trauma itself and then current and future maladaptive and inaccurate beliefs about world, self and others; patients taught to identify, question, challenge and replace faulty assumptions and thoughts about traumatic event and its implications in their current life.","Yes","Trauma-focused","No",,"Yes","Clinical hypnosis","No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","15",,"Completed treatment",,,,,,,,"practiced autohypnosis during sleep intervention phase: mean 4.7 times",,,,"Race and Ethnicity data reported","Community","100%","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence","High","Galovski TE, Harik JM, Blain LM, et al. Augmenting cognitive processing therapy to improve sleep impairment in PTSD: a randomized controlled trial. J Consult Clin Psychol. 2016 Feb;84(2):167-77. doi: 10.1037/ccp0000059. PMID: 26689303.","44664","2019"
"galovski2016_B","galovski2016","Psychotherapy & CIH","2016","PTSD","Active Control",,"92","B","48",,"Sleep and symptom monitoring + CPT","Sleep and symptom monitoring followed by Cognitive Processing Therapy (CPT)","Sleep and symptom monitoring for 3 weeks followed by 12 weeks of CPT.







Daily monitoring of PTSD, depressive symptoms, and sleep, with weekly phone checks.







CPT targeting interpretations of the trauma itself and then current and future maladaptive and inaccurate beliefs about world, self and others; patients taught to identify, question, challenge and replace faulty assumptions and thoughts about traumatic event and its implications in their current life.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"Symptom monitoring: NA







CPT sessions: 60 minutes","Weekly","15",,"Completed treatment",,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, community/school violence, intimate partner violence","High","Galovski TE, Harik JM, Blain LM, et al. Augmenting cognitive processing therapy to improve sleep impairment in PTSD: a randomized controlled trial. J Consult Clin Psychol. 2016 Feb;84(2):167-77. doi: 10.1037/ccp0000059. PMID: 26689303.","44664","2019"
"gamito2010_A","gamito2010","Psychotherapy","2010","PTSD","PTSD",,"10","A","5",,"Virtual reality exposure therapy","Virtual reality exposure therapy (VRET)","Treatment includes psychoeducation for anxiety management and exposure to traumatic event through a Z800 head-mounted display (e-Magin Corp) that displays a footpath surrounded by dense vegetation where participants had to follow a column of virtual soldiers. Ambush, gun firing, motor, and waiting for evacuation near an injured soldier were added gradually each session","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,,,"12 sessions total","See Detail",,"Study reported drop-out, unclear if treatment attrition or attrition to measuremen",,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"High","Gamito P, Oliveira J, Rosa P, et al. PTSD elderly war veterans: a clinical controlled pilot study. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):43-8. doi: 10.1089/cyber.2009.0237. PMID: 20528292.","33784","2019"
"gamito2010_B","gamito2010","Psychotherapy","2010","PTSD","Active Control",,"10","B","2",,"Imaginal Exposure","Trauma-focused cognitive behavioral therapy (TF-CBT)","Treatment includes psychoeducation for anxiety management and imaginal exposure","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,,"12 sessions total","See Detail",,"Study reported drop-out, unclear if treatment attrition or attrition to measuremen",,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"High","Gamito P, Oliveira J, Rosa P, et al. PTSD elderly war veterans: a clinical controlled pilot study. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):43-8. doi: 10.1089/cyber.2009.0237. PMID: 20528292.","33784","2019"
"gamito2010_C","gamito2010","Psychotherapy","2010","PTSD","Inactive Control",,"10","C","3",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"High","Gamito P, Oliveira J, Rosa P, et al. PTSD elderly war veterans: a clinical controlled pilot study. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):43-8. doi: 10.1089/cyber.2009.0237. PMID: 20528292.","33784","2019"
"gapen2016_A","gapen2016","Nonpharmacologic biological","2016","PTSD","PTSD",,"23","A","12",,"Neurofeedback","Neurofeedback","EEG biofeedback with sensors placed at T3-T4. Training parameters followed flexible, principle-based manual with defined rules to adjust reward frequency and training time; reward frequency adjusted based on the participant's clinical response (number of over- or under-arousal symptoms); training time increased in 3-minute increments when participant reported positive change.","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person","inhibit frequencies: 4 to 7 Hz and 22 to 36 Hz



reward frequency: 12 to 15 Hz","12 to 21 minutes","Twice weekly","20",,"completed 40 sessions",,,,,,,,,,,,"Race data reported","Community","65.22%","Mixed","child physical abuse, child sexual abuse, child other abuse, other (not specified)","High","Gapen MA, van der Kolk BA, Hamlin E, et al. A pilot study of neurofeedback for chronic PTSD. Appl Psychophysiol Biofeedback. 2016 Sep;41(3):251-61. doi: 10.1007/s10484-015-9326-5. PMID: 26782083.","44803","2019"
"gapen2016_B","gapen2016","Nonpharmacologic biological","2016","PTSD","PTSD",,"23","B","11",,"Neurofeedback","Neurofeedback","EEG biofeedback with sensors placed at T4-P4. Training parameters followed flexible, principle-based manual; inhibit frequencies: 4-7 Hz and 22-36 Hz; reward frequency: initial 12-15 Hz, adjusted based on the participant's clinical response (number of over- or under-arousal symptoms); training time increased in 3-minute increments when participant reported positive change.","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person","inhibit frequencies: 4 to 7 Hz and 22 to 36 Hz



reward frequency: 12 to 15 Hz","12 to 21 minutes","Twice weekly","20",,"completed 40 sessions",,,,,,,,,,,,"Race data reported","Community","65.22%","Mixed","child physical abuse, child sexual abuse, child other abuse, other (not specified)","High","Gapen MA, van der Kolk BA, Hamlin E, et al. A pilot study of neurofeedback for chronic PTSD. Appl Psychophysiol Biofeedback. 2016 Sep;41(3):251-61. doi: 10.1007/s10484-015-9326-5. PMID: 26782083.","44803","2019"
"gelkopf2013_A","gelkopf2013","Other study class","2013","PTSD","PTSD",,"42","A","28",,"Nature Adventure Rehabilitation","Recreational therapy","Activity-based sport intervention (sailing) that seeks to empower participant, change negative self-image, enhance self-efficacy, hope, and the ability to enjoy life, to develop control over symptoms, and improve social and emotional regulation skills. Each session began with a summary of previous lesson, followed by sailing in a group and different sea-related activities. Session ends with a debrief and discussion of sailing-related and personal issues","No",,"No",,"No",,"No","No","No","Yes","No","Group","In Person",,"3 hours","Weekly","52",,"Completed the 12 month program",,"""Of the 28 present at the first session 22 finished the 12-month program"", ""All NAR participants were present in at least 40 sessions""; and n=6 dropped out after first session",,,,,,">40/52",,,,"Not reported","Veteran","0%","Combat-related",,"High","Gelkopf M, Hasson-Ohayon I, Bikman M, et al. Nature adventure rehabilitation for combat-related posttraumatic chronic stress disorder: a randomized control trial. Psychiatry Res. 2013 Oct 30;209(3):485-93. doi: 10.1016/j.psychres.2013.01.026. PMID: 23541513.","40581","2019"
"gelkopf2013_B","gelkopf2013","Other study class","2013","PTSD","Inactive Control",,"42","B","20",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"52",,,,,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"High","Gelkopf M, Hasson-Ohayon I, Bikman M, et al. Nature adventure rehabilitation for combat-related posttraumatic chronic stress disorder: a randomized control trial. Psychiatry Res. 2013 Oct 30;209(3):485-93. doi: 10.1016/j.psychres.2013.01.026. PMID: 23541513.","40581","2019"
"geronilla2016_A","geronilla2016","CIH","2016","PTSD","PTSD",,"58","A","32",,"Emotional Freedom Technique","Emotional Freedom Technique (EFT)","Treatment followed The EFT Manual (Craig & Fowlie 1995; Church, 2013) where therapists guided participants through traumatic emotional events until emotional intensity reduces via office or telephone sessions or televideo conferencing calls. All participants received usual care by primary care provider","No",,"No",,"Yes","Energy therapies","No","No","No","No","No","Individual","In Person",,"1 hour",,,"6 sessions total","Completed all 6 sessions",,"n=5 withdrew after 3 sessions; n=27 received all 6 sessions",,,,,,,,,,"Not reported","Veteran","12.07%",,,"High","Geronilla L, Minewiser L, Mollon P, et al. EFT (Emotional Freedom Techniques) remediates PTSD and psychological symptoms in veterans: A randomized controlled replication trial. Energy Psychology. 2016;8(2):29.","1549292","2019"
"geronilla2016_B","geronilla2016","CIH","2016","PTSD","Inactive Control",,"58","B","26",,"TAU waitlist","Waitlist","Participants received usual care by primary care provider and completed a 30-day waiting period","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"4","30 day waiting period",,,,,,,,,,,,,"Not reported","Veteran","12.07%",,,"High","Geronilla L, Minewiser L, Mollon P, et al. EFT (Emotional Freedom Techniques) remediates PTSD and psychological symptoms in veterans: A randomized controlled replication trial. Energy Psychology. 2016;8(2):29.","1549292","2019"
"gersons2000_A","gersons2000","Psychotherapy","2000","PTSD","PTSD",,"44","A","22",,"Brief Eclectic Psychotherapy","Brief Eclectic Psychotherapy (BEP)","Individualized psychotherapy, consisting of psychoeducation, imaginary guidance, writing assignments and mementos, domain of meaning or integration, and a farewell ritual","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Once a week","16",,"Completed treatment",,"no participants dropped out, treatment sessions ""delivered as planned"", and ""no treatment dropouts""",,,,,,,,,,"Race data reported","Community","11.9%","Other","occupational events","Some Concerns","Gersons BP, Carlier IV, Lamberts RD, et al. Randomized clinical trial of brief eclectic psychotherapy for police officers with posttraumatic stress disorder. J Trauma Stress. 2000 Apr;13(2):333-47. doi: 10.1023/A:1007793803627. PMID: 10838679..","15124","2019"
"gersons2000_B","gersons2000","Psychotherapy","2000","PTSD","Inactive Control",,"44","B","20",,"Waitlist","Waitlist","Participants monitored by a nonassessor psychologist","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"16",,,,,,,,,,,,,,"Race data reported","Community","11.9%","Other","occupational events","Some Concerns","Gersons BP, Carlier IV, Lamberts RD, et al. Randomized clinical trial of brief eclectic psychotherapy for police officers with posttraumatic stress disorder. J Trauma Stress. 2000 Apr;13(2):333-47. doi: 10.1023/A:1007793803627. PMID: 10838679..","15124","2019"
"ghafoori2017_A","ghafoori2017","Psychotherapy","2017","PTSD","PTSD",,"71","A","47",,"PE","Prolonged Exposure (PE)","Treatment delivered using manual; elements included: psychoeducation, breathing retraining, imaginal exposure with processing or discussion of the content during session, and in vivo exposure.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 to 90 minutes","Weekly","12",,"completed 12 sessions",,,,,,"6.79","4.26",,,,,"Race and Ethnicity data reported","Community","83.1%","Mixed","natural or manmade disaster, accidents, rape/sexual assault, community/school violence, illness/medical procedure, combat-related, terrorism/political violence/forced displacement","High","Ghafoori B, Hansen MC, Garibay E, et al. Feasibility of training frontline therapists in prolonged exposure: a randomized controlled pilot study of treatment of complex trauma in diverse victims of crime and violence. J Nerv Ment Dis. 2017 Apr;205(4):283-93. doi: 10.1097/NMD.0000000000000659. PMID: 28157725.","1523171","2019"
"ghafoori2017_B","ghafoori2017","Psychotherapy","2017","PTSD","Active Control",,"71","B","24",,"PCT","Present-Centered Therapy (PCT)","Treatment delivered using manual; content shared directed by client with therapist offering support with respect to trauma related memories; elements included: psychoeducation, breathing retraining, reviewing daily difficulties as a manifestation of PTSD related to trauma (without directive imaginal exposure).","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"60 to 90 minutes","Weekly","12",,"completed 12 sessions",,,,,,"8.67","4.02",,,,,"Race and Ethnicity data reported","Community","83.1%","Mixed","natural or manmade disaster, accidents, rape/sexual assault, community/school violence, illness/medical procedure, combat-related, terrorism/political violence/forced displacement","High","Ghafoori B, Hansen MC, Garibay E, et al. Feasibility of training frontline therapists in prolonged exposure: a randomized controlled pilot study of treatment of complex trauma in diverse victims of crime and violence. J Nerv Ment Dis. 2017 Apr;205(4):283-93. doi: 10.1097/NMD.0000000000000659. PMID: 28157725.","1523171","2019"
"gibert2022_A","gibert2022","Other study class","2022","PTSD","PTSD",,"34","A","17",,"Meditative scuba diving","Recreational therapy","Bathysmed protocol with sessions including dive theory, psychoeducation, breathing techniques, mental preparation, and a meditative scuba dive. 10-day program, with 10 dives over 6 days plus an optional night dive .","No",,"No",,"No",,"No","No","No","Yes","No","Group","In Person",,,"Once or twice daily","1.43","10 days","Completed all dives",,"186 dives completed out of 187 total, so 1 subject did not completed one dive; intervention completion not defined in study, using participant completing all dives since that is data provided",,,,"10.94",,"Mean dives per participant; Of 187 planned dives [10 per person + one optional], 186 completed",,,,"Not reported","Community","64.71%","Terrorism/political violence/forced displacement",,"High","Gibert L, Coulange M, Reynier JC, et al. Comparing meditative scuba diving versus multisport activities to improve post-traumatic stress disorder symptoms: a pilot, randomized controlled clinical trial. Eur J Psychotraumatol. 2022 Feb 7;13(1):2031590. doi: 10.1080/20008198.2022.2031590. PMID: 35145610.","1587267","2023"
"gibert2022_B","gibert2022","Other study class","2022","PTSD","PTSD",,"34","B","17",,"Multisport activities","Recreational therapy","Multisport program including two hours of physical activity per day (e.g. sailing, surfing, canoeing, hiking and snorkelling); 10 days.","No",,"No",,"No",,"No","No","No","Yes","No","Group","In Person",,"2 hours","Once daily","1.43","10 days","Completed all sessions",,"All subjects completed all sessions",,,,"10",,"All subjects completed all sessions (total 10 sessions)",,,,"Not reported","Community","64.71%","Terrorism/political violence/forced displacement",,"High","Gibert L, Coulange M, Reynier JC, et al. Comparing meditative scuba diving versus multisport activities to improve post-traumatic stress disorder symptoms: a pilot, randomized controlled clinical trial. Eur J Psychotraumatol. 2022 Feb 7;13(1):2031590. doi: 10.1080/20008198.2022.2031590. PMID: 35145610.","1587267","2023"
"goldstein2018_A","goldstein2018","Other study class","2018","PTSD","PTSD",,"47","A","21",,"Integrative Exercise","Exercise","Combine aerobic and resistance exercise with yoga poses presented within a framework of mindfulness principles based on the Mindfulness-Based Stress Reduction and Mindful Breathing principles","No",,"No",,"No",,"No","No","No","Yes","No","Group","In Person",,"1 hour","3 times a week","12",,"Completed treatment",,,,,,"17.38",,,,,,"Race and Ethnicity data reported","Veteran","19.15%",,,"Some Concerns","Goldstein LA, Mehling WE, Metzler TJ, et al. Veterans group exercise: a randomized pilot trial of an integrative exercise program for veterans with posttraumatic stress. J Affect Disord. 2018 Feb;227:345-52. doi: 10.1016/j.jad.2017.11.002. PMID: 29145076.","49403","2019"
"goldstein2018_B","goldstein2018","Other study class","2018","PTSD","Inactive Control",,"47","B","26",,"Waitlist","Waitlist","Participants could participate in Integrative Exercise after 12 weeks of waiting period","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"12",,,,"completed waitlist: 84.61%",,,,,,,,,,"Race and Ethnicity data reported","Veteran","19.15%",,,"Some Concerns","Goldstein LA, Mehling WE, Metzler TJ, et al. Veterans group exercise: a randomized pilot trial of an integrative exercise program for veterans with posttraumatic stress. J Affect Disord. 2018 Feb;227:345-52. doi: 10.1016/j.jad.2017.11.002. PMID: 29145076.","49403","2019"
"golier2012_A","golier2012","Pharmacotherapy","2012","PTSD","PTSD",,"9","A",,,"Mifepristone","Mifepristone","Antiprogestogen","No",,"Yes","Steroids","No",,"No","No","No","No","No","Individual","In Person","600 mg",,"Daily at bedtime","1","one week",,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran",,"Combat-related",,"High","Golier JA, Caramanica K, Demaria R, et al. A pilot study of mifepristone in combat-related PTSD. Depress Res Treat. 2012;2012:393251. doi: 10.1155/2012/393251. PMID: 22611490.","39051","2019"
"golier2012_B","golier2012","Pharmacotherapy","2012","PTSD","Inactive Control",,"9","B",,,"Placebo","Placebo","Matched placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily at bedtime","1","one week",,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran",,"Combat-related",,"High","Golier JA, Caramanica K, Demaria R, et al. A pilot study of mifepristone in combat-related PTSD. Depress Res Treat. 2012;2012:393251. doi: 10.1155/2012/393251. PMID: 22611490.","39051","2019"
"golier2023_A","golier2023","Pharmacotherapy","2023","PTSD","PTSD",,"80","A","41",,"Mifepristone","Mifepristone","Oral mifepristone","No",,"Yes","Steroids","No",,"No","No","No","No","No","Individual","In Person","600 mg (two 300 mg tablets)",,"Daily","1","7 days",,,,"Treatment adherence ≥85% (≥12 of 14 pills taken), based on returned pill counts","92.68%",,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Mixed","Combat-related; Other (""military trauma"" not further specified)","Low","Golier JA, Li X, Bizien M, et al. Efficacy and Safety of Mifepristone in the Treatment of Male US Veterans With Posttraumatic Stress Disorder: A Phase 2a Randomized Clinical Trial. JAMA Netw Open. 2023 05 01;6(5):e2310223. doi: 10.1001/jamanetworkopen.2023.10223. PMID: 37159200.","1620832","2024"
"golier2023_B","golier2023","Pharmacotherapy","2023","PTSD","Inactive Control",,"80","B","39","40 initially randomized, 1 randomized in error and excluded from efficacy analyses","Placebo","Placebo","Matched oral placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","Dose NA (two tablets)",,"Daily","1","7 days",,,,"Treatment adherence ≥85% (≥12 of 14 pills taken), based on returned pill counts","89.74%","of n=39 (excludes one participant randomized in error who took 1 dose)",,,,,,,"Race and Ethnicity data reported","Veteran","0%","Mixed","Combat-related; Other (""military trauma"" not further specified)","Low","Golier JA, Li X, Bizien M, et al. Efficacy and Safety of Mifepristone in the Treatment of Male US Veterans With Posttraumatic Stress Disorder: A Phase 2a Randomized Clinical Trial. JAMA Netw Open. 2023 05 01;6(5):e2310223. doi: 10.1001/jamanetworkopen.2023.10223. PMID: 37159200.","1620832","2024"
"gray2019a_A","gray2019a","Psychotherapy","2019","PTSD","PTSD",,"74","A","37",,"Reconsolidation of Traumatic Memories","Reconsolidation of Traumatic Memories (RTM)","Brief, non-traumatizing trauma-focused CBT in which a consolidated trauma memory is reactivated using a brief narrative, then patients are presented with healthy dissociative distancing experiences and exercises to modify the perceptual structure of the memory","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"120 minutes",,"2","3 sessions","completed treatment",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Mixed","MST, combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (not specified)","Low","Gray R, Budden-Potts D, Bourke F. Reconsolidation of traumatic memories for PTSD: a randomized controlled trial of 74 male veterans. Psychother Res. 2019 29(5): 621-639. DOI: 10.1080/10503307.2017.1408973","49545","2020"
"gray2019a_B","gray2019a","Psychotherapy","2019","PTSD","Inactive Control",,"74","B","37",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"2",,"completed waiting period",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Mixed","MST, combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (not specified)","Low","Gray R, Budden-Potts D, Bourke F. Reconsolidation of traumatic memories for PTSD: a randomized controlled trial of 74 male veterans. Psychother Res. 2019 29(5): 621-639. DOI: 10.1080/10503307.2017.1408973","49545","2020"
"gray2021_A","gray2021","Psychotherapy","2021","PTSD","PTSD",,"30","A","15",,"Reconsolidation of Traumatic Memories","Reconsolidation of Traumatic Memories (RTM)","A brief manualized treatment generally targeting current-month intrusive symptoms and heightened arousal","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"≤120 minutes","Approximately weekly","3","Total of 3 sessions, ""typically completed in 3 weeks""","Completed treatment",,"not further defined",,,,,,,,,,"Race and Ethnicity data reported","Mixed","100%","Mixed","MST, Other (not specified)","Low","Gray RM, Budden-Potts D, Schwall RJ, et al. An open-label, randomized controlled trial of the reconsolidation of traumatic memories protocol (RTM) in military women. Psychol Trauma. 2021 Sep;13(6):641-51. doi: 10.1037/tra0000986. PMID: 33211519.","1561429","2022"
"gray2021_B","gray2021","Psychotherapy","2021","PTSD","Inactive Control",,"30","B","15",,"Waitlist","Waitlist","No direct intervention or contact from researchers received during 5-week period","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","100%","Mixed","MST, Other (not specified)","Low","Gray RM, Budden-Potts D, Schwall RJ, et al. An open-label, randomized controlled trial of the reconsolidation of traumatic memories protocol (RTM) in military women. Psychol Trauma. 2021 Sep;13(6):641-51. doi: 10.1037/tra0000986. PMID: 33211519.","1561429","2022"
"hall2019a_A","hall2019a","Other study class","2019","PTSD","PTSD",,"54","A","36",,"Warrior Wellness","Exercise","Supervised community-based exercise training for older veterans; integrates cognitive behavioral strategies during exercise program, targeting 5 sources of self-efficacy: ""(1) self-monitoring and mastery experi- ence; (2) education of physiologic responses to exercise; (3) outcome expectations; (4) barriers to participation; and (5) modeling and social support"". Includes individual exercise prescription, with one-on-one and independent exercises which emphasized ""aerobic, strength, balance, and flexibility exercises. Modalities included body weight, free weight, cables, and exercise bands; treadmills and stationary bikes were used for aerobic training"".","No",,"No",,"No",,"No","No","No","Yes","No","Individual","In Person",,"60 to 90 minutes","3 times a week","12",,"Completed exercise program",,,,,,,,"82% (range 23 to 100%) (of participants who attended at least one session)",,,,"Race and Ethnicity data reported","Veteran","90.74%",,,"High","Hall KS, Morey MC, Bosworth HB, et al. Pilot randomized controlled trial of exercise training for older veterans with PTSD. J Behav Med. 2019 Jul 1doi: 10.1007/s10865-019-00073-w. PMID: 31264055.","52094","2020"
"hall2019a_B","hall2019a","Other study class","2019","PTSD","Inactive Control",,"54","B","18",,"Waitlist","Waitlist","Continued usual care in VA clinics.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"12",,,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","90.74%",,,"High","Hall KS, Morey MC, Bosworth HB, et al. Pilot randomized controlled trial of exercise training for older veterans with PTSD. J Behav Med. 2019 Jul 1doi: 10.1007/s10865-019-00073-w. PMID: 31264055.","52094","2020"
"haller2023_A","haller2023","Psychotherapy & CIH","2023","PTSD","PTSD",,"74","A","40",,"Pranayama-assisted trauma-focused cognitive behavioral therapy","Trauma-focused cognitive behavioral therapy (TF-CBT) + yoga","Pranayama plus TF-CBT
Pranayama: 3 rounds lasting 5-10 minutes at the beginning of each TF-CBT session, described as a combination of mindful breathing and breath-holding techniques 
TF-CBT: following standard guideline for remainder of session (40-45 minutes), ""stabilization techniques included trauma education, progressive muscle relaxation, self-control and affect-control methods, imagination, and self-care/resource development and were followed by standard confrontation techniques""","Yes","Trauma-focused","No",,"Yes","Yoga","No","No","No","No","No","Individual","In Person",,"1 hour",,,"10 sessions","completed intervention; able to perform pranayama",,,,,,,,,,,,"Not reported","Community","83.78%",,,"Some Concerns","Haller H, Mitzinger D, Cramer H. The integration of yoga breathing techniques in cognitive behavioral therapy for post-traumatic stress disorder: A pragmatic randomized controlled trial. Front Psychiatr. 2023;14:1101046. doi: 10.3389/fpsyt.2023.1101046. PMID: 37139325.","1620534","2024"
"haller2023_B","haller2023","Psychotherapy & CIH","2023","PTSD","Active Control",,"74","B","34",,"Trauma-focused cognitive behavioral therapy","Trauma-focused cognitive behavioral therapy (TF-CBT)","Standard guideline TF-CBT for full session; ""stabilization techniques included trauma education, progressive muscle relaxation, self-control and affect-control methods, imagination, and self-care/resource development and were followed by standard confrontation techniques""","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"1 hour",,,"10 sessions","completed intervention",,,,,,,,,,,,"Not reported","Community","83.78%",,,"Some Concerns","Haller H, Mitzinger D, Cramer H. The integration of yoga breathing techniques in cognitive behavioral therapy for post-traumatic stress disorder: A pragmatic randomized controlled trial. Front Psychiatr. 2023;14:1101046. doi: 10.3389/fpsyt.2023.1101046. PMID: 37139325.","1620534","2024"
"hamner2009_A","hamner2009","Pharmacotherapy","2009","PTSD","PTSD",,"29","A","16",,"Divalproex","Divalproex","Anticonvulsant","No",,"Yes","Mood Stabilizer","No",,"No","No","No","No","No","Individual","In Person","Started at 750 mg/day ""in divided doses"", increased by 250 mg every 3 to 4 days, titrated until positive clinical response or desired trough level (50 to 125 mcg/mL); mean daily dose range 500 to 1500 mg",,,"10",,,,,,,,,,,"1250 mg/day","327",,"Race data reported","Veteran","3.45%","Mixed","combat-related, MST","High","Hamner MB, Faldowski RA, Robert S, et al. A preliminary controlled trial of divalproex in posttraumatic stress disorder. Ann Clin Psychiatry. 2009 Apr-Jun;21(2):89-94. PMID: 19439158.","33535","2019"
"hamner2009_B","hamner2009","Pharmacotherapy","2009","PTSD","Inactive Control",,"29","B","13",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"10",,,,,,,,,,,,,,"Race data reported","Veteran","3.45%","Mixed","combat-related, MST","High","Hamner MB, Faldowski RA, Robert S, et al. A preliminary controlled trial of divalproex in posttraumatic stress disorder. Ann Clin Psychiatry. 2009 Apr-Jun;21(2):89-94. PMID: 19439158.","33535","2019"
"hamner2019_A","hamner2019","Pharmacotherapy","2019","PTSD","PTSD",,"24","A","9",,"Ziprasidone augmentation","Ziprasidone augmentation","Ziprasidone augmentation to sertraline or paroxetine (open-label sertraline or paroxetine during phase 1 of study; see comments for phase 1 details).","No",,"Yes","Mixed","No",,"No","No","No","No","No","Individual","In Person","120 to 160 mg total daily dose, as tolerated",,"Twice daily in divided doses","8",,,,,,,,,,,,,"all individuals reached targeted dosing range","Race data reported","Veteran",,,,"High","Hamner MB, Hernandez-Tejada MA, Zuschlag ZD, et al. Ziprasidone augmentation of SSRI antidepressants in posttraumatic stress disorder: a randomized, placebo-controlled pilot study of augmentation therapy. J Clin Psychopharmacol. 2019 Mar/Apr;39(2):153-7. doi: 10.1097/JCP.0000000000001000. PMID: 30640209.","51867","2020"
"hamner2019_B","hamner2019","Pharmacotherapy","2019","PTSD","Active Control",,"24","B","15",,"Placebo augmentation","Placebo augmentation","Placebo augmentation to sertraline or paroxetine (open-label sertraline or paroxetine during phase 1 of study; see comments for phase 1 details).","No",,"Yes","Antidepressant: SSRI","No",,"No","No","Yes","No","No","Individual","In Person","Comparable dosing to ziprasidone 120 to 160 mg",,"Twice daily in divided doses","8",,,,,,,,,,,,,"all individuals reached targeted dosing range","Race data reported","Veteran",,,,"High","Hamner MB, Hernandez-Tejada MA, Zuschlag ZD, et al. Ziprasidone augmentation of SSRI antidepressants in posttraumatic stress disorder: a randomized, placebo-controlled pilot study of augmentation therapy. J Clin Psychopharmacol. 2019 Mar/Apr;39(2):153-7. doi: 10.1097/JCP.0000000000001000. PMID: 30640209.","51867","2020"
"hanling2016_A","hanling2016","Nonpharmacologic biological","2016","PTSD","PTSD",,"42","A","27",,"Stellate Ganglion Block","Stellate ganglion block (SGB)","Injection of ropivacaine (a local anesthetic) at right C5 or C6 vertebra into the stellate ganglion - sympathetic nerve tissue of the neck.","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person","5 mL of 0.5% ropivacaine",,"Once or twice, depending on response","0.14","single injection, second injection after 3 months if needed","See Detail",,"Reports in flow diagram as ""received allocated intervention"" (100% of participants); 2nd injection was allowed only for participants still meeting PTSD criteria, but unclear if all of these did receive 2nd injection, and no other information for treatment completion",,,,,,"66% received two injections","5 mL of 0.5% bupivacaine",,,"Race and Ethnicity data reported","Mixed","19.05%","Mixed","combat-related, other (noncombat unspecified)","Some Concerns","Hanling SR, Hickey A, Lesnik I, et al. Stellate Ganglion Block for the treatment of posttraumatic stress disorder: a randomized, double-blind, controlled trial. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):494-500. doi: 10.1097/aap.0000000000000402. PMID: 27187898.","46472","2019"
"hanling2016_B","hanling2016","Nonpharmacologic biological","2016","PTSD","Inactive Control",,"42","B","15",,"Sham stellate ganglion block","Sham","Normal saline injected in soft tissues superficial to the anterior tubercle of C6","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","5 mL",,"Once","0.14","single injection","See Detail",,"Reports in flow diagram as ""received allocated intervention"" (100% of participants); participants were allowed to crossover after sham intervention and asssessment and reports those who had 1st and 2nd active injections",,,,,,,,,,"Race and Ethnicity data reported","Mixed","19.05%","Mixed","combat-related, other (noncombat unspecified)","Some Concerns","Hanling SR, Hickey A, Lesnik I, et al. Stellate Ganglion Block for the treatment of posttraumatic stress disorder: a randomized, double-blind, controlled trial. Reg Anesth Pain Med. 2016 Jul-Aug;41(4):494-500. doi: 10.1097/aap.0000000000000402. PMID: 27187898.","46472","2019"
"harb2019_A","harb2019","Psychotherapy","2019","PTSD","PTSD",,"108","A","53",,"IR + CBT-I","Imagery Rehearsal Training (IRT) + Cognitive Behavioral Therapy for Insomnia (CBT-I)","IR combined with CBT-I as manualized treatment; participants completed standard daily sleep diaries.



CBT-I ""included psychoeducation about sleep and post-traumatic sleep problems and the following elements of standard CBT-I: grounding, aimed at reducing arousal and/or disso- citation after waking from nightmares (session 1), progressive muscle relaxation and discussion of the relationship between daily stressors, sleep, and nightmares (session 2), sleep hygiene and setting a regular sleep schedule (session 3), stimulus control (session 4), reduction of cognitive hyperarousal (session 5), and relapse prevention (session 6)""; did not include intentional sleep restriction.



IR was incorporated in sessions 2-4 with identification and rescripting of a recurrent nightmare.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","6",,"Received complete intervention",,,,,,,,,,,,"Race data reported","Veteran","13.9%","Combat-related",,"Some Concerns","Harb GC, Cook JM, Phelps AJ, et al. Randomized controlled trial of imagery rehearsal for posttraumatic nightmares in combat veterans. J Clin Sleep Med. 2019 May 15;15(5):757-67. doi: 10.5664/jcsm.7770. PMID: 31053215.","52095","2020"
"harb2019_B","harb2019","Psychotherapy","2019","PTSD","Active Control",,"108","B","55",,"CBT-I","Cognitive Behavioral Therapy for Insomnia (CBT-I)","CBT-I: manualized therapy; ""included psychoeducation about sleep and post-traumatic sleep problems and the following elements of standard CBT-I: grounding, aimed at reducing arousal and/or disso- citation after waking from nightmares (session 1), progressive muscle relaxation and discussion of the relationship between daily stressors, sleep, and nightmares (session 2), sleep hygiene and setting a regular sleep schedule (session 3), stimulus control (session 4), reduction of cognitive hyperarousal (session 5), and relapse prevention (session 6)""; CBT-I did not include intentional sleep restriction, discussion of nightmare content, and did not teach any imagery rescripting techniques. Participants completed standard daily sleep diaries.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"1 hour","Weekly","6",,"Received complete intervention",,,,,,,,,,,,"Race data reported","Veteran","13.9%","Combat-related",,"Some Concerns","Harb GC, Cook JM, Phelps AJ, et al. Randomized controlled trial of imagery rehearsal for posttraumatic nightmares in combat veterans. J Clin Sleep Med. 2019 May 15;15(5):757-67. doi: 10.5664/jcsm.7770. PMID: 31053215.","52095","2020"
"harris2018_A","harris2018","Psychotherapy & CIH","2018","PTSD","PTSD",,"138","A","71",,"Building Spiritual Strength","Building Spiritual Strength","Manualized, spiritually integrated, group counseling intervention designed to facilitate resolution of spiritual distress","No",,"No",,"Yes","Spirituality","No","No","No","No","No","Group","In Person",,"2 hours","Weekly","8",,"completed ≥5 sessions",,,,,,"4.52","3.33",,,,,"Race data reported","Veteran","23.91%","Mixed","combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (adverse childhood experiences, not specified)","Some Concerns","Harris JI, Usset T, Voecks C, et al. Spiritually integrated care for PTSD: a randomized controlled trial of ""Building Spiritual Strength"". Psychiatry Res. 2018 Jun 20;267:420-8. doi: 10.1016/j.psychres.2018.06.045. PMID: 29980120.","50585","2019"
"harris2018_B","harris2018","Psychotherapy & CIH","2018","PTSD","Active Control",,"138","B","67",,"Group PCT","Present-Centered Therapy (PCT)","Provides support and addresses participants' current problems but does not directly focus on the person's trauma-related memories or facilitate resolution of participants' spiritual distress","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Group","In Person",,"2 hour","Weekly","8",,"completed ≥5 sessions",,,,,,"4.78","3.34",,,,,"Race data reported","Veteran","23.91%","Mixed","combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, other (adverse childhood experiences, not specified)","Some Concerns","Harris JI, Usset T, Voecks C, et al. Spiritually integrated care for PTSD: a randomized controlled trial of ""Building Spiritual Strength"". Psychiatry Res. 2018 Jun 20;267:420-8. doi: 10.1016/j.psychres.2018.06.045. PMID: 29980120.","50585","2019"
"haynes2020_A","haynes2020","Psychotherapy","2020","PTSD","PTSD",,"43","A","21",,"Cognitive Behavioral Social Rhythm Group Therapy","Cognitive Behavioral Social Rhythm Group Therapy","Manualized, structured group therapy based on social rhythm model of mood disruption. Attempts to  increase the frequency and consistency of daily, habitual behaviors including social interactions and sleep, increase ambient light exposure, and challenge unhelpful thoughts that impede behavioral goals. No discussion of past events.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"2 hours","Weekly","12",,"Attend at least 9 (75%) sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Combat-related",,"Low","Haynes PL, Burger SB, Kelly M, et al. Cognitive behavioral social rhythm group therapy versus present centered group therapy for veterans with posttraumatic stress disorder and major depressive disorder: a randomized controlled pilot trial. J Affect Disord. 2020 Dec 1;277:800-9. doi: 10.1016/j.jad.2020.09.009. PMID: 33065820.","1559053","2022"
"haynes2020_B","haynes2020","Psychotherapy","2020","PTSD","PTSD",,"43","B","22",,"Group PCT","Present-Centered Therapy (PCT)","Manualized, unstructured group therapy based on group process model; focuses on current relationships, behaviors and feelings resulting from past trauma; included relaxation training and sleep hygeine rules. No discussion of past events.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"2 hours","Weekly","12",,"Attend at least 9 (75%) sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Combat-related",,"Low","Haynes PL, Burger SB, Kelly M, et al. Cognitive behavioral social rhythm group therapy versus present centered group therapy for veterans with posttraumatic stress disorder and major depressive disorder: a randomized controlled pilot trial. J Affect Disord. 2020 Dec 1;277:800-9. doi: 10.1016/j.jad.2020.09.009. PMID: 33065820.","1559053","2022"
"henseldittmann2011_A","henseldittmann2011","Psychotherapy","2011","PTSD","PTSD",,"28","A","15",,"NET","Narrative Exposure Therapy (NET)","According to manual by Schauer et al. (2005), participant constructs a detailed chronological account of his/her biography. The therapist provides empathic understanding, active listening, congruency, and unconditional positive regard for the participant. The participant is encouraged to relive the emotions while narrating, and therapist links the experiences to episodic facts and contrasts the time and place of the memory with those of the present","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","NR (mean 9.82 [SD 3.55] days between sessions for overall study population)","13","10 sessions total, lasting mean 13 weeks for overall study population","Completed NET",,,,,,,,,,,,"Not reported","Community",,"Terrorism/political violence/forced displacement",,"Some Concerns","Hensel-Dittmann D, Schauer M, Ruf M, et al. Treatment of traumatized victims of war and torture: a randomized controlled comparison of narrative exposure therapy and stress inoculation training. Psychother Psychosom. 2011 Oct;80(6):345-52. doi: 10.1159/000327253. PMID: 21829046.","37590","2019"
"henseldittmann2011_B","henseldittmann2011","Psychotherapy","2011","PTSD","PTSD",,"28","B","13",,"SIT","Stress Inoculation Training (SIT)","Modified version includes breathing techniques, relaxation training, cognitive restructuring, thought stopping, guided self-dialogue, covert modeling, and role play","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","NR (mean 9.82 [SD 3.55] days between sessions for overall study population)","13","10 sessions total, lasting mean 13 weeks for overall study population","Completed SIT",,,,,,,,,,,,"Not reported","Community",,"Terrorism/political violence/forced displacement",,"Some Concerns","Hensel-Dittmann D, Schauer M, Ruf M, et al. Treatment of traumatized victims of war and torture: a randomized controlled comparison of narrative exposure therapy and stress inoculation training. Psychother Psychosom. 2011 Oct;80(6):345-52. doi: 10.1159/000327253. PMID: 21829046.","37590","2019"
"herescolevy2002_A","herescolevy2002","Pharmacotherapy","2002","PTSD","PTSD",,"11","A","10",,"D-cycloserine","D-cycloserine","Partial agonist at the NMDA receptor-associated glycine site; also used as broad spectrum antibiotic. Cross-over design with 2 weeks of washout between treatment periods.","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","25 mg",,"Twice daily","4",,,,,,,,,,,,,,"Not reported","Community","18.18%","Mixed","accidents, terrorism/political violence/forced displacement, other (physical abuse)","Some Concerns","Heresco-Levy U, Kremer I, Javitt DC, et al. Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2002 Dec;5(4):301-7. doi: 10.1017/S1461145702003061. PMID: 12466030.","25345","2019"
"herescolevy2002_B","herescolevy2002","Pharmacotherapy","2002","PTSD","Inactive Control",,"11","B","8",,"Placebo","Placebo","Matched placebo. Cross-over design with 2 weeks of washout between treatment periods.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Twice daily","4",,,,,,,,,,,,,,"Not reported","Community","18.18%","Mixed","accidents, terrorism/political violence/forced displacement, other (physical abuse)","Some Concerns","Heresco-Levy U, Kremer I, Javitt DC, et al. Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2002 Dec;5(4):301-7. doi: 10.1017/S1461145702003061. PMID: 12466030.","25345","2019"
"herescolevy2009_A","herescolevy2009","Pharmacotherapy","2009","PTSD","PTSD",,"22","A","21",,"D-serine","D-serine","NMDA glutamate receptor agonist; cross-over design with 3 week washout period.","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","30 mg/kg total daily dose; titration: initiated at 10 mg/kg, increased after 1 week to 20 mg/kg and after 2 weeks to 30 mg/kg",,"Daily (3 divided doses)","6",,,,,,,,,,,"2.45 g/day","0.3",,"Not reported","Community","13.64%","Mixed","combat-related, accidents, terrorism/political violence/forced displacement, other (not specified)","Some Concerns","Heresco-Levy U, Vass A, Bloch B, et al. Pilot controlled trial of D-serine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2009 Oct;12(9):1275-82. doi: 10.1017/S1461145709000339. PMID: 19366490.","33582","2019"
"herescolevy2009_B","herescolevy2009","Pharmacotherapy","2009","PTSD","Inactive Control",,"22","B","22",,"Placebo","Placebo","Placebo in capsule identical to active treatment with same dose escalation schedule; cross-over design with 3 week washout period.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","30 mg/kg D-serine equivalent total daily dose; titration: initiated at 10 mg/kg, increased after 1 week to 20 mg/kg and after 2 weeks to 30 mg/kg",,"Daily","6",,,,,,,,,,,,,,"Not reported","Community","13.64%","Mixed","combat-related, accidents, terrorism/political violence/forced displacement, other (not specified)","Some Concerns","Heresco-Levy U, Vass A, Bloch B, et al. Pilot controlled trial of D-serine for the treatment of post-traumatic stress disorder. Int J Neuropsychopharmacol. 2009 Oct;12(9):1275-82. doi: 10.1017/S1461145709000339. PMID: 19366490.","33582","2019"
"hertzberg1999_A","hertzberg1999","Pharmacotherapy","1999","PTSD","PTSD",,"15","A","11",,"Lamotrigine","Lamotrigine","Glutamate-inhibiting anticonvulsant with antidepressant properties; flexible dosing to achieve maximal response","No",,"Yes","Mood Stabilizer","No",,"No","No","No","No","No","Individual","In Person","50 to 500 mg; flexible dosing; titration: 25 mg for 2 weeks, 50 mg for 2 weeks, 100 mg for 1 week, then increased in 100-mg increments every 1 to 2 weeks with maximum dose of 500 mg; taper over last 2 weeks with 50% reduction each week",,"Daily","12",,,,,,,,,,,"380 mg/day (range 50 to 500 mg/day)",,,"Race data reported","Mixed","36%","Mixed","combat-related, rape/sexual assault, other (abduction)","High","Hertzberg MA, Butterfield MI, Feldman ME, et al. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol psychiatry. 1999 May 1;45(9):1226-9. PMID: 10331117.","09744","2019"
"hertzberg1999_B","hertzberg1999","Pharmacotherapy","1999","PTSD","Inactive Control",,"15","B","4",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,,,,"Race data reported","Mixed","36%","Mixed","combat-related, rape/sexual assault, other (abduction)","High","Hertzberg MA, Butterfield MI, Feldman ME, et al. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol psychiatry. 1999 May 1;45(9):1226-9. PMID: 10331117.","09744","2019"
"hertzberg2000_A","hertzberg2000","Pharmacotherapy","2000","PTSD","PTSD",,"12","A","6",,"Fluoxetine","Fluoxetine","SSRI; flexible dosing with titration to maximal response or dose-limiting side effects","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","10 to 60 mg; titration: 10 mg for 1 week, then 20 mg for 2 weeks, then increased weekly in 10-mg increments with maximum daily dose of 60 mg",,"Daily","12",,,,,,,,,,,"48  mg/day (range 10 to 60  mg/day)",,,"Race data reported","Veteran","0%","Combat-related",,"High","Hertzberg MA, Feldman ME, Beckham JC, et al. Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry. 2000 Jun;12(2):101-5. doi: 10.1023/A:1009076231175. PMID: 10907802.","22432","2019"
"hertzberg2000_B","hertzberg2000","Pharmacotherapy","2000","PTSD","Inactive Control",,"12","B","6",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,,,,"Race data reported","Veteran","0%","Combat-related",,"High","Hertzberg MA, Feldman ME, Beckham JC, et al. Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry. 2000 Jun;12(2):101-5. doi: 10.1023/A:1009076231175. PMID: 10907802.","22432","2019"
"hien2004_A","hien2004","Psychotherapy","2004","PTSD+SUD","PTSD+SUD","Integrated","96","A",,"41 attended at least one session and were analyzed","Seeking Safety","Seeking Safety","Manualized individual therapy; cognitive behavioral ""integrated treatment that addresses PTSD symptoms in the context of substance abuse.""","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour","Twice a week","12",,"attended ≥25% of all therapy sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%",,,"High","Hien DA, Cohen LR, Miele GM, et al. Promising treatments for women with comorbid PTSD and substance use disorders. Am J Psychiatry. 2004 Aug;161(8):1426-32. doi: 10.1176/appi.ajp.161.8.1426. PMID: 15285969.","26661","2020"
"hien2004_B","hien2004","Psychotherapy","2004","PTSD+SUD","SUD","Not integrated","96","B",,"34 completed at least one session and were randomized","Relapse Prevention","Relapse Prevention","Manualized individual therapy addressing substance abuse; ""does not directly address trauma-related symptoms.""","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour","Twice a week","12",,"attended ≥25% of all therapy sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%",,,"High","Hien DA, Cohen LR, Miele GM, et al. Promising treatments for women with comorbid PTSD and substance use disorders. Am J Psychiatry. 2004 Aug;161(8):1426-32. doi: 10.1176/appi.ajp.161.8.1426. PMID: 15285969.","26661","2020"
"hien2009_A","hien2009","Psychotherapy","2009","PTSD+SUD","PTSD+SUD","Integrated","353","A","176",,"Seeking Safety","Seeking Safety","Group therapy sessions following set structure; abbreviated to 12 sessions (full Seeking Safety treatment protocol is 25 sessions), each with a different topic; included topics: ""safety, taking back power from PTSD, when substances are in control, honesty, setting boundaries in relationships, compassion, healing from anger, cre- ating meaning, integrating the split self, taking good care of oneself, red and green flags, and detaching from emotional pain (grounding)."" All participants also had TAU for substance abuse at a community-based substance abuse treatment program which did not include trauma-focused treatments.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"75 to 90 minutes","Twice a week","6",,"completed at least 6 treatment sessions (""at least minimal exposure"")",,,,,,"6.2","4.5",,,,,"Race and Ethnicity data reported","Community","100%","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")","Some Concerns","Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.","85825","2020"
"hien2009_B","hien2009","Psychotherapy","2009","PTSD+SUD","Inactive Control","Not integrated","353","B","177",,"Women's Health Education","Women's Health Education","Group format with all sessions following the same format; intervention is ""psychoeducational, manualized health curriculum focused on topics such as understanding the female body, human sexual behavior, pregnancy and childbirth, sexually trans- mitted diseases, HIV, and AIDS""; no ""explicit focus or psychoeducation specific to substance abuse or trauma"". All participants also had TAU for substance abuse at a community-based substance abuse treatment program which did not include trauma-focused treatments.","No",,"No",,"No",,"No","No","Yes","No","No","Group","In Person",,"75 to 90 minutes","Twice a week","6",,"completed at least 6 treatment sessions (""at least minimal exposure"")",,,,,,"6","4.3",,,,,"Race and Ethnicity data reported","Community","100%","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents, illness/medical procedure, other (""exposed to violent death"")","Some Concerns","Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug;77(4):607-19. doi: 10.1037/a0016227. PMID: 19634955.","85825","2020"
"hijazi2014_A","hijazi2014","Psychotherapy","2014","PTSD","PTSD",,"63","A","41",,"Brief NET","Narrative Exposure Therapy (NET)","Manualized treatment adapted for 3 sessions; intervention that fuses emotional processing, testimony, and expressive writing by helping people construct detailed narratives of their life stories with a focus on their traumatic experiences.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 to 90 minutes","Weekly","3",,"completed all 3 sessions",,,,,,,,,,,,"Not reported","Community","55.6%","Mixed","terrorism/political violence/forced displacement, rape/sexual assault, combat-related","High","Hijazi AM, Lumley MA, Ziadni MS, et al. Brief narrative exposure therapy for posttraumatic stress in Iraqi refugees: a preliminary randomized clinical trial. J Trauma Stress. 2014 Jun;27(3):314-22. doi: 10.1002/jts.21922. PMID: 24866253.","42387","2019"
"hijazi2014_B","hijazi2014","Psychotherapy","2014","PTSD","Inactive Control",,"63","B","22",,"Waitlist","Waitlist","Waitlist","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Not reported","Community","55.6%","Mixed","terrorism/political violence/forced displacement, rape/sexual assault, combat-related","High","Hijazi AM, Lumley MA, Ziadni MS, et al. Brief narrative exposure therapy for posttraumatic stress in Iraqi refugees: a preliminary randomized clinical trial. J Trauma Stress. 2014 Jun;27(3):314-22. doi: 10.1002/jts.21922. PMID: 24866253.","42387","2019"
"himmerich2016_A","himmerich2016","Other Mixed","2016","PTSD","PTSD",,"38","A","21",,"Inpatient psychotherapy","Treatment as usual (TAU)","Inpatient treatment, including EMDR, psychotherapy groups, physiotherapy, occupational and art therapy","Yes","Trauma-focused","No",,"No",,"No","No","No","Yes","No","Mixed","In Person",,,,"6",,,,,,,,,,,,,,"Not reported","Active Duty Military","0%","Combat-related",,"High","Himmerich H, Willmund GD, Zimmermann P, et al. Serum concentrations of TNF-alpha and its soluble receptors during psychotherapy in German soldiers suffering from combat-related PTSD. Psychiatr. 2016;28(3):293-8. PMID: 27658839.","48560","2024"
"himmerich2016_B","himmerich2016","Other Mixed","2016","PTSD","Active Control",,"38","B","17",,"Outpatient clinical management","Treatment as usual (TAU)","Outpatient management, including suppportive psychotherapy but not including EMDR","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Mixed","In Person",,,,"6",,,,,,,,,,,,,,"Not reported","Active Duty Military","0%","Combat-related",,"High","Himmerich H, Willmund GD, Zimmermann P, et al. Serum concentrations of TNF-alpha and its soluble receptors during psychotherapy in German soldiers suffering from combat-related PTSD. Psychiatr. 2016;28(3):293-8. PMID: 27658839.","48560","2024"
"hinton2009_A","hinton2009","Psychotherapy","2009","PTSD","PTSD",,"24","A","12",,"Culturally sensitive CBT","Cognitive behavioral therapy (CBT) without a trauma focus","Manualized treatment according to Hinton et al. (2005) that includes muscle relaxation, guided imagery and mindfulness training, yoga-like stretching linked to self images of flexibility, cognitive restructuring, exercises used to teach emotional distancing and switching, and interceptive exposure","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,,"Weekly","12",,"See Detail",,"Study reports all randomized patients completed the study and no missing data (no attrition from measurement), but does not provide information specifically for treatment completion.",,,,,,,,,,"Race data reported","Community","58.33%","Terrorism/political violence/forced displacement",,"Some Concerns","Hinton DE, Hofmann SG, Pollack MH, et al. Mechanisms of efficacy of CBT for Cambodian refugees with PTSD: improvement in emotion regulation and orthostatic blood pressure response. CNS Neurosci Ther. 2009 Fall;15(3):255-63. doi: 10.1111/j.1755-5949.2009.00100.x. PMID: 19691545.","33298","2019"
"hinton2009_B","hinton2009","Psychotherapy","2009","PTSD","Inactive Control",,"24","B","12",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"12",,,,,,,,,,,,,,"Race data reported","Community","58.33%","Terrorism/political violence/forced displacement",,"Some Concerns","Hinton DE, Hofmann SG, Pollack MH, et al. Mechanisms of efficacy of CBT for Cambodian refugees with PTSD: improvement in emotion regulation and orthostatic blood pressure response. CNS Neurosci Ther. 2009 Fall;15(3):255-63. doi: 10.1111/j.1755-5949.2009.00100.x. PMID: 19691545.","33298","2019"
"hinton2011_A","hinton2011","Psychotherapy & CIH","2011","PTSD","PTSD",,"24","A","12",,"Culturally adapted CBT","Cognitive behavioral therapy (CBT) without a trauma focus","Manualized group CBT with treatment culturally adapted for Latino patients.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"1 hour","Weekly","14",,"completed treatment course",,,,,,,,,,,,"Ethnicity data reported","Community","100%",,,"High","Hinton DE, Hofmann SG, Rivera E, et al. Culturally adapted CBT (CA-CBT) for Latino women with treatment-resistant PTSD: a pilot study comparing CA-CBT to applied muscle relaxation. Behav Res Ther. 2011 Apr;49(4):275-80. doi: 10.1016/j.brat.2011.01.005. PMID: 21333272.","36143","2019"
"hinton2011_B","hinton2011","Psychotherapy & CIH","2011","PTSD","Active Control",,"24","B","12",,"Applied muscle relaxation","Relaxation","Manualized treatment; includes: psychoeducation about PTSD, anxiety, and panic; how those disorders produce somatic symptoms; how treatment can reduce anxiety and improve those disorders.","No",,"No",,"Yes","Relaxation","No","No","Yes","No","No","Group","In Person",,"1 hour","Weekly","14",,"completed treatment course",,,,,,,,,,,,"Ethnicity data reported","Community","100%",,,"High","Hinton DE, Hofmann SG, Rivera E, et al. Culturally adapted CBT (CA-CBT) for Latino women with treatment-resistant PTSD: a pilot study comparing CA-CBT to applied muscle relaxation. Behav Res Ther. 2011 Apr;49(4):275-80. doi: 10.1016/j.brat.2011.01.005. PMID: 21333272.","36143","2019"
"hobart2025_A","hobart2025","Pharmacotherapy","2025","PTSD","PTSD",,"321","A","82",,"Brexpiprazole + sertraline","Brexpiprazole + sertraline","Brexpiprazole (atypical antipsychotic) + sertraline (SSRI), each with flexible dosing. Screening/washout period of 3-14 days then 1-week placebo run-in period, followed by 9 weeks active treatment including titration over 2-3 weeks (endpoint at week 10 for analysis), then 2 weeks follow-up (trial duration 12 weeks total).","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","Brexpiprazole 1 to 3 mg/day + sertraline 100 to 200 mg/day. Titration over 2 to 3 weeks. Decreases allowed through Week 6 for each drug (to minimum 1 mg/day brexpiprazole and 100 mg/day sertraline). Participants who required a dose increase/decrease had the doses changed for both drugs.
Brexpiprazole titration: Week 1, 0.5 mg/day; Week 2, 1 mg/day; Week 3, 2 mg/day; Week 4 stay at 2, increase to 3, or decrease to 1 mg/day.
Sertraline titration: Week 1, 50 mg/day; Week 2, 100 mg/day; Week 3, 150 mg/day; Week 4, stay at 150, increase to 200, or decrease to 100 mg/day.",,"daily","9","Treatment period 9 weeks, from week 1 to week 10 endpoint (considered end of treatment for trial). See study comments and publication for additional information.",,,,,,,,,,"brexpiprazole: 2.2 mg
sertraline: 161 mg",,"Mean dose at each participant's last visit (reported for all 80 treated, though some did not complete 12 weeks' treatment)","Race and Ethnicity data reported","Community","62%","Mixed","Combat-related; Other (not specified)","Low","Hobart M, Chang D, Hefting N, et al. Brexpiprazole in Combination With Sertraline and as Monotherapy in Posttraumatic Stress Disorder: A Full-Factorial Randomized Clinical Trial. J Clin Psychiatry. 2025 Feb 19;86(1):19. doi: 10.4088/JCP.24m15577. PMID: 40009045.","1645388","2025"
"hobart2025_B","hobart2025","Pharmacotherapy","2025","PTSD","Active Control",,"321","B","75",,"Brexpiprazole + placebo","Brexipiprazole","Brexpiprazole (atypical antipsychotic) with flexible dosing + placebo for sertraline. Screening/washout period of 3-14 days then 1-week placebo run-in period,  followed by 9 weeks active treatment including titration over 2-3 weeks (endpoint at week 10 for analysis), then 2 weeks follow-up (trial duration 12 weeks total). Matching placebo.","No",,"Yes","Other pharmacotherapy","No",,"No","No","Yes","No","No","Individual","In Person","Brexpiprazole 1 to 3 mg/day + placebo matching sertraline capsules.
Titration over 2 to 3 weeks. Decreases allowed through Week 6 (to minimum 1 mg/day).
Brexpiprazole titration: Week 1, 0.5 mg/day; Week 2, 1 mg/day; Week 3, 2 mg/day; Week 4 stay at 2, increase to 3, or decrease to 1 mg/day.",,"daily","9","Treatment period 9 weeks, from week 1 to week 10 endpoint (considered end of treatment for trial). See study comments and publication for additional information.",,,,,,,,,,"Brexpiprazole: 2.1 mg",,"Mean dose at each participant's last visit (reported for all 75 treated, though some did not complete 12 weeks' treatment)","Race and Ethnicity data reported","Community","62%","Mixed","Combat-related; Other (not specified)","Low","Hobart M, Chang D, Hefting N, et al. Brexpiprazole in Combination With Sertraline and as Monotherapy in Posttraumatic Stress Disorder: A Full-Factorial Randomized Clinical Trial. J Clin Psychiatry. 2025 Feb 19;86(1):19. doi: 10.4088/JCP.24m15577. PMID: 40009045.","1645388","2025"
"hobart2025_C","hobart2025","Pharmacotherapy","2025","PTSD","Active Control",,"321","C","81",,"Sertraline + placebo","Sertraline + placebo","Sertraline (SSRI) with flexible dosing + placebo for brexpiprazole. Screening/washout period of 3-14 days then 1-week placebo run-in period,  followed by 9 weeks active treatment including titration over 2-3 weeks (endpoint at week 10 for analysis), then 2 weeks follow-up (trial duration 12 weeks total). Matching placebo.","No",,"Yes","Other pharmacotherapy","No",,"No","No","Yes","No","No","Individual","In Person","Sertraline 100 to 200 mg/day + placebo matching brexpiprazole tablets. Titration over 2 to 3 weeks. Decreases allowed through Week 6 (to minimum 100 mg/day)
Sertraline titration: Week 1, 50 mg/day; Week 2, 100 mg/day; Week 3, 150 mg/day; Week 4, stay at 150, increase to 200, or decrease to 100 mg/day.",,"daily","9","Treatment period 9 weeks, from week 1 to week 10 endpoint (considered end of treatment for trial). See study comments and publication for additional information.",,,,,,,,,,"Sertraline: 158 mg",,"Mean dose at each participant's last visit (reported for all 79 treated, though some did not complete 12 weeks' treatment)","Race and Ethnicity data reported","Community","62%","Mixed","Combat-related; Other (not specified)","Low","Hobart M, Chang D, Hefting N, et al. Brexpiprazole in Combination With Sertraline and as Monotherapy in Posttraumatic Stress Disorder: A Full-Factorial Randomized Clinical Trial. J Clin Psychiatry. 2025 Feb 19;86(1):19. doi: 10.4088/JCP.24m15577. PMID: 40009045.","1645388","2025"
"hobart2025_D","hobart2025","Pharmacotherapy","2025","PTSD","Inactive Control",,"321","D","83",,"Placebo + placebo","Placebo","Placebos for brexpiprazole and sertraline. Screening/washout period of 3-14 days then 1-week placebo run-in period, followed by 9 weeks active treatment including titration over 2-3 weeks (endpoint at week 10 for analysis), then 2 weeks follow-up (trial duration 12 weeks total). Matching placebos to both active medications.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","Placebos matching brexpiprazole tablets and sertraline capsules.",,"daily","9","Treatment period 9 weeks, from week 1 to week 10 endpoint (considered end of treatment for trial). See study comments and publication for additional information.",,,,,,,,,,,,,"Race and Ethnicity data reported","Community","62%","Mixed","Combat-related; Other (not specified)","Low","Hobart M, Chang D, Hefting N, et al. Brexpiprazole in Combination With Sertraline and as Monotherapy in Posttraumatic Stress Disorder: A Full-Factorial Randomized Clinical Trial. J Clin Psychiatry. 2025 Feb 19;86(1):19. doi: 10.4088/JCP.24m15577. PMID: 40009045.","1645388","2025"
"hoffart2013_A","hoffart2013","Psychotherapy","2013","PTSD","PTSD",,"65","A","31",,"PE using imagery exposure","Prolonged Exposure (PE)","Manualized trauma-focused therapy following manual for PE using imagery exposure (Foa et al., 2007) adapted for inpatient setting; treatment included treatment rationale and psychoeducation, constructing exposure hierarchy, and imagery exposure (both entire memory and hot spots procedure).","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","10",,"did not drop out and received therapy according to protocol",,,,,,,,,,,,"Not reported","Community","58.46%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence","Some Concerns","Hoffart A, Øktedalen T, Langkaas TF, et al. Alliance and outcome in varying imagery procedures for PTSD: a study of within-person processes. J Couns Psychol. 2013 Oct;60(4):471-82. doi: 10.1037/a0033604. PMID: 23957768.","44042","2019"
"hoffart2013_B","hoffart2013","Psychotherapy","2013","PTSD","PTSD",,"65","B","34",,"PE using imagery rescripting","Prolonged Exposure (PE) + imagery rescripting","Manualized trauma-focused therapy following manual for PE using imagery rescripting (Smucker, 2005) adapted for inpatient setting; treatment included treatment rationale and psychoeducation, and 3 continuous phases of imagery rescripting: imagery reliving of the traumatic event, imagining current self entering the scene at the hot spot and bringing the situation to a solution, and imagining an interaction between the current self and the traumatized self back then.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","10",,"did not drop out and received therapy according to protocol",,,,,,,,,,,,"Not reported","Community","58.46%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence","Some Concerns","Hoffart A, Øktedalen T, Langkaas TF, et al. Alliance and outcome in varying imagery procedures for PTSD: a study of within-person processes. J Couns Psychol. 2013 Oct;60(4):471-82. doi: 10.1037/a0033604. PMID: 23957768.","44042","2019"
"hogberg2007_A","hogberg2007","Psychotherapy","2007","PTSD","PTSD",,"24","A","13",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Breathing and relaxation technique presented at beginning of each session. EMDR consists of therapist-guided psychotherapy designed to help shift negative thoughts and bodily distress to desired positive thoughts through sensory stimulations with rhythmic quality and left-right alternating character","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes",,"8","5 sessions total","Completed 5 sessions of EMDR",,,,,,,,,,,,"Not reported","Community","20.83%","Mixed","accidents, community/school violence","High","Hogberg G, Pagani M, Sundin O, et al. On treatment with eye movement desensitization and reprocessing of chronic post-traumatic stress disorder in public transportation workers--a randomized controlled trial. Nord J Psychiatry. 2007;61(1):54-61. doi:  10.1080/08039480601129408. PMID: 17365790.","38652","2019"
"hogberg2007_B","hogberg2007","Psychotherapy","2007","PTSD","Inactive Control",,"24","B","11",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"8",,,,,,,,,,,,,,"Not reported","Community","20.83%","Mixed","accidents, community/school violence","High","Hogberg G, Pagani M, Sundin O, et al. On treatment with eye movement desensitization and reprocessing of chronic post-traumatic stress disorder in public transportation workers--a randomized controlled trial. Nord J Psychiatry. 2007;61(1):54-61. doi:  10.1080/08039480601129408. PMID: 17365790.","38652","2019"
"hollifield2007_A","hollifield2007","Psychotherapy & CIH","2007","PTSD","PTSD",,"84","A","29",,"Acupuncture","Acupuncture","Solid needles were placed into rationally



chosen points in subcutaneous tissue or muscle for a given period of time with manipulation. Sessions comprised of 15 to 20 minute interview; 2 to 5 minute pulse and tongue evaluation; 25 to 40 minute needle insertion, manipulation and retention; 2 minute ear-seed placement.","No",,"No",,"Yes","Acupuncture","No","No","No","No","No","Individual","In Person",,"1 hour","Twice weekly","12",,"completed treatment course",,,,,,,,,,,,"Race and Ethnicity data reported","Community","67.86%",,,"High","Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.","29609","2019"
"hollifield2007_B","hollifield2007","Psychotherapy & CIH","2007","PTSD","Active Control",,"84","B","28",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Integrates 4 modalities that have direct and theoretical evidence of efficacy: psychoeducation, behavioral activation, activity planning, cognitive restructuring, imagery rehearsal, exposure and desensitization","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"2 hours","Once weekly","12",,,,,,,,,,,,,,"Race and Ethnicity data reported","Community","67.86%",,,"High","Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.","29609","2019"
"hollifield2007_C","hollifield2007","Psychotherapy & CIH","2007","PTSD","Inactive Control",,"84","C","27",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"12",,"completed treatment course",,,,,,,,,,,,"Race and Ethnicity data reported","Community","67.86%",,,"High","Hollifield M, Sinclair-Lian N, Warner TD, et al. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007 Jun;195(6):504-13. doi: 10.1097/NMD.0b013e31803044f8. PMID: 17568299.","29609","2019"
"hollifield2024_A","hollifield2024","CIH","2024","PTSD","PTSD",,"93","A","47",,"Verum acupuncture","Acupuncture","Acupuncture following traditional Chinese medicine protocols; standard point prescription and up to 3 discretionary points with electric stimulation during needle retention (across 2-point pairs at mixed freqency of 2/100 Hz).","No",,"No",,"Yes","Acupuncture","No","No","No","No","No","Individual","In Person",,"60 minutes","Twice a week","15","Aiming for 24 sessions over 15 weeks","Completed treatment (not further specified)",,"Completed all 24 sessions: 36.17%
Completed ≥19 sessions: 70.21%",,,,,,,,,,"Race and Ethnicity data reported","Veteran","8.6%","Mixed","Combat-related; MST; Accidents; Other (""another violence or loss event"")","Low","Hollifield M, Hsiao AF, Smith T, et al. Acupuncture for combat-related posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2024 Feb 21;21:21. doi: 10.1001/jamapsychiatry.2023.5651. PMID: 38381417.","30689","2024"
"hollifield2024_B","hollifield2024","CIH","2024","PTSD","Inactive Control",,"93","B","46","46 randomized, 45 analyzed (n=1 withdrawn due to COVID-19 and excluded from analysis)","Sham acupuncture","Sham","Sham acupuncture, differentiated by location (2 cm lateral or medial to reference points), superficial insertion, and sham electrostimulator (blinking light without current). Matched in time, frequency, and duration to verum acupuncture intervention.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"60 minutes","Twice a week","15","Aiming for 24 sessions over 15 weeks","Completed treatment (not further specified)",,"Completed all 24 sessions: 21.74%
Completed ≥19 sessions: 58.70%",,,,,,,,,,"Race and Ethnicity data reported","Veteran","8.6%","Mixed","Combat-related; MST; Accidents; Other (""another violence or loss event"")","Low","Hollifield M, Hsiao AF, Smith T, et al. Acupuncture for combat-related posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2024 Feb 21;21:21. doi: 10.1001/jamapsychiatry.2023.5651. PMID: 38381417.","30689","2024"
"hyer1996_A","hyer1996","Other mixed","1996","PTSD","PTSD",,"219","A","108",,"Outward Bound Experience adjunctive with TAU","Recreational therapy + inpatient therapy","TAU replaced by Outward Bound Experience for 1 week; remainder of TAU was not altered.







Outward Bound Experience: adventure experience comprised of: small group exercises focused on cooperation and trust; challenges that emphasize perseverance, self-reliance, and teamwork;  reflection with individual time for solitude, journal writing, and ""solo"" experiences; experiential tasks such as ropes course, hiking, rock climbing; group discussions functioning as debriefings of feeling and experiences, but without specific ""group therapy"" sessions or focus on war-trauma issues. 







TAU: specialized inpatient PTSD treatment program using multidisciplinary team approach, but differing by location. Location A: psychosocial emphasis with stress reduction treatment focus; treatment involves ongoing process group with up to 7 module groups on aspects of trauma coping; no psychopharmaceutical treatment is allowed. Location T: significant emphasis on processing war-related trauma issues in group setting and veteran involvement in therapeutic milieu (such as peer counseling); incorporates psychopharmaceutical treatments","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","Yes","No","Individual","In Person",,,"Daily during weekdays","1","Outward Bound Experience 1 week; overall inpatient treatment 11 to 14 weeks",,,,,,,,,,,,,"Race data reported","Veteran","0%","Combat-related",,"High","Hyer L, Boyd S, Scurfield R, et al. Effects of Outward Bound experience as an adjunct to inpatient PTSD treatment of war veterans. J Clin Psychol. 1996 May;52(3):263-78. doi: 10.1002/(SICI)1097-4679(199605)52:3<263::AID-JCLP3>3.0.CO;2-T. PMID: 8835688.","08065","2019"
"hyer1996_B","hyer1996","Other mixed","1996","PTSD","Active Control",,"219","B","111",,"TAU","Treatment as usual (TAU)","TAU: specialized inpatient PTSD treatment program using multidisciplinary team approach, but differing by location. Location A: psychosocial emphasis with stress reduction treatment focus; treatment involves ongoing process group with up to 7 module groups on aspects of trauma coping; no psychopharmaceutical treatment is allowed. Location T: significant emphasis on processing war-related trauma issues in group setting and veteran involvement in therapeutic milieu (such as peer counseling); incorporates psychopharmaceutical treatments","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No",,,,,,"11 to 14",,,,,,,,,,,,,,"Race data reported","Veteran","0%","Combat-related",,"High","Hyer L, Boyd S, Scurfield R, et al. Effects of Outward Bound experience as an adjunct to inpatient PTSD treatment of war veterans. J Clin Psychol. 1996 May;52(3):263-78. doi: 10.1002/(SICI)1097-4679(199605)52:3<263::AID-JCLP3>3.0.CO;2-T. PMID: 8835688.","08065","2019"
"isserles2013_A","isserles2013","Nonpharmacologic biological","2013","PTSD","PTSD",,"30","A","10",,"DTMS with traumatic experience","Transcranial magnetic stimulation (TMS)","Direct transcranial magnetic stimulation after script-driven imagery of the traumatic experience immediately followed by a script-driven imagery of a neutral event","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person","20 Hz trains of 2 seconds each with 20 seconds inter-train interval for 42 trains, 1680 pulses total","20 minutes","3 times a week","4",,"received ≥8 treatment sessions",,,,,,,,,,,,"Not reported",,"23.08%","Mixed","combat-related, other (not specified)","Some Concerns","Isserles M, Shalev AY, Roth Y, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder--a pilot study. Brain Stimul. 2013 May;6(3):377-83. doi: 10.1016/j.brs.2012.07.008. PMID: 22921765.","39466","2019"
"isserles2013_B","isserles2013","Nonpharmacologic biological","2013","PTSD","Active Control",,"30","B","10",,"DTMS with positive experience","Transcranial magnetic stimulation (TMS)","DTMS after script-driven imagery of a positive experience immediately followed by a script-driven imagery of a neutral event","No",,"No",,"No",,"Yes","No","Yes","No","No","Individual","In Person","20 Hz trains of 2 seconds each with 20 seconds inter-train interval for 42 trains, 1680 pulses total","20 minutes","Three times per week","4",,"received ≥ 8 treatment sessions",,,,,,,,,,,,"Not reported",,"23.08%","Mixed","combat-related, other (not specified)","Some Concerns","Isserles M, Shalev AY, Roth Y, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder--a pilot study. Brain Stimul. 2013 May;6(3):377-83. doi: 10.1016/j.brs.2012.07.008. PMID: 22921765.","39466","2019"
"isserles2013_C","isserles2013","Nonpharmacologic biological","2013","PTSD","Inactive Control",,"30","C","10",,"Sham DTMS with traumatic experience","Sham DTMS after script-driven imagery of the traumatic experience immediately followed by a script-driven imagery of a neutral event","DTMS after script-driven imagery of a positive experience immediately followed by a script-driven imagery of a neutral event.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","20 Hz trains of 2 seconds each with 20 seconds inter-train interval for 42 trains, 1680 pulses total","20 minutes","Three times per week","4",,"received ≥ 8 treatment sessions",,,,,,,,,,,,"Not reported",,"23.08%","Mixed","combat-related, other (not specified)","Some Concerns","Isserles M, Shalev AY, Roth Y, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder--a pilot study. Brain Stimul. 2013 May;6(3):377-83. doi: 10.1016/j.brs.2012.07.008. PMID: 22921765.","39466","2019"
"isserles2021_A","isserles2021","Nonpharmacologic biological","2021","PTSD","PTSD",,"125","A","60",,"Deep transcranial magnetic stimulation","Transcranial magnetic stimulation (TMS)","Direct transcranial magnetic stimulation after script-driven imagery of the traumatic experience immediately followed by a script-driven imagery of a neutral event","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person","18 Hz, 2-second trains, 20-second intertrain

intervals, with 80 trains at 100% of leg resting motor threshold",,"3 times a week","4",,"See Detail",,"Reports per protocol completers only, for group with post-randomization exclusions (per protocol completion 75.47%, 40/53), no information for treatment completion separately",,,,,,,,,,"Race and Ethnicity data reported","Community","66.4%","Mixed","Other (""Childhood trauma""), Other (not specified)","High","Isserles M, Tendler A, Roth Y, et al. Deep transcranial magnetic stimulation combined with brief exposure for posttraumatic stress disorder: a prospective multisite randomized trial. Biol Psychiatry. 2021 Nov 15;90(10):721-8. doi: 10.1016/j.biopsych.2021.04.019. PMID: 34274108.","1572922","2023"
"isserles2021_B","isserles2021","Nonpharmacologic biological","2021","PTSD","Active Control",,"125","B","65",,"Sham transcranial magnetic stimulation","Sham","Sham TMS","No",,"No",,"No",,"Yes","No","Yes","No","No","Individual","In Person",,,"3 times a week","4",,"See Detail",,"Reports per protocol completers only, for group with post-randomization exclusions (per protocol completion 91.07%, 51/56), no information for treatment completion separately",,,,,,,,,,"Race and Ethnicity data reported","Community","66.4%","Mixed","Other (""Childhood trauma""), Other (not specified)","High","Isserles M, Tendler A, Roth Y, et al. Deep transcranial magnetic stimulation combined with brief exposure for posttraumatic stress disorder: a prospective multisite randomized trial. Biol Psychiatry. 2021 Nov 15;90(10):721-8. doi: 10.1016/j.biopsych.2021.04.019. PMID: 34274108.","1572922","2023"
"ito2025_A","ito2025","Psychotherapy","2025","PTSD","PTSD",,"60","A","29",,"CPT + TAU","Cognitive Processing Therapy (CPT)","Manualized CPT without a trauma account, increasing standard 12 sessions to maximum 16 sessions.
TAU could include pharmacotherapy, clinical monitoring, psychoeducation, and supportive counseling, all commonly used for treating patient with PTSD in Japanese medical settings.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Weekly","16","12 to 16 weekly sessions; median treatment duration 88.9 (IQR 84.0-101.5) days","Completing ≥12 sessions",,,,,,"13.19","1.25","for treatment completers",,,,,"Community","90%","Mixed","Accidents; Illness/medical procedure; Natural or manmade disasters; Rape/sexual assault;  Community/school violence; Other (severe human suffering; sudden violent death; any other very stressful event or experience)","High","Ito M, Katayanagi A, Miyamae M, et al. Cognitive Processing Therapy for Posttraumatic Stress Disorder in Japan: A Randomized Clinical Trial. JAMA Netw Open. 2025 Feb 03;8(2):e2458059. doi: 10.1001/jamanetworkopen.2024.58059. PMID: 39908018.","1644497","2025"
"ito2025_B","ito2025","Psychotherapy","2025","PTSD","Inactive Control",,"60","B","31",,"WL + TAU","Waitlist","Waitlist participants received CPT following 17 week post-treatment assessment (during follow-up). TAU throughout study period, which could include pharmacotherapy, clinical monitoring, psychoeducation, and supportive counseling, all commonly used for treating patient with PTSD in Japanese medical settings.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Weekly","16","12 to 16 weekly sessions",,,,,,,,,,,,,,"Community","90%","Mixed","Accidents; Illness/medical procedure; Natural or manmade disasters; Rape/sexual assault;  Community/school violence; Other (severe human suffering; sudden violent death; any other very stressful event or experience)","High","Ito M, Katayanagi A, Miyamae M, et al. Cognitive Processing Therapy for Posttraumatic Stress Disorder in Japan: A Randomized Clinical Trial. JAMA Netw Open. 2025 Feb 03;8(2):e2458059. doi: 10.1001/jamanetworkopen.2024.58059. PMID: 39908018.","1644497","2025"
"ivarsson2014_A","ivarsson2014","Other study class","2014","PTSD","PTSD",,"62","A","31",,"CBT","Internet-based facilitated self-help","Guided internet-delivered CBT for PTSD: 8 text-based modules including validated components of ""psychoeducation, anxiety coping skills training, exposure, and cognitive restructuring"".","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology assisted",,,"Weekly","8",,"completed all modules",,,,,,"5.1","3.2",,,,,"Not reported","Community","82.3%","Mixed","intimate partner violence, accidents, illness/medical procedure, combat-related, natural or manmade disasters, community/school violence, other (torture, multiple stressors)","High","Ivarsson D, Blom M, Hesser H, et al. Guided internet-delivered cognitive behavior therapy for post-traumatic stress disorder: a randomized controlled trial. Internet Interv. 2014 March;1(1):33-40. doi: 10.1016/j.invent.2014.03.002.","44101","2019"
"ivarsson2014_B","ivarsson2014","Other study class","2014","PTSD","Inactive Control",,"62","B","31",,"Minimal support control","Minimal attention","Minimal support, delayed treatment control; non-passive condition comprised of voluntary participation in internet-delivered weekly sets of general questions regarding well-being, stress, and sleep. Treatment with guided internet-delivered CBT for PTSD offered after collection of post-treatment measures.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Technology alone",,,"Weekly (voluntary)","8",,,,,,,,,,,,,,"Not reported","Community","82.3%","Mixed","intimate partner violence, accidents, illness/medical procedure, combat-related, natural or manmade disasters, community/school violence, other (torture, multiple stressors)","High","Ivarsson D, Blom M, Hesser H, et al. Guided internet-delivered cognitive behavior therapy for post-traumatic stress disorder: a randomized controlled trial. Internet Interv. 2014 March;1(1):33-40. doi: 10.1016/j.invent.2014.03.002.","44101","2019"
"jacob2014_A","jacob2014","Psychotherapy","2014","PTSD","PTSD",,"76","A","38",,"NET","Narrative Exposure Therapy (NET) + Interpersonal Psychotherapy (IPT)","Combined NET with IPT. First treatment session consists of psychoeducation. NET consists of the therapist recording participant's story in writing while seeking to reactivate the associated thoughts and emotions and raise the participant's awareness of his/her concomitant bodily responses. The IPT portion targets symptoms of depression and grief related to the losses and to raise awareness about major current problems","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 to 150 minutes","Weekly","8",,"Did not drop out of therapy",,"n=1 dropped out of therapy, text states participants completed the treatment within 10 weeks, and ""The number of dropouts from therapy was low, with only 
1 orphan in each group discontinuing therapy.""",,,,,,,,,,"Not reported","Community","92.11%","Mixed","rape/sexual assault, terrorism/political violence/forced displacement","Some Concerns","Jacob N, Neuner F, Maedl A, et al. Dissemination of psychotherapy for trauma spectrum disorders in postconflict settings: a randomized controlled trial in Rwanda. Psychother Psychosom. 2014 Nov;83(6):354-63. doi: 10.1159/000365114. PMID: 25323203.","43991","2019"
"jacob2014_B","jacob2014","Psychotherapy","2014","PTSD","Inactive Control",,"76","B","38",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"8",,,,,,,,,,,,,,"Not reported","Community","92.11%","Mixed","rape/sexual assault, terrorism/political violence/forced displacement","Some Concerns","Jacob N, Neuner F, Maedl A, et al. Dissemination of psychotherapy for trauma spectrum disorders in postconflict settings: a randomized controlled trial in Rwanda. Psychother Psychosom. 2014 Nov;83(6):354-63. doi: 10.1159/000365114. PMID: 25323203.","43991","2019"
"jahanpour2019_A","jahanpour2019","CIH","2019","PTSD","PTSD",,"60","A","30",,"Poetry therapy","Creative therapy","Reading of Persian-language poetry. Poems selected for each participant ""according to the emotional situation of a person… poems were selected based on the connection, language, poet narration, motivation and perceptible concepts for better understanding"". ""Poems were read two or three times, and patients were asked to talk about the specific concepts and semantics, communication with the poem, verse or theme. Then, they select a new arbitrary poem from the booklet. Then the sound, sensation, tone, topic and the body language were surveyed.""","No",,"No",,"Yes","Creative therapies","No","No","No","No","No","Individual","In Person",,"45 minutes","Four sessions over one week","1","Four 45 min sessions over a week, timing not otherwise described","See Detail",,"No loss to follow-up, but no information on treatment attendance or completion",,,,,,,,,,"Not reported","Community","23.3%",,,"High","Jahanpour F, Armoon B, Mozafari N, et al. The comparison of the effect of poetry therapy on anxiety and post-traumatic stress disorders in patients with myocardial infarction. J Poet Ther. 2019 Dec;32(4):214-22. doi: 10.1080/08893675.2019.1639884.","1620169","2023"
"jahanpour2019_B","jahanpour2019","CIH","2019","PTSD","Inactive Control",,"60","B","30",,"Control","Control","No intervention","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Not reported","Community","23.3%",,,"High","Jahanpour F, Armoon B, Mozafari N, et al. The comparison of the effect of poetry therapy on anxiety and post-traumatic stress disorders in patients with myocardial infarction. J Poet Ther. 2019 Dec;32(4):214-22. doi: 10.1080/08893675.2019.1639884.","1620169","2023"
"jain2020_A","jain2020","Psychotherapy","2020","PTSD","PTSD",,"26","A","13",,"STAIR-PC","Skills Training in Affect and Interpersonal Regulation (STAIR)","Five 60-min appointments during which emotion regulation and interpersonal skills, or “tools,” were flexibly selected following a strengths-based approach whereby the skills selected were those that a client already used and was effective in implementing","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour",,,"5 total sessions","Attended all 5 sessions",,"11/13",,,,,,,,,,"Race and Ethnicity data reported","Veteran","15%",,,"High","Jain S, Ortigo K, Gimeno J, Baldor DA, Weiss BJ, Cloitre M. A Randomized Controlled Trial of Brief Skills Training in Affective and Interpersonal Regulation (STAIR) for Veterans in Primary Care. J Trauma Stress. 2020 Aug;33(4):401-409. doi: 10.1002/jts.22523. Epub 2020 Jun 7. PMID: 32506563.","1554457","2022"
"jain2020_B","jain2020","Psychotherapy","2020","PTSD","Inactive Control",,"26","B","13",,"TAU","Treatment as usual (TAU)","Identifying the primary presenting problem (i.e., PTSD symptoms or depression). For depression, TAU consisted of referral to the PCMHI psychologist for brief psychotherapy to target depression or, if applicable, referral to the PCMHI psychiatrist for a medication evaluation. For PTSD symptoms, TAU involved referral to specialty mental health care (i.e., PTSD clinics).","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,,,,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","15%",,,"High","Jain S, Ortigo K, Gimeno J, Baldor DA, Weiss BJ, Cloitre M. A Randomized Controlled Trial of Brief Skills Training in Affective and Interpersonal Regulation (STAIR) for Veterans in Primary Care. J Trauma Stress. 2020 Aug;33(4):401-409. doi: 10.1002/jts.22523. Epub 2020 Jun 7. PMID: 32506563.","1554457","2022"
"jak2019_A","jak2019","Psychotherapy","2019","PTSD","Active Control",,"100","A","49",,"CPT","Cognitive Processing Therapy (CPT)","Standard CPT without trauma narrative; included education about PTSD symptoms and treatment, a brief ""Impact Statement"" and identification of distorted thoughts (""stuck points""), learning connection between thoughts and feelings, and challenging distorted thoughts and stuck points.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"60 to 75 minutes","Weekly","12",,"completed all 12 treatment sessions",,,,,,"7.39","4.92",,,,,"Race and Ethnicity data reported","Veteran","11%",,,"High","Jak AJ, Jurick S, Crocker LD, et al. SMART-CPT for veterans with comorbid post-traumatic stress disorder and history of traumatic brain injury: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):333-41. doi: 10.1136/jnnp-2018-319315. PMID: 30554135.","51464","2020"
"jak2019_B","jak2019","Psychotherapy","2019","PTSD","PTSD",,"100","B","51",,"SMART-CPT","Cognitive Processing Therapy (CPT) adapted for traumatic brain injury (TBI)","A hybrid treatment with adapted CPT components plus elements from CogSMART; adaptations were focused on TBI and cognitive complaints including psychoeducation and compensatory strategies.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 to 75 minutes","Weekly","12",,"completed all 12 treatment sessions",,,,,,"8.53","4.51",,,,,"Race and Ethnicity data reported","Veteran","11%",,,"High","Jak AJ, Jurick S, Crocker LD, et al. SMART-CPT for veterans with comorbid post-traumatic stress disorder and history of traumatic brain injury: a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):333-41. doi: 10.1136/jnnp-2018-319315. PMID: 30554135.","51464","2020"
"jalal2020_A","jalal2020","Psychotherapy & CIH","2020","PTSD","PTSD",,"30","A","14","Enrolled until 10 completed (4 dropped out)","CA-CBT","Cognitive behavioral therapy (CBT) without a trauma focus","CBT featuring education about symptoms, exposure to somatic sensations associated with PTSD, yoga-like stretching and meditation, treatmetn of somatic sensations and anxiety-type psychopathalogical processes, anger reduction, and sleep improvement; cultural adaptation included addressing cultural stigma about trauma, using non-stigmatizing local expressions, and relying on culturally appropriate metaphors, analogies, and references, and a special emphasis on somatic and sensorial experiencing.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour","Twice per week","7","14 total sessions","See Detail",,"Study continued to enroll participants until n=10 had completed treatment",,,,,,,,,,"Not reported","Community","75%",,,"High","Jalal B, Kruger Q, Hinton DE. Culturally adapted CBT (CA-CBT) for traumatised indigenous South Africans (Sepedi): a randomised pilot trial comparing CA-CBT to applied muscle relaxation. Intervention 2020;18:61-5","1587977","2022"
"jalal2020_B","jalal2020","Psychotherapy & CIH","2020","PTSD","PTSD",,"30","B","16","Enrolled until 10 completed (6 dropped out)","Applied Muscle Relaxation","Relaxation","Manualized muscle relaxation therapy; not culturally adapted","No",,"No",,"Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"1 hour","Twice per week","7","14 total sessions","See Detail",,"Study continued to enroll participants until n=10 had completed treatment",,,,,,,,,,"Not reported","Community","75%",,,"High","Jalal B, Kruger Q, Hinton DE. Culturally adapted CBT (CA-CBT) for traumatised indigenous South Africans (Sepedi): a randomised pilot trial comparing CA-CBT to applied muscle relaxation. Intervention 2020;18:61-5","1587977","2022"
"jamshidi2021_A","jamshidi2021","Psychotherapy","2021","PTSD","PTSD",,"30","A","15",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Modified Shapiro protocol for EMDR with 8 phases: history-taking and planning; introducing procedures; assessment; desensitization, addressing disturbing emotions and eliciting insights; integration of cognitive reorganisation; body scan; closure with debriefing; and reevaluation","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Twice a week","4","Total 8 sessions",,,,,,,,,,,,,"Not reported","Community","100%","Mixed","Child physical abuse; Child sexual abuse; Child other abuse","High","Jamshidi F, Rajabi S, Dehghani Y. How to heal their psychological wounds? Effectiveness of EMDR therapy on post-traumatic stress symptoms, mind-wandering and suicidal ideation in Iranian child abuse victims. Counselling & Psychotherapy Research. 2021 Jun;21(2):412-21. doi: 10.1002/capr.12339.","1556672","2023"
"jamshidi2021_B","jamshidi2021","Psychotherapy","2021","PTSD","Inactive Control",,"30","B","15",,"Waitlist","Waitlist","Waitlist, not further described","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Not reported","Community","100%","Mixed","Child physical abuse; Child sexual abuse; Child other abuse","High","Jamshidi F, Rajabi S, Dehghani Y. How to heal their psychological wounds? Effectiveness of EMDR therapy on post-traumatic stress symptoms, mind-wandering and suicidal ideation in Iranian child abuse victims. Counselling & Psychotherapy Research. 2021 Jun;21(2):412-21. doi: 10.1002/capr.12339.","1556672","2023"
"jarero2019_A","jarero2019","Psychotherapy","2019","PTSD","PTSD",,"60","A","30",,"EMDR-PRECI","Eye Movement Desensitization and Reprocessing (EMDR)","EMDR Protocol for Recent Critical Incidents and Ongoing Traumatic Stress. Three-pronged approach addressing past, present, and future. Manualized treatment with eight phases: 1) Patient history (brief description of trauma), 2) Preparation (including butterfly hug as an alternative to EMDR, and postdisaster self-soothing strategies), 3) Assessment (patient reviews adverse experience from before it began through present into future, identifying disturbing memories), 4) Desensitization (reviewing disturbing memories simultaneously with EMDR or butterfly hug), 5) Global installation (developing a positive cognition applied to the whole adverse experience), 6) Body scan, 7) Self-soothing, and 8) Standard procedures (not described).","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Twice daily","0.14","Intensive therapy, two sessions in one day","Did not drop out of treatment",,"No dropouts during study period",,,,,,,,,,"Not reported","Community","31.7%","Other","traumas experienced as first responders (e.g. witnessing deaths; witnessing victims of child physical abuse, rape/sexual assault, intimate partner violence, accidents, pregnancy loss, community/school violence, and natural or manmade disasters (fire); threat of own death in a fire)","High","Jarero I, Schnaider S, Givaudan M. Randomized controlled trial: Provision of EMDR protocol for recent critical incidents and ongoing traumatic stress to first responders. Journal of EMDR Practice and Research. 2019;13(2):100-10. doi: 10.1891/1933-3196.13.2.100.","1618469","2022"
"jarero2019_B","jarero2019","Psychotherapy","2019","PTSD","Inactive Control",,"60","B","30",,"Waitlist","Waitlist","No treatment during study, received treatment after study.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Not reported","Community","31.7%","Other","traumas experienced as first responders (e.g. witnessing deaths; witnessing victims of child physical abuse, rape/sexual assault, intimate partner violence, accidents, pregnancy loss, community/school violence, and natural or manmade disasters (fire); threat of own death in a fire)","High","Jarero I, Schnaider S, Givaudan M. Randomized controlled trial: Provision of EMDR protocol for recent critical incidents and ongoing traumatic stress to first responders. Journal of EMDR Practice and Research. 2019;13(2):100-10. doi: 10.1891/1933-3196.13.2.100.","1618469","2022"
"jensen1994_A","jensen1994","Psychotherapy","1994","PTSD","PTSD",,"25","A","13",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Treatment included 1 history-taking session and 2 EMDR sessions. Therapist instructs the participant to visualize a picture of the traumatic scene and concentrate on previously identified negative statement associated with the trauma. Then the participant simultaneously focus on  the physical sensation of anxiety and visually track therapist's finger as it moves rapidly back-and-forth, inducing saccadic eye movement. Saccades were elicited continuously until subjective units of distress reached 0.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,,"1.43",,"See Detail",,"Study reports participants completing the study, unclear if this is also treatment completion rate.",,,,,,,,,,"Not reported","Veteran","0%",,,"High","Jensen JA. An investigation of Eye Movement Desensitization Reprocessing (EMD/R) as a treatment for posttraumatic stress disorder (PTSD) symptoms of Vietnam combat veterans. Behav Ther. 1994 Spring;25(2):311-25. doi: 10.1016/S0005-7894(05)80290-4.","04669","2019"
"jensen1994_B","jensen1994","Psychotherapy","1994","PTSD","Inactive Control",,"25","B","12",,"Control","Treatment as usual (TAU)","Participants informed of their group assignment and given a list of local alternative treatment sites","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"2.5",,,,,,,,,,,,,,"Not reported","Veteran","0%",,,"High","Jensen JA. An investigation of Eye Movement Desensitization Reprocessing (EMD/R) as a treatment for posttraumatic stress disorder (PTSD) symptoms of Vietnam combat veterans. Behav Ther. 1994 Spring;25(2):311-25. doi: 10.1016/S0005-7894(05)80290-4.","04669","2019"
"jespersen2012_A","jespersen2012","CIH","2012","PTSD","PTSD",,"19","A","10",,"Relaxation music at bedtime","Relaxation","Hour-long music from MusiCure series played through speakers around special pillow","No",,"No",,"Yes","Relaxation","No","No","No","No","No","Individual","Technology alone",,"Participant's choice of 15, 30, 60, or 120 minutes","Daily","3",,"Did not drop out",,"n=1 dropped out during study; ""All participants in the intervention group reported listening to the music every night during the 3 week intervention period"", so using treatment completion = did not drop out",,,,,,,,,,"Not reported","Community","60%","Terrorism/political violence/forced displacement",,"High","Jespersen KV, Vuust P. The effect of relaxation music listening on sleep quality in traumatized refugees: a pilot study. J Music Ther. 2012;49(2):205-29.  PMID: 26753218.","1548481","2019"
"jespersen2012_B","jespersen2012","CIH","2012","PTSD","Inactive Control",,"19","B","9",,"Ergonomic pillow","Ergonomic pillow","Same ergonomic pillow as treatment group without music","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Technology alone",,,"Daily","3",,"Did not drop out",,"n=3 dropped out during study, no other part of treatment adherence described, treatment completion = did not drop out",,,,,,,,,,"Not reported","Community","60%","Terrorism/political violence/forced displacement",,"High","Jespersen KV, Vuust P. The effect of relaxation music listening on sleep quality in traumatized refugees: a pilot study. J Music Ther. 2012;49(2):205-29.  PMID: 26753218.","1548481","2019"
"jiang2023_A","jiang2023","Other mixed","2023","PTSD","PTSD",,"57","A","19","n=20 randomized (assuming 1:1:1 randomization resulted in 20:20:20 groups from n=60 randomized); 1 participant excluded for stroke progression","rTMS + brief exposure","Transcranial magnetic stimulation (TMS)","rTMS (20 minutes): Immediately after brief exposure, using MagPro instrument with ""8"" shaped coil placed parallel to scalp, stimulation to right dorsolateral prefrontal cortex. Intensity 90% of motor threshold, frequency 1 Hz; 20 seconds stimulation per minute with 40-second intervals between.

Brief exposure (3 minutes): patients recorded audio scripts describing 3 experiences: positive emotional events, neutral emotional events, and stroke events. During sessions patients in 30-second intervals first listened to stroke event script, then imagined the event, then listened to neutral script, then imagined that event.","No",,"No",,"No",,"Yes","No","No","Yes","No","Individual","In Person","1 Hz for 20 minutes","rTMS: 20 minutes

brief exposure: 3 minutes","Daily","2","5 days/week for 2 weeks (total 10 sessions)","Did not withdraw during treatment",,"n=2 withdrew during treatment, all other dropouts lost to follow-up",,,,,,,,,,"Not reported","Community","36.84%","Illness/medical procedure",,"Some Concerns","Jiang C, Li Z, Wang J, et al. Effectiveness of repetitive transcranial magnetic stimulation combined with a brief exposure procedure for post-stroke posttraumatic stress disorder. Journal of affective disorders. 2023;326:89-95. doi: 10.1016/j.jad.2023.01.096. PMID: 36717030.","1615634","2023"
"jiang2023_B","jiang2023","Other mixed","2023","PTSD","Active Control",,"57","B","18","n=20 randomized (assuming 1:1:1 randomization resulted in 20:20:20 groups from n=60 randomized); 2 participants excluded for stroke progression","rTMS alone","Transcranial magnetic stimulation (TMS)","MagPro instrument with ""8"" shaped coil placed parallel to scalp, stimulation to right dorsolateral prefrontal cortex. Intensity 90% of motor threshold, frequency 1 Hz; 20 seconds stimulation per minute with 40-second intervals between.","No",,"No",,"No",,"Yes","No","Yes","No","No","Individual","In Person","1 Hz for 20 minutes","20 minutes","Daily","2","5 days/week for 2 weeks (total 10 sessions)","Did not withdraw during treatment",,"n=2 withdrew during treatment, all other dropouts lost to follow-up",,,,,,,,,,"Not reported","Community","36.84%","Illness/medical procedure",,"Some Concerns","Jiang C, Li Z, Wang J, et al. Effectiveness of repetitive transcranial magnetic stimulation combined with a brief exposure procedure for post-stroke posttraumatic stress disorder. Journal of affective disorders. 2023;326:89-95. doi: 10.1016/j.jad.2023.01.096. PMID: 36717030.","1615634","2023"
"jiang2023_C","jiang2023","Other mixed","2023","PTSD","Inactive Control",,"57","C","20",,"Sham rTMS + exposure","Sham","Sham rTMS (20 minutes): Immediately after sham exposure, using MagPro instrument with ""8"" shaped coil placed perpendicular to scalp, ""resulting in invalid stimulation""

Sham brief exposure (3 minutes): patients recorded audio scripts describing 3 experiences: positive emotional events, neutral emotional events, and stroke events. During sessions patients in 30-second intervals first listened to positive emotional event script, then imagined the event, then listened to neutral script, then imagined that event.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"sham rTMS: 20 minutes

sham brief exposure: 3 minutes","Daily","2","5 days/week for 2 weeks (total 10 sessions)","Did not withdraw during treatment",,"n=1 withdrew during treatment, all other dropouts lost to follow-up",,,,,,,,,,"Not reported","Community","36.84%","Illness/medical procedure",,"Some Concerns","Jiang C, Li Z, Wang J, et al. Effectiveness of repetitive transcranial magnetic stimulation combined with a brief exposure procedure for post-stroke posttraumatic stress disorder. Journal of affective disorders. 2023;326:89-95. doi: 10.1016/j.jad.2023.01.096. PMID: 36717030.","1615634","2023"
"jindani2015_A","jindani2015","CIH","2015","PTSD","PTSD",,"80","A","59",,"Kundalini Yoga","Yoga","Comprehensive yoga style which incorporates traditional elements of yoga practice including postures and physical exercises, breathing techniques, meditation, cultivation of mind-body awareness, and deep relaxation. The general class structure was active warm-up and loosening exercises, yoga postures and exercises, deep supine relaxation, yoga breathing techniques, meditation, and discussion of the physical, psychological, and philosophical principles of yoga; daily home practice of 15 minutes. The program integrated guidelines for trauma sensitive yoga.","No",,"No",,"Yes","Yoga","No","No","No","No","No","Group","In Person",,"90 minutes","Weekly","8",,"completed treatment course",,,,,,,,,,,,"Not reported","Community","88.75%","Mixed","rape/sexual assault, child sexual abuse, intimate partner violence, terrorism/political violence/forced displacement, illness/medical procedure, accidents, other (emotional abuse, systemic discrimination, compassion fatigue)","High","Jindani FA, Turner N, Khalsa SBS. A yoga intervention for posttraumatic stress: a preliminary randomized control trial. Evid Based Complement Alternat Med. 2015;2015:351746. doi: 10.1155/2015/351746. PMID: 26366179.","48111","2019"
"jindani2015_B","jindani2015","CIH","2015","PTSD","Inactive Control",,"80","B","21",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"8",,"completed treatment course",,,,,,,,,,,,"Not reported","Community","88.75%","Mixed","rape/sexual assault, child sexual abuse, intimate partner violence, terrorism/political violence/forced displacement, illness/medical procedure, accidents, other (emotional abuse, systemic discrimination, compassion fatigue)","High","Jindani FA, Turner N, Khalsa SBS. A yoga intervention for posttraumatic stress: a preliminary randomized control trial. Evid Based Complement Alternat Med. 2015;2015:351746. doi: 10.1155/2015/351746. PMID: 26366179.","48111","2019"
"johnson2011_A","johnson2011","Psychotherapy","2011","PTSD","PTSD",,"70","A","35",,"Helping to Overcome PTSD through Empowerment","Cognitive behavioral therapy (CBT) without a trauma focus","Participants provided with an ""empowerment toolbox"" that includes an exhaustive list of positive coping strategies regarding safety and empowerment, managing symptoms, and improving relationships. Core modules included engagement and goal setting, psychoeducation about abuse and PTSD, safety planning, establishing trust, cognitive restructuring, managing triggers, self-soothing, establishing boundaries, anger management, and establishing long-term support. Participants who left shelter prior to completing 12 sessions were referred to treatment in community","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 to 1.5 hours","Up to twice weekly","8","12 sessions total","attending ≥5 sessions",,,,,,"6.8","4.3",,,,,"Race and Ethnicity data reported","Community","100%","Intimate partner violence",,"Some Concerns","Johnson DM, Zlotnick C, Perez SK. Cognitive behavioral treatment of PTSD in residents of battered women's shelters: results of a randomized clinical trial. J Consult Clin Psychol. 2011 Aug;79(4):542-51. doi: 10.1037/a0023822. PMID: 21787052.","37002","2019"
"johnson2011_B","johnson2011","Psychotherapy","2011","PTSD","Inactive Control",,"70","B","35",,"Standard shelter service","Treatment as usual (TAU)","Provided referrals to treatment in community","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"12",,,,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Intimate partner violence",,"Some Concerns","Johnson DM, Zlotnick C, Perez SK. Cognitive behavioral treatment of PTSD in residents of battered women's shelters: results of a randomized clinical trial. J Consult Clin Psychol. 2011 Aug;79(4):542-51. doi: 10.1037/a0023822. PMID: 21787052.","37002","2019"
"johnson2020_A","johnson2020","Psychotherapy","2020","PTSD","PTSD",,"172","A","83",,"Helping to Overcome PTSD through Empowerment","Cognitive behavioral therapy (CBT) without a trauma focus","Short-term, present-centered, cognitive behavioral treatment designed for women in IPV shelters. Focuses on safety, self-care, and empowerment rather than recall and processing of trauma-related memories. Intervention begins in shelter and continues after residents leave shelter.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"50 to 60 minutes","At least weekly in shelter, at least bi-weekly post-shelter",,"up to 16 sessions total; up to 10 sessions over 10 weeks while in shelter, with remainder in the 3 months post-shelter; monthly booster sessions in shelter if stay >10 weeks","Attending ≥8 sessions",,,,,,"8.86","6.17",,,,,"Race and Ethnicity data reported","Community","100%","Intimate partner violence",,"Low","Johnson DM, Zlotnick C, Hoffman L, et al. A randomized controlled trial comparing HOPE treatment and present-centered therapy in women residing in shelter with PTSD from intimate partner violence. Psychol Women Q. 2020 Dec;44(4):539-53. doi: 10.1177/0361684320953120","1558706","2022"
"johnson2020_B","johnson2020","Psychotherapy","2020","PTSD","Active Control",,"172","B","89",,"PCT+","Present-Centered Therapy (PCT)","Problem-focused, supportive therapy used as an attention-matched control condition. PCT+ is a version of PCT adapted for IPV victims to include safety planning. Intervention begins in shelter and continues after residents leave shelter.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"50 to 60 minutes","At least weekly in shelter, at least bi-weekly post-shelter",,"up to 16 sessions total; up to 10 sessions over 10 weeks while in shelter, with remainder in the 3 months post-shelter; monthly booster sessions in shelter if stay >10 weeks","Attending ≥8 sessions",,,,,,"10.06","5.82",,,,,"Race and Ethnicity data reported","Community","100%","Intimate partner violence",,"Low","Johnson DM, Zlotnick C, Hoffman L, et al. A randomized controlled trial comparing HOPE treatment and present-centered therapy in women residing in shelter with PTSD from intimate partner violence. Psychol Women Q. 2020 Dec;44(4):539-53. doi: 10.1177/0361684320953120","1558706","2022"
"jung2013_A","jung2013","Psychotherapy","2013","PTSD","PTSD",,"34","A","17",,"CR and Imagery Modification","Cognitive restructuring and imagery modification","Therapy comprised of one treatment session and one booster session. Participants instructed to research skin cell rebuilding to see that dermal cells in trauma-related body region have been rebuilt completely since last contact with perpetrator. Then therapist confronts patient with her own ideas on contamination, and develop an idiosyncratic imagery representing the process of skin or cell renewal.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"Treatment session 90 minutes, booster session 50 minutes","Weekly","2","treatment session was one week after pre-treatment assessment; booster session administered one week after the treatment session","Treatment completion",,"no patient dropped out of treatment, n=2 were nonstarters; treatment completion at t2 (5 weeks after study intake)",,,,,,,,,,"Race data reported","Community","100%","Child sexual abuse",,"Some Concerns","Jung K, Steil R. A randomized controlled trial on cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse suffering from posttraumatic stress disorder. Psychother Psychosom. 2013 Jun;82(4):213-20. doi: 10.1159/000348450. PMID: 23712073.","41611","2019"
"jung2013_B","jung2013","Psychotherapy","2013","PTSD","Inactive Control",,"34","B","17",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"2",,,,,,,,,,,,,,"Race data reported","Community","100%","Child sexual abuse",,"Some Concerns","Jung K, Steil R. A randomized controlled trial on cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse suffering from posttraumatic stress disorder. Psychother Psychosom. 2013 Jun;82(4):213-20. doi: 10.1159/000348450. PMID: 23712073.","41611","2019"
"kanaan2023_A","kanaan2023","Pharmacotherapy","2023","PTSD","PTSD",,"104","A","52",,"N-acetylcysteine (NAC) + TAU","N-acetylcysteine","NAC: total 2.7 g/day NAC adjunctive to TAU. Drug initially supplied as effervescent tablets, later as capsules. TAU not further described.","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","Mixed","900 mg",,"Three times daily","12",,,,,,,,,,,,,,"Not reported","Community","57.69%",,,"Low","Kanaan RA, Oliver G, Dharan A, et al. A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial of adjunctive N-Acetylcysteine for treatment-resistant PTSD. Psychiatry Res. 2023 Sep;327:115398. doi: 10.1016/j.psychres.2023.115398. PMID: 37540942.","1623513","2024"
"kanaan2023_B","kanaan2023","Pharmacotherapy","2023","PTSD","Inactive Control",,"104","B","52","53 randomized, 1 later excluded who did not meet CAPS criteria (protocol violation)","Placebo + TAU","Placebo","Placebo: adjunctive to TAU. Initially supplied as effervescent tablets matching NAC tablets. Placebo formulation after switch to NAC capsules not described. ""Placebo containers were specially treated with microgram levels of NAC dust to mask its characteristic smell."" TAU not further described.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Mixed","Matched placebo",,"Three times daily","12",,,,,,,,,,,,,,"Not reported","Community","57.69%",,,"Low","Kanaan RA, Oliver G, Dharan A, et al. A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial of adjunctive N-Acetylcysteine for treatment-resistant PTSD. Psychiatry Res. 2023 Sep;327:115398. doi: 10.1016/j.psychres.2023.115398. PMID: 37540942.","1623513","2024"
"kaplan1996_A","kaplan1996","Pharmacotherapy","1996","PTSD","PTSD",,"17","A",,,"Inositol","Inositol","Glucose isomer that ""can affect the function of several neurotransmitters including serotonin;"" given in powder form, patients instructed to take in juice or tea.","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","6 grams (2 teaspoons)",,"Twice daily","4",,,,,,,,,,,,,,"Not reported","Community","38.46%","Mixed","combat-related, accidents, community/school violence, other (not specified)","High","Kaplan Z, Amir M, Swartz M, et al. Inositol treatment of post-traumatic stress disorder. Anxiety. 1996;2(1):51-2. doi: 10.1002/(SICI)1522-7154(1996)2:1<51::AID-ANXI8>3.0.CO;2-G. PMID: 9160600.","06980","2019"
"kaplan1996_B","kaplan1996","Pharmacotherapy","1996","PTSD","Inactive Control",,"17","B",,,"Placebo","Placebo","Glucose; in powder form of similar taste and texture to inositol; patients



instructed to take two teaspoons twice a day in juice or tea (12 grams/day).","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","12 grams",,"Daily","4",,,,,,,,,,,,,,"Not reported","Community","38.46%","Mixed","combat-related, accidents, community/school violence, other (not specified)","High","Kaplan Z, Amir M, Swartz M, et al. Inositol treatment of post-traumatic stress disorder. Anxiety. 1996;2(1):51-2. doi: 10.1002/(SICI)1522-7154(1996)2:1<51::AID-ANXI8>3.0.CO;2-G. PMID: 9160600.","06980","2019"
"karatzias2011_A","karatzias2011","Psychotherapy & CIH","2011","PTSD","PTSD",,"46","A","23",,"Emotional Freedom Technique","Emotional Freedom Technique (EFT)","Therapist lightly stimulate endpoints of traditional acupuncture meridians on the face, upper body, and hands, while patients focus on the traumatic event","No",,"No",,"Yes","Energy therapies","No","No","No","No","No","Individual","In Person",,"1 hour",,,,"See Detail",,"Study reports as attrition, unclear if attrition from measurement or from treatment; number is same for 'dropout' and 'failed to attend post-assessment'",,,,"3.8","2.6",,,,,"Not reported","Community","56.52%","Mixed","accidents, community/school violence, other (not specified)","Some Concerns","Karatzias A, Power KG, Brown KW, et al. A controlled comparison of the effectiveness and efficiency of two psychological therapies for posttraumatic stress disorder: Eye Movement Desensitization and Reprocessing vs. Emotional Freedom Techniques. J. Nerv. Ment. Dis. 2011 Jun;199(6):372-8. doi: 10.1097/NMD.0b013e31821cd262. PMID: 21629014.","36614","2019"
"karatzias2011_B","karatzias2011","Psychotherapy & CIH","2011","PTSD","PTSD",,"46","B","23",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","According to manual by Shapiro (2001, 2002) in which therapist utilizes bilateral stimulation while participant's attention is directed toward the traumatic event until Subjective Unit of Discomfort Scale reaches 0","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour",,,,"See Detail",,"Study reports as attrition, unclear if attrition from measurement or from treatment; number is same for 'dropout' and 'failed to attend post-assessment'",,,,"3.7","2.3",,,,,"Not reported","Community","56.52%","Mixed","accidents, community/school violence, other (not specified)","Some Concerns","Karatzias A, Power KG, Brown KW, et al. A controlled comparison of the effectiveness and efficiency of two psychological therapies for posttraumatic stress disorder: Eye Movement Desensitization and Reprocessing vs. Emotional Freedom Techniques. J. Nerv. Ment. Dis. 2011 Jun;199(6):372-8. doi: 10.1097/NMD.0b013e31821cd262. PMID: 21629014.","36614","2019"
"karatzias2019_A","karatzias2019","Psychotherapy","2019","PTSD","PTSD",,"29","A","15",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Eight-phase treatment protocol which includes components of affect management, psychoeducation, assessment of distressing memory components, bilateral stimulation to reach Subjective Units of Discomfort Scale score of 0 and Validity of Cognition Scale score of 7, and re-evaluation. The bilateral stimulation included standard light bar, tactile and auditory stimulus in order to accommodate the participants' disabilities.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour",,,"up to 8 sessions","Attended 4 or more of the 8 EMDR sessions",,"no other information on treatment completion, only assessment/study completion",,,,"3.1","2.15",,,,,"Not reported",,"62%",,,"High","Karatzias T, Brown M, Taggart L, et al. A mixed-methods, randomized controlled feasibility trial of Eye Movement Desensitization and Reprocessing (EMDR) plus Standard Care (SC) versus SC alone for DSM-5 Posttraumatic Stress Disorder (PTSD) in adults with intellectual disabilities. J Appl Res Intellect Disabil. 2019 Jul;32(4):806-18. doi: 10.1111/jar.12570. PMID: 30714684.","52277","2020"
"karatzias2019_B","karatzias2019","Psychotherapy","2019","PTSD","Inactive Control",,"29","B","14",,"Standard care","Treatment as usual (TAU)","Continuation of participants' usual psychological, psychiatric and medical care","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,,,,,,,,,,,,,,,"Not reported",,"62%",,,"High","Karatzias T, Brown M, Taggart L, et al. A mixed-methods, randomized controlled feasibility trial of Eye Movement Desensitization and Reprocessing (EMDR) plus Standard Care (SC) versus SC alone for DSM-5 Posttraumatic Stress Disorder (PTSD) in adults with intellectual disabilities. J Appl Res Intellect Disabil. 2019 Jul;32(4):806-18. doi: 10.1111/jar.12570. PMID: 30714684.","52277","2020"
"karatzias2024_A","karatzias2024","Psychotherapy","2024","PTSD","PTSD",,"56","A","28",,"Enhanced Skills Training in Affective and Interpersonal Regulation (STAIR)","Skills Training in Affect and Interpersonal Regulation (STAIR)","Enhanced STAIR; modular intervention guided by measurement-based assessment of symptoms, with a formulation session plus 4 modules each addressing the different symptom clusters of CPTSD. Four modules focused on 1) affective dysregulation (6 sessions), 2) disturbances in relationships (6 sessions), 3) negative self-concept (5 sessions), and 4) PTSD (7 sessions). ""The PTSD module focuses on emotional processing of trauma memories through verbal narration and cognitive reappraisal and targets reexperiencing, avoidance, and hyperarousal symptoms.""
Participants assessed at end of each module with ITQ, continued to next module if not CPTSD diagnosis free; if diagnosis free then offered post-treatment assessment.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,,"25","post-treatment = week 25; participants could complete treatment early if diagnosis free at end of given module","Completing all 4 modules (80% or more of treatment)",,"Treatment dropout defined as leaving treatment before all 4 modules completed (80% of treatment)",,,,,,,,,,,"Veteran","7.1%","Mixed","Combat-related; Other (""assault with a weapon"", ""fire or explosion"", ""sudden violent death"", ""exposure to a war zone"", ""any other very stressful event or experience"")","High","Karatzias T, Shevlin M, Cloitre M, Busuttil W, Graham K, Hendrikx L, Hyland P, Biscoe N, Murphy D. Enhanced Skills Training in Affective and Interpersonal Regulation versus Treatment as Usual for ICD-11 Complex PTSD: A Pilot Randomised Controlled Trial (The RESTORE Trial). Psychother Psychosom. 2024;93(3):203-215. doi: 10.1159/000538428. Epub 2024 Apr 30. PMID: 38688242; PMCID: PMC11152001.","1633817","2025"
"karatzias2024_B","karatzias2024","Psychotherapy","2024","PTSD","Active Control",,"56","B","28",,"Treatment as usual (TAU)","Treatment as usual (TAU)","Mental health assessment followed by a treatment package including psychoeducation, symptom management, and/or active monitoring. Interventions received: most (82%) received individual or group therapy (one participant received EMDR, no other participants received trauma-focused therapy), or active monitoring (but no active intervention; 18%).","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"25","post-treatment = week 25","Completing 24 weeks of treatment",,"Treatment dropout defined as leaving  before 24 weeks of treatment had been completed.",,,,,,,,,,,"Veteran","7.1%","Mixed","Combat-related; Other (""assault with a weapon"", ""fire or explosion"", ""sudden violent death"", ""exposure to a war zone"", ""any other very stressful event or experience"")","High","Karatzias T, Shevlin M, Cloitre M, Busuttil W, Graham K, Hendrikx L, Hyland P, Biscoe N, Murphy D. Enhanced Skills Training in Affective and Interpersonal Regulation versus Treatment as Usual for ICD-11 Complex PTSD: A Pilot Randomised Controlled Trial (The RESTORE Trial). Psychother Psychosom. 2024;93(3):203-215. doi: 10.1159/000538428. Epub 2024 Apr 30. PMID: 38688242; PMCID: PMC11152001.","1633817","2025"
"katz1994_A","katz1994","Pharmacotherapy","1994","PTSD","PTSD",,"64","A","33",,"Brofaromine","Brofaromine","MAOI; 2-week placebo run-in, responders excluded; titrated to maximum 3 tablets (150 mg) based on physician's judgment of best dose","No",,"Yes","Antidepressant: MAOI","No",,"No","No","No","No","No","Individual","In Person","50 to 150 mg (total daily dose); titration: initiated at 50 mg/day, maximum daily dose of 150 mg",,"Twice daily","up to 14",,,,,,,,,,,"Modal dose 2 tablets (100 mg/day)",,,"Not reported","Community","24.44%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (not specified)","High","Katz RJ, Lott MH, Arbus P, et al. Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic. Anxiety. 1994;1(4):169-74.  PMID: 9160569.","05306","2019"
"katz1994_B","katz1994","Pharmacotherapy","1994","PTSD","Inactive Control",,"64","B","31",,"Placebo","Placebo","After single-blind 2-week placebo run-in, responders excluded; double-blind phase started with one tablet/day identical to active treatment, titrated to maximum 3 tablets based on physician's judgment of best dose","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","up to 14",,,,,,,,,,,,,"Modal dose = 2 tablets","Not reported","Community","24.44%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (not specified)","High","Katz RJ, Lott MH, Arbus P, et al. Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic. Anxiety. 1994;1(4):169-74.  PMID: 9160569.","05306","2019"
"katz2014_A","katz2014","Psychotherapy","2014","PTSD","PTSD",,"51","A","17",,"Holographic reprocessing","Holographic reprocessing","Integrative treatment focusing on underlying causes or patterns of unfulfilling or abusive relationships rather than specific events. Practiced in 3 steps: 1) identifying patterns, 2) cognitive shifts and holistic reappraisals, and 3) reprocessing using imagery. Treatment included 2 to 4 reprocessing procedures.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,,,"10 sessions total",,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","100%","Mixed","MST, rape/sexual assault, child sexual abuse, intimate partner violence","High","Katz LS, Douglas S, Zaleski K, et al. Comparing holographic reprocessing and prolonged exposure for women veterans with sexual trauma: a pilot randomized trial. J Contemp Psychother. 2014 Mar;44(1):9-19. doi: 10.1007/s10879-013-9248-6.","1548483","2019"
"katz2014_B","katz2014","Psychotherapy","2014","PTSD","PTSD",,"51","B","17",,"PE","Prolonged Exposure (PE)","Therapy followed protocol by Foa et al. 2007; PE uses in vivo and imaginal exposure to enable patients to ""confront their fears and anxieties, repair a fragmented narrative, and desensitize to memories of trauma.""","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,,,"10 sessions total","completed treatment course",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","100%","Mixed","MST, rape/sexual assault, child sexual abuse, intimate partner violence","High","Katz LS, Douglas S, Zaleski K, et al. Comparing holographic reprocessing and prolonged exposure for women veterans with sexual trauma: a pilot randomized trial. J Contemp Psychother. 2014 Mar;44(1):9-19. doi: 10.1007/s10879-013-9248-6.","1548483","2019"
"katz2014_C","katz2014","Psychotherapy","2014","PTSD","Active Control",,"51","C","17",,"Person-centered therapy","Person centered Therapy","Treatment followed Rogerian supportive therapy and focuses on providing support and discussing and understanding here-and-now issues that are generated by patients; treatment included supportive listening, relaxation training, and problem solving.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,,"10 sessions total","completed treatment course",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","100%","Mixed","MST, rape/sexual assault, child sexual abuse, intimate partner violence","High","Katz LS, Douglas S, Zaleski K, et al. Comparing holographic reprocessing and prolonged exposure for women veterans with sexual trauma: a pilot randomized trial. J Contemp Psychother. 2014 Mar;44(1):9-19. doi: 10.1007/s10879-013-9248-6.","1548483","2019"
"keane1989_A","keane1989","Psychotherapy","1989","PTSD","PTSD",,"24","A","11",,"Implosive therapy","Implosive Therapy","Treatment following therapy manual; included relaxation therapy, flooding, integration of new information or emotions evoked from imagery just presented, and intersession homework; primary focus of therapy is gradual presentation of stimulus and response of traumatic memory in the context of a supportive clinical relationship.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes",,,"14 to 16 total sessions","See Detail",,"no information reported on treatment completion, no drop outs (from assessment or treatment) reported",,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Combat-related",,"High","Keane TM, Fairbank JA, Caddell JM, et al. Implosive (flooding) therapy reduces symptoms of PTSD in Vietnam combat veterans. Behav Ther. 1989 Spring;20(2):245-60. doi: 10.1016/S0005-7894(89)80072-3.","01015","2019"
"keane1989_B","keane1989","Psychotherapy","1989","PTSD","Inactive Control",,"24","B","13",,"Waitlist","Waitlist","Waitlist participants were not prohibited from obtaining or continuing psychiatric treatment during the waiting period.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"12","minimum 3 months, average 4.5 months",,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Combat-related",,"High","Keane TM, Fairbank JA, Caddell JM, et al. Implosive (flooding) therapy reduces symptoms of PTSD in Vietnam combat veterans. Behav Ther. 1989 Spring;20(2):245-60. doi: 10.1016/S0005-7894(89)80072-3.","01015","2019"
"kearney2013_A","kearney2013","CIH","2013","PTSD","PTSD",,"47","A","25",,"MBSR","Mindfulness-based stress reduction (MBSR)","Mindfulness-based stress reduction following format developed by Kabat-Zinn, including mindfulness exercises, attentional skills, daily meditation and yoga","No",,"No",,"Yes","Meditation","No","No","No","No","No","Group","In Person",,"2.5 hours weekly plus



7 hours on 1 Saturday","Once weekly, plus 1 Saturday session","8",,"≥4 sessions",,,,,,"7","2",,,,,"Race and Ethnicity data reported","Veteran","21.28%",,,"High","Kearney DJ, McDermott K, Malte C, et al. Effects of participation in a mindfulness program for veterans with posttraumatic stress disorder: a randomized controlled pilot study. J Clin Psychol. 2013 Jan;69(1):14-27. doi: 10.1002/jclp.21911. PMID: 22930491.","39341","2019"
"kearney2013_B","kearney2013","CIH","2013","PTSD","Inactive Control",,"47","B","22",,"TAU","Treatment as usual (TAU)","Usual care without intervention from the study team","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"8",,,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","21.28%",,,"High","Kearney DJ, McDermott K, Malte C, et al. Effects of participation in a mindfulness program for veterans with posttraumatic stress disorder: a randomized controlled pilot study. J Clin Psychol. 2013 Jan;69(1):14-27. doi: 10.1002/jclp.21911. PMID: 22930491.","39341","2019"
"kearney2016_A","kearney2016","CIH","2016","PTSD","PTSD",,"55","A","26",,"MBSR + TAU","Mindfulness-based stress reduction (MBSR)","MBSR: Group course with ""instruction on mindfulness meditation practices, including body scan meditation, breathing meditation, gentle yoga, walking meditation, and loving-kindness meditation"", between-session home practice meditation using audio CD, and other homework.



TAU: continuation of ""treatment as usual without intervention from the study team""","No",,"No",,"Yes","Meditation","No","No","No","No","No","Group","In Person",,"2.5 hours (plus single 7-hour session)","Weekly","8",,"attended ≥4 classes",,,,,,"5.7",,,,,,"Race data reported","Veteran","14.55%",,,"Some Concerns","Kearney DJ, Simpson TL, Malte CA, et al. Mindfulness-based stress reduction in addition to usual care is associated with improvements in pain, fatigue, and cognitive failures among veterans with Gulf War illness. Am J Med. 2016 Feb;129(2):204-14. doi: 10.1016/j.amjmed.2015.09.015. PMID: 26519614.","45996","2020"
"kearney2016_B","kearney2016","CIH","2016","PTSD","Inactive Control",,"55","B","29",,"TAU","Treatment as usual (TAU)","Continuation of ""treatment as usual without intervention from the study team"".","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,,,,,,,,,,,,,,,"Race data reported","Veteran","14.55%",,,"Some Concerns","Kearney DJ, Simpson TL, Malte CA, et al. Mindfulness-based stress reduction in addition to usual care is associated with improvements in pain, fatigue, and cognitive failures among veterans with Gulf War illness. Am J Med. 2016 Feb;129(2):204-14. doi: 10.1016/j.amjmed.2015.09.015. PMID: 26519614.","45996","2020"
"kearney2021_A","kearney2021","Psychotherapy & CIH","2021","PTSD","PTSD",,"184","A","91",,"Loving kindness meditation","Loving kindness meditation","Group meditation sessions focused on mindfulness and loving kindness meditation, homework consisted of 30 minutes of meditation 6 days per week using compact discs and informal loving-kindness meditation practices.","No",,"No",,"Yes","Meditation","No","No","No","No","No","Group","In Person",,"90 minutes","Weekly","12",,"Completing half or more of sessions",,,,,,"7.4","4.2",,,,,"Race and Ethnicity data reported","Veteran","16.8%","Mixed","Combat-related, Rape/sexual assault, Community/school violence, Accidents, Other (sudden death; other unspecified)","Some Concerns","Kearney DJ, Malte CA, Storms M, et al. Loving-kindness meditation vs cognitive processing therapy for posttraumatic stress disorder among veterans: a randomized clinical trial. JAMA Netw Open. 2021 Apr 1;4(4):e216604. doi: 10.1001/jamanetworkopen.2021.6604. PMID: 33861329.","1568095","2022"
"kearney2021_B","kearney2021","Psychotherapy & CIH","2021","PTSD","PTSD",,"184","B","93",,"Cognitive Processing Therapy","Cognitive Processing Therapy (CPT)","Cognitive only, does not include writing a trauma narrative; based on manual for CPT and combines cognitive restructuring with emotional processing of trauma-related content. Homework consisted of worksheets and exercises for 30 minutes 6 days a week plus writing an impact statement at start and end of treatment.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"90 minutes","Weekly","12",,"Completing half or more of sessions",,,,,,"6.01","4.6",,,,,"Race and Ethnicity data reported","Veteran","16.8%","Mixed","Combat-related, Rape/sexual assault, Community/school violence, Accidents, Other (sudden death; other unspecified)","Some Concerns","Kearney DJ, Malte CA, Storms M, et al. Loving-kindness meditation vs cognitive processing therapy for posttraumatic stress disorder among veterans: a randomized clinical trial. JAMA Netw Open. 2021 Apr 1;4(4):e216604. doi: 10.1001/jamanetworkopen.2021.6604. PMID: 33861329.","1568095","2022"
"kearney2023_A","kearney2023","Psychotherapy","2023","PTSD","PTSD",,"59","A","32","n=32 randomized, n=29 with post-treatment assessment analyzed","Deep-brain reorienting (DBR)","Deep brain reorienting","Deep brain reorienting, sessions conducted over videoconferencing due to COVID-19 pandemic. DBR is a psychotherapy approach that targets the ordered neurophysiological sequence that is thought to have ocurred in response to a traumatic event and which persists when triggered. Sessions structured using Orienting-Tension-(Shock)-Affect sequence by: indentifying the target; orienting to the present; orienting to the traumatic event; tension (identify and respond); shock (with therapist guidance in response); affect (identify and process with therapist support); closure of session (address residual tension, reflect on new perspective).","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Video",,"90 minutes","Weekly","8",,"Completed treatment",,"""Attrition was minimal with one participant not completing treatment"" (completed: 31/32)",,,,,,,,,,"Race and Ethnicity data reported","Community","90.7%","Mixed","Child physical abuse; Child sexual abuse; Child other abuse; Rape/sexual assault; Illness/medical procedure;  Community/school violence; Other (""Work-related"", ""Adult - Interpersonal"")","High","Kearney BE, Corrigan FM, Frewen PA, et al. A randomized controlled trial of Deep Brain Reorienting: a neuroscientifically guided treatment for post-traumatic stress disorder. Eur J Psychotraumatol. 2023;14(2) doi: 10.1080/20008066.2023.2240691. PMID: 37581275.","1624373","2024"
"kearney2023_B","kearney2023","Psychotherapy","2023","PTSD","Inactive Control",,"59","B","27","n=27 randomized, n=25 with post-treatment assessment analyzed","Waitlist","Waitlist","Waitlist","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"8",,,,,,,,,,,,,,"Race and Ethnicity data reported","Community","90.7%","Mixed","Child physical abuse; Child sexual abuse; Child other abuse; Rape/sexual assault; Illness/medical procedure;  Community/school violence; Other (""Work-related"", ""Adult - Interpersonal"")","High","Kearney BE, Corrigan FM, Frewen PA, et al. A randomized controlled trial of Deep Brain Reorienting: a neuroscientifically guided treatment for post-traumatic stress disorder. Eur J Psychotraumatol. 2023;14(2) doi: 10.1080/20008066.2023.2240691. PMID: 37581275.","1624373","2024"
"kehleforbes2019_A","kehleforbes2019","Psychotherapy","2019","PTSD+SUD","PTSD+SUD","Integrated","183","A","95",,"Integrated MET + PE","Integrated Motivational Enhancement Therapy (MET) + Prolonged Exposure (PE)","Integrated MET and PE, in which all sessions included components of both therapies. MET: ""evidence-based, structured adaptation of motivational interviewing that encourages change through the structured assessment and feedback of SUD behaviors"". PE: ""evidence-based psychotherapy for PTSD that includes in vivo (exposure to trauma-related safe situations, objects, or people that cause distress and are avoided) and imaginal (revisiting and processing of the trauma memory) exposure"".","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","16",,"attended ≥12 sessions",,,,,,"8.35","4.15",,,,,"Race and Ethnicity data reported","Veteran","7.65%",,,"Some Concerns","Kehle-Forbes SM, Chen S, Polusny MA, et al. A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders. Drug Alcohol Depend. 2019 Dec 1;205:107647. doi: 10.1016/j.drugalcdep.2019.107647. PMID: 31675546.","1546433","2020"
"kehleforbes2019_B","kehleforbes2019","Psychotherapy","2019","PTSD+SUD","Active Control","Not integrated","183","B","88",,"Phased MET + PE","Phased Motivational Enhancement Therapy (MET) + Prolonged Exposure (PE)","Phased MET and PE. Sessions 1-4: MET content (plus health education content to balance time with integrated MET plus PE arm); sessions 5-16: PE (12 session course) with ""brief SUD-check in at the beginning of each treatment session"" (issues raised were addressed as needed using MET framework). MET: ""evidence-based, structured adaptation of motivational interviewing that encourages change through the structured assessment and feedback of SUD behaviors"". PE: ""evidence-based psychotherapy for PTSD that includes in vivo (exposure to trauma-related safe situations, objects, or people that cause distress and are avoided) and imaginal (revisiting and processing of the trauma memory) exposure"".","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Weekly","16",,"attended ≥12 sessions",,,,,,"9.16","4.55",,,,,"Race and Ethnicity data reported","Veteran","7.65%",,,"Some Concerns","Kehle-Forbes SM, Chen S, Polusny MA, et al. A randomized controlled trial evaluating integrated versus phased application of evidence-based psychotherapies for military veterans with comorbid PTSD and substance use disorders. Drug Alcohol Depend. 2019 Dec 1;205:107647. doi: 10.1016/j.drugalcdep.2019.107647. PMID: 31675546.","1546433","2020"
"kelly2021_A","kelly2021","Psychotherapy & CIH","2021","PTSD","PTSD",,"104","A","56",,"Trauma Center Trauma-Sensitive Yoga","Yoga","Trauma-focused Hatha style yoga","No",,"No",,"Yes","Yoga","No","No","No","No","No","Group","In Person",,"60 minutes","Weekly","10",,"Attending at least 7 sessions",,,,,,,,,,,,"Race data reported","Veteran","100%","MST",,"High","Kelly U, Haywood T, Segell E, et al. Trauma-sensitive yoga for post-traumatic stress disorder in women veterans who experienced military sexual trauma: interim results from a randomized controlled trial. J Altern Complement Med. 2021 Mar;27(S1):S45-S59. doi: 10.1089/acm.2020.0417. PMID: 33788599.","1567680","2022"
"kelly2021_B","kelly2021","Psychotherapy & CIH","2021","PTSD","Active Control",,"104","B","45",,"CPT","Cognitive Processing Therapy (CPT)","Manualized trauma-focused psychotherapy","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Group","In Person",,"90 minutes","Weekly","12",,"Attending at least 9 sessions",,,,,,,,,,,,"Race data reported","Veteran","100%","MST",,"High","Kelly U, Haywood T, Segell E, et al. Trauma-sensitive yoga for post-traumatic stress disorder in women veterans who experienced military sexual trauma: interim results from a randomized controlled trial. J Altern Complement Med. 2021 Mar;27(S1):S45-S59. doi: 10.1089/acm.2020.0417. PMID: 33788599.","1567680","2022"
"kent2011_A","kent2011","Psychotherapy","2011","PTSD","PTSD",,"39","A","20",,"Resilience-oriented treatment","Resilience-oriented treatment","Manualized intervention fostering resilience resources (e.g., awareness of positive emotions; social connectedness) that individuals are encouraged to draw on in later sessions when they revisit traumatic episodes or experience PTSD symptoms. Week 1 = introduction to concept of resilience; weeks 2-3 = attention to bodily sensations as sources of vitality and engagement; weeks 4-7 = building positive emotional experiences and social bonds; weeks 8-10 = revisiting stressors and traumas while tapping into positive emotional resources and social bonds developed in earlier sessions; weeks 11-12 = developing a plan to sustain change.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"90 minutes","Weekly","12",,"Received allocated intervention",,"reports ""received allocated intervention"" and ""discontinued intervention and lost to posttest"" in flow diagram, no other information on treatment completion rates",,,,"9.75","2.24",,,,,"Race data reported","Veteran","33%","Mixed","combat-related, child physical abuse, child other abuse, rape/sexual assault, accidents, community/school violence","High","Kent M, Davis MC, Stark SL, et al. A resilience-oriented treatment for posttraumatic stress disorder: results of a preliminary randomized clinical trial. J Trauma Stress. 2011 Oct;24(5):591-5. doi: 10.1002/jts.20685. PMID: 21898603.","85582","2019"
"kent2011_B","kent2011","Psychotherapy","2011","PTSD","Inactive Control",,"39","B","19",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Race data reported","Veteran","33%","Mixed","combat-related, child physical abuse, child other abuse, rape/sexual assault, accidents, community/school violence","High","Kent M, Davis MC, Stark SL, et al. A resilience-oriented treatment for posttraumatic stress disorder: results of a preliminary randomized clinical trial. J Trauma Stress. 2011 Oct;24(5):591-5. doi: 10.1002/jts.20685. PMID: 21898603.","85582","2019"
"khan2021_A","khan2021","Psychotherapy","2021","PTSD","PTSD",,"30","A","15",,"Cognitive behavioral therapy","Cognitive behavioral therapy (CBT) without a trauma focus","CBT protocol recommended by Mueser et al (2008) and Cohen, Mannarino, Kliethermes, & Murray (2012), with 8 modules: Introduction; Crisis Plan Review; Psychoeducation (Core symptoms of PTSD); Breathing retraining; Pyschoeducation (associated symptoms of PTSD); Cognitive restructuring (common styles of thinking); Cognitive restructuring (5 steps of cognitive restructuring); Generalization Training and Termination.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Weekly","14",,"See Detail",,"reports number randomized to intervention only; there was no missing data and does not report on drop outs, but does not provide any information on treatment completion",,,,,,,,,,"Not reported","Community","16.7%",,,"High","Khan A, Ullah F, Abid O, et al. Efficacy of cognitive behavioral therapy in post-traumatic stress disorder among spinal cord injury patients: a randomized controlled pilot study. J Evid Based Psychother. 2021 Sep;21(2):143-62. doi: 10.24193/jebp.2021.2.16.","1620170","2023"
"khan2021_B","khan2021","Psychotherapy","2021","PTSD","Inactive Control",,"30","B","15",,"Treatment as usual (TAU)","Treatment as usual (TAU)","Usual services and medical care, including supportive counseling and pharmacotherapy; no psychotherapeutic treatment of PTSD symptoms","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"14",,"See Detail",,"reports number randomized to intervention only; there was no missing data and does not report on drop outs, but does not provide any information on treatment completion",,,,,,,,,,"Not reported","Community","16.7%",,,"High","Khan A, Ullah F, Abid O, et al. Efficacy of cognitive behavioral therapy in post-traumatic stress disorder among spinal cord injury patients: a randomized controlled pilot study. J Evid Based Psychother. 2021 Sep;21(2):143-62. doi: 10.24193/jebp.2021.2.16.","1620170","2023"
"khan2025_A","khan2025","Psychotherapy","2025","PTSD","PTSD",,"80","A","40",,"Eye movement desensitization and reprocessing (EMDR)","Eye Movement Desensitization and Reprocessing (EMDR)","Eight-stage EMDR protocolized treatment adapted for PTSD. Number of sessions determined by therapist, considering severity of PTSD symptoms (CAPS score ≤40 routine number of sessions, CAPS ≥80 required additional sessions until condition improved), assessment, patient feedback and clinical judgment (therapist determined optimal number of sessions), and literature guidelines.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,,,"Number of sessions determined by therapist; length and frequency of sessions NR","Completed treatment",,"""all 80 patients finished therapy""",,,,,,,,,,,"Community","26.3%","Mixed","Accidents; Community/school violence; Other (""witnessed death""; NR)","Some Concerns","Khan A, Madihie AB, Ullah F, Abid O, Awan KH. A comparative exploration of eye movement desensitisation and reprocessing versus cognitive behavioural therapy for post‐traumatic stress disorder in Pakistan: Insights from a full‐fledged randomised controlled trial. Counselling and Psychotherapy Research. 2025 Mar;25(1):e12870.","1650999","2025"
"khan2025_B","khan2025","Psychotherapy","2025","PTSD","PTSD",,"80","B","40",,"Cognitive behavioral therapy (CBT)","Trauma-focused cognitive behavioral therapy (TF-CBT)","Ten-stage trauma-focused CBT protocol. Number of sessions determined by therapist, considering severity of PTSD symptoms (CAPS score ≤40 routine number of sessions, CAPS ≥80 required additional sessions until condition improved), assessment, patient feedback and clinical judgment (therapist determined optimal number of sessions), and literature guidelines.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,,,"Number of sessions determined by therapist; length and frequency of sessions NR","Completed treatment",,"""all 80 patients finished therapy""",,,,,,,,,,,"Community","26.3%","Mixed","Accidents; Community/school violence; Other (""witnessed death""; NR)","Some Concerns","Khan A, Madihie AB, Ullah F, Abid O, Awan KH. A comparative exploration of eye movement desensitisation and reprocessing versus cognitive behavioural therapy for post‐traumatic stress disorder in Pakistan: Insights from a full‐fledged randomised controlled trial. Counselling and Psychotherapy Research. 2025 Mar;25(1):e12870.","1650999","2025"
"kip2013_A","kip2013","Psychotherapy","2013","PTSD","PTSD",,"57","A","29",,"Accelerated Resolution Therapy","Accelerated Resolution Therapy (ART)","Intervention involves imaginal exposure where participants were asked to recall the traumatic event while focusing on physiological sensations, thoughts, and emotions while engaging in clinician-directed eye movements. Second phase is imagery rescripting where participant is instructed to visualize their traumatic scene and imagine changing the imagery and sensory components of the scene to anything they choose","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 to 75 minutes",,"2","2 to 5 sessions total","Completed treatment",,,,,,"3.6","1.1",,,,,"Race and Ethnicity data reported","Mixed","19.3%","Mixed","MST, combat-related, community/school violence","High","Kip KE, Rosenzweig L, Hernandez DF, et al. Randomized controlled trial of Accelerated Resolution Therapy (ART) for symptoms of combat-related post-traumatic stress disorder (PTSD). Mil Med. 2013 Dec;178(12):1298-309. doi: 10.7205/MILMED-D-13-00298. PMID: 24306011.","88001","2019"
"kip2013_B","kip2013","Psychotherapy","2013","PTSD","Inactive Control",,"57","B","28",,"Attention Control","Fitness/career assessment and planning","Fitness or career assessment and planning","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"1 hour",,"2","2 sessions total","Completed treatment",,"received allocation (attention control, no crossover)",,,,"1.71",,,,,,"Race and Ethnicity data reported","Mixed","19.3%","Mixed","MST, combat-related, community/school violence","High","Kip KE, Rosenzweig L, Hernandez DF, et al. Randomized controlled trial of Accelerated Resolution Therapy (ART) for symptoms of combat-related post-traumatic stress disorder (PTSD). Mil Med. 2013 Dec;178(12):1298-309. doi: 10.7205/MILMED-D-13-00298. PMID: 24306011.","88001","2019"
"knaevelsrud2015_A","knaevelsrud2015","Other study class","2015","PTSD","PTSD",,"159","A","79",,"Interapy","Internet-based facilitated self-help","A Dutch Internet-based CBT manual translated into Arabic and culturally adapted. Interapy consists of writing activities that include self-confrontation with traumatic event, cognitive restructuring, and social sharing. Therapists provided individually written feedback and instructions on writing assignments","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology assisted",,"45 minutes","Twice weekly","5",,"Completed intervention",,,,,,,,,,,,"Not reported","Community","72.33%","Mixed","terrorism/political violence/forced displacement, rape/sexual assault, community/school violence","High","Knaevelsrud C, Brand J, Lange A, et al. Web-based psychotherapy for posttraumatic stress disorder in war-traumatized Arab patients: randomized controlled trial. J Med Internet Res. 2015 Mar 20;17(3):e71. doi: 10.2196/jmir.3582. PMID: 25799024.","46782","2019"
"knaevelsrud2015_B","knaevelsrud2015","Other study class","2015","PTSD","Inactive Control",,"159","B","80",,"Waitlist","Waitlist","Participants did not receive intervention during 6-week waiting period","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"6",,,,"completed waiting 58.75%",,,,,,,,,,"Not reported","Community","72.33%","Mixed","terrorism/political violence/forced displacement, rape/sexual assault, community/school violence","High","Knaevelsrud C, Brand J, Lange A, et al. Web-based psychotherapy for posttraumatic stress disorder in war-traumatized Arab patients: randomized controlled trial. J Med Internet Res. 2015 Mar 20;17(3):e71. doi: 10.2196/jmir.3582. PMID: 25799024.","46782","2019"
"knaevelsrud2017_A","knaevelsrud2017","Other study class","2017","PTSD","PTSD",,"94","A","47",,"Integrative Testimonial Therapy","Internet-based facilitated self-help","Internet-based structured CBT with writing assignments that focused on resource-oriented biographical reconstruction, moderated exposure, and cognitive reconstruction. Therapists provided feedback and instructions based on a disordered-specific CBT manual.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology assisted",,"45 minutes","Twice weekly","6",,"Completed intervention",,,,,,,,,,,,"Not reported","Community","64.89%","Terrorism/political violence/forced displacement",,"High","Knaevelsrud C, Böttche M, Pietrzak RH, et al. Efficacy and feasibility of a therapist-guided internet-based intervention for older persons with childhood traumatization: a randomized controlled trial. Am J Geriatr Psychiatry. 2017 Aug;25(8):878-88. doi: 10.1016/j.jagp.2017.02.024. PMID: 28365000.","47282","2019"
"knaevelsrud2017_B","knaevelsrud2017","Other study class","2017","PTSD","Inactive Control",,"94","B","47",,"Waitlist","Waitlist","Waitlist","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"6",,,,"completed waiting period 93.62%",,,,,,,,,,"Not reported","Community","64.89%","Terrorism/political violence/forced displacement",,"High","Knaevelsrud C, Böttche M, Pietrzak RH, et al. Efficacy and feasibility of a therapist-guided internet-based intervention for older persons with childhood traumatization: a randomized controlled trial. Am J Geriatr Psychiatry. 2017 Aug;25(8):878-88. doi: 10.1016/j.jagp.2017.02.024. PMID: 28365000.","47282","2019"
"kobayashi2021_A","kobayashi2021","Other mixed","2021","PTSD","PTSD",,"27","A","13",,"Suvorexant + written narrative exposure","Suvorexant + written narrative exposure","Suvorexant: dual orexin receptor antagonist, administered 30 minutes before going to bed (10 mg for first session, 20 mg for second session).

Written narrative exposure: 30 minutes writing about index trauma with facilitator, with periodic reporting of level of distress (SUDS); sessions at 9pm and 8am for each visit, paired with suvorexant at bedtime.","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","Yes","No","Individual","In Person","10 mg at visit 4 and 20 mg at visit 5 if the visit 1 dose was tolerated",,"Weekly","2","Received medication at visit 4 and visit 5, one week apart, with final followup one week later at visit 6",,,,,,,,,,,,,"Race and Ethnicity data reported","Community","70%","Mixed","Child sexual abuse; Rape/sexual assault; Intimate partner violence; Community/school violence; Other (""sudden violent death of someone close""; ""sudden accidental death of someone close"", not specified)","Low","Kobayashi I, Mellman TA, Cannon A, et al. Blocking the orexin system following therapeutic exposure promoted between session habituation, but not PTSD symptom reduction. J Psychiatr Res. 2021 Dec 14;145:222-9. doi: 10.1016/j.jpsychires.2021.12.027. PMID: 34933185.","1585481","2023"
"kobayashi2021_B","kobayashi2021","Other mixed","2021","PTSD","Active Control",,"27","B","14",,"Placebo + written narrative exposure","Placebo + written narrative exposure","Placebo administered 30 minutes before going to bed.

Written narrative exposure: 30 minutes writing about index trauma with facilitator, with periodic reporting of level of distress (SUDS); sessions at 9pm and 8am for each visit, paired with placebo at bedtime.","No",,"No",,"No",,"No","No","Yes","Yes","No","Individual","In Person",,,"Weekly","2",,,,,,,,,,,,,,"Race and Ethnicity data reported","Community","70%","Mixed","Child sexual abuse; Rape/sexual assault; Intimate partner violence; Community/school violence; Other (""sudden violent death of someone close""; ""sudden accidental death of someone close"", not specified)","Low","Kobayashi I, Mellman TA, Cannon A, et al. Blocking the orexin system following therapeutic exposure promoted between session habituation, but not PTSD symptom reduction. J Psychiatr Res. 2021 Dec 14;145:222-9. doi: 10.1016/j.jpsychires.2021.12.027. PMID: 34933185.","1585481","2023"
"koch2020_A","koch2020","Psychotherapy","2020","PTSD","PTSD",,"44","A","22",,"Skills-Training of Affect Regulation-A Culture-sensitive Approach","Skills Training in Affect and Interpersonal Regulation (STAIR)","A manualized group treatment of refugees aiming to improve emotional understanding, clarity, and expression on the one hand and adaptive emotion regulation on the other hand; consists of 4 modules: training of emotional clarity; training of specific emotion regulation strategies; management of specific emotions; consolidation.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"90 minutes","Weekly","14",,"Completed treatment",,"Did not drop out of treatment",,,,"11.27",,"among treatment completers



Range, 7-14",,,,"Not reported","Community","0%","Mixed","Combat-related, Terrorism/political violence/forced displacement, Community/school violence, Accidents, Other (""being close to death"", ""lack of shelter"", ""lack of food and water"")","High","Koch T, Ehring T, Liedl A. Effectiveness of a transdiagnostic group intervention to enhance emotion regulation in young Afghan refugees: A pilot randomized controlled study. Behav Res Ther. 2020 Jun 27;132:103689. doi: 10.1016/j.brat.2020.103689. Epub ahead of print. PMID: 32688046.","1556201","2022"
"koch2020_B","koch2020","Psychotherapy","2020","PTSD","Inactive Control",,"44","B","22",,"Waitlist","Waitlist","Participants allowed to receive services of standard care during waiting time, such as asylum or welfare counseling; excluded if received psychological treatment","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Not reported","Community","0%","Mixed","Combat-related, Terrorism/political violence/forced displacement, Community/school violence, Accidents, Other (""being close to death"", ""lack of shelter"", ""lack of food and water"")","High","Koch T, Ehring T, Liedl A. Effectiveness of a transdiagnostic group intervention to enhance emotion regulation in young Afghan refugees: A pilot randomized controlled study. Behav Res Ther. 2020 Jun 27;132:103689. doi: 10.1016/j.brat.2020.103689. Epub ahead of print. PMID: 32688046.","1556201","2022"
"koebach2021_A","koebach2021","Psychotherapy","2021","PTSD","PTSD",,"448","A","224",,"Revised adaptation of FORNET","Narrative Exposure Therapy (NET)","Narrative exposure therapy adapted for Forensic Offender Rehabilitation (FORNET) with revision specifically for the group of former combatants in Democratic Republic of Congo. Sessions include constructing a lifeline with traumatic events, perpetrated acts, and positive events listed chronologically; discussing role change from soldier to civilian; psychoeducation including anger recognition, emotion regulation, and behavior change to abstain from violence; a buddy system for peer support; and deconstruction of recent experiences of perpetrating or avoiding violence. Both individual and group sessions included.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Mixed","In Person",,"90 to 120 minutes","Weekly","6",,"Received intervention per protocol",,"participant flow diagram, receipt of intervention reported separate from follow-up assessment",,,,,,,,,,"Not reported","Community","0%","Mixed","Combat-related; Other (not specified)","High","Koebach A, Carleial S, Elbert T, et al. Treating trauma and aggression with narrative exposure therapy in former child and adult soldiers: A randomized controlled trial in Eastern DR Congo. J Consult Clin Psychol. 2021 Mar;89(3):143-55. doi: 10.1037/ccp0000632. PMID: 33829803.","1567894","2023"
"koebach2021_B","koebach2021","Psychotherapy","2021","PTSD","Inactive Control",,"448","B","224",,"TAU","Treatment as usual (TAU)","Treatment as usual with clients receiving services from non-governmental organizations where they had been recruited. Services available depending on the organization, which could include occupational training, empathic listening, problem-solving, and practical support.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,,,"Received TAU according to the protocol of each NGO",,"participant flow diagram; text notes n=157 clients came for at least one follow-up assessment, of those 62% had met with someone, only n=6 met with the NGO",,,,,,,,,,"Not reported","Community","0%","Mixed","Combat-related; Other (not specified)","High","Koebach A, Carleial S, Elbert T, et al. Treating trauma and aggression with narrative exposure therapy in former child and adult soldiers: A randomized controlled trial in Eastern DR Congo. J Consult Clin Psychol. 2021 Mar;89(3):143-55. doi: 10.1037/ccp0000632. PMID: 33829803.","1567894","2023"
"koochaki2018_A","koochaki2018","Psychotherapy","2018","PTSD","PTSD",,"90","A","45",,"CBT for PTSD + routine care counseling","Cognitive behavioral therapy (CBT) without a trauma focus","CBT for PTSD: 6 group sessions covering topics such as psychological aspects of feelings and thoughts, signs of stress and coping techniques, and problem-solving skills.



Routine care counseling: 8 group sessions covering routine infant care.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"40 to 60 minutes","CBT for PTSD: NR
Routine care counseling: twice a week",,"total 6 sessions of CBT plus 8 sessions of routine care counseling","attend all sessions",,,,,,,,,,,,"Not reported",,"100%","Illness/medical procedure",,"High","Koochaki M, Mahmoodi Z, Esmaelzadeh–Saeieh S, et al. Effects of cognitive-behavioral counseling on posttraumatic stress disorder in mothers with infants hospitalized at neonatal intensive care units: a randomized controlled trial. Iran J Psychiatry Behav Sci. 2018;12(4):e65159. doi: 10.5812/ijpbs.65159.","1547364","2020"
"koochaki2018_B","koochaki2018","Psychotherapy","2018","PTSD","Inactive Control",,"90","B","45",,"PTSD educational packet + routine care counseling","PTSD educational packet + Treatment as usual (TAU)","PTSD educational packet: contained information on the same topics covered in the CBT for PTSD intervention; psychological aspects of feelings and thoughts, signs of stress and coping techniques, and problem-solving skills.
TAU: routine care counseling, 8 group sessions covering routine infant care.","No",,"No",,"No",,"No","No","Yes","No","No","Group","In Person",,"40 to 60 minutes","Twice a week","4",,"attend all sessions",,,,,,,,,,,,"Not reported",,"100%","Illness/medical procedure",,"High","Koochaki M, Mahmoodi Z, Esmaelzadeh–Saeieh S, et al. Effects of cognitive-behavioral counseling on posttraumatic stress disorder in mothers with infants hospitalized at neonatal intensive care units: a randomized controlled trial. Iran J Psychiatry Behav Sci. 2018;12(4):e65159. doi: 10.5812/ijpbs.65159.","1547364","2020"
"kosten1991_A","kosten1991","Pharmacotherapy","1991","PTSD","PTSD",,"60","A","19",,"Phenelzine","Phenelzine","MAO-I antidepressant; dose titrated to achieve ≥85% platelet MAO inhibition with blood tested at week 2 and one week following any dosage changes, unless limited by side effects","No",,"Yes","Antidepressant: MAOI","No",,"No","No","No","No","No","Individual","In Person","15 to 75 mg; titration: initiated at 15 mg, increased to target maximum dose of 60 to 75 mg with ≥85% platelet MAO inhibition",,"Daily","8",,,,,,,,,,,"68 mg/day (4.5 tablets)","20",,"Race data reported","Veteran","0%","Combat-related",,"High","Kosten TR, Frank JB, Dan E, et al. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis. 1991;179(6):366-70. PMID: 2051152.","02658","2019"
"kosten1991_B","kosten1991","Pharmacotherapy","1991","PTSD","PTSD",,"60","B","23",,"Imipramine","Imipramine","TCA; dose titrated to attain blood levels >150 ng/ml after a week on stable dose, with blood tested at week 2 and one week following any dosage changes, unless limited by side effects","No",,"Yes","Antidepressant: TCA","No",,"No","No","No","No","No","Individual","In Person","50 to 300 mg; titration: 50 mg initial dose increased to achieve blood levels >150 ng/ml after 1 week of stable dosing, with maximum dose of 300 mg",,"Daily","8",,,,,,,,,,,"225 mg/day (4.5 tablets)","55",,"Race data reported","Veteran","0%","Combat-related",,"High","Kosten TR, Frank JB, Dan E, et al. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis. 1991;179(6):366-70. PMID: 2051152.","02658","2019"
"kosten1991_C","kosten1991","Pharmacotherapy","1991","PTSD","Inactive Control",,"60","C","18",,"Placebo","Placebo","Placebo pills; dose (number of pills) adjusted by nonblind physician monitoring blood levels in other intervention arms","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","8",,,,,,,,,,,"4.4 tablets/day","1.4",,"Race data reported","Veteran","0%","Combat-related",,"High","Kosten TR, Frank JB, Dan E, et al. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis. 1991;179(6):366-70. PMID: 2051152.","02658","2019"
"kozel2018_A","kozel2018","Other mixed","2018","PTSD","PTSD",,"103","A","54",,"rTMS + CPT","Cognitive Processing Therapy (CPT) + Transcranial magnetic stimulation (TMS)","TMS coil positioned over the right dorsolateral prefrontal cortex.







CPT according to Resick and Schnicke (1992), a trauma-focused therapy that elicit memories of traumatic events and directly confronting conflicts and maladaptive beliefs associated with the memories","Yes","Trauma-focused","No",,"No",,"Yes","No","No","No","No","Individual","In Person","1-Hz at 110% motor threshold, 1800 pulses per treatment","rTMS: 30 minutes



CPT: 60 minutes","rTMS: once







CPT: weekly","12",,"Completed all 12 CPT sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran",,"Combat-related",,"Some Concerns","Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.","49858","2019"
"kozel2018_B","kozel2018","Other mixed","2018","PTSD","Active Control",,"103","B","46",,"Sham rTMS + CPT","Cognitive Processing Therapy (CPT) + sham","Sham TMS coil positioned over the right dorsolateral prefrontal cortex. CPT according to Resick and Schnicke (1992), a trauma-focused therapy that elicit memories of traumatic events and directly confronting conflicts and maladaptive beliefs associated with the memories","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"rTMS: 30 minutes







CPT: 60 minutes","rTMS: once







CPT: weekly","12",,"Completed all 12 CPT sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran",,"Combat-related",,"Some Concerns","Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018 Mar 15;229:506-14. doi: 10.1016/j.jad.2017.12.046. PMID: 29351885.","49858","2019"
"kozel2019_A","kozel2019","Nonpharmacologic biological","2019","PTSD","PTSD",,"35","A","17",,"rTMS 1 Hz","Transcranial magnetic stimulation (TMS)","rTMS positioned over the dorsolateral prefrontal cortex; stimulus was 1 Hz frequency, continuous for 40 minutes with total of 2400 pulses per session and total pulses over all sessions (including taper) was 86,400. Treatment outcomes were assessed at the end of 6 weeks of rTMS (30 sessions); there was an additional 3-week taper period with 6 sessions (3 in week 1, 2 in week 2, and 1 in week 3).","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person","Dose: 1 Hz continuous","Session length: 40 minutes","5 days per week","6",,"completed 30 sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","28.57%",,,"High","Kozel FA, Van Trees K, Larson V, et al. One hertz versus ten hertz repetitive TMS treatment of PTSD: a randomized clinical trial. Psychiatry Res. 2019 Mar;273:153-62. doi: 10.1016/j.psychres.2019.01.004. PMID: 30641346.","51540","2020"
"kozel2019_B","kozel2019","Nonpharmacologic biological","2019","PTSD","PTSD",,"35","B","18",,"rTMS 10 Hz","Transcranial magnetic stimulation (TMS)","rTMS positioned over the dorsolateral prefrontal cortex; stimulus was 10 Hz frequency, 4 seconds on and 36 seconds off for 40 minutes with total of 2400 pulses per session and total pulses over all sessions (including taper) was 86,400. Treatment outcomes were assessed at the end of 6 weeks of rTMS (30 sessions); there was an additional 3-week taper period with 6 sessions (3 in week 1, 2 in week 2, and 1 in week 3).","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person","Dose: 10 Hz, 4 seconds on and 36 seconds off","Session length: 40 minutes","5 days per week","6",,"completed 30 sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","28.57%",,,"High","Kozel FA, Van Trees K, Larson V, et al. One hertz versus ten hertz repetitive TMS treatment of PTSD: a randomized clinical trial. Psychiatry Res. 2019 Mar;273:153-62. doi: 10.1016/j.psychres.2019.01.004. PMID: 30641346.","51540","2020"
"krakow2000_A","krakow2000","Psychotherapy","2000","PTSD","PTSD",,"169","A","87",,"Imagery rehearsal","Imagery Rehearsal Training (IRT)","Manual-based cognitive-imagery approach where participants practice pleasant imagery exercise, learn about cognitive-behavioral tools to deal with unpleasant images, and use imagery-rehearsal technique on a single nightmare. Participants rehearse a new dream daily","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"Two 3-hour sessions, one 1-hour followup session","First 2 sessions weekly, then followup 3 weeks later","6",,"Completed treatment",,"n=43 completed the treatment program and returned the follow-up packet, plus n=7 completed treatment but did not return follow-up packet",,,,,,,,,,"Race data reported","Community","100%","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters","High","Krakow BJ, Hollifield M, Schrader R, et al. A controlled study of imagery rehearsal for chronic nightmares in sexual assault survivors with PTSD: a preliminary report. Journal of Traumatic Stress. 2000 Oct;13(4):589-609. doi: 10.1023/A:1007854015481. PMID: 11109233.","15539","2020"
"krakow2000_B","krakow2000","Psychotherapy","2000","PTSD","Inactive Control",,"169","B","82",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"24",,,,,,,,,,,,,,"Race data reported","Community","100%","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters","High","Krakow BJ, Hollifield M, Schrader R, et al. A controlled study of imagery rehearsal for chronic nightmares in sexual assault survivors with PTSD: a preliminary report. Journal of Traumatic Stress. 2000 Oct;13(4):589-609. doi: 10.1023/A:1007854015481. PMID: 11109233.","15539","2020"
"krupnick2008_A","krupnick2008","Psychotherapy","2008","PTSD","PTSD",,"48","A","32",,"IPT","Interpersonal Psychotherapy (IPT)","Intervention adapted into group format that begins with developing group cohesion, addressing relationship disputes, social deficits, role transitions, and relationship losses. Last 3 sessions focus on anticipating future problems and identifying relationship triggers that could reactivate PTSD symptoms","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"2 hours",,,"16 sessions total","Attended more than 50% of sessions",,"n=24 entered treatment, n=17 attended more than 50% of sessions",,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Mixed","child physical abuse, child sexual abuse, other (interpersonal trauma)","High","Krupnick JL, Green BL, Stockton P, et al. Group interpersonal psychotherapy for low-income women with posttraumatic stress disorder. Psychother Res. 2008 Sep;18(5):497-507. doi: 10.1080/10503300802183678. PMID: 18816001.","32335","2019"
"krupnick2008_B","krupnick2008","Psychotherapy","2008","PTSD","Inactive Control",,"48","B","16",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Mixed","child physical abuse, child sexual abuse, other (interpersonal trauma)","High","Krupnick JL, Green BL, Stockton P, et al. Group interpersonal psychotherapy for low-income women with posttraumatic stress disorder. Psychother Res. 2008 Sep;18(5):497-507. doi: 10.1080/10503300802183678. PMID: 18816001.","32335","2019"
"krupnick2017_A","krupnick2017","Other study class","2017","PTSD","PTSD",,"34","A","18",,"Warriors Internet Recovery & Education + TAU","Internet-based facilitated self-help","Adjunct writing exercises through an online portal using principles of prolonged exposure and cognitive therapy. Therapist provides general response and specific instructions for subsequent writing session.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology assisted",,,,"12","10 writing sessions, posttreatment assessment 12 weeks postbaseline",,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","8.82%","Mixed","MST, combat-related","High","Krupnick JL, Green BL, Amdur RL, et al. An internet-based writing intervention for PTSD in veterans: a feasibility and pilot effectiveness trial. Psychol Trauma. 2017 Jul;9(4):461-70. doi: 10.1037/tra0000176. PMID: 27607767.","45679","2019"
"krupnick2017_B","krupnick2017","Other study class","2017","PTSD","Inactive Control",,"34","B","16",,"TAU","Treatment as usual (TAU)",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"12","posttreatment assessment 12 weeks postbaseline",,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","8.82%","Mixed","MST, combat-related","High","Krupnick JL, Green BL, Amdur RL, et al. An internet-based writing intervention for PTSD in veterans: a feasibility and pilot effectiveness trial. Psychol Trauma. 2017 Jul;9(4):461-70. doi: 10.1037/tra0000176. PMID: 27607767.","45679","2019"
"krystal2011_A","krystal2011","Pharmacotherapy","2011","PTSD","PTSD",,"296","A","147",,"Risperidone augmentation","Risperidone","Second-generation antipsychotic; augmentation of antidepressants with or without psychotherapy; titrated over 4 weeks, with further optional 1 mg increase determined by treating investigators (blinded to study medication status).","No",,"Yes","Antipsychotic","No",,"No","No","No","No","No","Individual","In Person","1 to 4 mg; titration: initiated at 1 mg and increased in 1-mg increments weekly to 3 mg with optional increase by 1 mg to maximum of 4 mg after 4 weeks",,"Daily at bedtime","24",,,,,,,,,,,"2.74 mg",,,"Race and Ethnicity data reported","Veteran","9%","Mixed","combat-related, other (physical or sexual abuse)","Low","Krystal JH, Rosenheck RA, Cramer JA, et al. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA. 2011;306(5):493-502. doi: 10.1001/jama.2011.1080. PMID: 21813427.","36863","2019"
"krystal2011_B","krystal2011","Pharmacotherapy","2011","PTSD","Inactive Control",,"296","B","149",,"Placebo","Placebo augmentation","Matching tablets. Initiated at 1 tablet orally at bedtime and increased by 1 tablet per week to a dose of 3 tablets at bedtime. After participants received study medication for 4 weeks, investigators who were blinded to study medication status and were treating patients had the option of further increasing the dose by 1 tablet.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","Equivalent of 1 to 4 mg in placebo tablets",,"Daily at bedtime","24",,,,,,,,,,,"3.35 mg equivalent",,,"Race and Ethnicity data reported","Veteran","9%","Mixed","combat-related, other (physical or sexual abuse)","Low","Krystal JH, Rosenheck RA, Cramer JA, et al. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA. 2011;306(5):493-502. doi: 10.1001/jama.2011.1080. PMID: 21813427.","36863","2019"
"kubany2004_A","kubany2004","Psychotherapy","2004","PTSD","PTSD",,"107","A","46",,"Cognitive trauma therapy","Trauma-focused cognitive behavioral therapy (TF-CBT)","Therapy components include trauma history exploration, psychoeducation regarding exposure technique, solution-oriented attitude, coping strategies, cognitive therapy for trauma-related guilt, training on self-advocacy and empowerment","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1.5 hours (median)","Twice weekly","4 to 5.5",,"Completed all sessions",,,,,,"9.5","1.6","Completers only",,,,"Race data reported",,"100%","Intimate partner violence",,"High","Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.","26300","2019"
"kubany2004_B","kubany2004","Psychotherapy","2004","PTSD","Inactive Control",,"107","B","40",,"Waitlist","Waitlist","Therapy delayed for 6 weeks","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"6",,,,,,,,,,,,,,"Race data reported",,"100%","Intimate partner violence",,"High","Kubany ES, Hill EE, Owens JA, et al. Cognitive trauma therapy for battered women with PTSD (CTT-BW). J Consult Clin Psychol. 2004 Feb;72(1):3-18. doi: 10.1037/0022-006x.72.1.3. PMID: 14756610.","26300","2019"
"kuckertz2014_A","kuckertz2014","Nonpharmacologic cognitive","2014","PTSD","PTSD",,"37","A","20",,"Attention Bias Modification","Attention bias modification (ABM)","Each trial began with a fixation cross that appeared in the center of the computer screen for 500 millisecond The fixation cross then disappeared and was replaced by a word pair consisting of one threat and one neutral word, presented vertically in the center of the screen for 500 millisecond, with one word directly above the other. The words then disappeared and a probe (either the letter ‘E’ or the letter ‘F’) appeared in the location of one of the two words. Participants were instructed to decide whether the probe replacing the word was an ‘E’ or an ‘F’ and press the corresponding mouse button (left mouse button for ‘E’ and right mouse button for ‘F’). The letter probe remained on the screen until the participant responded. Response latencies for each participant to identify the probe were recorded from the time the probe was presented to the time participants responded. Following each response, there was a 500 millisecond interval where participants saw a blank screen before the next trial began with a fixation cross. Each session consisted of 384 trials: 48 pre-session, 288 training or control sessions, and 48 post-sessions.","Yes","Trauma-focused","No",,"No",,"No","Yes","No","No","No","Individual","In Person",,,"Daily","2",,"See Detail",,"Study reports drop out, but unclear if attrition from measurement only or also attrition from treatment",,,,"6.67","5.25",,,,,"Race and Ethnicity data reported","Active Duty Military","6.9%",,,"Some Concerns","Kuckertz JM, Amir N, Boffa JW, et al. The effectiveness of an attention bias modification program as an adjunctive treatment for post-traumatic stress disorder. Behav Res Ther. 2014 Dec;63:25-35. doi: 10.1016/j.brat.2014.09.002. PMID: 25277496.","43075","2019"
"kuckertz2014_B","kuckertz2014","Nonpharmacologic cognitive","2014","PTSD","Active Control",,"37","B","17",,"Attention Control Condition","Attention bias modification (ABM)","Identical to the Attention Bias Modification procedure with the exception that the probe replaced the threat and neutral words with equal frequency.","Yes","Trauma-focused","No",,"No",,"No","Yes","Yes","No","No","Individual","In Person",,,"Daily","2",,"See Detail",,"Study reports drop out, but unclear if attrition from measurement only or also attrition from treatment",,,,"7.24","5.72",,,,,"Race and Ethnicity data reported","Active Duty Military","6.9%",,,"Some Concerns","Kuckertz JM, Amir N, Boffa JW, et al. The effectiveness of an attention bias modification program as an adjunctive treatment for post-traumatic stress disorder. Behav Res Ther. 2014 Dec;63:25-35. doi: 10.1016/j.brat.2014.09.002. PMID: 25277496.","43075","2019"
"kuhn2017_A","kuhn2017","Other study class","2017","PTSD","PTSD",,"120","A","62",,"PTSD Coach smartphone application","Internet-based self-help","A smarphone application; skill-based, nontrauma-focused intervention that provides evidence-based tools, assessments, and psychoeducation without a structured program of use","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology alone",,"No limit","No limit","12",,"Treatment completion",,"same as did not drop out; referred to in text as treatment completers and ""PTSD Coach condition completers""",,,,"2.27","1.76","Self-reported usage (n=51, completer sample): mean 2.27 (SD 1.76) times per week",,,,"Race and Ethnicity data reported","Community","69.2%","Mixed","Rape/sexual assault; Accidents; Illness/medical procedure; Natural or manmade disasters; Combat-related; Community/school violence; Other (""other event"")","High","Kuhn ER, Kanuri N, Hoffman JE, et al. A randomized controlled trial of a smartphone app for posttraumatic stress disorder symptoms. J Consult Clin Psychol. 2017 Mar;85(3):267-73. doi: 10.1037/ccp0000163. PMID: 28221061.","47101","2024"
"kuhn2017_B","kuhn2017","Other study class","2017","PTSD","Inactive Control",,"120","B","58",,"Waitlist","Waitlist","Waitlist, received no intervention during treatment period","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"12",,,,,,,,,,,,,,"Race and Ethnicity data reported","Community","69.2%","Mixed","Rape/sexual assault; Accidents; Illness/medical procedure; Natural or manmade disasters; Combat-related; Community/school violence; Other (""other event"")","High","Kuhn ER, Kanuri N, Hoffman JE, et al. A randomized controlled trial of a smartphone app for posttraumatic stress disorder symptoms. J Consult Clin Psychol. 2017 Mar;85(3):267-73. doi: 10.1037/ccp0000163. PMID: 28221061.","47101","2024"
"lang2019_A","lang2019","CIH","2019","PTSD","PTSD",,"37","A","17",,"Compassion meditation","Compassion meditation","Adaptation of Cognitively-Based Compassion Training (CBCT®), with exercises to stabilize attention, develop present-moment



awareness, and foster compassion toward self and others. Group sessions led by a clinical psychologist, with individual daily meditation assignments.","No",,"No",,"Yes","Meditation","No","No","No","No","No","Group","In Person",,"90 minutes","Weekly","10",,"attended ≥6 group sessions",,,"for daily meditation practice, total minutes of practice recorded divided by total minutes of practice assigned",,,"7.3","3","Total minutes of practice: 689.5 (423.1), an average of 75.5% of assigned practice",,,,"Race and Ethnicity data reported","Veteran","25%","Mixed","combat-related; Accidents; Community/ school violence; Other (sudden violent death, causing serious harm to another)","High","Lang AJ, Malaktaris AL, Casmar P, et al. Compassion meditation for posttraumatic stress disorder in veterans: a randomized proof of concept study. J Trauma Stress. 2019 Apr;32(2):299-309. doi: 10.1002/jts.22397. PMID: 30929283.","51896","2020"
"lang2019_B","lang2019","CIH","2019","PTSD","Active Control",,"37","B","20",,"Veteran.calm","Relaxation","Psychoeducation about PTSD, rationale for relaxation, relaxation training including progressive muscle relaxation, and sleep hygiene. Group sessions led by a graduate student in clinical psychology, with individual daily meditation practice between sessions.","No",,"No",,"Yes","Relaxation","No","No","Yes","No","No","Group","In Person",,"90 minutes","Weekly","10",,"attended ≥6 group sessions",,,"for daily meditation practice, total minutes of practice recorded divided by total minutes of practice assigned",,,"6.7","3.5","Total minutes of practice: 524.6 (236.4), an average of 49.6% of assigned practice",,,,"Race and Ethnicity data reported","Veteran","25%","Mixed","combat-related; Accidents; Community/ school violence; Other (sudden violent death, causing serious harm to another)","High","Lang AJ, Malaktaris AL, Casmar P, et al. Compassion meditation for posttraumatic stress disorder in veterans: a randomized proof of concept study. J Trauma Stress. 2019 Apr;32(2):299-309. doi: 10.1002/jts.22397. PMID: 30929283.","51896","2020"
"langkaas2017_A","langkaas2017","Psychotherapy","2017","PTSD","PTSD",,"65","A","34",,"Imagery Rescription","Imagery rescripting","Imagery-based cognitive restructuring consisting of imaginal exposure, mastery imagery, and self-calming/self-nurturing imagery, with psychoeducation about trauma and in vivo exposure","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 to 120 minutes","Weekly","10",,"Completed allocated treatment as planned",,,,,,,,,,,,"Not reported","Community","58.46%","Mixed","rape/sexual assault, accidents, community/school violence, other (war-related)","Low","Langkaas TF, Hoffart A, Øktedalen T, et al. Exposure and non-fear emotions: a randomized controlled study of exposure-based and rescripting-based imagery in PTSD treatment. Behav Res Ther. 2017 Oct;97:33-42. doi: 10.1016/j.brat.2017.06.007. PMID: 28689041.","48570","2019"
"langkaas2017_B","langkaas2017","Psychotherapy","2017","PTSD","PTSD",,"65","B","33",,"PE","Prolonged Exposure (PE)","Trauma-focused CBT","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 to 120 minutes","Weekly","10",,"Completed allocated treatment as planned",,,,,,,,,,,,"Not reported","Community","58.46%","Mixed","rape/sexual assault, accidents, community/school violence, other (war-related)","Low","Langkaas TF, Hoffart A, Øktedalen T, et al. Exposure and non-fear emotions: a randomized controlled study of exposure-based and rescripting-based imagery in PTSD treatment. Behav Res Ther. 2017 Oct;97:33-42. doi: 10.1016/j.brat.2017.06.007. PMID: 28689041.","48570","2019"
"larsen2019b_A","larsen2019b","Nonpharmacologic cognitive","2019","PTSD","PTSD",,"29","A","11",,"Adaptive computerized working memory training (n-back)","Working memory training","Computerized working memory training, including increasingly difficult trials (1-back, 2-back, 3-back, and 4-back); training involves constant updating of information stored in working memory and shifting between visual and auditory stimuli; task utilizes 8 different faces and 8 different negative words; there were 4 trial types: face change, no word change; no face change, word change; no face change, no word change; face change, word change; sessions consisted of 20 blocks of 20 + n trials, each block lasting about 1 minute.","No",,"No",,"No",,"No","Yes","No","No","No","Individual","Technology alone",,"20 minutes","3 times per week","5","15 sessions total","Completing at least 80% of trainings",,,,,,"14.9","0.3","Mean sessions completed",,,,"Race and Ethnicity data reported","Veteran","23.8%",,,"High","Larsen SE, Lotfi S, Bennett KP, et al. A pilot randomized trial of a dual n-back emotional working memory training program for veterans with elevated PTSD symptoms. Psychiatry Res. 2019b May;275:261-8. doi: 10.1016/j.psychres.2019.02.015. PMID: 30939398.","1511510","2024"
"larsen2019b_B","larsen2019b","Nonpharmacologic cognitive","2019","PTSD","Active Control",,"29","B","10",,"Non-adaptive computerized working memory training (1-back)","Working memory training","Computerized working memory training, including only 1-back trials (without increasing difficulty); training involves constant updating of information stored in working memory and shifting between visual and auditory stimuli; task utilizes 8 different faces and 8 different negative words; there were 4 trial types: face change, no word change; no face change, word change; no face change, no word change; face change, word change; sessions consisted of 20 blocks of 20 + n trials, each block lasting about 1 minute.","No",,"No",,"No",,"No","Yes","Yes","No","No","Individual","Technology alone",,"20 minutes","3 times per week","5","15 sessions total","Completing at least 80% of trainings",,,,,,"15","0","Mean sessions completed",,,,"Race and Ethnicity data reported","Veteran","23.8%",,,"High","Larsen SE, Lotfi S, Bennett KP, et al. A pilot randomized trial of a dual n-back emotional working memory training program for veterans with elevated PTSD symptoms. Psychiatry Res. 2019b May;275:261-8. doi: 10.1016/j.psychres.2019.02.015. PMID: 30939398.","1511510","2024"
"latif2021_A","latif2021","Psychotherapy","2021","PTSD","PTSD",,"50","A","25",,"Culturally adapted trauma-focused CBT-based guided self-help","Trauma-focused cognitive behavioral therapy (TF-CBT)","Self-help facilitated by research assistants (psychologists) using a culturally sensitive self-help manual for victims of trauma (BASID Ki Kahani). The manual focuses on psychoeducation, symptom management, graded exposure, cognitive restructuring, behavioural activation, problem-solving, improving relationships and communication skills; includes stories of victims of trauma and examples from local folklore and Islamic religion. Each session included 15-20 minute overview of the content of the corresponding chapter in the manual.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,,"12","9 sessions over 12 weeks","Attending ≥6 of 9 sessions",,,,,,,,"20 attended 9 sessions, 3 attended 6 to 9 sessions, and 2 attended 3 to 6 sessions",,,,"Not reported","Community","100%","Intimate partner violence",,"High","Latif M, Husain MI, Gul M, et al. Culturally adapted trauma-focused CBT-based guided self-help (CatCBT GSH) for female victims of domestic violence in Pakistan: feasibility randomized controlled trial. Behav. 2021 Jan;49(1):50-61. doi: 10.1017/S1352465820000685. PMID: 32993831","1559302","2022"
"latif2021_B","latif2021","Psychotherapy","2021","PTSD","Inactive Control",,"50","B","25",,"Waitlist","Waitlist","Shelter residents in waitlist control group not routinely offered psychological treatment.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Not reported","Community","100%","Intimate partner violence",,"High","Latif M, Husain MI, Gul M, et al. Culturally adapted trauma-focused CBT-based guided self-help (CatCBT GSH) for female victims of domestic violence in Pakistan: feasibility randomized controlled trial. Behav. 2021 Jan;49(1):50-61. doi: 10.1017/S1352465820000685. PMID: 32993831","1559302","2022"
"lazarov2019_A","lazarov2019","Nonpharmacologic cognitive","2019","PTSD","PTSD",,"50","A","26",,"Bias-contingent attention bias modification (BC-ABM)","Attention bias modification (ABM)","ABM using a face-based variant of the dot-probe task. Training protocol consisting of 160 trials per session (120 angry-neutral and 40 neutral-neutral trials). Training was contingent on the bias measured at pre-treatment for all threat-neutral trials -- for those showing bias toward the threat the target appeared at neutral-face location, and for those showing bias away from the threat the target appeared at the threat-face location.","No",,"No",,"No",,"No","Yes","No","No","No","Individual","Technology alone",,"20 minutes","Twice a week","4","8 total sessions","Did not discontinue treatment",,,,,,,,,,,,"Not reported","Community","62%",,,"Low","Lazarov A, Suarez-Jimenez B, Abend R, et al. Bias-contingent attention bias modification and attention control training in treatment of PTSD: a randomized control trial. Psychol Med. 2018 2019-02-01;49(14):2432-40. doi: 10.1017/s0033291718003367. PMID: 30415648.","51513","2024"
"lazarov2019_B","lazarov2019","Nonpharmacologic cognitive","2019","PTSD","PTSD",,"50","B","24",,"Attention control training (ACT)","Attention bias modification (ABM)","ACT using a face-based variant of the dot-probe task. Training protocol consisting of 160 trials per session (120 angry-neutral and 40 neutral-neutral trials). The threat-face location, probe location, and probe type were fully counter-balanced with no contingency between face valence and probe location.","No",,"No",,"No",,"No","Yes","No","No","No","Individual","Technology alone",,"20 minutes","Twice a week","4","8 total sessions","Did not discontinue treatment",,,,,,,,,,,,"Not reported","Community","62%",,,"Low","Lazarov A, Suarez-Jimenez B, Abend R, et al. Bias-contingent attention bias modification and attention control training in treatment of PTSD: a randomized control trial. Psychol Med. 2018 2019-02-01;49(14):2432-40. doi: 10.1017/s0033291718003367. PMID: 30415648.","51513","2024"
"lee2002_A","lee2002","Psychotherapy","2002","PTSD","PTSD",,"27","A","12",,"SIT with PE","Stress Inoculation Training (SIT) + Prolonged Exposure (PE)","Based on Foa 1991 but reduced sessions by excluding session containing thought stopping and condensing content of first three sessions into two. Sessions included assessment, controlled breathing, education, prolonged exposure, and coping skills.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","7",,"Treatment completion",,,,,,,,,,,,"Not reported","Mixed","45.83%","Mixed","combat-related, rape/sexual assault, accidents, other (murder)","High","Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.","24570","2019"
"lee2002_B","lee2002","Psychotherapy","2002","PTSD","PTSD",,"27","B","12",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Full standard 8-phase intervention as described in Shapiro 1995. Included preparation, target memory and desensitization, debriefing, and re-evaluation.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","weekly","7",,"Treatment completion",,,,,,,,,,,,"Not reported","Mixed","45.83%","Mixed","combat-related, rape/sexual assault, accidents, other (murder)","High","Lee CW, Gavriel H, Drummond PD, et al. Treatment of PTSD: stress inoculation training with prolonged exposure compared to EMDR. J Clin Psychol. 2002 Sep;58(9):1071-89. doi: 10.1002/jclp.10039. PMID: 12209866.","24570","2019"
"leem2021_A","leem2021","Nonpharmacologic biological","2021","PTSD","PTSD",,"22","A","11",,"Neurofeedback  + psychotherapy","Neurofeedback","Neurofeedback self-regulating training using ProComp2, 2-Channel EEG System. Neurofeedback normalizes dysregulated brain activity via EEG monitoring and audio or visual signals. EEG components are recorded and fed to participants during the procedure so that the subject is aware of changes in brainwaves and the effect of training. Study used alpha-theta brainwave neurofeedback to maintain a relaxed state by strengthening alpha and theta waves and suppressing beta waves. Participants also received ""Mentalizing the Rooms of the Mind"" (a psychotherapy technique) before and after each neurofeedback session.","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person",,"50 minutes","Twice weekly","8","16 sessions","Did not discontinue intervention",,"Reports ""received allocated intervention"" (n=11, 100%) and ""discontinued intervention"" (n=0); also reports lost to follow-up (n=1)",,,,,,,,,,"Not reported","Community","89.47%","Mixed","Intimate partner violence; Accidents; Community/school violence","High","Leem J, Cheong MJ, Lee H, et al. Effectiveness, cost-utility, and safety of neurofeedback self-regulating training in patients with post-traumatic stress disorder: a randomized controlled trial. Healthcare (Basel). 2021 Oct 11;9(10):1351. doi: 10.3390/healthcare9101351. PMID: 34683031.","1581886","2023"
"leem2021_B","leem2021","Nonpharmacologic biological","2021","PTSD","Inactive Control",,"22","B","11",,"Waitlist","Waitlist","Participants visited hospital four times (at screening and during weeks 1, 4, and 8) for assesment without neurofeedback training, and week 12 for follow-up. Usual treatment allowed during this period.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"8",,,,"Reports study dropout/loss to followup (n=0), withdrawal (n=2), and ""received allocated intervention"" (n=11)",,,,,,,,,,"Not reported","Community","89.47%","Mixed","Intimate partner violence; Accidents; Community/school violence","High","Leem J, Cheong MJ, Lee H, et al. Effectiveness, cost-utility, and safety of neurofeedback self-regulating training in patients with post-traumatic stress disorder: a randomized controlled trial. Healthcare (Basel). 2021 Oct 11;9(10):1351. doi: 10.3390/healthcare9101351. PMID: 34683031.","1581886","2023"
"lehavot2021_A","lehavot2021","Other study class","2021","PTSD","PTSD",,"102","A","51",,"DElivery of Self Training and Education for Stressful Situations","Internet-based facilitated self-help","Online coach-assisted cognitive behavioral intervention tailored for women Veterans. Participants were asked to log into the website twice a week for 8 weeks and complete homework assignments; coach called participants once a week and monitored participants' progress on website. Intervention sessions included: coping skills; cognitive strategies to identify and challenge thoughts; in vivo exposures; writing about stressful daily life events; writing about a traumatic experience; relapse prevention.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology assisted",,,"Twice per week","8","8 total weeks, could be completed over 12 weeks","At least 9 of 16 sessions",,,,,,"12.9","5.3","Number of coaching calls: mean 9.2 (SD 2.7)",,,,"Race and Ethnicity data reported","Veteran","100%","Mixed","MST, Combat-related, Child physical abuse, Child sexual abuse, Rape/sexual assault, Community/school violence, Other (""other military"", ""other"" not specified)","High","Lehavot K, Millard SP, Thomas RM, Yantsides K, Upham M, Beckman K, Hamilton AB, Sadler A, Litz B, Simpson T. A randomized trial of an online, coach-assisted self-management PTSD intervention tailored for women veterans. J Consult Clin Psychol. 2021 Feb;89(2):134-142. doi: 10.1037/ccp0000556. PMID: 33705169; PMCID: PMC8238393.","1566567","2022"
"lehavot2021_B","lehavot2021","Other study class","2021","PTSD","Inactive Control",,"102","B","51",,"Phone monitoring","Attention control","Weekly calls from study coach to assess safety and symptoms while providing general support; no CBT strategies used.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Phone",,"15 minutes","Weekly","8","9 scheduled calls in 8 weeks, could be extended up to 12 weeks","At least 5 of 9 calls",,,,,,,,"Number of coaching calls: mean 9.0 (SD 1.5)",,,,"Race and Ethnicity data reported","Veteran","100%","Mixed","MST, Combat-related, Child physical abuse, Child sexual abuse, Rape/sexual assault, Community/school violence, Other (""other military"", ""other"" not specified)","High","Lehavot K, Millard SP, Thomas RM, Yantsides K, Upham M, Beckman K, Hamilton AB, Sadler A, Litz B, Simpson T. A randomized trial of an online, coach-assisted self-management PTSD intervention tailored for women veterans. J Consult Clin Psychol. 2021 Feb;89(2):134-142. doi: 10.1037/ccp0000556. PMID: 33705169; PMCID: PMC8238393.","1566567","2022"
"lehrner2021_A","lehrner2021","Psychotherapy & pharmacotherapy","2021","PTSD","PTSD",,"60","A","30",,"Hydrocortisone + PE","Prolonged Exposure (PE) + hydrocortisone","Oral hydrocortisone given 30 minutes before final eight sessions of PE, which include imaginal exposure. PE includes 12 total sessions, with exposure to trauma memories (imaginal) and avoided trauma cues (in vivo).","Yes","Trauma-focused","Yes","Steroids","No",,"No","No","No","No","No","Individual","In Person","30 mg",,,,"Hydrocortisone: one dose given 30 minutes before each of the last 8 (of 12)  PE sessions

PE: total 12 sessions","""Completed treatment"", fewer than 12 sessions considered completion if considered recovered based on self report and clinician assessment",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","10%","Other","""deployment-related""","Low","Lehrner A, Hildebrandt T, Bierer LM, et al. A randomized, double-blind, placebo-controlled trial of hydrocortisone augmentation of prolonged exposure for PTSD in U.S. combat veterans. Behav Res Ther. 2021 Sep;144:103924. doi: 10.1016/j.brat.2021.103924. PMID: 34298438.","1574125","2023"
"lehrner2021_B","lehrner2021","Psychotherapy & pharmacotherapy","2021","PTSD","Active Control",,"60","B","30",,"Placebo + PE","Prolonged Exposure (PE) + placebo","Oral placebo given 30 minutes before final eight sessions of PE, which include imaginal exposure. PE includes 12 total sessions, with exposure to trauma memories (imaginal) and avoided trauma cues (in vivo).","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,,"Placebo: one dose given 30 minutes before each of the last 8 (of 12)  PE sessions

PE: total 12 sessions","""Completed treatment"", fewer than 12 sessions considered completion if considered recovered based on self report and clinician assessment",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","10%","Other","""deployment-related""","Low","Lehrner A, Hildebrandt T, Bierer LM, et al. A randomized, double-blind, placebo-controlled trial of hydrocortisone augmentation of prolonged exposure for PTSD in U.S. combat veterans. Behav Res Ther. 2021 Sep;144:103924. doi: 10.1016/j.brat.2021.103924. PMID: 34298438.","1574125","2023"
"lely2019_A","lely2019","Psychotherapy","2019","PTSD","PTSD",,"33","A","18",,"NET","Narrative Exposure Therapy (NET)","Standardized individual treatment following manual, based on trauma-focused CBT and incorporating components of testimonial therapy. ""Session one is dedicated to psychoeducation and treatment planning. In session two, the therapist and the participant create a visual timeline of traumatic and supporting experiences and select the events for exposure. Sessions three to ten are dedicated to imaginal exposure. The last session allows for receiving the documented narration, focusing on the future and saying goodbye.""","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Every 1 to 2 weeks","11 to 22","Mean (SD): 19.00 (8.31) (total 11 sessions)",,,,,,,,,,,,,"Not reported","Community","27.27%","Mixed","intimate partner violence, terrorism/political violence/forced displacement, other (unspecified child abuse, persecution)","Some Concerns","Lely JCG, Knipscheer JW, Moerbeek M, et al. Randomised controlled trial comparing narrative exposure therapy with present-centred therapy for older patients with post-traumatic stress disorder. Br J Psychiatry. 2019 Jun;214(6):369-77. doi: 10.1192/bjp.2019.59. PMID: 30957736.","1552210","2020"
"lely2019_B","lely2019","Psychotherapy","2019","PTSD","Active Control",,"33","B","15",,"PCT","Present-Centered Therapy (PCT)","Individual, non-trauma-focused therapy following PCT protocol; includes psychoeducation and homework, ""targeting current maladaptive relational patterns by including problem-solving techniques, and helps patients to focus on the ‘here and now’.""","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Every 1 to 2 weeks","11 to 22","Mean (SD): 19.00 (8.78) (total 11 sessions)",,,,,,,,,,,,,"Not reported","Community","27.27%","Mixed","intimate partner violence, terrorism/political violence/forced displacement, other (unspecified child abuse, persecution)","Some Concerns","Lely JCG, Knipscheer JW, Moerbeek M, et al. Randomised controlled trial comparing narrative exposure therapy with present-centred therapy for older patients with post-traumatic stress disorder. Br J Psychiatry. 2019 Jun;214(6):369-77. doi: 10.1192/bjp.2019.59. PMID: 30957736.","1552210","2020"
"leong2020_A","leong2020","Nonpharmacologic biological","2020","PTSD","PTSD",,"31","A","11",,"Low-frequency repetitive transcranial magnetic stimulation (rTMS)","Transcranial magnetic stimulation (TMS)","One-Hz rTMS with 2,250 pulses over 37.5 minutes, targeting the right dorsolateral prefrontal cortex (DLPFC) using Magstim Super Rapid2 model 3910-00 device","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person","Intensity: 1 Hz for 37.5 minutes",,"Daily on weekdays","2",,"Treatment completion",,"""double-blind phase completers analyzed"" in flow diagram (double-blind phase is 2 weeks of daily treatments, 10 total), participants randomized minus discontinued intervention",,,,,,,,,,"Not reported","Community","82.76%","Mixed","Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)","Some Concerns","Leong K, Chan P, Ong L, et al. A aandomized sham-controlled trial of 1-Hz and 10-Hz repetitive transcranial magnetic stimulation (rTMS) of the right dorsolateral prefrontal cortex in civilian post-traumatic stress disorder. Can J Psychiatry. 2020 Nov;65(11):770-8. doi: 10.1177/0706743720923064. PMID: 32379487.","1576966","2020"
"leong2020_B","leong2020","Nonpharmacologic biological","2020","PTSD","PTSD",,"31","B","10",,"High-frequency rTMS","Transcranial magnetic stimulation (TMS)","10-Hz rTMS with 3,000 pulses over 37.5 minutes, targeting the right DLPFC using Magstim Super Rapid2 model 3910-00 device","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person","Intensity: 10 Hz for 37.5 minutes",,"Daily on weekdays","2",,"Treatment completion",,"""double-blind phase completers analyzed"" in flow diagram (double-blind phase is 2 weeks of daily treatments, 10 total), participants randomized minus discontinued intervention",,,,,,,,,,"Not reported","Community","82.76%","Mixed","Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)","Some Concerns","Leong K, Chan P, Ong L, et al. A aandomized sham-controlled trial of 1-Hz and 10-Hz repetitive transcranial magnetic stimulation (rTMS) of the right dorsolateral prefrontal cortex in civilian post-traumatic stress disorder. Can J Psychiatry. 2020 Nov;65(11):770-8. doi: 10.1177/0706743720923064. PMID: 32379487.","1576966","2020"
"leong2020_C","leong2020","Nonpharmacologic biological","2020","PTSD","Inactive Control",,"31","C","10",,"Sham rTMS","Sham","Sham rTMS with either 1-Hz or 10-Hz sham stimulation using a Magstim D70 model 3950-00 device, identical in appearance and producing a similar sound and vibration as the active coil, targeting the right DLPFC","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","Intensity: Sham 1 or 10 Hz for 37.5 minutes",,"Daily on weekdays","2",,"Treatment completion",,"""double-blind phase completers analyzed"" in flow diagram (double-blind phase is 2 weeks of daily treatments, 10 total), participants randomized minus discontinued intervention",,,,,,,,,,"Not reported","Community","82.76%","Mixed","Rape/sexual assault; Other (exposure to actual or threatened death or serious injury, and witnessing such incidents)","Some Concerns","Leong K, Chan P, Ong L, et al. A aandomized sham-controlled trial of 1-Hz and 10-Hz repetitive transcranial magnetic stimulation (rTMS) of the right dorsolateral prefrontal cortex in civilian post-traumatic stress disorder. Can J Psychiatry. 2020 Nov;65(11):770-8. doi: 10.1177/0706743720923064. PMID: 32379487.","1576966","2020"
"lewis2017_A","lewis2017","Other study class","2017","PTSD","PTSD",,"42","A","21",,"Internet-based guided self-help","Internet-based facilitated self-help","Interactive online program and therapist guidance. Online program consisted of 8 modules covering psychoeducation, grounding, relaxation and anxiety management, behavioral reactivation, imaginal and in-vivo exposure, cognitive therapy, and relapse prevention. Therapist guidance (face-to-face or telephone) for support, monitoring, motivation, and problem-solving; brief check-ins between appointments.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology assisted",,"Session length: therapist 30 minutes (initial appointment 1 hour)","Therapist guidance every 2 weeks, brief check-in weekly","8",,"completed all 8 modules",,,,,,,,,,,,"Not reported","Community","59.5%","Mixed","accidents, illness/medical procedure, rape/sexual assault, terrorism/political violence/forced displacement, community/school violence","Some Concerns","Lewis CE, Farewell D, Groves V, et al. Internet-based guided self-help for posttraumatic stress disorder (PTSD): randomized controlled trial. Depress Anxiety. 2017 Jun;34(6):555-65. doi: 10.1002/da.22645. PMID: 28557299.","48301","2019"
"lewis2017_B","lewis2017","Other study class","2017","PTSD","Inactive Control",,"42","B","21",,"Delayed treatment","Waitlist","Waiting period during which there was no therapist contact","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"8",,,,,,,,,,,,,,"Not reported","Community","59.5%","Mixed","accidents, illness/medical procedure, rape/sexual assault, terrorism/political violence/forced displacement, community/school violence","Some Concerns","Lewis CE, Farewell D, Groves V, et al. Internet-based guided self-help for posttraumatic stress disorder (PTSD): randomized controlled trial. Depress Anxiety. 2017 Jun;34(6):555-65. doi: 10.1002/da.22645. PMID: 28557299.","48301","2019"
"li2017_A","li2017","Pharmacotherapy","2017","PTSD","PTSD",,"72","A","36",,"Sertraline","Sertraline","SSRI, fixed-dose","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","135 mg",,"Daily","12",,,,,,,,,,,,,,"Race data reported","Mixed","12.5%","Mixed","combat-related, other (chemical burn)","Low","Li W, Ma YB, Yang Q, et al. Effect and safety of sertraline for treat posttraumatic stress disorder: a multicenter randomised controlled study. Int. J. Psychiatry Clin. Pract. 2017 Jun;21(2):151-5. doi: 10.1080/13651501.2017.1291838. PMID: 28266242.","49934","2019"
"li2017_B","li2017","Pharmacotherapy","2017","PTSD","Inactive Control",,"72","B","36",,"Placebo","Placebo","Placebo matched to sertraline (3 tablets)","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,,,,"Race data reported","Mixed","12.5%","Mixed","combat-related, other (chemical burn)","Low","Li W, Ma YB, Yang Q, et al. Effect and safety of sertraline for treat posttraumatic stress disorder: a multicenter randomised controlled study. Int. J. Psychiatry Clin. Pract. 2017 Jun;21(2):151-5. doi: 10.1080/13651501.2017.1291838. PMID: 28266242.","49934","2019"
"lian2024_A","lian2024","Psychotherapy","2024","PTSD","PTSD",,"30","A","15",,"Schema therapy","Schema therapy","Schema therapy adapted for Malaysian context. ""Schema therapy is an integrative psychotherapy which combines different aspects of cognitive-behavioural, experiential, interpersonal and psychoanalytic therapies.""  Developed as treatment for borderline personality disorder. Begins with gentle approaches and progresses to confrontational approaches depending on patient's readiness. Features include a strong emphasis on the therapeutic relationship, a focus on experiential techniques, and schema theory with ""early maladaptive schema"" and ""schema modes"" (""predominant emotional states and coping responses that occur when trauma is triggered""). Therapy for this trial was adapted for Malaysian context, by incorporating art therapy, dream work, and psychodynamic techiques.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","16","16 sessions total","Treatment completion",,"No dropouts during study period",,,,,,,,,,,"Community","100%","Mixed","Rape/sexual assault; Other (""childhood trauma"", ""relational trauma"", ""work-related trauma"", ""school-related trauma"")","Some Concerns","Lian AEZ, Chooi W-T, Bono SA. The development and the effectiveness of schema therapy on eMalaysian female young adults who experienced continuous trauma and post-traumatic stress disorder. European Journal of Trauma & Dissociation Vol 8(3), 2024, ArtID 100427. 2024 Sep;8(3). doi: 10.1016/j.ejtd.2024.100427.","1640928","2025"
"lian2024_B","lian2024","Psychotherapy","2024","PTSD","Active Control",,"30","B","15",,"Trauma-focused CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","CBT with a focus on PTSD symptoms such as ""replacing maladaptive trauma-related cognitions and trauma-related behaviours with more adaptive cognitions and behaviours"". Incorporates ""psychoeducation, relaxation skills, cognitive coping strategies such as cognitive restructuring, and exposure therapy"".","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"60 minutes","Weekly","16","16 sessions total","Treatment completion",,"1 dropout during study period",,,,,,,,,,,"Community","100%","Mixed","Rape/sexual assault; Other (""childhood trauma"", ""relational trauma"", ""work-related trauma"", ""school-related trauma"")","Some Concerns","Lian AEZ, Chooi W-T, Bono SA. The development and the effectiveness of schema therapy on eMalaysian female young adults who experienced continuous trauma and post-traumatic stress disorder. European Journal of Trauma & Dissociation Vol 8(3), 2024, ArtID 100427. 2024 Sep;8(3). doi: 10.1016/j.ejtd.2024.100427.","1640928","2025"
"lindauer2005_A","lindauer2005","Psychotherapy","2005","PTSD","PTSD",,"24","A","12",,"BEP","Brief Eclectic Psychotherapy (BEP)","Following manual by Gersons et al. 2004, includes psychoeducation, imaginal exposure, writing tasks and memorabilia, meaning and integration, and farewell ritual","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"45 to 60 minutes","Weekly","16",,"Treatment completion",,,,,,,,,,,,"Not reported","Community","54.17%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (unspecified)","High","Lindauer RJ, Gersons BP, van Meijel EP, et al. Effects of brief eclectic psychotherapy in patients with posttraumatic stress disorder: randomized clinical trial. Journal of traumatic stress. 2005 Jun;18(3):205-12. doi: 10.1002/jts.20029. PMID: 16281214.","19181","2020"
"lindauer2005_B","lindauer2005","Psychotherapy","2005","PTSD","Inactive Control",,"24","B","12",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"16",,"Treatment completion",,,,,,,,,,,,"Not reported","Community","54.17%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (unspecified)","High","Lindauer RJ, Gersons BP, van Meijel EP, et al. Effects of brief eclectic psychotherapy in patients with posttraumatic stress disorder: randomized clinical trial. Journal of traumatic stress. 2005 Jun;18(3):205-12. doi: 10.1002/jts.20029. PMID: 16281214.","19181","2020"
"lindley2007_A","lindley2007","Pharmacotherapy","2007","PTSD","PTSD",,"40","A","20",,"Topiramate","Topiramate","Anticonvulsant","No",,"Yes","Mood Stabilizer","No",,"No","No","No","No","No","Individual","In Person","25 to 100 mg (total daily dose 50 to 200 mg); titration: initiated at 25 mg twice a day and increased weekly by 50 mg/day as tolerated with maximum dose of 200 mg/day",,"Twice daily","7",,,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Combat-related",,"High","Lindley SE, Carlson EB, Hill K. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Dec;27(6):677-81. doi: 10.1097/jcp.0b013e31815a43ee. PMID: 18004136..","50965","2019"
"lindley2007_B","lindley2007","Pharmacotherapy","2007","PTSD","Inactive Control",,"40","B","20",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"7",,,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Combat-related",,"High","Lindley SE, Carlson EB, Hill K. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. J Clin Psychopharmacol. 2007 Dec;27(6):677-81. doi: 10.1097/jcp.0b013e31815a43ee. PMID: 18004136..","50965","2019"
"littleton2016_A","littleton2016","Other study class","2016","PTSD","PTSD",,"87","A","46",,"From Survivor to Thriver","Internet-based facilitated self-help","Online interactive program providing psychoeducation, distress management strategies, healthy coping skills, and cognitive behavioral techniques through video, written description of skills, and written examples modeling the skills","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology assisted",,,,"14",,"completed baseline online questionnaires and logged in to assigned program at least once",,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, intimate partner violence","High","Littleton HL, Grills AE, Kline KD, et al. The From Survivor to Thriver program: RCT of an online therapist-facilitated program for rape-related PTSD. J Anxiety Disord. 2016 Oct;43:41-51. doi: 10.1016/j.janxdis.2016.07.010. PMID: 27513363.","45583","2019"
"littleton2016_B","littleton2016","Other study class","2016","PTSD","Active Control",,"87","B","41",,"Psychoeducation website","Psychoeducation","Written information providing same psychoeducation, distress management strategies, and healthy coping skills as From Survivor to Thriver program","No",,"No",,"No",,"No","No","Yes","Yes","No","Individual","Technology alone",,,,"14",,"completed baseline online questionnaires and logged in to assigned program at least once",,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Mixed","child sexual abuse, child physical abuse, rape/sexual assault, intimate partner violence","High","Littleton HL, Grills AE, Kline KD, et al. The From Survivor to Thriver program: RCT of an online therapist-facilitated program for rape-related PTSD. J Anxiety Disord. 2016 Oct;43:41-51. doi: 10.1016/j.janxdis.2016.07.010. PMID: 27513363.","45583","2019"
"litz2007_A","litz2007","Other study class","2007","PTSD","PTSD",,"45","A","24",,"Internet-delivered self-management cognitive behavioral therapy","Internet-based self-help","Internet-based CBT teaching coping strategies through a series of homework assignments. Specific components were: self-monitoring of situations that triggered trauma-related distress; make hierarchy of triggers; stress management strategies; graduated self-guided in vivo exposure; online trauma writing sessions; review of progess, relapse prevention education.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Mixed",,,"ad lib access to website","8",,"See Detail",,"Unclear, study reports n=45 randomized and ""33 completed treatment"" but doesn't give numbers by arm (overall treatment completion rate 73.33%); table 1 has ""for completer study group"" in title but reports data for n=45 randomized",,,,"41.05","20.1","Mean times logged on",,,,"Not reported","Mixed","22.2%","Mixed","Combat-related; Terrorism/political violence/forced displacement","Some Concerns","Litz BT, Engel CC, Bryant RA, Papa A. A randomized, controlled proof-of-concept trial of an internet-based, therapist-assisted self-management treatment for posttraumatic stress disorder. Am J Psychiatry. 2007 Nov;164(11):1676-83. doi: 10.1176/appi.ajp.2007.06122057. PMID: 17974932.","30116","2024"
"litz2007_B","litz2007","Other study class","2007","PTSD","Active Control",,"45","B","21",,"Internet-delivered supportive counseling","Internet-based facilitated self-help","Internet-based supportive counseling asking participants to self-monitor non-trauma-related concerns and write about them; psychoeducation materials available but there was no skills training or prescriptions for proactive action; could request phone call from therapist, and therapist checked in by phone periodically; therapists were supportive and nondirective, focusing on non-trauma-related current concerns.","No",,"No",,"No",,"No","No","Yes","Yes","No","Individual","Mixed",,,"ad lib access to website","8",,"See Detail",,"Unclear, study reports n=45 randomized and ""33 completed treatment"" but doesn't give numbers by arm (overall treatment completion rate 73.33%); table 1 has ""for completer study group"" in title but reports data for n=45 randomized",,,,"23.63","17.52","Mean times logged on",,,,"Not reported","Mixed","22.2%","Mixed","Combat-related; Terrorism/political violence/forced displacement","Some Concerns","Litz BT, Engel CC, Bryant RA, Papa A. A randomized, controlled proof-of-concept trial of an internet-based, therapist-assisted self-management treatment for posttraumatic stress disorder. Am J Psychiatry. 2007 Nov;164(11):1676-83. doi: 10.1176/appi.ajp.2007.06122057. PMID: 17974932.","30116","2024"
"litz2012_A","litz2012","Psychotherapy & pharmacotherapy","2012","PTSD","PTSD",,"26","A","13",,"D-cycloserine + brief exposure therapy","Imaginal exposure +D-cycloserine","Partial NMDA receptor agonist, given 50 minutes before exposure therapy in sessions 2 through 5. Patients in both treatment arms received therapy; 4 of 6 total sessions included 50 minutes of imaginal exposure focused on most distressing war trauma memory.","Yes","Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","Session length: 60 to 90 minutes







Dose: 50 mg",,"Psychotherapy: NR







D-cycloserine: NR",,"Psychotherapy: 6 sessions total
D-cycloserine: 4 doses total, at sessions 2 through 5","Treatment completion",,,,,,,,,,,,"Race data reported","Veteran","0%","Combat-related",,"Low","Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.","38885","2019"
"litz2012_B","litz2012","Psychotherapy & pharmacotherapy","2012","PTSD","Active Control",,"26","B","13",,"Placebo + brief exposure therapy","Imaginal exposure (experimental paradigm)","Placebo pill given 50 minutes before exposure therapy. Patients in both treatment arms received therapy; of 6 total sessions, four included 50-minute imaginal exposure focused on most distressing war trauma memory.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person","Session length: 60 to 90 minutes







Dose: NA",,"Psychotherapy: 6 sessions, interval NR







Placebo: 4 doses, sessions 2 through 5",,"Psychotherapy: 6 sessions total
Placebo: 4 doses total, at sessions 2 through 5","Treatment completion",,,,,,,,,,,,"Race data reported","Veteran","0%","Combat-related",,"Low","Litz BT, Salters-Pedneault K, Steenkamp MM, et al. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012;46(9):1184-90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905.","38885","2019"
"litz2021_A","litz2021","Psychotherapy","2021","PTSD","PTSD",,"122","A","62",,"Adaptive Disclosure","Adaptive Disclosure (AD)","Manualized trauma-focused psychotherapy that targets danger-loss- and moral injury-related trauma using different experiental strategies. Expanded number of treatments for this study from 6 sessions to 8 sessions to equilibrate treatment hours for both interventions","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","8","expanded treatment duration so that treatment hours were equivalent for both groups (Adaptive Disclosure designed to be 6 sessions)","Did not drop out of treatment (did not miss last treatment session)",,,,,,,,"""Patients in the AD arm attended a mean of 75% of the eight sessions""",,,,"Race data reported","Active Duty Military","8.3%",,,"High","Litz BT, Rusowicz-Orazem L, Doros G, Grunthal B, Gray M, Nash W, Lang AJ. Adaptive disclosure, a combat-specific PTSD treatment, versus cognitive-processing therapy, in deployed marines and sailors: A randomized controlled non-inferiority trial. Psychiatry Res. 2021 Mar;297:113761. doi: 10.1016/j.psychres.2021.113761. Epub 2021 Jan 24. PMID: 33540206.","1564968","2022"
"litz2021_B","litz2021","Psychotherapy","2021","PTSD","PTSD",,"122","B","60",,"Cognitive Processing Therapy-Cognitive Therapy","Cognitive Processing Therapy (CPT)","Trauma-focused cognitive therapy, omitting written trauma narrative in CPT","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","12",,"Did not drop out of treatment (did not miss last treatment session)",,,,,,,,"""patients in the CPT-C arm attended a mean of 71% of the twelve sessions""",,,,"Race data reported","Active Duty Military","8.3%",,,"High","Litz BT, Rusowicz-Orazem L, Doros G, Grunthal B, Gray M, Nash W, Lang AJ. Adaptive disclosure, a combat-specific PTSD treatment, versus cognitive-processing therapy, in deployed marines and sailors: A randomized controlled non-inferiority trial. Psychiatry Res. 2021 Mar;297:113761. doi: 10.1016/j.psychres.2021.113761. Epub 2021 Jan 24. PMID: 33540206.","1564968","2022"
"litz2024_A","litz2024","Psychotherapy","2024","PTSD","PTSD",,"174","A","89",,"Adaptive Disclosure-Enhanced","Adaptive Disclosure (AD)","Manualized treatment focusing on addressing traumatic loss and moral injury. Modifications for enhanced version of adaptive disclosure included: a ""compassion history assessment"", letter-writing as a change agent, loving-kindness meditation and mindfulness training, using a personlized recovery/rehabilitation approach, and a ""Healing & Repair Plan"" for activities outside of therapy (e.g. self-care and in vivo exposure).","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12","12 sessions total","Completed all 12 sessions within 16 weeks or early completer (therapist assessed)",,"Completed 12 sessions: 62.92%
Completed ≥8 sessions: 75.28%",,,,"9.24","4.25",,,,,"Race and Ethnicity data reported","Veteran","21.3%",,,"Low","Litz BT, Yeterian J, Berke D, et al. A controlled trial of adaptive disclosure-enhanced to improve functioning and treat posttraumatic stress disorder. J Consult Clin Psychol. 2024 Mar;92(3):150-64. doi: 10.1037/ccp0000873. PMID: 38358703.","1630850","2024"
"litz2024_B","litz2024","Psychotherapy","2024","PTSD","Active Control",,"174","B","85",,"PCT","Present-Centered Therapy (PCT)","Manualized therapy including empathic reflective listening, discussion of patient's life stressors and issues, and homework using adpative responses to stressors. Discussion of traumatic events not allowed.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Weekly","12","12 sessions total","Completed all 12 sessions within 16 weeks or early completer (therapist assessed)",,"Completed 12 sessions: 58.82%
Completing ≥8 sessions: 71.76%",,,,"9.07","4.2",,,,,"Race and Ethnicity data reported","Veteran","21.3%",,,"Low","Litz BT, Yeterian J, Berke D, et al. A controlled trial of adaptive disclosure-enhanced to improve functioning and treat posttraumatic stress disorder. J Consult Clin Psychol. 2024 Mar;92(3):150-64. doi: 10.1037/ccp0000873. PMID: 38358703.","1630850","2024"
"liu2019_A","liu2019","Psychotherapy","2019","PTSD","PTSD",,"207","A","103",,"CPT by videoconference","Cognitive Processing Therapy (CPT)","Participant used videoconference equipment at a community-based outpatient clinic and the therapist was located at another VA site. CPT followed manual used by the VA (for CPT-C or cognitive-only version) which doesn't include written account of the trauma. ""Per protocol, participants were educated about PTSD symptoms, cognitive theory, and treatment goals; wrote about how traumatic experiences have influenced thoughts and beliefs about themselves, others, and the world; identified problematic thoughts (‘stuck points’) related to the traumatic event; learned how these thoughts influence emotions; and learned to challenge distorted thoughts and identify more balanced alternative thoughts.""","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Video",,"60 minutes","Weekly","12",,"completed ≥9 sessions",,,,,,"8.9","4.5",,,,,"Race and Ethnicity data reported","Veteran","22.6%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")","Some Concerns","Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.","52097","2020"
"liu2019_B","liu2019","Psychotherapy","2019","PTSD","PTSD",,"207","B","104",,"CPT in person","Cognitive Processing Therapy (CPT)","In-person CPT; therapy followed manual used by the VA (for CPT-C or cognitive-only version) which doesn't include written account of the trauma. ""Per protocol, participants were educated about PTSD symptoms, cognitive theory, and treatment goals; wrote about how traumatic experiences have influenced thoughts and beliefs about themselves, others, and the world; identified problematic thoughts (‘stuck points’) related to the traumatic event; learned how these thoughts influence emotions; and learned to challenge distorted thoughts and identify more balanced alternative thoughts.""","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","12",,"completed ≥9 sessions",,,,,,"9.7","4",,,,,"Race and Ethnicity data reported","Veteran","22.6%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unspecified type of child abuse, ""unexpected death"", ""others"")","Some Concerns","Liu L, Thorp SR, Moreno L, et al. Videoconferencing psychotherapy for veterans with PTSD: results from a randomized controlled non-inferiority trial. J Telemed Telecare. 2019 Jun 19doi: 10.1177/1357633X19853947. PMID: 31216210.","52097","2020"
"ludascher2015_A","ludascher2015","Pharmacotherapy","2015","PTSD","PTSD",,"30","A","30",,"Hydrocortisone","Hydrocortisone","Corticosteroid; placebo first week, 10 mg hydrocortisone second week, placebo third week, 30 mg hydrocortisone fourth week","No",,"Yes","Steroids","No",,"No","No","No","No","No","Individual","In Person","10 mg",,"Once daily","4","each dose taken for 1 week, followed by placebo for 1 week",,,,,,,,,,,,,"Not reported","Community","100%","Mixed","child sexual abuse, rape/sexual assault, child physical abuse, child other abuse","Some Concerns","Ludascher P, Schmahl C, Feldmann RE, Jr., et al. No evidence for differential dose effects of hydrocortisone on intrusive memories in female patients with complex post-traumatic stress disorder--a randomized, double-blind, placebo-controlled, crossover study. J Psychopharmacol. 2015 Oct;29(10):1077-84. doi: 10.1177/0269881115592339. PMID: 26152322.","49607","2019"
"ludascher2015_B","ludascher2015","Pharmacotherapy","2015","PTSD","PTSD",,"30","B","30",,"Hydrocortisone","Hydrocortisone","Corticosteroid; 30 mg hydrocortisone first week, placebo second week, 10 mg hydrocortisone third week, placebo fourth week","No",,"Yes","Steroids","No",,"No","No","No","No","No","Individual","In Person","30 mg",,"Once daily","4","each dose taken for 1 week, followed by placebo for 1 week",,,,,,,,,,,,,"Not reported","Community","100%","Mixed","child sexual abuse, rape/sexual assault, child physical abuse, child other abuse","Some Concerns","Ludascher P, Schmahl C, Feldmann RE, Jr., et al. No evidence for differential dose effects of hydrocortisone on intrusive memories in female patients with complex post-traumatic stress disorder--a randomized, double-blind, placebo-controlled, crossover study. J Psychopharmacol. 2015 Oct;29(10):1077-84. doi: 10.1177/0269881115592339. PMID: 26152322.","49607","2019"
"ludascher2015_C","ludascher2015","Pharmacotherapy","2015","PTSD","Active Control",,"30","C","30",,"Placebo","Placebo",,"No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Once daily","4",,,,,,,,,,,,,,"Not reported","Community","100%","Mixed","child sexual abuse, rape/sexual assault, child physical abuse, child other abuse","Some Concerns","Ludascher P, Schmahl C, Feldmann RE, Jr., et al. No evidence for differential dose effects of hydrocortisone on intrusive memories in female patients with complex post-traumatic stress disorder--a randomized, double-blind, placebo-controlled, crossover study. J Psychopharmacol. 2015 Oct;29(10):1077-84. doi: 10.1177/0269881115592339. PMID: 26152322.","49607","2019"
"maguen2017_A","maguen2017","Psychotherapy","2017","PTSD","PTSD",,"33","A","17",,"Impact of Killing","Impact of Killing","Cognitive-behavioral intervention incorporating self-forgiveness, existential, gestalt, and relational theories to reduce mental health symptoms and functional impairment associated with killing in a war.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 to 90 minutes","Weekly","6 to 8",,"Full participation in all content outlined in 6 sessions, completion of all between-session assignments, and completion of outcome measures",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Combat-related",,"High","Maguen S, Burkman KM, Madden E, et al. Impact of killing in war: a randomized, controlled pilot trial. J Clin Psychol. 2017 Sep;73(9):997-1012. doi: 10.1002/jclp.22471. PMID: 28294318.","47285","2019"
"maguen2017_B","maguen2017","Psychotherapy","2017","PTSD","Inactive Control",,"33","B","16",,"Waitlist","Waitlist","While on waitlist could engage in TAU, including medication management, brief case management visits, and supportive group psychotherapy. Participants were prohibited from enrolling in individual psychotherapy or cognitive-behaviorally based group psychotherapy.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"6",,,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Combat-related",,"High","Maguen S, Burkman KM, Madden E, et al. Impact of killing in war: a randomized, controlled pilot trial. J Clin Psychol. 2017 Sep;73(9):997-1012. doi: 10.1002/jclp.22471. PMID: 28294318.","47285","2019"
"mahabir2016_A","mahabir2016","Pharmacotherapy","2016","PTSD","PTSD",,"41","A","20",,"Propranolol","Propranolol","Beta-adrenergic receptor antagonist","No",,"Yes","Antiadrenergic","No",,"No","No","No","No","No","Individual","In Person","1 mg/kg",,"Once (single dose)","0.14","single dose",,,,,,,,,,,,,"Not reported","Community","73.17%","Mixed","accidents, rape/sexual assault, combat-related, community/school violence, other (non-specified)","Some Concerns","Mahabir M, Ashbaugh AR, Saumier D, et al. Propranolol's impact on cognitive performance in post-traumatic stress disorder. J Affect Disord. 2016 Mar 1;192:98-103. doi: 10.1016/j.jad.2015.11.051. PMID: 26707354.","46886","2019"
"mahabir2016_B","mahabir2016","Pharmacotherapy","2016","PTSD","Inactive Control",,"41","B","21",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Once (single dose)","0.14","Single dose",,,,,,,,,,,,,"Not reported","Community","73.17%","Mixed","accidents, rape/sexual assault, combat-related, community/school violence, other (non-specified)","Some Concerns","Mahabir M, Ashbaugh AR, Saumier D, et al. Propranolol's impact on cognitive performance in post-traumatic stress disorder. J Affect Disord. 2016 Mar 1;192:98-103. doi: 10.1016/j.jad.2015.11.051. PMID: 26707354.","46886","2019"
"maieritsch2016_A","maieritsch2016","Psychotherapy","2016","PTSD","PTSD",,"90","A","45",,"CPT via Telehealth","Cognitive Processing Therapy (CPT)","CPT provided over video teleconference","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Video",,"50 minutes","Once or twice weekly","5 to 10","10 sessions total","Completed at least 10 sessions",,,,,,,,,,,,"Not reported","Veteran","6.7%","Mixed","MST, combat-related, community/school violence","High","Maieritsch KP, Smith TL, Hessinger JD, et al. Randomized controlled equivalence trial comparing videoconference and in person delivery of cognitive processing therapy for PTSD. J Telemed Telecare. 2016 Jun;22(4):238-43. doi: 10.1177/1357633x15596109. PMID: 26231819.","45182","2019"
"maieritsch2016_B","maieritsch2016","Psychotherapy","2016","PTSD","PTSD",,"90","B","45",,"CPT","Cognitive Processing Therapy (CPT)","In-person sessions","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"50 minutes","Once or twice weekly","5 to 10","10 sessions total","Completed at least 10 sessions",,,,,,,,,,,,"Not reported","Veteran","6.7%","Mixed","MST, combat-related, community/school violence","High","Maieritsch KP, Smith TL, Hessinger JD, et al. Randomized controlled equivalence trial comparing videoconference and in person delivery of cognitive processing therapy for PTSD. J Telemed Telecare. 2016 Jun;22(4):238-43. doi: 10.1177/1357633x15596109. PMID: 26231819.","45182","2019"
"manteghi2014_A","manteghi2014","Pharmacotherapy","2014","PTSD","PTSD",,"40","A","20",,"Citalopram + baclofen","Citalopram + baclofen","Citalopram: SSRI; baclofen: GABA-B agonist","No",,"Yes","Mixed","No",,"No","No","No","No","No","Individual","In Person","Citalopram: 60 mg; titrated from 10 mg to 60 mg







Baclofen: 40 mg; started at 10 mg titrated up to 40 mg",,"Once daily







3 times daily","8",,,,,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"High","Manteghi AA, Hebrani P, Mortezania M, et al. Baclofen add-on to citalopram in treatment of posttraumatic stress disorder. J Clin Psychopharmacol. 2014 Apr;34(2):240-3. doi: 10.1097/jcp.0000000000000089. PMID: 24525635.","42065","2019"
"manteghi2014_B","manteghi2014","Pharmacotherapy","2014","PTSD","Active Control",,"40","B","20",,"Citalopram + placebo","Citalopram + placebo","SSRI plus placebo","No",,"Yes","Antidepressant: SSRI","No",,"No","No","Yes","No","No","Individual","In Person","10 mg/day titrated up to 60 mg/day",,"Once daily citalopram and three time a day for placebo","8",,,,,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"High","Manteghi AA, Hebrani P, Mortezania M, et al. Baclofen add-on to citalopram in treatment of posttraumatic stress disorder. J Clin Psychopharmacol. 2014 Apr;34(2):240-3. doi: 10.1097/jcp.0000000000000089. PMID: 24525635.","42065","2019"
"marcus1997_A","marcus1997","Psychotherapy","1997","PTSD","PTSD",,"67","A",,,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Individual psychotherapy according to Shapiro (1995), includes history taking and treatment planning, assessment of target trauma, desensitization of the targeted trauma, installation of positive cognition, body scan to identify residual disturbing body sensations or affect, and EMDR closure. Treatment was offered until individual no long met DSM-III-R criteria for PTSD or study ended. Participants also received TAU, including medication visits and group therapy.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"50 minutes",,,,,,,,,,,,,,,,"Race and Ethnicity data reported","Community","79.1%","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disaster","High","Marcus SV, Marquis P, Sakai CE. Controlled study of treatment of PTSD using EMDR in an HMO setting. Psychotherapy (Chic). 1997;34(3):307-15. doi: 10.1037/h0087791.","09960","2019"
"marcus1997_B","marcus1997","Psychotherapy","1997","PTSD","Active Control",,"67","B",,,"Standard care","Treatment as usual (TAU)","All individuals received either individual psychotherapy (cognitive, psychodynamic, or behavior), medication, and/or group therapy (treated as provider preferred)","No",,"No",,"No",,"No","No","Yes","No","No",,,,"Individual therapy: 50 minutes







Medication visits: 30 to 45 minutes







Group therapy: 90 minutes",,,,,,,,,,,,,,,,"Race and Ethnicity data reported","Community","79.1%","Mixed","rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disaster","High","Marcus SV, Marquis P, Sakai CE. Controlled study of treatment of PTSD using EMDR in an HMO setting. Psychotherapy (Chic). 1997;34(3):307-15. doi: 10.1037/h0087791.","09960","2019"
"margolies2013_A","margolies2013","Psychotherapy","2013","PTSD","PTSD",,"40","A","20",,"CBT-I + IRT","Cognitive Behavioral Therapy for Insomnia (CBT-I) + Imagery Rehearsal Training (IRT)","Treatment includes CBT-I following Morin & Epsie 2003 protocol, imaginal rehearsal of new dream, and stimulus control following Bootzin & Epstine 2000.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","6","4 sessions","Completed 4 sessions",,,,,,,,,,,,"Race data reported","Veteran","10%",,,"High","Margolies SO, Rybarczyk B, Vrana SR, et al. Efficacy of a cognitive-behavioral treatment for insomnia and nightmares in Afghanistan and Iraq veterans with PTSD. Journal of Clinical Psychology. 2013 Oct;69(10):1026-42. doi: 10.1002/jclp.21970. PMID: 23629959.","40515","2020"
"margolies2013_B","margolies2013","Psychotherapy","2013","PTSD","Inactive Control",,"40","B","20",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"6",,,,,,,,,,,,,,"Race data reported","Veteran","10%",,,"High","Margolies SO, Rybarczyk B, Vrana SR, et al. Efficacy of a cognitive-behavioral treatment for insomnia and nightmares in Afghanistan and Iraq veterans with PTSD. Journal of Clinical Psychology. 2013 Oct;69(10):1026-42. doi: 10.1002/jclp.21970. PMID: 23629959.","40515","2020"
"markowitz2015a_A","markowitz2015a","Psychotherapy & CIH","2015","PTSD","PTSD",,"110","A","38",,"PE","Prolonged Exposure (PE)","Patients narrate an increasingly detailed trauma narrative (imaginal exposure) and confront trauma reminders (in vivo exposure) to extinguish fear responses","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly for 7 weeks, then 3 sessions over next 7 weeks","14",,"completed PE",,,,,,"8.3","3.1",,,,,"Race and Ethnicity data reported","Community","70%","Mixed","rape/sexual assault, other (child abuse unspecified, interpersonal, not specified)","Some Concerns","Markowitz JC, Petkova E, Neria Y, et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry. 2015 May;172(5):430-40. doi: 10.1176/appi.ajp.2014.14070908. PMID: 25677355.","43409","2019"
"markowitz2015a_B","markowitz2015a","Psychotherapy & CIH","2015","PTSD","PTSD",,"110","B","40",,"Interpersonal Psychotherapy","Interpersonal Psychotherapy (IPT)","Addresses not trauma but its interpersonal aftermath, and assigns no homework. The first half of Interpersonal Psychotherapy emphasized affective attunement, recognizing, naming, and expressing one’s feelings in non-trauma-related interpersonal situations; the remainder addressed typical Interpersonal Psychotherapy problem areas (e.g., role disputes, transitions) not trauma but its interpersonal aftermath, and assigns no homework. The first half of Interpersonal Psychotherapy emphasized affective attunement, recognizing, naming, and expressing one’s feelings in non-trauma-related interpersonal situations; the remainder addressed typical Interpersonal Psychotherapy problem areas (e.g., role disputes, transitions)","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"50 minutes","Weekly","14",,"completed interpersonal therapy",,,,,,"12.6","3.4",,,,,"Race and Ethnicity data reported","Community","70%","Mixed","rape/sexual assault, other (child abuse unspecified, interpersonal, not specified)","Some Concerns","Markowitz JC, Petkova E, Neria Y, et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry. 2015 May;172(5):430-40. doi: 10.1176/appi.ajp.2014.14070908. PMID: 25677355.","43409","2019"
"markowitz2015a_C","markowitz2015a","Psychotherapy & CIH","2015","PTSD","Active Control",,"110","C","32",,"Relaxation Therapy","Relaxation","Highly scripted, induces progressive muscle and mental relaxation","No",,"No",,"Yes","Relaxation","No","No","Yes","No","No","Individual","In Person",,"90 minutes for weekly session, 30 minutes for final session","Weekly for 7 weeks, then 3 sessions over next 7 weeks","14",,"completed therapy",,,,,,"7.8","3.5",,,,,"Race and Ethnicity data reported","Community","70%","Mixed","rape/sexual assault, other (child abuse unspecified, interpersonal, not specified)","Some Concerns","Markowitz JC, Petkova E, Neria Y, et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry. 2015 May;172(5):430-40. doi: 10.1176/appi.ajp.2014.14070908. PMID: 25677355.","43409","2019"
"marks1998_A","marks1998","Psychotherapy & CIH","1998","PTSD","PTSD",,"87","A","23",,"Exposure Therapy","Trauma-focused cognitive behavioral therapy (TF-CBT)","Sessions 1-5: Patients asked to talk in first-person and present-tense about their experience; then rewind and 'hold' on memory of trauma until distress reduced. Homework involved listening to parts of their audiotaped description for 1 hour daily, noting peak distress before, during, and after listening sessions in diary. Sessions 6-10: Prolonged live exposure to stimuli; exposure repeated and accompanied by therapist. Homework involved live exposure for 1 hour daily, recording distress levels in diaries.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Usually weekly","10",,"completed 10 sessions",,,,,,,,,,,,"Not reported","Community","36%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement","Some Concerns","Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.","09640","2019"
"marks1998_B","marks1998","Psychotherapy & CIH","1998","PTSD","PTSD",,"87","B","19",,"CR","Cognitive restructuring","Patients taught to identify dysfunctional thoughts, develop rational alternatives, and re-appraise beliefs about themselves, their trauma, and the world. Homework involved use of daily thought records.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Usually weekly","10",,"completed 10 sessions",,,,,,,,,,,,"Not reported","Community","36%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement","Some Concerns","Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.","09640","2019"
"marks1998_C","marks1998","Psychotherapy & CIH","1998","PTSD","PTSD",,"87","C","24",,"Exposure combined with CR","Trauma-focused cognitive behavioral therapy (TF-CBT)","First half of sessions involved imaginal exposure, then cognitive restructuring; second half of sessions involved in vivo exposure, then cognitive restructuring (45 minutes of exposure therapy, followed by 15 minute break, followed by 45 minutes of cognitive restructuring therapy). Homework involved one hour of daily exposure and cognitive tasks.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"105 minutes","Usually weekly","10",,"completed 10 sessions",,,,,,,,,,,,"Not reported","Community","36%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement","Some Concerns","Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.","09640","2019"
"marks1998_D","marks1998","Psychotherapy & CIH","1998","PTSD","Active Control",,"87","D","21",,"Relaxation","Relaxation","Patients taught to relax. Homework involved listening to relaxation tape daily and to record anxiety in daily diary.","No",,"No",,"Yes","Relaxation","No","No","Yes","No","No","Individual","In Person",,"90 minutes","Usually weekly","10",,"completed 10 sessions",,,,,,,,,,,,"Not reported","Community","36%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement","Some Concerns","Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: a controlled study. Arch Gen Psychiatry. 1998 Apr;55(4):317-25.  PMID: 9554427.","09640","2019"
"marshall2001_A","marshall2001","Pharmacotherapy","2001","PTSD","PTSD",,"563","A","187",,"Paroxetine (flexible dose)","Paroxetine","SSRI; started at 20 mg/day, received 30 mg/day during week 2, 40 mg/day from start of week 3; followed 1-week placebo run-in to assess compliance","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","40 mg; titration: 20 mg/day for 1 week, then 30 mg/day for 1 week, then 40 mg/day for remainder",,"Daily","12",,,,,,,,,,,,,,"Not reported","Community","68.42%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, witnessing injury or death)","Some Concerns","Marshall RD, Beebe KL, Oldham M, et al. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry. 2001;158(12):1982-8. doi: 10.1176/appi.ajp.158.12.1982. PMID: 11729013.","23882","2019"
"marshall2001_B","marshall2001","Pharmacotherapy","2001","PTSD","PTSD",,"563","B","188",,"Paroxetine (fixed dose)","Paroxetine","SSRI, fixed-dose; followed 1-week placebo run-in to assess compliance","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","20 mg",,"Daily","12",,,,,,,,,,,,,,"Not reported","Community","68.42%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, witnessing injury or death)","Some Concerns","Marshall RD, Beebe KL, Oldham M, et al. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry. 2001;158(12):1982-8. doi: 10.1176/appi.ajp.158.12.1982. PMID: 11729013.","23882","2019"
"marshall2001_C","marshall2001","Pharmacotherapy","2001","PTSD","Inactive Control",,"563","C","188",,"Placebo","Placebo","1-week placebo run-in to assess compliance, followed by placebo treatment after randomization","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,,,,"Not reported","Community","68.42%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, witnessing injury or death)","Some Concerns","Marshall RD, Beebe KL, Oldham M, et al. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry. 2001;158(12):1982-8. doi: 10.1176/appi.ajp.158.12.1982. PMID: 11729013.","23882","2019"
"marshall2007_A","marshall2007","Pharmacotherapy","2007","PTSD","PTSD",,"63","A","25",,"Paroxetine (flexible dose)","Paroxetine","SSRI, initiated at 10 mg daily. If patients remained symptomatic, dosage was increased to 20 mg for weeks 2 and 3, 40mg daily for weeks 4–6, and 60 mg daily for weeks 7–10 as tolerated. Followed 1-week single-blind placebo run-in period, with responders excluded from the study.","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","10 mg titrated to maximum 60 mg",,"Daily","10",,,,,,,,,,,"40.4 mg","17.7",,"Race and Ethnicity data reported","Community","67.31%","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing events, fire)","Some Concerns","Marshall RD, Lewis-Fernández R, Blanco C, et al. A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults. Depress Anxiety. 2007;24(2):77-84. doi: 10.1002/da.20176. PMID: 16892419.","29847","2019"
"marshall2007_B","marshall2007","Pharmacotherapy","2007","PTSD","Inactive Control",,"63","B","27",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","10",,,,,,,,,,,"43.2 mg equivalent","17.3",,"Race and Ethnicity data reported","Community","67.31%","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing events, fire)","Some Concerns","Marshall RD, Lewis-Fernández R, Blanco C, et al. A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults. Depress Anxiety. 2007;24(2):77-84. doi: 10.1002/da.20176. PMID: 16892419.","29847","2019"
"martenyi2002_A","martenyi2002","Pharmacotherapy","2002","PTSD","PTSD",,"301","A","226",,"Fluoxetine","Fluoxetine","SSRI antidepressant; dose could be increased in 20-mg increments at each of 3 titration points based on predefined response criteria","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","Initiated at 20 mg, titrated to maximum 80 mg",,"Daily","12",,,,,"Determined by direct questioning and medication counts; noncompliant if missed >4 consecutive days, >10 total days, or if ratio of capsules taken to those prescribed was <0.8 or >1.2",,"97%-100% at all timepoints for each group",,,,"57 mg/day",,,"Race data reported","Mixed","19%","Mixed","combat-related, other (""victim of war or witness of war event,"" ""witness of another person's death"")","High","Martenyi F, Brown EB, Zhang H, et al. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry. 2002;63(3):199-206.  PMID: 11926718","24911","2019"
"martenyi2002_B","martenyi2002","Pharmacotherapy","2002","PTSD","Inactive Control",,"301","B","75",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,"Determined by direct questioning and medication counts; noncompliant if missed >4 consecutive days, >10 total days, or if ratio of capsules taken to those prescribed was <0.8 or >1.2",,"97%-100% at all timepoints for each group",,,,,,,"Race data reported","Mixed","19%","Mixed","combat-related, other (""victim of war or witness of war event,"" ""witness of another person's death"")","High","Martenyi F, Brown EB, Zhang H, et al. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry. 2002;63(3):199-206.  PMID: 11926718","24911","2019"
"martenyi2007_A","martenyi2007","Pharmacotherapy","2007","PTSD","PTSD",,"411","A","163",,"Fluoxetine","Fluoxetine","SSRI, fixed-dose (no titration) 20 mg","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","20 mg",,"Daily","12",,,,,,,,,,,,,,"Race and Ethnicity data reported",,"71.53%","Mixed","combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)","High","Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.","29532","2019"
"martenyi2007_B","martenyi2007","Pharmacotherapy","2007","PTSD","PTSD",,"411","B","160",,"Fluoxetine","Fluoxetine","SSRI, initiated at 20 mg and increased to 40 mg after 2 weeks","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","40 mg; titration: initiated at 20 mg, titrated to 40 mg",,"Daily","12",,,,,,,,,,,,,,"Race and Ethnicity data reported",,"71.53%","Mixed","combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)","High","Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.","29532","2019"
"martenyi2007_C","martenyi2007","Pharmacotherapy","2007","PTSD","Inactive Control",,"411","C","88",,"Placebo","Placebo",,"No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,,,,"Race and Ethnicity data reported",,"71.53%","Mixed","combat-related, rape/sexual assault, intimate partner violence, accidents, other (incest, witnessed a death)","High","Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol. 2007;27(2):166-70. doi: 10.1097/JCP.0b013e31803308ce. PMID: 17414240.","29532","2019"
"mathew2011_A","mathew2011","Pharmacotherapy","2011","PTSD","PTSD",,"47","A","22",,"GR205171 investigational drug","GR205171 investigational drug","Investigational neurokinin-1 receptor antagonist, fixed-dose; followed 2-week placebo lead-in","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","5 mg",,"Daily","8",,,,,"determined by capsule counts","98.2%",,,,,,,,"Race and Ethnicity data reported","Community","58.97%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death)","High","Mathew SJ, Vythilingam M, Murrough JW, et al. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Eur. Neuropsychopharmacol. 2011;21(3):221-9. doi: 10.1016/j.euroneuro.2010.11.012. PMID: 21194898.","35587","2019"
"mathew2011_B","mathew2011","Pharmacotherapy","2011","PTSD","Inactive Control",,"47","B","25",,"Placebo","Placebo","Placebo capsules identical to active drug; double-blind period followed 2-week placebo lead-in","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","8",,,,,"determined by capsule counts","97.7%",,,,,,,,"Race and Ethnicity data reported","Community","58.97%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (unexpected death)","High","Mathew SJ, Vythilingam M, Murrough JW, et al. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial. Eur. Neuropsychopharmacol. 2011;21(3):221-9. doi: 10.1016/j.euroneuro.2010.11.012. PMID: 21194898.","35587","2019"
"matthijssen2024_A","matthijssen2024","Psychotherapy","2024","PTSD","PTSD",,"57","A","19",,"Visual Schema Displacement Therapy","Visual Schema Displacement Therapy","Used ""Standard VSDT protocol"". Patient identifies ""laughter point"" based on a person or a memory and ""trauma point"" based on a traumatic memory, and locates these points in space at two locations around a circle. Therapist then redirects patient's attention from the trauma point to the laughter point while saying ""Whoosh!"" This displacement process is repeated three times and includes a sequence of instructions to blink, tightly close eyes, and exhale deeply.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","6","7 appointments after screening: one for preparation, 6 for treatment","See Detail",,"only reports rate for early completion (all trauma targets treated in fewer than 6 sessions; 33.3%), no other information on treatment completion; flow diagram only reports ""received allocated intervention"" (78.95%, 15/19)",,,,"4.87",,"Early completer = all trauma targets treated in fewer than 6 sessions: 33.3%",,,,"Not reported","Community","95.7%",,,"High","Matthijssen S, Brouwers TC, de Jongh A. Visual Schema Displacement Therapy versus Eye Movement Desensitization and Reprocessing therapy versus waitlist in the treatment of post-traumatic stress disorder: results of a randomized clinical trial. Front Psychiatry. 2024;15(1377108). doi: 10.3389/fpsyt.2024.1377108. PMID: 38651013.","1633611","2025"
"matthijssen2024_B","matthijssen2024","Psychotherapy","2024","PTSD","PTSD",,"57","B","19",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Follows EMDR standard protocol, excluding stabilization/emotion regulation techniques. Not further described.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","6","7 appointments after screening: one for preparation, 6 for treatment","See Detail",,"only reports rate for early completion (all trauma targets treated in fewer than 6 sessions; 41.2%), no other information on treatment completion; flow diagram only reports ""received allocated intervention"" (89.47%, 17/19)",,,,"5.1",,"Early completer = all trauma targets treated in fewer than 6 sessions: 41.2%",,,,"Not reported","Community","95.7%",,,"High","Matthijssen S, Brouwers TC, de Jongh A. Visual Schema Displacement Therapy versus Eye Movement Desensitization and Reprocessing therapy versus waitlist in the treatment of post-traumatic stress disorder: results of a randomized clinical trial. Front Psychiatry. 2024;15(1377108). doi: 10.3389/fpsyt.2024.1377108. PMID: 38651013.","1633611","2025"
"matthijssen2024_C","matthijssen2024","Psychotherapy","2024","PTSD","Inactive Control",,"57","C","19",,"Waitlist control","Waitlist","Waiting period covered same 6-week ""treatment"" period and 12-week follow-up period as active treatment groups","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Not reported","Community","95.7%",,,"High","Matthijssen S, Brouwers TC, de Jongh A. Visual Schema Displacement Therapy versus Eye Movement Desensitization and Reprocessing therapy versus waitlist in the treatment of post-traumatic stress disorder: results of a randomized clinical trial. Front Psychiatry. 2024;15(1377108). doi: 10.3389/fpsyt.2024.1377108. PMID: 38651013.","1633611","2025"
"maxwell2016_A","maxwell2016","Psychotherapy","2016","PTSD","PTSD",,"18","A","9",,"Group memory specificity training","Memory specificity training","Group therapy following manual; sessions are directed toward teaching how to retrieve specific memories rather than over general memories, based on cue words of negative, positive, and neutral emotion levels; group interactions involved sharing examples and asking questions; homework assignments involved cue words and were reviewed at each session.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"90 minutes","Weekly","6",,"attended ≥4 sessions",,,,,,"5.38",,,,,,"Race and Ethnicity data reported","Community","81.25%","Mixed","rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence, other (military-related, not specified)","Some Concerns","Maxwell K, Callahan JL, Holtz P, et al. Comparative study of group treatments for posttraumatic stress disorder. Psychotherapy (Chic). 2016 Dec;53(4):433-45. doi: 10.1037/pst0000032. PMID: 26390014.","50402","2019"
"maxwell2016_B","maxwell2016","Psychotherapy","2016","PTSD","PTSD",,"18","B","9",,"Group CPT","Cognitive Processing Therapy (CPT)","Group therapy following manual by Resick et al. 2010; group members write down, in great detail, their experience of their traumatic event, and refer back to this direct account throughout treatment; sessions involved psychoeducation, writing and sharing an impact statement, discussing the meaning of their trauma, Socratic questioning of ""stuck points"", reading full trauma account, challenging assumptions and problematic beliefs, and behavioral assignments.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"90 minutes","Biweekly","6",,"attended ≥8  sessions",,,,,,"10.37",,,,,,"Race and Ethnicity data reported","Community","81.25%","Mixed","rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence, other (military-related, not specified)","Some Concerns","Maxwell K, Callahan JL, Holtz P, et al. Comparative study of group treatments for posttraumatic stress disorder. Psychotherapy (Chic). 2016 Dec;53(4):433-45. doi: 10.1037/pst0000032. PMID: 26390014.","50402","2019"
"mccall2018_A","mccall2018","Pharmacotherapy","2018","PTSD","PTSD",,"20","A","10",,"Prazosin","Prazosin","Dose increased on Day 3 and Weeks 2 through 6. Treatment directed at nightmares thought to contribute to suicidality.","No",,"Yes","Antiadrenergic","No",,"No","No","No","No","No","Individual","In Person","Prazosin initiated at 1 mg and titrated up to a maximum dose of 20 mg for men and 10 mg for women",,"Once daily at bedtime","8",,,,,,"91%",,,,,"5.5 mg","3.5 mg",,"Race data reported","Mixed","85%","Mixed","combat-related, other (not specified)","High","McCall WV, Pillai A, Case D, et al. A pilot, randomized clinical trial of bedtime doses of prazosin versus placebo in suicidal posttraumatic stress disorder patients with nightmares. J Clin Psychopharmacol. 2018 Dec;38(6):618-21. doi: 10.1097/JCP.0000000000000968. PMID: 30335633.","51299","2020"
"mccall2018_B","mccall2018","Pharmacotherapy","2018","PTSD","Inactive Control",,"20","B","10",,"Placebo","Placebo","Placebo identical to prazosin","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Once daily at bedtime","8",,,,,,,,,,,"7.6 mg","5.3 mg",,"Race data reported","Mixed","85%","Mixed","combat-related, other (not specified)","High","McCall WV, Pillai A, Case D, et al. A pilot, randomized clinical trial of bedtime doses of prazosin versus placebo in suicidal posttraumatic stress disorder patients with nightmares. J Clin Psychopharmacol. 2018 Dec;38(6):618-21. doi: 10.1097/JCP.0000000000000968. PMID: 30335633.","51299","2020"
"mcdonagh2005_A","mcdonagh2005","Psychotherapy","2005","PTSD","PTSD",,"74","A","29",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Manualized, modified version of treatment developed by Foa et al., 1999; primary components of prolonged exposure, in vivo exposure, and cognitive restructuring; additional components included psychoeducation, breathing retraining, and homework.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1.5 to 2 hours","Approximately once a week","14","14 sessions total","completed treatment course",,,,,,,,,,,,"Race data reported","Community","100%","Child sexual abuse",,"High","McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.","27712","2019"
"mcdonagh2005_B","mcdonagh2005","Psychotherapy","2005","PTSD","Active Control",,"74","B","22",,"PCT","Present-Centered Therapy (PCT)","Manualized, collaborative therapeutic intervention with focus on here-and-now problem-solving; main elements include psychoeducation, training in problem solving, and journal writing.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"1.5 to 2 hours","approximately once a week","14","14 sessions total","completed treatment course",,,,,,,,,,,,"Race data reported","Community","100%","Child sexual abuse",,"High","McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.","27712","2019"
"mcdonagh2005_C","mcdonagh2005","Psychotherapy","2005","PTSD","Inactive Control",,"74","C","23",,"Waitlist","Waitlist","Waitlist; participants were contacted after randomization and encouraged to seek additional phone contact as needed during waiting period and were offered help seeking treatment as usual in the community (none requested such help).","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"14",,"completed treatment course",,,,,,,,,,,,"Race data reported","Community","100%","Child sexual abuse",,"High","McDonagh A, Friedman MJ, McHugo GJ, et al. Randomized trial of cognitive-behavioral therapy for chronic posttraumatic stress disorder in adult female survivors of childhood sexual abuse. J Consult Clin Psychol. 2005 Jun;73(3):515-24. doi: 10.1037/0022-006X.73.3.515. PMID: 15982149.","27712","2019"
"mcfall2010_A","mcfall2010","Psychotherapy & pharmacotherapy","2010","PTSD+SUD","PTSD+SUD","Integrated","943","A","472",,"Integrated Care","Smoking cessation integrated into PTSD TAU","Tobacco cessation counseling and optional  cessation medication integrated into participant's ongoing PTSD treatment. Tobacco cessation counseling delivered in individual sessions using treatment manual; core sessions included ""tobacco use education, behavioral skills for quitting smoking, setting a quit date..., and relapse prevention""; follow-up visits and booster sessions in which clinicians ""assessed tobacco use, reinforced abstinence and relapse prevention, and re-applied cessation treatment to continued smokers."" Cessation medication following algorithm for ""standard prescribing practices for nicotine replacement therapy, bupropion, and varenicline"".","Yes","Non-Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person",,,"Weekly for 8 sessions, then monthly","12","patients completed the initial course of smoking cessation treatment within 3 months of randomization
≥8 total sessions [5 core sessions + 3 follow-up sessions + as needed booster sessions]","See Detail",,"reports by number of smoking cessation sessions received (Table 3 of publication): 0, 10.1%; 1-2, 7.1%; 3-5, 14.8%; 6-8, 20.9%; >8, 47.1%",,,,,,"median 8 (IQR 4 to 12)",,,,"Race and Ethnicity data reported","Veteran","6.36%","Other","""related to military service""","Some Concerns","McFall ME, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA. 2010 Dec 8;304(22):2485-93. doi: 10.1001/jama.2010.1769. PMID: 21139110.","35450","2020"
"mcfall2010_B","mcfall2010","Psychotherapy & pharmacotherapy","2010","PTSD+SUD","Active Control","Not integrated","943","B","471",,"Smoking Cessation Clinic","PTSD TAU + referral to smoking cessation clinic","Specialized cessation clinic (VA standard of care) that following smoking cessation practice guidelines; ""provided treatment within 6 weeks of referral, prescribed cessation medications directly or through patients' primary care provider"", and provided cessation treatment sessions.","Yes","Non-Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","Yes","No","No","Individual","In Person",,,,"12","patients completed the initial course of smoking cessation treatment within 3 months of randomization","See Detail",,"reports by number of smoking cessation sessions received (Table 3 of publication): 0, 32.6%; 1-2, 32.2%; 3-5, 24.2%; 6-8, 5.8%; >8, 5.2%",,,,,,"median 1 (IQR 0 to 4)",,,,"Race and Ethnicity data reported","Veteran","6.36%","Other","""related to military service""","Some Concerns","McFall ME, Saxon AJ, Malte CA, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA. 2010 Dec 8;304(22):2485-93. doi: 10.1001/jama.2010.1769. PMID: 21139110.","35450","2020"
"mcgeary2022_A","mcgeary2022","Psychotherapy","2022","PTSD","PTSD",,"193","A","65",,"Cogntiive Behavioral Therapy for Headache (CBTH)","Cognitive behavioral therapy for headache (CBTH)","Cogntive behavioral therapy focused exclusively on headache and stress; used behavioral interventions, stress management, and cognitive therapy.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour","Once or twice a week","8","8 weekly or bi-weekly sessions, 4-8 weeks total","6 ore more sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","13.47%",,,"High","McGeary DD, Resick PA, Penzien DB, et al. Cognitive behavioral therapy for veterans with comorbid posttraumatic headache and posttraumatic stress disorder symptoms: a randomized clinical trial. JAMA Neurol. 2022;79(8):746-57. doi: 10.1001/jamaneurol.2022.1567. PMID: 35759281.","1595720","2023"
"mcgeary2022_B","mcgeary2022","Psychotherapy","2022","PTSD","PTSD",,"193","B","64",,"CPT","Cognitive Processing Therapy (CPT)","Manualized PTSD intervention; emphasized cognitive therapy and focused on PTSD only.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour","Twice a week","6","Erronously reported as 12-hour sessions over 6 weeks","9 or more sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","13.47%",,,"High","McGeary DD, Resick PA, Penzien DB, et al. Cognitive behavioral therapy for veterans with comorbid posttraumatic headache and posttraumatic stress disorder symptoms: a randomized clinical trial. JAMA Neurol. 2022;79(8):746-57. doi: 10.1001/jamaneurol.2022.1567. PMID: 35759281.","1595720","2023"
"mcgeary2022_C","mcgeary2022","Psychotherapy","2022","PTSD","Inactive Control",,"193","C","64",,"Treatment as usual (TAU)","Treatment as usual (TAU)","VA standard of care for mTBI; multidisciplinary treatment including pharmacotherapy, pain management, physical therapy, and complementary and integrative health treatments","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"6",,"completed treatment (not further described)",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","13.47%",,,"High","McGeary DD, Resick PA, Penzien DB, et al. Cognitive behavioral therapy for veterans with comorbid posttraumatic headache and posttraumatic stress disorder symptoms: a randomized clinical trial. JAMA Neurol. 2022;79(8):746-57. doi: 10.1001/jamaneurol.2022.1567. PMID: 35759281.","1595720","2023"
"mcgovern2011_A","mcgovern2011","Psychotherapy","2011","PTSD+SUD","PTSD+SUD","Integrated","53","A","32",,"Integrated CBT + Standard Care","Integrated Cognitive Behavioral Therapy (ICBT)","Integrated CBT: manualized individual therapy for PTSD and SUD, crisis/relapse prevention, breathing retraining, PTSD symptom education, PTSD associated symptoms, cognitive restructuring, generalization training



Standard care: intensive outpatient program or methadone maintenance","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"45 to 50 minutes","Weekly","8 to12","8 to 12 weeks (12 to 14 sessions)","≥75% of sessions",,,,,,,,,,,,"Race data reported","Community","56.6%","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents","Some Concerns","McGovern MP, Lambert-Harris C, Alterman AI, et al. A randomized controlled trial comparing integrated cognitive behavioral therapy versus individual addiction counseling for co-occurring substance use and posttraumatic stress disorders. J Dual Diagn. 2011 Jan 1;7(4):207-27. doi: 10.1080/15504263.2011.620425. PMID: 22383864.","85821","2020"
"mcgovern2011_B","mcgovern2011","Psychotherapy","2011","PTSD+SUD","Active Control","Not integrated","53","B","21",,"Individual Addiction Counseling + Standard Care","Addiction Counseling","Individual addiction counseling: manual guided therapy targeting substance use only, ""designed to be integrated into an addiction treatment or methadone maintenance programs""; consists of 5 modules: treatment initiation; early abstinence; maintaining abstinence; recovery; termination.



Standard care: intensive outpatient program or methadone maintenance","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Weekly","8 to12","8 to 12 weeks (10 to 12 sessions)","≥75% of sessions",,,,,,,,,,,,"Race data reported","Community","56.6%","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, accidents","Some Concerns","McGovern MP, Lambert-Harris C, Alterman AI, et al. A randomized controlled trial comparing integrated cognitive behavioral therapy versus individual addiction counseling for co-occurring substance use and posttraumatic stress disorders. J Dual Diagn. 2011 Jan 1;7(4):207-27. doi: 10.1080/15504263.2011.620425. PMID: 22383864.","85821","2020"
"mcgovern2015_A","mcgovern2015","Psychotherapy","2015","PTSD+SUD","PTSD+SUD","Integrated","221","A","73",,"Integrated CBT + Standard Care","Integrated Cognitive Behavioral Therapy (ICBT)","Integrated CBT: manualized individual therapy for PTSD and SUD; 3 main components are: education, mindful relaxation, and flexible thinking.



Standard care: intensive outpatient program, includes individual and group therapy and medication management","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"45 to 50 minutes","Weekly","8 to12","8-12 sessions","See Detail",,"Study reports on assessment completion only, no information on treatment completion; treatment completers described in secondary publication (Meier, 2015) but sum of N completed and N drop out for each group is more than reported N randomized in any of the publications (reports completers n=62, dropouts n=29)",,,,,,,,,,"Race and Ethnicity data reported","Community","59.3%","Mixed","child sexual abuse, community/school violence, other (not specified)","Low","McGovern MP, Lambert-Harris C, Xie H, et al. A randomized controlled trial of treatments for co-occurring substance use disorders and post-traumatic stress disorder. Addiction. 2015 Jul;110(7):1194-204. doi: 10.1111/add.12943. PMID: 25846251.","44027","2020"
"mcgovern2015_B","mcgovern2015","Psychotherapy","2015","PTSD+SUD","Active Control","Not integrated","221","B","75",,"Individual Addiction Counseling + Standard Care","Addiction Counseling","Individual addiction counseling: manual guided individual therapy focused only on substance use and recovery (doesn't directly address PTSD); modules included: treatment initiation, early abstinence, maintaining abstinence, and recovery; adaptation of ""individual drug counseling (IDC) from the NIDA Cocaine Collaborative Study and Twelve-Step facilitation (TSF) from the NIAAA Project Match"".



Standard care: intensive outpatient program, includes individual and group therapy and medication management.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"45 to 50 minutes","Weekly","8 to12","≥8 sessions","See Detail",,"Study reports on assessment completion only, no information on treatment completion; treatment completers described in secondary publication (Meier, 2015) but sum of N completed and N drop out for each group is more than reported N randomized in any of the publications (reports completers n=58, dropouts n=32)",,,,,,,,,,"Race and Ethnicity data reported","Community","59.3%","Mixed","child sexual abuse, community/school violence, other (not specified)","Low","McGovern MP, Lambert-Harris C, Xie H, et al. A randomized controlled trial of treatments for co-occurring substance use disorders and post-traumatic stress disorder. Addiction. 2015 Jul;110(7):1194-204. doi: 10.1111/add.12943. PMID: 25846251.","44027","2020"
"mcgovern2015_C","mcgovern2015","Psychotherapy","2015","PTSD+SUD","Active Control","Not integrated","221","C","73",,"Standard Care","Treatment as usual (TAU)","Standard care: intensive outpatient program, includes individual and group therapy and medication management","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"Varied (9-12 hours per week of individual and group therapy)","Varied (daily to weekly)","6 to 18","6 to 8 weeks intensive outpatient, followed by 12 weeks continuing care group",,,,,,,,,,,,,"Race and Ethnicity data reported","Community","59.3%","Mixed","child sexual abuse, community/school violence, other (not specified)","Low","McGovern MP, Lambert-Harris C, Xie H, et al. A randomized controlled trial of treatments for co-occurring substance use disorders and post-traumatic stress disorder. Addiction. 2015 Jul;110(7):1194-204. doi: 10.1111/add.12943. PMID: 25846251.","44027","2020"
"mcgranahan2025_A","mcgranahan2025","Other study class","2025","PTSD","PTSD",,"38","A","20",,"High intensity interval training (HIIT)","Exercise","High-intensity interval-based cycle exercise training; 30-second high intensity cycling ergometer bouts followed by a 1-minute active recovery interval for first 2 weeks, followed by increase to 10 60-second bouts. All sessions started with a 3-minute warm-up and ended with a 2-minute cool down. Participants did not talk with research staff or listen to music during exercise.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","In Person",,"~23 minutes","Three times a week","6","total 18 sessions","Treatment completion",,"treatment completion = ""received allocated intervention"" are those allocated minus did not receive allocated intervention",,,,"17.21","0.79","Exercise sessions",,,,"Race data reported","Community","100%","Mixed","Rape/sexual assault; Accidents; Community/school violence; Other (""child abuse"" not further specified, ""other"")","High","McGranahan MJ, O'Connor PJ. Effect of high-intensity interval training exercise on sleep quality in women with probable post-traumatic stress disorder: A pilot randomized controlled trial. Sleep Med. 2025 May;129:245-256. doi: 10.1016/j.sleep.2025.02.029. Epub 2025 Feb 21. PMID: 40056660.","1645648","2025"
"mcgranahan2025_B","mcgranahan2025","Other study class","2025","PTSD","Inactive Control",,"38","B","18",,"Waitlist","Waitlist","Waitlist","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"6",,,,,,,,,,,,,,"Race data reported","Community","100%","Mixed","Rape/sexual assault; Accidents; Community/school violence; Other (""child abuse"" not further specified, ""other"")","High","McGranahan MJ, O'Connor PJ. Effect of high-intensity interval training exercise on sleep quality in women with probable post-traumatic stress disorder: A pilot randomized controlled trial. Sleep Med. 2025 May;129:245-256. doi: 10.1016/j.sleep.2025.02.029. Epub 2025 Feb 21. PMID: 40056660.","1645648","2025"
"mcguirestanbury2020_A","mcguirestanbury2020","Psychotherapy","2020","PTSD","PTSD",,"20","A","10",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Target memories selected and saccadic eye movements used to desensitize, substituting positive for negative beliefs and eliminating negative body sensations","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"Session length: 90 minutes","Twice weekly","6",,,,,,,,"12",,,,,,"Not reported","Community",,"Mixed","Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Natural or manmade disasters; Other (childhood trauma, not specified)","High","McGuire Stanbury TM, Drummond PD, Laugharne J, et al. Comparative Efficiency of EMDR and Prolonged Exposure in Treating Posttraumatic Stress Disorder: A Randomized Trial. Journal of EMDR Practice and Research. 2020;14(1):2-12. doi: 10.1891/1933-3196.14.1.2.","1587978","2020"
"mcguirestanbury2020_B","mcguirestanbury2020","Psychotherapy","2020","PTSD","PTSD",,"20","B","10",,"PE","Prolonged Exposure (PE)","Included initial trauma interview and breathing retraining; in vivo exposure homework; and imaginal exposure during treatment sessions","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"Session length: 90 minutes","Twice weekly","6",,,,,,,,"12",,,,,,"Not reported","Community",,"Mixed","Rape/sexual assault; Intimate partner violence; Accidents; Community/school violence; Natural or manmade disasters; Other (childhood trauma, not specified)","High","McGuire Stanbury TM, Drummond PD, Laugharne J, et al. Comparative Efficiency of EMDR and Prolonged Exposure in Treating Posttraumatic Stress Disorder: A Randomized Trial. Journal of EMDR Practice and Research. 2020;14(1):2-12. doi: 10.1891/1933-3196.14.1.2.","1587978","2020"
"mclay2011_A","mclay2011","Psychotherapy","2011","PTSD","PTSD",,"20","A","10",,"Virtual reality-graded exposure therapy","Virtual reality exposure therapy (VRET)","Manualized treatment; initial sessions focused on rationale for therapy, meditation and attentional control with autonomic control using biofeedback (J&J Engineering Biofeedback system), skill practice during trauma recall, and discussion of PTSD symptoms; remaining sessions focused on exposure using virtual reality simulation with three-dimensional visual scenarios and relevant sounds, and cognitive restructuring conducted at the end of each session.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Up to twice weekly","10","up to 20 sessions total","Participated in treatment",,"Study reports ""all participants participated in treatment""; also reports all in VR-GET completed post-treatment assessment, but separate from treatment",,,,"8.8",,"SD range 4 to 20",,,,"Not reported","Active Duty Military","5%","Combat-related",,"High","McLay RN, Wood DP, Webb-Murphy JA, et al. A randomized, controlled trial of virtual reality-graded exposure therapy for post-traumatic stress disorder in active duty service members with combat-related post-traumatic stress disorder. Cyberpsychol Behav Soc Netw. 2011 Apr;14(4):223-9. doi: 10.1089/cyber.2011.0003. PMID: 21332375.","36339","2019"
"mclay2011_B","mclay2011","Psychotherapy","2011","PTSD","Inactive Control",,"20","B","10",,"TAU","Treatment as usual (TAU)","TAU included any of the regular services available at the Naval Medical Center San Diego and Naval Hospital Camp Pendleton, including PTSD treatment with medication and/or therapy (individual and/or group).","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"10",,"Participated in treatment",,"Study reports ""all participants participated in treatment""; also reports n=1 did not return for post-treatment assessment, but separate from treatment",,,,,,,,,,"Not reported","Active Duty Military","5%","Combat-related",,"High","McLay RN, Wood DP, Webb-Murphy JA, et al. A randomized, controlled trial of virtual reality-graded exposure therapy for post-traumatic stress disorder in active duty service members with combat-related post-traumatic stress disorder. Cyberpsychol Behav Soc Netw. 2011 Apr;14(4):223-9. doi: 10.1089/cyber.2011.0003. PMID: 21332375.","36339","2019"
"mclay2017_A","mclay2017","Psychotherapy","2017","PTSD","PTSD",,"81","A","43",,"Virtual reality exposure therapy","Virtual reality exposure therapy (VRET)","In vivo exposure using virtual reality with computer-simulation and head-mounted display with optional vibration and smells; this exposure combined with participant recounting traumatic experience wile confronting simulated aspects of that trauma in virtual reality with increasing intensity throughout therapy; homework for confronting real life stresses in vivo; cognitive reframing, discussion, and symptom monitoring at each session.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Up to twice weekly","9","up to 18 sessions total","See Detail",,"Study reports attrition from measurement; performed analysis of treatment completers (completed at least 8 sessions) but data not provided",,,,"10.28",,,,,,"Race data reported","Active Duty Military","3.7%","Combat-related",,"Some Concerns","McLay RN, Baird A, Webb-Murphy J, et al. A randomized, head-to-head study of virtual reality exposuretherapy for posttraumatic stress disorder. Cyberpsychol Behav Soc Netw. 2017 Apr;20(4):218-24. doi: 10.1089/cyber.2016.0554. PMID: 28394217.","49936","2019"
"mclay2017_B","mclay2017","Psychotherapy","2017","PTSD","Active Control",,"81","B","38",,"Control exposure therapy","Exposure therapy","Exposure therapy following the same protocol as virtual reality exposure therapy but without virtual reality headset or other immersive technology; instead still images were viewed on standard computer screen for participant to focus on during in-session exposure.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Up to twice weekly","9","up to 18 sessions total","See Detail",,"Study reports attrition from measurement; performed analysis of treatment completers (completed at least 8 sessions) but data not provided",,,,"9.24",,,,,,"Race data reported","Active Duty Military","3.7%","Combat-related",,"Some Concerns","McLay RN, Baird A, Webb-Murphy J, et al. A randomized, head-to-head study of virtual reality exposuretherapy for posttraumatic stress disorder. Cyberpsychol Behav Soc Netw. 2017 Apr;20(4):218-24. doi: 10.1089/cyber.2016.0554. PMID: 28394217.","49936","2019"
"mclean2020_A","mclean2020","Other mixed","2020","PTSD","PTSD",,"40","A","19",,"Web-based prolonged exposure therapy","Internet-based facilitated self-help","A 10-session self-guided online program that follows the prolonged exposure protocol, with therapist faciitation through asynchronous feedback after each session and scheduled phone calls.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology assisted",,"60 minutes",,"8","10 sessions total","Completed all sessions",,,,,,"6.68","3.5",,,,,"Race and Ethnicity data reported","Mixed","25%",,"Inclusion required exposure to a Criterion A combat-related traumatic event but index trauma could be non-combat-related","High","McLean CP, Foa EB, Dondanville KA, et al. The effects of web-prolonged exposure among military personnel and veterans with posttraumatic stress disorder. Psychol Trauma. 2020 Nov 19;19:19. doi: 10.1037/tra0000978. PMID: 33211517.","1561431","2022"
"mclean2020_B","mclean2020","Other mixed","2020","PTSD","Active Control",,"40","B","21",,"Present-centered therapy","Present-Centered Therapy (PCT)","A non-trauma focused manualized therapy designed to help patients disclose and problem solve current life problems that may or may not



be trauma- or PTSD-related","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"60 minutes",,"8","10 sessions total","Completed all sessions",,,,,,"8.62","3.1",,,,,"Race and Ethnicity data reported","Mixed","25%",,"Inclusion required exposure to a Criterion A combat-related traumatic event but index trauma could be non-combat-related","High","McLean CP, Foa EB, Dondanville KA, et al. The effects of web-prolonged exposure among military personnel and veterans with posttraumatic stress disorder. Psychol Trauma. 2020 Nov 19;19:19. doi: 10.1037/tra0000978. PMID: 33211517.","1561431","2022"
"mclean2022_A","mclean2022","Other study class","2022","PTSD","Active Control",,"93","A","31",,"Renew smartphone application without coaching support","Internet-based self-help","Smartphone application focusing on exposure therapy and social support for users to self-manage PTSD symptoms; includes 2 primary exposure components: process (imaginal exposure) and approach (guided in vivo exposure); also includes psychoeducation, self-care, and a support function allowing users to invite support persons to a support team in the application.","No",,"No",,"No",,"No","No","Yes","Yes","No","Individual","Technology alone",,,"Free use of smartphone application","6",,"Received intervention and did not discontinue intervention",,"flow diagram: ""received intervention"" (n=30),""did not receive intervention due to withdrawal"" (n=1), and ""discontinued intervention"" (n=0)",,,,,,"Time in app: median (IQR) 102 (62-267) minutes
Time in exposure: median (IQR) 41 (3-113) minutes
Number of points: median (IQR) 155 (50-140)",,,,"Race and Ethnicity data reported","Veteran","69%",,,"High","McLean C, Davis CA, Miller M, et al. The effects of an exposure-based mobile app on symptoms of posttraumatic stress disorder in veterans: pilot randomized controlled trial. JMIR Mhealth Uhealth. 2022;10(11):e38951. doi: 10.2196/38951. PMID: 36331540.","1605000","2023"
"mclean2022_B","mclean2022","Other study class","2022","PTSD","PTSD",,"93","B","31",,"Renew smartphone application with coaching support","Internet-based facilitated self-help","Smartphone application focusing on exposure therapy and social support for users to self-manage PTSD symptoms; includes 2 primary exposure components: process (imaginal exposure) and approach (guided in vivo exposure); also includes psychoeducation, self-care, and a support function allowing users to invite support persons to a support team in the application.

Coaching support: study research assistant (RA) added as member of the app support team, RA responded to all notifications with reinforcing messages, and sent reminders.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology alone",,,"Free use of smartphone application","6",,"Received intervention and did not discontinue intervention",,"flow diagram: ""received intervention"" (n=31),""did not receive intervention"" (n=0), and ""discontinued intervention"" (n=0)",,,,,,"Time in app: median (IQR) 122 (57-231) minutes
Time in exposure: median (IQR) 27 (6-106) minutes
Number of points: median (IQR) 185 (60-510)
Support messages received: median (IQR) 19 (18-21)",,,,"Race and Ethnicity data reported","Veteran","69%",,,"High","McLean C, Davis CA, Miller M, et al. The effects of an exposure-based mobile app on symptoms of posttraumatic stress disorder in veterans: pilot randomized controlled trial. JMIR Mhealth Uhealth. 2022;10(11):e38951. doi: 10.2196/38951. PMID: 36331540.","1605000","2023"
"mclean2022_C","mclean2022","Other study class","2022","PTSD","Inactive Control",,"93","C","31",,"Waitlist","Waitlist","Waitlist","No",,"No",,"No",,"No","No","Yes","No","No","Individual",,,,,"6",,,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","69%",,,"High","McLean C, Davis CA, Miller M, et al. The effects of an exposure-based mobile app on symptoms of posttraumatic stress disorder in veterans: pilot randomized controlled trial. JMIR Mhealth Uhealth. 2022;10(11):e38951. doi: 10.2196/38951. PMID: 36331540.","1605000","2023"
"mclean2024_A","mclean2024","Other study class","2024","PTSD","PTSD",,"124","A","64",,"Written exposure therapy (WET)","Internet-based facilitated self-help","Variable-length written exposure therapy delivered online with peer coach support. WET adapted to ""(a) delivery through an online program, (b) typing the trauma narrative instead of writing it by hand, (c) the use of peer coaches rather than therapists, and (d) variable length treatment between four and eight sessions"", exposure was related to participant's worst (index) traumatic event. Treatment included 30-minute self-guided exposure sessions with participant typing their narrative into the program and reported SUDS before and after the exercise, and a brief (5-15 minute) online chat with a peer coach before and after each session and coaches reviewed the narrative prior to the next session. Sessions could be completed at any time during a 10-week window, with participants encouraged to complete multiple sessions per week (up to 1 session per day). If the participant's PCL-5 score was 21 or lower, the next session was the final session.
Due to limited availability of peer coaches midway through the study, a change was made allowing participants to skip the the presession and/or postsession chat with peer coach and were provided text instructional information and reminders; this was nonpersonalized and based on session number rather than individualized based on the narrative.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology alone",,"30-45 minutes","ad lib (up to 1 session/day)","10","4 to 8 sessions total","Completing full treatment program",,"of randomized sample",,,,,,"NR by group
overall randomized sample: 2.46 (SD 3.26)
participants who initiated treatment (n=62): 4.92 (SD 3.02)",,,,"Race and Ethnicity data reported","Veteran","33.1%",,,"High","McLean CP, Malek N, Straud CL. A pilot randomized controlled trial of online written exposure therapy delivered by peer coaches to veterans with posttraumatic stress disorder. J Trauma Stress. 2024 Feb 13. doi: 10.1002/jts.23020. Epub ahead of print. PMID: 38348490.","1630900","2024"
"mclean2024_B","mclean2024","Other study class","2024","PTSD","PTSD",,"124","B","60",,"Verbal exposure therapy","Internet-based facilitated self-help","Variable-length verbal exposure therapy delivered online with peer coach support. Treatment the same as for Arm A (WET) but with trauma narrative through self-guided verbal recounting, which was converted to a written account through text to type software for the peer coach to review.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology alone",,"30-45 minutes","ad lib (up to 1 session/day)","10","4 to 8 sessions total","Completing full treatment program",,"of randomized sample",,,,,,"NR by group
overall randomized sample: 2.46 (SD 3.26)
participants who initiated treatment (n=62): 4.92 (SD 3.02)",,,,"Race and Ethnicity data reported","Veteran","33.1%",,,"High","McLean CP, Malek N, Straud CL. A pilot randomized controlled trial of online written exposure therapy delivered by peer coaches to veterans with posttraumatic stress disorder. J Trauma Stress. 2024 Feb 13. doi: 10.1002/jts.23020. Epub ahead of print. PMID: 38348490.","1630900","2024"
"mcrae2004_A","mcrae2004","Pharmacotherapy","2004","PTSD","PTSD",,"37","A","18",,"Nefazodone","Nefazodone","Atypical antidepressant; titrated based on response and tolerability with adjustments at least weekly","No",,"Yes","Antidepressant: Other","No",,"No","No","No","No","No","Individual","In Person","Initiated at 50 mg, titrated to target dose 300 mg",,"Twice daily","12",,,,,"counted returned medication, counseled nonadherent patients",,,,,,"463 mg/day",,,"Not reported","Community","76.92%","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)","High","McRae AL, Brady KT, Mellman TA, et al. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004;19(3):190-6. doi: 10.1002/da.20008. PMID: 15129422.","26720","2019"
"mcrae2004_B","mcrae2004","Pharmacotherapy","2004","PTSD","PTSD",,"37","B","19",,"Sertraline","Sertraline","SSRI; titrated based on response and tolerability with adjustments at least weekly","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","Initiated at 25 mg, titrated to target dose 100 mg",,"Twice daily","12",,,,,"counted returned medication, counseled nonadherent patients",,,,,,"153 mg/day",,,"Not reported","Community","76.92%","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)","High","McRae AL, Brady KT, Mellman TA, et al. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004;19(3):190-6. doi: 10.1002/da.20008. PMID: 15129422.","26720","2019"
"meffert2021_A","meffert2021","Psychotherapy","2021","PTSD","PTSD",,"256","A","123",,"IPT + TAU","Interpersonal Psychotherapy (IPT)","Interpersonal Psychotherapy delivered by non-specialist therapists; IPT ""helps patients improve social functioning and manage interpersonal crises characterized as grief, role dispute, or role transition, by building social skills and gathering social support""



Treatment as usual: HIV clinic services and providers available as needed; ""TAU resources for HIV+GBV+ women included informal counseling and HIV treatment adherence counseling, medical professionals, community elders, church leaders, police [e.g., GBV legal issues], and pro bono legal aid."" No explicit, evidence-based mental health treatment was provided.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","12",,"completed IPT at 3 months",,,,,,,,,,,,"Not reported","Community","100%","Intimate partner violence",,"High","Meffert SM, Neylan TC, McCulloch CE, et al. Interpersonal psychotherapy delivered by nonspecialists for depression and posttraumatic stress disorder among Kenyan HIV-positive women affected by gender-based violence: randomized controlled trial. PLoS Med. 2021 Jan;18(1):e1003468. doi: 10.1371/journal.pmed.1003468. PMID: 33428625.","1563915","2022"
"meffert2021_B","meffert2021","Psychotherapy","2021","PTSD","Inactive Control",,"256","B","133",,"Waitlist + TAU","Waitlist","Waitlist: about 12 weeks, concurrently received TAU



Treatment as usual: HIV clinic services and providers available as needed; ""TAU resources for HIV+GBV+ women included informal counseling and HIV treatment adherence counseling, medical professionals, community elders, church leaders, police [e.g., GBV legal issues], and pro bono legal aid."" No explicit, evidence-based mental health treatment was provided.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,"As needed","12","12 weeks of usual care ""available for access as needed"" concurrent with waiting period",,,,,,,,,,,,,"Not reported","Community","100%","Intimate partner violence",,"High","Meffert SM, Neylan TC, McCulloch CE, et al. Interpersonal psychotherapy delivered by nonspecialists for depression and posttraumatic stress disorder among Kenyan HIV-positive women affected by gender-based violence: randomized controlled trial. PLoS Med. 2021 Jan;18(1):e1003468. doi: 10.1371/journal.pmed.1003468. PMID: 33428625.","1563915","2022"
"meredith2016_A","meredith2016","Collaborative care","2016","PTSD","PTSD",,"404","A","206","n=206 randomized, n=184 completed baseline interview","Collaborative Care","Collaborative care","Care manager provided active patient education and engagement using NIMH PTSD brochures and motivational interviewing and community resource support and facilitated continuity of care via ≥ 15 phone or in-person contacts (an initial in-person visit in conjunction with a scheduled primary care medical visit and up to 14 additional follow-up contacts by phone or in-person, over 1 year). Also, Primary Care Clinician education about trauma, PTSD and evidence-based psychopharmacology, including 2-hour training onsite and 2 booster training sessions via Webcast; laminated medication guide; patients provided with NIMH brochure","No",,"No",,"No",,"No","No","No","No","Yes","Individual","Mixed",,,"As needed","52",,"See Detail",,"Treatment complation not defined; assessment completion reported only. Completed initial visit to care manager and primary care clinician: 73% (134/184)
Completed at least half of the intended 14 follow-ups: 11%",,,,"4.2",,,,,,"Race and Ethnicity data reported","Community","80.56%",,,"Some Concerns","Meredith LS, Eisenman DP, Han B, et al. Impact of collaborative care for underserved patients with PTSD in primary care: a randomized controlled trial. J Gen Intern Med. 2016 May;31(5):509-17. doi: 10.1007/s11606-016-3588-3. PMID: 26850413.","44675","2019"
"meredith2016_B","meredith2016","Collaborative care","2016","PTSD","Inactive Control",,"404","B","198","n=198 randomized, n=171 completed baseline interview","Minimally Enhanced Usual Care","Minimally enhanced usual care","Primary Care Clinician education about trauma, PTSD and evidence-based psychopharmacology, including 2-hour training onsite and 2 booster training sessions via Webcast; laminated medication guide; patients provided with NIMH brochure.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Mixed",,,,"52",,"See Detail",,"Treatment complation not defined; assessment completion reported only. Study reports process of care outcomes (any mental health prescription; any mental health care utilization; any mental health counseling)",,,,,,,,,,"Race and Ethnicity data reported","Community","80.56%",,,"Some Concerns","Meredith LS, Eisenman DP, Han B, et al. Impact of collaborative care for underserved patients with PTSD in primary care: a randomized controlled trial. J Gen Intern Med. 2016 May;31(5):509-17. doi: 10.1007/s11606-016-3588-3. PMID: 26850413.","44675","2019"
"meredith2022_A","meredith2022","Collaborative care","2022","PTSD","PTSD",,"40","A","19","21 initially randomized; 1 exluded from analysis (double counted in both arms) and 1 dropped out before completing baseline assessments.","Trauma-Informed Collaborative Care (TICC)","Collaborative care","Collaborative care including regular contacts with a care manager (2 in-person and 6 by phone), patient education on PTSD, motivational interviewing to boost self-efficacy and coping, and linking to community resources. Model adapted from the Violence and Stress Assessment (ViStA) study for use with African American patients in Federally Qualified Health Centers, using a community workgroup to improve cultural sensitivity. Program includes integrated behavioral health. Also included all elements of Enhanced Usual Care.","No",,"No",,"No",,"No","No","No","No","Yes","Individual","Mixed",,,"8 care manager contacts over 9 months","39","9 months","See Detail",,"treatment completion not defined; does report study/assessment completion (n=16). Completed initial in-person visit with care manager: 78.95% (15/19)
Completed at least 2 follow-up encounters: 78.95% (15/19)
Completed all 7 follow-up encounters: 21.05% (4/19)",,,,,,"for n=15 who completed initial in-person visit: mean 5.2 follow-up phone encounters (out of 7) over the 9-month intervention period (""a 65% dose"")",,,,"Race data reported","Community","80%",,,"High","Meredith LS, Wong E, Osilla KC, et al. Trauma-informed Collaborative Care for African American Primary Care Patients in Federally Qualified Health Centers: A Pilot Randomized Trial. Med Care. 2022;60(3):232-9. doi: 10.1097/MLR.0000000000001681. PMID: 35157622.","1587537","2023"
"meredith2022_B","meredith2022","Collaborative care","2022","PTSD","Active Control",,"40","B","21",,"Enhanced Usual Care (EUC)","Treatment as usual (TAU)","Educated primary care clinic staff about PTSD and trauma-informed care, and trained physicians on evidence-based medication for PTSD. Primary care providers were informed of provisional diagnosis of PTSD for patients in the study, and patients were given an information sheet adapted from patient education resources from NIMH and ISTSS.","No",,"No",,"No",,"No","No","Yes","No","Yes","Individual","In Person",,,,,,"See Detail",,"treatment completion not defined; does report study/assessment completion (n=20)",,,,,,,,,,"Race data reported","Community","80%",,,"High","Meredith LS, Wong E, Osilla KC, et al. Trauma-informed Collaborative Care for African American Primary Care Patients in Federally Qualified Health Centers: A Pilot Randomized Trial. Med Care. 2022;60(3):232-9. doi: 10.1097/MLR.0000000000001681. PMID: 35157622.","1587537","2023"
"millergraff2021_A","millergraff2021","Other study class","2021","PTSD","PTSD",,"105","A","41","Excludes participants who did not complete baseline assessment after randomization (total n=18, NR by group)","PTSD Coach Online-Arabic","Internet-based self-help","Self-directed online tool (web or mobile app) addressing PTSD symptoms. Translated into Arabic with culturally-relevant pictures. Offered 17 cognitive-behavioral tools including psychoeducation, identifying distorted thoughts, cognitive restructuring, relaxation and mindfulness, interpersonal functioning, behavioral activation, and sleep. Participants chose how much to use the program and which tools to use.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology alone",,"Mean 16.85 minutes/day across 6 weeks","Mean 1.82 days/week across 6 weeks","6","""Target engagement period""","See Detail",,"treatment completion not defined, reports study/assessment completion; Treatment uptake (accessed app at any point during 6-week target engagement period, 78.0%, n=32), regular engagement (reported use every week, 22.0%)",,,,,,"Total mean estimated usage 311.13 minutes across 6 weeks",,,,"Not reported","Community","71.3%",,,"High","Miller‐Graff L, Ellis K, Hosny N. PTSD Coach Online–Arabic: a randomized controlled pilot trial to examine feasibility, acceptability, and preliminary effectiveness. J Trauma Stress. 2021;34(1):23-34. doi: 10.1002/jts.22621. PMID: 33159373.","1560791","2024"
"millergraff2021_B","millergraff2021","Other study class","2021","PTSD","Inactive Control",,"105","B","46","Excludes participants who did not complete baseline assessment after randomization (total n=18, NR by group)","Waitlist","Waitlist","Waitlist control. Participants instructed in use of online tool after completing all study assessments.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,"waiting period through completion of all assessments",,,,,,,,,,,,,"Not reported","Community","71.3%",,,"High","Miller‐Graff L, Ellis K, Hosny N. PTSD Coach Online–Arabic: a randomized controlled pilot trial to examine feasibility, acceptability, and preliminary effectiveness. J Trauma Stress. 2021;34(1):23-34. doi: 10.1002/jts.22621. PMID: 33159373.","1560791","2024"
"mills2012_A","mills2012","Psychotherapy","2012","PTSD+SUD","PTSD+SUD","Integrated","103","A","55",,"COPE + Usual Treatment","Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE)","COPE: modified version of Concurrent Treatment of PTSD and Cocaine Dependence. ""The version of COPE used in present study represents an integration of existing evidence-based manualized CBT interventions for PTSD and substance dependence... Treatment components include motivational enhancement and CBT for substance use (sessions 1-4 and throughout); psychoeducation relating to both disorders and their interaction (sessions 1-4); in vivo exposure (sessions 5-12); imaginal exposure (sessions 6-12); and cognitive therapy for PTSD (sessions 8-12). The final session (session 13) is dedicated to providing a review of the treatment, devising an after-care plan, and termination of therapy.""



Usual Treatment: participants could engage in usual treatment for substance dependence ""currently available in the community, including outpatient counseling, inpatient or outpatient detoxification, residential rehabilitation, and pharmacotherapies (e.g.,, methadone, buprenorphine, buprenorphine plus naloxone, naltrexone).""","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"COPE: 90 minutes; Usual Treatment: NR","COPE: weekly; Usual Treatment: NR","13","Intended to be delivered in 13 weekly sessions, but actual treatment duration ranged from 0 to 271 days (median 71 days)","attended all 13 sessions",,,,,,,,"median 5 (range 0 to 13)",,,,"Not reported","Community","62.1%","Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)","Low","Mills KL, Teesson M, Back SE, et al. Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):690-9. doi: 10.1001/jama.2012.9071. PMID: 22893166..","39123","2020"
"mills2012_B","mills2012","Psychotherapy","2012","PTSD+SUD","Inactive Control","Not integrated","103","B","48",,"Usual Treatment","Treatment as usual (TAU)","Usual treatment for substance dependence ""currently available in the community, including outpatient counseling, inpatient or outpatient detoxification, residential rehabilitation, and pharmacotherapies (e.g.,, methadone, buprenorphine, buprenorphine plus naloxone, naltrexone).""","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,,"usual treatment through follow-ups",,,,,,,,,,,,,"Not reported","Community","62.1%","Mixed","combat-related, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)","Low","Mills KL, Teesson M, Back SE, et al. Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):690-9. doi: 10.1001/jama.2012.9071. PMID: 22893166..","39123","2020"
"miner2016_A","miner2016","Other study class","2016","PTSD","PTSD",,"49","A","25",,"PTSD Coach smartphone application","Internet-based self-help","A smarphone application providing evidence-based tools, assessments, and psychoeducation without a structured program of use.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology alone",,"No limit","No limit","4",,,,"treatment completion not defined; does report app usage statistics for treatment feasibility",,,,,,"weekly usage of app: mean 2.65 (SD 1.03)",,,,"Race and Ethnicity data reported","Community","81.6%",,,"High","Miner A, Kuhn E, Hoffman JE, et al. Feasibility, acceptability, and potential efficacy of the PTSD Coach app: a pilot randomized controlled trial with community trauma survivors. Psychol Traum. 2016 May;8(3):384-92. doi: 10.1037/tra0000092. PMID: 27046668.","44676","2024"
"miner2016_B","miner2016","Other study class","2016","PTSD","Inactive Control",,"49","B","24",,"Waitlist","Waitlist","Waitlist","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"4",,,,,,,,,,,,,,"Race and Ethnicity data reported","Community","81.6%",,,"High","Miner A, Kuhn E, Hoffman JE, et al. Feasibility, acceptability, and potential efficacy of the PTSD Coach app: a pilot randomized controlled trial with community trauma survivors. Psychol Traum. 2016 May;8(3):384-92. doi: 10.1037/tra0000092. PMID: 27046668.","44676","2024"
"mitchell2021_A","mitchell2021","Psychotherapy & pharmacotherapy","2021","PTSD","PTSD",,"90","A","46",,"MDMA-assisted therapy","MDMA-assisted psychotherapy","3,4-methylenedioxymethamphetamine (MDMA) + therapy following the MDMA-assisted therapy treatment manual. Therapy was 



inner-directed and designed to invite inquiry and to facilitate therapeutic effect by providing support for approaching difficult material. Three experimental sessions with MDMA, overnight stay after each with first integration session the following morning and 2 more integration sessions over the following 3 to 4 weeks.","Yes","Trauma-focused","Yes","Psychostimulant","No",,"No","No","No","No","No","Individual","In Person","Single divided dose of 80 to 180mg","Experimental sessions: 8 hours



Integration sessions: 90 minutes","Experimental sessions: 3 sessions approximately 4 weeks apart



Integration sessions: 9 sessions, approximately 1 week apart","18","3 experimental sessions with MDMA and 9 integration sessions","Completed 3 experimental sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","65.6%","Mixed","Combat-related; Other (""developmental trauma"", ""multiple trauma"")","Low","Mitchell JM, Bogenschutz M, Lilienstein A, et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med. 2021 Jun;27(6):1025-33. doi: 10.1038/s41591-021-01336-3. PMID: 33972795.","1569198","2022"
"mitchell2021_B","mitchell2021","Psychotherapy & pharmacotherapy","2021","PTSD","Active Control",,"90","B","44","45 randomized, one withdrew consent before treatment","Placebo + therapy","Psychotherapy","Placebo + therapy following the MDMA-assisted therapy treatment manual. Therapy was inner-directed and designed to invite inquiry and to facilitate therapeutic effect by providing support for approaching difficult material. Three experimental sessions with inactive placebo, overnight stay after each with first integration session the following morning and 2 more integration sessions over the following 3 to 4 weeks.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person","Single divided placebo equivalent dose of 80 to 180 mg","Experimental sessions: 8 hours



Integration sessions: 90 minutes","Experimental sessions: 3 sessions approximately 4 weeks apart



Integration sessions: 9 sessions, approximately 1 week apart","18","3 experimental sessions with placebo and 9 integration sessions","Completed 3 experimental sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","65.6%","Mixed","Combat-related; Other (""developmental trauma"", ""multiple trauma"")","Low","Mitchell JM, Bogenschutz M, Lilienstein A, et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat Med. 2021 Jun;27(6):1025-33. doi: 10.1038/s41591-021-01336-3. PMID: 33972795.","1569198","2022"
"mitchell2023_A","mitchell2023","Psychotherapy & pharmacotherapy","2023","PTSD","PTSD",,"104","A","53","Randomized and completed first experimental session","MDMA-assisted therapy","MDMA-assisted psychotherapy","Experimental sessions included MDMA administration + therapy administered by 2-therapist team, at least one of whom was a licensed psychotherapist. Therapy followed MDMA-assisted therapy manual but not further described. Participants either stayed overnight at site with attendant or went home with a support person. First integration session (""non-drug therapy to support the participant in processing and understanding their experience"") occurred the morning after the experimental session, and two more occurred over 3 to 4 weeks before next experimental session.","Yes","Non-Trauma-focused","Yes","Psychostimulant","No",,"No","No","No","No","No","Individual","In Person","120 mg split dose 1st session (80 + 40) and 120 mg or 180 mg (120 + 60) split dose following sessions, as tolerated","Experimental: 8 hours + optional overnight with attendant
Integration sessions: 90 minutes","Weekly (approximately)","12","approximate treatment period 12 weeks; 12 in-person sessions over 12 weeks (3 experimental sessions each followed by 3 integration sessions)","completed experimental session 3 (last session)",,"flow diagram reports n=53 completers for each of experimental sessions 1, 2 and 3",,,,,,,,,"Three participants did not escalate dose, and one received 140 mg instead of 180 mg in session 3.","Race and Ethnicity data reported","Mixed","71.15%","Mixed","Combat-related; Other (""veteran status""; ""developmental trauma events"")","Low","Mitchell JM, Ot'alora GM, van der Kolk B, et al. MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial. Nature Medicine. 2023 10;29(10):2473-80. doi: 10.1038/s41591-023-02565-4. PMID: 37709999.","1624623","2024"
"mitchell2023_B","mitchell2023","Psychotherapy & pharmacotherapy","2023","PTSD","Inactive Control",,"104","B","51","Randomized and completed first experimental session","Placebo + therapy","Psychotherapy","Experimental sessions included placebo administration + therapy administered by 2-therapist team, at least one of whom was a licensed psychotherapist. Therapy followed MDMA-assisted therapy manual but not further described. Participants either stayed overnight at site with attendant or went home with a support person. First integration session (""non-drug therapy to support the participant in processing and understanding their experience"") occurred the morning after the experimental session, and two more occurred over 3 to 4 weeks before next experimental session.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"Experimental: 8 hours + optional overnight with attendant
Integration sessions: 90 minutes","Weekly (approximately)","12","approximate treatment period 12 weeks; 12 in-person sessions over 12 weeks (3 experimental sessions each followed by 3 integration sessions)","completed experimental session 3 (last session)",,"flow diagram reports n=51 completers for experimental session 1, n=46 for experimental session 2, and n=43 for experimental session 3",,,,,,,,,,"Race and Ethnicity data reported","Mixed","71.15%","Mixed","Combat-related; Other (""veteran status""; ""developmental trauma events"")","Low","Mitchell JM, Ot'alora GM, van der Kolk B, et al. MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial. Nature Medicine. 2023 10;29(10):2473-80. doi: 10.1038/s41591-023-02565-4. PMID: 37709999.","1624623","2024"
"mithoefer2011_A","mithoefer2011","Psychotherapy & pharmacotherapy","2011","PTSD","PTSD",,"23","A","15",,"MDMA-assisted psychotherapy","MDMA-assisted psychotherapy","Psychotherapy with concomitant MDMA administration: 2 MDMA-assisted sessions, 11 non-drug psychotherapy sessions with option of additional integration sessions as needed.","Yes","Non-Trauma-focused","Yes","Psychostimulant","No",,"No","No","No","No","No","Individual","In Person","MDMA dose: 125 mg, optional supplemental dose of 62.5 mg







Session length: psychotherapy 90 minutes, MDMA-assisted psychotherapy sessions 8 to 10 hours with overnight stay",,"MDMA: Monthly







Psychotherapy: Weekly","18",,"received allocated intervention",,,,,,,,,,,,"Race data reported","Community","85%","Mixed","combat-related, child physical abuse, child sexual abuse, child other abuse, rape/sexual assault, community/school violence, other (family violence)","High","Mithoefer MC, Wagner MT, Mithoefer AT, et al. The safety and efficacy of ±3,4-psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. [Erratum appears in J Psychopharmacol. 2011;25(6):852.] J Psychopharmacol. 2010 June;25(4):439-52. doi: 10.1177/0269881110378371.","35036","2019"
"mithoefer2011_B","mithoefer2011","Psychotherapy & pharmacotherapy","2011","PTSD","Active Control",,"23","B","8",,"Placebo-assisted psychotherapy","Trauma-focused psychotherapy","Psychotherapy with concomitant placebo (lactose) administration: 2 psychotherapy sessions with placebo administration, 11 non-drug psychotherapy sessions with option of additional integration sessions as needed.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person","Dose: NA







Psychotherapy: 90 minutes







Placebo-assisted psychotherapy sessions: 8 to 10 hours with overnight stay",,"Placebo: Monthly







Psychotherapy: Weekly","18",,"received allocated intervention",,,,,,,,,,,,"Race data reported","Community","85%","Mixed","combat-related, child physical abuse, child sexual abuse, child other abuse, rape/sexual assault, community/school violence, other (family violence)","High","Mithoefer MC, Wagner MT, Mithoefer AT, et al. The safety and efficacy of ±3,4-psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. [Erratum appears in J Psychopharmacol. 2011;25(6):852.] J Psychopharmacol. 2010 June;25(4):439-52. doi: 10.1177/0269881110378371.","35036","2019"
"mithoefer2018_A","mithoefer2018","Psychotherapy & pharmacotherapy","2018","PTSD","PTSD",,"26","A","12",,"MDMA-assisted psychotherapy","MDMA-assisted psychotherapy","MDMA, a psychoactive compound scheduled in the U.S. as a drug of abuse (ecstasy), and also used as an adjunct to psychotherapy. Patients received both MDMA-assisted ""non-directive or client-directed"" therapy sessions, following a treatment manual with a male or female co-therapy team, and additional non-drug therapy sessions. Treatment sessions of (double blind stage): 3 preparatory sessions with co-therapy team; 2 MDMA experimental sessions about one month (3-5 weeks) apart, each experimental session included an overnight stay with an integration session the next morning, daily phone contact for the following week, and 2 more integration psychotherapy sessions (approximately weekly).","Yes","Non-Trauma-focused","Yes","Psychostimulant","No",,"No","No","No","No","No","Individual","In Person","Session length: MDMA sessions 8 hours, nondrug (preparatory) sessions 90 minutes

Dose: 125 mg (followed 1.5 to 2 hours later by an optional supplemental dose of half the initial dose)",,"Every 3 to 5 weeks","6 to 8","primary endpoint was 1 month after 2nd MDMA session; treatment duration entered as approximation (3-5 weeks between experimental session 1 and 2, plus 1 week for phone contact and 2 weeks for integration sessions)","Treatment completion through primary assessment",,"assessment prior to crossover",,,,,,,,,,"Race and Ethnicity data reported","Mixed","26.92%","Mixed","combat-related, other (firefighter/police officer)","Low","Mithoefer MC, Mithoefer AT, Feduccia AA, et al. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Lancet Psychiatry. 2018 Jun;5(6):486-97. doi: 10.1016/S2215-0366(18)30135-4. PMID: 29728331.","50277","2019"
"mithoefer2018_B","mithoefer2018","Psychotherapy & pharmacotherapy","2018","PTSD","PTSD",,"26","B","7",,"MDMA-assisted psychotherapy","MDMA-assisted psychotherapy","MDMA, a psychoactive compound scheduled in the U.S. as a drug of abuse (ecstasy), and also used as an adjunct to psychotherapy. Patients received both MDMA-assisted ""non-directive or client-directed"" therapy sessions, following a treatment manual with a male or female co-therapy team, and additional non-drug therapy sessions. Treatment sessions of (double blind stage): 3 preparatory sessions with co-therapy team; 2 MDMA experimental sessions about one month (3-5 weeks) apart, each experimental session included an overnight stay with an integration session the next morning, daily phone contact for the following week, and 2 more integration psychotherapy sessions (approximately weekly).","Yes","Non-Trauma-focused","Yes","Psychostimulant","No",,"No","No","No","No","No","Individual","In Person","Session length: MDMA sessions 8 hours, non-drug sessions 90 minutes







Dose: 75 mg  (followed 1.5 to 2 hours later by an optional supplemental dose of half the initial dose, but NR on final cumulative dose)",,"Every 3 to 5 weeks","6 to 8","primary endpoint was 1 month after 2nd MDMA session; treatment duration entered as approximation (3-5 weeks between experimental session 1 and 2, plus 1 week for phone contact and 2 weeks for integration sessions)","Treatment completion through primary assessment",,"assessment prior to crossover",,,,,,,,,,"Race and Ethnicity data reported","Mixed","26.92%","Mixed","combat-related, other (firefighter/police officer)","Low","Mithoefer MC, Mithoefer AT, Feduccia AA, et al. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Lancet Psychiatry. 2018 Jun;5(6):486-97. doi: 10.1016/S2215-0366(18)30135-4. PMID: 29728331.","50277","2019"
"mithoefer2018_C","mithoefer2018","Psychotherapy & pharmacotherapy","2018","PTSD","Active Control",,"26","C","7",,"Low-dose MDMA-assisted psychotherapy","MDMA-assisted psychotherapy","MDMA, a psychoactive compound scheduled in the U.S. as a drug of abuse (ecstasy), and also used as an adjunct to psychotherapy. Patients received both MDMA-assisted ""non-directive or client-directed"" therapy sessions, following a treatment manual with a male or female co-therapy team, and additional non-drug therapy sessions. Treatment sessions of (double blind stage): 3 preparatory sessions with co-therapy team; 2 MDMA experimental sessions about one month (3-5 weeks) apart, each experimental session included an overnight stay with an integration session the next morning, daily phone contact for the following week, and 2 more integration psychotherapy sessions (approximately weekly).","Yes","Non-Trauma-focused","Yes","Psychostimulant","No",,"No","No","Yes","No","No","Individual","In Person","Session length: MDMA sessions 8 hours, non-drug sessions 90 minutes







Dose: 30 mg  (followed 1.5 to 2 hours later by an optional supplemental dose of half the initial dose)",,"Every 3 to 5 weeks","6 to 8","primary endpoint was 1 month after 2nd MDMA session; treatment duration entered as approximation (3-5 weeks between experimental session 1 and 2, plus 1 week for phone contact and 2 weeks for integration sessions)","Treatment completion through primary assessment",,"assessment prior to crossover",,,,,,,,,,"Race and Ethnicity data reported","Mixed","26.92%","Mixed","combat-related, other (firefighter/police officer)","Low","Mithoefer MC, Mithoefer AT, Feduccia AA, et al. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Lancet Psychiatry. 2018 Jun;5(6):486-97. doi: 10.1016/S2215-0366(18)30135-4. PMID: 29728331.","50277","2019"
"miyahira2012_A","miyahira2012","Psychotherapy","2012","PTSD","PTSD",,"42","A","29",,"CBT with virtual reality exposure","Virtual reality exposure therapy (VRET)","Manualized CBT treatment protocol with virtual reality exposure showing combat environment","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Twice weekly","5",,,,,,,,,,,,,,"Not reported","Active Duty Military",,"Combat-related",,"High","Miyahira SD, Folen RA, Hoffman HG, et al. The effectiveness of VR exposure therapy for PTSD in returning warfighters. Stud Health Technol Inform. 2012;181:128-32.  PMID: 22954842.","43675","2019"
"miyahira2012_B","miyahira2012","Psychotherapy","2012","PTSD","Inactive Control",,"42","B","13",,"Minimal attention","Minimal attention","Brief telephone contacts","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Phone",,,"Once every 2 weeks","5",,,,,,,,,,,,,,"Not reported","Active Duty Military",,"Combat-related",,"High","Miyahira SD, Folen RA, Hoffman HG, et al. The effectiveness of VR exposure therapy for PTSD in returning warfighters. Stud Health Technol Inform. 2012;181:128-32.  PMID: 22954842.","43675","2019"
"monga2023_A","monga2023","Pharmacotherapy","2023","PTSD","PTSD",,"72","A","36",,"Topiramate","Topiramate","Drug dose titrated upward by 25-50 mg increments weekly over 8 weeks to maximum tolerated dose or ""until complete or near-complete efficacy achieved"" or maximum allowed dose reached, then maintained for 4 more weeks. Preceded by washout phase (up to 30 days) for protocol-prohibited medications if indicated.","No",,"Yes","Mood Stabilizer","No",,"No","No","No","No","No","Individual","In Person","25 to 400 mg/day
titration: started at 25 mg/day, increased by 25 to 50 mg increments weekly over up to 8 weeks based on efficacy and tolerability; maximum dose 400 mg/day",,,"12","12 weeks total
titration: ≤8 weeks maintenance: ≥4 weeks (remainder of duration)",,,,,,,,,,,,"Median 100 mg/day, range 25 to 400 mg/day","Race data reported","Community","86.96%",,,"High","Monga V, Petty F, Padala K, et al. Topiramate monotherapy for civilian posttraumatic stress disorder: a controlled pilot study. Prim Care Companion CNS Disord. 2023 Oct 19;25(5):19. doi: 10.4088/PCC.23m03555. PMID: 37857291.","1626168","2024"
"monga2023_B","monga2023","Pharmacotherapy","2023","PTSD","Inactive Control",,"72","B","36",,"Placebo","Placebo","Look-alike placebo pills","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"12",,,,,,,,,,,,,,"Race data reported","Community","86.96%",,,"High","Monga V, Petty F, Padala K, et al. Topiramate monotherapy for civilian posttraumatic stress disorder: a controlled pilot study. Prim Care Companion CNS Disord. 2023 Oct 19;25(5):19. doi: 10.4088/PCC.23m03555. PMID: 37857291.","1626168","2024"
"monson2006_A","monson2006","Psychotherapy","2006","PTSD","PTSD",,"60","A","30",,"CPT","Cognitive Processing Therapy (CPT)","CPT according to Resick (2001), CBT with primary focus on cognitive interventions and includes exposure to traumatic memory through writing and reading accounts","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Twice weekly","6",,"completed CPT",,,,,,,,,,,,"Race data reported","Veteran","10%","Other","""military-related""","Low","Monson CM, Schnurr PP, Resick PA, et al. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. J Consult Clin Psychol. 2006 Oct;74(5):898-907. doi: 10.1037/0022-006X.74.5.898. PMID: 17032094.","28862","2019"
"monson2006_B","monson2006","Psychotherapy","2006","PTSD","Inactive Control",,"60","B","30",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"6",,,,,,,,,,,,,,"Race data reported","Veteran","10%","Other","""military-related""","Low","Monson CM, Schnurr PP, Resick PA, et al. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. J Consult Clin Psychol. 2006 Oct;74(5):898-907. doi: 10.1037/0022-006X.74.5.898. PMID: 17032094.","28862","2019"
"monson2012_A","monson2012","Psychotherapy","2012","PTSD","PTSD",,"80","A","20",,"Cognitive Behavioral Couple Therapy","Cognitive Behavioral Conjoint Therapy (CBCT)","Includes 3 phases that include both in- and out-of-session exercises. Phase I: establishing rationale for therapy and relationship safety. Phase 2: Avoidance. Phase 3: Influence of trauma on relationship trust, control, emotional closeness, and physical intimacy","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Couple","In Person",,,"Twice weekly for phases 1 and 2, weekly during phase 3.","12",,"Completed treatment",,,,,,,,,,,,"Race data reported","Mixed","75%","Mixed","rape/sexual assault, child sexual abuse, accidents, illness/medical procedure, combat-related, community/school violence, other (not specified)","Low","Monson CM, Fredman SJ, Macdonald A, et al. Effect of cognitive-behavioral couple therapy for PTSD: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):700-9. doi: 10.1001/jama.2012.9307. PMID: 22893167.","39124","2019"
"monson2012_B","monson2012","Psychotherapy","2012","PTSD","Inactive Control",,"80","B","20",,"Waitlist","Waitlist","Wait for 3 months before receiving treatment","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"12",,,,,,,,,,,,,,"Race data reported","Mixed","75%","Mixed","rape/sexual assault, child sexual abuse, accidents, illness/medical procedure, combat-related, community/school violence, other (not specified)","Low","Monson CM, Fredman SJ, Macdonald A, et al. Effect of cognitive-behavioral couple therapy for PTSD: a randomized controlled trial. JAMA. 2012 Aug 15;308(7):700-9. doi: 10.1001/jama.2012.9307. PMID: 22893167.","39124","2019"
"monson2024_A","monson2024","Psychotherapy","2024","PTSD","PTSD",,"32","A","15",,"Cognitive-Behavioral Conjoint Therapy (CBCT)","Cognitive Behavioral Conjoint Therapy (CBCT)","Trauma-focused therapy delivered in a couple therapy format and consisting of three phases: ""(1) psychoeducation about PTSD and conflict management skills, (2) communication skills training and behavioural exposures designed to overcome avoidance, and (3) making new meaning of the trauma and addressing cognitions that maintain PTSD and/or relationship conflict via a dyadic cognitive strategy designed to increase cognitive flexibility in each partner.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Couple","In Person",,"75 minutes","Weekly","15","total 15 sessions","Completing all sessions",,,,,,,,,,,,"Not Reported","Mixed","6.25%","Combat-related",,"High","Monson CM, Pukay-Martin ND, Wagner AC, Crenshaw AO, Blount TH, Schobitz RP, Dondanville KA, Young-McCaughan S, Mintz J, Riggs DS, Brundige A, Hembree EA, Litz BT, Roache JD, Yarvis JS, Peterson AL; STRONG STAR Consortium. Cognitive-behavioural conjoint therapy versus prolonged exposure for PTSD in military service members and veterans: results and lessons from a randomized controlled trial. Eur J Psychotraumatol. 2024;15(1):2330305. doi: 10.1080/20008066.2024.2330305. Epub 2024 Apr 8. PMID: 38590124; PMCID: PMC11005874.","1633301","2025"
"monson2024_B","monson2024","Psychotherapy","2024","PTSD","PTSD",,"32","B","17",,"Prolonged Exposure (PE)","Prolonged Exposure (PE)","Trauma-focused therapy consisting of ""imaginal exposure to specific traumatic memories and in vivo exposures designed to overcome avoidance of specific trauma reminders.""","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12","total 12 sessions","Completing all sessions",,,,,,,,,,,,"Not Reported","Mixed","6.25%","Combat-related",,"High","Monson CM, Pukay-Martin ND, Wagner AC, Crenshaw AO, Blount TH, Schobitz RP, Dondanville KA, Young-McCaughan S, Mintz J, Riggs DS, Brundige A, Hembree EA, Litz BT, Roache JD, Yarvis JS, Peterson AL; STRONG STAR Consortium. Cognitive-behavioural conjoint therapy versus prolonged exposure for PTSD in military service members and veterans: results and lessons from a randomized controlled trial. Eur J Psychotraumatol. 2024;15(1):2330305. doi: 10.1080/20008066.2024.2330305. Epub 2024 Apr 8. PMID: 38590124; PMCID: PMC11005874.","1633301","2025"
"moradi2014_A","moradi2014","Psychotherapy","2014","PTSD","PTSD",,"24","A","12",,"Group memory specificity training","Memory specificity training","Training group sessions following manual; aim of treatment is to enhance the specificity with which participants retrieve personal events from their autobiographical memory; uses concepts of specific vs over general memories; sessions involve training using neutral, positive, and negative cues, recall exercises and homework.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"1 hour","Weekly","4",,"Completion of all (8) workbook sessions",,,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"High","Moradi AR, Moshirpanahi S, Parhon H, et al. A pilot randomized controlled trial investigating the efficacy of Memory Specificity Training in improving symptoms of posttraumatic stress disorder. Behav Res Ther. 2014 May;56:68-74. doi: 10.1016/j.brat.2014.03.002. PMID: 24705337.","46541","2019"
"moradi2014_B","moradi2014","Psychotherapy","2014","PTSD","Inactive Control",,"24","B","12",,"Control","Assessment","No additional contact.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"4",,,,,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"High","Moradi AR, Moshirpanahi S, Parhon H, et al. A pilot randomized controlled trial investigating the efficacy of Memory Specificity Training in improving symptoms of posttraumatic stress disorder. Behav Res Ther. 2014 May;56:68-74. doi: 10.1016/j.brat.2014.03.002. PMID: 24705337.","46541","2019"
"moradi2021_A","moradi2021","Nonpharmacologic cognitive","2021","PTSD","PTSD",,"43","A","22",,"Memory flexibility training (MemFlex)","Memory flexibility training","Workbook-based program intended to improved autobiographical memory processes, by improving access to emotionally positive or benign memories and ability to move between specific and general memory. No retrieval of traumatic memories. Trains three core skills: balancing, elaboration, and flexibility.  Initial brief in-person orientation, which may be delivered by someone without mental healthcare training, followed by 8 independent sessions using a paper workbook. Participant may contact researcher with questions via text message.","No",,"No",,"No",,"No","Yes","No","No","No","Individual","Written",,"Initial in-person session: 30 to 45 minutes","Workbook sessions: twice a week","4","8 total workbook sessions



Pre-intervention to post-intervention: mean 31.7 days","Completed all 8 workbook sessions",,,,,,,,,,,,"Race data reported","Community","67.44%","Accidents",,"High","Moradi AR, Piltan M, Choobin MH, et al. Proof of concept for the autobiographical memory flexibility (MemFlex) intervention for posttraumatic stress disorder. Clin Psychol Sci. 2021 Jul;9(4):686-98. doi: 10.1177/2167702620982576. PMID: 34354873.","1574865","2022"
"moradi2021_B","moradi2021","Nonpharmacologic cognitive","2021","PTSD","Inactive Control",,"43","B","21",,"Waitlist","Waitlist","Initial in-person meeting, then no contact until follow-up assessments; same number of face-to-face appointments as MemFlex intervention. Received MemFlex intervention after 3-month follow-up.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,"For overall sample:
Pre-intervention to post-intervention: mean 31.7 days (range = 28–36); post-intervention to follow-up: mean 92.4 days (range = 84–103)",,,,,,,,,,,,,"Race data reported","Community","67.44%","Accidents",,"High","Moradi AR, Piltan M, Choobin MH, et al. Proof of concept for the autobiographical memory flexibility (MemFlex) intervention for posttraumatic stress disorder. Clin Psychol Sci. 2021 Jul;9(4):686-98. doi: 10.1177/2167702620982576. PMID: 34354873.","1574865","2022"
"morath2014_A","morath2014","Psychotherapy","2014","PTSD","PTSD",,"34","A","17",,"NET","Narrative Exposure Therapy (NET)","Trauma-focused treatment according to Schauer et al. (2011)","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12",,"See Detail",,"Study reports attrition from measurement, no dropouts at post-test but no information for treatment completion specifically",,,,,,,,,,"Not reported","Community","41.18%","Terrorism/political violence/forced displacement",,"High","Morath J, Gola H, Sommershof A, et al. The effect of trauma-focused therapy on the altered T cell distribution in individuals with PTSD: evidence from a randomized controlled trial. J Psychiatr Res. 2014 Jul;54:1-10. doi: 10.1016/j.jpsychires.2014.03.016. PMID: 24726027.","49697","2019"
"morath2014_B","morath2014","Psychotherapy","2014","PTSD","Inactive Control",,"34","B","17",,"Waitlist","Waitlist","Waiting period witout any standardized intervention","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"32","about 8 months",,,,,,,,,,,,,"Not reported","Community","41.18%","Terrorism/political violence/forced displacement",,"High","Morath J, Gola H, Sommershof A, et al. The effect of trauma-focused therapy on the altered T cell distribution in individuals with PTSD: evidence from a randomized controlled trial. J Psychiatr Res. 2014 Jul;54:1-10. doi: 10.1016/j.jpsychires.2014.03.016. PMID: 24726027.","49697","2019"
"morland2014_A","morland2014","Psychotherapy","2014","PTSD","PTSD",,"125","A","61",,"Group CPT-cognitive only delivered via videoteleconferencing","Cognitive Processing Therapy (CPT)","Variant of CPT that excludes the written trauma narrative. Modified version includes psychoeducation, skill building exercises, and practice strategies to restructure thoughts","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Group","Video",,"90 minutes","Twice weekly","6",,"attended >10 sessions",,,,,,,,,,,,"Race data reported","Veteran","0%","Combat-related",,"Low","Morland LA, Mackintosh M-A, Greene CJ, et al. Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. J Clin Psychiatry. 2014;75(5):470-6. doi: 10.4088/JCP.13m08842. PMID: 24922484.","42407","2019"
"morland2014_B","morland2014","Psychotherapy","2014","PTSD","PTSD",,"125","B","64",,"In person group CPT-cognitive only","Cognitive Processing Therapy (CPT)","Variant of CPT that excludes the written trauma narrative. Modified version includes psychoeducation, skill building exercises, and practice strategies to restructure thoughts","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"90 minutes","Twice weekly","6",,"attended >10 sessions",,,,,,,,,,,,"Race data reported","Veteran","0%","Combat-related",,"Low","Morland LA, Mackintosh M-A, Greene CJ, et al. Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. J Clin Psychiatry. 2014;75(5):470-6. doi: 10.4088/JCP.13m08842. PMID: 24922484.","42407","2019"
"morland2015_A","morland2015","Psychotherapy","2015","PTSD","PTSD",,"126","A","63",,"CPT by video teleconferencing","Cognitive Processing Therapy (CPT)","Individual manualized cognitive processing therapy delivered by video teleconferencing","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Video",,"90 minutes","Once or twice weekly","6 to12","12 sessions total","attended 10 or more sessions",,,"number of assignments completed",,,,,,,,,"Race data reported","Mixed","100%",,,"Some Concerns","Morland LA, Mackintosh MA, Rosen CS, et al. Telemedicine versus in-person delivery of cognitive processing therapy for women with posttraumatic stress disorder: a randomized noninferiority trial. Depress Anxiety. 2015 Nov;32(11):811-20. doi: 10.1002/da.22397. PMID: 26243685.","44260","2019"
"morland2015_B","morland2015","Psychotherapy","2015","PTSD","PTSD",,"126","B","63",,"CPT","Cognitive Processing Therapy (CPT)","Individual manualized cognitive processing therapy delivered in person","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Once or twice weekly","6 to12","12 sessions total","attended 10 or more sessions",,,,,,"10.3",,,,,,"Race data reported","Mixed","100%",,,"Some Concerns","Morland LA, Mackintosh MA, Rosen CS, et al. Telemedicine versus in-person delivery of cognitive processing therapy for women with posttraumatic stress disorder: a randomized noninferiority trial. Depress Anxiety. 2015 Nov;32(11):811-20. doi: 10.1002/da.22397. PMID: 26243685.","44260","2019"
"morland2019_A","morland2019","Psychotherapy","2019","PTSD","PTSD",,"175","A","58",,"In-home in-person PE","Prolonged Exposure (PE)","In-home-in-person individual PE; includes psychoeducation, breathing retraining, imaginal and in vivo exposure. Number of sessions dependent on treatment response - early responders ""could graduate before attending 15 sessions if they completed six or seven sessions of PE and had PCL‐5 scores <21 for two consecutive sessions"" or PCL-5 score <30 (cutoff score for PCL-5 revised during study).","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Once a week","6 to15",,"completed ≥8 sessions",,,,,,"9.8","5",,,,,"Race and Ethnicity data reported","Veteran","25.1%",,,"Some Concerns","Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.","1549280","2020"
"morland2019_B","morland2019","Psychotherapy","2019","PTSD","Active Control",,"175","B","58",,"Home-based telehealth PE","Prolonged Exposure (PE)","Individual PE delivered by home-based telehealth; includes psychoeducation, breathing retraining, imaginal and in vivo exposure. Number of sessions dependent on treatment response - early responders ""could graduate before attending 15 sessions if they completed six or seven sessions of PE and had PCL‐5 scores <21 for two consecutive sessions"" or PCL-5 score <30 (cutoff score for PCL-5 revised during study).","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","Video",,"90 minutes","Once a week","6 to15",,"completed ≥8 sessions",,,,,,"8.3","4.96",,,,,"Race and Ethnicity data reported","Veteran","25.1%",,,"Some Concerns","Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.","1549280","2020"
"morland2019_C","morland2019","Psychotherapy","2019","PTSD","Active Control",,"175","C","59",,"Office-based telehealth PE","Prolonged Exposure (PE)","Individual PE delivered in office-based telehealth; includes psychoeducation, breathing retraining, imaginal and in vivo exposure. Number of sessions dependent on treatment response - early responders ""could graduate before attending 15 sessions if they completed six or seven sessions of PE and had PCL‐5 scores <21 for two consecutive sessions"" or PCL-5 score <30 (cutoff score for PCL-5 revised during study).","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","Video",,"90 minutes","Once a week","6 to15",,"completed ≥8 sessions",,,,,,"7","4.55",,,,,"Race and Ethnicity data reported","Veteran","25.1%",,,"Some Concerns","Morland L, Mackintosh MA, Glassman L, et al. Home-based delivery of variable length prolonged exposure therapy: a comparison of clinical efficacy between service modalities. 2019 Dec 24. doi: 10.1002/da.22979. PMID: 31872563.","1549280","2020"
"morland2022_A","morland2022","Psychotherapy","2022","PTSD","PTSD",,"137","A","46",,"Office-based brief conjoint CBT","Cognitive Behavioral Conjoint Therapy (CBCT)","Brief version of manualized conjoint CBT protocol, conducted in VA office setting. Original protocol included 15 sessions in 3 phases. Brief version includes phases 1 and 2 (7 sessions) plus an eighth session corresponding to the final session in the original protocol. Phase 1 includes psychoeducation on PTSD and relationships, anger, and conflict management. Phase 2 builds communication skills and emotional intimacy, and also includes cognitive challenging of trauma-related thoughts.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Couple","In Person",,"75 minutes","Weekly","8",,"Seven of eight sessions considered ""meaningful dose""",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","18.98%",,,"High","Morland LA, Knopp KC, Khalifian CE, et al. A randomized trial of brief couple therapy for PTSD and relationship satisfaction. J Consult Clin Psychol. 2022 May;90(5):392-404. doi: 10.1037/ccp0000731. PMID: 35604746.","1593669","2023"
"morland2022_B","morland2022","Psychotherapy","2022","PTSD","PTSD",,"137","B","46",,"Home-based brief conjoint CBT","Cognitive Behavioral Conjoint Therapy (CBCT)","Brief version of manualized conjoint CBT protocol, conducted remotely. Original version included 15 sessions in 3 phases. Brief version includes phases 1 and 2 (7 sessions) plus an eighth session corresponding to the final session in the original protocol. Phase 1 includes psychoeducation on PTSD and relationships, anger, and conflict management. Phase 2 builds communication skills and emotional intimacy, and also includes cognitive challenging of trauma-related thoughts.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Couple","Video",,"75 minutes","Weekly","8",,"Seven of eight sessions considered ""meaningful dose""",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","18.98%",,,"High","Morland LA, Knopp KC, Khalifian CE, et al. A randomized trial of brief couple therapy for PTSD and relationship satisfaction. J Consult Clin Psychol. 2022 May;90(5):392-404. doi: 10.1037/ccp0000731. PMID: 35604746.","1593669","2023"
"morland2022_C","morland2022","Psychotherapy","2022","PTSD","Active Control",,"137","C","45",,"PTSD family education","Psychoeducation","Manualized PTSD-focused psychoeducation about PTSD, comorbid conditions, effect on health and relationships, and treatment. No skills training.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Couple","In Person",,"75 minutes","Weekly","8",,"Seven of eight sessions considered ""meaningful dose""",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","18.98%",,,"High","Morland LA, Knopp KC, Khalifian CE, et al. A randomized trial of brief couple therapy for PTSD and relationship satisfaction. J Consult Clin Psychol. 2022 May;90(5):392-404. doi: 10.1037/ccp0000731. PMID: 35604746.","1593669","2023"
"mueser2008_A","mueser2008","Psychotherapy","2008","PTSD","PTSD",,"108","A","54",,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Program includes psychoeducation, breathing retraining, and cognitive restructuring","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,,"16 to 24","12 to 16 sessions total","completed ≥6 sessions",,,,,,,,,,,,"Race data reported","Community","78.7%","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)","Some Concerns","Mueser KT, Rosenberg SD, Xie HY, et al. A randomized controlled trial of cognitive-behavioral treatment for posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol. 2008 Apr;76(2):259-71. doi: 10.1037/0022-006X.76.2.259. PMID: 18377122.","30794","2019"
"mueser2008_B","mueser2008","Psychotherapy","2008","PTSD","Inactive Control",,"108","B","54",,"TAU","Treatment as usual (TAU)",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"16 to 24",,,,,,,,,,,,,,"Race data reported","Community","78.7%","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, other (not specified)","Some Concerns","Mueser KT, Rosenberg SD, Xie HY, et al. A randomized controlled trial of cognitive-behavioral treatment for posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol. 2008 Apr;76(2):259-71. doi: 10.1037/0022-006X.76.2.259. PMID: 18377122.","30794","2019"
"mueser2015_A","mueser2015","Psychotherapy","2015","PTSD","PTSD",,"201","A","104",,"CBT for severe mental illness","Trauma-focused cognitive behavioral therapy (TF-CBT)","CBT program including breath retraining and cognitive restructuring","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,,"12 to 16",,"completing ≥ 6 sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Community","68.66%",,,"Low","Mueser KT, Gottlieb JD, Xie H, et al. Evaluation of cognitive restructuring for post-traumatic stress disorder in people with severe mental illness. Br J Psychiatry. 2015 Jun;206(6):501-8. doi: 10.1192/bjp.bp.114.147926. PMID: 25858178.","43698","2019"
"mueser2015_B","mueser2015","Psychotherapy","2015","PTSD","Active Control",,"201","B","97",,"Brief Treatment","Psychoeducation","Includes breathing retraining and educational components of the CBT program","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"3",,"completing ≥ 2 sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Community","68.66%",,,"Low","Mueser KT, Gottlieb JD, Xie H, et al. Evaluation of cognitive restructuring for post-traumatic stress disorder in people with severe mental illness. Br J Psychiatry. 2015 Jun;206(6):501-8. doi: 10.1192/bjp.bp.114.147926. PMID: 25858178.","43698","2019"
"mullerengelmann2024_A","mullerengelmann2024","Psychotherapy","2024","PTSD","PTSD",,"32","A","16",,"C-METTA (cognitive techniques + loving-kindness meditations)","C-METTA","C-METTA is an intervention combining cognitive techniques and loving-kindness meditation. In-person treatments for 6 weeks (treatment phase) followed by a 4-week self-guided practice phase.
Treatment phase: Inital sessions include psychoeducation on trauma-related guilt and shame, and Socratic questioning to restructure guilt/shame cognitions. Later sessions combine cognitive techniques with loving-kindness meditation, directed towards oneself, a specific ""benefactor"" in the patient's life, and towards all human beings. Up to 2 additional 50-minute sessions were allowed ""to address severe comorbid symptoms and problems"" at therapist discretion. Audiotapes provided for home practice.
Pracice phase: Participants were asked to continue self-guided meditation for 4 weeks after the in-person intervention was complete.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"100 minutes","Weekly (treatment phase)","10","6 weekly in-person sessions (treatment phase) followed by 4 weeks of self-guided home meditation (practice phase)","Attended all 6 treatment sessions and completed the 4-week practice phase",,"No",,,,,,"all participants completed the 6 sessions in treatment phase, ""half of the patients received additional sessions"" (overall mean number of sessions NR)",,,,"Not reported","Community","93.75%","Mixed","Child physical abuse; Child sexual abuse; Rape/sexual assault;  Community/school violence; Other (not specified)","Some Concerns","Muller-Engelmann M, Bahnemann L, Kummerle S. The effects of a combination of cognitive interventions and loving-kindness meditations (C-METTA) on guilt, shame and PTSD symptoms: results from a pilot randomized controlled trial. Eur J Psychotraumatol. 2024;15(1):2308439. doi: 10.1080/20008066.2024.2308439. PMID: 38323870.","1630513","2024"
"mullerengelmann2024_B","mullerengelmann2024","Psychotherapy","2024","PTSD","Inactive Control",,"32","B","16",,"Waitlist","Waitlist","Waitlist","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Not reported","Community","93.75%","Mixed","Child physical abuse; Child sexual abuse; Rape/sexual assault;  Community/school violence; Other (not specified)","Some Concerns","Muller-Engelmann M, Bahnemann L, Kummerle S. The effects of a combination of cognitive interventions and loving-kindness meditations (C-METTA) on guilt, shame and PTSD symptoms: results from a pilot randomized controlled trial. Eur J Psychotraumatol. 2024;15(1):2308439. doi: 10.1080/20008066.2024.2308439. PMID: 38323870.","1630513","2024"
"nacasch2011_A","nacasch2011","Psychotherapy","2011","PTSD","PTSD",,"30","A","15",,"PE","Prolonged Exposure (PE)","Trauma-focused individual therapy; sessions included: psychoeducation about trauma and related symptoms, treatment rationale and description, breathing retraining, in vivo exposure, imaginal exposure, and discussion/processing, as well as in vivo homework assignments between sessions.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 to 120 minutes","Weekly","9 to 15","9 to 15 sessions total","See Detail",,"reports study/assessment completion only, no information on treatment completion",,,,"11","2.9",,,,,"Not reported","Veteran","6.67%","Mixed","combat-related, terrorism/political violence","Some Concerns","Nacasch N, Foa EB, Huppert JD, et al. Prolonged exposure therapy for combat- and terror-related posttraumatic stress disorder: a randomized control comparison with treatment as usual. J Clin Psychiatry. 2011 Sep;72(9):1174-80. doi: 10.4088/JCP.09m05682blu. PMID: 21208581.","35512","2019"
"nacasch2011_B","nacasch2011","Psychotherapy","2011","PTSD","Active Control",,"30","B","15",,"TAU","Supportive counseling","Usual treatment with nondirective, psychodynamically oriented therapy and/or medication and counseling; therapy delivered by the same therapists as the PE intervention and was not focused on the traumatic event.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No",,,,"1 hour","Weekly",,,"See Detail",,"reports study/assessment completion only, no information on treatment completion",,,,,,,,,,"Not reported","Veteran","6.67%","Mixed","combat-related, terrorism/political violence","Some Concerns","Nacasch N, Foa EB, Huppert JD, et al. Prolonged exposure therapy for combat- and terror-related posttraumatic stress disorder: a randomized control comparison with treatment as usual. J Clin Psychiatry. 2011 Sep;72(9):1174-80. doi: 10.4088/JCP.09m05682blu. PMID: 21208581.","35512","2019"
"nacasch2015_A","nacasch2015","Psychotherapy","2015","PTSD","PTSD",,"39","A","20",,"PE","Prolonged Exposure (PE)","Short-duration PE therapy according to treatment manual for PE (Foa et al., 2007), with imaginal exposure portion limited to 20 minutes of a 60-minute session. The first 2 sessions (pre-randomization) included treatment rationale, information gathering about trauma history, most disturbing trauma, breathing retraining, construction of in vivo exposure hierarchy and homework assignments. Remaining sessions (postrandomization) included homework review, imaginal exposure for 20 minutes followed by processing, and assignment of in vivo exposure homework.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"Session length: 60 minutes



Imaginal exposure portion: 20 minutes",,,"10 to 15 sessions total","Supervisor and therapist agreed that the patient's self-reported symptoms of PTSD remained low and stable (minimum 10, maximum 15 sessions)",,,,,,"13.6","2.23",,,,,"Not reported","Veteran","38.46%","Mixed","combat-related, rape/sexual assault, child sexual abuse, community/school violence, terrorism/political violence/forced displacement, accidents","Low","Nacasch N, Huppert JD, Su Y-J, et al. Are 60-minute prolonged exposure sessions with 20-minute imaginal exposure to traumatic memories sufficient to successfully treat PTSD? A randomized nonininferiority clinical trial. Behav Ther. 2015 May;46(3):328-41. doi: 10.1016/j.beth.2014.12.002. PMID: 25892169.","43927","2019"
"nacasch2015_B","nacasch2015","Psychotherapy","2015","PTSD","PTSD",,"39","B","19",,"PE","Prolonged Exposure (PE)","Long-duration (typical) PE therapy according to treatment manual for PE (Foa et al., 2007), with imaginal exposure portion of 40 minutes and a 90-minute session. The first 2 sessions (prerandomization) included treatment rationale, information gathering about trauma history, most disturbing trauma, breathing retraining, construction of in vivo exposure hierarchy and homework assignments. Remaining sessions (postrandomization) included homework review, imaginal exposure for 40 minutes followed by processing, and assignment of in vivo exposure homework.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"Session length: 90 minutes



Imaginal exposure portion: 40 minutes",,,"10 to 15 sessions total","Supervisor and therapist agreed that the patient's self-reported symptoms of PTSD remained low and stable (minimum 10, maximum 15 sessions)",,,,,,"13.21","2.59",,,,,"Not reported","Veteran","38.46%","Mixed","combat-related, rape/sexual assault, child sexual abuse, community/school violence, terrorism/political violence/forced displacement, accidents","Low","Nacasch N, Huppert JD, Su Y-J, et al. Are 60-minute prolonged exposure sessions with 20-minute imaginal exposure to traumatic memories sufficient to successfully treat PTSD? A randomized nonininferiority clinical trial. Behav Ther. 2015 May;46(3):328-41. doi: 10.1016/j.beth.2014.12.002. PMID: 25892169.","43927","2019"
"najavits2018_A","najavits2018","Psychotherapy","2018","PTSD+SUD","PTSD+SUD","Integrated","52","A","26",,"Creating Change","Creating Change","Individual, past-focused cognitive-behavioral therapy for PTSD/SUD; covered 17 topics relevant to both PTSD and SUD. Both interventions included ""a check-in, inspirational quotation, handouts, and check-out""; participants also allowed to ""attend nonstudy therapies and supports including 12-step self-help groups, except for current PTSD or PTSD/SUD evidence-based therapy models.""","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","17",,"See Detail",,"reports study/assessment completion only; treatment attendance reported for overall arm (67% of available CC sessions attended), and a note that one participant attended no sessions (intervention arm of this participant not provided)",,,,"11.42","5.36",,,,,"Race and Ethnicity data reported","Veteran","26.92%","Mixed","combat-related, rape/sexual assault, other (NR)","High","Najavits LM, Krinsley K, Waring ME, et al. A randomized controlled trial for veterans with PTSD and substance use disorder: creating change versus seeking safety. Subst Use Misuse. 2018 Sep 19;53(11):1788-800. doi: 10.1080/10826084.2018.1432653. PMID: 29461920.","49779","2020"
"najavits2018_B","najavits2018","Psychotherapy","2018","PTSD+SUD","PTSD+SUD","Integrated","52","B","26",,"Seeking Safety","Seeking Safety","Individual, present-focused cognitive-behavioral therapy for PTSD/SUD; 17 of the 25 topics in Seeking Safety were used in order to keep dose of therapy the same between interventions (the 17 topics were same for all participants). Both interventions included ""a check-in, inspirational quotation, handouts, and check-out""; participants also allowed to ""attend nonstudy therapies and supports including 12-step self-help groups, except for current PTSD or PTSD/SUD evidence-based therapy models.""","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","17",,"See Detail",,"reports study/assessment completion only; treatment attendance reported for overall arm (68% of available SS sessions attended), and a note that one participant attended no sessions (intervention arm of this participant not provided)",,,,"11.62","5.36",,,,,"Race and Ethnicity data reported","Veteran","26.92%","Mixed","combat-related, rape/sexual assault, other (NR)","High","Najavits LM, Krinsley K, Waring ME, et al. A randomized controlled trial for veterans with PTSD and substance use disorder: creating change versus seeking safety. Subst Use Misuse. 2018 Sep 19;53(11):1788-800. doi: 10.1080/10826084.2018.1432653. PMID: 29461920.","49779","2020"
"nam2013_A","nam2013","Nonpharmacologic biological","2013","PTSD","PTSD",,"18","A","9",,"rTMS","Transcranial magnetic stimulation (TMS)","Low-frequency rTMS to the right prefrontal cortex","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person","1 Hz at 100% motor threshold, 18,000 pulses total","20 minutes","Daily","2.14",,"Completed treatment",,"publication reports for study completers only, dropouts were before or during treatment period (all in active arm) so appears study completers also completed treatment",,,,,,,,,,"Not reported","Community","62.5%","Mixed","intimate partner violence, accidents, community/school violence","Some Concerns","Nam D-H, Pae C-U, Chae J-H. Low-frequency, repetitive transcranial magnetic stimulation for the treatment of patients with posttraumatic stress disorder: a double-blind, sham-controlled study. Clin Psychopharmacol Neurosci. 2013 Aug;11(2):96-102. doi: 10.9758/cpn.2013.11.2.96. PMID: 24023554.","46490","2019"
"nam2013_B","nam2013","Nonpharmacologic biological","2013","PTSD","Inactive Control",,"18","B","9",,"Sham rTMS","Sham","Identical rTMS treatment except lateral wing of coil raised 90 degrees off the head, with edge of medial wing of the coil still touching scalp.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"20 minutes","daily","2.14",,"Completed treatment",,"publication reports for study completers only, dropouts were before or during treatment period (all in active arm) so appears study completers also completed treatment",,,,,,,,,,"Not reported","Community","62.5%","Mixed","intimate partner violence, accidents, community/school violence","Some Concerns","Nam D-H, Pae C-U, Chae J-H. Low-frequency, repetitive transcranial magnetic stimulation for the treatment of patients with posttraumatic stress disorder: a double-blind, sham-controlled study. Clin Psychopharmacol Neurosci. 2013 Aug;11(2):96-102. doi: 10.9758/cpn.2013.11.2.96. PMID: 24023554.","46490","2019"
"nasiri2024_A","nasiri2024","Psychotherapy & CIH","2024","PTSD","PTSD",,"84","A","42",,"Mandala coloring + TAU","Art therapy","TAU + mandala coloring
Mandala coloring: group sessions following group therapy. A 1-hour training lecture on art-making was given prior to intervention, covering mandala designs and instructions on coloring. For mandala sessions, participants were provided identical sets of uncolored mandala designs and crayons to color one mandala per session.
TAU: group therapy as routine care in which psychologist taught self-care, stress and emotion management, and exercises such as muscle relaxation, slow breathing, and body scanning.","Yes","Non-Trauma-focused","No",,"Yes","Creative therapy","No","No","No","No","No","Group","In Person",,"15 minutes","Twice a week","3","6 coloring sessions total","See Detail",,"no information on treatment completion, only reports participants ""received allocated intervention""(n=42)",,,,,,,,,,,"Veteran","0%",,,"High","Nasiri MA, Sajadi SA, Farsi Z, Heidarieh M. The Effects of Mandala Coloring and Free Coloring on Mindfulness and the Score of Posttraumatic Stress Disorder in Veterans: A Randomized Controlled Trial. Holist Nurs Pract. 2024 Aug 5. doi: 10.1097/HNP.0000000000000680. Epub ahead of print. PMID: 39102487.","1637400","2025"
"nasiri2024_B","nasiri2024","Psychotherapy & CIH","2024","PTSD","Active Control",,"84","B","24",,"Control coloring + group therapy","Attention control","TAU + free coloring
Free coloring: group sessions following group therapy. No training lectuire given. Participants were  provided blank paper and crayons to color freely for each session.
TAU: group therapy as routine care in which psychologist taught self-care, stress and emotion management, and exercises such as muscle relaxation, slow breathing, and body scanning.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Group","In Person",,"15 minutes","Twice a week","3","6 coloring sessions total","See Detail",,"no information on treatment completion, only reports participants ""received allocated intervention""(n=42)",,,,,,,,,,,"Veteran","0%",,,"High","Nasiri MA, Sajadi SA, Farsi Z, Heidarieh M. The Effects of Mandala Coloring and Free Coloring on Mindfulness and the Score of Posttraumatic Stress Disorder in Veterans: A Randomized Controlled Trial. Holist Nurs Pract. 2024 Aug 5. doi: 10.1097/HNP.0000000000000680. Epub ahead of print. PMID: 39102487.","1637400","2025"
"naylor2015_A","naylor2015","Pharmacotherapy","2015","PTSD","PTSD",,"16","A",,,"Aripiprazole augmentation","Aripiprazole augmentation","Second-generation antipsychotic augmentation; all patients also continued baseline antidepressant treatment for PTSD. Following a 2-week placebo lead-in, aripiprazole 5 mg/day taken for 2 weeks, 5 to 10 mg/day for 2 weeks, 5 to 15 mg/day for 2 weeks, and finally 5 to 20 mg/day taken for 2 weeks.","No",,"Yes","Mixed","No",,"No","No","No","No","No","Individual","In Person","Initiated at 5 mg, titrated to maximum 20 mg",,"Daily","8",,,,,,,,,,,"10.0 mg/day",,,"Race and Ethnicity data reported","Veteran","35.71%","Combat-related",,"High","Naylor JC, Kilts JD, Bradford DW, et al. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment. Int. Clin Psychopharmacol. 2015;30(3):167-74. doi: 10.1097/YIC.0000000000000061. PMID: 25647451.","46407","2019"
"naylor2015_B","naylor2015","Pharmacotherapy","2015","PTSD","Active Control",,"16","B",,,"Placebo augmentation","Placebo augmentation","Augmentation with placebo capsules identical to active drug; all patients also continued baseline antidepressant treatment for PTSD. Double-blind treatment followed a 2-week placebo lead-in.","No",,"Yes","Other pharmacotherapy","No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","8",,,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","35.71%","Combat-related",,"High","Naylor JC, Kilts JD, Bradford DW, et al. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment. Int. Clin Psychopharmacol. 2015;30(3):167-74. doi: 10.1097/YIC.0000000000000061. PMID: 25647451.","46407","2019"
"neuner2008_A","neuner2008","Psychotherapy","2008","PTSD","PTSD",,"277","A","111",,"NET","Narrative Exposure Therapy (NET)","Carried out according to manual by Schauer et al. (2005). Participants construct a chronological account of his own biography. Then the counselor discussed traumatic experiences with focus on current emotional, physiological, cognitive, and behavioral reactions to the experience until habituation of the emotional reactions","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 to 2 hours","Twice weekly","3","6 sessions total","Completed treatment",,"Study reports 4% ""dropped out of NET treatment"" in abstract; study results show n=4 (3.6%) refused or dropped out of treatment, describes remainder as treatment completers",,,,,,,,,,"Not reported","Community","51.26%","Terrorism/political violence/forced displacement",,"High","Neuner F, Onyut PL, Ertl V, et al. Treatment of posttraumatic stress disorder by trained lay counselors in an African refugee settlement: a randomized controlled trial. J Consult Clin Psychol. 2008 Aug;76(4):686-94. doi: 10.1037/0022-006X.76.4.686. PMID: 18665696.","31216","2019"
"neuner2008_B","neuner2008","Psychotherapy","2008","PTSD","PTSD",,"277","B","111",,"Trauma counseling","Trauma counseling","Counselors address psychological and social needs expressed by the participant by relating current problems to past traumatic experiences. Counselors can use narrative exposure of traumatic events as part of therapy, but is not required","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 to 2 hours","Twice weekly","3","6 sessions total","Completed treatment",,"Study reports n=22 did not complete therapy, describes remainder as treatment completers",,,,,,,,,,"Not reported","Community","51.26%","Terrorism/political violence/forced displacement",,"High","Neuner F, Onyut PL, Ertl V, et al. Treatment of posttraumatic stress disorder by trained lay counselors in an African refugee settlement: a randomized controlled trial. J Consult Clin Psychol. 2008 Aug;76(4):686-94. doi: 10.1037/0022-006X.76.4.686. PMID: 18665696.","31216","2019"
"neuner2008_C","neuner2008","Psychotherapy","2008","PTSD","Inactive Control",,"277","C","55",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Not reported","Community","51.26%","Terrorism/political violence/forced displacement",,"High","Neuner F, Onyut PL, Ertl V, et al. Treatment of posttraumatic stress disorder by trained lay counselors in an African refugee settlement: a randomized controlled trial. J Consult Clin Psychol. 2008 Aug;76(4):686-94. doi: 10.1037/0022-006X.76.4.686. PMID: 18665696.","31216","2019"
"neuner2010_A","neuner2010","Psychotherapy","2010","PTSD","PTSD",,"32","A","16",,"NET","Narrative Exposure Therapy (NET)","Intervention according to manual by Schauer et al. (2005) containing psychoeducation and participants narrating their biography","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"NR (mean 120 minutes)","Once or twice weekly",,"terminated at therapist's discretion","did not discontinue intervention",,"Study reports n=2 dropped out, neither completed NET, flow diagram shows only these 2 as discontinued intervention",,,,"8.79","3.77",,,,,"Not reported","Community","31.25%","Terrorism/political violence/forced displacement",,"High","Neuner F, Kurreck S, Ruf M, et al. Can asylum-seekers with posttraumatic stress disorder be successfully treated? A randomized controlled pilot study. Cogn Behav Ther. 2010;39(2):81-91. doi: 10.1080/16506070903121042. PMID: 19816834.","33877","2019"
"neuner2010_B","neuner2010","Psychotherapy","2010","PTSD","Inactive Control",,"32","B","16",,"TAU","Treatment as usual (TAU)","Participants encouraged to continue their current treatment or were referred to institutions of public mental health care","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,"no set treatment (TAU), study states ""except for one patient, all patients in the TAU condition received treatment""",,,,,,,,,,"Not reported","Community","31.25%","Terrorism/political violence/forced displacement",,"High","Neuner F, Kurreck S, Ruf M, et al. Can asylum-seekers with posttraumatic stress disorder be successfully treated? A randomized controlled pilot study. Cogn Behav Ther. 2010;39(2):81-91. doi: 10.1080/16506070903121042. PMID: 19816834.","33877","2019"
"neylan2006_A","neylan2006","Pharmacotherapy","2006","PTSD","PTSD",,"63","A","29",,"Guanfacine","Guanfacine","Centrally acting alpha-2 receptor agonist","No",,"Yes","Antiadrenergic","No",,"No","No","No","No","No","Individual","In Person","0.5 mg at week 1, titrated by 0.5 mg per week up to 1 to 3 mg",,"Once daily","8",,,,,"assessed by pill count",,,,,,"2.4 mg/day","0.7",,"Not reported","Veteran",,,,"Some Concerns","Neylan TC, Lenoci M, Samuelson KW, et al. No improvement of posttraumatic stress disorder symptoms with guanfacine treatment. Am J Psychiatry. 2006 Dec;163(12):2186-8. doi: 10.1176/appi.ajp.163.12.2186. PMID: 17151174.","28964","2019"
"neylan2006_B","neylan2006","Pharmacotherapy","2006","PTSD","Inactive Control",,"63","B","34",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Once daily","8",,,,,"assessed by pill count",,,,,,,,,"Not reported","Veteran",,,,"Some Concerns","Neylan TC, Lenoci M, Samuelson KW, et al. No improvement of posttraumatic stress disorder symptoms with guanfacine treatment. Am J Psychiatry. 2006 Dec;163(12):2186-8. doi: 10.1176/appi.ajp.163.12.2186. PMID: 17151174.","28964","2019"
"nicholson2020_A","nicholson2020","Nonpharmacologic biological","2020","PTSD","PTSD",,"36","A","18",,"Alpha-rhythm electroencephalogram neurofeedback (EEG-NFB)","Neurofeedback","Neurofeedback training; participants down-regulated alpha amplitude (8–12 Hz) using real-time EEG feedback signal from the midline parietal cortex (Pz- electrode). Incorporated  interactive gaming with visual and auditory cues indicating when participants were suppressing alpha amplitude.","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person",,"20 minutes","Weekly","15 to 20","mean duration of treatment 161.1 days (SD 36.3)","Complete ≥15 sessions",,,,,,"19.6","0.98",,,,,"Not reported","Mixed","72.22%","Mixed","Rape/sexual assault; Community/school violence; Other (first responder occupational trauma, military occupational trauma)","Low","Nicholson AA, Ros T, Densmore M, et al. A randomized, controlled trial of alpha-rhythm EEG neurofeedback in posttraumatic stress disorder: a preliminary investigation showing evidence of decreased PTSD symptoms and restored default mode and salience network connectivity using fMRI. Neuroimage Clin. 2020;28:102490. doi: 10.1016/j.nicl.2020.102490. PMID: 33395981.","1562230","2022"
"nicholson2020_B","nicholson2020","Nonpharmacologic biological","2020","PTSD","Inactive Control",,"36","B","18",,"Sham control","Sham","Participants given the same instructions as experimental group, but received sham NFB signal (replayed feedback signal from a successful participant in the experimental group).","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"20 minutes","Weekly","15 to 20","mean duration of treatment 182.2 days (SD 39.7)","Complete ≥15 sessions",,,,,,"19.9","0.24",,,,,"Not reported","Mixed","72.22%","Mixed","Rape/sexual assault; Community/school violence; Other (first responder occupational trauma, military occupational trauma)","Low","Nicholson AA, Ros T, Densmore M, et al. A randomized, controlled trial of alpha-rhythm EEG neurofeedback in posttraumatic stress disorder: a preliminary investigation showing evidence of decreased PTSD symptoms and restored default mode and salience network connectivity using fMRI. Neuroimage Clin. 2020;28:102490. doi: 10.1016/j.nicl.2020.102490. PMID: 33395981.","1562230","2022"
"nidich2018_A","nidich2018","Psychotherapy & CIH","2018","PTSD","PTSD",,"202","A","68",,"Transcendental meditation","Transcendental meditation","Sitting meditation with eyes closed to quiet thoughts; PTSD symptoms not specifically addressed. Meditation technique taught in 5 sessions on consecutive days in a group format with lectures and some one-on-one instruction. Seven group maintenance sessions taught over the rest of the 3-month period. Home practice of two 20-minute daily sessions encouraged.","No",,"No",,"Yes","Meditation","No","No","No","No","No","Mixed","In Person",,"Instructor sessions: 90 minutes","Daily for 5 days then on average every 11 days (""gradually spaced"")","12",,"≥8 sessions",,,,,,"9","4.3",,,,,"Race and Ethnicity data reported","Veteran","16.83%","Mixed","MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness)","Low","Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.","51386","2020"
"nidich2018_B","nidich2018","Psychotherapy & CIH","2018","PTSD","PTSD",,"202","B","68",,"PE","Prolonged Exposure (PE)","Trauma-focused behavioural treatment with graduated exposure to imaginal and in-vivo trauma experiences delivered Individually. Homework involved listening to imaginal and engaging in in-vivo exposures.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12",,"≥8 sessions",,,,,,"8.2","3.7",,,,,"Race and Ethnicity data reported","Veteran","16.83%","Mixed","MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness)","Low","Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.","51386","2020"
"nidich2018_C","nidich2018","Psychotherapy & CIH","2018","PTSD","Active Control",,"202","C","66",,"PTSD health education","Psychoeducation","Health education specific to PTSD veterans, including symptoms, negative coping behaviors, and healthy lifestyle. Group sessions fostered social support and personal expression","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Group","In Person",,"90 minutes","Weekly","12",,"≥8 sessions",,,,,,"7.9","3.6",,,,,"Race and Ethnicity data reported","Veteran","16.83%","Mixed","MST; Combat-related; Illness/medical procedure; Natural or manmade disasters; Other (life-threatening or serious injury; life-threatening illness)","Low","Nidich S, Mills PJ, Rainforth M, et al. Non-trauma-focused meditation versus exposure therapy in veterans with post-traumatic stress disorder: a randomised controlled trial. Lancet Psychiatry. 2018 Dec;5(12):975-86. doi: 10.1016/S2215-0366(18)30384-5. PMID: 30449712.","51386","2020"
"nijdam2012_A","nijdam2012","Psychotherapy","2012","PTSD","PTSD",,"140","A","70",,"Brief eclectic psychotherapy","Brief Eclectic Psychotherapy (BEP)","Psychoeducation, imaginal exposure, cognitive restructuring and writing assignments","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"45 to 60 minutes","Weekly","16",,"completed treatment course",,,,,,"14.7","4.5",,,,,"Not reported","Community","56.4%","Mixed","rape/sexual assault, accidents, natural or manmade disasters, community/school violence, other (war-related)","Low","Nijdam MJ, Gersons BP, Reitsma JB, et al. Brief eclectic psychotherapy v. Eye Movement Desensitization and Reprocessing therapy for post-traumatic stress disorder: randomised controlled trial. Br J Psychiatry. 2012 Mar;200(3):224-31. doi: 10.1192/bjp.bp.111.099234. PMID: 22322458.","38273","2019"
"nijdam2012_B","nijdam2012","Psychotherapy","2012","PTSD","PTSD",,"140","B","70",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","During EMDR therapy, the most distressing images of the traumatic event are identified and processed consecutively. After the patient has focused on an image with the corresponding negative cognition, the most distressing emotion and the bodily location of the emotion, the patient is continuously asked to follow the therapist’s finger making saccadic movements in alternation with the patient’s own associations.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","16",,"completed treatment course",,,,,,"6.5","3.8",,,,,"Not reported","Community","56.4%","Mixed","rape/sexual assault, accidents, natural or manmade disasters, community/school violence, other (war-related)","Low","Nijdam MJ, Gersons BP, Reitsma JB, et al. Brief eclectic psychotherapy v. Eye Movement Desensitization and Reprocessing therapy for post-traumatic stress disorder: randomised controlled trial. Br J Psychiatry. 2012 Mar;200(3):224-31. doi: 10.1192/bjp.bp.111.099234. PMID: 22322458.","38273","2019"
"niles2012_A","niles2012","Psychotherapy & CIH","2012","PTSD","PTSD",,"33","A","17",,"Mindfulness","Mindfulness","2 in-person sessions and 6 phone sessions; participants given Mindfulness Handbook which covered mindfulness topics: defining mindfulness, noticing sensations, noticing thoughts and emotions, beginners' mind, choice, patience, and continuing to practice; in-person sessions included mindfulness exercises; participants instructed to practice with guided mindfulness exercises on provided CD and track practice.","No",,"No",,"Yes","Meditation","No","No","No","No","No","Individual","Mixed",,"Session length: 45-minute in-person sessions and 20-minute phone sessions","Weekly","8",,"Attended intervention and post-treatment assessment",,,"Self-reported proportion of assigned readings completed and the amount of unguided practice",,,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Combat-related",,"High","Niles BL, Klunk-Gillis J, Ryngala DJ, et al. Comparing mindfulness and psychoeducation treatments for combat-related PTSD using a telehealth approach. Psychol Trauma. 2012 Sep;4(5):538-47. doi: 10.1037/a0026161","37920","2019"
"niles2012_B","niles2012","Psychotherapy & CIH","2012","PTSD","Active Control",,"33","B","16",,"Psychoeducation","Psychoeducation","2 in-person sessions and 6 telephone sessions; participants given PTSD Education Handbook complementing treatment and providing education on issues of trust, safety, self-care, relationships and trauma, coping and healing, change, and moving forward; treatment focused on educating participants on how PTSD may affect their lives, and encouraged reflection and gave suggestions on positive coping without specific coping techniques (no relaxation exercises or behavioral activation).","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","Mixed",,"Session length: 45-minute in-person sessions and 20-minute phone sessions","Weekly","8",,"Attended intervention and post-treatment assessment",,,"Self-reported proportion of assigned readings completed",,,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Combat-related",,"High","Niles BL, Klunk-Gillis J, Ryngala DJ, et al. Comparing mindfulness and psychoeducation treatments for combat-related PTSD using a telehealth approach. Psychol Trauma. 2012 Sep;4(5):538-47. doi: 10.1037/a0026161","37920","2019"
"niles2020_A","niles2020","Nonpharmacologic cognitive","2020","PTSD","PTSD",,"1,001","A","336","234 completed baseline assessment and analyzed","Personalized attention bias modification (ABM)","Attention bias modification (ABM)","Mobile app to administer attention-bias modification remotely, using words selected as highly threatening for individual participants. Two words presented on screen for each trial, one neutral and one threatening. Probe letter (""E"" or ""F"")  then appears in the location of the neutral word, and participant asked to select corresponding letter at the bottom of the screen, thus directing attention away from threatening and towards neutral word stimulus. 90 trials/session. Less-threatening words used in first week, more-threatening words in second week.","No",,"No",,"No",,"No","Yes","No","No","No","Individual","Technology alone",,,"Daily","3","Given 21 days to complete 15 sessions","Completing ≥10 sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Community","80%","Mixed","Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Natural or manmade disasters; Other (""military"" not further specified, ""sudden death"", ""sudden move/loss of possessions"", ""sudden abandonment"", ""other"" not further specified)","Some Concerns","Niles AN, Woolley JD, Tripp P, et al. Randomized controlled trial testing mobile-based attention-bias modification for posttraumatic stress using personalized word stimuli. Clin Psychol Sci. 2020 Jul;8(4):756-72. doi: 10.1177/2167702620902119. PMID: 34414018.","1556474","2024"
"niles2020_B","niles2020","Nonpharmacologic cognitive","2020","PTSD","Active Control",,"1,001","B","323","219 completed baseline assessment and analyzed","Non-personalized ABM","Attention bias modification (ABM)","Mobile app to administer attention-bias modification remotely, using the same set of threat words for all participants.Two words presented on screen for each trial, one neutral and one threatening. Probe letter (""E"" or ""F"")  then appears in the location of the neutral word, and participant asked to select corresponding letter at the bottom of the screen, thus directing attention away from threatening and towards neutral word stimulus. 90 trials/session.","No",,"No",,"No",,"No","Yes","Yes","No","No","Individual","Technology alone",,,"Daily","3","Given 21 days to complete 15 sessions","Completing ≥10 sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Community","80%","Mixed","Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Natural or manmade disasters; Other (""military"" not further specified, ""sudden death"", ""sudden move/loss of possessions"", ""sudden abandonment"", ""other"" not further specified)","Some Concerns","Niles AN, Woolley JD, Tripp P, et al. Randomized controlled trial testing mobile-based attention-bias modification for posttraumatic stress using personalized word stimuli. Clin Psychol Sci. 2020 Jul;8(4):756-72. doi: 10.1177/2167702620902119. PMID: 34414018.","1556474","2024"
"niles2020_C","niles2020","Nonpharmacologic cognitive","2020","PTSD","Inactive Control",,"1,001","C","342","236 completed baseline assessment and analyzed","Placebo training","Attention control","Mobile app presenting two neutral words for each trial. Probe letter (""E"" or ""F"")  then appears in the location of one of the neutral words, and participant asked to select corresponding letter at the bottom of the screen. 90 trials/session.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Technology alone",,,"Daily","3","Given 21 days to complete 15 sessions","Completing ≥10 sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Community","80%","Mixed","Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Natural or manmade disasters; Other (""military"" not further specified, ""sudden death"", ""sudden move/loss of possessions"", ""sudden abandonment"", ""other"" not further specified)","Some Concerns","Niles AN, Woolley JD, Tripp P, et al. Randomized controlled trial testing mobile-based attention-bias modification for posttraumatic stress using personalized word stimuli. Clin Psychol Sci. 2020 Jul;8(4):756-72. doi: 10.1177/2167702620902119. PMID: 34414018.","1556474","2024"
"noohi2017_A","noohi2017","Nonpharmacologic biological","2017","PTSD","PTSD",,"30","A","15",,"Neurofeedback","Neurofeedback","Treatment followed the alpha/theta protocol by El-Hage, Quide, Radua & Olff (2013) where participants relax with eyes closed. Participants asked to recall positive memory to increase cerebral theta waves. Feedback consisted of audio of river waves representing alpha waves and ocean waves representing theta waves","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person",,"30 to 40 minutes","4 sessions per week","6","25 sessions total",,,,,,,,,,,,,"Not reported","Community","0%","Combat-related",,"High","Noohi S, Miraghaie AM, Arabi A, et al. Effectiveness of neuro-feedback treatment with alpha/theta method on PTSD symptoms and their executing function. Biomed Res. 2017;28(5):2019-27.","47468","2019"
"noohi2017_B","noohi2017","Nonpharmacologic biological","2017","PTSD","Inactive Control",,"30","B","15",,"Control","Control",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Not reported","Community","0%","Combat-related",,"High","Noohi S, Miraghaie AM, Arabi A, et al. Effectiveness of neuro-feedback treatment with alpha/theta method on PTSD symptoms and their executing function. Biomed Res. 2017;28(5):2019-27.","47468","2019"
"nordbrandt2020_A","nordbrandt2020","Other mixed","2020","PTSD","PTSD",,"318","A","105",,"Basic body awareness therapy + TAU","Exercise","Basic body awareness therapy: manualized physical exercise with ""slow, guided movements while standing, sitting and lying down, aiming at normalising and improving balance, muscle tension, free breathing and awareness."" Participants also encouraged to do exercises as homework.



TAU: interdisciplinary treatmen with medical doctor and psychologist; medical doctor focused on pharmacological treatment as needed and psychoeducation; psychologist followed manual for treatment - ""individual flexible CBT with elements of acceptance and commitment therapy, stress management and mindfulness.""","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","Yes","No","Individual","In Person",,"1 hour","Weekly","20",,"≥10 physiotherapy sessions",,,,,,"10",,,,,,"Not reported","Community","52.8%","Mixed","combat-related, rape/sexual assault, terrorism/political violence/forced dsplacement, other (""violence from relatives"")","Some Concerns","Nordbrandt MS, Sonne C, Mortensen EL, et al. Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual-a pragmatic randomised controlled trial. PLoS One. 2020;10:846. doi: 10.1371/journal.pone.0230300. PMID: 32163509.","1551115","2020"
"nordbrandt2020_B","nordbrandt2020","Other mixed","2020","PTSD","PTSD",,"318","B","109",,"Mixed physical activity + TAU","Exercise","Mixed physical activity: followed manual; ""bsic exercises focusing on improving strength, endurance, balance and coordination, using simple tools such as water bottles, bicycle, resistance bands, grocery bags etc."" (tools selected which would allow participants to practice exercises at home). Participants also encouraged to do exercises as homework.



TAU: interdisciplinary treatmen with medical doctor and psychologist; medical doctor focused on pharmacological treatment as needed and psychoeducation; psychologist followed manual for treatment - ""individual flexible CBT with elements of acceptance and commitment therapy, stress management and mindfulness.""","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","Yes","No","Individual","In Person",,"2 hours","Twice weekly","20",,"≥10 physiotherapy sessions",,,,,,"10",,,,,,"Not reported","Community","52.8%","Mixed","combat-related, rape/sexual assault, terrorism/political violence/forced dsplacement, other (""violence from relatives"")","Some Concerns","Nordbrandt MS, Sonne C, Mortensen EL, et al. Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual-a pragmatic randomised controlled trial. PLoS One. 2020;10:846. doi: 10.1371/journal.pone.0230300. PMID: 32163509.","1551115","2020"
"nordbrandt2020_C","nordbrandt2020","Other mixed","2020","PTSD","Active Control",,"318","C","104",,"TAU","Psychotherapy as usual","Interdisciplinary treatmen with medical doctor and psychologist; medical doctor focused on pharmacological treatment as needed and psychoeducation; psychologist followed manual for treatment - ""individual flexible CBT with elements of acceptance and commitment therapy, stress management and mindfulness.""","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"1 hour","Weekly","20",,,,,,,,,,,,,,"Not reported","Community","52.8%","Mixed","combat-related, rape/sexual assault, terrorism/political violence/forced dsplacement, other (""violence from relatives"")","Some Concerns","Nordbrandt MS, Sonne C, Mortensen EL, et al. Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual-a pragmatic randomised controlled trial. PLoS One. 2020;10:846. doi: 10.1371/journal.pone.0230300. PMID: 32163509.","1551115","2020"
"norman2019_A","norman2019","Psychotherapy","2019","PTSD+SUD","PTSD+SUD","Integrated","119","A","63",,"Concurrent Treatment for PTSD and Substance Use Disorder Prolonged Exposure (COPE)","Concurrent Treatment for PTSD and Substance Use Disorder Using Prolonged Exposure (COPE)","Integrated prolonged exposure with cognitive behavioral relapse prevention skills for SUD, includes in vivo and imaginal exposure; 12 sessions with option of up to 16 sessions if participant and therapist agreed that treatment goals not yet met; encouraged to attend 1-2 sessions per week but allowed up to 6 months to complete.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","1-2 times per week","6 to 26","12-16 sessions, up to 6 months to complete","completed ≥12 sessions",,,,,,"8.4","4.6",,,,,"Race and Ethnicity data reported","Veteran","10.08%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, illness/medical procedure","High","Norman SB, Trim R, Haller M, et al. Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Apr 24;76(8):791-9. doi: 10.1001/jamapsychiatry.2019.0638. PMID: 31017639.","52065","2020"
"norman2019_B","norman2019","Psychotherapy","2019","PTSD+SUD","Active Control","Integrated","119","B","56",,"Seeking Safety (SS)","Seeking Safety","Present-focused therapy teaching cognitive behavioral and interpersonal techniques and case management with 24 modules, each module includes safe coping skills; trauma discussed in context of its current affect on patient; 12 sessions with option of up to 16 sessions if participant and therapist agreed that treatment goals not yet met; encouraged to attend 1-2 sessions per week but allowed up to 6 months to complete.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","1-2 times per week","6 to 26","12-16 sessions, up to 6 months to complete","completed ≥12 sessions",,,,,,"11.4","4.8",,,,,"Race and Ethnicity data reported","Veteran","10.08%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, illness/medical procedure","High","Norman SB, Trim R, Haller M, et al. Efficacy of integrated exposure therapy vs integrated coping skills therapy for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Apr 24;76(8):791-9. doi: 10.1001/jamapsychiatry.2019.0638. PMID: 31017639.","52065","2020"
"norman2022_A","norman2022","Psychotherapy","2022","PTSD","PTSD",,"145","A","74",,"Trauma‐Informed Guilt Reduction (TrIGR)","Trauma-focused cognitive behavioral therapy (TF-CBT)","Cognitive-behavioral psychotherapy targeting non-adaptive guilt and shame and moral injury associated with deployment trauma in veterans. Helps patients reevaluate their role in the trauma and re‐engage in adaptive ways to express values other than through guilt. One additional off-protocol session allowed.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","6","6 protocol sessions; allowed on additional off protocol session during treatment","Attending ≥4 protocol sessions",,,,,,"5.3","1.6","16.2% of participants had an off-protocol session",,,,"Race and Ethnicity data reported","Veteran","6.2%","Mixed","Combat-related; Rape/sexual assault;  Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (life-threatening injury)","Low","Norman SB, Capone C, Panza KE, et al. A clinical trial comparing trauma-informed guilt reduction therapy (TrIGR), a brief intervention for trauma-related guilt, to supportive care therapy. Depress Anxiety. 2022 Apr;39(4):262-73. doi: 10.1002/da.23244. PMID: 35075738.","1586433","2023"
"norman2022_B","norman2022","Psychotherapy","2022","PTSD","Active Control",,"145","B","71",,"Supportive Care Therapy (SCT)","Supportive counseling","Adapted from present-centered therapy, omitting problem-solving and daily diary. Patients guide session content. First session includes psychoeducation about trauma-related guilt; patients may choose to discuss guilt and trauma in subsequent sessions. One additional off-protocol session allowed.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Weekly","6","6 protocol sessions; allowed on additional off protocol session during treatment","Attending ≥4 protocol sessions",,,,,,"5.3","1.8","1.4% of participants had an off-protocol session",,,,"Race and Ethnicity data reported","Veteran","6.2%","Mixed","Combat-related; Rape/sexual assault;  Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (life-threatening injury)","Low","Norman SB, Capone C, Panza KE, et al. A clinical trial comparing trauma-informed guilt reduction therapy (TrIGR), a brief intervention for trauma-related guilt, to supportive care therapy. Depress Anxiety. 2022 Apr;39(4):262-73. doi: 10.1002/da.23244. PMID: 35075738.","1586433","2023"
"numata2014_A","numata2014","CIH","2014","PTSD","PTSD",,"43","A","21",,"Saikokeishikankyoto","Saikokeishikankyoto","Traditional Japanese-Chinese herbal formula containing a mixture of 7 dried herbs each registered in the Pharmacopoeia of Japan version 15","No",,"No",,"Yes","Natural products","No","No","No","No","No","Individual","In Person","2.5 grams (contains 1.17 grams herb extract)",,"3 times daily","2",,,,,,,,,,,,,,"Not reported","Community","48.84%","Natural or manmade disasters",,"High","Numata T, GunFan S, Takayama S, et al. Treatment of posttraumatic stress disorder using the traditional Japanese herbal medicine saikokeishikankyoto: a randomized, observer-blinded, controlled trial in survivors of the great East Japan earthquake and tsunami. Evid Based Complement Alternat Med. 2014;2014:683293. doi: 10.1155/2014/683293. PMID: 24790634.","46973","2019"
"numata2014_B","numata2014","CIH","2014","PTSD","Inactive Control",,"43","B","22",,"Control","Control","""control""","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"2",,,,,,,,,,,,,,"Not reported","Community","48.84%","Natural or manmade disasters",,"High","Numata T, GunFan S, Takayama S, et al. Treatment of posttraumatic stress disorder using the traditional Japanese herbal medicine saikokeishikankyoto: a randomized, observer-blinded, controlled trial in survivors of the great East Japan earthquake and tsunami. Evid Based Complement Alternat Med. 2014;2014:683293. doi: 10.1155/2014/683293. PMID: 24790634.","46973","2019"
"oehen2013_A","oehen2013","Psychotherapy & pharmacotherapy","2013","PTSD","PTSD",,"14","A","9",,"MDMA-assisted psychotherapy","MDMA-assisted psychotherapy","MDMA is a psychoactive compound [Schedule 1 in the U.S. as a drug of abuse (ecstasy]). MDMA was given as an adjunct to psychotherapy. Patients received MDMA-assisted psychotherapy, music therapy and ""body work"" (e.g. hand-holding) with 2 therapists present over an 8-hour period, followed by non-drug therapy sessions the following day, and at one- and two-weeks post MDMA treatment.","Yes","Non-Trauma-focused","Yes","Psychostimulant","No",,"No","No","No","No","No","Individual","In Person","Session length: MDMA sessions 8 hours, NR for non-drug sessions







Dose: 187.5 mg (125 mg followed 2.5 hours later by 62.5 mg)",,"Interval between MDMA sessions NR; one non-drug session the morning after each MDMA-assisted session, followed by 2 non-drug sessions one week apart",,"Interval between MDMA sessions NR; MDMA sessions followed by 2 non-drug sessions one week apart","Received allocated intervention",,"Study reports ""received allocated intervention"" and dropout/withdrew after first MDMA session separately",,,,,,,,,,"Not reported","Community","83.33%","Mixed","child sexual abuse, rape/sexual assault, accidents, illness/medical procedure","High","Oehen P, Traber R, Widmer V, et al. A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). J Psychopharmacol. 2013 Jan;27(1):40-52. doi: 10.1177/0269881112464827. PMID: 23118021.","41195","2019"
"oehen2013_B","oehen2013","Psychotherapy & pharmacotherapy","2013","PTSD","Active Control",,"14","B","5",,"Low-dose MDMA-assisted psychotherapy","MDMA-assisted psychotherapy","Low-dose MDMA used as an ""active placebo"" to maintain blinding ""since MDMA's effects can be easily discerned by both subjects and investigators."" Chosen dose expected ""to produce minimal, but detectable subjective effects,"" but no significant therapeutic effect. Low-dose MDMA was given as an adjunct to psychotherapy. Patients received low-dose MDMA-assisted psychotherapy, music therapy and ""body work"" (e.g. hand-holding) with 2 therapists present over an 8-hour period, followed by non-drug therapy sessions the following day, and at one- and two-weeks post MDMA treatment.","Yes","Non-Trauma-focused","Yes","Psychostimulant","No",,"No","No","Yes","No","No","Individual","In Person","Session length: MDMA sessions 8 hours, NR for non-drug sessions







Dose: 37.5 mg (25 mg followed 2.5 hours later by 12.5 mg)",,"Interval between MDMA sessions NR; one non-drug session the morning after each MDMA-assisted session, followed by 2 non-drug sessions one week apart",,"Interval between MDMA sessions NR; MDMA sessions followed by 2 non-drug sessions one week apart","Received allocated intervention",,"Study reports ""received allocated intervention"" and dropout/withdrew after first MDMA session separately",,,,,,,,,,"Not reported","Community","83.33%","Mixed","child sexual abuse, rape/sexual assault, accidents, illness/medical procedure","High","Oehen P, Traber R, Widmer V, et al. A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). J Psychopharmacol. 2013 Jan;27(1):40-52. doi: 10.1177/0269881112464827. PMID: 23118021.","41195","2019"
"onder2006_A","onder2006","Pharmacotherapy","2006","PTSD","PTSD",,"103","A","38",,"Fluoxetine","Fluoxetine","SSRI; flexible dosing, single dose in the morning; if no response at week 8, dose increased from 20 to 40 mg","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","Initiated at 20 mg, could be increased to 40 mg",,"Once daily","12",,,,,,,,,,,"27.4 mg/day","9.8",,"Not reported","Community","50.49%","Natural or manmade disasters",,"Some Concerns","Önder E, Tural Ü, Aker AT. A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake. Eur Psychiatry. 2006 Apr;21(3):174-9. doi: 10.1016/j.eurpsy.2005.03.007. PMID: 15964747.","28188","2019"
"onder2006_B","onder2006","Pharmacotherapy","2006","PTSD","PTSD",,"103","B","35",,"Moclobemide","Moclobemide","MAOI Antidepressant; flexible dosing, daily dose divided between 8 am and 8 pm; if no response at week 8, increased from 450 mg to 900 mg","No",,"Yes","Antidepressant: MAOI","No",,"No","No","No","No","No","Individual","In Person","Initiated at 450 mg, could be increased to 900 mg",,"Daily, divided","12",,,,,,,,,,,"565.7 mg/day","115.5",,"Not reported","Community","50.49%","Natural or manmade disasters",,"Some Concerns","Önder E, Tural Ü, Aker AT. A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake. Eur Psychiatry. 2006 Apr;21(3):174-9. doi: 10.1016/j.eurpsy.2005.03.007. PMID: 15964747.","28188","2019"
"onder2006_C","onder2006","Pharmacotherapy","2006","PTSD","PTSD",,"103","C","30",,"Tianeptine","Tianeptine","Atypical antidepressant; flexible dosing, daily dose divided between 8 am, 4 pm, and 11 pm; if no response at 8 weeks, increased from 37.5 to 50 mg","No",,"Yes","Antidepressant: Other","No",,"No","No","No","No","No","Individual","In Person","Initiated at 37.5 mg, could be increased to 50 mg",,"Daily, divided","12",,,,,,,,,,,"41.3 mg","5.8",,"Not reported","Community","50.49%","Natural or manmade disasters",,"Some Concerns","Önder E, Tural Ü, Aker AT. A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake. Eur Psychiatry. 2006 Apr;21(3):174-9. doi: 10.1016/j.eurpsy.2005.03.007. PMID: 15964747.","28188","2019"
"oprel2021_A","oprel2021","Psychotherapy","2021","PTSD","Active Control",,"149","A","48",,"Prolonged exposure","Prolonged Exposure (PE)","Manualized treatment; PE is a form of cognitive behavioural therapy involving psychoeducation about PTSD, imaginal



exposure (repeatedly recounting most disturbing traumatic memories) and exposure in vivo.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Weekly","16","16 total sessions","Patients completed all sessions or had PCL-5 score <16 for three consecutive weeks",,"34/48",,,,,,,,,,"Not reported","Community","76.5%","Mixed","Child physical abuse; Child sexual abuse; Community/school violence; Other (sexual abuse in adulthood)","Some Concerns","Oprel DAC, Hoeboer CM, Schoorl M, et al. Effect of prolonged exposure, intensified prolonged exposure and STAIR+prolonged exposure in patients with PTSD related to childhood abuse: a randomized controlled trial. Eur J Psychotraumatol. 2021;12(1) doi: 10.1080/20008198.2020.1851511. PMID: 34630934.","1580811","2022"
"oprel2021_B","oprel2021","Psychotherapy","2021","PTSD","PTSD",,"149","B","51",,"Intensive prolonged exposure","Prolonged Exposure (PE)","iPE was implemented similarly to the PE condition, except for the time format of the sessions; started with 3 sessions per week for 4 weeks (12 sessions total) followed by 2 sessions after one and 2 months.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","3 sessions per week for 4 weeks, then one per month for 2 months","16","14 total sessions","Patients completed all sessions or had PCL-5 score <16 for three consecutive weeks",,"37/52",,,,,,,,,,"Not reported","Community","76.5%","Mixed","Child physical abuse; Child sexual abuse; Community/school violence; Other (sexual abuse in adulthood)","Some Concerns","Oprel DAC, Hoeboer CM, Schoorl M, et al. Effect of prolonged exposure, intensified prolonged exposure and STAIR+prolonged exposure in patients with PTSD related to childhood abuse: a randomized controlled trial. Eur J Psychotraumatol. 2021;12(1) doi: 10.1080/20008198.2020.1851511. PMID: 34630934.","1580811","2022"
"oprel2021_C","oprel2021","Psychotherapy","2021","PTSD","PTSD",,"149","C","50",,"Skills training in affective and interpersonal regulation + prolonged exposure","Skills Training in Affect and Interpersonal Regulation (STAIR) followed by Prolonged Exposure (PE)","Manualized phase-based treatment of STAIR followed by PE. STAIR is a skill training programme with 4 sessions focused on improving emotion regulation skills followed by 4 sessions focused on developing interpersonal skills. PE was implemented similar to the PE



condition.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"STAIR: 60 minutes



PE: 90 minutes","Weekly","16","16 total sessions","Patients completed all sessions or had PCL-5 score <16 for three consecutive weeks",,"41/50",,,,,,,,,,"Not reported","Community","76.5%","Mixed","Child physical abuse; Child sexual abuse; Community/school violence; Other (sexual abuse in adulthood)","Some Concerns","Oprel DAC, Hoeboer CM, Schoorl M, et al. Effect of prolonged exposure, intensified prolonged exposure and STAIR+prolonged exposure in patients with PTSD related to childhood abuse: a randomized controlled trial. Eur J Psychotraumatol. 2021;12(1) doi: 10.1080/20008198.2020.1851511. PMID: 34630934.","1580811","2022"
"orang2018_A","orang2018","Psychotherapy","2018","PTSD","PTSD",,"45","A","24",,"NET","Narrative Exposure Therapy (NET)","Psychoeducation in the first session, then treatment proceeds with ""lifeline"" exercise where patient chronologically narrates her life using stones to mark traumatic events and flowers to mark joyful events. Therapists also provided consultation on safety issues and current violence.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"120-150 minutes",,"12 to 26","10-12 sessions; ""Each therapy period lasted between 3 and 6 months, due to various cancellations and interruptions""","Completed treatment",,"""received intervention"" in flow diagram, text describes as completers (other participants described as ""did not begin or complete the treatment"")",,,,"11.88","1.76",,,,,"Not reported","Community","100%","Intimate partner violence",,"High","Orang T, Ayoughi S, Moran JK, et al. The efficacy of narrative exposure therapy in a sample of Iranian women exposed to ongoing intimate partner violence-a randomized controlled trial. Clin Psychol Psychother. 2018 Nov;25(6):827-41. doi: 10.1002/cpp.2318. PMID: 30079583.","1529973","2020"
"orang2018_B","orang2018","Psychotherapy","2018","PTSD","Active Control",,"45","B","21",,"TAU","Supportive counseling","Psychoeducation and supportive counseling individually tailored to each patient, including life skill training, cognitive-behavioral techniques, acceptance and commitment therapy, improvement of self-knowledge, and involvement of violent husbands as needed.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 to 120 minutes",,"12 to 26","10-12 sessions; ""Each therapy period lasted between 3 and 6 months, due to various cancellations and interruptions""","Completed treatment",,"""received intervention"" in flow diagram, text describes as completers (other participants described as ""did not begin or complete the treatment"")",,,,"10.88","1.16",,,,,"Not reported","Community","100%","Intimate partner violence",,"High","Orang T, Ayoughi S, Moran JK, et al. The efficacy of narrative exposure therapy in a sample of Iranian women exposed to ongoing intimate partner violence-a randomized controlled trial. Clin Psychol Psychother. 2018 Nov;25(6):827-41. doi: 10.1002/cpp.2318. PMID: 30079583.","1529973","2020"
"otalora2018_A","otalora2018","Psychotherapy & pharmacotherapy","2018","PTSD","PTSD",,"28","A","13",,"Psychotherapy + higher-dose MDMA","MDMA-assisted psychotherapy","Manualized therapy developed for use with psychedelics; followed patients' process with no agenda or solutions offered. Three preparatory sessions followed by two eight-hour MDMA sessions (with overnight observation), each drug session followed by three non-drug integrative sessions over one month and daily phone contact for a week.","Yes","Non-Trauma-focused","Yes","Psychostimulant","No",,"No","No","No","No","No","Individual","In Person","Dose: 125 mg + 62.5 mg available supplemental dose","Preparatory sessions: 90 minutes; MDMA sessions: 8 hours; Integrative sessions: NR","Preparatory sessions: interval NR; MDMA sessions: one month apart; Integrative sessions: ~10 days apart","8","approximate duration based on 1 month between MDMA sessions and 1 month of integrative sessions after last MDMA session","Did not discontinue treatment",,"participant flow diagram: 1 treatment discontinuation (12/13 did not discontinue); does not appear to include open-label sessions",,,,,,,,,,"Race and Ethnicity data reported","Community","67.9%","Mixed","Combat-related; Child physical abuse; Child sexual abuse; Accidents; Community/school violence; Other (ritual abuse, witnessing a crime)","Low","Ot'alora GM, Grigsby J, Poulter B, et al. 3,4-methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: a randomized phase 2 controlled trial. J Psychopharmacol. 2018 Dec;32(12):1295-307. doi: 10.1177/0269881118806297. PMID: 30371148.","51494","2020"
"otalora2018_B","otalora2018","Psychotherapy & pharmacotherapy","2018","PTSD","PTSD",,"28","B","9",,"Psychotherapy + lower-dose MDMA","MDMA-assisted psychotherapy","Manualized therapy developed for use with psychedelics; followed patients' process with no agenda or solutions offered. Three preparatory sessions followed by two eight-hour MDMA sessions (with overnight observation), each drug session followed by three non-drug integrative sessions over one month and daily phone contact for a week.","Yes","Non-Trauma-focused","Yes","Psychostimulant","No",,"No","No","No","No","No","Individual","In Person","Dose: 100 mg + 50 mg available supplemental dose","Preparatory sessions: 90 minutes; MDMA sessions: 8 hours; Integrative sessions: NR","Preparatory sessions: interval NR; MDMA sessions: one month apart; Integrative sessions: ~10 days apart","8","approximate duration based on 1 month between MDMA sessions and 1 month of integrative sessions after last MDMA session","Did not discontinue treatment",,"participant flow diagram: none for treatment discontinuation (9/9 did not discontinue); does not appear to include open-label sessions",,,,,,,,,,"Race and Ethnicity data reported","Community","67.9%","Mixed","Combat-related; Child physical abuse; Child sexual abuse; Accidents; Community/school violence; Other (ritual abuse, witnessing a crime)","Low","Ot'alora GM, Grigsby J, Poulter B, et al. 3,4-methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: a randomized phase 2 controlled trial. J Psychopharmacol. 2018 Dec;32(12):1295-307. doi: 10.1177/0269881118806297. PMID: 30371148.","51494","2020"
"otalora2018_C","otalora2018","Psychotherapy & pharmacotherapy","2018","PTSD","Active Control",,"28","C","6",,"Psychotherapy + control dose MDMA","MDMA-assisted psychotherapy comparator","Manualized therapy developed for use with psychedelics; followed patients' process with no agenda or solutions offered. Three preparatory sessions followed by two eight-hour MDMA sessions (with overnight observation), each drug session followed by three non-drug integrative sessions over one month and daily phone contact for a week. This arm given ""control"" dose.","Yes","Non-Trauma-focused","Yes","Psychostimulant","No",,"No","No","Yes","No","No","Individual","In Person","Dose: 40 mg + 20 mg available supplemental dose","Preparatory sessions: 90 minutes; MDMA sessions: 8 hours; Integrative sessions: NR","Preparatory sessions: interval NR; MDMA sessions: one month apart; Integrative sessions: ~10 days apart","8","approximate duration based on 1 month between MDMA sessions and 1 month of integrative sessions after last MDMA session","Did not discontinue treatment",,"participant flow diagram: 1 treatment discontinuation (5/6 did not discontinue); does not appear to include open-label sessions",,,,,,,,,,"Race and Ethnicity data reported","Community","67.9%","Mixed","Combat-related; Child physical abuse; Child sexual abuse; Accidents; Community/school violence; Other (ritual abuse, witnessing a crime)","Low","Ot'alora GM, Grigsby J, Poulter B, et al. 3,4-methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: a randomized phase 2 controlled trial. J Psychopharmacol. 2018 Dec;32(12):1295-307. doi: 10.1177/0269881118806297. PMID: 30371148.","51494","2020"
"padala2006_A","padala2006","Pharmacotherapy","2006","PTSD","PTSD",,"20","A","11",,"Risperidone","Risperidone","Initiated at 1 mg/day, increase weekly by up to 1 mg/day to target dose of 4 to 6 mg/day","No",,"Yes","Antipsychotic","No",,"No","No","No","No","No","Individual","In Person","4 to 6 mg total daily dose",,"Twice daily","10",,,,,,,,,,,"2.62 mg",,,"Race data reported","Community","100%","Mixed","rape/sexual assault, intimate partner violence, child physical abuse, community/school violence, other (violent death of a loved one)","High","Padala PR, Madison J, Monnahan M, et al. Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women. Int Clin Psychopharmacol. 2006 Sep;21(5):275-80. PMID: 16877898.","50966","2019"
"padala2006_B","padala2006","Pharmacotherapy","2006","PTSD","Inactive Control",,"20","B","9",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Twice daily","10",,,,,,,,,,,,,,"Race data reported","Community","100%","Mixed","rape/sexual assault, intimate partner violence, child physical abuse, community/school violence, other (violent death of a loved one)","High","Padala PR, Madison J, Monnahan M, et al. Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women. Int Clin Psychopharmacol. 2006 Sep;21(5):275-80. PMID: 16877898.","50966","2019"
"panahi2011_A","panahi2011","Pharmacotherapy","2011","PTSD","PTSD",,"70","A","35",,"Sertraline","Sertraline","SSRI; patients visited every 2 weeks by a psychiatrist who adjusted dose based on response and adverse effects","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","Initiated at 50 mg, titrated to maximum 200 mg",,"Daily","10",,,,,,,,,,,"140 mg/day","33",,"Not reported","Mixed","0%","Combat-related",,"Some Concerns","Panahi Y, Moghaddam BR, Sahebkar A, et al. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder. Psychol Med. 2011;41(10):2159-66. doi: 10.1017/S0033291711000201. PMID: 21349225.","36061","2019"
"panahi2011_B","panahi2011","Pharmacotherapy","2011","PTSD","Inactive Control",,"70","B","35",,"Placebo","Placebo","Placebo matched to active treatment","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","10",,,,,,,,,,,"131 mg equivalent","29",,"Not reported","Mixed","0%","Combat-related",,"Some Concerns","Panahi Y, Moghaddam BR, Sahebkar A, et al. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder. Psychol Med. 2011;41(10):2159-66. doi: 10.1017/S0033291711000201. PMID: 21349225.","36061","2019"
"papapetropoulos2025_A","papapetropoulos2025","Pharmacotherapy","2025","PTSD","PTSD",,"212","A","106",,"BNC210","BNC210","BNC210 is a novel anticholinergic drug acting on the α7 nicotinic acetylcholine receptor, in development to treat PTSD and anxiety disorders. Taken orally.","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No",,,"900 mg",,"Twice daily","12",,,,,,,"0 participants excluded from mITT population due to nonadherence",,,,,,,"Race and Ethnicity data reported","Community","64.1%","Mixed","Rape/sexual assault; Community/school violence; Other (""witnessing or learning of a sudden violent death""; NR)","High","Papapetropoulos S, Doolin E, O'Connor S, et al. BNC210, an alpha7 Nicotinic Receptor Modulator, in Post-Traumatic Stress Disorder. NEJM Evid. 2025 Jan;4(1):EVIDoa2400380. doi: 10.1056/EVIDoa2400380. PMID: 39647171.","1642899","2025"
"papapetropoulos2025_B","papapetropoulos2025","Pharmacotherapy","2025","PTSD","Inactive Control",,"212","B","106",,"Placebo","Placebo","Placebo matching BNC210 tablets.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,"Twice daily","12",,,,,,,"1 participant excluded from mITT population due to nonadherence",,,,,,,"Race and Ethnicity data reported","Community","64.1%","Mixed","Rape/sexual assault; Community/school violence; Other (""witnessing or learning of a sudden violent death""; NR)","High","Papapetropoulos S, Doolin E, O'Connor S, et al. BNC210, an alpha7 Nicotinic Receptor Modulator, in Post-Traumatic Stress Disorder. NEJM Evid. 2025 Jan;4(1):EVIDoa2400380. doi: 10.1056/EVIDoa2400380. PMID: 39647171.","1642899","2025"
"parmenter2024_A","parmenter2024","Pharmacotherapy","2024","PTSD","PTSD",,"358","A","179",,"TNX-102 SL (cyclobenzaprine sublingual)","TNX-102 SL","Sublingual cyclobenzaprine (TNX-102 SL), 5.6 mg fixed dose (2 tablets of 2.8 mg each) at bedtime.","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","5.6 mg",,"Daily at bedtime","12",,,,,,,,,,,,,,"Race and Ethnicity data reported",,"10.3%","Mixed","Combat-related; Other (not specified)","Some Concerns","Parmenter ME, Lederman S, Weathers FW, Davis LL, Vaughn B, Engels J, Sullivan GM. A phase 3, randomized, placebo-controlled, trial to evaluate the efficacy and safety of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related posttraumatic stress disorder. Psychiatry Res. 2024 Apr;334:115764. doi: 10.1016/j.psychres.2024.115764. Epub 2024 Feb 1. PMID: 38350291.","1630894","2024"
"parmenter2024_B","parmenter2024","Pharmacotherapy","2024","PTSD","Inactive Control",,"358","B","179",,"Placebo","Placebo","Placebo; 2 placebo sublingual tablets at bedtime","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily at bedtime","12",,,,,,,,,,,,,,"Race and Ethnicity data reported",,"10.3%","Mixed","Combat-related; Other (not specified)","Some Concerns","Parmenter ME, Lederman S, Weathers FW, Davis LL, Vaughn B, Engels J, Sullivan GM. A phase 3, randomized, placebo-controlled, trial to evaluate the efficacy and safety of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related posttraumatic stress disorder. Psychiatry Res. 2024 Apr;334:115764. doi: 10.1016/j.psychres.2024.115764. Epub 2024 Feb 1. PMID: 38350291.","1630894","2024"
"paunovic2001_A","paunovic2001","Psychotherapy","2001","PTSD","PTSD",,"20","A",,,"Exposure therapy","Exposure therapy","Patients were exposed to anxiety-provoking trauma-related images and situations until habituated to each.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 to 120 minutes","Weekly","16 to 20",,"See Detail",,"Reports number who dropped out of exposure therapy (n=1), remainder described as ""completed the study"", however N randomized to each arm NR (only overall, n=20 randomized)",,,,,,,,,,"Not reported","Community","18.75%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (exposure to toxic substance)","High","Paunovic N, Öst L-G. Cognitive-behavior therapy vs exposure therapy in the treatment of PTSD in refugees. Behav Res Ther. 2001 Oct;39(10):1183-97. doi: 10.1016/S0005-7967(00)00093-0. PMID: 11579988.","07357","2019"
"paunovic2001_B","paunovic2001","Psychotherapy","2001","PTSD","Active Control",,"20","B",,,"CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Flexible combination of exposure, cognitive therapy, and controlled breathing.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"60 to 120 minutes","Weekly","16 to 20",,"See Detail",,"Reports number who dropped out of CBT (n=3), remainder described as ""completed the study"", however N randomized to each arm NR (only overall, n=20 randomized)",,,,,,,,,,"Not reported","Community","18.75%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, terrorism/political violence/forced displacement, other (exposure to toxic substance)","High","Paunovic N, Öst L-G. Cognitive-behavior therapy vs exposure therapy in the treatment of PTSD in refugees. Behav Res Ther. 2001 Oct;39(10):1183-97. doi: 10.1016/S0005-7967(00)00093-0. PMID: 11579988.","07357","2019"
"peck2023_A","peck2023","Psychotherapy & pharmacotherapy","2023","PTSD+SUD","PTSD+SUD","Not integrated","30","A","10",,"PE + financial incentives + TAU for OUD","Prolonged Exposure (PE) + financial incentive + Treatment as usual (TAU) for substance use","PE: included breathing exercises, in vivo and imaginal exposures; modified for co-occurring PTSD and OUD clinical population by reducing sessions to 60 minutes and including psychoeducation about the association between PTSD and opioid use disorder
Financial incentives contingent on session attendance (maximum $920 for attending all sessions).
TAU: All participants continued medication for OUD with methadone or buprenorphine","Yes","Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","Mixed","At baseline:
Buprenorphine, mean (SD) mg/day (N=5): 13.2 (5.0)
Methadone, mean (SD) mg/day (N=5): 112.0 (44.4)","60 minutes","Weekly","12",,"Completed at least 8 sessions of PE",,,,,,,,"87% of PE sessions attended",,,,"Race data reported","Community","63.3%","Mixed","Combat-related; Rape/sexual assault; Accidents; Community/school violence; Other (""witnessed or learned about injury or death""; ""other"" not further described)","High","Peck K, Badger G, Cole R, et al. Prolonged exposure therapy for PTSD in individuals with opioid use disorder: a randomized pilot study. Addict Behav. 2023;143 doi: 10.1016/j.addbeh.2023.107688. PMID: 36989699.","1618957","2024"
"peck2023_B","peck2023","Psychotherapy & pharmacotherapy","2023","PTSD+SUD","Active Control",,"30","B","10",,"PE + TAU for OUD","Prolonged Exposure (PE) + Treatment as usual (TAU) for substance use","PE: included breathing exercises, in vivo and imaginal exposures; modified for co-occurring PTSD and OUD clinical population by reducing sessions to 60 minutes and including psychoeducation about the association between PTSD and opioid use disorder
No financial incentives.
TAU: All participants continued medication for OUD with methadone or buprenorphine","Yes","Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","Yes","No","No","Individual","Mixed","At baseline:
Buprenorphine, mean (SD) mg/day (N=6): 16.3 (5.7)
Methadone, mean (SD) mg/day (N=4): 55.8 (17.3)","60 minutes","Weekly","12",,"Completed at least 8 sessions of PE",,,,,,,,"35% of PE sessions attended",,,,"Race data reported","Community","63.3%","Mixed","Combat-related; Rape/sexual assault; Accidents; Community/school violence; Other (""witnessed or learned about injury or death""; ""other"" not further described)","High","Peck K, Badger G, Cole R, et al. Prolonged exposure therapy for PTSD in individuals with opioid use disorder: a randomized pilot study. Addict Behav. 2023;143 doi: 10.1016/j.addbeh.2023.107688. PMID: 36989699.","1618957","2024"
"peck2023_C","peck2023","Psychotherapy & pharmacotherapy","2023","PTSD+SUD","Active Control",,"30","C","10",,"TAU for OUD","Treatment as usual (TAU) for substance use","All participants continued medication for OUD with methadone or buprenorphine. No PTSD treatment","No",,"Yes","Other pharmacotherapy","No",,"No","No","Yes","No","No","Individual","Mixed","At baseline:
Buprenorphine, mean (SD) mg/day (N=6): 17.0 (6.2)
Methadone, mean (SD) mg/day (N=4): 103.8 (44.2)",,,"12",,,,,,,,,,,,,,"Race data reported","Community","63.3%","Mixed","Combat-related; Rape/sexual assault; Accidents; Community/school violence; Other (""witnessed or learned about injury or death""; ""other"" not further described)","High","Peck K, Badger G, Cole R, et al. Prolonged exposure therapy for PTSD in individuals with opioid use disorder: a randomized pilot study. Addict Behav. 2023;143 doi: 10.1016/j.addbeh.2023.107688. PMID: 36989699.","1618957","2024"
"peck2025_A","peck2025","Psychotherapy & pharmacotherapy","2025","PTSD+SUD","PTSD+SUD","Not integrated","52","A","18",,"PE + financial incentives + TAU medication for OUD","Prolonged Exposure (PE) + financial incentive","PE: included education about PTSD and its relationship to OUD, breathing exercises to manage arousal, and both in-vivo and imaginal exposures. PE modified for OUD participants by decreasing session length to 60 minutes, adding education about association between PTSD and OUD and weekly check-ins about about substance use, and providing therapy in person or via telemedicine. Participants were not required to abstain from non-prescribed substances.
Financial incentives: contingent on therapy session attendance (but not on substance use abstinence), maximum value $920.
TAU medication for OUD: continued medication treatment for OUD (methadone, buprenorphine) from current provider.","Yes","Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","Mixed",,"60 minutes","Weekly","12",,"Attending ≥8 PE sessions",,,,,,"10.5","2.9",,,,"Baseline medication
buprenorphine: 61.1%; mean daily dose 11.6 (SD 5.7) mg
methadone: 38.9%; mean daily dose 90.4 (SD 43.9) mg","Race data reported","Community","69.2%","Mixed","Accidents; Community/ school violence; Natural or manmade disasters; Rape/sexual assault; Other (witnessed or learned about injury or death)","High","Peck KR, Giannini J, Badger GJ, et al. A novel prolonged exposure therapy protocol for improving therapy session attendance and PTSD symptoms among adults receiving buprenorphine or methadone treatment. Drug Alcohol Depend. 2025 Jan 01;266:112507. doi: 10.1016/j.drugalcdep.2024.112507. PMID: 39642783.","1642153","2025"
"peck2025_B","peck2025","Psychotherapy & pharmacotherapy","2025","PTSD+SUD","Active Control","Not integrated","52","B","17",,"PE + TAU medication for OUD","Prolonged Exposure (PE)","PE: included education about PTSD and its relationship to OUD, breathing exercises to manage arousal, and both in-vivo and imaginal exposures. PE modified for OUD participants by decreasing session length to 60 minutes, adding education about association between PTSD and OUD and weekly check-ins about about substance use, and providing therapy in person or via telemedicine. Participants were not required to abstain from non-prescribed substances.
TAU medication for OUD: continued medication treatment for OUD (methadone, buprenorphine) from current provider.","Yes","Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","Yes","No","No","Individual","Mixed",,"60 minutes","Weekly","12",,"Attending ≥8 PE sessions",,,,,,"3.9","4.9",,,,"Baseline medication
buprenorphine: 70.6%; mean daily dose 18.0 (SD 5.8) mg
methadone: 29.4%; mean daily dose 76.0 (SD 54.2) mg","Race data reported","Community","69.2%","Mixed","Accidents; Community/ school violence; Natural or manmade disasters; Rape/sexual assault; Other (witnessed or learned about injury or death)","High","Peck KR, Giannini J, Badger GJ, et al. A novel prolonged exposure therapy protocol for improving therapy session attendance and PTSD symptoms among adults receiving buprenorphine or methadone treatment. Drug Alcohol Depend. 2025 Jan 01;266:112507. doi: 10.1016/j.drugalcdep.2024.112507. PMID: 39642783.","1642153","2025"
"peck2025_C","peck2025","Psychotherapy & pharmacotherapy","2025","PTSD+SUD","Active Control",,"52","C","17",,"TAU medication for OUD","Treatment as usual (TAU) for substance use","Continued medication treatment for OUD (methadone, buprenorphine) from current provider. No PTSD treatment.","No",,"Yes","Other pharmacotherapy","No",,"No","No","Yes","No","No","Individual",,,,,"12",,,,,,,,,,,,,"Baseline medication
buprenorphine: 70.6%; mean daily dose 17.5 (SD 5.1) mg
methadone: 29.4%; mean daily dose 101.0 (SD 39.1) mg","Race data reported","Community","69.2%","Mixed","Accidents; Community/ school violence; Natural or manmade disasters; Rape/sexual assault; Other (witnessed or learned about injury or death)","High","Peck KR, Giannini J, Badger GJ, et al. A novel prolonged exposure therapy protocol for improving therapy session attendance and PTSD symptoms among adults receiving buprenorphine or methadone treatment. Drug Alcohol Depend. 2025 Jan 01;266:112507. doi: 10.1016/j.drugalcdep.2024.112507. PMID: 39642783.","1642153","2025"
"perezdandieu2014_A","perezdandieu2014","Psychotherapy","2014","PTSD+SUD","PTSD+SUD","Not integrated","12","A","6",,"EMDR + TAU","Eye Movement Desensitization and Reprocessing (EMDR)","EMDR follows protocol according to Shapiro (2005), which involves participant isolating a visual representation of a traumatic memory, holding the memory, negative statement, evoked emotion, and area of body where the emotion is experienced while visually follow clinician's fingers for a set of 25 eye movements. All participants also received standard treatment for addiction, including clinical interviews, baclofen administration, anxiolytics/antidepressants administration, heroin substitution therapy, medications for PTSD treatment, and psychoeducation","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Three sessions in first month, followed by monthly sessions","26","8 sessions total",,,,,,,,,,,,,"Not reported","Community","100%","Mixed","other (sexual abuse, physical abuse or physical threatening or negligence, emotional abuse)","High","Perez-Dandieu B, Tapia G. Treating trauma in addiction with EMDR: a pilot study. J Psychoactive Drugs. 2014 Oct-Dec;46(4):303-9. doi: 10.1080/02791072.2014.921744. PMID: 25188700.","1548480","2019"
"perezdandieu2014_B","perezdandieu2014","Psychotherapy","2014","PTSD+SUD","Inactive Control",,"12","B","6",,"TAU","Treatment as usual (TAU)","Clinical interviews, baclofen administration, anxiolytics/antidepressants administration, heroin substitution therapy, medications for PTSD treatment, and psychoeducation","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"26",,,,,,,,,,,,,,"Not reported","Community","100%","Mixed","other (sexual abuse, physical abuse or physical threatening or negligence, emotional abuse)","High","Perez-Dandieu B, Tapia G. Treating trauma in addiction with EMDR: a pilot study. J Psychoactive Drugs. 2014 Oct-Dec;46(4):303-9. doi: 10.1080/02791072.2014.921744. PMID: 25188700.","1548480","2019"
"peterson2023_A","peterson2023","Psychotherapy","2023","PTSD","PTSD",,"234","A","117",,"Intensive Outpatient Program PE","Prolonged Exposure (PE)","Compressed 3-week PE protocol, including psychoeducation about trauma, diaphragmatic breathing, in vivo exposure, imaginal exposure, and processing of the trauma, with 8 treatment augmentations: team-based treatment, completing homework in clinic, brief therapist feedback, enhanced social support, processing top 3 traumas using graduated imaginal exposure, brief review of all traumas, and posttreatment booster sessions.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"""full day"", 90 minute PE sessions plus treatment augmentations","Daily","3","15 PE sessions over 3 weeks","Completing all 15 sessions, or ≥12 sessions with ≥10-point reduction in PCL-5 and participant-therapist agreement to terminate treatment",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","22%","Combat-related",,"Some Concerns","Peterson AL, Blount TH, Foa EB, et al. Massed vs intensive outpatient prolonged exposure for combat-related posttraumatic stress disorder: a randomized clinical trial. JAMA Netw Open. 2023;6(1):e2249422. doi: 10.1001/jamanetworkopen.2022.49422. PMID: 36602803.","1614713","2023"
"peterson2023_B","peterson2023","Psychotherapy","2023","PTSD","Active Control",,"234","B","117",,"Massed PE","Prolonged Exposure (PE)","Compressed 3-week PE protocol, including psychoeducation about trauma, diaphragmatic breathing, in vivo exposure, imaginal exposure, and processing of the trauma.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Daily","3","15 sessions over 3 weeks","Completing all 15 sessions, or ≥12 sessions with ≥10-point reduction in PCL-5 and participant-therapist agreement to terminate treatment",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","22%","Combat-related",,"Some Concerns","Peterson AL, Blount TH, Foa EB, et al. Massed vs intensive outpatient prolonged exposure for combat-related posttraumatic stress disorder: a randomized clinical trial. JAMA Netw Open. 2023;6(1):e2249422. doi: 10.1001/jamanetworkopen.2022.49422. PMID: 36602803.","1614713","2023"
"petrakis2012_A","petrakis2012","Pharmacotherapy","2012","PTSD+SUD","PTSD+SUD","Not integrated","88","A","22",,"Paroxetine + naltrexone","Paroxetine + naltrexone","Paroxetine: SSRI; naltrexone: opioid antagonist","No",,"Yes","Mixed","No",,"No","No","No","No","No","Individual","In Person","Paroxetine initiated at 10 mg, titrated over 2 weeks to 40 mg







Naltrexone initiated at 25 mg for 1 day then 50 mg for rest of treatment",,"Daily







Daily","12",,,,,"monitored by pill count",,,,,,,,,"Race data reported","Mixed","9.09%",,,"High","Petrakis IL, Ralevski E, Desai N, et al. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology. 2012 Mar;37(4):996-1004. doi: 10.1038/npp.2011.283. PMID: 22089316.","36777","2019"
"petrakis2012_B","petrakis2012","Pharmacotherapy","2012","PTSD+SUD","Active Control","Not integrated","88","B","20",,"Paroxetine + placebo","Paroxetine + placebo","SSRI","No",,"Yes","Antidepressant: SSRI","No",,"No","No","Yes","No","No","Individual","In Person","Paroxetine initiated at 10 mg/day, titrated over 2 weeks to 40 mg/day.",,"Daily","12",,,,,"monitored by pill count",,,,,,,,,"Race data reported","Mixed","9.09%",,,"High","Petrakis IL, Ralevski E, Desai N, et al. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology. 2012 Mar;37(4):996-1004. doi: 10.1038/npp.2011.283. PMID: 22089316.","36777","2019"
"petrakis2012_C","petrakis2012","Pharmacotherapy","2012","PTSD+SUD","PTSD+SUD","Not integrated","88","C","22",,"Desipramine + naltrexone","Desipramine + naltrexone","TCA plus opioid antagonist","No",,"Yes","Mixed","No",,"No","No","No","No","No","Individual","In Person","Desipramine initiated at 25 mg/day, titrated over 2 weeks to 200 mg/day. Naltrexone initiated at 25 mg/day for first day then 50 mg/day for rest of treatment.",,"Daily","12",,,,,"monitored by pill count",,,,,,,,,"Race data reported","Mixed","9.09%",,,"High","Petrakis IL, Ralevski E, Desai N, et al. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology. 2012 Mar;37(4):996-1004. doi: 10.1038/npp.2011.283. PMID: 22089316.","36777","2019"
"petrakis2012_D","petrakis2012","Pharmacotherapy","2012","PTSD+SUD","Active Control","Not integrated","88","D","24",,"Desipramine + placebo","Desipramine + placebo","TCA","No",,"Yes","Antidepressant: TCA","No",,"No","No","Yes","No","No","Individual","In Person","Desipramine initiated at 25 mg/day, titrated over 2 weeks to 200 mg/day",,"Daily","12",,,,,"monitored by pill count",,,,,,,,,"Race data reported","Mixed","9.09%",,,"High","Petrakis IL, Ralevski E, Desai N, et al. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology. 2012 Mar;37(4):996-1004. doi: 10.1038/npp.2011.283. PMID: 22089316.","36777","2019"
"petrakis2016_A","petrakis2016","Pharmacotherapy","2016","PTSD+SUD","PTSD+SUD","Not integrated","96","A","50",,"Prazosin","Prazosin","Alpha-1 adrenergic receptor inverse agonist. Initiated at 2 mg/day, titrated over 2 weeks up to 16 mg/day","No",,"Yes","Antiadrenergic","No",,"No","No","No","No","No","Individual","In Person","Initiated at 2 mg, titrated over 2 weeks up to 16 mg",,"Daily","12",,,,,"remained on study medication for 12 weeks","60%",,,,,"14.5 mg/day","3.14 mg/day",,"Race data reported","Veteran","6.25%",,,"Some Concerns","Petrakis IL, Desai N, Gueorguieva R, et al. Prazosin for veterans with posttraumatic stress disorder and comorbid alcohol dependence: a clinical trial. Alcohol Clin Exp Res. 2016 Jan;40(1):178-86. doi: 10.1111/acer.12926. PMID: 26683790.","44663","2020"
"petrakis2016_B","petrakis2016","Pharmacotherapy","2016","PTSD+SUD","Inactive Control","Not integrated","96","B","46",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,"remained on study medication for 12 weeks","52.17%",,,,,,,,"Race data reported","Veteran","6.25%",,,"Some Concerns","Petrakis IL, Desai N, Gueorguieva R, et al. Prazosin for veterans with posttraumatic stress disorder and comorbid alcohol dependence: a clinical trial. Alcohol Clin Exp Res. 2016 Jan;40(1):178-86. doi: 10.1111/acer.12926. PMID: 26683790.","44663","2020"
"petrakis2020_A","petrakis2020","Psychotherapy & pharmacotherapy","2020","PTSD+SUD","PTSD+SUD","Integrated","24","A","18",,"Zonisamide + CPT","Cognitive Processing Therapy (CPT) + zonisamide","Zonisamide: anticonvulsant dose titrated upwards over 6 weeks to maximum of 400 mg, tapered down for 2 weeks after study completed at week 12. CPT: All patients received up to 12 sessions of CPT standardized to address alcohol use.","Yes","Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","Dose: zonisamide initiated at 100 mg/day, titrated every 2 weeks by 100 mg to maximum 400 mg/day, maintained from week 6 to week 12",,"Zonisamide: daily



CPT: NR","12",,"""CPT completion""",,,"Complied with medication regimen","55.5%","compliance monitored by pill count, adherence not defined","7",,"Unclear if mean number of sessions for each arm or overall sample. States no difference between groups.",,,"Reported for overall sample; mean maximum dose 327.8 (SD 101.7) mg/day; 66.6% reached maximum dose","Race and Ethnicity data reported","Veteran","8.33%",,,"High","Petrakis I, Ralevski E, Arias AJ, et al. Zonisamide as an adjunctive treatment to cognitive processing therapy for veterans with posttraumatic stress disorder and comorbid alcohol use disorder: a pilot study. Am J Addict. 2020 11;29(6):515-24. doi: 10.1111/ajad.13061. PMID: 32462773","1553678","2022"
"petrakis2020_B","petrakis2020","Psychotherapy & pharmacotherapy","2020","PTSD+SUD","Active Control","Integrated","24","B","6",,"Placebo + CPT","Cognitive Processing Therapy (CPT) + placebo","Placebo: identical appearance and administration to zonisamide. CPT: All patients received up to 12 sessions of CPT standardized to address alcohol use.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person","Matching placebo equivalent dose",,"Pacebo: daily



CPT: NR","12",,"""CPT completion""",,,"Complied with medication regimen","50%","compliance monitored by pill count, adherence not defined","7",,"Unclear if mean number of sessions for each arm or overall sample. States no difference between groups.",,,"Reported for overall sample; mean maximum dose 327.8 (SD 101.7) mg/day; 66.6% reached maximum dose","Race and Ethnicity data reported","Veteran","8.33%",,,"High","Petrakis I, Ralevski E, Arias AJ, et al. Zonisamide as an adjunctive treatment to cognitive processing therapy for veterans with posttraumatic stress disorder and comorbid alcohol use disorder: a pilot study. Am J Addict. 2020 11;29(6):515-24. doi: 10.1111/ajad.13061. PMID: 32462773","1553678","2022"
"petrakis2024_A","petrakis2024","Psychotherapy","2024","PTSD+SUD","PTSD+SUD","Not integrated","38","A","20",,"CPT","Cognitive Processing Therapy (CPT)","Standard manualized CPT protocol without written component. Goals include accepting reality of event, challenging dysfunctional thoughts, and establishing realistic beliefs. Uses Socratic questioning to challenge distorted cognitions. All participants also received buprenorphine for OUD.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Mixed",,,"Weekly","12","Mean 8.60 weeks completed","Completed ≥7 therapy sessions within 12 weeks and PCL-5 at either Week 8 or 12",,"3 completed all visits, 7 more completed ≥7 and 8- or 12-week assessment",,,,"7.05","3.51",,,,,"Race and Ethnicity data reported","Veteran","7.9%","Mixed","Combat-related; Rape/sexual assault; Accidents; Community/school violence; Other (witnessing severe injury or death)","High","Petrakis IL, Meshberg-Cohen S, Nich C, et al. Cognitive processing therapy (CPT) versus individual drug counseling (IDC) for PTSD for veterans with opioid use disorder maintained on buprenorphine. Am J Addict. 2024. doi: 10.1111/ajad.13557. PMID: 38624259.","1638138","2025"
"petrakis2024_B","petrakis2024","Psychotherapy","2024","PTSD+SUD","SUD",,"38","B","18",,"Individual drug counseling","Addiction Counseling","Manualized drug counseling supporting abstinence through behavior changes like avoiding triggers, establishing life structure, and engaging in healthy behaviors. All participants also received buprenorphine for OUD.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Mixed",,,"Weekly","12","Mean 8.33 weeks completed","Completed ≥7 therapy sessions within 12 weeks and PCL-5 at either Week 8 or 12",,"6 completed all visits, 4 more completed ≥7 and 8- or 12-week assessment",,,,"7.22","4.96",,,,,"Race and Ethnicity data reported","Veteran","7.9%","Mixed","Combat-related; Rape/sexual assault; Accidents; Community/school violence; Other (witnessing severe injury or death)","High","Petrakis IL, Meshberg-Cohen S, Nich C, et al. Cognitive processing therapy (CPT) versus individual drug counseling (IDC) for PTSD for veterans with opioid use disorder maintained on buprenorphine. Am J Addict. 2024. doi: 10.1111/ajad.13557. PMID: 38624259.","1638138","2025"
"philip2019a_A","philip2019a","Nonpharmacologic biological","2019","PTSD","PTSD",,"50","A","25",,"Intermittent theta-burst transcranial magnetic stimulation","Transcranial magnetic stimulation (TMS)","Intermittent theta-burst transcranial magnetic stimulation to right dorsolateral prefrontal cortex at 80% motor threshold (1800 pulses, 9.5 minutes) using a Magstim Rapid 2+1 system.","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person","Dose: 1800 pulses at 80% of active motor threshold","Session length: 9.5 minutes","Daily (weekdays)","2","total 10 sessions","completed allocated intervention per protocol",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","16%","Mixed","combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (unspecified childhood trauma, ""serious injury, harm, or death you caused to someone else"", ""other very stressful event/experiences"")","Low","Philip NS, Barredo J, Aiken E, et al. Theta-burst transcranial magnetic stimulation for posttraumatic stress disorder. Am J Psychiatry. 2019 Jun 24;176(11):939-48. doi: 10.1176/appi.ajp.2019.18101160. PMID: 31230462.","52101","2020"
"philip2019a_B","philip2019a","Nonpharmacologic biological","2019","PTSD","Inactive Control",,"50","B","25",,"Sham intermittent theta-burst transcranial magnetic stimulation","Sham","Sham treatment; used separate coils for sham stimulation using a Magstim Rapid 2+1 system.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","Dose: NR (sham treatment)","Session length: 9.5 minutes","Daily (weekdays)","2","total 10 sessions","completed allocated intervention per protocol",,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","16%","Mixed","combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (unspecified childhood trauma, ""serious injury, harm, or death you caused to someone else"", ""other very stressful event/experiences"")","Low","Philip NS, Barredo J, Aiken E, et al. Theta-burst transcranial magnetic stimulation for posttraumatic stress disorder. Am J Psychiatry. 2019 Jun 24;176(11):939-48. doi: 10.1176/appi.ajp.2019.18101160. PMID: 31230462.","52101","2020"
"philip2019b_A","philip2019b","Nonpharmacologic biological","2019","PTSD","PTSD",,"23","A","10",,"Synchronized TMS","Transcranial magnetic stimulation (TMS)","Active synchronized TMS for 4 weeks. Optional unblinded synchronized TMS for another 4 weeks, delivered on a separate device from the one used for blinded stimulation.","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person",,,"5 times a week","4 to 8","blinded: 4 weeks; optional unblinded: 4 weeks",,,"publication doesn't report on study dropout, no information on TMS completion",,,,,,,,,,"Not reported","Veteran","22%",,,"Some Concerns","Philip NS, Aiken EE, Kelley ME, et al. Synchronized transcranial magnetic stimulation for posttraumatic stress disorder and comorbid major depression. Brain Stimul. 2019 Sep-Oct;12(5):1335-7. doi: 10.1016/j.brs.2019.06.010. PMID: 31204205.","1511859","2020"
"philip2019b_B","philip2019b","Nonpharmacologic biological","2019","PTSD","Inactive Control",,"23","B","13",,"Sham synchronized TMS","Sham","Sham synchronized TMS was identical to active synchronized TMS except it did not use rotating magnets. Sham stimulation followed by optional unblinded synchronized TMS for another 4 weeks, delivered on a separate device from the one used for blinded stimulation.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"5 times a week","4 to 8","blinded: 4 weeks; optional unblinded: 4 weeks",,,"publication doesn't report on study dropout, no information on TMS completion",,,,,,,,,,"Not reported","Veteran","22%",,,"Some Concerns","Philip NS, Aiken EE, Kelley ME, et al. Synchronized transcranial magnetic stimulation for posttraumatic stress disorder and comorbid major depression. Brain Stimul. 2019 Sep-Oct;12(5):1335-7. doi: 10.1016/j.brs.2019.06.010. PMID: 31204205.","1511859","2020"
"pigeon2022_A","pigeon2022","Psychotherapy","2022","PTSD","PTSD",,"110","A","56",,"CBTi + CPT","Cognitive Behavioral Therapy for Insomnia (CBT-I) + Cognitive Processing Therapy (CPT)","CBT-i followed by CPT

CBT-i: standardized, multicomponent CBT intervention; components included: stimulus control therapy including establishment of a prebedtime routine; sleep psychoeducation; sleep restriction therapy; sleep hygeine; cognitive therapy; and self management/relapse prevention. Daily sleep diaries (started 1 week prior to first session, continued throughout intervention)

CPT: standard structured 12-session protocol; included psychoeducation, cognitive therapy, written trauma accounts, identifying and challenging beliefs, impact statement.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Weekly","16","CBT-i: 4 total sessions

CPT: total 12 weekly sessions","See Detail",,"Reports number completing measurement/assessment only, no information for treatment completion specifically",,,,,,,,,,"Race data reported","Community","97.3%",,,"High","Pigeon WR, Crean HF, Cerulli C, et al. A randomized clinical trial of cognitive-behavioral therapy for insomnia to augment posttraumatic stress disorder treatment in survivors of interpersonal violence. Psychother Psychosom. 2022 Jan;91(1):50-62. doi: 10.1159/000517862. PMID: 34265777.","1587109","2023"
"pigeon2022_B","pigeon2022","Psychotherapy","2022","PTSD","Active Control",,"110","B","54",,"Waitlist + CPT","Cognitive Processing Therapy (CPT)","Waitlist followed by CPT.

Waitlist period: participants completed daily sleep diaries (started 1 week prior to first session, continued throughout waitlist period), and received 4 weekly phone calls from the clinical coordinator (limited to brief check ins and reminders).

CPT: standard structured 12-session protocol; included psychoeducation, cognitive therapy, written trauma accounts, identifying and challenging beliefs, impact statement.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"WL: NA

CPT: weekly","16","WL: 4 week waiting period

CPT: total 12 weekly sessions","See Detail",,"Reports number completing measurement/assessment only, no information for treatment completion specifically",,,,,,,,,,"Race data reported","Community","97.3%",,,"High","Pigeon WR, Crean HF, Cerulli C, et al. A randomized clinical trial of cognitive-behavioral therapy for insomnia to augment posttraumatic stress disorder treatment in survivors of interpersonal violence. Psychother Psychosom. 2022 Jan;91(1):50-62. doi: 10.1159/000517862. PMID: 34265777.","1587109","2023"
"polak2015_A","polak2015","Psychotherapy & CIH","2015","PTSD","PTSD",,"8","A","4",,"Trauma-focused CBT with breathing biofeedback","Trauma-focused cognitive behavioral therapy (TF-CBT) + biofeedback","CBT following model developed by Foa et al (1995) that included imaginal and in vivo exposure, psychoeducation, and anxiety management. A device measures breathing frequency and provides immediate feedback (sound) when breathing frequency is outside preprogrammed frequency","Yes","Trauma-focused","No",,"Yes","Relaxation","No","No","No","No","No","Individual","In Person",,,"Weekly",,"flexible number of sessions until subjective units of distress‚ ≤30","Completed treatment",,"all participants attended all sessions",,,,,,"median 7.5 (range 6 to 11)",,,,"Not reported","Community","75%","Mixed","accidents, other (sexual or physical abuse)","Some Concerns","Polak AR, Witteveen AB, Denys D, et al. Breathing biofeedback as an adjunct to exposure in cognitive behavioral therapy hastens the reduction of PTSD symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2015 Mar;40(1):25-31. doi: 10.1007/s10484-015-9268-y. PMID: 25750106.","47793","2019"
"polak2015_B","polak2015","Psychotherapy & CIH","2015","PTSD","Active Control",,"8","B","4",,"Trauma-focused CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","CBT following model developed by Foa et al (1995) that included imaginal and in vivo exposure, psychoeducation, and anxiety management","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Weekly",,"flexible number of sessions until subjective units of distress‚ ≤30","Completed treatment (not lost to treatment)",,"one participant did not attend one session, and another was ""lost to treatment"" after session 5; variable number of sessions allowed, so counting all not ""lost to treatment"" as treatment completion",,,,,,"median 8.0 (range 5 to 18)",,,,"Not reported","Community","75%","Mixed","accidents, other (sexual or physical abuse)","Some Concerns","Polak AR, Witteveen AB, Denys D, et al. Breathing biofeedback as an adjunct to exposure in cognitive behavioral therapy hastens the reduction of PTSD symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2015 Mar;40(1):25-31. doi: 10.1007/s10484-015-9268-y. PMID: 25750106.","47793","2019"
"polusny2015_A","polusny2015","Psychotherapy & CIH","2015","PTSD","PTSD",,"116","A","58",,"MBSR","Mindfulness-based stress reduction (MBSR)","Program teaches participants to attend to the present moment (immediate emotional and physical states) in a nonjudgmental and accepting way. Sessions include didactic training and formal practice in 3 meditation techniques: body scan, sitting meditation, and mindful yoga. Intervention modified to include PTSD psychoeducation.","No",,"No",,"Yes","Meditation","No","No","No","No","No","Group","In Person",,"Weekly session: 2.5 hours







Retreat: 6.5 hours","8 weekly sessions plus 1 daylong retreat","9","8 weekly sessions plus 1 daylong retreat","completed ≥7 sessions",,,,,,"6.96","2.6",,,,,"Race data reported","Veteran","15.52%","Mixed","combat-related, rape/sexual assault, illness/medical procedure, community/school violence, natural or manmade disaster, other (not specified)","Some Concerns","Polusny MA, Erbes CR, Thuras P, et al. Mindfulness-based stress reduction for posttraumatic stress disorder among veterans: a randomized clinical trial. JAMA. 2015 Aug 4;314(5):456-65. doi: 10.1001/jama.2015.8361. PMID: 26241597.","44257","2019"
"polusny2015_B","polusny2015","Psychotherapy & CIH","2015","PTSD","Active Control",,"116","B","58",,"PCT","Present-Centered Therapy (PCT)","Therapy focuses on current life problems as manifestations of PTSD. Therapists are nondirective and encourage patients to provide each other with support, problem solving, and validation","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Group","In Person",,"1.5 hour","Weekly","9",,"completed ≥7 sessions",,,,,,"8.08","1.8",,,,,"Race data reported","Veteran","15.52%","Mixed","combat-related, rape/sexual assault, illness/medical procedure, community/school violence, natural or manmade disaster, other (not specified)","Some Concerns","Polusny MA, Erbes CR, Thuras P, et al. Mindfulness-based stress reduction for posttraumatic stress disorder among veterans: a randomized clinical trial. JAMA. 2015 Aug 4;314(5):456-65. doi: 10.1001/jama.2015.8361. PMID: 26241597.","44257","2019"
"popiel2015_A","popiel2015","Psychotherapy & pharmacotherapy","2015","PTSD","PTSD",,"228","A","114",,"PE","Prolonged Exposure (PE)","Treatment according to manual by Foa, Hembree & Rothbaum, 2007 and Foa, Rothbaum, Riggs, & Murdock 1991","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person","90 minutes",,"Weekly","12",,"Completed treatment",,"""completed treatment"" in flow diagram",,,,"8.6","3.5",,,,,"Not reported","Community","23.68%","Accidents",,"High","Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.","45183","2019"
"popiel2015_B","popiel2015","Psychotherapy & pharmacotherapy","2015","PTSD","Active Control",,"228","B","57",,"Paroxetine","Paroxetine","SSRI","No",,"Yes","Antidepressant: SSRI","No",,"No","No","Yes","No","No","Individual","In Person","20 mg/day achieved over 3 to 7 days",,"Daily","12",,,,,,,"""completed treatment"" in flow diagram (40.3%); not described as adherence",,,,,,,"Not reported","Community","23.68%","Accidents",,"High","Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.","45183","2019"
"popiel2015_C","popiel2015","Psychotherapy & pharmacotherapy","2015","PTSD","PTSD",,"228","C","57",,"PE + paroxetine","Prolonged Exposure (PE) + paroxetine","PE protocol according to Foa, Hembree & Rothbaum, 2007 and Foa, Rothbaum, Riggs, & Murdock, 1991; plus SSRI","Yes","Trauma-focused","Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","Session length: 90 minutes







Doses: 20 mg/day",,"Psychotherapy: weekly







SSRI: daily","12",,"Completed treatment",,"""completed treatment"" in flow diagram",,,,"8","3.4",,,,,"Not reported","Community","23.68%","Accidents",,"High","Popiel A, Zawadzki B, Praglowska E, et al. Prolonged exposure, paroxetine and the combination in the treatment of PTSD following a motor vehicle accident. A randomized clinical trial - the ""TRAKT"" study. J Behav Ther Exp Psychiatry. 2015 Sep;48:17-26. doi: 10.1016/j.jbtep.2015.01.002. PMID: 25677254.","45183","2019"
"possemato2016_A","possemato2016","Other study class","2016","PTSD","PTSD",,"20","A","10",,"PTSD Coach mobile application with clinician support","Internet-based facilitated self-help","Self-management app with psychoeducation, symptom monitoring, coping skills, and links to social support and professional resources with clinician support","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology assisted",,"20 minutes","Biweekly","8",,"attended all coaching sessions",,,,,,"4","0",,,,,"Race data reported","Veteran","5%","Other","military-related","Some Concerns","Possemato K, Kuhn E, Johnson E, et al. Using PTSD Coach in primary care with and without clinician support: a pilot randomized controlled trial. General hospital psychiatry. 2016 Jan-Feb;38:94-8. doi: 10.1016/j.genhosppsych.2015.09.005. PMID: 26589765.","44682","2019"
"possemato2016_B","possemato2016","Other study class","2016","PTSD","Active Control",,"20","B","10",,"PTSD Coach mobile application without clinician support","Internet-based facilitated self-help","Self-management app with psychoeducation, symptom monitoring, coping skills, and links to social support and professional resources","No",,"No",,"No",,"No","No","Yes","Yes","No","Individual","Technology alone",,,,"8",,"attended all coaching sessions",,,,,,,,,,,,"Race data reported","Veteran","5%","Other","military-related","Some Concerns","Possemato K, Kuhn E, Johnson E, et al. Using PTSD Coach in primary care with and without clinician support: a pilot randomized controlled trial. General hospital psychiatry. 2016 Jan-Feb;38:94-8. doi: 10.1016/j.genhosppsych.2015.09.005. PMID: 26589765.","44682","2019"
"possemato2022_A","possemato2022","Psychotherapy & CIH","2022","PTSD","PTSD",,"55","A","28",,"Primary Care Brief Mindfulness Training","Mindfulness","Brief Primary Care–Based Mindfulness Training. Instruction includes sitting & moving meditations, body scan, yoga stretching, and group processing of class experiences. At-home practice encouraged.","No",,"No",,"Yes","Meditation","No","No","No","No","No","Group","In Person",,"90 minutes","Weekly","4","4 weekly classes, plus 2 one-on-one brief meetings with class peer cofacilitators (one prior to start of group classes, and one after the 4 classes ended)","Completing ≥3 sessions",,,,,,"4.61","1.55","includes pre- and post-class peer meetings",,,,"Race and Ethnicity data reported","Veteran","13%",,,"High","Possemato K, Bergen-Cico D, Buckheit K, et al. Randomized clinical trial of brief primary care-based mindfulness training versus a psychoeducational group for veterans with posttraumatic stress disorder. J Clin Psychiatry. 2022;84(1) doi: 10.4088/JCP.22m14510. PMID: 36576365.","1614949","2023"
"possemato2022_B","possemato2022","Psychotherapy & CIH","2022","PTSD","Active Control",,"55","B","27",,"Psychoeducation","Psychoeducation","Psychoeducational classes about PTSD and recovery options; included in TAU at study sites.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Group","In Person",,,,"4","4-session format with optional additional sessions at facilitator discretion.","Completing ≥3 sessions",,,,,,"5.11","3.06",,,,,"Race and Ethnicity data reported","Veteran","13%",,,"High","Possemato K, Bergen-Cico D, Buckheit K, et al. Randomized clinical trial of brief primary care-based mindfulness training versus a psychoeducational group for veterans with posttraumatic stress disorder. J Clin Psychiatry. 2022;84(1) doi: 10.4088/JCP.22m14510. PMID: 36576365.","1614949","2023"
"possemato2024_A","possemato2024","Psychotherapy","2024","PTSD+SUD","PTSD+SUD","Integrated","63","A","33",,"Primary care treatment integrating motivation and exposure (PC-TIME)","Primary Care Treatment Integrating Motivation and Exposure (PC-TIME)","Primary care-based integrated treatment for co-occurring PTSD and harmful alcohol use combining motivational interviewing and prolonged exposure.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Mixed",,"30 minutes","Every 1-2 weeks","8","5 sessions, 1-2 additional sessions could be added based on patient need","Attended 4 or more sessions",,,,,,"4","2.08",,,,,"Race and Ethnicity data reported","Veteran","12.7%",,,"High","Possemato K, Mastroleo NR, Balderrama-Durbin C, King P, Davis A, Borsari B, Rauch SAM. A Randomized Controlled Pilot Trial of Primary Care Treatment Integrating Motivation and Exposure Treatment (PC-TIME) in Veterans With PTSD and Harmful Alcohol Use. Behav Ther. 2024 May;55(3):570-584. doi: 10.1016/j.beth.2023.08.011. Epub 2023 Sep 10. PMID: 38670669; PMCID: PMC11056732.","1633529","2024"
"possemato2024_B","possemato2024","Psychotherapy","2024","PTSD+SUD","Inactive Control",,"63","B","30",,"Primary care treatment as usual (PC-TAU)","Treatment as usual (TAU)","Primary care treatment as usual, including VA mental health integration; treatment received (for some but not all participants) included VA primary care mental health integration treatment, PTSD clinic treatment, substance use clinic treatment, and/or psychiatric medication; no participants recieved PE or CPT during intervention period.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Mixed",,,,"8",,,,,,,,"2.43","2.6","average sessions attended (not further specified for specific type of treatment sessions)",,,,"Race and Ethnicity data reported","Veteran","12.7%",,,"High","Possemato K, Mastroleo NR, Balderrama-Durbin C, King P, Davis A, Borsari B, Rauch SAM. A Randomized Controlled Pilot Trial of Primary Care Treatment Integrating Motivation and Exposure Treatment (PC-TIME) in Veterans With PTSD and Harmful Alcohol Use. Behav Ther. 2024 May;55(3):570-584. doi: 10.1016/j.beth.2023.08.011. Epub 2023 Sep 10. PMID: 38670669; PMCID: PMC11056732.","1633529","2024"
"power2002_A","power2002","Psychotherapy","2002","PTSD","PTSD",,"105","A","39",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Patient's attention is directed to an external stimulus while they simultaneously concentrate on an identified source of emotional disturbance. External stimuli used included bilateral saccadic eye movements or alternating hand taps. When distress had sufficiently reduced on the part of the patient negative belief statements were replaced by preferred belief statements and saccadic eye movements or hand taps","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","10",,"See Detail",,"reports only ""completion"" and drop-out from assessment, does not provide information specifically for treatment dropout/completion",,,,"4.2",,,,,,"Not reported","Community","41.67%","Mixed","accidents, rape/sexual assault, community/school violence, other (traumatic death, not specified)","High","Power K, McGoldrick T, Brown K, et al. A controlled comparison of Eye Movement Desensitization and Reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post-traumatic stress disorder. Clin Psychol Psychother. 2002 Sep/Oct;9(5):299-318. doi: 10.1002/cpp.341.","25144","2019"
"power2002_B","power2002","Psychotherapy","2002","PTSD","PTSD",,"105","B","37",,"Exposure + cognitive restructuring","Trauma-focused cognitive behavioral therapy (TF-CBT)","Imaginal exposure sessions which were audio-taped. Therapists facilitated this process by prompting, questioning and encouraging. Patients were provided with audio-tape copies and asked to listen to the recording at least once per day as homework.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","10",,"See Detail",,"reports only ""completion"" and drop-out from assessment, does not provide information specifically for treatment dropout/completion",,,,"6.4",,,,,,"Not reported","Community","41.67%","Mixed","accidents, rape/sexual assault, community/school violence, other (traumatic death, not specified)","High","Power K, McGoldrick T, Brown K, et al. A controlled comparison of Eye Movement Desensitization and Reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post-traumatic stress disorder. Clin Psychol Psychother. 2002 Sep/Oct;9(5):299-318. doi: 10.1002/cpp.341.","25144","2019"
"power2002_C","power2002","Psychotherapy","2002","PTSD","Inactive Control",,"105","C","29",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"10",,,,,,,,,,,,,,"Not reported","Community","41.67%","Mixed","accidents, rape/sexual assault, community/school violence, other (traumatic death, not specified)","High","Power K, McGoldrick T, Brown K, et al. A controlled comparison of Eye Movement Desensitization and Reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post-traumatic stress disorder. Clin Psychol Psychother. 2002 Sep/Oct;9(5):299-318. doi: 10.1002/cpp.341.","25144","2019"
"powers2015_A","powers2015","Other mixed","2015","PTSD","PTSD",,"9","A",,,"PE + exercise","Prolonged Exposure (PE) + exercise","Participants completed a 30-minute bout of moderate-intensity treadmill exercise (70% of age-predicted HRmax) immediately prior to each PE session. PE was manualized treatment program including education about trauma; breathing retraining: prolonged and repeated imaginal exposure to the trauma memories; prolonged and repeated in vivo exposure to safe situations; assignment of homework; and monitoring compliance of homework assignments.","Yes","Trauma-focused","No",,"No",,"No","No","No","Yes","No","Individual","In Person",,"90 minutes","Weekly","12",,,,,,,,,,,,,,"Race and Ethnicity data reported","Community","88.89%",,,"High","Powers MB, Medina JL, Burns S, et al. Exercise augmentation of exposure therapy for PTSD: rationale and pilot efficacy data. Cogn Behav Ther. 2015;44(4):314-27. doi: 10.1080/16506073.2015.1012740. PMID: 25706090.","43517","2019"
"powers2015_B","powers2015","Other mixed","2015","PTSD","Active Control",,"9","B",,,"PE","Prolonged Exposure (PE)","PE was manualized treatment program including education about trauma; breathing retraining: prolonged and repeated imaginal exposure to the trauma memories; prolonged and repeated in vivo exposure to safe situations; assignment of homework; and monitoring compliance of homework assignments.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Weekly","12",,,,,,,,,,,,,,"Race and Ethnicity data reported","Community","88.89%",,,"High","Powers MB, Medina JL, Burns S, et al. Exercise augmentation of exposure therapy for PTSD: rationale and pilot efficacy data. Cogn Behav Ther. 2015;44(4):314-27. doi: 10.1080/16506073.2015.1012740. PMID: 25706090.","43517","2019"
"prguda2023_A","prguda2023","Psychotherapy","2023","PTSD","PTSD",,"31","A","15",,"CBT for insomnia (CBT-I) + imagery rehearsal therapy (IRT) for nightmares","Cognitive Behavioral Therapy for Insomnia (CBT-I) + Imagery Rehearsal Training (IRT)","Group sessions including both CBT-I and IRT. CBT-I included psychoeducation, sleep efficiency training, stimulus control, relaxation training, and sleep hygiene. IRT followed a protocol with minimal exposure to nightmare content and included grounding strategies to reduce arousal after nightmares; imagery exercises; challenging nightmare identities; and nightmare identification, rescripting, and rescript rehearsal. Participants asked to complete a daily sleep diary. Individual catch-up sessions offered as needed, following the same structure and content as the group sessions.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"120 minutes","Weekly","8",,"Completed full dose of intervention",,"Full dose of intervention not further defined (number of sessions not stated)",,,,,,,,,,"Race data reported","Veteran","6.45%",,,"Some Concerns","Prguda E, Evans J, McLeay S, et al. Posttraumatic sleep disturbances in veterans: a pilot randomized controlled trial of cognitive behavioral therapy for insomnia and imagery rehearsal therapy. J Clin Psychol. 2023 Nov;79(11):2493-514. doi: 10.1002/jclp.23561. PMID: 37392411.","1626275","2024"
"prguda2023_B","prguda2023","Psychotherapy","2023","PTSD","Active Control",,"31","B","16",,"CBT for insomnia (CBT-I)","Cognitive Behavioral Therapy for Insomnia (CBT-I)","Group sessions of CBT-I; included psychoeducation, sleep efficiency training, stimulus control, relaxation training, and sleep hygiene. Participants asked to complete a daily sleep diary. Individual catch-up sessions offered as needed, following the same structure and content as the group sessions.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Group","In Person",,"60 minutes","Weekly","8",,"Completed full dose of intervention",,"Full dose of intervention not further defined (number of sessions not stated)",,,,,,,,,,"Race data reported","Veteran","6.45%",,,"Some Concerns","Prguda E, Evans J, McLeay S, et al. Posttraumatic sleep disturbances in veterans: a pilot randomized controlled trial of cognitive behavioral therapy for insomnia and imagery rehearsal therapy. J Clin Psychol. 2023 Nov;79(11):2493-514. doi: 10.1002/jclp.23561. PMID: 37392411.","1626275","2024"
"proenca2022_A","proenca2022","Psychotherapy & pharmacotherapy","2022","PTSD","PTSD",,"74","A","39",,"Interpersonal Psychotherapy adapted for PTSD (IPT-PTSD)","Interpersonal Psychotherapy (IPT)","Manualized psychotherapy modified for PTSD, addressing the effect of trauma on interpersonal function: ""focus is to help the individual understand emotions to regain safety and trust in interpersonal relationships and to mobilize social supports.""","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"50 minutes","Weekly","14",,"Completed treatment",,"""completers"" in participant flow diagram, text describes completers for sertraline arm as treatment completers (and only treatment dropout described for IPT), so using completion = treatment completion",,,,,,,,,,"Race data reported","Community","100%","Rape/sexual assault",,"Some Concerns","Proenca CR, Markowitz JC, Coimbra BM, et al. Interpersonal psychotherapy versus sertraline for women with posttraumatic stress disorder following recent sexual assault: a randomized clinical trial. Eur J Psychotraumatol. 2022;13(2):2127474. doi: 10.1080/20008066.2022.2127474. PMID: 36267873.","1605384","2023"
"proenca2022_B","proenca2022","Psychotherapy & pharmacotherapy","2022","PTSD","Active Control",,"74","B","35",,"Sertraline","Sertraline","Sertraline with dose titrated based on symptoms and tolerance; appointments scheduled at regular intervals with psychiatrists experienced in pharmacotherapy","No",,"Yes","Antidepressant: SSRI","No",,"No","No","Yes","No","No","Individual","In Person","50 to 200 mg",,"Daily","14",,,,,,,"11 participants dropped out (total 15 participants ""did not complete treatment"" per text; medication adherence not reported",,,,"118 mg","62",,"Race data reported","Community","100%","Rape/sexual assault",,"Some Concerns","Proenca CR, Markowitz JC, Coimbra BM, et al. Interpersonal psychotherapy versus sertraline for women with posttraumatic stress disorder following recent sexual assault: a randomized clinical trial. Eur J Psychotraumatol. 2022;13(2):2127474. doi: 10.1080/20008066.2022.2127474. PMID: 36267873.","1605384","2023"
"quinones2015_A","quinones2015","Psychotherapy & CIH","2015","PTSD","PTSD",,"100","A","50",,"Yoga + supportive therapy","Yoga + supportive therapy","Satyananda yoga includes postures, breathing techniques, deep relaxation, and meditation. Supportive therapy provided by trained psychologist and follows mandatory ordinary assistance protocol designed by Agencia Colombiana para la Reintegracion for reintegrating individuals","Yes","Non-Trauma-focused","No",,"Yes","Yoga","No","No","No","No","No","Individual","In Person",,"1 hour","Satyananda yoga: twice weekly







Supportive therapy: once monthly","16",,"Attended at least 75% of the sessions",,"""Participants whose data were included in the final analysis attended at least 75% of the sessions offered during the intervention""",,,,,,,,,,"Not reported","Community","27%","Combat-related",,"High","Quinones N, Maquet YG, Velez DM, et al. Efficacy of a Satyananda yoga intervention for reintegrating adults diagnosed with posttraumatic stress disorder. Int J Yoga Therap. 2015;25(1):89-99. doi: 10.17761/1531-2054-25.1.89. PMID: 26667292.","44694","2019"
"quinones2015_B","quinones2015","Psychotherapy & CIH","2015","PTSD","Active Control",,"100","B","50",,"Waitlist + supportive therapy","Supportive counseling","Wait list for yoga with monthly appointment with a trained psychologist following the mandatory ordinary assistance protocol designed by Agencia Colombiana para la Reintegracion for reintegrating individuals.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Once monthly","16",,,,,,,,,,,,,,"Not reported","Community","27%","Combat-related",,"High","Quinones N, Maquet YG, Velez DM, et al. Efficacy of a Satyananda yoga intervention for reintegrating adults diagnosed with posttraumatic stress disorder. Int J Yoga Therap. 2015;25(1):89-99. doi: 10.17761/1531-2054-25.1.89. PMID: 26667292.","44694","2019"
"raabe2022_A","raabe2022","Psychotherapy","2022","PTSD","PTSD",,"61","A","20",,"STAIR","Skills Training in Affect and Interpersonal Regulation (STAIR)","Treatment followed STAIR manual; first 4 sessions focused on emotion regulation; last 4 sessions on trauma-related interpersonal schemas, maladaptive schemas, assertiveness, flexibility, and comnpassion. Each session includes psychoeducation, skill demonstration and practice, and homework exercises.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","8","8 sessions","Dd not discontinue intervention",,"did not discontinue intervention, participant flow diagram",,,,,,,,,,"Not reported","Community","88.52%","Mixed","Child physical abuse; Child sexual abuse","Low","Raabe S, Ehring T, Marquenie L, et al. Imagery rescripting as a stand-alone treatment for posttraumatic stress disorder related to childhood abuse: a randomized controlled trial. J Behav Ther Exp Psychiatry. 2022;77:101769. doi: 10.1016/j.jbtep.2022.101769. PMID: 36113906.","1600567","2023"
"raabe2022_B","raabe2022","Psychotherapy","2022","PTSD","PTSD",,"61","B","21",,"Imagery Rescripting","Imagery rescripting","First session is used to compose list of traumatic situations and pilot imagery rescripting with non-traumatic material; sessions 2-16, imagery rescripting is applied to process trauma memories. ""procedure consists of 3 phases: in Phase 1, patients are asked to imagine a traumatic childhood experience as vividly as possible from the child's perspective, with their eyes closed. As soon as strong trauma-related emotions are triggered, therapist and patient move to the next phase. In Phase 2, patients enter the image as an adult who witnesses the situation, and are prompted to intervene and do whatever they think is necessary. This is followed by Phase 3, in which patients imagine the scene again as a child, and experience the adult's intervention developed in Phase 2 from the child's perspective. Patients can then ask for additional interventions until the child feels safe and is satisfied with the intervention.""","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Twice a week","8","16 sessions","Dd not discontinue intervention",,"did not discontinue intervention, participant flow diagram",,,,,,"Mean 13 sessions but not reported separately for group A (received ImRs after STAIR) and group B (ImRs only) (stated as not significantly different between conditions)",,,,"Not reported","Community","88.52%","Mixed","Child physical abuse; Child sexual abuse","Low","Raabe S, Ehring T, Marquenie L, et al. Imagery rescripting as a stand-alone treatment for posttraumatic stress disorder related to childhood abuse: a randomized controlled trial. J Behav Ther Exp Psychiatry. 2022;77:101769. doi: 10.1016/j.jbtep.2022.101769. PMID: 36113906.","1600567","2023"
"raabe2022_C","raabe2022","Psychotherapy","2022","PTSD","Inactive Control",,"61","C","20",,"Waitlist","Waitlist","No contact with therapist during waitlist period.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Not reported","Community","88.52%","Mixed","Child physical abuse; Child sexual abuse","Low","Raabe S, Ehring T, Marquenie L, et al. Imagery rescripting as a stand-alone treatment for posttraumatic stress disorder related to childhood abuse: a randomized controlled trial. J Behav Ther Exp Psychiatry. 2022;77:101769. doi: 10.1016/j.jbtep.2022.101769. PMID: 36113906.","1600567","2023"
"raeolmsted2020_A","raeolmsted2020","Nonpharmacologic biological","2020","PTSD","PTSD",,"113","A","74",,"SGB","Stellate ganglion block (SGB)","Two right-sided SGB treatments, with ropivicaine injected into ganglion site at level of C6 anterior tubercle, performed at 0 and 2 weeks with outcomes measured at 8 weeks","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person","7 to 10 mL of 0.5% ropivacaine",,"Twice separated by 2 weeks","2",,"Completed treatment visits",,"injections at study week 0 and 2, flow diagram reports ""in study through week-2 visit"", data entered is participants completed baseline visit and in study through week-2 visit and completed week-2 visit",,,,,,,,,,"Not reported","Active Duty Military","11.5%",,,"Low","Rae Olmsted KL, Bartoszek M, Mulvaney S, et al. Effect of stellate ganglion block treatment on posttraumatic stress disorder symptoms: a randomized clinical trial. JAMA Psychiatry. 2020 Feb 1;77(2):130-8. doi: 10.1001/jamapsychiatry.2019.3474. PMID: 31693083.","1546434","2020"
"raeolmsted2020_B","raeolmsted2020","Nonpharmacologic biological","2020","PTSD","Inactive Control",,"113","B","39",,"Sham SGB","Sham","Two sham right-sided SGB treatments, with normal saline injected into musculature anterolateral to the anterior tubercle of C6, performed at 0 and 2 weeks with outcomes measured at 8 weeks","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","1 to 2 mL of normal saline",,"Twice separated by 2 weeks","2",,"Completed treatment visits",,"injections at study week 0 and 2, flow diagram reports ""in study through week-2 visit"", data entered is participants completed baseline visit and in study through week-2 visit and completed week-2 visit",,,,,,,,,,"Not reported","Active Duty Military","11.5%",,,"Low","Rae Olmsted KL, Bartoszek M, Mulvaney S, et al. Effect of stellate ganglion block treatment on posttraumatic stress disorder symptoms: a randomized clinical trial. JAMA Psychiatry. 2020 Feb 1;77(2):130-8. doi: 10.1001/jamapsychiatry.2019.3474. PMID: 31693083.","1546434","2020"
"rajabi2023_A","rajabi2023","Pharmacotherapy","2023","PTSD","PTSD",,"26","A","13",,"Memantine","Memantine","Memantine added to patient's existing PTSD regimen. Dose increased over 3 weeks as tolerated.","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","20 mg maintenance dose
Initial dose 5 mg, increased by 5 mg each week up to 20 mg, adjusted based on tolerability",,"Daily","16",,,,,,,,,,,,,,"Not reported","Active Duty Military","11.54%","Combat-related",,"Low","Rajabi F, Fozveh F, Maracy MR. The effect of add-on memantine in new onset combat-related posttraumatic stress disorder core symptoms: a pilot study. Iranian Journal of Psychiatry. 2023 Jul;18(3):266-74. doi: 10.18502/ijps.v18i3.13003. PMID: 37575607.","1624399","2024"
"rajabi2023_B","rajabi2023","Pharmacotherapy","2023","PTSD","Inactive Control",,"26","B","13",,"Placebo","Placebo","Placebo added to patient's existing PTSD regimen, matching placebo tablet.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","matched placebo",,"Daily","16",,,,,,,,,,,,,,"Not reported","Active Duty Military","11.54%","Combat-related",,"Low","Rajabi F, Fozveh F, Maracy MR. The effect of add-on memantine in new onset combat-related posttraumatic stress disorder core symptoms: a pilot study. Iranian Journal of Psychiatry. 2023 Jul;18(3):266-74. doi: 10.18502/ijps.v18i3.13003. PMID: 37575607.","1624399","2024"
"rajan2020_A","rajan2020","Psychotherapy","2020","PTSD","PTSD",,"36","A","21","57 total randomized, NR by arm; 21 in arm A after post-randomization exclusions","Modified Lifespan Integration","Modified Lifespan Integration","One session of Modified Lifespan Integration, a manualized procedure to identify and visualize episodic ""memory cues"" chronologically from time of trauma to present, with the goal of converting trauma to a past episode rather than current threat (""trauma clearing"").","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 to 140 minutes","Single session","0.14","single session","Received allocated intervention",,"single session, ""received allocated intervention"" = completed treatment",,,,,,,,,,"Race data reported","Community","100%","Rape/sexual assault",,"High","Rajan G, Wachtler C, Lee S, et al. A one-session treatment of PTSD after single sexual assault trauma. A pilot study of the WONSA MLI project: a randomized controlled trial. J Interpers Violence. 2020 doi: 10.1177/0886260520965973. PMID: 33084475","1560532","2022"
"rajan2020_B","rajan2020","Psychotherapy","2020","PTSD","Inactive Control",,"36","B","17","57 total randomized, NR by arm; 17 in arm B after post-randomization exclusions","Waitlist control","Waitlist","Waitlist control: attention control in the form of the same initial doctor visit as the intervention arm, at which they were clinically assessed and given information about the treatment. Asked to prepare a memory cue list 1 to 2 days before intervention, which was offered after the second outcome measurement at time point 2 (25 ± 6 days after baseline).","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Race data reported","Community","100%","Rape/sexual assault",,"High","Rajan G, Wachtler C, Lee S, et al. A one-session treatment of PTSD after single sexual assault trauma. A pilot study of the WONSA MLI project: a randomized controlled trial. J Interpers Violence. 2020 doi: 10.1177/0886260520965973. PMID: 33084475","1560532","2022"
"ramakrishnan2021_A","ramakrishnan2021","Pharmacotherapy","2021","PTSD","PTSD",,"24","A","12",,"Lanicemine","Lanicemine","NMDA receptor antagonist; total of 3 infusions over 5 days (Monday, Wednesday, and Friday)","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","100 mg, as 1.0mg/mL solution","60 minutes","Every other day","0.71","3 infusions total, over 5 days",,,,"received 3 infusions",,"100%",,,,,,,"Race data reported","Mixed","58.33%","Mixed","Combat-related; Child sexual abuse;  Rape/sexual assault; Community/school violence; Other (not specified)","High","Ramakrishnan N, Lijffijt M, Green CE, et al. Neurophysiological and clinical effects of the NMDA receptor antagonist lanicemine (BHV-5500) in PTSD: a randomized, double-blind, placebo-controlled trial. Depress Anxiety. 2021 Nov;38(11):1108-19. doi: 10.1002/da.23194. PMID: 34254405.","1573927","2023"
"ramakrishnan2021_B","ramakrishnan2021","Pharmacotherapy","2021","PTSD","Inactive Control",,"24","B","12",,"Placebo","Placebo","Placebo (0.9% saline); total of 3 infusions over 5 days (Monday, Wednesday, and Friday)","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"60 minutes","Every other day","0.71","3 infusions total, over 5 days",,,,"received 3 infusions",,"100%",,,,,,,"Race data reported","Mixed","58.33%","Mixed","Combat-related; Child sexual abuse;  Rape/sexual assault; Community/school violence; Other (not specified)","High","Ramakrishnan N, Lijffijt M, Green CE, et al. Neurophysiological and clinical effects of the NMDA receptor antagonist lanicemine (BHV-5500) in PTSD: a randomized, double-blind, placebo-controlled trial. Depress Anxiety. 2021 Nov;38(11):1108-19. doi: 10.1002/da.23194. PMID: 34254405.","1573927","2023"
"ramaswamy2016_A","ramaswamy2016","Pharmacotherapy","2016","PTSD","PTSD",,"30","A","15",,"Ziprasidone","Ziprasidone","Atypical antipsychotic; dose increased in increments of 20 mg twice daily","No",,"Yes","Antipsychotic","No",,"No","No","No","No","No","Individual","In Person","Initiated at 20 mg, titrated to maximum 80 mg",,"Twice daily","9",,,,,,,,,,,,,,"Not reported","Community","86.67%","Mixed","rape/sexual assault, community/school violence, other (not specified)","High","Ramaswamy S, Driscoll D, Smith LM, et al. Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder. Contemp Clin Trials Commun. 2016 Dec;2:1-5. doi: 10.1016/j.conctc.2015.12.003. PMID: 29736440.","1551835","2019"
"ramaswamy2016_B","ramaswamy2016","Pharmacotherapy","2016","PTSD","Inactive Control",,"30","B","15",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"9",,,,,,,,,,,,,,"Not reported","Community","86.67%","Mixed","rape/sexual assault, community/school violence, other (not specified)","High","Ramaswamy S, Driscoll D, Smith LM, et al. Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder. Contemp Clin Trials Commun. 2016 Dec;2:1-5. doi: 10.1016/j.conctc.2015.12.003. PMID: 29736440.","1551835","2019"
"ramaswamy2017_A","ramaswamy2017","Pharmacotherapy","2017","PTSD","PTSD",,"59","A","29",,"Vilazodone","Vilazodone","SSRI and partial agonist of 5-HT1A receptor; 10 mg/day on days 1 to 7, 20 mg/day on days 8 to 14, 40 mg/day weeks 3 through 12, with the option to adjust dose based on response and tolerability; tapered off vilazodone over weeks 13 and 14, no treatment week 15","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","Initiated at 10 mg/day, increased to maximum 40 mg/day",,"Once daily","12",,,,,"counts of returned medications",,,,,,,,,"Race and Ethnicity data reported","Veteran","3.39%","Combat-related",,"Some Concerns","Ramaswamy S, Driscoll D, Reist C, et al. A double-blind, placebo-controlled randomized trial of vilazodone in the treatment of posttraumatic stress disorder and comorbid depression. Prim Care Companion CNS Disord. 2017 Aug 24;19(4):17m02138. doi: 10.4088/PCC.17m02138. PMID: 28858440.","49046","2019"
"ramaswamy2017_B","ramaswamy2017","Pharmacotherapy","2017","PTSD","Inactive Control",,"59","B","30",,"Placebo","Placebo","Matched active treatment","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Once daily","12",,,,,"counts of returned medications",,,,,,,,,"Race and Ethnicity data reported","Veteran","3.39%","Combat-related",,"Some Concerns","Ramaswamy S, Driscoll D, Reist C, et al. A double-blind, placebo-controlled randomized trial of vilazodone in the treatment of posttraumatic stress disorder and comorbid depression. Prim Care Companion CNS Disord. 2017 Aug 24;19(4):17m02138. doi: 10.4088/PCC.17m02138. PMID: 28858440.","49046","2019"
"rankins2024_A","rankins2024","Other study class","2024","PTSD","PTSD",,"9","A","6",,"Adaptive horsemanship lessons","Animal Assisted","Lessons in safety working with horses, horse behavior (including fight or flight responses), and grooming. Later lessons included leading the horse. Progress tailored to the individual. Riding not reported.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","In Person",,"30 minutes","Weekly","8",,"Completed intervention",,"reported sample are those who completed all data collection and were analyzed, of these ""no participants were lost after starting the AH intervention""",,,,"8",,"100% attendance at horsemanship sessions",,,,"Race and Ethnicity data reported","Veteran","0%",,,"High","Rankins EM, Quinn A, McKeever KH, et al. Ground-based adaptive horsemanship lessons for veterans with post-traumatic stress disorder: a randomized controlled pilot study. Front Psychiatry. 2024;15(1390212). doi: 10.3389/fpsyt.2024.1390212. PMID: 38863605.","1635204","2025"
"rankins2024_B","rankins2024","Other study class","2024","PTSD","Inactive Control",,"9","B","3",,"Waitlist control","Waitlist","No change in daily activities until after post-waitlist outcome measures completed, when group was offered horsemanship lessons.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"8",,,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%",,,"High","Rankins EM, Quinn A, McKeever KH, et al. Ground-based adaptive horsemanship lessons for veterans with post-traumatic stress disorder: a randomized controlled pilot study. Front Psychiatry. 2024;15(1390212). doi: 10.3389/fpsyt.2024.1390212. PMID: 38863605.","1635204","2025"
"raskind2003_A","raskind2003","Pharmacotherapy","2003","PTSD","PTSD",,"10","A","10",,"Prazosin","Prazosin","Alpha-1 adrenergic receptor antagonist; 1 mg/day for 3 days, 2 mg/day for 4 days, then based on response and tolerability increased to 4 mg/day for 7 days, 6 mg/day for 7 days, and then 10 mg/day.","No",,"Yes","Antiadrenergic","No",,"No","No","No","No","No","Individual","In Person","Initiated at 1 mg and titrated to maximum 10 mg",,"Daily","9",,,,,,,,,,,"9.5 mg/day","0.5",,"Not reported","Veteran","0%","Combat-related",,"High","Raskind MA, Peskind ER, Kanter ED, et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry. 2003 Feb;160(2):371-3. doi: 10.1176/appi.ajp.160.2.371. PMID: 12562588.","25442","2019"
"raskind2003_B","raskind2003","Pharmacotherapy","2003","PTSD","Inactive Control",,"10","B","10",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","9",,,,,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"High","Raskind MA, Peskind ER, Kanter ED, et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry. 2003 Feb;160(2):371-3. doi: 10.1176/appi.ajp.160.2.371. PMID: 12562588.","25442","2019"
"raskind2007_A","raskind2007","Pharmacotherapy","2007","PTSD","PTSD",,"40","A","20",,"Prazosin","Prazosin","Alpha-1 adrenergic receptor antagonist; 1 mg for 3 days, 2 mg through day 7, then titrated based on response and tolerability to 4 mg through day 14, 6 mg through day 21, 10 mg through day 28, 15 mg after 28-day visit.","No",,"Yes","Antiadrenergic","No",,"No","No","No","No","No","Individual","In Person","Initiated at 1 mg, titrated to maximum 15 mg",,"Daily","8",,,,,,,,,,,"13 mg","3",,"Race and Ethnicity data reported","Veteran","5%","Combat-related",,"Some Concerns","Raskind MA, Peskind ER, Hoff DJ, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007 Apr 15;61(8):928-34. doi: 10.1016/j.biopsych.2006.06.032. PMID: 17069768.","29403","2019"
"raskind2007_B","raskind2007","Pharmacotherapy","2007","PTSD","Inactive Control",,"40","B","20",,"Placebo","Placebo","Placebo capsules indistinguishable from prazosin","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","8",,,,,,,,,,,"14 mg equivalent","2",,"Race and Ethnicity data reported","Veteran","5%","Combat-related",,"Some Concerns","Raskind MA, Peskind ER, Hoff DJ, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007 Apr 15;61(8):928-34. doi: 10.1016/j.biopsych.2006.06.032. PMID: 17069768.","29403","2019"
"raskind2013_A","raskind2013","Pharmacotherapy","2013","PTSD","PTSD",,"67","A","32",,"Prazosin","Prazosin","Alpha-1 adrenergic receptor antagonist; titrated for up to 6 weeks based on response and tolerability, with a lower morning dose and higher bedtime dose, and separate titration schedules for men and women with lower doses for women","No",,"Yes","Antiadrenergic","No",,"No","No","No","No","No","Individual","In Person","Initiated at 1 mg for both men and women, titrated to maximum 25 mg for men and 12 mg for women",,"Daily (divided into smaller morning and larger bedtime doses)","15",,,,,,,,,,,"Bedtime dose 15.6 mg for men and 7.0 mg for women. Midmorning dose 4.0 mg for men and 1.7 mg for women.","Bedtime dose (6.0) mg for men and (3.5) mg for women. Midmorning dose (1.4) mg for men and (0.5) mg for women.",,"Race and Ethnicity data reported","Mixed","14.93%","Combat-related",,"Some Concerns","Raskind MA, Peterson K, Williams T, et al. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am J Psychiatry. 2013 Sep;170(9):1003-10. doi: 10.1176/appi.ajp.2013.12081133. PMID: 23846759.","41028","2019"
"raskind2013_B","raskind2013","Pharmacotherapy","2013","PTSD","Inactive Control",,"67","B","35",,"Placebo","Placebo","Capsules indistinguishable from the 3 active drug capsules (1 mg, 2 mg, 5 mg); titration period for both placebo and active arms","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily (morning and bedtime)","15",,,,,,,,,,,"Bedtime dose 18.8 mg for men and 10.0 mg for women. Midmorning dose 4.8 mg for men and 2.0 mg for women.","Bedtime dose (3.3) mg for men and (0.0) mg for women. Midmorning dose (0.8) mg for men and (0.0) mg for women.",,"Race and Ethnicity data reported","Mixed","14.93%","Combat-related",,"Some Concerns","Raskind MA, Peterson K, Williams T, et al. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am J Psychiatry. 2013 Sep;170(9):1003-10. doi: 10.1176/appi.ajp.2013.12081133. PMID: 23846759.","41028","2019"
"raskind2018_A","raskind2018","Pharmacotherapy","2018","PTSD","PTSD",,"304","A","152",,"Prazosin","Prazosin","Alpha-1 adrenergic receptor antagonist; titrated based on response and tolerability, with a lower morning dose and higher bedtime dose, and separate titration schedules for men and women with lower doses for women. After the first 10 weeks, other pharmacologic therapies (except prazosin, trazodone, or psychostimulants) or psychotherapeutic treatments could be added, discontinued, or modified by treating clinicians.","No",,"Yes","Adrenergic","No",,"No","No","No","No","No","Individual","In Person","Initiated at 1 mg for both men and women, titrated to maximum 20 mg for men and 12 mg for women",,"Daily (divided into smaller morning and larger bedtime doses)","26",,,,,,,,,,,"14.8 mg/day","6.1",,"Race and Ethnicity data reported","Veteran","2.3%","Combat-related",,"High","Raskind MA, Peskind ER, Chow B, et al. Trial of prazosin for post-traumatic stress disorder in military veterans. N Engl J Med. 2018 Feb 8;378(6):507-17. doi: 10.1056/NEJMoa1507598. PMID: 29414272.","49659","2019"
"raskind2018_B","raskind2018","Pharmacotherapy","2018","PTSD","Inactive Control",,"304","B","152",,"Placebo","Placebo","Capsules identical to the 3 active drug capsules (1 mg, 2 mg, 5 mg); titration period for both placebo and active arms. After the first 10 weeks, other pharmacologic therapies (except prazosin, trazodone, or psychostimulants) or psychotherapeutic treatments could be added, discontinued, or modified by treating clinicians.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily (morning and bedtime)","26",,,,,,,,,,,"16.4 mg/day","5.9",,"Race and Ethnicity data reported","Veteran","2.3%","Combat-related",,"High","Raskind MA, Peskind ER, Chow B, et al. Trial of prazosin for post-traumatic stress disorder in military veterans. N Engl J Med. 2018 Feb 8;378(6):507-17. doi: 10.1056/NEJMoa1507598. PMID: 29414272.","49659","2019"
"rasmusson2017_A","rasmusson2017","Pharmacotherapy","2017","PTSD","PTSD",,"112","A","59",,"Ganaxolone","Ganaxolone","Investigational anxiolytic and anticonvulsant; biweekly dose escalations by 200 mg twice daily, based on tolerability","No",,"Yes","Steroids","No",,"No","No","No","No","No","Individual","In Person","Initiated at 200 mg, titrated to maximum 600 mg",,"Twice daily","6",,,,,"counted returned supplies; and compared plasma trough levels of ganaxolone to predicted therapeutic levels (≥20 ng/mL)","64.71%",,,,,,,,"Race and Ethnicity data reported","Mixed","21.43%","Mixed","combat-related, child physical abuse, child sexual abuse, child other abuse","Low","Rasmusson AM, Marx CE, Jain S, et al. A randomized controlled trial of ganaxolone in posttraumatic stress disorder. Psychopharmacology (Berl). 2017;234(15):2245-57. doi: 10.1007/s00213-017-4649-y. PMID: 28667510.","48368","2019"
"rasmusson2017_B","rasmusson2017","Pharmacotherapy","2017","PTSD","Inactive Control",,"112","B","53",,"Placebo","Placebo","Gelatin capsules identical to those containing ganaxolone","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Twice daily","6",,,,,"counted returned supplies",,,,,,,,,"Race and Ethnicity data reported","Mixed","21.43%","Mixed","combat-related, child physical abuse, child sexual abuse, child other abuse","Low","Rasmusson AM, Marx CE, Jain S, et al. A randomized controlled trial of ganaxolone in posttraumatic stress disorder. Psychopharmacology (Berl). 2017;234(15):2245-57. doi: 10.1007/s00213-017-4649-y. PMID: 28667510.","48368","2019"
"rauch2015_A","rauch2015","Psychotherapy","2015","PTSD","PTSD",,"36","A","18",,"PE","Prolonged Exposure (PE)","Manualized therapy including psychoeducation, imaginal exposure, in vivo exposure, and emotional processing.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"80 minutes",,"10 to 12",,"completed ≥7 sessions",,,,,,,,,,,,"Race data reported","Veteran","8.33%",,,"High","Rauch SAM, King AP, Abelson JL, et al. Biological and symptom changes in posttraumatic stress disorder treatment: a randomized clinical trial. Depress Anxiety. 2015 Mar;32(3):204-12. doi: 10.1002/da.22331. PMID: 25639570.","43645","2019"
"rauch2015_B","rauch2015","Psychotherapy","2015","PTSD","Active Control",,"36","B","18",,"PCT","Present-Centered Therapy (PCT)","Therapy following the Shea manual (Schnurr 2007), with psychoeducation (2 sessions) and discussion of current experience of PTSD symptoms and coping (remaining sessions).","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"80 minutes",,"10 to 12",,"completed ≥7 sessions",,,,,,,,,,,,"Race data reported","Veteran","8.33%",,,"High","Rauch SAM, King AP, Abelson JL, et al. Biological and symptom changes in posttraumatic stress disorder treatment: a randomized clinical trial. Depress Anxiety. 2015 Mar;32(3):204-12. doi: 10.1002/da.22331. PMID: 25639570.","43645","2019"
"rauch2019_A","rauch2019","Psychotherapy & pharmacotherapy","2019","PTSD","PTSD",,"223","A","75",,"PE + sertraline","Prolonged Exposure (PE) + sertraline","Prolonged exposure therapy sessions included psychoeducation, imaginal exposure to traumatic memories, discussion, and in vivo exposure homework. Sertraline titrated with last dose increase at 10 weeks.","Yes","Trauma-focused","Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","Dose: sertraline adjusted between 50 and 200 mg","Session length: 90 minutes","Psychotherapy: 13 sessions over 24 weeks; Sertraline: daily","24",,"See adherence (completion defined by adherence)",,,"completing all 13 sessions and taking sertraline at week 24","53.6%","defined for both interventions together",,,,"171.6 mg","45.0 mg",,"Race and Ethnicity data reported","Mixed","13%","Combat-related",,"High","Rauch SAM, Kim HM, Powell C, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Feb 1;76(2):117-26. doi: 10.1001/jamapsychiatry.2018.3412. PMID: 30516797.","51290","2020"
"rauch2019_B","rauch2019","Psychotherapy & pharmacotherapy","2019","PTSD","Active Control",,"223","B","74",,"PE + placebo","Prolonged Exposure (PE) + placebo","Prolonged exposure therapy sessions included psychoeducation, imaginal exposure to traumatic memories, discussion, and in vivo exposure homework. Placebo titrated with last dose increase at 10 weeks.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"Session length: 90 minutes","Psychotherapy: 13 sessions over 24 weeks; Placebo: daily","24",,"See adherence (completion defined by adherence)",,,"completing all 13 sessions and taking sertraline at week 24","46.3%","defined for both interventions together",,,,"197.4 mg","11.3 mg",,"Race and Ethnicity data reported","Mixed","13%","Combat-related",,"High","Rauch SAM, Kim HM, Powell C, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Feb 1;76(2):117-26. doi: 10.1001/jamapsychiatry.2018.3412. PMID: 30516797.","51290","2020"
"rauch2019_C","rauch2019","Psychotherapy & pharmacotherapy","2019","PTSD","Active Control",,"223","C","74",,"Sertraline","Sertraline","Sertraline titrated with last dose increase at 10 weeks. Enhanced medication management ending at week 12 provided to balance time, psychoeducation, and clinician support compared with PE therapy groups","No",,"Yes","Antidepressant: SSRI","No",,"No","No","Yes","No","No","Individual","In Person","50 to 100 mg",,"Daily","24",,,,,"taking sertraline at week 24","73.2%",,,,,"170.7 mg","46.9 mg",,"Race and Ethnicity data reported","Mixed","13%","Combat-related",,"High","Rauch SAM, Kim HM, Powell C, et al. Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2019 Feb 1;76(2):117-26. doi: 10.1001/jamapsychiatry.2018.3412. PMID: 30516797.","51290","2020"
"ready2010_A","ready2010","Psychotherapy","2010","PTSD","PTSD",,"11","A","6",,"Virtual reality exposure  therapy","Virtual reality exposure therapy (VRET)","Therapist provided trauma-related stimuli in a gradual manner through a virtual reality environment. Participants were asked to give a Subjective Units of Distress Scale every 5 minutes and to scan their body to report levels of tension.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes",,,"10 sessions total","Completed treatment",,,,,,"8.67","3.27",,,,,"Race data reported","Veteran","0%","Combat-related",,"High","Ready DJ, Gerardi RJ, Backscheider AG, et al. Comparing virtual reality exposure therapy to present-centered therapy with 11 U.S. Vietnam veterans with PTSD. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):49-54.  PMID: 20528293.","34258","2019"
"ready2010_B","ready2010","Psychotherapy","2010","PTSD","Active Control",,"11","B","5",,"PCT","Present-Centered Therapy (PCT)","Supportive therapy involving psychoeducation, teaching problem-solving techniques, and helping participants through a focus on problems occurring in their lives","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes",,,"10 sessions total","Completed treatment",,,,,,"8","4.47",,,,,"Race data reported","Veteran","0%","Combat-related",,"High","Ready DJ, Gerardi RJ, Backscheider AG, et al. Comparing virtual reality exposure therapy to present-centered therapy with 11 U.S. Vietnam veterans with PTSD. Cyberpsychol Behav Soc Netw. 2010 Feb;13(1):49-54.  PMID: 20528293.","34258","2019"
"ready2018_A","ready2018","Psychotherapy","2018","PTSD","PTSD",,"81","A","41",,"Group-based exposure therapy","Exposure therapy","Treatment involves creation of group cohesion, improving coping skills, imaginal and in vivo exposure exercises, and guided imagery exercise","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"4 hours","Twice weekly","16",,"Completed treatment",,"""completed"" in participant flow diagram, n=4 dropped out during treatment",,,,,,,,,,"Race data reported","Veteran","0%","Combat-related",,"Some Concerns","Ready DJ, Mascaro N, Wattenberg MS, et al. A controlled study of group-based exposure therapy with Vietnam-era veterans. J Loss Trauma. 2018;23(6):439-57. doi: 10.1080/15325024.2018.1485268.","1533924","2020"
"ready2018_B","ready2018","Psychotherapy","2018","PTSD","Active Control",,"81","B","40",,"PCGT","Present-Centered Therapy (PCT)","Sessions focus on current problems related to PTSD symptoms and problem-solving","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Group","In Person",,"90-minute session","Twice weekly; Booster session once every 3 weeks","16","Booster sessions: 6","Completed treatment",,"""completed"" in participant flow diagram, n=4 dropped out during treatment",,,,,,,,,,"Race data reported","Veteran","0%","Combat-related",,"Some Concerns","Ready DJ, Mascaro N, Wattenberg MS, et al. A controlled study of group-based exposure therapy with Vietnam-era veterans. J Loss Trauma. 2018;23(6):439-57. doi: 10.1080/15325024.2018.1485268.","1533924","2020"
"reeve2020_A","reeve2020","CIH","2020","PTSD","PTSD",,"40","A","20",,"Healing Touch + Standard of care","Healing Touch","Each session included healing touch using two protocols: biofield treatment, and amygdala treatment. Participants also received standard of care during both phases.","No",,"No",,"Yes","Energy therapies","No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","10",,"Completed intervention",,"""1 subject dropped over the course of treatment""",,,,,,,,,,"Not reported","Veteran",,,,"High","Reeve K, et al. Examining the impact of a Healing Touch intervention to reduce posttraumatic stress disorder symptoms in combat veterans. Psychological Trauma: Theory, Research, Practice, and Policy. 2020. doi: 10.1037/tra0000591.","1555617","2020"
"reeve2020_B","reeve2020","CIH","2020","PTSD","Inactive Control",,"40","B","20",,"Standard of care","Treatment as usual (TAU)","Medication and psychotherapy delivered by the subjects regular practitioners and a variety of other interventions, such as relaxation training, meditation, archery, or yoga.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,,,,,,,,,,,,,,,"Not reported","Veteran",,,,"High","Reeve K, et al. Examining the impact of a Healing Touch intervention to reduce posttraumatic stress disorder symptoms in combat veterans. Psychological Trauma: Theory, Research, Practice, and Policy. 2020. doi: 10.1037/tra0000591.","1555617","2020"
"reger2016_A","reger2016","Psychotherapy","2016","PTSD","PTSD",,"162","A","54",,"PE with virtual reality exposure","Virtual reality exposure therapy (VRET)","Intervention follow PE treatment protocol according to Foa et al. (2007) with traumatic memory shown through virtual reality headset. While wearing headset, patient verbally describe the events.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Once or twice weekly","5","10 sessions total","completed 10 sessions",,,,,,"7.11","3.58",,,,,"Race and Ethnicity data reported","Active Duty Military","3.7%","Combat-related",,"Some Concerns","Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.","45485","2020"
"reger2016_B","reger2016","Psychotherapy","2016","PTSD","Active Control",,"162","B","54",,"PE","Prolonged Exposure (PE)","Manualized intervention according to Foa et al. (2007), includes psychoeducation, breathing retraining, repeated and prolonged imaginal exposure to traumatic memory, cognitive and emotional processing of traumatic material, and in vivo exposure to safe but feared situations","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Once or twice weekly","5","10 sessions total","completed 10 sessions",,,,,,"7.5","3.46",,,,,"Race and Ethnicity data reported","Active Duty Military","3.7%","Combat-related",,"Some Concerns","Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.","45485","2020"
"reger2016_C","reger2016","Psychotherapy","2016","PTSD","Inactive Control",,"162","C","54",,"Waitlist minimal attention","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"5",,"completing 5-week waiting period",,,,,,,,,,,,"Race and Ethnicity data reported","Active Duty Military","3.7%","Combat-related",,"Some Concerns","Reger GM, Koenen-Woods P, Zetocha K, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs. virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin. Psychol. 2016 Nov;84(11):946-59. doi: 10.1037/ccp0000134. PMID: 27606699.","45485","2020"
"reich2004_A","reich2004","Pharmacotherapy","2004","PTSD","PTSD",,"21","A","12",,"Risperidone","Risperidone","Atypical antipsychotic","No",,"Yes","Antipsychotic","No",,"No","No","No","No","No","Individual","In Person","0.5 mg for 3 days, then 1 mg/day after 3 days, then increase weekly by up to 1 mg/day to 4 mg/day.  Could increase to maximum of 8 mg/day after week 5",,"Daily at bedtime initially, then could be 2 or 3 times daily","8",,,,,,,,,,,"overall 1.41 mg, mean 2.05 mg at week 8",,,"Race data reported","Community","100%","Mixed","child physical abuse, child sexual abuse, child other abuse","Some Concerns","Reich DB, Winternitz S, Hennen J, et al. A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women. J Clin Psychiatry. 2004 Dec;65(12):1601-6. PMID: 15641864.","27284","2019"
"reich2004_B","reich2004","Pharmacotherapy","2004","PTSD","Inactive Control",,"21","B","9",,"Control","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Once daily at bedtime initially, then up to 2 or 3 times daily","8",,,,,,,,,,,,,,"Race data reported","Community","100%","Mixed","child physical abuse, child sexual abuse, child other abuse","Some Concerns","Reich DB, Winternitz S, Hennen J, et al. A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women. J Clin Psychiatry. 2004 Dec;65(12):1601-6. PMID: 15641864.","27284","2019"
"reinhardt2018_A","reinhardt2018","CIH","2018","PTSD","PTSD",,"51","A","26",,"Kripalu yoga","Yoga","Group yoga sessions comprised of centering and breathing exercises, body warm-ups, physical poses, breath work, moving meditation, and relaxation; participants asked to practice yoga for 15 minutes daily.","No",,"No",,"Yes","Yoga","No","No","No","No","No","Group","In Person",,"90 minutes","Twice weekly","10",,"Completed treatment stage",,"completed stage 1 (randomization through post assessment), ""completed"" in table 1",,,,,,,,,,"Race and Ethnicity data reported","Mixed","11.76%",,,"High","Reinhardt KM, Noggle Taylor JJ, Johnston J, et al. Kripalu yoga for military veterans With PTSD: a randomized trial. J Clin Psychol. 2018 Jan;74(1):93-108. doi: 10.1002/jclp.22483. PMID: 28524358.","48190","2019"
"reinhardt2018_B","reinhardt2018","CIH","2018","PTSD","Inactive Control",,"51","B","25",,"Control","Assessment","No treatment; participants completed assessments as a group (except CAPS, completed individually).","No",,"No",,"No",,"No","No","Yes","No","No","Group","In Person",,,,"10",,,,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","11.76%",,,"High","Reinhardt KM, Noggle Taylor JJ, Johnston J, et al. Kripalu yoga for military veterans With PTSD: a randomized trial. J Clin Psychol. 2018 Jan;74(1):93-108. doi: 10.1002/jclp.22483. PMID: 28524358.","48190","2019"
"resick2002_A","resick2002","Psychotherapy","2002","PTSD","PTSD",,"171","A","62",,"CPT","Cognitive Processing Therapy (CPT)","Manualized therapy including cognitive therapy and exposure in the form of writing and reading about the traumatic event","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes for initial session, all others 90 minutes","Twice weekly","6",,"completed all 12 sessions",,,,,,,,,,,,"Race data reported","Community","100%","Mixed","child sexual abuse, rape/sexual assault","High","Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.","14652","2019"
"resick2002_B","resick2002","Psychotherapy","2002","PTSD","PTSD",,"171","B","62",,"PE","Prolonged Exposure (PE)","Includes education-rationale, breathing retraining, behavioral exposures, and imaginal exposures","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes for initial session, all others 90 minutes","Twice weekly","6",,"completed all 12 sessions",,,,,,,,,,,,"Race data reported","Community","100%","Mixed","child sexual abuse, rape/sexual assault","High","Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.","14652","2019"
"resick2002_C","resick2002","Psychotherapy","2002","PTSD","Inactive Control",,"171","C","47",,"Waitlist with minimal attention","Minimal attention","Participants were encouraged to call therapist for client-centered telephone counseling","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Phone",,,,"6",,"completed treatment course",,,,,,,,,,,,"Race data reported","Community","100%","Mixed","child sexual abuse, rape/sexual assault","High","Resick PA, Nishith P, Weaver TL, et al. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. J Consult Clin Psychol. 2002 Aug;70(4):867-79.  PMID: 12182270.","14652","2019"
"resick2008_A","resick2008","Psychotherapy","2008","PTSD","PTSD",,"162","A","56",,"CPT","Cognitive Processing Therapy (CPT)","Manualized therapy that teaches skill of recognizing and challenging dysfunctional cognitions","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Twice weekly","6",,"completed all 12 sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence","Low","Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.","30597","2019"
"resick2008_B","resick2008","Psychotherapy","2008","PTSD","Active Control",,"162","B","51",,"Written account","Written narrative exposure","Exposure-focused component of CPT where patients wrote about index event and discussed emotional response regarding event, but did not include cognitive therapy or challenge to client's dysfunctional statements","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"60 minutes for initial 2 sessions, 2 hours for remaining sessions","Twice weekly for first week, then weekly","6","7 sessions total","completed all 7 sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence","Low","Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.","30597","2019"
"resick2008_C","resick2008","Psychotherapy","2008","PTSD","Active Control",,"162","C","55",,"CPT-cognitive therapy","Cognitive Processing Therapy (CPT)","Identical to manualized CPT but without written account component","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"60 minutes","Twice weekly","6",,"completed all 12 sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence","Low","Resick PA, Galovski TE, Uhlmansiek MOB, et al. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008 Apr;76(2):243-58. doi: 10.1037/0022-006X.76.2.243. PMID: 18377121.","30597","2019"
"resick2015_A","resick2015","Psychotherapy","2015","PTSD","PTSD",,"108","A","56",,"CPT-Cognitive only version","Cognitive Processing Therapy (CPT)","Trauma-focused cognitive therapy where patients learn to label events, thoughts, and subsequent emptions while therapist uses Socratic questioning to help patients examine the facts and context, and develop new, more balanced thinking about traumatic events","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"90 minutes","Twice weekly","6",,"Completed intervention",,,,,,"8.4","3.5",,,,,"Race and Ethnicity data reported","Active Duty Military","7.41%","Mixed","combat-related, child sexual abuse","Some Concerns","Resick PA, Wachen JS, Mintz J, et al. A randomized clinical trial of group cognitive processing therapy compared with group present-centered therapy for PTSD among active duty military personnel. J Consult Clin Psychol. 2015 Dec;83(6):1058-68. doi: 10.1037/ccp0000016. PMID: 25939018.","43929","2020"
"resick2015_B","resick2015","Psychotherapy","2015","PTSD","Active Control",,"108","B","52",,"PCT","Present-Centered Therapy (PCT)","Therapists help patients manage current symptoms through problem solving, directing discussion of trauma back to present time","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Group","In Person",,"90 minutes","Twice weekly","6",,"Completed intervention",,,,,,"9.8","2.3",,,,,"Race and Ethnicity data reported","Active Duty Military","7.41%","Mixed","combat-related, child sexual abuse","Some Concerns","Resick PA, Wachen JS, Mintz J, et al. A randomized clinical trial of group cognitive processing therapy compared with group present-centered therapy for PTSD among active duty military personnel. J Consult Clin Psychol. 2015 Dec;83(6):1058-68. doi: 10.1037/ccp0000016. PMID: 25939018.","43929","2020"
"resick2017_A","resick2017","Psychotherapy","2017","PTSD","PTSD",,"268","A","133",,"Group CPT","Cognitive Processing Therapy (CPT)","Trauma-focused cognitive therapy in groups of 8 to 10 participants; cognitive-only version following manual developed for military and veterans and incorporating special considerations for military population; one individual meeting with therapist prior to treatment to review trauma history; therapy aim to teach patients to recognize and challenge dysfunctional cognitions (stuck points) about the traumatic event(s) and current thoughts about themselves, others, and the world. Participants who missed 4 sessions were dropped from group treatment.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"90 minutes","Twice weekly","6",,"completed ≥9 sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Active Duty Military","9%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)","Some Concerns","Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.","45949","2019"
"resick2017_B","resick2017","Psychotherapy","2017","PTSD","PTSD",,"268","B","135",,"Individual CPT","Cognitive Processing Therapy (CPT)","Individual trauma-focused cognitive therapy; cognitive-only version following manual developed for military and veterans and incorporating special considerations for military population; therapy aim to teach patients to recognize and challenge dysfunctional cognitions (stuck points) about the traumatic event(s) and current thoughts about themselves, others, and the world. Participants who couldn't complete treatment in 3 months for reasons other than military assignments had treatment ended.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Twice weekly","6",,"completed ≥9 sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Active Duty Military","9%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (noncombat death)","Some Concerns","Resick PA, Wachen JS, Dondanville KA, et al. Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017 Jan;74(1):28-36.  PMID: 27893032.","45949","2019"
"reyes2024_A","reyes2024","Other study class","2024","PTSD","PTSD",,"60","A","30",,"Mindfulness- and acceptance-based smartphone app","Mindfulness","App based on principles of Acceptance and Commitment Therapy, including engaging with the present moment, clarifying values, and committing to a value-based life. Daily audio-guided mindfulness exercises, weekly videos and reflections. Weekly calls from research team to address technical issues.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology alone",,,"Daily","6","""Participants were advised to practice at least one daily audio-guided mindfulness meditation""","Completed the 6 week intervention",,,,,,,,,,,,"Race and Ethnicity data reported","Community","66.67%",,,"High","Reyes AT, Fudolig M, Sharma M, et al. Testing the effectiveness of a mindfulness- and acceptance-based smartphone app for nurses traumatized by the COVID-19 pandemic: a pilot study. Issues Ment Health Nurs. 2024 Oct;45(10):1034-45. doi: 10.1080/01612840.2024.2385571. PMID: 39173125.","1641014","2025"
"reyes2024_B","reyes2024","Other study class","2024","PTSD","Inactive Control",,"60","B","30",,"Waitlist","Waitlist","No intervention; offered mindfulness app after 10-week followup","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,"completed the control procedures 100%",,,,,,,,,,"Race and Ethnicity data reported","Community","66.67%",,,"High","Reyes AT, Fudolig M, Sharma M, et al. Testing the effectiveness of a mindfulness- and acceptance-based smartphone app for nurses traumatized by the COVID-19 pandemic: a pilot study. Issues Ment Health Nurs. 2024 Oct;45(10):1034-45. doi: 10.1080/01612840.2024.2385571. PMID: 39173125.","1641014","2025"
"richards1994_A","richards1994","Psychotherapy","1994","PTSD","PTSD",,"14","A","7",,"Imaginal exposure followed by live exposure","Exposure therapy","Imaginal exposure involved patients reliving their traumatic memories until anxiety is reduced. Live exposure involved patients re-entering trauma-related situations that they had been avoiding.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","8","4 sessions each of imaginal and live exposure","Completed treatment",,,,,,,,,,,,"Not reported","Community","69.23%","Mixed","rape/sexual assault, accidents, community/school violence, natural or manmade disasters","High","Richards DA, Lovell K, Marks IM. Post-traumatic stress disorder: evaluation of a behavioral treatment program. J Trauma Stress. 1994 Oct;7(4):669-80. doi: 10.1007/BF02103014. PMID: 7820356.","12187","2019"
"richards1994_B","richards1994","Psychotherapy","1994","PTSD","PTSD",,"14","B","7",,"Live exposure followed by imaginal exposure","Exposure therapy","Imaginal exposure involved patients reliving their traumatic memories until anxiety is reduced. Live exposure involved patients re-entering trauma-related situations that they had been avoiding.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","8","4 sessions each of imaginal and live exposure","completed treatment",,,,,,,,,,,,"Not reported","Community","69.23%","Mixed","rape/sexual assault, accidents, community/school violence, natural or manmade disasters","High","Richards DA, Lovell K, Marks IM. Post-traumatic stress disorder: evaluation of a behavioral treatment program. J Trauma Stress. 1994 Oct;7(4):669-80. doi: 10.1007/BF02103014. PMID: 7820356.","12187","2019"
"richerson2023_A","richerson2023","Other study class","2023","PTSD","PTSD",,"213","A","111","114 initially randomized, n=3 excluded for no longer meeting inclusion criteria; 97 received intervention","Service Dog","Animal Assisted","Veteran paired with service dog trained to perform five PTSD-specific tasks: turning on a light in a dark room, entering and sweeping the perimeter of a room, retrieving an object at handler's request, blocking a person approaching from the front, and blocking a person approaching from behind","No",,"No",,"No",,"No","No","No","Yes","No","Individual","In Person",,,,"78","18 months' follow-up after paired with dog","Did not discontinue the intervention",,"n=97 received a service dog, of those, n=9 discontinued the intervention before completing 18 months of follow-up = 88 received a dog and did not discontinue",,,,,,,,,,"Race and Ethnicity data reported","Veteran","20%",,,"High","Richerson JT, Wagner TH, Abrams T, et al. Therapeutic and economic benefits of service dogs versus emotional support dogs for veterans with PTSD. Psychiatr Serv. 2023:appips20220138. doi: 10.1176/appi.ps.20220138. PMID: 36718602.","1615319","2023"
"richerson2023_B","richerson2023","Other study class","2023","PTSD","Active Control",,"213","B","102","113 initially randomized, n=11 excluded for no longer meeting inclusion criteria; 84 received intervention","Emotional Support Dog","Animal Assisted","Veteran paired with companion dog not trained in PTSD-specific tasks","No",,"No",,"No",,"No","No","Yes","Yes","No","Individual","In Person",,,,"78","18 months' follow-up after paired with dog","Did not discontinue the intervention",,"n=84 received a support dog, of those, n=9 discontinued the intervention before completing 18 months of follow-up = 65 received a dog and did not discontinue",,,,,,,,,,"Race and Ethnicity data reported","Veteran","20%",,,"High","Richerson JT, Wagner TH, Abrams T, et al. Therapeutic and economic benefits of service dogs versus emotional support dogs for veterans with PTSD. Psychiatr Serv. 2023:appips20220138. doi: 10.1176/appi.ps.20220138. PMID: 36718602.","1615319","2023"
"robjant2019_A","robjant2019","Psychotherapy","2019","PTSD","PTSD",,"92","A","46",,"Adapted FORNET","Narrative Exposure Therapy (NET)","Individual + group therapy sessions; adapted version expanded group component to ""maximize the focus on behaviour change away from ongoing perpetration of violence within the community, and to increase the emphasis on peer support"". Individual sessions involved construction of lifeline, exploration of traumatic events (act of perpetrated violence). Group sessions ""aimed to develop skills and motivation to avoid perpetrating violence within the community"" and group members encouraged to support each other and introduced a 'buddy system'.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Mixed","In Person",,"Individual sessions: 90 to 120 minutes; Group sessions: 60 to 90 minutes","Individual sessions: weekly; Group sessions: weekly","6",,"attended all individual and group therapy sessions (6 sessions each)",,,,,,,,,,,,"Not reported","Community","100%","Terrorism/political violence/forced displacement",,"Some Concerns","Robjant K, Koebach A, Schmitt S, et al. The treatment of posttraumatic stress symptoms and aggression in female former child soldiers using adapted Narrative Exposure therapy - a RCT in Eastern Democratic Republic of Congo. Behav Res Ther. 2019 Dec;123:103482. doi: 10.1016/j.brat.2019.103482. PMID: 31639529.","1545978","2020"
"robjant2019_B","robjant2019","Psychotherapy","2019","PTSD","Inactive Control",,"92","B","46",,"TAU","Treatment as usual (TAU)","Services available through NGO, including: ""occupational training courses, empathic listening and basic counselling, problem solving and practical support, provided whenever needed""; participant was visited at home if more than a week from last drop in.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Weekly","6",,,,,,,,,,,,,,"Not reported","Community","100%","Terrorism/political violence/forced displacement",,"Some Concerns","Robjant K, Koebach A, Schmitt S, et al. The treatment of posttraumatic stress symptoms and aggression in female former child soldiers using adapted Narrative Exposure therapy - a RCT in Eastern Democratic Republic of Congo. Behav Res Ther. 2019 Dec;123:103482. doi: 10.1016/j.brat.2019.103482. PMID: 31639529.","1545978","2020"
"rodgman2016_A","rodgman2016","Pharmacotherapy","2016","PTSD","PTSD",,"8","A","8","3 in first study period","Doxazosin extended release","Doxazosin","Extended-release alpha-1 noradrenergic antagonist with 15 to 19 hour half-life; initiated at 4 mg/day and increased by 4 mg every 4 days to final dose of 16 mg/day","No",,"Yes","Antiadrenergic","No",,"No","No","No","No","No","Individual","In Person","Initiated at 4 mg, titrated to 16 mg",,"Daily","2.29",,,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Combat-related",,"High","Rodgman C, Verrico CD, Holst M, et al. Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial. J Clin Psychiatry. 2016 May;77(5):e561-5. doi: 10.4088/JCP.14m09681. PMID: 27249080.","49795","2019"
"rodgman2016_B","rodgman2016","Pharmacotherapy","2016","PTSD","Inactive Control",,"8","B","8","5 in first study period","Placebo","Placebo","Placebo capsules identical to active treatment, dose increased over study period","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","2.29",,,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Combat-related",,"High","Rodgman C, Verrico CD, Holst M, et al. Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial. J Clin Psychiatry. 2016 May;77(5):e561-5. doi: 10.4088/JCP.14m09681. PMID: 27249080.","49795","2019"
"rogers1999_A","rogers1999","Psychotherapy","1999","PTSD","PTSD",,"12","A","6",,"Group EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Intervention follow method as described by Shapiro (1995). Subjects asked to concentrate on a visual image, the negative statement, and the sensation while tracking the therapist's finger back and forth. When subjects report minimal distress, they were asked to concentrate on the visual image and positive cognition during eye movements.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 to 90 minutes","Once","0.14","single session","See Detail",,"sample is participants who completed posttreatment assessment, part of an ongoing study; this is a single session intervention, but posttreatment assessment was 1 week after the session; no further information on treatment completion provided",,,,,,,,,,"Not reported","Veteran",,"Combat-related",,"Some Concerns","Rogers S, Silver SM, Goss J, et al. A single session, group study of exposure and Eye Movement Desensitization and Reprocessing in treating posttraumatic stress disorder among Vietnam War veterans: preliminary data. J Anxiety Disord. 1999 Jan-Apr;13(1-2):119-30. doi: 10.1016/S0887-6185(98)00043-7. PMID: 10225504.","14686","2019"
"rogers1999_B","rogers1999","Psychotherapy","1999","PTSD","PTSD",,"12","B","6",,"Exposure therapy","Exposure therapy","Intervention based on explosion procedure described in Lyons and Keane (1989). Subjects were guided in a progress muscle relaxation exercise, then visualized the experience while paying attention to sensory, cognitive, and emotional cues. The scene was repeated with relaxation.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 to 90 minutes","Once","0.14","single session","See Detail",,"sample is participants who completed posttreatment assessment, part of an ongoing study; this is a single session intervention, but posttreatment assessment was 1 week after the session; no further information on treatment completion provided",,,,,,,,,,"Not reported","Veteran",,"Combat-related",,"Some Concerns","Rogers S, Silver SM, Goss J, et al. A single session, group study of exposure and Eye Movement Desensitization and Reprocessing in treating posttraumatic stress disorder among Vietnam War veterans: preliminary data. J Anxiety Disord. 1999 Jan-Apr;13(1-2):119-30. doi: 10.1016/S0887-6185(98)00043-7. PMID: 10225504.","14686","2019"
"rosenbaum2015_A","rosenbaum2015","Other study class","2015","PTSD","PTSD",,"81","A","39",,"Exercise program","Exercise","Resistance training and pedometer-based walking program. Resistance training included one supervised exercise session and two home-based unsupervised exercise sessions per week.







Participants also received usual care which could include psychotherapy, pharmaceutical interventions, and group therapy.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","In Person",,"30 minutes","Three times weekly","12",,"See Detail",,"study reports mean attendance (58% of sessions) but not number of participants attending sessions; completion of assessments also reported",,,,,"2","7/12 supervised exercise sessions",,,,"Not reported","Community","16.05%","Mixed","other (trauma experienced through occupation, not specified)","High","Rosenbaum S, Sherrington C, Tiedemann A. Exercise augmentation compared with usual care for post-traumatic stress disorder: a randomized controlled trial. Acta Psychiatr Scand. 2015 May;131(5):350-9. doi: 10.1111/acps.12371. PMID: 25443996.","44069","2019"
"rosenbaum2015_B","rosenbaum2015","Other study class","2015","PTSD","Inactive Control",,"81","B","42",,"TAU","Treatment as usual (TAU)","Usual care which could include psychotherapy, pharmaceutical interventions, and group therapy.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"12",,,,,,,,,,,,,,"Not reported","Community","16.05%","Mixed","other (trauma experienced through occupation, not specified)","High","Rosenbaum S, Sherrington C, Tiedemann A. Exercise augmentation compared with usual care for post-traumatic stress disorder: a randomized controlled trial. Acta Psychiatr Scand. 2015 May;131(5):350-9. doi: 10.1111/acps.12371. PMID: 25443996.","44069","2019"
"rothbaum1997_A","rothbaum1997","Psychotherapy","1997","PTSD","PTSD",,"21","A","11",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Individual sessions following treatment manual; patient imagines a scene that represents the entire trauma, focusing on sensations of anxiety while rehearsing words that match the picture and simultaneously follows therapist's finger moving back and forth until anxiety is decreased; patient then follows same procedure while rehearsing new, preferred belief, until the new statement feels true to the patient. The first session was comprised of information gathering, without EMDR.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","4",,"Did not drop out of treatment",,"reports study/assessment completion and drop out; completed treatment = did not drop out; n=1 drop out after baseline assessment",,,,,,,,,,"Not reported","Community","100%","Rape/sexual assault",,"High","Rothbaum BO. A controlled study of Eye Movement Desensitization and Reprocessing in the treatment of posttraumatic stress disordered sexual assault victims. Bull Menninger Clin. 1997 Summer;61(3):317-34.  PMID: 9260344.","09058","2019"
"rothbaum1997_B","rothbaum1997","Psychotherapy","1997","PTSD","Inactive Control",,"21","B","10",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"4",,"Did not drop out of treatment",,"reports study/assessment completion and drop out; n=2 drop out from wait list",,,,,,,,,,"Not reported","Community","100%","Rape/sexual assault",,"High","Rothbaum BO. A controlled study of Eye Movement Desensitization and Reprocessing in the treatment of posttraumatic stress disordered sexual assault victims. Bull Menninger Clin. 1997 Summer;61(3):317-34.  PMID: 9260344.","09058","2019"
"rothbaum2005_A","rothbaum2005","Psychotherapy","2005","PTSD","PTSD",,"72","A","25",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Patient imagines a scene representing the worst part of the trauma, focuses on sensations of distress and rehearses negative thoughts, simultaneously following therapist's fingers back and forth at least 20 times each repetition until distress drops to 0 or 1 (measured 0 to 10 on subjective units of discomfort scale); patient then rehearses new, preferred belief while tracking therapist's finger until new statement feels true to the participant; uses cognitive interweaves to accomplish cognitive work. First two sessions for education and treatment planning; remaining 7 sessions were EMDR treatment.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Twice weekly","4 to 5","9 sessions total","completed treatment protocol",,,,,,,,,,,,"Race data reported","Community","100%","Rape/sexual assault",,"High","Rothbaum BO, Astin MC, Marsteller F. Prolonged exposure versus Eye Movement Desensitization and Reprocessing (EMDR) for PTSD rape victims. J Trauma Stress. 2005 Dec;18(6):607-16. doi: 10.1002/jts.20069. PMID: 16382428.","19662","2019"
"rothbaum2005_B","rothbaum2005","Psychotherapy","2005","PTSD","PTSD",,"72","B","23",,"PE","Prolonged Exposure (PE)","Patients instructed to imaging assault scene and describe aloud while anxiety levels are monitored, repeating the process for 45 to 60 minutes, followed by discussion of patient's reaction; patients instructed to listen to recording of narrative at least once a day and assigned homework. Two sessions for treatment planning including construction of a hierarchy of avoided situations for in vivo exposure homework; 7 sessions of imaginative exposure.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Twice weekly","4 to 5","9 sessions total","completed treatment protocol",,,,,,,,,,,,"Race data reported","Community","100%","Rape/sexual assault",,"High","Rothbaum BO, Astin MC, Marsteller F. Prolonged exposure versus Eye Movement Desensitization and Reprocessing (EMDR) for PTSD rape victims. J Trauma Stress. 2005 Dec;18(6):607-16. doi: 10.1002/jts.20069. PMID: 16382428.","19662","2019"
"rothbaum2005_C","rothbaum2005","Psychotherapy","2005","PTSD","Inactive Control",,"72","C","24",,"Waitlist","Waitlist","Waitlist after pretreatment assessment, then randomly assigned to PE or EMDR after posttreatment assessment.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"4 to 5",,"completed treatment protocol",,,,,,,,,,,,"Race data reported","Community","100%","Rape/sexual assault",,"High","Rothbaum BO, Astin MC, Marsteller F. Prolonged exposure versus Eye Movement Desensitization and Reprocessing (EMDR) for PTSD rape victims. J Trauma Stress. 2005 Dec;18(6):607-16. doi: 10.1002/jts.20069. PMID: 16382428.","19662","2019"
"rothbaum2006_A","rothbaum2006","Psychotherapy & pharmacotherapy","2006","PTSD","PTSD",,"65","A","34",,"Sertraline + PE","Prolonged Exposure (PE) + sertraline","SSRI antidepressant and prolonged exposure therapy comprised of psychoeducation, breathing retraining, in vivo exposure, prolonged imaginal exposure, and homework.","Yes","Trauma-focused","Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","Sertraline dose: 25 to 200 mg, previously titrated to maximum dose tolerated in Phase I







PE session length: 90 to 120 minutes",,"Sertraline: daily







PE: Twice a week","5",,"Did not drop out of treatment",,"""completed"" in participant flow diagram; did not drop out of treatment","Sertraline: compliance as number of tablets taken divided by number of tablets that should have been taken, using medication dispensing data and unused medication returns (average % compliance with regimen)",,"Average % compliance with regimen 7.1% (SD 7.99) at Week 10 and 97.1% (SD 5.86) at Week 15 endpoint for both sertraline groups (% of patients being 100% adherent NR)",,,,"173.1 mg at Week 10 and 173.5 mg at Week 15 (average for both sertraline groups)","(44.26) mg at Week 10 and (42.82) mg at Week 15 (average for both sertraline groups)",,"Race data reported","Community","64.6%","Mixed","child sexual abuse, child physical abuse, accidents, combat-related, other (death [not combat-related] of another person)","Some Concerns","Rothbaum BO, Cahill SP, Foa EB, et al. Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder. J Trauma Stress. 2006 Oct;19(5):625-38. doi: 10.1002/jts.20170. PMID: 17075912.","80288","2019"
"rothbaum2006_B","rothbaum2006","Psychotherapy & pharmacotherapy","2006","PTSD","Active Control",,"65","B","31",,"Sertraline","Sertraline","SSRI antidepressant, continuation of medication following 10 weeks of open-label treatment with flexible dosing titrated over first 5 weeks.","No",,"Yes","Antidepressant: SSRI","No",,"No","No","Yes","No","No","Individual","In Person","Dose: 25 to 200 mg, previously titrated to maximum dose tolerated prior to randomization",,"Daily","5",,,,,"Sertraline: compliance as number of tablets taken divided by number of tablets that should have been taken, using medication dispensing data and unused medication returns (average % compliance with regimen)",,"Average % compliance with regimen 7.1% (SD 7.99) at Week 10 and 97.1% (SD 5.86) at Week 15 endpoint for both sertraline groups (% of patients being 100% adherent NR)",,,,"173.1 mg at Week 10 and 173.5 mg at Week 15 (average for both sertraline groups)","(44.26) mg at Week 10 and (42.82) mg at Week 15 (average for both sertraline groups)",,"Race data reported","Community","64.6%","Mixed","child sexual abuse, child physical abuse, accidents, combat-related, other (death [not combat-related] of another person)","Some Concerns","Rothbaum BO, Cahill SP, Foa EB, et al. Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder. J Trauma Stress. 2006 Oct;19(5):625-38. doi: 10.1002/jts.20170. PMID: 17075912.","80288","2019"
"rothbaum2008_A","rothbaum2008","Pharmacotherapy","2008","PTSD","PTSD",,"25","A","14",,"Risperidone augmentation","Risperidone augmentation","Augmentation of an SSRI antidepressant (sertraline) with an atypical antipsychotic; all participants treated with sertraline in phase 1, and non-responders randomized to augmentation with risperidone or placebo; dose increased weekly by 0.5 mg/day as tolerated to maximum 2 mg/day, or 3 mg/day ""on a case-by-case basis."" Sertraline continued through phase 2, mean dose at endpoint 147 mg for risperidone arm.","No",,"Yes","Mixed","No",,"No","No","No","No","No","Individual","In Person","Initiated at 0.5 mg, titrated to maximum of 2 or 3 mg",,"Daily","8",,,,,,,,,,,"2.1 mg",,,"Race data reported","Community","80%","Mixed","rape/sexual assault, intimate partner violence, accidents, community/school violence, other (stalking, break-in, witnessed killing or suicide attempt)","High","Rothbaum BO, Killeen TK, Davidson JRT, et al. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J. Clin. Psychiatry. 2008;69(4):520-5. doi: 10.4088/JCP.v69n0402. PMID: 18278987.","30519","2019"
"rothbaum2008_B","rothbaum2008","Pharmacotherapy","2008","PTSD","Active Control",,"25","B","11",,"Placebo augmentation","Placebo augmentation","Augmentation of an SSRI antidepressant (sertraline) with placebo matching risperidone; all participants treated with sertraline in phase 1, and non-responders randomized to augmentation with risperidone or placebo; sertraline continued through phase 2.","No",,"Yes","Antidepressant: SSRI","No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","8",,,,,,,,,,,"1.77 mg equivalent",,,"Race data reported","Community","80%","Mixed","rape/sexual assault, intimate partner violence, accidents, community/school violence, other (stalking, break-in, witnessed killing or suicide attempt)","High","Rothbaum BO, Killeen TK, Davidson JRT, et al. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J. Clin. Psychiatry. 2008;69(4):520-5. doi: 10.4088/JCP.v69n0402. PMID: 18278987.","30519","2019"
"rothbaum2014_A","rothbaum2014","Psychotherapy & pharmacotherapy","2014","PTSD","PTSD",,"156","A","53",,"Virtual reality exposure therapy + D-cycloserine","Virtual reality exposure therapy (VRET) + D-cycloserine","Virtual reality exposure: sessions comprised of exposure to subject's most traumatic memories using computer-generated virtual Iraq or Afghanistan environments with simulated field/combat situations and trigger stimuli (auditory, visual, olfactory, and tactile), manipulated by the therapist with attempt to match patient-described stimuli followed by experience processing, integration, and associations. This therapy differed from typical exposure therapy in that there was no homework assigned. 







D-cycloserine: NMDA glutamate receptor partial agonist","Yes","Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","Drug dose: 50 mg (30 minutes prior to session)







Sessions: 90 minutes (30 minutes prior to exposure for medication and assessments including startle responses and cortisol sampling). 30 to 45 minutes continuous exposure, until anxiety level decreases, 15 to 20 minutes processing time. One introductory session without medication or exposure was given.",,"Weekly","6",,"Completed treatment",,"participant flow diagram lists as ""Post/Completed Treatment"", this is same Ns as for ""completed postttreatment"" follow-up (using those Ns for treatment completion)",,,,,,,,,,"Race and Ethnicity data reported","Veteran","5.13%","Combat-related",,"Some Concerns","Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.","42150","2019"
"rothbaum2014_B","rothbaum2014","Psychotherapy & pharmacotherapy","2014","PTSD","Active Control",,"156","B","50",,"Virtual reality exposure + alprazolam","Virtual reality exposure therapy (VRET) + alprazolam","Virtual reality exposure: sessions comprised of exposure to subject's most traumatic memories using computer-generated virtual Iraq or Afghanistan environments with simulated field/combat situations and trigger stimuli (auditory, visual, olfactory, and tactile), manipulated by the therapist with attempt to match patient-described stimuli followed by experience processing, integration, and associations. This therapy differed from typical exposure therapy in that there was no homework assigned. 







Alprazolam: benzodiazepine","Yes","Trauma-focused","Yes","Antianxiety: benzodiazepine","No",,"No","No","Yes","No","No","Individual","In Person","Dose: 0.25 mg (30 minutes prior to session)







Sessions: 90 minutes (30 minutes prior to exposure for medication and assessments including startle responses and cortisol sampling). 30 to 45 minutes continuous exposure, until anxiety level decreases, 15 to 20 minutes processing time. One introductory session without medication or exposure was given.",,"Weekly","6",,"completed treatment",,"participant flow diagram lists as ""Post/Completed Treatment"", this is same Ns as for ""completed postttreatment"" follow-up (using those Ns for treatment completion)",,,,,,,,,,"Race and Ethnicity data reported","Veteran","5.13%","Combat-related",,"Some Concerns","Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.","42150","2019"
"rothbaum2014_C","rothbaum2014","Psychotherapy & pharmacotherapy","2014","PTSD","Active Control",,"156","C","53",,"Virtual reality exposure + placebo","Virtual reality exposure therapy (VRET)","Virtual reality exposure: sessions comprised of exposure to subject's most traumatic memories using computer-generated virtual Iraq or Afghanistan environments with simulated field/combat situations and trigger stimuli (auditory, visual, olfactory, and tactile), manipulated by the therapist with attempt to match patient-described stimuli followed by experience processing, integration, and associations. This therapy differed from typical exposure therapy in that there was no homework assigned. 







Placebo: administered 30 minutes prior to session.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person","Dose: NA







Sessions: 90 minutes (30 minutes prior to exposure for medication and assessments including startle responses and cortisol sampling). 30 to 45 minutes continuous exposure, until anxiety level decreases, 15 to 20 minutes processing time. One introductory session without medication or exposure was given.",,"Weekly","6",,"completed treatment",,"participant flow diagram lists as ""Post/Completed Treatment"", this is same Ns as for ""completed postttreatment"" follow-up (using those Ns for treatment completion)",,,,,,,,,,"Race and Ethnicity data reported","Veteran","5.13%","Combat-related",,"Some Concerns","Rothbaum BO, Price M, Jovanovic T, et al. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640-8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802.","42150","2019"
"roullet2021_A","roullet2021","Other mixed","2021","PTSD","PTSD",,"66","A","33",,"Propranolol + traumatic memory reactivation","Traumatic memory reactivation + propranolol","Propranolol: centrally acting β1- and β2-noradrenergic receptor blocker given 90 minutes before trauma memory reactivation sessions, intended to disrupt memory reconsolidation.



Traumatic memory reactivation: therapy included writing a trauma narrative focusing on disturbing moments and emotional details; in later sessions patient read traumatic script to therapist.","No",,"Yes","Antiadrenergic","No",,"No","No","No","Yes","No","Individual","In Person","Dose: 1.67 mg/kg, given as divided dose during first session; full dose given at once at later sessions if tolerated",,"Weekly","6",,"Did not drop out during treatment period",,"""four patients (12.12%) per group dropped out between the first and seventh weeks"" (treatment period), leaving n=29 completing",,,,,,,,,,"Not reported","Community","62.12%","Mixed","Combat-related; Rape/sexual assault; Accidents; Community/school violence; Terrorism/political violence/forced displacement; Other (""life threatening event"", ""sudden unexpected death"")","Low","Roullet P, Vaiva G, Very E, et al. Traumatic memory reactivation with or without propranolol for PTSD and comorbid MD symptoms: a randomised clinical trial. Neuropsychopharmacology. 2021 Feb 21;21:21. doi: 10.1038/s41386-021-00984-w. PMID: 33612830.","1575030","2022"
"roullet2021_B","roullet2021","Other mixed","2021","PTSD","Active Control",,"66","B","33",,"Placebo + traumatic memory reactivation","Traumatic memory reactivation + placebo","Placebo: lactose-containing placebo capsule, same size and color as active drug capsules, given 90 minutes before trauma memory reactivation sessions.



Traumatic memory reactivation: therapy included writing a trauma narrative focusing on disturbing moments and emotional details; in later sessions patient read traumatic script to therapist.","No",,"No",,"No",,"No","No","Yes","Yes","No","Individual","In Person","Placebo equivalent dose to proporanolol",,"Weekly","6",,"Did not drop out during treatment period",,"""four patients (12.12%) per group dropped out between the first and seventh weeks"" (treatment period), leaving n=29 completing",,,,,,,,,,"Not reported","Community","62.12%","Mixed","Combat-related; Rape/sexual assault; Accidents; Community/school violence; Terrorism/political violence/forced displacement; Other (""life threatening event"", ""sudden unexpected death"")","Low","Roullet P, Vaiva G, Very E, et al. Traumatic memory reactivation with or without propranolol for PTSD and comorbid MD symptoms: a randomised clinical trial. Neuropsychopharmacology. 2021 Feb 21;21:21. doi: 10.1038/s41386-021-00984-w. PMID: 33612830.","1575030","2022"
"roy2022_A","roy2022","Psychotherapy","2022","PTSD","PTSD",,"20","A","10",,"Motion-assisted, multi-modal memory desensitization and reconsolidation, with eye movement","Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR)","Motion-assisted, multi-modal memory desensitization and reconsolidation, including eye movement component; ""exposure-based 'walk and talk' cognitive therapy"" delivered over 10 sessions (3 preparatory, 6 intervention, and 1 consolidation session). ""Participants provided songs and pictures that they rated on impactfulness. While walking in the 3MDR virtual environment, participants started with a song to bring them back to the time of their trauma, and then traversed two hallways, actively walking toward emotionally evocative pictures that they then discussed with their therapist. Key words or feelings they expressed were superimposed over the picture, then read aloud, whereupon EM + participants recited numbers flashing on a ball crisscrossing the picture. These procedures were repeated for multiple pictures per session. A song to return the participant to present day closed each session.""","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Technology assisted",,,,,"total 10 sessions","""completed the full intervention""",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","50%","Mixed","Combat-related; Other (""sexual traumas""; not specified)","High","Roy MJ, Bellini P, Kruger SE, et al. Randomized controlled trial of motion-assisted exposure therapy for posttraumatic stress disorder after mild traumatic brain injury, with and without an eye movement task. Front Virtual Real. 2022;3 doi: 10.3389/frvir.2022.1005774.","1620650","2023"
"roy2022_B","roy2022","Psychotherapy","2022","PTSD","PTSD",,"20","B","10",,"Motion-assisted, multi-modal memory desensitization and reconsolidation, without eye movement","Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR) minus eye movement","Motion-assisted, multi-modal memory desensitization and reconsolidation, with no eye movement component; ""exposure-based 'walk and talk' cognitive therapy"" delivered over 10 sessions (3 preparatory, 6 intervention, and 1 consolidation session). ""Participants provided songs and pictures that they rated on impactfulness. While walking in the 3MDR virtual environment, participants started with a song to bring them back to the time of their trauma, and then traversed two hallways, actively walking toward emotionally evocative pictures that they then discussed with their therapist. Key words or feelings they expressed were superimposed over the picture, then read aloud"" The no EM participants continued to look at their image for another 30 seconds. ""These procedures were repeated for multiple pictures per session. A song to return the participant to present day closed each session.""","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Technology assisted",,,,,"total 10 sessions","""completed the full intervention""",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","50%","Mixed","Combat-related; Other (""sexual traumas""; not specified)","High","Roy MJ, Bellini P, Kruger SE, et al. Randomized controlled trial of motion-assisted exposure therapy for posttraumatic stress disorder after mild traumatic brain injury, with and without an eye movement task. Front Virtual Real. 2022;3 doi: 10.3389/frvir.2022.1005774.","1620650","2023"
"rudstam2022_A","rudstam2022","CIH","2022","PTSD","PTSD",,"45","A","22",,"Trauma-focused group music and imagery","Trauma-focused psychotherapy + music therapy","Modification of the Bonny Method of Guided Imagery and Music for group format and trauma treatment; includes guided relaxation, music listening, and expressive arts. Delivered in 12 weekly 2.5-hour sessions.","No",,"No",,"Yes","Other CIH","No","No","No","No","No","Group","In Person",,"150 minutes","Weekly","12",,"Completing treatment",,"52% (11/21) attended all 12 sessions",,,,"10.66",,,,,,"Not reported","Community","100%","Mixed","Child physical abuse; Child sexual abuse; Child other abuse; Rape/sexual assault; Community/school violence; Other (adult psychological abuse)","High","Rudstam G, Elofsson UOE, Söndergaard HP, et al. Trauma-focused group music and imagery with women suffering from PTSD/Complex PTSD: A randomized controlled study. Eur. J. Trauma Dissociation. 2022;6(3) doi: 10.1016/j.ejtd.2022.100277.","1602811","2023"
"rudstam2022_B","rudstam2022","CIH","2022","PTSD","Inactive Control",,"45","B","23",,"Waitlist","Waitlist","Waitlist","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"12",,,,,,,,,,,,,,"Not reported","Community","100%","Mixed","Child physical abuse; Child sexual abuse; Child other abuse; Rape/sexual assault; Community/school violence; Other (adult psychological abuse)","High","Rudstam G, Elofsson UOE, Söndergaard HP, et al. Trauma-focused group music and imagery with women suffering from PTSD/Complex PTSD: A randomized controlled study. Eur. J. Trauma Dissociation. 2022;6(3) doi: 10.1016/j.ejtd.2022.100277.","1602811","2023"
"rzepka2024_A","rzepka2024","Other study class","2024","PTSD","PTSD",,"32","A","17",,"Mindfulness training","Mindfulness","Three mindfulness-based and guided imagery techniques (breathing exercise, inner safe space, and body scan); exercises provided as audio files to participant mobile phone. These had been translated to common languages used by refugees for the study setting (English, French, Turkish, Arabic, Farsi, Serbian). Participants also had 2 meetings with a member of the study team, which included psychoeducation about PTSD and its symptoms, introduction and practice of stablization techniques.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Mixed",,,"Ad libatum","4","Individual meetings at start of treatment and at 2 weeks","See Detail",,"ad lib use, treatment completion not defined; publication provides self-reported use of exercises (5 participants did not use at all, 2 used between 1 and 10 times, and 5 participants used more than 10 times during study period)",,,,,,"reported use of exercises: mean 8.25 (SD 11.04, range 0-30) times",,,,,"Community","46.9%",,,"High","Rzepka I, Zehetmair C, Nagy E, Friederich HC, Nikendei C. Implementing a stabilizing intervention for traumatized refugees in temporary accommodations in South-West Germany - a randomized controlled pilot trial. Front Psychiatry. 2024 Oct 31;15:1453957. doi: 10.3389/fpsyt.2024.1453957. PMID: 39544372; PMCID: PMC11560747.","1641153","2025"
"rzepka2024_B","rzepka2024","Other study class","2024","PTSD","Inactive Control",,"32","B","15",,"Waitlist","Waitlist","Waitlist","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,,"Community","46.9%",,,"High","Rzepka I, Zehetmair C, Nagy E, Friederich HC, Nikendei C. Implementing a stabilizing intervention for traumatized refugees in temporary accommodations in South-West Germany - a randomized controlled pilot trial. Front Psychiatry. 2024 Oct 31;15:1453957. doi: 10.3389/fpsyt.2024.1453957. PMID: 39544372; PMCID: PMC11560747.","1641153","2025"
"sack2016_A","sack2016","Psychotherapy","2016","PTSD","PTSD",,"139","A","47",,"Exposure with eyes fixated and moving","Eye Movement Desensitization and Reprocessing (EMDR)","Exposure with eyes moving while fixated on therapist's moving hand; treatment followed EMDR manual by Solomon and Shapiro, except for variation in stimulation (eye movement); treatment focuses on  distressing trauma-related images, beliefs, and bodily sensations; therapy ended when PTSD diagnostic criteria no longer met, or 3 sessions without subjective symptom reduction, with maximum of 8 sessions.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Weekly","up to 8","maximum 8 sessions","completed treatment course",,,,,,"4.2","1.8",,,,,"Not reported","Community","64%","Mixed","accidents, natural or manmade disasters, community/school violence, other (sexual trauma)","Low","Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.","49086","2019"
"sack2016_B","sack2016","Psychotherapy","2016","PTSD","Active Control",,"139","B","47",,"Exposure with eyes fixated and not moving","Eye Movement Desensitization and Reprocessing (EMDR)","Exposure with eyes fixated on therapist's nonmoving hand; treatment followed EMDR manual by Solomon and Shapiro, except for variation in stimulation (eye movement); treatment focuses on distressing trauma-related images, beliefs, and bodily sensations; therapy ended when PTSD diagnostic criteria no longer met, or 3 sessions without subjective symptom reduction, with maximum of 8 sessions.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Weekly","up to 8","maximum 8 sessions","completed treatment course",,,,,,"4.7","1.9",,,,,"Not reported","Community","64%","Mixed","accidents, natural or manmade disasters, community/school violence, other (sexual trauma)","Low","Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.","49086","2019"
"sack2016_C","sack2016","Psychotherapy","2016","PTSD","Active Control",,"139","C","45",,"Exposure without eye fixation","Eye Movement Desensitization and Reprocessing (EMDR)","Exposure without explicit task of fixating on external focus of attention (eyes closed or eyes open and looking unfocused into the room); treatment followed EMDR manual by Solomon and Shapiro, except for variation in stimulation (eye movement); treatment focuses on distressing trauma-related images, beliefs, and bodily sensations; therapy ended when PTSD diagnostic criteria no longer met, or 3 sessions without subjective symptom reduction, with maximum of 8 sessions.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Weekly","up to 8","maximum 8 sessions","completed treatment course",,,,,,"3.9","1.8",,,,,"Not reported","Community","64%","Mixed","accidents, natural or manmade disasters, community/school violence, other (sexual trauma)","Low","Sack M, Zehl S, Otti A, et al. A comparison of dual attention, eye movements, and exposure only during Eye Movement Desensitization and Reprocessing for posttraumatic stress disorder: results from a randomized clinical trial. Psychother Psychosom. 2016;85(6):357-65. doi: 10.1159/000447671. PMID: 27744424.","49086","2019"
"sack2017_A","sack2017","Other mixed","2017","PTSD","PTSD",,"35","A","35",,"Oxytocin + trauma memory reactivation","Imaginal exposure (experimental paradigm) + oxytocin","Intranasal oxytocin (Syntocinon, Novartis, Brazil) administered 45 minutes before trauma-script exposure. Trauma-script stress exposure used a script of 2 minutes and did not include an imagery period.","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","Yes","No","Individual","In Person","24 IU",,"Once (single dose)","0.14","single dose","Received allocated intervention",,"""received allocated intervention"" in flow diagram, intervention comprised of two treatment sessions, no further details","NA (administered in clinic)","100%",,,,,"24 IU",,,"Race data reported","Community","100%","Mixed","rape/sexual assault, child sexual abuse, community/school violence, accidents, natural or manmade disasters, other (""non-sexual violence by a family member"")","Low","Sack M, Spieler D, Wizelman L, et al. Intranasal oxytocin reduces provoked symptoms in female patients with posttraumatic stress disorder despite exerting sympathomimetic and positive chronotropic effects in a randomized controlled trial. BMC Med. 2017 Feb 17;15:40. doi: 10.1186/s12916-017-0801-0. PMID: 28209155.","47377","2019"
"sack2017_B","sack2017","Other mixed","2017","PTSD","Active Control",,"35","B","35",,"Placebo + trauma memory reactivation","Imaginal exposure (experimental paradigm) + placebo","Intranasal placebo administered 45 minutes before trauma-script exposure. Placebo spray included all ingredients as the oxytocin intranasal spray except for the oxytocin. Trauma-script stress exposure used a script of 2 minutes and did not include an imagery period.","No",,"No",,"No",,"No","No","Yes","Yes","No","Individual","In Person",,,"Once (single dose)","0.14","single dose","Received allocated intervention",,"""received allocated intervention"" in flow diagram, intervention comprised of two treatment sessions, no further details","NA (administered in clinic)","100%",,,,,,,,"Race data reported","Community","100%","Mixed","rape/sexual assault, child sexual abuse, community/school violence, accidents, natural or manmade disasters, other (""non-sexual violence by a family member"")","Low","Sack M, Spieler D, Wizelman L, et al. Intranasal oxytocin reduces provoked symptoms in female patients with posttraumatic stress disorder despite exerting sympathomimetic and positive chronotropic effects in a randomized controlled trial. BMC Med. 2017 Feb 17;15:40. doi: 10.1186/s12916-017-0801-0. PMID: 28209155.","47377","2019"
"sandahl2021_A","sandahl2021","Psychotherapy & pharmacotherapy","2021","PTSD","PTSD",,"219","A","54","58 randomized; post-randomization exclusion of 4","Imagery rehearsal therapy + mianserin + TAU","Imagery Rehearsal Training (IRT) + mianserin augmentation","Imagery rehearsal therapy: adaptation of manual-based CBTsessions; includes psychoeducation about sleep and dreams, cognitive restructuring, imagery education and exercises, and imagery rescripting of disturbing dream or nightmare with rehearsal of a new, non-disturbing dream. Mianserin: an oral sedating tetracyclic antidepressant (not FDA-approved; similar to mirtazapine) used to treat sleep disturbance; increased from 10 to 30 mg/day based on effectiveness and side effects. TAU: interdisciplinary treatment over 8 to 12 months including medication, physical therapy, psychoeducation (including sleep hygiene and relaxation), and manual-based CBT, provided by physician, physical therapist, and psychologist.","Yes","Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","Mianserin initiated at 10 mg nightly, could increase ""gradually"" to maximum 30 mg/day",,"Weekly","Drug: 23



Therapy: 6



TAU: 26 to 35","Mean total duration: 12.40 (SD 4.92) months
Drug distributed during physician visits, weekly x 6 then monthly x 4; TAU CBT given weekly x 16, imagery therapy during 6 of these sessions; TAU overall 6 to 8 months","≥4 of 6 imagery sessions",,"""per-protocol completers of IRT were defined as participants for whom IRT methods had been used in a minimum of four sessions""","Plasma concentration of mianserin >0 post-treatment","43%","Value for mITT sample entered.



Of patients with blood samples: 72% (23/NR)



Discrepancy in calculated denominators with samples for Arms A and C (total 36 + 32 ≠ 70)","3.61","4.24","entered value is for imagery sessions
Imagery, number of sessions where imagery therapy used: mean 3.61 (SD 4.24)
TAU, number of sessions with psychologist: mean 13.56 (SD 6.27)","14.22","8.43","mg/day","Not reported","Community","49%","Mixed","Combat-related; Rape/sexual assault; Terrorism/political violence/forced displacement; Other (""violence from relatives"", ""cranial trauma"")","High","Sandahl H, Jennum P, Baandrup L, et al. Imagery rehearsal therapy and/or mianserin in treatment of refugees diagnosed with PTSD: results from a randomized controlled trial. J Sleep Res. 2021 Feb 02:e13276. doi: 10.1111/jsr.13276. PMID: 33529449.","1565023","2022"
"sandahl2021_B","sandahl2021","Psychotherapy & pharmacotherapy","2021","PTSD","Active Control",,"219","B","56","62 randomized; post-randomization exclusion of 6","Imagery rehearsal therapy + TAU","Imagery Rehearsal Training (IRT)","Imagery rehearsal therapy:adaptation of manual-based CBTsessions; includes psychoeducation about sleep and dreams, cognitive restructuring, imagery education and exercises, and imagery rescripting of disturbing dream or nightmare with rehearsal of a new, non-disturbing dream. TAU: interdisciplinary treatment over 8 to 12 months including medication, physical therapy, psychoeducation (including sleep hygiene and relaxation), and manual-based CBT, provided by physician, physical therapist, and psychologist.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Weekly","Therapy: 6



TAU: 26 to 35","Mean total duration: 10.96 (SD 5.14) months



TAU CBT given weekly x 16, imagery therapy during 6 of these sessions; TAU overall 6 to 8 months","≥4 of 6 imagery sessions",,"""per-protocol completers of IRT were defined as participants for whom IRT methods had been used in a minimum of four sessions""",,,,"3.19","4.57","entered value is for imagery sessions
Imagery, number of sessions where imagery therapy used: mean 3.19 (SD 4.57)
TAU, number of sessions with psychologist: mean 12.04 (SD 7.19)",,,,"Not reported","Community","49%","Mixed","Combat-related; Rape/sexual assault; Terrorism/political violence/forced displacement; Other (""violence from relatives"", ""cranial trauma"")","High","Sandahl H, Jennum P, Baandrup L, et al. Imagery rehearsal therapy and/or mianserin in treatment of refugees diagnosed with PTSD: results from a randomized controlled trial. J Sleep Res. 2021 Feb 02:e13276. doi: 10.1111/jsr.13276. PMID: 33529449.","1565023","2022"
"sandahl2021_C","sandahl2021","Psychotherapy & pharmacotherapy","2021","PTSD","Active Control",,"219","C","54","60 randomized; post-randomization exclusion of 6","Mianserin + TAU","Mianserin augmentation","Mianserin: an oral sedating tetracyclic antidepressant (not FDA-approved; similar to mirtazapine) used to treat sleep disturbance; increased from 10 to 30 mg/day based on effectiveness and side effects. TAU: interdisciplinary treatment over 8 to 12 months including medication, physical therapy, psychoeducation (including sleep hygiene and relaxation), and manual-based CBT, provided by physician, physical therapist, and psychologist.","Yes","Non-Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","Yes","No","No","Individual","In Person","Mianserin initiated at 10 mg nightly, could increase ""gradually"" to maximum 30 mg/day",,"Weekly","Drug: 23



TAU: 26 to 35","Mean total duration: 11.52 (SD 4.52) months
Drug distributed during physician visits, weekly x 6 then monthly x 4; TAU CBT given weekly x 16, TAU overall 6 to 8 months",,,,"Plasma concentration of mianserin >0 post-treatment","26%","Value for mITT sample entered.



Of patients with blood samples: 39% (14/NR)



Discrepancy in calculated denominators with samples for Arms A and C (total 36 + 32 ≠ 70)","12.06","6.86","entered value is for TAU sessions","12","4.41","mg/day","Not reported","Community","49%","Mixed","Combat-related; Rape/sexual assault; Terrorism/political violence/forced displacement; Other (""violence from relatives"", ""cranial trauma"")","High","Sandahl H, Jennum P, Baandrup L, et al. Imagery rehearsal therapy and/or mianserin in treatment of refugees diagnosed with PTSD: results from a randomized controlled trial. J Sleep Res. 2021 Feb 02:e13276. doi: 10.1111/jsr.13276. PMID: 33529449.","1565023","2022"
"sandahl2021_D","sandahl2021","Psychotherapy & pharmacotherapy","2021","PTSD","Active Control",,"219","D","55","60 randomized; post-randomization exclusion of 5","TAU","Interdisciplinary treatment","TAU: interdisciplinary treatment over 8 to 12 months including medication, physical therapy, psychoeducation (including sleep hygiene and relaxation), and manual-based CBT, provided by physician, physical therapist, and psychologist.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Weekly","26 to 35","Mean total duration: 10.28 (SD 5.55) months



TAU CBT given weekly x 16, TAU overall 6 to 8 months",,,,,,,"10.87","6.76","entered value is for TAU sessions",,,,"Not reported","Community","49%","Mixed","Combat-related; Rape/sexual assault; Terrorism/political violence/forced displacement; Other (""violence from relatives"", ""cranial trauma"")","High","Sandahl H, Jennum P, Baandrup L, et al. Imagery rehearsal therapy and/or mianserin in treatment of refugees diagnosed with PTSD: results from a randomized controlled trial. J Sleep Res. 2021 Feb 02:e13276. doi: 10.1111/jsr.13276. PMID: 33529449.","1565023","2022"
"sannibale2013_A","sannibale2013","Psychotherapy","2013","PTSD+SUD","PTSD+SUD","Integrated","62","A","33",,"Integrated therapy","Integrated cognitive behavioral therapy for PTSD and AUD","Integrated exposure-based CBT for PTSD and AUD. CBT for PTSD was manualized, and incorporated exposure therapy and cognitive restructuring; integrated with CBT for AUD, a manual-guided therapy based on Project MATCH and the Combined Behavioral Intervention Manual (same as AUD portion for Alcohol support intervention). Included structured homework.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12",,"completed ≥9 sessions",,,,,,,,"median 11.0 (NR)",,,,"Not reported","Community","53.23%","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, intimate partner violence, accidents, other (""witnessed injury/killing/mutilation"", ""news of someone close"", ""danger of losing life/other"")","Low","Sannibale C, Teesson M, Creamer MC, et al. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction. 2013 Aug;108(8):1397-410. doi: 10.1111/add.12167. PMID: 25328957.","40190","2020"
"sannibale2013_B","sannibale2013","Psychotherapy","2013","PTSD+SUD","Active Control","Not integrated","62","B","29",,"Alcohol support","Cognitive behavioral therapy (CBT) without a trauma focus","CBT for AUD plus supportive counseling. CBT was based on Project MATCH and the Combined Behavioral Intervention Manual (same as AUD portion for Integrated therapy intervention). Included structured homework. Supportive counseling is present-centered, manualized therapy, and targeted AUD symptoms only in this intervention.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Weekly","12",,"completed ≥9 sessions",,,,,,,,"median 10.00 (NR)",,,,"Not reported","Community","53.23%","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, intimate partner violence, accidents, other (""witnessed injury/killing/mutilation"", ""news of someone close"", ""danger of losing life/other"")","Low","Sannibale C, Teesson M, Creamer MC, et al. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction. 2013 Aug;108(8):1397-410. doi: 10.1111/add.12167. PMID: 25328957.","40190","2020"
"santarnecchi2019_A","santarnecchi2019","Psychotherapy","2019","PTSD","PTSD",,"37","A","14",,"Trauma-focused CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Includes narrative recollection of traumatic event, relaxation exercises, psychoeducation, exposure therapy, and home assignments","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Weekly","10","average","See Detail",,"reports study completion only; ""completed the study (i.e., both clinical and MRI data acquired before and after psychotherapy)"", unclear if this is also treatment completion rate",,,,"10","2",,,,,"Not reported","Community","38.71%","Natural or manmade disasters",,"High","Santarnecchi E, Bossini L, Vatti G, et al. Psychological and brain connectivity changes following trauma-focused CBT and EMDR treatment in single-episode PTSD patients. Front Psychol. 2019;10:129. doi: 10.3389/fpsyg.2019.00129. PMID: 30858808.","52130","2020"
"santarnecchi2019_B","santarnecchi2019","Psychotherapy","2019","PTSD","PTSD",,"37","B","17",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Therapy includes identification of  disturbing memories of traumatic event and focusing on these memories while following finger movements performed by therapist","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","4","average","See Detail",,"reports study completion only; ""completed the study (i.e., both clinical and MRI data acquired before and after psychotherapy)"", unclear if this is also treatment completion rate",,,,"4","2",,,,,"Not reported","Community","38.71%","Natural or manmade disasters",,"High","Santarnecchi E, Bossini L, Vatti G, et al. Psychological and brain connectivity changes following trauma-focused CBT and EMDR treatment in single-episode PTSD patients. Front Psychol. 2019;10:129. doi: 10.3389/fpsyg.2019.00129. PMID: 30858808.","52130","2020"
"saraiya2022_A","saraiya2022","Other mixed","2022","PTSD","PTSD",,"39","A","29",,"Guided prolonged exposure with wearable technology","Prolonged Exposure (PE)","Manualized prolonged exposure therapy with guided use of wearable technology (Bio Ware), ""an integrated platform that consists of a clinician dashboard, backend applications, a patient-facing mobile application, wearables, and system devices"" to facilitate in vivo exposures. Clinician-guided in vivo exposure using Bio Ware system.","Yes","Trauma-focused","No",,"No",,"No","No","No","Yes","No","Individual","Technology alone",,"90 minutes",,,"total 10-12 sessions","At least 8 sessions of PE and used the Bio Ware device at least once",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","46.15%","Mixed","Accidents; Community/school violence; Rape/sexual assault; Combat-related; Illness/medical procedure; Other (""severe human suffering"", ""sudden violent death"", ""sudden accidental death"")","High","Saraiya TC, Jarnecke AM, Rothbaum AO, et al. Technology-enhanced in vivo exposures in Prolonged Exposure for PTSD: A pilot randomized controlled trial. J Psychiatr Res. 2022;156:467-75. doi: 10.1016/j.jpsychires.2022.10.056. PMID: 36347106","1609221","2023"
"saraiya2022_B","saraiya2022","Other mixed","2022","PTSD","Active Control",,"39","B","10",,"Unguided prolonged exposure","Prolonged Exposure (PE)","Manualized prolonged exposure therapy, with unguided use of wearable technology (Bio Ware), ""an integrated platform that consists of a clinician dashboard, backend applications, a patient-facing mobile application, wearables, and system devices"" to facilitate in vivo exposures. Participants completed assigned in vivo exposure exercises while using Bio Ware device on their own (no clinican guidance).","Yes","Trauma-focused","No",,"No",,"No","No","Yes","Yes","No","Individual","Technology alone",,"90 minutes",,,"total 10-12 sessions","At least 8 sessions of PE and used the Bio Ware device at least once",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","46.15%","Mixed","Accidents; Community/school violence; Rape/sexual assault; Combat-related; Illness/medical procedure; Other (""severe human suffering"", ""sudden violent death"", ""sudden accidental death"")","High","Saraiya TC, Jarnecke AM, Rothbaum AO, et al. Technology-enhanced in vivo exposures in Prolonged Exposure for PTSD: A pilot randomized controlled trial. J Psychiatr Res. 2022;156:467-75. doi: 10.1016/j.jpsychires.2022.10.056. PMID: 36347106","1609221","2023"
"sautter2015_A","sautter2015","Psychotherapy","2015","PTSD","PTSD",,"114","A","58","29 couples","Structured Approach Therapy","Structured Approach Therapy","PTSD treatment and couples-based therapy by individual therapist; manual-based interventions organized within a stress inoculation therapy (SIT) framework including psychoeducation (2 sessions), emotion activation and skills training (4 sessions), and disclosure-based exposure (6 sessions); homework assignment with each session. Up to 3 additional sessions were permitted if it wasn't possible to complete the protocol within 12 sessions.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Couple","In Person",,"60 minutes",,,"12 to 15 sessions total","received ≥12 sessions","7,241%",,,,,"10.31",,,,,,"Race and Ethnicity data reported","Veteran","1.75%",,,"Some Concerns","Sautter FJ, Glynn SM, Cretu JB, et al. Efficacy of structured approach therapy in reducing PTSD in returning veterans: A randomized clinical trial. Psychol Serv. 2015 Aug;12(3):199-212. doi: 10.1037/ser0000032. PMID: 26213789.","44509","2019"
"sautter2015_B","sautter2015","Psychotherapy","2015","PTSD","Active Control",,"114","B","56","28 couples","PTSD Family Education","PTSD Family Education","PTSD treatment and couples-based therapy, manualized and adapted from the Support and Family Education (SAFE) program and behavioral family therapy family education sections; treatment using lectures, discussion, and written materials designed to educate about PTSD and PTSD-related conditions. Avoided skills training and other therapeutic interventions. Up to 3 additional sessions were permitted if it wasn't possible to complete the protocol within 12 sessions.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Couple","In Person",,"60 minutes",,,"12 to 15 sessions total","received ≥12 sessions",,,,,,"9.61",,,,,,"Race and Ethnicity data reported","Veteran","1.75%",,,"Some Concerns","Sautter FJ, Glynn SM, Cretu JB, et al. Efficacy of structured approach therapy in reducing PTSD in returning veterans: A randomized clinical trial. Psychol Serv. 2015 Aug;12(3):199-212. doi: 10.1037/ser0000032. PMID: 26213789.","44509","2019"
"saygin2002_A","saygin2002","Pharmacotherapy","2002","PTSD","PTSD",,"60","A","30",,"Sertraline","Sertraline","SSRI antidepressant; flexible dosing based on ""clinical status""","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","50 to 100 mg",,"Daily","20",,,,,,,,,,,"68.33 mg/day","21.7",,"Not reported","Community","75.93%","Natural or manmade disasters",,"High","Saygin MZ, Sungur MZ, Sabol EU, et al. Nefazodone versus sertraline in the treatment of posttraumatic stress disorder. Klinik Psikofarmakol Bülteni. 2002 Jan;12(1):1-5.","24668","2019"
"saygin2002_B","saygin2002","Pharmacotherapy","2002","PTSD","PTSD",,"60","B","30",,"Nefazodone","Nefazodone","Serotonin antagonist and reuptake inhibitor; flexible dose based on ""clinical status""","No",,"Yes","Antidepressant: Other","No",,"No","No","No","No","No","Individual","In Person","200 to 400 mg",,"Daily","20",,,,,,,,,,,"332.35 mg/day","63.5",,"Not reported","Community","75.93%","Natural or manmade disasters",,"High","Saygin MZ, Sungur MZ, Sabol EU, et al. Nefazodone versus sertraline in the treatment of posttraumatic stress disorder. Klinik Psikofarmakol Bülteni. 2002 Jan;12(1):1-5.","24668","2019"
"schacht2017_A","schacht2017","Psychotherapy","2017","PTSD","PTSD","Not integrated","58","A","28",,"PE with incentive","Prolonged Exposure (PE)","Manualized therapy according to Foa, Hembree, & Rothbaum (2007) that includes breathing retraining for relaxation and imaginal and in vivo exposure. Incentive was gift card or clinic fee voucher beginning at $30 for Session 1, escalating $10 per session  with maximum total amount equaling $480. If the participant missed a session, the next attended session reset earnings to $30. Participants who missed 4 consecutive weeks were withdrawn from PE therapy but remained eligible to participate in followup assessments","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","12",,"completed 12 sessions or at least 9 sessions and demonstrated a 70% reduction on MPSS-R score",,,,,,"7.11","4.1",,,,,"Race data reported","Community","79.31%","Mixed","child sexual assault, child physical assault, intimate partner violence, other (unexpected death of loved one)","Some Concerns","Schacht RL, Brooner RK, King VL, et al. Incentivizing attendance to prolonged exposure for PTSD with opioid use disorder patients: a randomized controlled trial. J Consult Clin Psychol. 2017 Jul;85(7):689-701. doi: 10.1037/ccp0000208. PMID: 28414485","47904","2019"
"schacht2017_B","schacht2017","Psychotherapy","2017","PTSD","PTSD","Not integrated","58","B","30",,"PE","Prolonged Exposure (PE)","Manualized therapy according to Foa, Hembree, & Rothbaum (2007) that includes breathing retraining for relaxation and imaginal and in vivo exposure. Participants received $40 for completing each followup assessment","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","12",,"completed 12 sessions or at least 9 sessions and demonstrated a 70% reduction on MPSS-R score",,,,,,"1.8","2.57",,,,,"Race data reported","Community","79.31%","Mixed","child sexual assault, child physical assault, intimate partner violence, other (unexpected death of loved one)","Some Concerns","Schacht RL, Brooner RK, King VL, et al. Incentivizing attendance to prolonged exposure for PTSD with opioid use disorder patients: a randomized controlled trial. J Consult Clin Psychol. 2017 Jul;85(7):689-701. doi: 10.1037/ccp0000208. PMID: 28414485","47904","2019"
"schneier2012_A","schneier2012","Psychotherapy & pharmacotherapy","2012","PTSD","PTSD",,"37","A","19",,"PE + paroxetine","Prolonged Exposure (PE) + paroxetine","PE: trauma-focused CBT comprised of guided exposure to traumatic memories and situations to enhance emotional processing.







Paroxetine: controlled-release; SSRI","Yes","Trauma-focused","Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","Session length: 90 minutes







Dose: 12.5 mg for 1 week, then 25 mg for 3 weeks, then increased as tolerated to maximum of 50 mg",,"Psychotherapy: weekly







Paroxetine: daily","10",,"completed 10 weeks randomized treatment",,,"NR (""monitored compliance using pill counts"")",,,,,,"32.2 mg (mean maximum daily dose for at least 1 week)","13.4",,"Race and Ethnicity data reported","Community","54.05%","Terrorism/political violence/forced displacement",,"Low","Schneier FR, Neria Y, Pavlicova M, et al. Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial. Am J Psychiatry. 2012 Jan;169(1):80-8. doi: 10.1176/appi.ajp.2011.11020321. PMID: 21908494.","37261","2019"
"schneier2012_B","schneier2012","Psychotherapy & pharmacotherapy","2012","PTSD","Active Control",,"37","B","18",,"PE + placebo","Prolonged Exposure (PE) + placebo","PE: trauma-focused CBT comprised of guided exposure to traumatic memories and situations to enhance emotional processing.







Placebo: matching placebo tablets","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person","Session length: 90 minutes







Dose: matching placebo to paroxetine which was prescribed at 12.5 mg for 1 week, then 25 mg for 3 weeks, then increased as tolerated to maximum of 50 mg",,"Psychotherapy: weekly







Placebo: daily","10",,"completed 10 weeks randomized treatment",,,"NR (""monitored compliance using pill counts"")",,,,,,"36.8 mg (paroxetine equivalent) (mean maximum daily dose attained for at least 1 week)","12.1",,"Race and Ethnicity data reported","Community","54.05%","Terrorism/political violence/forced displacement",,"Low","Schneier FR, Neria Y, Pavlicova M, et al. Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial. Am J Psychiatry. 2012 Jan;169(1):80-8. doi: 10.1176/appi.ajp.2011.11020321. PMID: 21908494.","37261","2019"
"schneier2015_A","schneier2015","Pharmacotherapy","2015","PTSD","PTSD",,"38","A","18",,"Mirtazapine augmentation","Mirtazapine augmentation","Atypical antidepressant (tetracyclic, alpha-2 antagonist); mirtazapine increased after 4 weeks' treatment based on response and adverse events. All patients in both treatment arms also received the SSRI sertraline, initiated at 25 mg/day and titrated up to 200 mg/day.","No",,"Yes","Mixed","No",,"No","No","No","No","No","Individual","In Person","15 to 45 mg; initiated at 30 mg for 4 weeks, increased as tolerated if continued PTSD symptoms to maximum of 45 mg, decreased if needed for adverse events to minimum dose of 15 mg",,"Daily at bedtime","24",,,,,,,,,,,"32.5 mg/d","11.8",,"Race and Ethnicity data reported","Community","63.89%","Mixed","rape/sexual assault, community/school violence","High","Schneier FR, Campeas R, Carcamo J, et al. Combined mirtazapine and SSRI treatment of PTSD: a placebo-controlled trial. Depress Anxiety. 2015 Aug;32(8):570-9. doi: 10.1002/da.22384. PMID: 26115513.","44165","2019"
"schneier2015_B","schneier2015","Pharmacotherapy","2015","PTSD","PTSD",,"38","B","20",,"Placebo augmentation","Placebo augmentation","Placebo capsules matching mirtazapine; all patients in both treatment arms also received the SSRI sertraline, initiated at 25 mg/day and titrated up to 200 mg/day.","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","15 to 45 mg mirtazapine equivalent; initiated at 30 mg for 4 weeks, increased as tolerated if continued PTSD symptoms to maximum of 45 mg, decreased if needed for adverse events to minimum dose of 15 mg",,"Daily at bedtime","24",,,,,,,,,,,"36.7 mg/day placebo equivalent to mirtazapine","7.7",,"Race and Ethnicity data reported","Community","63.89%","Mixed","rape/sexual assault, community/school violence","High","Schneier FR, Campeas R, Carcamo J, et al. Combined mirtazapine and SSRI treatment of PTSD: a placebo-controlled trial. Depress Anxiety. 2015 Aug;32(8):570-9. doi: 10.1002/da.22384. PMID: 26115513.","44165","2019"
"schnurr2003_A","schnurr2003","Psychotherapy","2003","PTSD","PTSD",,"360","A","180",,"Trauma-focused group therapy","Trauma-focused cognitive behavioral therapy (TF-CBT)","Exposure-based treatment in a group context following manualized protocol; includes psychoeducation, symptom self-management, coping resource assessment, exposure, cognitive restructuring, relapse prevention, and coping skills training, and exposure homework.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"1.5 to 2 hours","Active treatment: weekly







Booster sessions: monthly","30",,"Completed active treatment",,"additional data: adequate dose, defined as completed ≥80% of weekly sessions, 58.90%; completed active treatment and boosters, 65.55%",,,,,,"Active treatment: 21.77/30; Booster sessions: 3.24/5",,,,"Race data reported","Veteran","0%","Combat-related",,"Low","Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.","23438","2019"
"schnurr2003_B","schnurr2003","Psychotherapy","2003","PTSD","PTSD",,"360","B","180",,"Group PCT","Present-Centered Therapy (PCT)","Group therapy following manualized protocol; includes psychoeducation, connection between PTSD symptoms and difficulties in relationships, problem-solving, specific individual issues, development of plans to deal with issues with interaction of group members for input and feedback, review of experience and progress.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"1.5 hours","Active treatment: weekly







Booster sessions: monthly","30",,"Completed active treatment",,"additional data: adequate dose, defined as completed ≥80% of weekly sessions, 61.70%; completed active treatment and boosters, 75.00%",,,,,,"Active treatment: 23.49/30; Booster sessions: 3.65/5",,,,"Race data reported","Veteran","0%","Combat-related",,"Low","Schnurr PP, Friedman MJ, Foy DW, et al. Randomized trial of trauma-focused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry. 2003 May;60(5):481-9. doi: 10.1001/archpsyc.60.5.481. PMID: 12742869.","23438","2019"
"schnurr2007_A","schnurr2007","Psychotherapy","2007","PTSD","PTSD",,"284","A","141",,"PE","Prolonged Exposure (PE)","Individual therapy delivered according to a manual; treatment included psychoeducation about common reactions to trauma; breathing retraining; imaginal exposure through prolonged (repeated) recounting of trauma memories during sessions; exposure homework, both imaginal (listen to recording of trauma recounting) and in vivo (safe situations avoided due to trauma-related fear); discussion of thoughts and feelings related to exposure exercises.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","10","10 sessions total","completed treatment course",,,,,,"8",,,,,,"Race and Ethnicity data reported","Mixed","100%","Mixed","combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)","Low","Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.","29137","2020"
"schnurr2007_B","schnurr2007","Psychotherapy","2007","PTSD","Active Control",,"284","B","143",,"PCT","Present-Centered Therapy (PCT)","Individual therapy delivered according to a manual, with focus on current life problems as manifestations of PTSD; included psychoeducation about PTSD and treatment rationale; review of general daily difficulties,  with therapist helping patient to identifying daily stresses and discussing in supportive, nondirective mode; reviewing accomplishments made during therapy; and making plans for the future.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Weekly","10","10 sessions total","completed treatment course",,,,,,"9.3",,,,,,"Race and Ethnicity data reported","Mixed","100%","Mixed","combat-related, MST, rape/sexual assault, community/school violence, natural or manmade disasters, illness/medical procedure, accidents, other (sexual trauma, not specified)","Low","Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA. 2007 Feb 28;297(8):820-30. doi: 10.1001/jama.297.8.820. PMID: 17327524.","29137","2020"
"schnurr2013_A","schnurr2013","Collaborative care","2013","PTSD","PTSD",,"195","A","96",,"Three Component Model","Collaborative care","Collaborative care delivered by primary care provider and care manager (psychologist). Treatment at primary care provider's discretion and could include mental health specialty referral. Support calls by care managers until trial end or participant met response criteria (30% reduction in PCL, for those with depression also 50% reduction in PHQ-9 score); calls focused on barriers to adherence, helping to overcome barriers, and measuring treatment response.","No",,"No",,"No",,"No","No","No","No","Yes","Individual","Phone",,"Support calls: 15 minutes","Support calls: weeks 1, 4, and 8, then every 4 weeks","24",,"See Detail",,"Treatment completion not defined. Study assessed process of care outcomes (such as number of mental health visits, antidepressant prescriptions), and reports % of participants receiving high-fidelity, low-fidelity, or no care",,,,,,,,,,"Race and Ethnicity data reported","Veteran","8.72%","Mixed","combat-related, rape/sexual assault, accidents, natural or manmade disaster, community/school violence","Some Concerns","Schnurr PP, Friedman MJ, Oxman TE, et al. RESPECT-PTSD: re-engineering systems for the primary care treatment of PTSD, a randomized controlled trial. J Gen Intern Med. 2013 Jan;28(1):32-40. doi: 10.1007/s11606-012-2166-6. PMID: 22865017.","39174","2019"
"schnurr2013_B","schnurr2013","Collaborative care","2013","PTSD","Inactive Control",,"195","B","99",,"TAU","Treatment as usual (TAU)","Treatment at primary care provider's discretion and could include referral to a mental health specialist.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"26",,,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","8.72%","Mixed","combat-related, rape/sexual assault, accidents, natural or manmade disaster, community/school violence","Some Concerns","Schnurr PP, Friedman MJ, Oxman TE, et al. RESPECT-PTSD: re-engineering systems for the primary care treatment of PTSD, a randomized controlled trial. J Gen Intern Med. 2013 Jan;28(1):32-40. doi: 10.1007/s11606-012-2166-6. PMID: 22865017.","39174","2019"
"schnurr2022_A","schnurr2022","Psychotherapy","2022","PTSD","PTSD",,"916","A","455",,"PE","Prolonged Exposure (PE)","Prolonged Exposure therapy including in vivo exposure, approaching distressing trauma-related situations, places, and people, and remaining until distress is reduced; and imaginal exposure, with repeated revisiting and retelling of traumatic event in detail. Psychoeducation and breathing exercises also included. Flexible protocol, number os sessions adjusted for patient need: 12 weekly sessions planned, participants could finish in 10 or 11 sessions if PCL-5 ≤18 for 2 sessions by session 8. Two additional sessions allowed if PCL-5 ≥38 at session 12.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12","flexible according to patient need; 10-14 sessions total (12 weekly sessions per protocol)","Completion according to study protocol (10 to 14 sessions)",,"Completed standard 12 session protocol: 25.3%",,,,"8.2",,"95% CI 7.8 to 8.6",,,,"Race and Ethnicity data reported","Veteran","20.3%","Mixed","MST; Combat-related; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (life threatening injury; other traumatic event not specified)","Some Concerns","Schnurr PP, Chard KM, Ruzek JI, et al. Comparison of prolonged exposure vs cognitive processing therapy for treatment of posttraumatic stress disorder among US veterans: a randomized clinical trial. JAMA Netw Open. 2022 Jan 4;5(1):e2136921. doi: 10.1001/jamanetworkopen.2021.36921. PMID: 35044471.","1586155","2023"
"schnurr2022_B","schnurr2022","Psychotherapy","2022","PTSD","PTSD",,"916","B","461",,"CPT","Cognitive Processing Therapy (CPT)","Cognitive Processing Therapy including briefly processing trauma by writing accounts of the event, its causes, and impacts, and sessions including dialogue and worksheets to challenge problematic beliefs. Flexible protocol, number os sessions adjusted for patient need: 12 weekly sessions planned, participants could finish in 10 or 11 sessions if PCL-5 ≤18 for 2 sessions by session 8. Two additional sessions allowed if PCL-5 ≥38 at session 12.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","12","flexible according to patient need; 10-14 sessions total (12 weekly sessions per protocol)","Completion according to study protocol (10 to 14 sessions)",,"Completed standard 12 session protocol: 41.0%",,,,"9.1",,"95% CI 8.7 to 9.5",,,,"Race and Ethnicity data reported","Veteran","20.3%","Mixed","MST; Combat-related; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Natural or manmade disasters; Other (life threatening injury; other traumatic event not specified)","Some Concerns","Schnurr PP, Chard KM, Ruzek JI, et al. Comparison of prolonged exposure vs cognitive processing therapy for treatment of posttraumatic stress disorder among US veterans: a randomized clinical trial. JAMA Netw Open. 2022 Jan 4;5(1):e2136921. doi: 10.1001/jamanetworkopen.2021.36921. PMID: 35044471.","1586155","2023"
"schoofs2024_A","schoofs2024","Other study class","2024","PTSD","PTSD",,"40","A","20",,"High intensity interval exercise training (HIIT)","Exercise","High intensity training sessions on an exercise bike with 5 minutes each for warm up and cool down and 20 minutes of exercise with 10 1-minute intervals exceeding 77% heart rate max interspersed with 1-minute intervals of <77% heart rate max; sessions supervised 1:1 with trained study personnel providing HR monitoring and motivation.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","In Person",,"30 minutes","Every other day","1.71","12 days, 6 treatment sessions","Did not drop out during intervention",,,,,,,,,,,,"Not reported","Mixed","80%","Mixed","Child sexual abuse; Child physical abuse; Rape/sexual assault; Community/school violence; Combat-related; Terrorism/political violence/forced displacement; Other (""other incident"")","Low","Schoofs N, Pieper A, Meyer K, Herrmann S, Jäger A, Wülfing F, Grummt M, Wolfarth B, Ströhle A, Priebe K. High-intensity interval training in individuals with posttraumatic stress disorder: A randomized controlled pilot trial. Mental Health and Physical Activity. 2024 Feb 5:100579.","1635628","2024"
"schoofs2024_B","schoofs2024","Other study class","2024","PTSD","Active Control",,"40","B","20",,"Low intensity exercise training (LIT)","Exercise","Low intensity training with mobilization, stretching, and stabilization aerobic exercises with frequency and duration matched to high intensity training intervention and supervision monitoring HR (keeping <70% of HR max).","No",,"No",,"No",,"No","No","Yes","Yes","No","Individual","In Person",,"30 minutes","Every other day","1.71","12 days, 6 treatment sessions","Did not drop out during intervention",,,,,,,,,,,,"Not reported","Mixed","80%","Mixed","Child sexual abuse; Child physical abuse; Rape/sexual assault; Community/school violence; Combat-related; Terrorism/political violence/forced displacement; Other (""other incident"")","Low","Schoofs N, Pieper A, Meyer K, Herrmann S, Jäger A, Wülfing F, Grummt M, Wolfarth B, Ströhle A, Priebe K. High-intensity interval training in individuals with posttraumatic stress disorder: A randomized controlled pilot trial. Mental Health and Physical Activity. 2024 Feb 5:100579.","1635628","2024"
"schoorl2013_A","schoorl2013","Nonpharmacologic cognitive","2013","PTSD","PTSD",,"102","A","48",,"Attention Bias Modification","Attention bias modification (ABM)","200 trials of the Dot-Probe test (80% neutral/trauma-related pairs; 20% neutral/neutral pairs); performed at home on a secured website.","No",,"No",,"No",,"No","Yes","No","No","No","Individual","Technology alone",,"15 to 20 minutes",,"3","8 sessions total","completed the training",,,,,,,,,,,,"Not reported","Community","75.49%","Mixed","other (childhood trauma unspecified, adult trauma unspecified)","Some Concerns","Schoorl M, Putman P, Van Der Does W. Attentional bias modification in posttraumatic stress disorder: a randomized controlled trial. Psychother Psychosom. 2013;82(2):99-105. doi: 10.1159/000341920. PMID: 23295710","41171","2019"
"schoorl2013_B","schoorl2013","Nonpharmacologic cognitive","2013","PTSD","Active Control",,"102","B","54",,"Attention Control Training","Attention bias modification (ABM)","200 trials of the Dot-Probe test (no neutral/neutral pairs), probes appear behind threat and neutral equally; performed at home on a secured website.","No",,"No",,"No",,"No","Yes","Yes","No","No","Individual","Technology alone",,"15 to 20 minutes",,"3","8 sessions total","completed the training",,,,,,,,,,,,"Not reported","Community","75.49%","Mixed","other (childhood trauma unspecified, adult trauma unspecified)","Some Concerns","Schoorl M, Putman P, Van Der Does W. Attentional bias modification in posttraumatic stress disorder: a randomized controlled trial. Psychother Psychosom. 2013;82(2):99-105. doi: 10.1159/000341920. PMID: 23295710","41171","2019"
"schuman2023_A","schuman2023","CIH","2023","PTSD","PTSD",,"35","A","18",,"Heart rate variability (HRV) biofeedback","Biofeedback","Clinical HRV biofeedback training sessions using slow diaphragmatic breathing at personal resonance frequency rate established during first session using Alive Pioneer software and blood volume pulse sensor placed on earlobe. Instructed in home practice using smartphone app.","No",,"No",,"Yes","Relaxation","No","No","No","No","No","Individual","Mixed",,"20 minutes HRV biofeedback training with additional time for education, assessments, review and discussion (~42 to ~85 minutes total/session)","Weekly","4","Initial session + 3 clinical sessions spaced ~1 week apart","See Detail",,"Treatment completion not defined, study completion reported (88.89%, n=16); also states ""Fifteen (83.33%) HRVB participants completed all aspects of the study and these participants all reported continued use of the resonance frequency breathing technique, both with and without feedback""","moderate to high adherence to home practice (at least 50% completed, 245 minutes)","22.22%","n=4 participants",,,"Of n=12 with verified practice: total minutes practiced mean 263.34 (SD 202.25, range 74.21 to 792.17), total number of times device used mean 36.50 (SD 25.55, range 12 to 102)",,,,"Race data reported","Veteran","14.3%","Mixed","MST; Combat-related; Natural or manmade disasters","High","Schuman DL, Lawrence KA, Boggero I, et al. A pilot study of a three-session heart rate variability biofeedback intervention for veterans with posttraumatic stress disorder. Appl Psychophysiol Biofeedback. 2023;48(1):51-65. doi: 10.1007/s10484-022-09565-z. PMID: 36331685.","1604999","2023"
"schuman2023_B","schuman2023","CIH","2023","PTSD","Inactive Control",,"35","B","17",,"Waitlist","Waitlist","Not further described","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Race data reported","Veteran","14.3%","Mixed","MST; Combat-related; Natural or manmade disasters","High","Schuman DL, Lawrence KA, Boggero I, et al. A pilot study of a three-session heart rate variability biofeedback intervention for veterans with posttraumatic stress disorder. Appl Psychophysiol Biofeedback. 2023;48(1):51-65. doi: 10.1007/s10484-022-09565-z. PMID: 36331685.","1604999","2023"
"segal2020_A","segal2020","Nonpharmacologic cognitive","2020","PTSD","PTSD",,"60","A","20",,"Personalized Attention Control Therapy","Attention bias modification (ABM)","Computerized protocol for word-based probe detection, using words rated by patient as most threatening. Each session included 160 trials, 128 including one threat and one neutral word, 32 including two neutral words. Initial central fixation cross shown followed by two words above and below the fixation point. Target letter (probe) 'E' or 'F' then displayed where one of the words had been, until patient identified the target by pressing a button. Faster reaction time for probes appearing in location of threatening word indicates attention bias towards threat.","No",,"No",,"No",,"No","Yes","No","No","No","Individual","In Person",,,"Weekly","6",,"Completed all 6 sessions",,,,,,"6",,"100% of participants completed all 6 sessions; mean 5.7 (SD 0.94) across all groups",,,,"Not reported","Community","65%","Mixed","Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Terrorism/political violence/forced displacement; Other (tragic death of a close relative;  repeated and extreme occupational exposure to aversive details of traumatic events)","Low","Segal A, Pine DS, Bar-Haim Y. Personalized attention control therapy for PTSD: effectiveness and moderators of outcome in a randomized controlled trial. Psychol Med. 2022 Sep;52(12):2365-75. doi: 10.1017/S0033291720004304. PMID: 33231534.","1561826","2024"
"segal2020_B","segal2020","Nonpharmacologic cognitive","2020","PTSD","Active Control",,"60","B","20",,"Non-Personalized Attention Control Therapy","Attention bias modification (ABM)","Computerized protocol for word-based probe detection, using randomly chosen threat words. Each session included 160 trials, 128 including one threat and one neutral word, 32 including two neutral words. Initial central fixation cross shown followed by two words above and below the fixation point. Target letter (probe) 'E' or 'F' then displayed where one of the words had been, until patient identified the target by pressing a button. Faster reaction time for probes appearing in location of threatening word indicates attention bias towards threat.","No",,"No",,"No",,"No","Yes","Yes","No","No","Individual","In Person",,,"Weekly","6",,"Completed all 6 sessions",,,,,,,,"Mean 5.7 (SD 0.94) across all groups",,,,"Not reported","Community","65%","Mixed","Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Terrorism/political violence/forced displacement; Other (tragic death of a close relative;  repeated and extreme occupational exposure to aversive details of traumatic events)","Low","Segal A, Pine DS, Bar-Haim Y. Personalized attention control therapy for PTSD: effectiveness and moderators of outcome in a randomized controlled trial. Psychol Med. 2022 Sep;52(12):2365-75. doi: 10.1017/S0033291720004304. PMID: 33231534.","1561826","2024"
"segal2020_C","segal2020","Nonpharmacologic cognitive","2020","PTSD","Inactive Control",,"60","C","20",,"Placebo training","Attention control","Computerized task with one neutral word presented centrally, followed by a probe also displayed centrally which the patient identified. ""Does not include the essential ingredients thought to drive symptom reduction in [attention control therapy]: exposure to threat content and competition for attentional resources.""","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Weekly","6",,"Completed all 6 sessions",,,,,,,,"Mean 5.7 (SD 0.94) across all groups",,,,"Not reported","Community","65%","Mixed","Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Terrorism/political violence/forced displacement; Other (tragic death of a close relative;  repeated and extreme occupational exposure to aversive details of traumatic events)","Low","Segal A, Pine DS, Bar-Haim Y. Personalized attention control therapy for PTSD: effectiveness and moderators of outcome in a randomized controlled trial. Psychol Med. 2022 Sep;52(12):2365-75. doi: 10.1017/S0033291720004304. PMID: 33231534.","1561826","2024"
"sele2023_A","sele2023","Psychotherapy","2023","PTSD","PTSD",,"99","A","31","n=33 randomized, 2 excluded (no longer eligible at start of treatment)","STAIR Narrative Therapy","Skills Training in Affect and Interpersonal Regulation (STAIR) followed by Narrative Exposure Therapy (NET)","STAIR followed by narrative therapy.
STAIR: group version provided by two therapists, ""adapted from the original individual protocol by the treatment developers."" Study-specific elements added: residential staff support and encourage participants to complete homework, and non-protocol individual therapy sessions added (without trauma-focused intervention).
Narrative therapy: individual exposure sessions with ""imaginal reliving of trauma memories and cognitive restructuring of trauma-generated beliefs."" Staff could also help with homework for narrative therapy.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Mixed","In Person",,"STAIR group: 90 minutes
STAIR individual: 45 minutes
Narrative therapy: 60 minutes","STAIR group: NR
STAIR individual: weekly
Narrative therapy: NR","16","STAIR group: 12 sessions over 10 weeks 
Narrative therapy: 8 sessions over 6 weeks","Did not drop out of treatment",,"n=30 started treatment, 2 dropped out during treatment (28/31 for treatment completion)",,,,,,"Overall: NR
STAIR group: NR
STAIR individual: mean 12.0 (SD 2.9)
Narrative therapy: mean 7.1 (SD 2.1)",,,,"Race and Ethnicity data reported","Community","80.4%","Mixed","Child physical abuse; Child sexual abuse; Child other abuse","Low","Sele P, Hoffart A, Cloitre M, et al. Comparing phase-based treatment, prolonged exposure, and skills-training for complex posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2023 Dec;100:102786. doi: 10.1016/j.janxdis.2023.102786. PMID: 37871452.","1626426","2024"
"sele2023_B","sele2023","Psychotherapy","2023","PTSD","Active Control",,"99","B","31","n=33 randomized, 2 excluded (no longer eligible at start of treatment)","STAIR","Skills Training in Affect and Interpersonal Regulation (STAIR)","STAIR in same format and content as in STAIR narrative therapy arm.
Group version of STAIR provided by two therapists, ""adapted from the
original individual protocol by the treatment developers."" Study-specific elements added: residential staff support and encourage participants to complete homework, and non-protocol individual therapy sessions added (without trauma-focused intervention).","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Mixed","In Person",,"STAIR group: 90 minutes
STAIR individual: 45 minutes","STAIR group: NR
STAIR individual: weekly","10","STAIR group: 12 sessions over 10 weeks","Did not drop out of treatment",,"n=30 started treatment, none dropped out during treatment (30/31 for treatment completion)",,,,,,"Overall: NR
Group: NR
Individual: mean 14.5 (SD 1.2)",,,,"Race and Ethnicity data reported","Community","80.4%","Mixed","Child physical abuse; Child sexual abuse; Child other abuse","Low","Sele P, Hoffart A, Cloitre M, et al. Comparing phase-based treatment, prolonged exposure, and skills-training for complex posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2023 Dec;100:102786. doi: 10.1016/j.janxdis.2023.102786. PMID: 37871452.","1626426","2024"
"sele2023_C","sele2023","Psychotherapy","2023","PTSD","Active Control",,"99","C","37",,"PE","Prolonged Exposure (PE)","Standard PE protocol with flexible number of treatment sessions; some modifications to ""strengthen"" the core components. Treatment involves repeated imaginal exposure to traumatic memories and in vivo exposure to avoided stimuli. Study-specific elements added: contact nurse present for some imaginal exposure sessions, and optionally for in vivo sessions. Residential staff also support and encourage participants to complete homework.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes",,"10","Flexible number of sessions (8 to 16)","Did not drop out of treatment",,"n=32 started treatment, 2 dropped out during treatment (30/37 for treatment completion)",,,,"12.1","2.37",,,,,"Race and Ethnicity data reported","Community","80.4%","Mixed","Child physical abuse; Child sexual abuse; Child other abuse","Low","Sele P, Hoffart A, Cloitre M, et al. Comparing phase-based treatment, prolonged exposure, and skills-training for complex posttraumatic stress disorder: a randomized controlled trial. J Anxiety Disord. 2023 Dec;100:102786. doi: 10.1016/j.janxdis.2023.102786. PMID: 37871452.","1626426","2024"
"seo2010_A","seo2010","Pharmacotherapy","2010","PTSD","PTSD",,"40","A","20",,"Mirtazapine","Mirtazapine","Atypical antidepressant; could be titrated upward after second visit at clinician's discretion","No",,"Yes","Antidepressant: Other","No",,"No","No","No","No","No","Individual","In Person","Initiated at 15 mg, titrated to maximum 60 mg",,"Daily","8",,,,,,,,,,,,,,"Not reported","Community","70%","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing accident)","Some Concerns","Seo H-J, Jung Y-E, Bahk W-M, et al. A comparison of mirtazapine and paroxetine for the treatment of patients with posttraumatic stress disorder: a randomized open-label trial. Clin Psychopharmacol Neurosci. 2010;8(2):84-9.","35572","2019"
"seo2010_B","seo2010","Pharmacotherapy","2010","PTSD","PTSD",,"40","B","20",,"Paroxetine","Paroxetine","SSRI antidepressant; could be titrated upward after second visit at clinician's discretion","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","Initiated at 10 mg, titrated to maximum 60 mg",,"Daily","8",,,,,,,,,,,,,,"Not reported","Community","70%","Mixed","rape/sexual assault, accidents, community/school violence, other (witnessing accident)","Some Concerns","Seo H-J, Jung Y-E, Bahk W-M, et al. A comparison of mirtazapine and paroxetine for the treatment of patients with posttraumatic stress disorder: a randomized open-label trial. Clin Psychopharmacol Neurosci. 2010;8(2):84-9.","35572","2019"
"shapiro2015_A","shapiro2015","Psychotherapy","2015","PTSD","PTSD",,"17","A","8",,"EMDR for Recent Trauma Episode","Eye Movement Desensitization and Reprocessing (EMDR)","Brief EMDR (2 to 4 sessions), consisting of an adaptation of EMDR and Recent Event protocols","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Once daily","0.29",,"See Detail",,"all ""received treatment"", no dropouts reported, no information on treatment completion specifically",,,,,,,,,,"Not reported","Community","94.1%","Terrorism/political violence/forced displacement",,"High","Shapiro E, Laub B. Early EMDR intervention following a community critical incident: a randomized clinical trial. Journal of EMDR Practice and Research. 2015 Feb;9(1):17-27. doi: 10.1891/1933-3196.9.1.17.","47811","2019"
"shapiro2015_B","shapiro2015","Psychotherapy","2015","PTSD","Inactive Control",,"17","B","9",,"Waitlist/Delayed Treatment","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Not reported","Community","94.1%","Terrorism/political violence/forced displacement",,"High","Shapiro E, Laub B. Early EMDR intervention following a community critical incident: a randomized clinical trial. Journal of EMDR Practice and Research. 2015 Feb;9(1):17-27. doi: 10.1891/1933-3196.9.1.17.","47811","2019"
"shea2023_A","shea2023","Psychotherapy","2023","PTSD","PTSD",,"115","A","58",,"Interpersonal psychotherapy (IPT)","Interpersonal Psychotherapy (IPT)","IPT for PTSD manualized treatment; IPT is a psychotherapy focusing on interpersonal connection and social support, and problem areas including role disputes, role transitions, grief, and interpersonal deficits.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"50 minutes","Weekly","12","early completion allowed with sufficient improvement and agreement with therapist","Completing ≥10 sessions or early completer (sufficient improvement and agreement with therapist)",,"Completing ≥10 sessions: 63.9%
Completed ≥8 sessions (minimum therapeutic dose): 73.8%",,,,"9.8","3.4","Unclear if reported for overall or only participants who started treatment",,,,"Race and Ethnicity data reported","Veteran","5%","Mixed","Combat-related; Rape/sexual assault","High","Shea MT, Krupnick JL, Sautter FJ, et al. A randomized clinical trial comparing Interpersonal Psychotherapy with Prolonged Exposure for the treatment of PTSD in veterans. J Anxiety Disord. 2023 Oct;99:102770. doi: 10.1016/j.janxdis.2023.102770. PMID: 37738685.","30172","2024"
"shea2023_B","shea2023","Psychotherapy","2023","PTSD","PTSD",,"115","B","51",,"Prolonged exposure (PE)","Prolonged Exposure (PE)","Manualized PE following standard manual used throughout the VA system, but delivered in 12 sessions; treatment includes imaginal exposure and in vivo exposure, and participants were ""assigned homework to listen to session recordings daily and implement in vivo exposures"".","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12","early completion allowed with sufficient improvement and agreement with therapist","Completing ≥10 sessions or early completer (sufficient improvement and agreement with therapist)",,"Completing ≥10 sessions: 38.9%
Completed ≥8 sessions (minimum therapeutic dose): 44.4%",,,,"7.1","4.2","Unclear if reported for overall or only participants who started treatment",,,,"Race and Ethnicity data reported","Veteran","5%","Mixed","Combat-related; Rape/sexual assault","High","Shea MT, Krupnick JL, Sautter FJ, et al. A randomized clinical trial comparing Interpersonal Psychotherapy with Prolonged Exposure for the treatment of PTSD in veterans. J Anxiety Disord. 2023 Oct;99:102770. doi: 10.1016/j.janxdis.2023.102770. PMID: 37738685.","30172","2024"
"shemesh2011_A","shemesh2011","Psychotherapy","2011","PTSD","PTSD",,"60","A","30",,"CBT using imaginal exposure","Imaginal exposure","Trauma-focused CBT with imaginal exposure following manual; differs from commonly used CBT for trauma by: no homework or in vivo exposure; fewer number of sessions; therapy delivered on premises of cardiology clinic.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,,,"3 to 5 sessions total","received full course of CBT",,,,,,,,"median 3",,,,"Not reported","Community","33.33%","Illness/medical procedure",,"High","Shemesh E, Annunziato RA, Weatherley BD, et al. A randomized controlled trial for the safety and promise of cognitive-behavioral therapy using imaginal exposure in patients with posttraumatic stress disorder resulting from cardiovascular illness. J Clin Psychiatry. 2011 Feb;72(2):168-74. doi: 10.4088/JCP.09m05116blu. PMID: 20441725","34244","2019"
"shemesh2011_B","shemesh2011","Psychotherapy","2011","PTSD","Inactive Control",,"60","B","30",,"Control","Education","Educational sessions discussing adherence to medical regimen.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,,"1 to 3 sessions total","received intervention",,,,,,,,"median 2",,,,"Not reported","Community","33.33%","Illness/medical procedure",,"High","Shemesh E, Annunziato RA, Weatherley BD, et al. A randomized controlled trial for the safety and promise of cognitive-behavioral therapy using imaginal exposure in patients with posttraumatic stress disorder resulting from cardiovascular illness. J Clin Psychiatry. 2011 Feb;72(2):168-74. doi: 10.4088/JCP.09m05116blu. PMID: 20441725","34244","2019"
"shestatsky1988_A","shestatsky1988","Pharmacotherapy","1988","PTSD","PTSD",,"13","A","13","7 in first period","Phenelzine","Phenelzine","MAOI antidepressant, titrated to maximum tolerated dosage; 1st period 5 weeks, washout 2 weeks, 2nd period 5 weeks","No",,"Yes","Antidepressant: MAOI","No",,"No","No","No","No","No","Individual","In Person","Initiated at 30 mg, titrated to maximum 90 mg",,"Daily","5",,,,,,,,,,,"66",,,"Not reported","Mixed",,"Mixed","combat-related, accidents, terrorism/political violence/forced displacement, other (accident with death of son)","High","Shestatsky M, Greenberg D, Lerer B. A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res. 1988 May;24(2):149-55. doi: 10.1016/0165-1781(88)90057-1. PMID: 3406235.","00758","2019"
"shestatsky1988_B","shestatsky1988","Pharmacotherapy","1988","PTSD","Inactive Control",,"13","B","13","6 in first period","Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","5",,,,,,,,,,,,,,"Not reported","Mixed",,"Mixed","combat-related, accidents, terrorism/political violence/forced displacement, other (accident with death of son)","High","Shestatsky M, Greenberg D, Lerer B. A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res. 1988 May;24(2):149-55. doi: 10.1016/0165-1781(88)90057-1. PMID: 3406235.","00758","2019"
"simon2008_A","simon2008","Psychotherapy & pharmacotherapy","2008","PTSD","PTSD",,"25","A","11",,"PE + paroxetine controlled release","Prolonged Exposure (PE) + paroxetine","Trauma-focused CBT plus SSRI; 5 additional sessions of PE augmented with addition of controlled release paroxetine. (Participants randomized after Phase I if SPRINT ≥6 or CGI-S ≥3 after eight 90- to 120-minute individual PE sessions over a 4- to 6-week period).","Yes","Trauma-focused","Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","Session length: 90 to 120 minutes







Dose: 12.5 to 62.5 mg; titration: flexible dose initiated at 12.5 mg titrated up to maximum dose of 62.5 mg based on efficacy and tolerability",,"Psychotherapy: every 2 weeks







Paroxetine: daily","10",,"See Detail",,"parrticipants randomized only after completion of phase I (PE intervention)",,,,,,,"45.8 mg/day","16.5",,"Race and Ethnicity data reported","Community","56.52%","Mixed","rape/sexual assault, intimate partner violence, accidents, illness/medical procedure, other (exposure to war)","Some Concerns","Simon NM, Connor KM, Lang AJ, et al. Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy. J Clin Psychiatry. 2008 Mar;69(3):400-5. PMID: 18348595.","30521","2019"
"simon2008_B","simon2008","Psychotherapy & pharmacotherapy","2008","PTSD","Active Control",,"25","B","14",,"PE + placebo","Prolonged Exposure (PE) + placebo","Trauma-focused CBT plus placebo; 5 additional sessions of PE augmented with addition of matched pill placebo. (Participants randomized after Phase I if SPRINT ≥6 or CGI-S ≥3 after eight 90- to 120-minute individual PE sessions over a 4- to 6-week period).","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person","Session length: 90 to 120 minutes







Dose: equivalent to 12.5 to 62.5 mg paroxetine controlled release; titration: flexible dose initiated at 12.5 mg titrated up to maximum dose of 62.5 mg based on efficacy and tolerability",,"Psychotherapy: once every 2 weeks







Placebo: daily","10",,"See Detail",,"parrticipants randomized only after completion of phase I (PE intervention)",,,,,,,"44.8 mg equivalent to paroxetine controlled release","15.5",,"Race and Ethnicity data reported","Community","56.52%","Mixed","rape/sexual assault, intimate partner violence, accidents, illness/medical procedure, other (exposure to war)","Some Concerns","Simon NM, Connor KM, Lang AJ, et al. Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy. J Clin Psychiatry. 2008 Mar;69(3):400-5. PMID: 18348595.","30521","2019"
"simpson2022_A","simpson2022","Psychotherapy","2022","PTSD","SUD","Not integrated","101","A","38",,"Relapse prevention (RP)","Relapse Prevention","12-session CBT program focusing on self-monitoring and coping skills to address high-risk drinking and can address PTSD-related triggers","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Once or twice per week","20","12 sessions could be completed in 6-20 weeks","Attending 9-12 sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","56%","Mixed","Combat-related; Rape/sexual assault; Community/school violence; Other (""traumatic loss"", ""another trauma type"")","Low","Simpson TL, Kaysen DL, Fleming CB, et al. Cognitive processing therapy or relapse prevention for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. PLoS One. 2022;17(11):e0276111. doi: 10.1371/journal.pone.0276111. PMID: 36445895.","1613818","2023"
"simpson2022_B","simpson2022","Psychotherapy","2022","PTSD","PTSD","Not integrated","101","B","41",,"CPT","Cognitive Processing Therapy (CPT)","12-session cognitive processing therapy without trauma narratives","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Once or twice per week","20","12 sessions could be completed in 6-20 weeks","Attending 9-12 sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","56%","Mixed","Combat-related; Rape/sexual assault; Community/school violence; Other (""traumatic loss"", ""another trauma type"")","Low","Simpson TL, Kaysen DL, Fleming CB, et al. Cognitive processing therapy or relapse prevention for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. PLoS One. 2022;17(11):e0276111. doi: 10.1371/journal.pone.0276111. PMID: 36445895.","1613818","2023"
"simpson2022_C","simpson2022","Psychotherapy","2022","PTSD","Inactive Control","Not integrated","101","C","22",,"Assessment only (AO)","Assessment","Brief 15-minute weekly support/safety calls with study therapist","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Phone",,"15 minutes","Weekly","6","post-treatment assessment at 6 week post-baseline",,,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","56%","Mixed","Combat-related; Rape/sexual assault; Community/school violence; Other (""traumatic loss"", ""another trauma type"")","Low","Simpson TL, Kaysen DL, Fleming CB, et al. Cognitive processing therapy or relapse prevention for comorbid posttraumatic stress disorder and alcohol use disorder: a randomized clinical trial. PLoS One. 2022;17(11):e0276111. doi: 10.1371/journal.pone.0276111. PMID: 36445895.","1613818","2023"
"sloan2004_A","sloan2004","Psychotherapy","2004","PTSD","PTSD",,"51","A","28",,"Written emotional disclosure","Written narrative exposure","Participants instructed to write about most traumatic/distressing experience of their lives with as much emotion and feeling as possible; in second and third sessions, could write about same or different experience.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Written",,"20 minutes","Daily","0.43",,"completed all writing sessions",,,,,,"3",,,,,,"Race data reported","Community","100%","Mixed","rape/sexual assault, accidents, child sexual abuse, community/school violence, other (witness to murder)","High","Sloan DM, Marx BP. A closer examination of the structured written disclosure procedure. J Consult Clin Psychol. 2004 Apr;72(2):165-75. doi: 10.1037/0022-006X.72.2.165. PMID: 15065952.","28170","2019"
"sloan2004_B","sloan2004","Psychotherapy","2004","PTSD","Inactive Control",,"51","B","23",,"Control writing condition","Control writing","Participants instructed to write about how they spent their time without describing any emotion or opinions, in as much detail as possible.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Written",,"20 minutes","Daily","0.43",,"completed all 3 writing sessions",,,,,,"3",,,,,,"Race data reported","Community","100%","Mixed","rape/sexual assault, accidents, child sexual abuse, community/school violence, other (witness to murder)","High","Sloan DM, Marx BP. A closer examination of the structured written disclosure procedure. J Consult Clin Psychol. 2004 Apr;72(2):165-75. doi: 10.1037/0022-006X.72.2.165. PMID: 15065952.","28170","2019"
"sloan2007_A","sloan2007","Psychotherapy","2007","PTSD","PTSD",,"85","A","28",,"Written disclosure focused on emotional expression","Written narrative exposure","Participants instructed to write about most traumatic experience of their lives with as much emotion and feeling as possible; participant asked to write about the same experience at each writing session.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Written",,"20 minutes","Daily","0.43",,"Completed all 3 writing sessions",,"Overall 98.82%, not reported by arm",,,,,,,,,,"Race data reported","Community","80.49%","Mixed","rape/sexual assault, community/school violence, accidents, other (witness to murder)","Some Concerns","Sloan DM, Marx BP, Epstein EM, et al. Does altering the writing instructions influence outcome associated with written disclosure? Behav Ther. 2007 Jun;38(2):155-68. doi: 10.1016/j.beth.2006.06.005. PMID: 17499082.","32045","2019"
"sloan2007_B","sloan2007","Psychotherapy","2007","PTSD","Active Control",,"85","B","27",,"Written disclosure focused on insight and cognitive assimilation","Written narrative exposure","Participants instructed to write about most traumatic experience of their lives with a focus on what the event has meant to them, how the event changed their lives (both good and bad), and challenge their dissonant thoughts about the event; asked to write about the same experience at each writing session.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","Written",,"20 minutes","Daily","0.43",,"Completed all 3 writing sessions",,"Overall 98.82%, not reported by arm",,,,,,,,,,"Race data reported","Community","80.49%","Mixed","rape/sexual assault, community/school violence, accidents, other (witness to murder)","Some Concerns","Sloan DM, Marx BP, Epstein EM, et al. Does altering the writing instructions influence outcome associated with written disclosure? Behav Ther. 2007 Jun;38(2):155-68. doi: 10.1016/j.beth.2006.06.005. PMID: 17499082.","32045","2019"
"sloan2007_C","sloan2007","Psychotherapy","2007","PTSD","Inactive Control",,"85","C","27",,"Control writing condition","Control writing","Participants instructed to write about how they spent their time without describing any emotion or opinions.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Written",,"20 minutes","Daily","0.43",,"Completed all 3 writing sessions",,"Overall 98.82%, not reported by arm",,,,,,,,,,"Race data reported","Community","80.49%","Mixed","rape/sexual assault, community/school violence, accidents, other (witness to murder)","Some Concerns","Sloan DM, Marx BP, Epstein EM, et al. Does altering the writing instructions influence outcome associated with written disclosure? Behav Ther. 2007 Jun;38(2):155-68. doi: 10.1016/j.beth.2006.06.005. PMID: 17499082.","32045","2019"
"sloan2011_A","sloan2011","Psychotherapy","2011","PTSD","PTSD",,"47","A","24",,"Written emotional disclosure","Written narrative exposure","Procedure following Pennebaker 1997; participants were asked to write about the most traumatic experience of their lives with as much emotion and feeling as possible; asked to write about the same traumatic experience at each session.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Written",,"20 minutes","Daily","0.43",,"completed treatment course",,,,,,,,,,,,"Race and Ethnicity data reported","Community",,"Mixed","rape/sexual assault, community/school violence, accidents, combat-related, other (witness to a murder)","High","Sloan DM, Marx BP, Greenberg EM. A test of written emotional disclosure as an intervention for posttraumatic stress disorder. Behav Res Ther. 2011 Apr;49(4):299-304. doi: 10.1016/j.brat.2011.02.001. PMID: 21367400.","36171","2019"
"sloan2011_B","sloan2011","Psychotherapy","2011","PTSD","Inactive Control",,"47","B","23",,"Control writing condition","Control writing","Procedure following Pennebaker 1997; participants were asked to write about how they spent their time each day without describing any emotion or opinions.","No",,"No",,"No",,"No","No","Yes","No","No","Individual",,,"20 minutes","Daily","0.43",,"completed treatment course",,,,,,,,,,,,"Race and Ethnicity data reported","Community",,"Mixed","rape/sexual assault, community/school violence, accidents, combat-related, other (witness to a murder)","High","Sloan DM, Marx BP, Greenberg EM. A test of written emotional disclosure as an intervention for posttraumatic stress disorder. Behav Res Ther. 2011 Apr;49(4):299-304. doi: 10.1016/j.brat.2011.02.001. PMID: 21367400.","36171","2019"
"sloan2012_A","sloan2012","Psychotherapy","2012","PTSD","PTSD",,"46","A","22",,"Written exposure therapy","Written Exposure Therapy (WET)","Exposure through writing about the same motor vehicle accident each session. Initial session focused on describing the event in detail and delving into deepest emotions and thoughts at the time of the accident; remaining sessions focused on most distressing part of the event (""hot spot""), and how it had affected participant's life. The therapist read writing instructions and answered questions; participants were left alone in the room for the writing exercise; therapists addressed concerns at the end of the writing exercise, checked that instructions were followed, and instructed participant to allow experiencing of trauma-related memories, images, thoughts, or feelings in between sessions.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour (first session), 40 minutes (remaining 4 sessions); writing exercises 30 minutes per session","Weekly","5",,"completed all 5 treatment sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Community","65%","Accidents",,"Low","Sloan DM, Marx BP, Bovin MJ, et al. Written exposure as an intervention for PTSD: a randomized clinical trial with motor vehicle accident survivors. Behav Res Ther. 2012 Oct;50(10):627-35. doi: 10.1016/j.brat.2012.07.001. PMID: 22863540.","39268","2019"
"sloan2012_B","sloan2012","Psychotherapy","2012","PTSD","Inactive Control",,"46","B","24",,"Waitlist","Waitlist","Participants encouraged to contact project coordinator any time if experiencing problems; contacted prior to followup assessments for reminder and to make sure they had not experienced a substantial increase in PTSD symptom severity. Participants were offered written exposure therapy after the 18-week assessment was completed.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"18",,,,,,,,,,,,,,"Race and Ethnicity data reported","Community","65%","Accidents",,"Low","Sloan DM, Marx BP, Bovin MJ, et al. Written exposure as an intervention for PTSD: a randomized clinical trial with motor vehicle accident survivors. Behav Res Ther. 2012 Oct;50(10):627-35. doi: 10.1016/j.brat.2012.07.001. PMID: 22863540.","39268","2019"
"sloan2018a_A","sloan2018a","Psychotherapy","2018","PTSD","PTSD",,"126","A","63",,"Written exposure therapy","Written Exposure Therapy (WET)","Patients instructed to write about a specific traumatic event, focusing on details of the event and the thoughts and feelings that occurred during the event, for 30 minutes each session; no assignments between sessions.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes (initial session); 40 minutes (remaining 4 sessions)","Weekly","5",,"received written exposure therapy as randomized",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","47.62%","Mixed","combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence","Low","Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.","49592","2020"
"sloan2018a_B","sloan2018a","Psychotherapy","2018","PTSD","PTSD",,"126","B","63",,"CPT","Cognitive Processing Therapy (CPT)","Trauma-focused therapy; patients taught to recognize and challenge dysfunctional cognitions about their traumatic event and current thoughts about themselves, others, and the world; write 2 trauma accounts (at home) including sensory details, thoughts, and feelings associated with the trauma then read the account daily until the next session; additional between-session assignments given after each session.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","12",,"received CPT as randomized",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","47.62%","Mixed","combat-related, rape/sexual assault, child sexual abuse, child physical abuse, accidents, community/school violence","Low","Sloan DM, Marx BP, Lee DJ, et al. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-9. doi: 10.1001/jamapsychiatry.2017.4249. PMID: 29344631.","49592","2020"
"sloan2018b_A","sloan2018b","Psychotherapy","2018","PTSD","PTSD",,"198","A","98",,"Group CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Group cognitive-behavioral intervention focused on trauma. Includes in vivo, written, and imaginal exposure, progressive muscle relaxation, cognitive restructuring, and behavioral activation. Between-session practice (homework) emphasized.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"2 hours","Approximately weekly (14 sessions over 16 weeks)","16",,"attended ≥10 of 14 sessions",,,,,,,,,,,,"Race data reported","Veteran","0%","Mixed","Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one)","Low","Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.","51291","2020"
"sloan2018b_B","sloan2018b","Psychotherapy","2018","PTSD","Active Control",,"198","B","100",,"Group PCT","Present-Centered Therapy (PCT)","Core components of present-centered treatment include psychoeducation, peer support, and  peer-facilitated problem solving. No trauma-focused work or clinician instruction in skill development. Weekly home therapy assignments.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Group","In Person",,"2 hours","Approximately weekly (14 sessions over 16 weeks)","16",,"attended ≥10 of 14 sessions",,,,,,,,,,,,"Race data reported","Veteran","0%","Mixed","Combat-related; Child physical abuse; Child sexual abuse; Rape/sexual assault; Accidents; Community/school violence; Other (death or trauma to friend or loved one)","Low","Sloan DM, Unger W, Lee DJ, et al. A randomized controlled trial of group cognitive behavioral treatment for veterans diagnosed with chronic posttraumatic stress disorder. J Trauma Stress. 2018b Dec;31(6):886-98. doi: 10.1002/jts.22338. PMID: 30499227.","51291","2020"
"sloan2022_A","sloan2022","Psychotherapy","2022","PTSD","PTSD",,"169","A","84",,"CPT","Cognitive Processing Therapy (CPT)","CPT: trauma-focused therapy in which patients are taught to recognize and challenge dysfunctional cognitions about their traumas and current thoughts about themselves, others, and the world. Delivered in 12 one-hour sessions held twice per week.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Twice per week","6","12 total sessions","Completed all treatment sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Active Duty Military","19.5%",,,"Some Concerns","Sloan DM, Marx BP, Resick PA, et al. Effect of written exposure therapy vs cognitive processing therapy on increasing treatment efficiency among military service members with posttraumatic stress disorder: a randomized noninferiority trial. JAMA Netw Open. 2022 Jan 4;5(1):e2140911. doi: 10.1001/jamanetworkopen.2021.40911. PMID: 35015065.","1586434","2023"
"sloan2022_B","sloan2022","Psychotherapy","2022","PTSD","PTSD",,"169","B","85",,"WET","Written Exposure Therapy (WET)","WET: psychoeducation and writing sessions in which participant writes about their trauma for 30 minutes with brief check ins by therapist after writing to determine challenges. Consisted of 5 sessions; no between-session assignments.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"45-60 minutes (first session 60 minutes, remaining 4 sessions 45 minutes)","Weekly","5","5 total sessions","Completed all treatment sessions",,,,,,,,,,,,"Race and Ethnicity data reported","Active Duty Military","19.5%",,,"Some Concerns","Sloan DM, Marx BP, Resick PA, et al. Effect of written exposure therapy vs cognitive processing therapy on increasing treatment efficiency among military service members with posttraumatic stress disorder: a randomized noninferiority trial. JAMA Netw Open. 2022 Jan 4;5(1):e2140911. doi: 10.1001/jamanetworkopen.2021.40911. PMID: 35015065.","1586434","2023"
"sloan2023_A","sloan2023","Psychotherapy","2023","PTSD","PTSD",,"178","A","88",,"Written exposure therapy (WET)","Written Exposure Therapy (WET)","WET delivered in person or through video conferencing at participant's preference. Treatment consists of sessions during which participants write about a specific trauma event. Initial session for psychoeducation and treatment rationale; subsequent sessions included 30 minutes of writing-based imaginal exposure and therapist feedback on prior written narrative. Initial sessions include writing details of index trauma and resulting thoughts and feelings; in later sessions participants discuss effect of event on their lives. Participants had no between-treatment assignments. An additional 1-2 sessions were allowed to be added by the therapist to ensure adequate exposure to the trauma memory; there was no option to end treatment early (before session 5).","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Mixed",,"45 minutes (first session 60 minutes)","Weekly","5 to 7","5 sessions minimum, study therapist had option for 1-2 additional sessions","Did not drop out prior to completion",,,,,,"6.18","0.87","Among completers",,,,"Race and Ethnicity data reported","Veteran","24.7%","Mixed","MST; Combat-related; Rape/sexual assault; Accidents; Community/school violence; Other (sudden violent death)","Low","Sloan DM, Marx BP, Acierno R, et al. Written exposure therapy vs prolonged exposure therapy in the treatment of posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2023 Nov 1;80(11):1093-100. doi: 10.1001/jamapsychiatry.2023.2810. PMID: 37610727.","1624550","2024"
"sloan2023_B","sloan2023","Psychotherapy","2023","PTSD","PTSD",,"178","B","90",,"Prolonged exposure therapy (PE)","Prolonged Exposure (PE)","Exposure-based treatment delivered in person or through video conferencing at participant's preference; sessions included 40 minutes of in-session imaginal exposure and between-session in vivo exposures."" Imaginal exposure focuses on most distressing traumatic event; in vivo exercises require exposure to people, places and situations related to index trauma. Early completion was allowed at ≥8 sessions if participant score <33 on PCL-5 for at least 2 consecutive sessions and both therapist and participant agreed additional sessions were not necessary.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Mixed",,"90 minutes","Weekly","8 to 15","8 to 15 sessions total","Did not drop out prior to completion",,,,,,"12.48","2.31","Among completers",,,,"Race and Ethnicity data reported","Veteran","24.7%","Mixed","MST; Combat-related; Rape/sexual assault; Accidents; Community/school violence; Other (sudden violent death)","Low","Sloan DM, Marx BP, Acierno R, et al. Written exposure therapy vs prolonged exposure therapy in the treatment of posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2023 Nov 1;80(11):1093-100. doi: 10.1001/jamapsychiatry.2023.2810. PMID: 37610727.","1624550","2024"
"smaik2023_A","smaik2023","Psychotherapy","2023","PTSD","PTSD",,"40","A","20",,"Narrative exposure therapy (NET)","Narrative Exposure Therapy (NET)","Short-term, trauma-focused cognitive behavioral therapy, with the goal to ""contextualize the sensory, affective, and cognitive memories of
trauma within the client’s life course""; NET protocol of this study followed Schauer, Elbert, and Neuner guidelines.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60-120 minutes","Weekly","10",,"Completing all 10 sessions",,,,,,"10",,"All subjects completed all 10 sessions",,,,"Not reported","Community","75%","Mixed","Terrorism/political violence/forced displacement; Other (""seeing the deformed body of a relative""; ""witnessing or experiencing torture"")","High","Smaik N, Simmons LA, Abdulhaq B, et al. The feasibility and preliminary efficacy of narrative exposure therapy on post-traumatic stress disorder among Syrian refugees in Jordan. Int J Nurs Sci. 2023 Oct;10(4):518-26. doi: 10.1016/j.ijnss.2023.09.007. PMID: 38020837.","30180","2024"
"smaik2023_B","smaik2023","Psychotherapy","2023","PTSD","Inactive Control",,"40","B","20",,"Waitlist","Waitlist","Waiting list participants received an educational lecture about positive child-rearing practices, but no active treatment.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"10",,,,,,,,,,,,,,"Not reported","Community","75%","Mixed","Terrorism/political violence/forced displacement; Other (""seeing the deformed body of a relative""; ""witnessing or experiencing torture"")","High","Smaik N, Simmons LA, Abdulhaq B, et al. The feasibility and preliminary efficacy of narrative exposure therapy on post-traumatic stress disorder among Syrian refugees in Jordan. Int J Nurs Sci. 2023 Oct;10(4):518-26. doi: 10.1016/j.ijnss.2023.09.007. PMID: 38020837.","30180","2024"
"smajkic2001_A","smajkic2001","Pharmacotherapy","2001","PTSD","PTSD",,"40","A","15",,"Sertraline","Sertraline","SSRI antidepressant, initiated at 50 mg, dose increased to 100 mg after 14 days based on tolerability","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","Initiated at 50 mg, titrated to 100 mg",,"Once daily","6",,,,,,,,,,,,,,"Not reported","Community","56.25%","Terrorism/political violence/forced displacement",,"High","Smajkic A, Weine SM, Djuric-Bijedic Z, et al. Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms. J Trauma. Stress. 2001 Jul;14(3):445-52. doi: 10.1023/A:1011177420069. PMID: 11534876.","16085","2019"
"smajkic2001_B","smajkic2001","Pharmacotherapy","2001","PTSD","PTSD",,"40","B","12",,"Paroxetine","Paroxetine","SSRI antidepressant, dose maintained after 14 days if tolerated","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","20 mg",,"Once daily","6",,,,,,,,,,,,,,"Not reported","Community","56.25%","Terrorism/political violence/forced displacement",,"High","Smajkic A, Weine SM, Djuric-Bijedic Z, et al. Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms. J Trauma. Stress. 2001 Jul;14(3):445-52. doi: 10.1023/A:1011177420069. PMID: 11534876.","16085","2019"
"smajkic2001_C","smajkic2001","Pharmacotherapy","2001","PTSD","PTSD",,"40","C","13",,"Venlafaxine","Venlafaxine","SNRI antidepressant, initiated at 37.5 mg, dose increased to 75 mg after 14 days based on tolerability","No",,"Yes","Antidepressant: SNRI","No",,"No","No","No","No","No","Individual","In Person","Initiated at 37.5 mg, titrated to 75 mg",,"Twice daily","6",,,,,,,,,,,,,,"Not reported","Community","56.25%","Terrorism/political violence/forced displacement",,"High","Smajkic A, Weine SM, Djuric-Bijedic Z, et al. Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms. J Trauma. Stress. 2001 Jul;14(3):445-52. doi: 10.1023/A:1011177420069. PMID: 11534876.","16085","2019"
"smyth2008_A","smyth2008","Psychotherapy","2008","PTSD","PTSD",,"25","A","15",,"Expressive writing","Written narrative exposure","Participants write about traumatic event, it's effect on their thoughts, feelings, and sensations, and the rationality of their negative beliefs; three 20-minute writing sessions with 15-minute rest interval between sessions","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Written",,"20 minutes","Once (all sessions in single day)","0.14","3 sessions in 1 day","Completed intervention",,"adherence, defined as ""completed the expermental manipulation""",,,,,,,,,,"Race data reported",,"56%","Mixed","combat-related, rape/sexual assault","High","Smyth JM, Hockemeyer JR, Tulloch H. Expressive writing and post-traumatic stress disorder: effects on trauma symptoms, mood states, and cortisol reactivity. Br J Health Psychol. 2008 Feb;13(1):85-93. doi: 10.1348/135910707X250866. PMID: 18230238.","30627","2019"
"smyth2008_B","smyth2008","Psychotherapy","2008","PTSD","Inactive Control",,"25","B","10",,"Emotionally neutral writing","Control writing","Participants write about time management and their daily plans; three 20-minute writing sessions with 15-minute rest interval between sessions","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"20 minutes","Once (all sessions in single day)","0.14","3 sessions in 1 day","Completed intervention",,"adherence, defined as ""completed the expermental manipulation""",,,,,,,,,,"Race data reported",,"56%","Mixed","combat-related, rape/sexual assault","High","Smyth JM, Hockemeyer JR, Tulloch H. Expressive writing and post-traumatic stress disorder: effects on trauma symptoms, mood states, and cortisol reactivity. Br J Health Psychol. 2008 Feb;13(1):85-93. doi: 10.1348/135910707X250866. PMID: 18230238.","30627","2019"
"snoek2025_A","snoek2025","Psychotherapy","2025","PTSD","PTSD",,"125","A","62","62 randomized, 61 in ITT (one excluded for starting treatment after study completion)","Concurrent EMDR + DBT","Eye Movement Desensitization and Reprocessing (EMDR) + Dialectical Behavior Therapy (DBT)","Concurrent EMDR + DBT, delivered by separate therapists. EMDR started after the 6th DBT group session, while patients concurrently received the rest of DBT.
EMDR following standard protocol (Shapiro), with optional supplementary EMDR techniques such as cognitive interweaves employed as deemed appropriate. Minimum 12 and maximum 18 sessions; exact number of sessions determined based on individual needs of participant collaboratively by patient and therapist.
DBT following protocol (Linehan) in both group and individual sessions. DBT started with up to 6 individual (motivational) 45-minute pre-treatment sessions, followed by 12-month program including 48 weekly group sessions and biweekly individual sessions. Group training focused on skills to enhance emotional regulation, interpersonal effectiveness, mindfulness, and distress tolerance.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Mixed","In Person",,"EMDR: 75 minutes
DBT: 150 minutes (group), 45 minutes (individual)","EMDR: weekly
DBT: weekly (group) and biweekly (individual)","52","EMDR: 12-18 weekly sessions, concurrent with DBT
DBT: 12 months, concurrent with EMDR","EMDR: Attended ≥9 sessions (≥75% of minimum 12 sessions)
DBT: attended ≥37 group sessions (>75% of 48 sessions)",,"Completed EMDR treatment: 39%
Completed DBT group treatment: 43%",,,,,,"for overall sample
EMDR sessions: mean 6.8 (SD 5.9)
DBT sessions: mean 26.6 (SD 19.4)
for EMDR treatment completers
EMDR sessions: mean 13.5 (SD 3.3)
DBT sessions: mean 43.4 (SD 10.6)",,,,,"Community","79%","Mixed","Child physical abuse; Child sexual abuse; Child other abuse; Rape/sexual assault; Illness/medical procedure; Other (""physical violence"" victim or witness, ""sudden death"" as witness, and ""other"" not specified)","High","Snoek A, Beekman ATF, Dekker J, Aarts I, van Grootheest G, Blankers M, Vriend C, van den Heuvel O, Thomaes K. A randomized controlled trial comparing the clinical efficacy and cost-effectiveness of eye movement desensitization and reprocessing (EMDR) and integrated EMDR-Dialectical Behavioural Therapy (DBT) in the treatment of patients with post-traumatic stress disorder and comorbid (Sub)clinical borderline personality disorder: study design. BMC Psychiatry. 2020 Aug 6;20(1):396. doi: 10.1186/s12888-020-02713-x. PMID: 32762677; PMCID: PMC7409691.","1645356","2025"
"snoek2025_B","snoek2025","Psychotherapy","2025","PTSD","Active Control",,"125","B","63",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","EMDR following standard protocol (Shapiro), with optional supplementary EMDR techniques such as cognitive interweaves employed as deemed appropriate. Minimum 12 and maximum 18 sessions; exact number of sessions determined based on individual needs of participant collaboratively by patient and therapist.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"75 minutes","Weekly","12 to 18","12-18 weekly sessions","Attended ≥9 sessions (≥75% of minimum 12 sessions)",,,,,,"10.5","5.7","for treatment completers: 13.6 (SD 3.2)",,,,,"Community","79%","Mixed","Child physical abuse; Child sexual abuse; Child other abuse; Rape/sexual assault; Illness/medical procedure; Other (""physical violence"" victim or witness, ""sudden death"" as witness, and ""other"" not specified)","High","Snoek A, Beekman ATF, Dekker J, Aarts I, van Grootheest G, Blankers M, Vriend C, van den Heuvel O, Thomaes K. A randomized controlled trial comparing the clinical efficacy and cost-effectiveness of eye movement desensitization and reprocessing (EMDR) and integrated EMDR-Dialectical Behavioural Therapy (DBT) in the treatment of patients with post-traumatic stress disorder and comorbid (Sub)clinical borderline personality disorder: study design. BMC Psychiatry. 2020 Aug 6;20(1):396. doi: 10.1186/s12888-020-02713-x. PMID: 32762677; PMCID: PMC7409691.","1645356","2025"
"somohano2022_A","somohano2022","Psychotherapy","2022","PTSD+SUD","PTSD+SUD","Integrated","83","A","38","Cluster randomized 10 groups of participants to one of the two therapies","Trauma-integrated mindfulness-based relapse prevention (TI-MBRP)","Trauma-integrated mindfulness-based relapse prevention","Integrated gender-focused topics and cognitive processing therapy  into MBRP. CPT designed to bring awareness to trauma-related beliefs that include exaggerated blame toward the trauma survivor or generalizing trauma cues to safe situations. Sessions also included mindfulness practices bringing awareness to cognitons and behaviors contributing to substance use, and substance use as a way to cope with PTSD.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"90 minutes","Twice a week","4","8 sessions","Received minimally adequate dose",,"not further defined",,,,"4.34","2.95",,,,,"Race and Ethnicity data reported","Community","100%",,,"High","Somohano VC, Bowen S. Trauma-Integrated Mindfulness-Based Relapse Prevention for Women with Comorbid Post-Traumatic Stress Disorder and Substance Use Disorder: A Cluster Randomized Controlled Feasibility and Acceptability Trial. J Integr Complement Med. 2022 May 31;31:31. doi: 10.1089/jicm.2021.0306. PMID: 35648046.","1602354","2023"
"somohano2022_B","somohano2022","Psychotherapy","2022","PTSD+SUD","SUD",,"83","B","45","Cluster randomized 10 groups of participants to one of the two therapies","Mindfulness-based relapse prevention (MBRP)","Mindfulness-based relapse prevention","Protocol including mindfulness practice, cognitive-behavioral methods, and psychoeducation on habit patterns associated with substance use. Includes navigating high-risk situations and supporting lifestyle wellness.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"90 minutes","Twice a week","4","8 sessions","Received minimally adequate dose",,"not further defined",,,,"4.95","2.43",,,,,"Race and Ethnicity data reported","Community","100%",,,"High","Somohano VC, Bowen S. Trauma-Integrated Mindfulness-Based Relapse Prevention for Women with Comorbid Post-Traumatic Stress Disorder and Substance Use Disorder: A Cluster Randomized Controlled Feasibility and Acceptability Trial. J Integr Complement Med. 2022 May 31;31:31. doi: 10.1089/jicm.2021.0306. PMID: 35648046.","1602354","2023"
"sonne2016_A","sonne2016","Psychotherapy & pharmacotherapy","2016","PTSD","Active Control",,"207","A","109",,"Sertraline + CBT","Trauma-focused cognitive behavioral therapy (TF-CBT) + sertraline","SSRI with 10 sessions with psychiatrist/medical doctor for drug management and pscyhoeducation, 16 sessions with psychologist using flexible manual-based cognitive therapy with elements of trauma-focused therapy, acceptance commitment therapy, and mindfulness. Group and individual sessions with a social worker offered.","Yes","Trauma-focused","Yes","Antidepressant: SSRI","No",,"No","No","Yes","No","No","Individual","In Person","Session length: NR







Dose: sertraline initiated at 25 to 50 mg/day, titrated weekly by 25 to 50 mg for first 6 weeks, then monthly up to 200 mg/day",,"Psychotherapy: weekly







Sertraline: daily","24 to 28",,"≥8 consecutive weeks of pharmacological treatment",,,"compliance monitored by pill count",,,,,,"96.21 mg/day",,,"Not reported","Community","40.1%","Terrorism/political violence/forced displacement",,"Some Concerns","Sonne C, Carlsson JM, Bech P, et al. Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study. BMC Psychiatry. 2016 Nov 8;16(1):383. doi: 10.1186/s12888-016-1081-5. PMID: 27825327.","45853","2019"
"sonne2016_B","sonne2016","Psychotherapy & pharmacotherapy","2016","PTSD","PTSD",,"207","B","98",,"Venlafaxine + CBT","Trauma-focused cognitive behavioral therapy (TF-CBT) + venlafaxine","SNRI with 10 sessions with psychiatrist/medical doctor for drug management and pscyho-education, 16 sessions with psychologist using flexible manual-based cognitive therapy with elements of trauma-focused therapy, acceptance commitment therapy, and mindfulness. Group and individual sessions with a social worker offered.","Yes","Trauma-focused","Yes","Antidepressant: SNRI","No",,"No","No","No","No","No","Individual","In Person","Session length: NR







Dose: venlafaxine initiated at 37.5 to 75 mg/day, titrated weekly by 37.5 to 75 mg for first 6 weeks, then monthly up to maximum 375 mg/day",,"Psychotherapy: weekly







Venlafaxine: daily","24 to 28",,"≥8 consecutive weeks of pharmacological compliance during the study period",,,"compliance monitored by pill count",,,,,,"125.41 mg/day",,,"Not reported","Community","40.1%","Terrorism/political violence/forced displacement",,"Some Concerns","Sonne C, Carlsson JM, Bech P, et al. Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study. BMC Psychiatry. 2016 Nov 8;16(1):383. doi: 10.1186/s12888-016-1081-5. PMID: 27825327.","45853","2019"
"spangler2020_A","spangler2020","Pharmacotherapy","2020","PTSD","PTSD",,"75","A","36",,"Riluzole","Riluzole","Riluzole capsules,  50 mg bid for 2 weeks and then 100 mg bid unless patients PCL-S score decreased by 10 or more points","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","50 mg bid for first 2 weeks, then 100 mg bid",,"Twice daily","8",,,,,,,,,,,"125.65 mg/day","37.01",,"Race data reported","Mixed","14.9%",,"Combat-related","Low","Spangler PT, West JC, Dempsey CL, et al. Randomized controlled trial of riluzole augmentation for posttraumatic stress disorder: efficacy of a glutamatergic modulator for antidepressant-resistant symptoms. J Clin Psychiatry. 2020 Oct 27;81(6):27. doi: 10.4088/JCP.20m13233. PMID: 33113596.","1560381","2022"
"spangler2020_B","spangler2020","Pharmacotherapy","2020","PTSD","Inactive Control",,"75","B","38",,"Placebo","Placebo","Placebo capsules, identical to treatment capsules","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","Placebo",,"Twice daily","8",,,,,,,,,,,"133.50 mg/day","39.39",,"Race data reported","Mixed","14.9%",,"Combat-related","Low","Spangler PT, West JC, Dempsey CL, et al. Randomized controlled trial of riluzole augmentation for posttraumatic stress disorder: efficacy of a glutamatergic modulator for antidepressant-resistant symptoms. J Clin Psychiatry. 2020 Oct 27;81(6):27. doi: 10.4088/JCP.20m13233. PMID: 33113596.","1560381","2022"
"spence2011_A","spence2011","Other study class","2011","PTSD","PTSD",,"44","A","23",,"Internet-delivered CBT","Internet-based facilitated self-help","Online lessons include in vivo and imaginal exposure, cognitive restructuring, and de-arousal strategies. Also includes an online discussion forum moderated by the therapist and written resources about assertiveness skills, anger management, strategies for improving sleep, diet, exercise, and reducing drug and alcohol use","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology assisted",,,,"8","7 lessons total","Completed all lessons during treatment period",,"n=18 completed all 7 lessons within the 8 weeks of the program, another n=3 completed within 4 days of program end (not included as treatment completers in data entered), reports n=5 did not complete the program (this includes the n=3 completing after program end)",,,,"6.74","0.54",,,,,"Not reported","Community","80.95%","Mixed","rape/sexual assault, accidents, community/school violence, other (not specified)","High","Spence J, Titov N, Dear BF, et al. Randomized controlled trial of internet-delivered cognitive behavioral therapy for posttraumatic stress disorder. Depress Anxiety. 2011 Jul;28(7):541-50. doi: 10.1002/da.20835. PMID: 21721073.","37944","2019"
"spence2011_B","spence2011","Other study class","2011","PTSD","Inactive Control",,"44","B","21",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"8",,,,,,,,,,,,,,"Not reported","Community","80.95%","Mixed","rape/sexual assault, accidents, community/school violence, other (not specified)","High","Spence J, Titov N, Dear BF, et al. Randomized controlled trial of internet-delivered cognitive behavioral therapy for posttraumatic stress disorder. Depress Anxiety. 2011 Jul;28(7):541-50. doi: 10.1002/da.20835. PMID: 21721073.","37944","2019"
"spence2014_A","spence2014","Other study class","2014","PTSD","Active Control",,"125","A","66",,"Non-exposure, internet-delivered CBT","Internet-based facilitated self-help","Lessons include psychoeducation, stress management, and cognitive restructuring","No",,"No",,"No",,"No","No","Yes","Yes","No","Individual","Technology assisted",,"10 to 20 minutes reading time",,"8","4 lessons total","reading all 4 lessons within 8 weeks",,,,,,,,,,,,"Not reported","Community","86.4%","Mixed","combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)","Some Concerns","Spence J, Titov N, Johnston L, et al. Internet-based trauma-focused cognitive behavioural therapy for PTSD with and without exposure components: a randomised controlled trial. J Affect Disord. 2014 Jun;162:73-80. doi: 10.1016/j.jad.2014.03.009. PMID: 24767009.","42408","2019"
"spence2014_B","spence2014","Other study class","2014","PTSD","PTSD",,"125","B","59",,"Internet-delivered CBT","Internet-based facilitated self-help","Lessons include psychoeducation, stress management, cognitive restructuring, and exposure components","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology assisted",,"10 to 20 minutes reading time",,"8","6 lessons total","reading all 6 lessons within 8 weeks",,,"completing ≥2 session of in vivo exposure, ≥2 sessions of imaginal exposure, or ≥2 sessions each of in vivo exposure and imaginal exposure",,"63.83%, 46.81%, 42.55%",,,,,,,"Not reported","Community","86.4%","Mixed","combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, terrorism/political violence/forced displacement, other (not specified)","Some Concerns","Spence J, Titov N, Johnston L, et al. Internet-based trauma-focused cognitive behavioural therapy for PTSD with and without exposure components: a randomised controlled trial. J Affect Disord. 2014 Jun;162:73-80. doi: 10.1016/j.jad.2014.03.009. PMID: 24767009.","42408","2019"
"spivak2006_A","spivak2006","Pharmacotherapy","2006","PTSD","PTSD",,"40","A","20",,"Reboxetine","Reboxetine","Norepinephrine reuptake inhibitor antidepressant, 8 mg/day fixed dose","No",,"Yes","Antidepressant: SNRI","No",,"No","No","No","No","No","Individual","In Person","4 mg",,"Twice daily","8",,,,,"ensured by ""direct questioning and by counting of medication capsules""",,,,,,,,,"Not reported","Community","47.5%","Accidents",,"High","Spivak B, Strous RD, Shaked G, et al. Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial. J Clin Psychopharmacol. 2006 Apr;26(2):152-6. doi: 10.1097/01.jcp.0000203195.65710.f0. PMID: 16633143.","1548487","2019"
"spivak2006_B","spivak2006","Pharmacotherapy","2006","PTSD","PTSD",,"40","B","20",,"Fluvoxamine","Fluvoxamine","SSRI antidepressant, fixed dose of 150 mg/day","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","75 mg",,"Twice daily","8",,,,,"ensured by ""direct questioning and by counting of medication capsules""",,,,,,,,,"Not reported","Community","47.5%","Accidents",,"High","Spivak B, Strous RD, Shaked G, et al. Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial. J Clin Psychopharmacol. 2006 Apr;26(2):152-6. doi: 10.1097/01.jcp.0000203195.65710.f0. PMID: 16633143.","1548487","2019"
"stappenbeck2015_A","stappenbeck2015","Psychotherapy","2015","PTSD+SUD","PTSD+SUD","Not integrated","80","A","31",,"Cognitive Restructuring","Trauma-focused psychotherapy","Scripted condition for coping skills training;  participants given a copy of the script, short overview statement, homework materials, and a CD recording of the script and overview; therapist also provided 4 coaching calls. Participants were taught ""how trauma exposure can lead to distorted thoughts and beliefs, which in turn can lead to negative feelings and unhealthy behaviors. They were given “A-B-C” sheets and taught how to identify the antecedent..., beliefs and thoughts, and consequences"" and taught 3 questions from skill set in Cognitive Processing Therapy to evaluate accuracy of thought/belief, and guided through use of ABC sheet for a recent drinking or craving episode; participants were to practice at home with ABC sheets.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"Coaching calls: average 11 to 13 minutes","In-person session: once (single session); Coaching calls: weekly","5",,"Received intervention",,"received intervention (single in-person session) and started IVR monitoring",,,,,,"Coaching calls: 2.9 (NR)",,,,"Race and Ethnicity data reported","Mixed","48.7%",,,"Some Concerns","Stappenbeck CA, Luterek JA, Kaysen DL, et al. A controlled examination of two coping skills for daily alcohol use and PTSD symptom severity among dually diagnosed individuals. Behav Res Ther. 2015a Mar;66:8-17. doi: 10.1016/j.brat.2014.12.013. PMID: 25617814.","43808","2020"
"stappenbeck2015_B","stappenbeck2015","Psychotherapy","2015","PTSD+SUD","PTSD+SUD","Not integrated","80","B","29",,"Experiential Acceptance","Experiential Acceptance","Scripted condition for coping skills training;  participants given a copy of the script, short overview statement, homework materials, and a CD recording of the script and overview; therapist also provided 4 coaching calls. Participants introduced ""to the idea that avoiding thoughts and feelings is often associated with more distress and poorer coping. Instead, accepting thoughts and feelings can enable one to make choices consistent with one's values rather than having one's behavior driven by distress or urges to drink."", and to ""urge surfing"" and mindful breathing meditation; participants identified ways they avoided or tried to change thoughts or feelings and how experiential acceptance concepts could be used.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"Coaching calls: average 11 to 13 minutes","In-person session: once (single session); Coaching calls: weekly","5",,"Received intervention",,"received intervention (single in-person session) and started IVR monitoring",,,,,,"Coaching calls: 3.1 (NR)",,,,"Race and Ethnicity data reported","Mixed","48.7%",,,"Some Concerns","Stappenbeck CA, Luterek JA, Kaysen DL, et al. A controlled examination of two coping skills for daily alcohol use and PTSD symptom severity among dually diagnosed individuals. Behav Res Ther. 2015a Mar;66:8-17. doi: 10.1016/j.brat.2014.12.013. PMID: 25617814.","43808","2020"
"stappenbeck2015_C","stappenbeck2015","Psychotherapy","2015","PTSD+SUD","Inactive Control","Not integrated","80","C","20",,"Attention control","Attention control","Scripted condition for attention control condition; participants given a copy of the script, short overview statement, homework materials, and a CD recording of the script and overview; therapist also provided 4 coaching calls. Nutrition guidance as ""comparable length interaction with the therapist that involved learning something germane to health but not specifically relevant to either PTSD or problematic alcohol use"". Participants learned plate method of nutrition, assessed current eating habits, and how to align diet with recommendations.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"Coaching calls: average 11 to 13 minutes","In-person session: once (single session); Coaching calls: weekly","5",,"Received intervention",,"received intervention (single in-person session) and started IVR monitoring",,,,,,"Coaching calls: 3.4 (NR)",,,,"Race and Ethnicity data reported","Mixed","48.7%",,,"Some Concerns","Stappenbeck CA, Luterek JA, Kaysen DL, et al. A controlled examination of two coping skills for daily alcohol use and PTSD symptom severity among dually diagnosed individuals. Behav Res Ther. 2015a Mar;66:8-17. doi: 10.1016/j.brat.2014.12.013. PMID: 25617814.","43808","2020"
"stecker2014_A","stecker2014","Psychotherapy","2014","PTSD","PTSD",,"300","A","143",,"Brief CBT by telephone","Cognitive behavioral therapy (CBT) without a trauma focus","CBT-based telephone session to identify and address beliefs about PTSD treatment","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Phone",,"45 to 60 minutes","Once","0.14","single session","received intervention",,,,,,,,,,,,"Race data reported","Mixed","12.77%",,,"High","Stecker T, McHugo GJ, Xie HY, et al. RCT of a brief phone-based CBT intervention to improve PTSD treatment utilization by returning service members. Psychiatr Serv. 2014 Oct;65(10):1232-7. doi: 10.1176/appi.ps.201300433. PMID: 24933496.","44566","2020"
"stecker2014_B","stecker2014","Psychotherapy","2014","PTSD","Inactive Control",,"300","B","157",,"TAU","Treatment as usual (TAU)","Received baseline assessment and followup assessments calls only.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Phone",,,,,,,,,,,,,,,,,,"Race data reported","Mixed","12.77%",,,"High","Stecker T, McHugo GJ, Xie HY, et al. RCT of a brief phone-based CBT intervention to improve PTSD treatment utilization by returning service members. Psychiatr Serv. 2014 Oct;65(10):1232-7. doi: 10.1176/appi.ps.201300433. PMID: 24933496.","44566","2020"
"stein2002_A","stein2002","Pharmacotherapy","2002","PTSD","PTSD",,"19","A","10",,"Olanzapine augmentation","Olanzapine augmentation","Atypical antipsychotic + previously prescribed SSRI (fluoxetine, paroxetine or sertraline). Olanzapine started at 10 mg daily for 2 weeks, increased to 20 mg daily if needed and tolerated.","No",,"Yes","Mixed","No",,"No","No","No","No","No","Individual","In Person","10 to 20 mg; titration: 10 mg for 2 weeks, optional increase to maximum of 20 mg",,"Daily at bedtime","8",,,,,,,,,,,"15.00 mg/day","5.25",,"Not reported","Veteran","0%","Combat-related",,"High","Stein MB, Kline NA, Matloff JL. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry. 2002 Oct;159(10):1777-9. doi: 10.1176/appi.ajp.159.10.1777. PMID: 12359687.","24689","2019"
"stein2002_B","stein2002","Pharmacotherapy","2002","PTSD","Active Control",,"19","B","9",,"Placebo augmentation","Placebo augmentation","Placebo + previously prescribed SSRI. Placebo started at 10 mg equivalent daily for 2 weeks, increased to 20 mg equivalent daily if needed and tolerated.","No",,"Yes","Antidepressant: SSRI","No",,"No","No","Yes","No","No","Individual","In Person","10 to 20 mg equivalent; titration: 10 mg daily for 2 weeks, then optional; increase to 20 mg maximum",,"Daily at bedtime","8",,,,,,,,,,,"20.00 mg/day equivalent","0",,"Not reported","Veteran","0%","Combat-related",,"High","Stein MB, Kline NA, Matloff JL. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry. 2002 Oct;159(10):1777-9. doi: 10.1176/appi.ajp.159.10.1777. PMID: 12359687.","24689","2019"
"stein2021_A","stein2021","Pharmacotherapy","2021","PTSD","PTSD",,"149","A","75",,"Losartan","Losartan","Losartan, an angiotensin type 1 receptor inhibitor, flexible dose with titration. Titration: initial dose 25 mg, increased as tolerated to 50 mg by week 2, 75 mg by week 4, and 100 mg at week 6; maintained at highest tolerated dose from week 6. Participants unable to tolerate 25 mg losartan were withdrawn from the study.","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","25 to 100 mg",,"Daily","10",,,,,"""by pill count and self-report""",,"""did not differ significantly between losartan and placebo arms""",,,,,,,"Race data reported","Mixed","65.1%","Mixed","Combat-related; Other (not specified)","Low","Stein MB, Jain S, Simon NM, et al. Randomized, placebo-controlled trial of the angiotensin receptor antagonist losartan for posttraumatic stress disorder. Biol Psychiatry. 2021 Oct 1;90(7):473-81. doi: 10.1016/j.biopsych.2021.05.012. PMID: 34275593.","1574095","2023"
"stein2021_B","stein2021","Pharmacotherapy","2021","PTSD","Inactive Control",,"149","B","74",,"Placebo","Placebo","Placebo matched to losartan, flexible dose with titration. Placebo capsules contained lactose monohydrate powder and were identical to losartan capsules, Titration: initial dose 25 mg, increased as tolerated to 50 mg by week 2, 75 mg by week 4, and 100 mg at week 6; maintained at highest tolerated dose from week 6. Participants unable to tolerate 25 mg losartan were withdrawn from the study.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","25 to 100 mg equivalent",,"Daily","10",,,,,"""by pill count and self-report""",,"""did not differ significantly between losartan and placebo arms""",,,,,,,"Race data reported","Mixed","65.1%","Mixed","Combat-related; Other (not specified)","Low","Stein MB, Jain S, Simon NM, et al. Randomized, placebo-controlled trial of the angiotensin receptor antagonist losartan for posttraumatic stress disorder. Biol Psychiatry. 2021 Oct 1;90(7):473-81. doi: 10.1016/j.biopsych.2021.05.012. PMID: 34275593.","1574095","2023"
"stein2023_A","stein2023","Other study class","2023","PTSD","PTSD",,"365","A","118",,"Cognitive restructuring (CR)","Internet-based facilitated self-help","Internet-based cogntive behavioral therapy based on Interapy, with cognitive restructuring and social sharing. Protocol adapted to be linguistically and culturally appropriate and to fit within the format of the web portal. Treatment using structured writing assignments (letter-writing) and consisted of introduction, first phase ""to reflect on automatic dysfunctional cognitions and adjust unrealistic assumptions (e.g. guilt)"" (4 letters), and phase 2 social sharing ""focused on a symbolic farewell letter.. to themselves or to a significant other"". Writing sessions were scheduled and letters provided to counselor, who provided individual feedback and instructions for the next letter; psychoeducation was included at the beginning of each module.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology alone",,"45 minutes","Twice per week","3",,"Completing all 6 letters",,,,,,,,,,,,"Not reported","Community","74.5%","Mixed","Rape/sexual assault; Child sexual abuse; Other (not specified)","High","Stein J, Vohringer M, Wagner B, et al. Exposure versus cognitive restructuring techniques in brief internet-based cognitive behavioral treatment for Arabic-speaking people with posttraumatic stress disorder: randomized clinical trial. JMIR Ment Health. 2023 Dec 13;10:e48689. doi: 10.2196/48689. PMID: 38090792.","30187","2024"
"stein2023_B","stein2023","Other study class","2023","PTSD","PTSD",,"365","B","122",,"Exposure treatment (EXPO)","Internet-based facilitated self-help","Internet-based cogntive behavioral therapy based on Interapy, with self-confrontation and social sharing. Protocol adapted to be linguistically and culturally appropriate and to fit within the format of the web portal. Treatment using structured writing assignments (letter-writing) and consisted of introduction, first phase (self-controntation) participants wrote letters ""about the traumatic event and their related thoughts, fears, and physiological reactions"" (4 letters), and phase 2 social sharing ""focused on a symbolic farewell letter.. to themselves or to a significant other"". Writing sessions were scheduled and letters provided to counselor, who provided individual feedback and instructions for the next letter; psychoeducation was included at the beginning of each module.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology alone",,"45 minutes","Twice per week","3",,"Completing all 6 letters",,,,,,,,,,,,"Not reported","Community","74.5%","Mixed","Rape/sexual assault; Child sexual abuse; Other (not specified)","High","Stein J, Vohringer M, Wagner B, et al. Exposure versus cognitive restructuring techniques in brief internet-based cognitive behavioral treatment for Arabic-speaking people with posttraumatic stress disorder: randomized clinical trial. JMIR Ment Health. 2023 Dec 13;10:e48689. doi: 10.2196/48689. PMID: 38090792.","30187","2024"
"stein2023_C","stein2023","Other study class","2023","PTSD","Inactive Control",,"365","C","125",,"Waitlist","Waitlist","Waiting period during which participants completed assessment measures but did not receive treatment.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Technology alone",,,,"3",,,,,,,,,,,,,,"Not reported","Community","74.5%","Mixed","Rape/sexual assault; Child sexual abuse; Other (not specified)","High","Stein J, Vohringer M, Wagner B, et al. Exposure versus cognitive restructuring techniques in brief internet-based cognitive behavioral treatment for Arabic-speaking people with posttraumatic stress disorder: randomized clinical trial. JMIR Ment Health. 2023 Dec 13;10:e48689. doi: 10.2196/48689. PMID: 38090792.","30187","2024"
"steinert2016_A","steinert2016","Psychotherapy","2016","PTSD","PTSD",,"86","A","53",,"Resource-oriented trauma therapy","Coping skills treatment","Manualized trauma therapy aimed at strengthening resilience and coping capacities. Treatment elements include: psychoeducation; establishing a sense of safety and control; strengthening the adult ego of the patient, and focus on resource activation to enhance emotion regulation; techniques taught to patients include: imaginative techniques to distance from overwhelming traumatic emotions and intrusions; grounding techniques to help manage dissociative crises; and resource development and installation (an EMDR technique).","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","5",,"Completion: completed treatment course",,,,,,,,,,,,"Not reported","Community","60.71%","Mixed","intimate partner violence, accidents, rape/sexual assault, combat-related, community/school violence, other (trafficking)","High","Steinert C, Bumke PJ, Hollekamp RL, et al. Treating post-traumatic stress disorder by resource activation in Cambodia. World Psychiatry. 2016 Jun;15(2):183-5. doi: 10.1002/wps.20303. PMID: 27265714.","45144","2019"
"steinert2016_B","steinert2016","Psychotherapy","2016","PTSD","Inactive Control",,"86","B","33",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"5",,"completed treatment course",,,,,,,,,,,,"Not reported","Community","60.71%","Mixed","intimate partner violence, accidents, rape/sexual assault, combat-related, community/school violence, other (trafficking)","High","Steinert C, Bumke PJ, Hollekamp RL, et al. Treating post-traumatic stress disorder by resource activation in Cambodia. World Psychiatry. 2016 Jun;15(2):183-5. doi: 10.1002/wps.20303. PMID: 27265714.","45144","2019"
"stenmark2013_A","stenmark2013","Psychotherapy","2013","PTSD","PTSD",,"81","A","51",,"NET","Narrative Exposure Therapy (NET)","Therapist assists patient construct a chronological narrative of their life stories with emphasis on traumatic experiences. Therapeutic re-exposures to traumatic experiences continue until associated fear responses decline","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","10",,"Treatment completion",,"not further defined",,,,,,,,,,"Not reported","Community","30.86%","Terrorism/political violence/forced displacement",,"Low","Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.","46540","2019"
"stenmark2013_B","stenmark2013","Psychotherapy","2013","PTSD","Active Control",,"81","B","30",,"TAU","Supportive counseling","Therapists can use any intervention except for steps specific to NET, such as help with sleep problems, depressive symptoms, problems related to asylum status, etc.","No",,"No",,"No",,"No","No","Yes","No","No",,,,"90 minutes","Weekly","10",,"Treatment completion",,"not further defined",,,,,,,,,,"Not reported","Community","30.86%","Terrorism/political violence/forced displacement",,"Low","Stenmark H, Catani C, Neuner F, et al. Treating PTSD in refugees and asylum seekers within the general health care system. A randomized controlled multicenter study. Behav Res Ther. 2013 Oct;51(10):641-7. doi: 10.1016/j.brat.2013.07.002. PMID: 23916633.","46540","2019"
"stern2024_A","stern2024","Other study class","2024","PTSD","PTSD",,"20","A","10","One later found ineligible and excluded","Adopting a companion dog","Animal Assisted","Choosing and adopting a companion dog (not a service dog) from a Humane Society shelter. Participants paid for care, except veterinary care during which was provided by study during 6-month duration. Veterans attended 8 weekly obedience classes. ""Participants anticipated keeping their companion indefinitely after the end of the study.""","No",,"No",,"No",,"No","No","No","Yes","No","Individual","In Person",,,,"12","Remained in study for 6 months, but non-comparative after 3 months when waitlist participants adopted dogs","See Detail",,"treatment completion not defined; n=6 participants kept their dogs more than 2 weeks",,,,,,,,,,"Race and Ethnicity data reported","Veteran","42.11%","Mixed","MST; Combat-related; Other (not specified)","High","Stern SL, Finley EP, Mintz J, et al. Adopting a companion dog helps veterans with posttraumatic stress disorder in a pilot randomized trial. Society & Animals: Journal of Human-Animal Studies. 2024 Mar;32(2):196-218. doi: 10.1163/15685306-bja10089.","1651000","2025"
"stern2024_B","stern2024","Other study class","2024","PTSD","Inactive Control",,"20","B","10",,"Waitlist","Waitlist","Adopted dog after 3-month waiting period.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Race and Ethnicity data reported","Veteran","42.11%","Mixed","MST; Combat-related; Other (not specified)","High","Stern SL, Finley EP, Mintz J, et al. Adopting a companion dog helps veterans with posttraumatic stress disorder in a pilot randomized trial. Society & Animals: Journal of Human-Animal Studies. 2024 Mar;32(2):196-218. doi: 10.1163/15685306-bja10089.","1651000","2025"
"steuwe2021_A","steuwe2021","Psychotherapy","2021","PTSD","PTSD",,"58","A","29","1 excluded from ITT analysis due to protocol violation (30 randomized initially, 29 analyzed)","Narrative exposure therapy","Narrative Exposure Therapy (NET)","NET delivered over 15 sessions. Sessions 1-3  (50 minutes each, non-exposure) included psychoeducation on trauma, PTSD and the NET procedures. Sessions 4-15 (90 minutes each) involved trauma exposure via NET. In the last two sessions, patients received their narrative and short cognitive interventions, as needed, to reduce emotions of shame and guilt. Patients were also encouraged to reintegrate into and refocus on their daily routines.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"50-90 minutes (50 minutes for non-exposure sessions, 90 minutes for exposure sessions; total 1,330 minutes individual therapy)","1-2 times per week (non-exposure sessions weekly, exposure sessions twice a week)","10",,"Treatment completion",,"no definition provided",,,,,,,,,,"Not reported","Community","100%","Mixed","Child physical abuse; Child sexual abuse; Child other abuse; Community/school violence","High","Steuwe C, Berg M, Beblo T, et al. Narrative exposure therapy in patients with posttraumatic stress disorder and borderline personality disorder in a naturalistic residential setting: a randomized controlled trial. Front Psychiatry 2021 Nov 26;12:765348. doi: 10.3389/fpsyt.2021.765348. PMID: 34899426.","1584985","2023"
"steuwe2021_B","steuwe2021","Psychotherapy","2021","PTSD","Active Control",,"58","B","29","1 excluded from ITT analysis due to protocol violation (30 randomized initially, 29 analyzed)","Dialectic behavior therapy","Dialectical Behavior Therapy (DBT)","DBT in individual and group sessions. DBT is a cognitive-behavioral treatment program that was developed to treat suicidal patients with BPD. DBT aims to help patients achieve the following: (1) reduction of suicidal behaviors, (2) reduction of therapy interfering behaviors, and (3) other risky or destabilizing behaviors. Standard DBT aims to achieve these goals by (1) conveying behavioral capabilities (skills), (2) motivating to apply these skills, (3) helping to generalize learned skills to the patient’s natural environment, (4) structuring the treatment environment to reinforce functional behavior, and 5) conveying therapeutic resources and motivation to effectively treat patients with BPD. Treatment consisted of weekly 50-min sessions of individual treatment (ten sessions over the 10 weeks) plus the following weekly group treatments: 180 min of skills training, 45 min of practicing mindfulness and psychoeducation on BPS as well as 60 min of patient-guided support group (ten sessions each over the 10 weeks).","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Mixed","In Person",,"50 minutes for individual sessions; 285 minutes for group sessions (total 500 minutes individual therapy and 2,850 minutes group therapy)","Weekly","10",,"Treatment completion",,"no definition provided",,,,,,,,,,"Not reported","Community","100%","Mixed","Child physical abuse; Child sexual abuse; Child other abuse; Community/school violence","High","Steuwe C, Berg M, Beblo T, et al. Narrative exposure therapy in patients with posttraumatic stress disorder and borderline personality disorder in a naturalistic residential setting: a randomized controlled trial. Front Psychiatry 2021 Nov 26;12:765348. doi: 10.3389/fpsyt.2021.765348. PMID: 34899426.","1584985","2023"
"sturt2023_A","sturt2023","Psychotherapy","2023","PTSD","PTSD",,"60","A","35",,"Reconsolidation of Traumatic Memories","Reconsolidation of Traumatic Memories (RTM)","Manualized 89-step protocol; ""brief cognitive intervention with minimal and non-traumatising exposure to the original stimulus."" Reactivation of traumatic memories in a setting that allows threat to appear less relevant and reduces intensity of emotional response.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Video",,"90 minutes","NR (""at least one mandatory sleep session between sessions"")","3 to 4","Two to four sessions over 3 to 4 weeks","Did not discontinue intervention",,"""compliance with therapy"" reported for overall sample only (60%, 95% CI 46.96 to 71.76); this does not appear to be the same as % of participants that did not discontinue intervention (n=4 discontinued), but no further details provided",,,,,,"""RTM was almost 5% short of the threshold of 70% retention""",,,,"Race data reported","Veteran","8.3%",,,"High","Sturt J, Rogers R, Armour C, et al. Reconsolidation of traumatic memories protocol compared to trauma-focussed cognitive behaviour therapy for post-traumatic stress disorder in UK military veterans: a randomised controlled feasibility trial. Pilot & Feasibility Studies. 2023 Oct 13;9(1):175. doi: 10.1186/s40814-023-01396-x. PMID: 37833734.","1626031","2024"
"sturt2023_B","sturt2023","Psychotherapy","2023","PTSD","PTSD",,"60","B","25",,"Trauma-focused CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","CBT focused on identifying the relevant appraisals, memory characteristics and triggers, and behavioural and cognitive strategies that maintain PTSD symptoms."" Based on Ehlers and Clark congitive processing model.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Video",,"60 to 90 minutes","Weekly","18","Up to 18 sessions","Did not discontinue intervention",,"""compliance with therapy"" reported for overall sample only (60%, 95% CI 46.96 to 71.76); this does not appear to be the same as % of participants that did not discontinue intervention (n=6 discontinued), but no further details provided",,,,,,"""Fifty percent threshold for retention in TFCBT was achieved""",,,,"Race data reported","Veteran","8.3%",,,"High","Sturt J, Rogers R, Armour C, et al. Reconsolidation of traumatic memories protocol compared to trauma-focussed cognitive behaviour therapy for post-traumatic stress disorder in UK military veterans: a randomised controlled feasibility trial. Pilot & Feasibility Studies. 2023 Oct 13;9(1):175. doi: 10.1186/s40814-023-01396-x. PMID: 37833734.","1626031","2024"
"sullivan2021_A","sullivan2021","Pharmacotherapy","2021","PTSD","PTSD",,"245","A","50","49 in modified ITT analysis","TNX-102 SL (cyclobenzaprine)","TNX-102 SL","5.6 mg TNX-102 SL daily at bedtime, taken as two 2.8 mg tablets","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","5.6 mg",,"Daily","12",,,,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","6.9%","Mixed","Combat-related, Other (unspecified)","Some Concerns","Sullivan GM, Gendreau RM, Gendreau J, et al. Randomized clinical trial of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related PTSD and the role of sleep quality in treatment response. Psychiatry Res. 2021 Jul;301:113974. doi: 10.1016/j.psychres.2021.113974. PMID: 33979763.","1569175","2022"
"sullivan2021_B","sullivan2021","Pharmacotherapy","2021","PTSD","PTSD",,"245","B","101","90 in modified ITT analysis","TNX-102 SL (cyclobenzaprine)","TNX-102 SL","2.8 mg TNX-102 SL daily at bedtime, taken as one 2.8 mg tablet and one placebo tablet","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","2.8 mg",,"Daily","12",,,,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","6.9%","Mixed","Combat-related, Other (unspecified)","Some Concerns","Sullivan GM, Gendreau RM, Gendreau J, et al. Randomized clinical trial of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related PTSD and the role of sleep quality in treatment response. Psychiatry Res. 2021 Jul;301:113974. doi: 10.1016/j.psychres.2021.113974. PMID: 33979763.","1569175","2022"
"sullivan2021_C","sullivan2021","Pharmacotherapy","2021","PTSD","Inactive Control",,"245","C","94","92 in modified ITT analysis","Placebo","Placebo","Placebo daily at bedtime, taken as two placebo tablets","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","6.9%","Mixed","Combat-related, Other (unspecified)","Some Concerns","Sullivan GM, Gendreau RM, Gendreau J, et al. Randomized clinical trial of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related PTSD and the role of sleep quality in treatment response. Psychiatry Res. 2021 Jul;301:113974. doi: 10.1016/j.psychres.2021.113974. PMID: 33979763.","1569175","2022"
"suris2013a_A","suris2013a","Psychotherapy","2013","PTSD","PTSD",,"129","A","72","n=52 analyzed","CPT","Cognitive Processing Therapy (CPT)","CBT designed for treatment of rape-related PTSD, includes education, cognitive restructuring, and writing trauma narratives","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Once or twice weekly","12","12 sessions total","Completed all 12 sessions",,,,,,"9.7","3.5",,,,,"Race data reported","Veteran","84.88%","MST",,"High","Surís A, Link-Malcolm J, Chard K, Ahn C, North C. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. Epub 2013 Jan 16. PMID: 23325750.","41233","2019"
"suris2013a_B","suris2013a","Psychotherapy","2013","PTSD","Active Control",,"129","B","57","n=34 analyzed","PCT","Present-Centered Therapy (PCT)","General support, education, problem-solving and improving relationships, daily journaling","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Once or twice weekly","12","12 sessions total","Completed all 12 sessions",,,,,,"10.7","3.1",,,,,"Race data reported","Veteran","84.88%","MST",,"High","Surís A, Link-Malcolm J, Chard K, Ahn C, North C. A randomized clinical trial of cognitive processing therapy for veterans with PTSD related to military sexual trauma. J Trauma Stress. 2013 Feb;26(1):28-37. doi: 10.1002/jts.21765. Epub 2013 Jan 16. PMID: 23325750.","41233","2019"
"suris2013b_A","suris2013b","Other mixed","2013","PTSD","PTSD",,"54","A","27","n=27 analyzed; number randomized not reported by arm","Sirolimus + trauma memory reactivation","Present-Centered Therapy (PCT)","Single dose paired with reactivation of a specific trauma memory.







Sirolimus also known as rapamycin; developed as an antifungal, used as an immunosuppressant; regulates dendritic protein synthesis in the amygdala and dorsal hippocampus through the systemic inhibition of the protein kinase mTOR (mammalian target of rapamycin) pathway. After administration of sirolimus, participants wrote script describing most distressing combat trauma memory (about 45 minute process), in next session (physicologic asessment) 7 days later, the participant listened to 3 recordings: standard neutral script, followed by personal combat script, then another standard neutral script (scripts approximately 30 to 40 seconds duration).","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","Yes","No","Individual","In Person","15 mg","Session length (session 2 when drug administered): mean 45 minutes (range 30 to 75)","Once (single dose)","1","single session for medication and traumatic memory reactivation","Completed treatment",,"single treatment session, all analyzed had complete data, no other dropouts reported",,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Combat-related",,"High","Surís AM, Smith JC, Powell CM, et al. Interfering with the reconsolidation of traumatic memory: sirolimus as a novel agent for treating veterans with posttraumatic stress disorder. Ann Clin Psychiatry. 2013 Feb;25(1):33-40. PMID: 23376868.","87369","2019"
"suris2013b_B","suris2013b","Other mixed","2013","PTSD","Active Control",,"54","B","24","n=24 analyzed; number randomized not reported by arm","Placebo + trauma memory reactivation","Present-Centered Therapy (PCT)","Placebo. After administration, participants wrote script describing most distressing combat trauma memory (about 45 minute process), in next session (physiologic assessment) 7 days later, the participant listened to 3 recordings: standard neutral script, followed by personal combat script, then another standard neutral script (scripts approximately 30 to 40 seconds duration).","No",,"No",,"No",,"No","No","Yes","Yes","No","Individual","In Person",,"Session length (session 2 when drug administered): mean 45 minutes (range 30 to 75)","Once (single dose)","1","single session for medication and traumatic memory reactivation","Completed treatment",,"single treatment session, all analyzed had complete data, no other dropouts reported",,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Combat-related",,"High","Surís AM, Smith JC, Powell CM, et al. Interfering with the reconsolidation of traumatic memory: sirolimus as a novel agent for treating veterans with posttraumatic stress disorder. Ann Clin Psychiatry. 2013 Feb;25(1):33-40. PMID: 23376868.","87369","2019"
"suris2017_A","suris2017","Other mixed","2017","PTSD","PTSD",,"54","A","26",,"Dexamethasone + brief trauma memory reactivation task","Imaginal exposure (experimental paradigm) + dexamethasone","Glucocorticoid paired with brief trauma memory reactivation task; patients in each arm received four treatment sessions, receiving drug or placebo 60 minutes before therapy sessions that included writing a trauma narrative and listening to staff audio recordings of the narrative; audio recordings were 30 to 45 seconds.","No",,"Yes","Other pharmacotherapy","No",,"No","No","No","Yes","No","Individual","In Person","0.15 mg/kg",,"Weekly","3",,"Completed intervention",,"""completed DEX"" in flow chart, matches with ""43 who provided
treatment completion data in the study"" (15 in DEX, 28 in placebo)",,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Combat-related",,"Some Concerns","Surís A, Holliday R, Adinoff B, Holder N, North CS. Facilitating Fear-Based Memory Extinction With Dexamethasone: A Randomized Controlled Trial in Male Veterans With Combat-Related PTSD. Psychiatry. 2017 Winter;80(4):399-410. doi: 10.1080/00332747.2017.1286892. PMID: 29466111.","49780","2019"
"suris2017_B","suris2017","Other mixed","2017","PTSD","Active Control",,"54","B","28",,"Placebo + brief trauma memory reactivation task","Imaginal exposure (experimental paradigm) + placebo","Placebo paired with brief trauma memory reactivation task; patients in each arm received four treatment sessions, receiving drug or placebo 60 minutes before therapy sessions that included writing a trauma narrative and listening to staff audio recordings of the narrative; audio recordings were 30 to 45 seconds.","No",,"No",,"No",,"No","No","Yes","Yes","No","Individual","In Person",,,"Weekly","3",,"Completed intervention",,"""completed DEX"" in flow chart, matches with ""43 who provided
treatment completion data in the study"" (15 in DEX, 28 in placebo)",,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%","Combat-related",,"Some Concerns","Surís A, Holliday R, Adinoff B, Holder N, North CS. Facilitating Fear-Based Memory Extinction With Dexamethasone: A Randomized Controlled Trial in Male Veterans With Combat-Related PTSD. Psychiatry. 2017 Winter;80(4):399-410. doi: 10.1080/00332747.2017.1286892. PMID: 29466111.","49780","2019"
"susanty2022_A","susanty2022","Psychotherapy","2022","PTSD","PTSD",,"91","A","47",,"Eye Movement Desensitization (EMD)","Eye Movement Desensitization and Reprocessing (EMDR)","Followed standard EMDR protocol, but omitting installation phase (using eye movements with a positive cognition). Protocol used had the following steps: 1) client history and tratment planning; 2) preparation; 3) assessment, including identification of the target visual image of trauma and associated emotions and rating of subjective units of distress; 4) desensitization, by asking client  to focus on trauma while following therapist's finger moving left to right and back in visual field, with 24 cycles repeated several times, and rating of subjective units of distress, and body scan; 5) closure, including stabilization techniques and relaxation exercises.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"45 to 60 minutes","Weekly","4 to 6","Minimum 4, maximum 6; ended if patient attained a Subjective Units of Distress (SUD) score of 0 or 1 at 4th or 5th session","Received complete sessions of treatment (at least 4 sessions)",,,,,,,,,,,,"Not reported","Community","91.2%","Mixed","Rape/sexual assault; Intimate partner violence; Other (not specified)","High","Susanty E, Sijbrandij M, Srisayekti W, et al. The Effectiveness of Eye Movement Desensitization for Post-traumatic Stress Disorder in Indonesia: A Randomized Controlled Trial. Front Psychol. 2022;13:845520. doi: https://dx.doi.org/10.3389/fpsyg.2022.845520. PMID: 35548495.","1593739","2023"
"susanty2022_B","susanty2022","Psychotherapy","2022","PTSD","PTSD",,"91","B","44",,"Retrieval only","Eye Movement Desensitization and Reprocessing (EMDR)","Trauma retrieval-only group followed same protocol as EMD group (arm A) but without eye movements. Identified a target visual image of trauma and associated emotions. Asked to focus on trauma, but omitted eye movement procedure.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"45 to 60 minutes","Weekly","4 to 6","Minimum 4, maximum 6; ended if patient attained a Subjective Units of Distress (SUD) score of 0 or 1 at 4th or 5th session","Received complete sessions of treatment (at least 4 sessions)",,,,,,,,,,,,"Not reported","Community","91.2%","Mixed","Rape/sexual assault; Intimate partner violence; Other (not specified)","High","Susanty E, Sijbrandij M, Srisayekti W, et al. The Effectiveness of Eye Movement Desensitization for Post-traumatic Stress Disorder in Indonesia: A Randomized Controlled Trial. Front Psychol. 2022;13:845520. doi: https://dx.doi.org/10.3389/fpsyg.2022.845520. PMID: 35548495.","1593739","2023"
"talbot2014_A","talbot2014","Psychotherapy","2014","PTSD","PTSD",,"45","A","29",,"CBT for insomnia","Cognitive Behavioral Therapy for Insomnia (CBT-I)","Patients instructed to write about a specific traumatic event, focusing on details of the event and the thoughts and feelings that occurred during the event, for 30 minutes each session; no assignments between sessions.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,,"8",,"received allocated intervention",,,,,,,,,,,,"Race data reported","Mixed","68.89%",,,"Low","Talbot LS, Maguen S, Metzler TJ, et al. Cognitive behavioral therapy for insomnia in posttraumatic stress disorder: a randomized controlled trial. Sleep. 2014 Feb 1;37(3):327-41. doi: 10.5665/sleep.3408. PMID: 24497661.","42060","2020"
"talbot2014_B","talbot2014","Psychotherapy","2014","PTSD","Inactive Control",,"45","B","16",,"Waitlist","Waitlist","Monitored sleep using sleep diary and actigraphy; weekly telephone or email check-ins from study coordinator.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"8",,"received allocated intervention",,,,,,,,,,,,"Race data reported","Mixed","68.89%",,,"Low","Talbot LS, Maguen S, Metzler TJ, et al. Cognitive behavioral therapy for insomnia in posttraumatic stress disorder: a randomized controlled trial. Sleep. 2014 Feb 1;37(3):327-41. doi: 10.5665/sleep.3408. PMID: 24497661.","42060","2020"
"tang2021_A","tang2021","Other mixed","2021","PTSD","PTSD",,"28","A","14",,"ECT + traumatic memory reactivation","Electroconvulsive therapy (ECT) + traumatic memory reactivation","Electroconvulsive therapy followed by reactivation of the trauma memories with script-driven imagery","Yes","Trauma-focused","No",,"No",,"Yes","No","No","Yes","No","Individual","In Person","Right unilateral: stimulus intensity at 6 times seizure threshold, pulse width 0.3-0.37 ms



Bilateral: stimulus intensity at 1.5 times seizure threshold, pulse width 1.0 ms",,,,"""Prescribed course of ECT"" not further defined; mean number of ECT treatments; 10.8 (SD 3.4)","Received intervention and did not discontinue",,"reports on participants ""received allocated intervention"" (n=14) and discontinued intervention (n=3); treatment completed = received allocated interventin and did not discontinue intervention",,,,,,,,,,"Not reported","Community","100%",,,"Low","Tang VM, Trought K, Gicas KM, Kozak M, Josselyn SA, Daskalakis ZJ, Blumberger DM, Voineskos D, Knyahnytska Y, Pasricha S, Chung Y, Zhou Y, Isserles M, Wong AHC. Electroconvulsive therapy with a memory reactivation intervention for post-traumatic stress disorder: A randomized controlled trial. Brain Stimul. 2021 May-Jun;14(3):635-642. doi: 10.1016/j.brs.2021.03.015. Epub 2021 Mar 27. PMID: 33785406.","1572125","2022"
"tang2021_B","tang2021","Other mixed","2021","PTSD","Active Control",,"28","B","14","n=14 randomized, n=11 analyzed","ECT + neutral memory reactivation","Electroconvulsive therapy (ECT) + neutral memory reactivation","Electroconvulsive therapy followed by reactivation of memories of typical morning routine","No",,"No",,"No",,"Yes","No","Yes","Yes","No","Individual","In Person","Right unilateral: stimulus intensity at 6 times seizure threshold, pulse width 0.3-0.37 ms



Bilateral: stimulus intensity at 1.5 times seizure threshold, pulse width 1.0 ms",,,,"""Prescribed course of ECT"" not further defined; mean number of ECT treatments: 14.3 (SD 3.1)","Received intervention and did not discontinue",,"reports on participants ""received allocated intervention"" (n=13) (n=14 minus n-1 withdrawal before ECT start) and discontinued intervention (n=3); treatment completed = received allocated interventin and did not discontinue intervention",,,,,,,,,,"Not reported","Community","100%",,,"Low","Tang VM, Trought K, Gicas KM, Kozak M, Josselyn SA, Daskalakis ZJ, Blumberger DM, Voineskos D, Knyahnytska Y, Pasricha S, Chung Y, Zhou Y, Isserles M, Wong AHC. Electroconvulsive therapy with a memory reactivation intervention for post-traumatic stress disorder: A randomized controlled trial. Brain Stimul. 2021 May-Jun;14(3):635-642. doi: 10.1016/j.brs.2021.03.015. Epub 2021 Mar 27. PMID: 33785406.","1572125","2022"
"tarrier1999a_A","tarrier1999a","Psychotherapy","1999","PTSD","PTSD",,"72","A","35",,"Imaginal exposure therapy","Exposure therapy","Trauma-focused therapy seeking habituation of emotional responses; patient described and visualized event with exposure continuing until emotional reactions decreased; hierarchy of events approaching most intense aspect of trauma could be used","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","16",,"completed treatment",,,,,,"10.4","4.2",,,,,"Not reported","Community","58.06%","Mixed","accidents, other (crime, not specified)","Some Concerns","Tarrier N, Pilgrim H, Sommerfield C, et al. A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. J Consult Clin Psychol. 1999 Feb;67(1):13-8. doi: 10.1037//0022-006X.67.1.13. PMID: 10028204.","09173","2019"
"tarrier1999a_B","tarrier1999a","Psychotherapy","1999","PTSD","PTSD",,"72","B","37",,"Cognitive therapy","Trauma-focused psychotherapy","Emotion focused therapy eliciting patients' beliefs about the meaning of the traumatic event, and identifying and modifying maladaptive cognitions and emotions; discussion of trauma itself avoided","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour","Weekly","16",,"completed treatment",,,,,,"11.9","4.6",,,,,"Not reported","Community","58.06%","Mixed","accidents, other (crime, not specified)","Some Concerns","Tarrier N, Pilgrim H, Sommerfield C, et al. A randomized trial of cognitive therapy and imaginal exposure in the treatment of chronic posttraumatic stress disorder. J Consult Clin Psychol. 1999 Feb;67(1):13-8. doi: 10.1037//0022-006X.67.1.13. PMID: 10028204.","09173","2019"
"taylor2003a_A","taylor2003a","Psychotherapy & CIH","2003","PTSD","PTSD",,"60","A","22",,"PE","Prolonged Exposure (PE)","Treatment following Marks et al. 1998 manual, including imaginal and in vivo exposure but does not include breathing retraining as part of Foa 1999 protocol","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes",,,"8 sessions","treatment completion",,"not further defined",,,,,,,,,,"Race data reported","Community","75%","Mixed","rape/sexual assault, accidents, community/school violence","High","Taylor S, Thordarson DS, Maxfield L, et al. Comparative efficacy, speed, and adverse effects of three PTSD treatments: exposure therapy, EMDR, and relaxation training. J Consult Clin Psychol. 2003a Apr;71(2):330-8. doi: 10.1037/0022-006X.71.2.330. PMID: 12699027.","25484","2020"
"taylor2003a_B","taylor2003a","Psychotherapy & CIH","2003","PTSD","PTSD",,"60","B","19",,"Relaxation training","Relaxation","Treatment following Marks et al. 1998 protocol, including 3 different relaxation exercises","No",,"No",,"Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"90 minutes",,,"8 sessions","treatment completion",,"not further defined",,,,,,,,,,"Race data reported","Community","75%","Mixed","rape/sexual assault, accidents, community/school violence","High","Taylor S, Thordarson DS, Maxfield L, et al. Comparative efficacy, speed, and adverse effects of three PTSD treatments: exposure therapy, EMDR, and relaxation training. J Consult Clin Psychol. 2003a Apr;71(2):330-8. doi: 10.1037/0022-006X.71.2.330. PMID: 12699027.","25484","2020"
"taylor2003a_C","taylor2003a","Psychotherapy & CIH","2003","PTSD","PTSD",,"60","C","19",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Treatment following Shapiro 1995 protocol, including Safe Place exercise and processing of a traumatic memory by recalling the memory and its associated feature while making lateral eye movements following therapist's finger until distress subsides","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes",,,"8 sessions","treatment completion",,"not further defined",,,,,,,,,,"Race data reported","Community","75%","Mixed","rape/sexual assault, accidents, community/school violence","High","Taylor S, Thordarson DS, Maxfield L, et al. Comparative efficacy, speed, and adverse effects of three PTSD treatments: exposure therapy, EMDR, and relaxation training. J Consult Clin Psychol. 2003a Apr;71(2):330-8. doi: 10.1037/0022-006X.71.2.330. PMID: 12699027.","25484","2020"
"taylor2008_A","taylor2008","Pharmacotherapy","2008","PTSD","PTSD",,"13","A","13",,"Prazosin","Prazosin","Alpha-1 adrenoreceptor antagonist, titrated over 10 days with 1-mg dose increases every 2 to 3 days based on response and tolerability; 3-week crossover periods separated by 1-week washout","No",,"Yes","Antiadrenergic","No",,"No","No","No","No","No","Individual","In Person","Initiated at 1 mg, maximum NR",,"Daily at bedtime","3",,,,,,,,,,,"3.1 mg/day","1.3",,"Not reported","Community","84.62%","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence","High","Taylor FB, Martin P, Thompson C, et al. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study. Biol Psychiatry. 2008 Mar 15;63(6):629-32. doi: 10.1016/j.biopsych.2007.07.001. PMID: 17868655.","1548486","2019"
"taylor2008_B","taylor2008","Pharmacotherapy","2008","PTSD","Inactive Control",,"13","B","13",,"Placebo","Placebo","Placebo capsules indistinguishable from active drug, titrated over 10 days with 1-mg equivalent dose increases every 2 to 3 days based on response and tolerability; 3-week crossover periods separated by 1-week washout","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","Initiated at 1 mg equivalent, maximum NR",,"Daily at bedtime","3",,,,,,,,,,,"3.2 mg/day equivalent","1.2",,"Not reported","Community","84.62%","Mixed","child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence","High","Taylor FB, Martin P, Thompson C, et al. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study. Biol Psychiatry. 2008 Mar 15;63(6):629-32. doi: 10.1016/j.biopsych.2007.07.001. PMID: 17868655.","1548486","2019"
"taylor2023_A","taylor2023","Psychotherapy","2023","PTSD","PTSD",,"93","A","31",,"CBT for insomnia and nightmares followed by CPT","Cognitive Behavioral Therapy for Insomnia (CBT-I) + Imagery Rehearsal Training (IRT) followed by Cognitive Processing Therapy (CPT)","CBT for insomnia and nightmares followed by CPT
CBT for insomnia and nightmares: manualized therapy combining CBT for insomia and exposure, relaxation, and rescripting therapy for nightmares; 6 weekly sessions
CPT: structured cognitive therapy following manual; 12 sessions of twice-weekly CPT","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour","12 CPT sessions: twice weekly
6 CBT sessions: weekly","12","18 total sessions","Received both components of intervention (did not drop out)",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","26.9%",,,"High","Taylor DJ, Pruiksma KE, Mintz J, et al. Treatment of comorbid sleep disorders and posttraumatic stress disorder in U.S. active duty military personnel: a pilot randomized clinical trial. J Trauma Stress. 2023 Jun 15;15:15. doi: 10.1002/jts.22939. PMID: 37322836.","1622028","2024"
"taylor2023_B","taylor2023","Psychotherapy","2023","PTSD","Active Control",,"93","B","31",,"CPT followed by CBT for insomnia and nightmares","Cognitive Processing Therapy (CPT) followed by Cognitive Behavioral Therapy for Insomnia (CBT-I) + Imagery Rehearsal Training (IRT)","CPT followed by CBT for insomnia and nightmares
CPT: structured cognitive therapy following manual; 12 sessions of twice-weekly CPT
CBT for insomnia and nightmares: manualized therapy combining CBT for insomia and exposure, relaxation, and rescripting therapy for nightmares; 6 weekly sessions","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"1 hour","12 CPT sessions: twice weekly
6 CBT sessions: weekly","12","18 total sessions","Received both components of intervention (did not drop out)",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","26.9%",,,"High","Taylor DJ, Pruiksma KE, Mintz J, et al. Treatment of comorbid sleep disorders and posttraumatic stress disorder in U.S. active duty military personnel: a pilot randomized clinical trial. J Trauma Stress. 2023 Jun 15;15:15. doi: 10.1002/jts.22939. PMID: 37322836.","1622028","2024"
"taylor2023_C","taylor2023","Psychotherapy","2023","PTSD","Active Control",,"93","C","31",,"CPT","Cognitive Processing Therapy (CPT)","CPT: structured cognitive therapy following manual; 12 sessions of twice-weekly CPT followed by 6 sessions of weekly CPT, the additional 6 sessions included practicing skills learned in 12-session protocol and working on problematic beliefs that had not been resolved","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"1 hour","12 sessions: twice weekly
6 sessions: weekly","12","18 total sessions","Received  intervention (did not drop out)",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","26.9%",,,"High","Taylor DJ, Pruiksma KE, Mintz J, et al. Treatment of comorbid sleep disorders and posttraumatic stress disorder in U.S. active duty military personnel: a pilot randomized clinical trial. J Trauma Stress. 2023 Jun 15;15:15. doi: 10.1002/jts.22939. PMID: 37322836.","1622028","2024"
"terheide2016_A","terheide2016","Psychotherapy","2016","PTSD","PTSD",,"72","A","37",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","Included treatment planning and preparing patient for trauma-focused treatment (3 sessions), followed by desensitization and reprocessing (6 sessions), and evaluation; total 12 hours treatment. During desensitization and reprocessing, a focus on a traumatic image and the thoughts, sensations, feelings and memories that it elicits, is combined with an attention-demanding task such as tracking the therapist's fingers with the eyes. Followed Dutch version of EMDR protocol.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"Treatment planning and preparation sessions: 60 minutes







EMDR sessions: 90 minutes",,,"9 sessions total (12 hours)","Started treatment and no treatment dropout",,"n=1 did not start any treatment; n=6 discontinued intervention",,,,,,,,,,"Not reported","Community","27.78%","Mixed","terrorism/political violence/forced displacement, community/school violence","Low","Ter Heide FJJ, Mooren TM, Van de Schoot R, et al. Eye Movement Desensitisation and Reprocessing therapy v. stabilisation as usual for refugees: randomised controlled trial. Br J Psychiatry. 2016 Oct;209(4):311-8. doi: 10.1192/bjp.bp.115.167775. PMID: 26892849.","45021","2019"
"terheide2016_B","terheide2016","Psychotherapy","2016","PTSD","Active Control",,"72","B","37",,"Stabilization","Supportive counseling","Non-structured stabilization treatment as usual aimed at enhancing safety, control over symptoms, and socio-psychological competencies through interventions such as emotion regulation and relational skills building, stress management, and cognitive restructuring; asked to not do trauma exposure. 12 weekly hour sessions provided.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"60 minutes",,,"12 sessions total (12 hours)","Started treatment and no treatment dropout",,"n=1 did not start any treatment; n=8 discontinued intervention",,,,,,,,,,"Not reported","Community","27.78%","Mixed","terrorism/political violence/forced displacement, community/school violence","Low","Ter Heide FJJ, Mooren TM, Van de Schoot R, et al. Eye Movement Desensitisation and Reprocessing therapy v. stabilisation as usual for refugees: randomised controlled trial. Br J Psychiatry. 2016 Oct;209(4):311-8. doi: 10.1192/bjp.bp.115.167775. PMID: 26892849.","45021","2019"
"thierree2021_A","thierree2021","Other mixed","2021","PTSD","PTSD",,"38","A","18",,"HF rTMS and exposure therapy","Transcranial magnetic stimulation (TMS)","High frequency (10 Hz) rTMS to the right dorsolateral prefrontal cortex. 60 trains of 5-sec duration with 20-sec intertrain intervals, resulting in 3000 pulses per session. At enrollment patients prepare written trauma narratives, which they read throughout rTMS sessions.","No",,"No",,"No",,"Yes","No","No","Yes","No","Individual","In Person","Frequency 10 Hz with intensity at 110% of resting motor threshold.","45 minutes for procedure, 25 minutes for rTMS","Daily on weekdays","2","8 sessions total, missed sessions added to end of treatment course","Received 8 rTMS sessions",,,,,,"7.83",,"calculated from reported number of sessions completed by noncompleters and completers",,,,"Not reported","Community","65.79%","Mixed","Combat-related; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Terrorism/political violence/forced displacement; Other (injury threatening survival)","Some Concerns","Thierree S, Raulin-Briot M, Legrand M, et al. Combining trauma script exposure with rTMS to reduce symptoms of post-traumatic stress disorder: randomized controlled trial. Neuromodulation. 2021 Jun;25(4):549-57. doi: 10.1111/ner.13505. PMID: 35667770.","1576800","2023"
"thierree2021_B","thierree2021","Other mixed","2021","PTSD","Active Control",,"38","B","20",,"Sham rTMS and exposure therapy","Sham","Low frequency (1 Hz) rTMS (this frequency thought to have no effect on dorsolateral prefrontal cortex, so considered sham treatment). 60 trains of 5-sec duration with 20-sec intertrain intervals, totaling 300 pulses per session. At enrollment patients prepare written trauma narratives, which they read throughout rTMS sessions.","No",,"No",,"No",,"No","No","Yes","Yes","No","Individual","In Person","Frequency 1 Hz with intensity at 70% of resting motor threshold.","45 minutes for procedure, 25 minutes for rTMS","Daily on weekdays","2","8 sessions total, missed sessions added to end of treatment course","Received 8 rTMS sessions",,,,,,"7.6",,"calculated from reported number of sessions completed by noncompleters and completers",,,,"Not reported","Community","65.79%","Mixed","Combat-related; Rape/sexual assault; Accidents; Illness/medical procedure; Community/school violence; Terrorism/political violence/forced displacement; Other (injury threatening survival)","Some Concerns","Thierree S, Raulin-Briot M, Legrand M, et al. Combining trauma script exposure with rTMS to reduce symptoms of post-traumatic stress disorder: randomized controlled trial. Neuromodulation. 2021 Jun;25(4):549-57. doi: 10.1111/ner.13505. PMID: 35667770.","1576800","2023"
"thorp2019_A","thorp2019","Psychotherapy & CIH","2019","PTSD","PTSD",,"87","A","41",,"PE","Prolonged Exposure (PE)","Treatment following Foa et al. 2007 protocol, including breathing retraining skills, imaginal exposure, and in-vivo exposures","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes",,,"12 sessions","received complete PE intervention",,,,,,"9.39","4.51",,,,,"Not reported","Veteran","0%","Mixed","combat-related, natural or manmade disasters","High","Thorp S, Glassman LH. A randomized controlled trial of prolonged exposure therapy versus relaxation training for older veterans with military-related PTSD. J Anxiety Disord. 2019 May;64:45-54. doi: 10.1016/j.janxdis.2019.02.003. PMID: 30978622.","51843","2020"
"thorp2019_B","thorp2019","Psychotherapy & CIH","2019","PTSD","Active Control",,"87","B","46",,"Relaxation training","Relaxation","Treatment following Taylor et al. 2003 protocol, includes systematic steps to relax through tensing and releasing 16 muscle groups","No",,"No",,"Yes","Relaxation","No","No","Yes","No","No","Individual","In Person",,"90 minutes",,,"12 sessions","received complete relaxation training intervention",,,,,,"9.89","4.18",,,,,"Not reported","Veteran","0%","Mixed","combat-related, natural or manmade disasters","High","Thorp S, Glassman LH. A randomized controlled trial of prolonged exposure therapy versus relaxation training for older veterans with military-related PTSD. J Anxiety Disord. 2019 May;64:45-54. doi: 10.1016/j.janxdis.2019.02.003. PMID: 30978622.","51843","2020"
"tripodi2019_A","tripodi2019","Psychotherapy","2019","PTSD+SUD","PTSD+SUD","Integrated","40","A","20",,"Seeking Safety","Seeking Safety","Seeking Safety in group format (2 groups of 10 women each); manualized intervention addressing both trauma and substance abuse, and ""designed to promote trauma recovery, increase coping strategies, reduce drug and alcohol use, and address mental health issues such as depression and PTSD that stem from traumatic exposure""; consists of 25 modules covering cognitive-behavioral and interpersonal skills, with group leader tailoring topics to the needs of participants.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","2 times a week","12",,"See Detail",,"Study reports drop out before post-test and between post-test and follow-up, reports completed post-test assessment but unclear if this was also treatment completion",,,,,,,,,,"Race data reported","Community","100%",,,"High","Tripodi SJ, Mennicke AM, McCarter SA, et al. Evaluating seeking safety for women in prison: a randomized controlled trial. Res Soc Work Pract. 2019 Mar;29(3):281-90. doi: 10.1177/1049731517706550.","1587979","2020"
"tripodi2019_B","tripodi2019","Psychotherapy","2019","PTSD+SUD","Inactive Control","Not integrated","40","B","20",,"TAU","Treatment as usual (TAU)","Treatment-as-usual, available programming included residential substance abuse treatment, psychological services, mindful meditation, group intervention, and anger management.","No",,"No",,"No",,"No","No","Yes","No","No","Mixed","In Person",,,,"12",,"See Detail",,"Study reports drop out before post-test and between post-test and follow-up, reports completed post-test assessment but unclear if this was also treatment completion",,,,,,,,,,"Race data reported","Community","100%",,,"High","Tripodi SJ, Mennicke AM, McCarter SA, et al. Evaluating seeking safety for women in prison: a randomized controlled trial. Res Soc Work Pract. 2019 Mar;29(3):281-90. doi: 10.1177/1049731517706550.","1587979","2020"
"tucker2001_A","tucker2001","Pharmacotherapy","2001","PTSD","PTSD",,"323","A","151",,"Paroxetine","Paroxetine","SSRI antidepressant, dose increase of 10 mg/day allowed every 2 weeks based on clinician judgment; one dose reduction allowed for illness or adverse event if taking at least 30 mg/day; randomization followed 1-week placebo run-in, with responders excluded","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","Initiated at 20 mg, titrated to maximum 50 mg",,"Daily","12",,,,,,,,,,,,,,"Race data reported","Mixed","65.8%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, seeing someone hurt or die)","High","Tucker PM, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62(11):860-8. PMID: 11775045.","24214","2019"
"tucker2001_B","tucker2001","Pharmacotherapy","2001","PTSD","Inactive Control",,"323","B","156",,"Placebo","Placebo","Titration not described, but one dose reduction allowed for illness or adverse event if taking at least 30 mg equivalent per day; randomization followed 1-week placebo run-in, with responders excluded","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,,,,"Race data reported","Mixed","65.8%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (serious injury, seeing someone hurt or die)","High","Tucker PM, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62(11):860-8. PMID: 11775045.","24214","2019"
"tucker2003_A","tucker2003","Pharmacotherapy","2003","PTSD","PTSD",,"59","A","25",,"Citalopram","Citalopram","SSRI","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","Start at 20 mg/day, titrated up or down by 10 mg/day each week to maximum 50 mg/day",,"Once daily","10",,,,,,,,,,,"36.2 mg/day",,,"Race and Ethnicity data reported","Community","74.14%","Mixed","rape/sexual assault, combat-related, natural or manmade disasters, accidents, terrorism/political violence/forced displacement, community/school violence","Some Concerns","Tucker P, Potter-Kimball R, Wyatt DB, et al. Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo. Psychopharmacol Bull. 2003 Summer;37(3):135-49.  PMID: 14608246.","26085","2019"
"tucker2003_B","tucker2003","Pharmacotherapy","2003","PTSD","PTSD",,"59","B","23",,"Sertraline","Sertraline","SSRI","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","Start at 50 mg/day, titrated up or down by 50 mg/day per week, up to maximum 200 mg/day",,"Once daily","10",,,,,,,,,,,"134.1 mg/day",,,"Race and Ethnicity data reported","Community","74.14%","Mixed","rape/sexual assault, combat-related, natural or manmade disasters, accidents, terrorism/political violence/forced displacement, community/school violence","Some Concerns","Tucker P, Potter-Kimball R, Wyatt DB, et al. Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo. Psychopharmacol Bull. 2003 Summer;37(3):135-49.  PMID: 14608246.","26085","2019"
"tucker2003_C","tucker2003","Pharmacotherapy","2003","PTSD","Inactive Control",,"59","C","10",,"Placebo","Placebo",,"No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Once daily","10",,,,,,,,,,,,,,"Race and Ethnicity data reported","Community","74.14%","Mixed","rape/sexual assault, combat-related, natural or manmade disasters, accidents, terrorism/political violence/forced displacement, community/school violence","Some Concerns","Tucker P, Potter-Kimball R, Wyatt DB, et al. Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo. Psychopharmacol Bull. 2003 Summer;37(3):135-49.  PMID: 14608246.","26085","2019"
"tucker2007_A","tucker2007","Pharmacotherapy","2007","PTSD","PTSD",,"40","A","20",,"Topiramate","Topiramate","Anticonvulsant","No",,"Yes","Mood Stabilizer","No",,"No","No","No","No","No","Individual","In Person","Initiated at 25 mg/day, titrated by 25 to 50 mg/week up to 400 mg/day over 8 weeks, then maintained at same dose for 4 weeks",,"Twice daily","12",,,,,,,,,,,"150 mg/day",,,"Race data reported","Community","78.95%","Mixed","child sexual abuse, child physical abuse, intimate partner violence, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (non-specified)","Low","Tucker P, Trautman RP, Wyatt DB, et al. Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2007 Feb;68(2):201-6. PMID: 17335317.","31122","2019"
"tucker2007_B","tucker2007","Pharmacotherapy","2007","PTSD","Inactive Control",,"40","B","20",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Twice daily","12",,,,,,,,,,,,,,"Race data reported","Community","78.95%","Mixed","child sexual abuse, child physical abuse, intimate partner violence, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (non-specified)","Low","Tucker P, Trautman RP, Wyatt DB, et al. Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2007 Feb;68(2):201-6. PMID: 17335317.","31122","2019"
"tuerk2018_A","tuerk2018","Psychotherapy & pharmacotherapy","2018","PTSD","PTSD",,"26","A","14",,"PE + Yohimbine","Prolonged Exposure (PE) + yohimbine","Yohimbine HCl: alpha-2 adrenergic receptor antagonist; oral dose given 1 hour prior to first imaginal exposure of PE treatment (session 3). PE: manualized trauma-focused treatment including psychoeducation, in vivo exposure, imaginal exposure, and discussion or processing of traumatic events, with homework focused on imaginal and in vivo exposures; early termination criteria: ≥1.5 standard deviation improvement from baseline on PCL-M, or total PCL-M score <30.","Yes","Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","21.6 mg",,"PE: weekly







Yohimbine: once (single dose)","up to 15","PE: up to 15 sessions","completed the entire course of care",,,"administered in clinic",,,,,,,,,"Race data reported","Veteran","0%","Combat-related",,"Some Concerns","Tuerk PW, Wangelin BC, Powers MB, et al. Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cogn. Behav. Ther. 2018 Sep;47(5):351-71. doi: 10.1080/16506073.2018.1432679. PMID: 29448886.","50114","2019"
"tuerk2018_B","tuerk2018","Psychotherapy & pharmacotherapy","2018","PTSD","Active Control",,"26","B","12",,"PE + placebo","Prolonged Exposure (PE) + placebo","Placebo: matching placebo given 1 hour prior to first imaginal exposure of PE treatment (session 3). PE: manualized trauma-focused treatment including psychoeducation, in vivo exposure, imaginal exposure, and discussion or processing of traumatic events, with homework focused on imaginal and in vivo exposures; early termination criteria: ≥1.5 standard deviation improvement from baseline on PCL-M, or total PCL-M score <30.","Yes","Trauma-focused","No","Other pharmacotherapy","No",,"No","No","Yes","No","No","Individual","In Person",,,"PE: weekly







Placebo: once","up to 15","PE: up to 15 sessions","completed the entire course of care",,,"administered in clinic",,,,,,,,,"Race data reported","Veteran","0%","Combat-related",,"Some Concerns","Tuerk PW, Wangelin BC, Powers MB, et al. Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cogn. Behav. Ther. 2018 Sep;47(5):351-71. doi: 10.1080/16506073.2018.1432679. PMID: 29448886.","50114","2019"
"tylee2017_A","tylee2017","Psychotherapy","2017","PTSD","PTSD",,"30","A","15",,"Reconsolidation of traumatic memories","Reconsolidation of Traumatic Memories (RTM)","Brief cognitive intervention targeting the intrusive symptoms of PTSD; procedure includes minimal, nontraumatizing exposure to target trauma, providing dissociative experiences of traumatic memory with structural alterations as needed, design of nontraumatizing versions, and ending when trauma can't be evoked and narrative can be told without significant autonomic arousal. Sessions were separated by ‚â•24 hours.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"120 minutes",,"1 to 3","3 sessions total","completed treatment course",,,,,,,,,,,,"Race data reported","Veteran","0%","Mixed","combat-related, other (not specified)","Some Concerns","Tylee DS, Gray R, Glatt SJ, et al. Evaluation of the reconsolidation of traumatic memories protocol for the treatment of PTSD: a randomized, wait-list-controlled trial. J Mil Veteran Fam Health. 2017;3(1):21-33. doi: 10.3138/jmvfh.4120.","49612","2019"
"tylee2017_B","tylee2017","Psychotherapy","2017","PTSD","Inactive Control",,"30","B","15",,"Waitlist","Waitlist","Waitlist with no active contact with research team outside of assessments.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"5",,"completed waiting period",,,,,,,,,,,,"Race data reported","Veteran","0%","Mixed","combat-related, other (not specified)","Some Concerns","Tylee DS, Gray R, Glatt SJ, et al. Evaluation of the reconsolidation of traumatic memories protocol for the treatment of PTSD: a randomized, wait-list-controlled trial. J Mil Veteran Fam Health. 2017;3(1):21-33. doi: 10.3138/jmvfh.4120.","49612","2019"
"ulmer2011_A","ulmer2011","Psychotherapy","2011","PTSD","PTSD",,"22","A","13",,"Sleep intervention for PTSD","Cognitive Behavioral Therapy for Insomnia (CBT-I) + Imagery Rehearsal Training (IRT)","3 sessions of CBT for insomnia followed by 3 sessions of imagery rehearsal therapy; CBT for insomnia: individually tailored behavioral regimen based on sleep restriction theory, stimulus control, sleep hygiene, and identification and restructuring of dysfunctional beliefs and attitudes regarding sleep; imagery rehearsal therapy: included education about the role of learning in nightmares, visual imagery skill building, and instruction in rescripting nightmares. Participants also used an electronic sleep diary to record subjective sleep symptoms daily (interactive program on hand-held computer).","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour","Biweekly","12",,"completed treatment course",,,,,,,,,,,,"Race data reported","Veteran","31.82%",,,"High","Ulmer CS, Edinger JD, Calhoun PS. A multi-component cognitive-behavioral intervention for sleep disturbance in veterans with PTSD: a pilot study. J Clin Sleep Med. 2011 Feb 15;7(1):57-68.  PMID: 21344046.","36068","2019"
"ulmer2011_B","ulmer2011","Psychotherapy","2011","PTSD","Inactive Control",,"22","B","9",,"Usual care","Electronic sleep diary","Participants also used an electronic sleep diary to record subjective sleep symptoms daily (interactive program on hand-held computer).","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Written",,,,"12",,,,,,,,,,,,,,"Race data reported","Veteran","31.82%",,,"High","Ulmer CS, Edinger JD, Calhoun PS. A multi-component cognitive-behavioral intervention for sleep disturbance in veterans with PTSD: a pilot study. J Clin Sleep Med. 2011 Feb 15;7(1):57-68.  PMID: 21344046.","36068","2019"
"vandenberg2015_A","vandenberg2015","Psychotherapy","2015","PTSD","PTSD",,"155","A","53",,"PE","Prolonged Exposure (PE)","A psychotherapeutic approach that reduces PTSD symptom-severity by systematically exposing the subject, in both imaginary and in vivo ways, to previously avoided traumatic internal and external stimuli.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","8",,"Completed treatment",,"15.1% of participants were early completers, early completion allowed when PSS-SR ≤10 on two consecutive occasions",,,,"7.1",,"Completers only",,,,"Not reported","Community","54.19%","Mixed","rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)","Low","van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.","43279","2019"
"vandenberg2015_B","vandenberg2015","Psychotherapy","2015","PTSD","PTSD",,"155","B","55",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","A psychotherapeutic approach in which memory representations of traumatic life experiences are processed in order to change dysfunctional beliefs about self or others that originated from damaging traumatic experiences.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","8",,"Completed treatment",,"3.6%  of participants were early completers, early completion allowed when PSS-SR ≤10 on two consecutive occasions",,,,"7.8",,"Completers only",,,,"Not reported","Community","54.19%","Mixed","rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)","Low","van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.","43279","2019"
"vandenberg2015_C","vandenberg2015","Psychotherapy","2015","PTSD","Inactive Control",,"155","C","47",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"24",,,,,,,,,,,,,,"Not reported","Community","54.19%","Mixed","rape/sexual assault, child sexual abuse, child other abuse, accidents, natural or manmade disasters, other (traumatic psychosis, war, physical abuse)","Low","van den Berg DP, de Bont PA, van der Vleugel BM, et al. Prolonged exposure vs Eye Movement Desensitization and Reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637. PMID: 25607833.","43279","2019"
"vandenderen2018_A","vandenderen2018","Psychotherapy","2018","PTSD","PTSD",,"85","A","20",,"EMDR + CBT","Eye Movement Desensitization and Reprocessing (EMDR) + cognitive behavioral therapy (CBT) without a trauma focus","EMDR followed by CBT. Two introductory sessions with psychoeducation and discussion of grief and social support (introductory session content was the same for all interventions); 3 sessions of EMDR with alternating eye movements following standard Dutch EMDR treatment protocol; 3 sessions of CBT focused on identifying, challenging, and changing negative cognitions related to the loss with use of behavioral experiments and cognitive restructuring.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"EMDR: 45 to 90 minutes







CBT: 45 minutes",,,"8 sessions total","completed all 8 sessions of treatment",,"also reports number that did not drop out between sessions 1 and 8, so infer that completion is 8 sessions",,,,,,,,,,"Not reported","Community","74.12%","Other","homicidally bereaved","High","van Denderen M, de Keijser J, Stewart R, et al. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: a randomized controlled trial. Clin Psychol Psychother. 2018 Feb 26(25):497-508. doi: 10.1002/cpp.2183. PMID: 29479767.","49818","2019"
"vandenderen2018_B","vandenderen2018","Psychotherapy","2018","PTSD","PTSD",,"85","B","22",,"CBT + EMDR","Cognitive behavioral therapy (CBT) + Eye Desensitization and Reprocessing (EMDR)","CBT followed by EMDR. Two introductory sessions with psychoeducation and discussion of grief and social support (introductory session content was the same for all interventions); 3 sessions of CBT focused on identifying, challenging, and changing negative cognitions related to the loss with use of behavioral experiments and cognitive restructuring; 3 sessions of EMDR with alternating eye movements following standard Dutch EMDR treatment protocol.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"CBT: 45 minutes



EMDR: 45 to 90 minutes",,,"8 sessions total","completed all 8 sessions of treatment",,"also reports number that did not drop out between sessions 1 and 8, so infer that completion is 8 sessions",,,,,,,,,,"Not reported","Community","74.12%","Other","homicidally bereaved","High","van Denderen M, de Keijser J, Stewart R, et al. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: a randomized controlled trial. Clin Psychol Psychother. 2018 Feb 26(25):497-508. doi: 10.1002/cpp.2183. PMID: 29479767.","49818","2019"
"vandenderen2018_C","vandenderen2018","Psychotherapy","2018","PTSD","Inactive Control",,"85","C","43",,"Waitlist","Waitlist","4 month waitin period; 2 arms with initial randomization to waitlist condition (WC then EMDR-CBT or WC the CBT-EMDR)","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"16",,,,,,,,,,,,,,"Not reported","Community","74.12%","Other","homicidally bereaved","High","van Denderen M, de Keijser J, Stewart R, et al. Treating complicated grief and posttraumatic stress in homicidally bereaved individuals: a randomized controlled trial. Clin Psychol Psychother. 2018 Feb 26(25):497-508. doi: 10.1002/cpp.2183. PMID: 29479767.","49818","2019"
"vandenend2024_A","vandenend2024","Psychotherapy","2024","PTSD","PTSD",,"130","A","64",,"Imagery rescripting + group schema therapy","Imagery rescripting + schema therapy","Group schema therapy (GST): treatment for personality disorder ""aimed at identifying and meeting core emotional needs that have not been met in early life (i.e. secure attachment, autonomy, freedom to express, spontaneity and play, and realistic limits)."" Supplemented with additional schema-focused psychomoter therapy (SF-PMT) sessions.
Imagery rescripting (ImRs): standalone PTSD intervention delivered individually, ""aimed at changing emotional and cognitive aspects of aversive memories by changing the course of events within the traumatic memory by using imagination."" Protocol based on existing manuals. Included 4 pre-treatment sessions to acquaint participants with schema concepts and make schema mode case conceptualization.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Mixed","In Person",,"GST -
pre-treatment sessions: 45 minutes
regular GST sessions: 90 minutes
experiential GST block sessions: 75 min
ImRs: 75 minutes","GST -
pre-treatment sessions: weekly
regular GST sessions: weekly
experiential GST block sessions: NR
ImRs: weekly","40 to 52","""40 weekly GST sessions"" + 12 to 18 SF-PMT sessions in 2 to 3 blocks + 12 to 18 weekly ImRs sessions + 3 optional individual booster sessions (schema therapy, SF-PMT, or ImRs). Total duration unclear; Figure S1 shows GST, SF-PMT, and ImRs series running concurrently, but over 12 months instead of 40 weeks","Attending >8 (75%) ImRs
sessions",,"attending at least 75% of GST sessions: 51.56%",,,,,,"for overall sample
GST sessions: mean 33.3 (SD 18.7)
ImRs sessions: mean 9.2 (SD 6.1)
data also provided for completers and non-completers (not entered)",,,,"Not reported","Community","84.61%","Mixed","Child physical abuse; Child sexual abuse; Child other abuse; Rape/sexual assault;  Community/school violence; Other (""life threat"", ""serious injury"")","Some Concerns","van den End A, Beekman ATF, Dekker J, et al. Trauma-focused and personality disorder treatment for posttraumatic stress disorder and comorbid cluster C personality disorder: a randomized clinical trial. Eur J Psychotraumatol. 2024;15(1). doi: 10.1080/20008066.2024.2382652. PMID: 39087734.","1637016","2025"
"vandenend2024_B","vandenend2024","Psychotherapy","2024","PTSD","Active Control",,"130","B","66",,"Imagery rescripting","Imagery rescripting","Standalone PTSD intervention ""aimed at changing emotional and cognitive aspects of aversive memories by changing the course of events within the traumatic memory by using imagination."" Protocol based on existing manuals. Included 4 pre-treatment sessions to acquaint participants with schema concepts and make schema mode case conceptualization.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"75 minutes","Weekly","12 to 18",,"Completing ≥9 ImRs sessions",,,,,,"9.3","6.4","data also provided for completers and non-completers",,,,"Not reported","Community","84.61%","Mixed","Child physical abuse; Child sexual abuse; Child other abuse; Rape/sexual assault;  Community/school violence; Other (""life threat"", ""serious injury"")","Some Concerns","van den End A, Beekman ATF, Dekker J, et al. Trauma-focused and personality disorder treatment for posttraumatic stress disorder and comorbid cluster C personality disorder: a randomized clinical trial. Eur J Psychotraumatol. 2024;15(1). doi: 10.1080/20008066.2024.2382652. PMID: 39087734.","1637016","2025"
"vanderheijden2024_A","vanderheijden2024","Psychotherapy","2024","PTSD","PTSD",,"33","A","17",,"EMDR +  targeted memory reactivation using EMDR clicks","Eye Movement Desensitization and Reprocessing (EMDR) + targeted memory reactivation","Single session of EMDR including standard auditory clicks. While asleep during the following night, patients received targeted memory reactivation (TMR) using the EMDR clicks as auditory cue. TMR: slow oscillation (SO) phase-targeted TMR, using modeling-based closed-loop neurostimulation (M-CLNS) of polysomnography EEG signal to time lock EMDR clicks to SO upwaves.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Single session","0.14","1 day; single EMDR session + TMR during subsequent sleep cycle","completed session",,"single session, infer that all participants completed/assessed",,,,,,"Single session",,,,,"Community","60.6%",,,"High","van der Heijden AC, van der Werf YD, van den Heuvel OA, Talamini LM, van Marle HJF. Targeted memory reactivation to augment treatment in post-traumatic stress disorder. Curr Biol. 2024 Aug 19;34(16):3735-3746.e5. doi: 10.1016/j.cub.2024.07.019. Epub 2024 Aug 7. PMID: 39116885.","1637327","2025"
"vanderheijden2024_B","vanderheijden2024","Psychotherapy","2024","PTSD","Active Control",,"33","B","16",,"EMDR + sham targeted memory reactivation","Eye Movement Desensitization and Reprocessing (EMDR) + sham memory reactivation","Single session of EMDR including standard auditory clicks. While asleep during the following night, patients received no auditory cue (sham targeted memory reactivation [TMR]). Polysomnography EEG was marked at same time targets as in active TMR group (slow oscillation upwaves).","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Single session","0.14","1 day; single EMDR session + sham TMR during subsequent sleep cycle","completed session",,"single session, infer that all participants completed/assessed",,,,,,"Single session",,,,,"Community","60.6%",,,"High","van der Heijden AC, van der Werf YD, van den Heuvel OA, Talamini LM, van Marle HJF. Targeted memory reactivation to augment treatment in post-traumatic stress disorder. Curr Biol. 2024 Aug 19;34(16):3735-3746.e5. doi: 10.1016/j.cub.2024.07.019. Epub 2024 Aug 7. PMID: 39116885.","1637327","2025"
"vanderkolk1994_A","vanderkolk1994","Pharmacotherapy","1994","PTSD","PTSD",,"64","A","33",,"Fluoxetine","Fluoxetine","SSRI antidepressant, Initiated at 20 mg, could titrate by 20 mg weekly up to 60 mg","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","20 mg to 60 mg",,"Daily","5",,,,,,,,,,,"20 mg",,,"Not reported","Mixed","34.38%","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, terrorism/political violence/forced displacement","High","Van der Kolk BA, Dreyfuss D, Michaels MJ, et al. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry. 1994;55(12):517-22. PMID: 7814344.","05244","2019"
"vanderkolk1994_B","vanderkolk1994","Pharmacotherapy","1994","PTSD","Inactive Control",,"64","B","31",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","5",,,,,,,,,,,,,,"Not reported","Mixed","34.38%","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, community/school violence, terrorism/political violence/forced displacement","High","Van der Kolk BA, Dreyfuss D, Michaels MJ, et al. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry. 1994;55(12):517-22. PMID: 7814344.","05244","2019"
"vanderkolk2007_A","vanderkolk2007","Psychotherapy & pharmacotherapy","2007","PTSD","PTSD",,"88","A","29",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","EMDR followed a manual developed for the study that was based on a standard protocol, and targeted trauma memories identified at baseline","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person","90 minutes",,"Weekly","8",,"completed treatment",,"did not drop out during 8 week treatment phase",,,,,,,,,,"Race data reported","Community","82.95%","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)","Some Concerns","Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.","29236","2019"
"vanderkolk2007_B","vanderkolk2007","Psychotherapy & pharmacotherapy","2007","PTSD","PTSD",,"88","B","30",,"Fluoxetine","Fluoxetine","SSRI antidepressant; dose increased weekly in 10-mg increments based on physician assessment of response and adverse effects","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","Sessions: 20 to 30 minute monitoring sessions







Dose: Initiated at 10 mg, titrated to maximum 60 mg",,"Sessions: Weekly







Drug: Daily","8",,"completed treatment",,"did not drop out during 8 week treatment phase",,,,,,,"modal dose 40 mg/day",,,"Race data reported","Community","82.95%","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)","Some Concerns","Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.","29236","2019"
"vanderkolk2007_C","vanderkolk2007","Psychotherapy & pharmacotherapy","2007","PTSD","Inactive Control",,"88","C","29",,"Placebo","Placebo","Placebo pills increased weekly in 10-mg equivalent increments based on physician assessment of response and adverse effects","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","Sessions: 20 to 30 minute monitoring sessions







Dose: NA",,"Sessions: Weekly







Drug: Daily","8",,"completed treatment",,"reported as treatment completers for pill placebo group",,,,,,,,,,"Race data reported","Community","82.95%","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, intimate partner violence, accidents, community/school violence, terrorism/political violence/forced displacement, other (""other adult victimization,"" ""traumatic loss,"" injury)","Some Concerns","Van der Kolk BA, Spinazzola J, Blaustein ME, et al. A randomized clinical trial of Eye Movement Desensitization and Reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. J Clin Psychiatry. 2007 Jan;68(1):37-46. doi: 10.4088/JCP.v68n0105. PMID: 17284128.","29236","2019"
"vanderkolk2014_A","vanderkolk2014","CIH","2014","PTSD","PTSD",,"76","A","32","total n=76 randomized, n=12 withdrew consent prior to treatment (Ns not given by arm), reports on and analyzed n=32","Yoga","Yoga","Trauma-informed Hatha yoga, including breathing, postures, and meditation elements","No",,"No",,"Yes","Yoga","No","No","No","No","No","Group","In Person",,"1 hour","Weekly","10",,"Completed treatment",,"did not drop out during the 10-week treatment phase",,,,,,,,,,"Race and Ethnicity data reported","Community","100%",,,"Some Concerns","van der Kolk BA, Stone L, West J, et al. Yoga as an adjunctive treatment for posttraumatic stress disorder: a randomized controlled trial. J Clin Psychiatry. 2014 Jun;75(6):e559-65. doi: 10.4088/JCP.13m08561. PMID: 25004196.","42647","2019"
"vanderkolk2014_B","vanderkolk2014","CIH","2014","PTSD","Inactive Control",,"76","B","32","total n=76 randomized, n=12 withdrew consent prior to treatment (Ns not given by arm), reports on and analyzed n=32","Women's Health Education","Education","Education focusing on active participation and support, and to increase self-efficacy (no discussion of trauma)","No",,"No",,"No",,"No","No","Yes","No","No","Group","In Person",,"1 hour","Weekly","10",,"Completed treatment",,"did not drop out during the 10-week treatment phase",,,,,,,,,,"Race and Ethnicity data reported","Community","100%",,,"Some Concerns","van der Kolk BA, Stone L, West J, et al. Yoga as an adjunctive treatment for posttraumatic stress disorder: a randomized controlled trial. J Clin Psychiatry. 2014 Jun;75(6):e559-65. doi: 10.4088/JCP.13m08561. PMID: 25004196.","42647","2019"
"vanderkolk2016_A","vanderkolk2016","Nonpharmacologic biological","2016","PTSD","PTSD",,"52","A","28",,"Neurofeedback + TAU","Neurofeedback","EEG training following flexible, principle-based manual; training intended to teach subjects to alter the power spectrum of specific filtered frequencies of activity; reward indicated with auditory and visual feedback (auditory tones, progress in simple computer games); adjustment of reward frequency based on rated symptoms of over-arousal and under-arousal; training time increased by 3-minute increments when subject reported positive change.







Continuation of all ongoing treatments (psychotherapeutic and pharmacological).","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person","Dose:



Inhibit frequencies: 2 to 6 Hz, and 22 to 36 Hz



Reward frequency: initial 10 to 13 Hz","Training time: 12 to 30 minutes","Twice weekly","12",,"completed protocol",,,,,,,,,,,,"Race data reported","Community","85.71%","Mixed","child other abuse, rape/sexual assault, intimate partner violence, other (not specified)","Low","Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.","46581","2019"
"vanderkolk2016_B","vanderkolk2016","Nonpharmacologic biological","2016","PTSD","Inactive Control",,"52","B","24",,"TAU","Treatment as usual (TAU)","Continuation of all ongoing treatments (psychotherapeutic and pharmacological) during waiting period, received neurofeedback intervention after completing week 12 evaluation","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"12",,,,,,,,,,,,,,"Race data reported","Community","85.71%","Mixed","child other abuse, rape/sexual assault, intimate partner violence, other (not specified)","Low","Van der Kolk BA, Hodgdon HB, Gapen MA, et al. A randomized controlled study of neurofeedback for chronic PTSD. PLoS One. 2016 Dec 16;11(12):e0166752. doi: 10.1371/journal.pone.0166752. PMID: 27992435.","46581","2019"
"vangelderen2020_A","vangelderen2020","Other mixed","2020","PTSD","PTSD",,"43","A","22",,"Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR)","Multi-modular motion-assisted memory desensitization and reconsolidation (3MDR)","Manualized intervention combining techniques of virtual reality and EMDR. Participant walks on treadmill while viewing synchronized virtual reality environment, personalized for individual participant with images and music, and going through sequence for EMDR. Each session ended wth therapist-led discussion of experiences.","Yes","Trauma-focused","No",,"No",,"No","No","No","Yes","No","Individual","In Person",,"70 to 90 minutes","Weekly","6",,"Received intervention and did not discontinue",,"flow diagram, participants ""received  intervention"" (n=21) minus those discontinued intervention (n=1)",,,,,,"treatment hours: mean 22.27 (SD 13.49)",,,,"Not reported","Veteran","2.3%","Mixed","combat-related, accidents, illness/medical procedure, community/school violence, terrorism/political violence/forced displacement, other (""severe human suffering"", ""death caused to someone else"", ""explosion or fire"")","Low","van Gelderen MJ, Nijdam MJ, Haagen JFG, et al. Interactive motion-assisted exposure therapy for veterans with treatment-resistant posttraumatic stress disorder: a randomized controlled trial. Psychother Psychosom. 2020 Mar 23;89(4):215-27. doi: 10.1159/000505977. PMID: 32203971.","1569382","2020"
"vangelderen2020_B","vangelderen2020","Other mixed","2020","PTSD","Active Control",,"43","B","21",,"Non-specific treatment component control","Interdisciplinary treatment as usual","Non-trauma-focused treatment delivered by a team with psychiatrist and mental health worker; allowed ""case management, medication consults, stabilizing interventions, psychoeducation, systemic interventions and cognitive behavioral therapy without trauma-focused elements such as exposure or cognitive restructuring of distorted cognitions related to traumatic events""","No",,"No",,"No",,"No","No","Yes","Yes","No","Individual","In Person",,,,"up to 16","Up to 16 weeks","Received intervention and did not discontinue",,"flow diagram, participants ""received  intervention"" (n=21) minus those discontinued intervention (n=1)",,,,,,"treatment hours: mean 20.35 (SD 22.79)",,,,"Not reported","Veteran","2.3%","Mixed","combat-related, accidents, illness/medical procedure, community/school violence, terrorism/political violence/forced displacement, other (""severe human suffering"", ""death caused to someone else"", ""explosion or fire"")","Low","van Gelderen MJ, Nijdam MJ, Haagen JFG, et al. Interactive motion-assisted exposure therapy for veterans with treatment-resistant posttraumatic stress disorder: a randomized controlled trial. Psychother Psychosom. 2020 Mar 23;89(4):215-27. doi: 10.1159/000505977. PMID: 32203971.","1569382","2020"
"vanmeggelen2022_A","vanmeggelen2022","Other mixed","2022","PTSD","PTSD",,"44","A","22",,"Multi Modal Memory Restructuring (3MR)","Multi-modal Memory Restructuring (3MR)","Software application focused on restructuring and relearning past events using photos, narrative texts, maps, and 3D virtual worlds. Participant received introductory session with trained therapist and provided with treatment manual, then autonomously followed through the 12 sessions of 3MR intervention at home with use of the treatment manual.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology alone",,,"Twice a week","6",,"Completed intervention, not further described",,,,,,,,,,,,"Not reported","Mixed","48%","Mixed","Child sexual abuse; Other (""war related"")","High","van Meggelen M, Morina N, van der Heiden C, et al. A randomized controlled trial to pilot the efficacy of a computer-based intervention with elements of virtual reality and limited therapist assistance for the treatment of post-traumatic stress disorder. Front Digit Health. 2022;4:974668. doi: 10.3389/fdgth.2022.974668. PMID: 36329832.","1605011","2023"
"vanmeggelen2022_B","vanmeggelen2022","Other mixed","2022","PTSD","PTSD",,"44","B","22",,"Treatment as usual (TAU)","Treatment as usual (TAU)","12 sessions of a trauma-focused intervention for PTSD (imaginal exposure, eye movement desnsitization and reprocessing, or narrative exposure therapy)","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,,"6","total 12 sessions","Completed intervention, not further described",,,,,,,,,,,,"Not reported","Mixed","48%","Mixed","Child sexual abuse; Other (""war related"")","High","van Meggelen M, Morina N, van der Heiden C, et al. A randomized controlled trial to pilot the efficacy of a computer-based intervention with elements of virtual reality and limited therapist assistance for the treatment of post-traumatic stress disorder. Front Digit Health. 2022;4:974668. doi: 10.3389/fdgth.2022.974668. PMID: 36329832.","1605011","2023"
"vantwoutfrank2019_A","vantwoutfrank2019","Other mixed","2019","PTSD","PTSD",,"20","A",,,"Transcranial direct current stimulation + Virtual reality exposure","Virtual reality exposure therapy (VRET) + Transcranial direct current stimulation (tDCS)","Simultaneous transcranial direct current stimulation and virtual reality exposure



Transcranial direct current stimulation: stimulation targeting ventromedial prefrontal cortex using neuroConn DC Stimulator Plus



Virtual reality exposure: ""head-mounted display with integrated head tracking and stereo earphones presenting combat-related multisensory information"". Each session included driving scenarios with presentation of warzone events.","Yes","Trauma-focused","No",,"No",,"Yes","No","No","No","No","Individual","In Person","Dose: 2 mA (transcranial direct current stimulation)","Session length: 25 minutes",,"2","total 6 sessions","completed 6 VR sessions",,"Infer from study text that all participants completed all sessions, ""Twelve male Veterans with warzone-related PTSD… completed six VR sessions… over two weeks """,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"Some Concerns","van 't Wout-Frank M, Shea MT, Larson VC, et al. Combined transcranial direct current stimulation with virtual reality exposure for posttraumatic stress disorder: feasibility and pilot results. Brain Stimul. 2019 Jan - Feb;12(1):41-3. doi: 10.1016/j.brs.2018.09.011. PMID: 30266416.","1512333","2020"
"vantwoutfrank2019_B","vantwoutfrank2019","Other mixed","2019","PTSD","Active Control",,"20","B",,,"Sham transcranial direct current stimulation + Virtual reality exposure","Virtual reality exposure therapy (VRET) + sham","Simultaneous sham transcranial direct current stimulation and virtual reality exposure



Sham transcranial direct current stimulation: sham stimulation using neuroConn DC Stimulator Plus



Virtual reality exposure: ""head-mounted display with integrated head tracking and stereo earphones presenting combat-related multisensory information"". Each session included driving scenarios with presentation of warzone events.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"Session length: 25 minutes",,"2","total 6 sessions","completed 6 VR sessions",,"Infer from study text that all participants completed all sessions, ""Twelve male Veterans with warzone-related PTSD… completed six VR sessions… over two weeks """,,,,,,,,,,"Not reported","Veteran","0%","Combat-related",,"Some Concerns","van 't Wout-Frank M, Shea MT, Larson VC, et al. Combined transcranial direct current stimulation with virtual reality exposure for posttraumatic stress disorder: feasibility and pilot results. Brain Stimul. 2019 Jan - Feb;12(1):41-3. doi: 10.1016/j.brs.2018.09.011. PMID: 30266416.","1512333","2020"
"vantwoutfrank2024_A","vantwoutfrank2024","Nonpharmacologic biological","2024","PTSD","PTSD",,"54","A","26",,"Transcranial direct current stimulation (tDCS) + warzone virtual reality","Virtual reality exposure therapy (VRET) + Transcranial direct current stimulation (tDCS)","tDCS delivered using NeuroConn DC-Stimulator Plus to ventromedial prefrontal cortex with 2mA current, simultaneous with VR. Bravemind VR application included ""visual, auditory, haptic, and olfactory immersion into virtual Iraq or Afghanistan,"" with events increasing in intensity from riding in an armored vehicle and a distant gun battle to an improvised explosive device [IED] detonating in front of the participant's vehicle causing a lead vehicle to flip.","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person",,"60 minutes total, 25 minutes tDCS","Up to 3 times a week (at least one day between sessions)","2 weeks","Up to 6 sessions over 10 business days, with at least 1 day between sessions","Completed all 6 sessions",,,,,,"5.27",,,,,,"Race and Ethnicity data reported","Veteran","5.56%","Combat-related",,"Low","van't Wout-Frank M, Arulpragasam AR, Faucher C, et al. Virtual reality and transcranial direct current stimulation for posttraumatic stress disorder a randomized clinical trial. JAMA Psychiatry. 2024;81(5):437-46. doi: 10.1001/jamapsychiatry.2023.5661. PMID: 38446471.","1631651","2025"
"vantwoutfrank2024_B","vantwoutfrank2024","Nonpharmacologic biological","2024","PTSD","Inactive Control",,"54","B","28","29 randomized, 1 became ineligible due to increased suicidal ideation and was excluded","Sham direct current stimulation (DCS) + warzone virtual reality","Sham","Sham DCS delivered using NeuroConn study mode to ventromedial prefrontal cortex with 10 µA current pulse over 15 milliseconds every 550 milliseconds and 3 ms peak current, simultaneous with VR. Bravemind VR application included ""visual, auditory, haptic, and olfactory immersion into virtual Iraq or Afghanistan,"" with events increasing in intensity from riding in an armored vehicle and a distant gun battle to an improvised explosive device [IED] detonating in front of the participant's vehicle causing a lead vehicle to flip.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"60 minutes total, 25 minutes sham DCS","Up to 3 times a week (at least one day between sessions)","2 weeks","Up to 6 sessions over 10 business days, with at least 1 day between sessions","Completed all 6 sessions",,,,,,"5.82",,,,,,"Race and Ethnicity data reported","Veteran","5.56%","Combat-related",,"Low","van't Wout-Frank M, Arulpragasam AR, Faucher C, et al. Virtual reality and transcranial direct current stimulation for posttraumatic stress disorder a randomized clinical trial. JAMA Psychiatry. 2024;81(5):437-46. doi: 10.1001/jamapsychiatry.2023.5661. PMID: 38446471.","1631651","2025"
"vanvliet2021_A","vanvliet2021","Psychotherapy","2021","PTSD","PTSD",,"121","A","57",,"STAIR-EMDR","Skills Training in Affect and Interpersonal Regulation (STAIR) + Eye Movement Desensitization and Reprocessing (EMDR)","Phase-based approach with STAIR (8 sessions) followed by EMDR (16 sessions).","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Twice weekly","12","Total 24 sessions (8 STAIR, 16 EMDR)","Completed all sessions",,"Early completer (defined as all trauma targets processed and no longer meet criteria for PTSD), included in count for completers: 50.9%",,,,,,,,,,"Not reported","Community","68.6%","Mixed","Child sexual abuse; Child physical abuse","High","Van Vliet NI, Huntjens RJC, Van DMK, et al. Phase-based treatment versus immediate trauma-focused treatment for post-traumatic stress disorder due to childhood abuse: randomised clinical trial. BJPsych Open. 2021 Nov;7(6):e211. doi: 10.1192/bjo.2021.1057.","1585381","2023"
"vanvliet2021_B","vanvliet2021","Psychotherapy","2021","PTSD","Active Control",,"121","B","64",,"EMDR","Eye Movement Desensitization and Reprocessing (EMDR)","EMDR only (16 sessions)","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"90 minutes","Twice weekly","8","Total 16 sessions","Completed all sessions",,"Early completer (defined as all trauma targets processed and no longer meet criteria for PTSD), included in count for completers: 45.3%",,,,,,,,,,"Not reported","Community","68.6%","Mixed","Child sexual abuse; Child physical abuse","High","Van Vliet NI, Huntjens RJC, Van DMK, et al. Phase-based treatment versus immediate trauma-focused treatment for post-traumatic stress disorder due to childhood abuse: randomised clinical trial. BJPsych Open. 2021 Nov;7(6):e211. doi: 10.1192/bjo.2021.1057.","1585381","2023"
"vera2011_A","vera2011","Psychotherapy","2011","PTSD","PTSD",,"14","A","7",,"PE","Prolonged Exposure (PE)","Individual therapy delivered following the culturally adapted Spanish version of PE manual; this version includes language, idioms, and examples relevant to Latino culture. An addition, optional introductory session was provided with participants and spouse or partner, giving an overview of PTSD and the goals and methods of PE. PE therapy included psychoeducation, imaginal exposure, in vivo exposure, discussion of exposure and processing of traumatic memories, and homework with imaginal and in vivo exposure.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 to 120 minutes","Weekly","16",,"completed all sessions",,,,,,,,,,,,"Not reported","Community","0%",,,"High","Vera M, Reyes-Rabanillo ML, Juarbe D, et al. Prolonged exposure for the treatment of Spanish-speaking Puerto Ricans with posttraumatic stress disorder: a feasibility study. BMC Res. Notes. 2011 Oct 17;4:415. doi: 10.1186/1756-0500-4-415. PMID: 22005187.","38256","2019"
"vera2011_B","vera2011","Psychotherapy","2011","PTSD","Inactive Control",,"14","B","7",,"Usual care","Treatment as usual (TAU)","Participants referred to mental health provider at the study setting or could self-refer for outside provider; treatment in ""most cases"" included pharmacologic medication and/or psychotherapy; allowed changes in psychotropic medication.","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"16",,"≥1 mental health visit",,,,,,,,,,,,"Not reported","Community","0%",,,"High","Vera M, Reyes-Rabanillo ML, Juarbe D, et al. Prolonged exposure for the treatment of Spanish-speaking Puerto Ricans with posttraumatic stress disorder: a feasibility study. BMC Res. Notes. 2011 Oct 17;4:415. doi: 10.1186/1756-0500-4-415. PMID: 22005187.","38256","2019"
"vera2021_A","vera2021","Psychotherapy & CIH","2021","PTSD","PTSD",,"98","A","49",,"Prolonged Exposure","Prolonged Exposure (PE)","PE intervention culturally adapted for Spanish-speaking Latino population in Puerto Rico. Twelve sessions, with a possible extension of up to 15 sessions if needed to reinforce skills. Included breathing training, education about trauma and PTSD, and imaginal and in vivo exposure in sessions and at home.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12 to 15","12 sessions, allowed up to 15 sessions","Completing ≥8 sessions",,"69.4% completed ≥12 sessions",,,,"10.87",,,,,,"Ethnicity data reported","Community","81.6%","Mixed","Combat-related; Rape/sexual assault; Accidents; Community/school violence; Other (exposure to ""unexpected or violent death"")","Some Concerns","Vera M, Oben A, Juarbe D, et al. A randomized clinical trial of prolonged exposure and applied relaxation for the treatment of Latinos with posttraumatic stress disorder. J Trauma Stress. 2022 Apr;35(2):593-604. doi: 10.1002/jts.22773. PMID: 34973048.","1585591","2023"
"vera2021_B","vera2021","Psychotherapy & CIH","2021","PTSD","Active Control",,"98","B","49",,"Applied Relaxation","Relaxation","Applied relaxation skills included detecting early signs of stress, and learning relaxation skills (diaphragmatic breathing and progressive muscle relaxation) to apply at initial signs of stress. Practiced skills in sessions and at home. Twelve sessions, with a possible extension of up to 15 sessions if needed to reinforce skills. Engagement session included to collect information on trauma exposure and reactions.","No",,"No",,"Yes","Relaxation","No","No","Yes","No","No","Individual","In Person",,"60 to 90 minutes","Weekly","12 to 15","12 sessions, allowed up to 15 sessions","Completing ≥8 sessions",,"71.4% completed ≥12 sessions",,,,"11.46",,,,,,"Ethnicity data reported","Community","81.6%","Mixed","Combat-related; Rape/sexual assault; Accidents; Community/school violence; Other (exposure to ""unexpected or violent death"")","Some Concerns","Vera M, Oben A, Juarbe D, et al. A randomized clinical trial of prolonged exposure and applied relaxation for the treatment of Latinos with posttraumatic stress disorder. J Trauma Stress. 2022 Apr;35(2):593-604. doi: 10.1002/jts.22773. PMID: 34973048.","1585591","2023"
"villarreal2016_A","villarreal2016","Pharmacotherapy","2016","PTSD","PTSD",,"80","A","42",,"Quetiapine","Quetiapine","Second generation antipsychotic","No",,"Yes","Antipsychotic","No",,"No","No","No","No","No","Individual","In Person","Target 400 mg, initiated at 25 mg daily, titrate to 400 mg by 2 weeks. Could go up to 800 mg max (50 mg minimum)",,"Daily","12",,,,,,,,,,,"258 mg/day",,,"Race data reported","Veteran","6.25%",,,"High","Villarreal G, Hamner MB, Ca√±ive JM, et al. Efficacy of quetiapine monotherapy in posttraumatic stress disorder: a randomized, placebo-controlled trial. Am J Psychiatry. 2016 Dec;173(12):1205-12. doi: 10.1176/appi.ajp.2016.15070967. PMID: 27418378.","45102","2019"
"villarreal2016_B","villarreal2016","Pharmacotherapy","2016","PTSD","Inactive Control",,"80","B","38",,"Placebo","Placebo","Placebo titrated as per active study drug","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","12",,,,,,,,,,,"463 mg quetiapine equivalent",,,"Race data reported","Veteran","6.25%",,,"High","Villarreal G, Hamner MB, Ca√±ive JM, et al. Efficacy of quetiapine monotherapy in posttraumatic stress disorder: a randomized, placebo-controlled trial. Am J Psychiatry. 2016 Dec;173(12):1205-12. doi: 10.1176/appi.ajp.2016.15070967. PMID: 27418378.","45102","2019"
"voigt2024_A","voigt2024","Psychotherapy & CIH","2024","PTSD","PTSD",,"70","A","35","n=39 randomized; 6 excluded post-randomization for not meeting PTSD criteria","Prebiotic bars + CPT-based intensive PTSD treatment program","Prebiotic","Prebiotic bars using a proprietary formula, designed to promote complementary groups of core beneficial intestinal bacteria and augment production of short chain fatty acids. Bars contained 10 g fiber per bar from 4 prebiotic fibers: resistant starch, rice bran, resistant maltodextrin, and inulin. One bar daily during the first week, then two bars per day for the remaining 11 weeks (total 161 bars). Concurrent with intensive treatment program, and continued at home following completion of intensive treatment program.
All participants also attended the same two-week CPT-based intensive PTSD treatment program, which is comprised of 16 twice daily 50-min sessions of individual CPT as well as adjunctive services such as psychoeducation, art therapy, and mindfulness training.","Yes","Trauma-focused","No",,"Yes","Natural products","No","No","No","No","No","Individual","In Person","10 g prebiotic fiber/bar",,"Week 1: daily
Weeks 2-12: twice a day","12","total 161 bars over 12 weeks; intensive PTSD treatment program 2 weeks",,,,"Average compliance (%, bars consumed out of 161)","94%","Mean bars consumed: 151",,,,,,,"Race and Ethnicity data reported","Mixed","54.3%","Mixed","MST; Combat-related","High","Voigt RM, Engen PA, Villanueva M, Bambi SA, Green SJ, Naqib A, Raeisi S, Shaikh M, Hamaker BR, Cantu-Jungles TM, Pridgen SA, Held P, Keshavarzian A. Prebiotics as an adjunct therapy for posttraumatic stress disorder: a pilot randomized controlled trial. Front Neurosci. 2025 Jan 7;18:1477519. doi: 10.3389/fnins.2024.1477519. PMID: 39840022; PMCID: PMC11747240.","1643865","2025"
"voigt2024_B","voigt2024","Psychotherapy & CIH","2024","PTSD","Active Control",,"70","B","35","n=41 randomized; 6 excluded post-randomization for not meeting PTSD criteria","Placebo bars + CPT-based intensive PTSD treatment program","Placebo","Placebo bars were produced by the same manufacturer and
used the same ingredients but without the prebiotic fibers and had
identical packaging. One bar daily during the first week, then two bars per day for the remaining 11 weeks (total 161 bars). Concurrent with intensive treatment program, and continued at home following completion of intensive treatment program.
All participants also attended the same two-week CPT-based intensive PTSD treatment program, which is comprised of 16 twice daily 50-min sessions of individual CPT as well as adjunctive services such as psychoeducation, art therapy, and mindfulness training.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Week 1: daily
Weeks 2-12: twice a day","12","total 161 bars over 12 weeks; intensive PTSD treatment program 2 weeks",,,,"Average compliance (%, bars consumed out of 161)","80%","Mean bars consumed: 129",,,,,,,"Race and Ethnicity data reported","Mixed","54.3%","Mixed","MST; Combat-related","High","Voigt RM, Engen PA, Villanueva M, Bambi SA, Green SJ, Naqib A, Raeisi S, Shaikh M, Hamaker BR, Cantu-Jungles TM, Pridgen SA, Held P, Keshavarzian A. Prebiotics as an adjunct therapy for posttraumatic stress disorder: a pilot randomized controlled trial. Front Neurosci. 2025 Jan 7;18:1477519. doi: 10.3389/fnins.2024.1477519. PMID: 39840022; PMCID: PMC11747240.","1643865","2025"
"voorendonk2023_A","voorendonk2023","Other mixed","2023","PTSD","PTSD",,"119","A","59",,"Intensive trauma-focused treatment for PTSD + Physical activity","Exercise","Physical activity: prescribed combination of aerobic and resistance training performed at moderate intensity, including outside walking sessions, aerobic group games, and online physical activity sessions in individual and group formats.
Intensive trauma-focused treatment for PTSD: daily treatment including individual PE, EMDR, and group psychoeducation. All participants received the same duration and frequency of these components.","Yes","Trauma-focused","No",,"No",,"No","No","No","Yes","No","Mixed","Mixed",,"Physical activity: 90 minutes","Daily","2","8 sessions total over 2 weeks (2x4 consecutive days with a 3 day pause in between)","Completed intervention",,"Not specified whether intervention completion definition included completion of both physical activity and intensive trauma-focused treatment for PTSD or physical activity sessions only",,,,,,,,,,"Not reported","Community","84.9%","Mixed","Natural or manmade disasters; Other (sexual abuse, not further specified; physical abuse, not further specified)","Some Concerns","Voorendonk EM, Sanches SA, Tollenaar MS, et al. Adding physical activity to intensive trauma-focused treatment for post-traumatic stress disorder: results of a randomized controlled trial. Front Psychol. 2023;14 doi: 10.3389/fpsyg.2023.1215250. PMID: 37546473.","1624212","2024"
"voorendonk2023_B","voorendonk2023","Other mixed","2023","PTSD","Active Control",,"119","B","60",,"Intensive trauma-focused treatment for PTSD + Non-physical activity","Attention control","Non-physical activity: prescribed mix of guided (creative) tasks that did not involve physical activity and performed while seated, including craft activities, board games, or reading, and a mix of individual and group and indoor and outdoor activities.
Intensive trauma-focused treatment for PTSD: daily treatment including individual PE, EMDR, and group psychoeducation. All participants received the same duration and frequency of these components.","Yes","Trauma-focused","No",,"Yes","Creative therapies","No","No","Yes","No","No","Mixed","Mixed",,"Non-physical activity: 90 minutes","Daily","2","8 sessions total over 2 weeks (2x4 consecutive days with a 3 day pause in between)","Completed intervention",,"Not specified whether intervention completion definition included completion of both non-physical activity and intensive trauma-focused treatment for PTSD or non-physical activity sessions only",,,,,,,,,,"Not reported","Community","84.9%","Mixed","Natural or manmade disasters; Other (sexual abuse, not further specified; physical abuse, not further specified)","Some Concerns","Voorendonk EM, Sanches SA, Tollenaar MS, et al. Adding physical activity to intensive trauma-focused treatment for post-traumatic stress disorder: results of a randomized controlled trial. Front Psychol. 2023;14 doi: 10.3389/fpsyg.2023.1215250. PMID: 37546473.","1624212","2024"
"wagner2007_A","wagner2007","Psychotherapy","2007","PTSD","PTSD",,"8","A","4",,"Behavioral Activation","Behavioral activation (BA)","Identification and enactment of activities that are reinforcing to individual's long-term goals. Program includes identification of goals and activities, identification of patterns of avoidance that block attainment of these goals, and alternative coping strategies. Psychoeducation modified to include descriptions of PTSD symptoms and emphasize the role of avoidance in PTSD","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 to 90 minutes",,,"4 to 6 sessions total, mean 9.8 (SD = 3.0) weeks from first session to last session","completed treatment",,"""One of the four patients was not done with treatment at the time of the 3-month assessment""",,,,"5.75","0.5",,,,,"Race data reported","Community","62.5%","Accidents",,"High","Wagner AW, Zatzick DF, Ghesquiere A, et al. Behavioral activation as an early intervention for posttraumatic stress disorder and depression among physically injured trauma survivors. Cogn Behav Pract. 2007 Nov;14(4):341-9. doi: 10.1016/j.cbpra.2006.05.002.","32469","2019"
"wagner2007_B","wagner2007","Psychotherapy","2007","PTSD","Inactive Control",,"8","B","4",,"TAU","Treatment as usual (TAU)","Participants offered a list of community referrals","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Race data reported","Community","62.5%","Accidents",,"High","Wagner AW, Zatzick DF, Ghesquiere A, et al. Behavioral activation as an early intervention for posttraumatic stress disorder and depression among physically injured trauma survivors. Cogn Behav Pract. 2007 Nov;14(4):341-9. doi: 10.1016/j.cbpra.2006.05.002.","32469","2019"
"wagner2019_A","wagner2019","Psychotherapy","2019","PTSD","PTSD",,"80","A","42",,"Behavioral activation","Behavioral activation (BA)","Treatment following Bartell et al. 2001 protocol, including behavioral analyses for assessing avoidance patterns, activity scheduling and monitoring of reactions, present-centered strategies to decrease rumination, and psychoeducation","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"45 to 60 minutes",,,"8 sessions",,,,,,,"6.65","2.88",,,,,"Race and Ethnicity data reported","Veteran","6.25%","Other","military-related","Some Concerns","Wagner AW, Jakupcak M, Kowalski HM, et al. Behavioral activation as a treatment for posttraumatic stress disorder among returning veterans: a randomized trial. Psychiatr Serv. 2019 Oct 1;70(10):867-73. doi: 10.1176/appi.ps.201800572. PMID: 31337325.","52288","2020"
"wagner2019_B","wagner2019","Psychotherapy","2019","PTSD","Active Control",,"80","B","38",,"Standard care","Treatment as usual (TAU)","Participants were allowed any standard care, including PE, CPT, alternative treatments and coping-skills training (e.g., acceptance and commitment therapy, anger management). All patients were offered ≥6 individual psychotherapy appointments","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,,"≥6 sessions",,,,,,,"2.55","2.4","individual psychotherapy sessions",,,,"Race and Ethnicity data reported","Veteran","6.25%","Other","military-related","Some Concerns","Wagner AW, Jakupcak M, Kowalski HM, et al. Behavioral activation as a treatment for posttraumatic stress disorder among returning veterans: a randomized trial. Psychiatr Serv. 2019 Oct 1;70(10):867-73. doi: 10.1176/appi.ps.201800572. PMID: 31337325.","52288","2020"
"wahbeh2016_A","wahbeh2016","CIH","2016","PTSD","PTSD",,"114","A","27","total n=114 randomized (Ns not given by arm), n=12 withdrew (Ns not given by arm), reports on and analyzed n=27","Mindfulness meditation","Mindfulness","Body scan mindfulness technique training; at each session the research assistant read a script defining mindfulness, explaining each aspect of the definition and provided examples for how to deepen the skills and their importance to mindfulness practice; training was with an audio recording, performed in silence, stillness and sitting upright; instructed to gently redirect wandering attention back to the body part that was the focus of awareness. Guided meditation did not direct attention to the breath or breathing process. Participants were asked to practice at home daily between sessions using the same recording, and submit weekly logs of practice.","No",,"No",,"Yes","Meditation","No","No","No","No","No","Individual","In Person",,"20 minutes","Weekly","6",,"See Detail",,"publication reports study/assessment completion only, no information specifically on treatment completion",,,,,,,,,,"Race data reported","Veteran","5.88%",,,"High","Wahbeh H, Goodrich E, Goy E, et al. Mechanistic pathways of mindfulness meditation in combat veterans with posttraumatic stress disorder. J Clin Psychol. 2016 Apr;72(4):365-83. doi: 10.1002/jclp.22255. PMID: 26797725.","48070","2019"
"wahbeh2016_B","wahbeh2016","CIH","2016","PTSD","PTSD",,"114","B","25","total n=114 randomized (Ns not given by arm), n=12 withdrew (Ns not given by arm), reports on and analyzed n=25","Slow breathing (RESPeRATE biofeedback device)","Biofeedback","Used the RESPeRATE breathing biofeedback device designed to reduce respiratory rate.","No",,"No",,"Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"20 minutes","Weekly","6",,"See Detail",,"publication reports study/assessment completion only, no information specifically on treatment completion",,,,,,,,,,"Race data reported","Veteran","5.88%",,,"High","Wahbeh H, Goodrich E, Goy E, et al. Mechanistic pathways of mindfulness meditation in combat veterans with posttraumatic stress disorder. J Clin Psychol. 2016 Apr;72(4):365-83. doi: 10.1002/jclp.22255. PMID: 26797725.","48070","2019"
"wahbeh2016_C","wahbeh2016","CIH","2016","PTSD","PTSD",,"114","C","25","total n=114 randomized (Ns not given by arm), n=12 withdrew (Ns not given by arm), reports on and analyzed n=25","Mindfulness meditation + slow breathing","Mindfulness meditation + slow breathing","Mindfulness training focusing attention on the breath; at each session the research assistant read a script defining mindfulness, explaining each aspect of the definition and provided examples for how to deepen the skills and their importance to mindfulness practice; training was with an audio recording and participants sat upright; attention directed to the breath with conscious observation of breathing, naturally slowing their breath. Participants were asked to practice at home daily between sessions using the same recording, and submit weekly logs of practice.","No",,"No",,"Yes","Meditation","No","No","No","No","No","Individual","In Person",,"20 minutes","Weekly","6",,"See Detail",,"publication reports study/assessment completion only, no information specifically on treatment completion",,,,,,,,,,"Race data reported","Veteran","5.88%",,,"High","Wahbeh H, Goodrich E, Goy E, et al. Mechanistic pathways of mindfulness meditation in combat veterans with posttraumatic stress disorder. J Clin Psychol. 2016 Apr;72(4):365-83. doi: 10.1002/jclp.22255. PMID: 26797725.","48070","2019"
"wahbeh2016_D","wahbeh2016","CIH","2016","PTSD","Inactive Control",,"114","D","25","total n=114 randomized (Ns not given by arm), n=12 withdrew (Ns not given by arm), reports on and analyzed n=25","Sitting quietly","Sitting quietly","Participants sat quietly while listening to a neutral-content audiobook during sessions. Participants were asked to practice at home daily between sessions by sitting quietly alone and engaging in an activity besides watching TV or browsing the internet, asked to submit weekly logs of practice.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"20 minutes","Weekly","6",,"See Detail",,"publication reports study/assessment completion only, no information specifically on treatment completion",,,,,,,,,,"Race data reported","Veteran","5.88%",,,"High","Wahbeh H, Goodrich E, Goy E, et al. Mechanistic pathways of mindfulness meditation in combat veterans with posttraumatic stress disorder. J Clin Psychol. 2016 Apr;72(4):365-83. doi: 10.1002/jclp.22255. PMID: 26797725.","48070","2019"
"wakusawa2023_A","wakusawa2023","Other mixed","2023","PTSD","PTSD",,"22","A","11",,"Traumatic stress protocol","Traumatic stress protocol","Traumatic stress protocol (TSP): simplified somatic EMDR
protocol consisting of simplified eye movement desensitization and reprocessing (EMDR) with bilateral tactile stimuli at 4 body points, in combination with microdosed pharmacotherapy and Kampo (traditional Chinese herbal medicines. Microdosed pharmacotherapy: 0.2 mg/day aripiprazole, 2 mg/day lithium carbonate, 0.8 mg/day ramelteon. Kampo: 5 g/day of Gui Zhi Jia Shao Yao Tang (GST) or Xiao Jian Zhong Wan (XJW) and 5 g/day or Si Wu Tang Wan (SWW) or Shi Quan Da Bu Wan (SDW).","Yes","Trauma-focused","Yes","Other pharmacotherapy","Yes","Natural products","No","No","No","No","No","Individual","In Person","aripiprazole: 0.2 mg/day
lithium carbonate: 2 mg/day
ramelteon: 0.8 mg/day ramelteon
Chinese traditional herbal medicine (Kampo): total 10 g/day","EMDR: 15 minutes","every 2 weeks","8","4-5 EMDR sessions every 2-3 weeks, over about 2 months",,,,,,,"5.4","0.8",,,,,"Not reported","Community","90.9%","Mixed","Other (""childhood abuse"" not further specified); Other (not specified)","High","Wakusawa K, Sugiyama T, Hotta H, et al. Triadic therapy based on somatic eye movement desensitization and reprocessing for complex posttraumatic stress disorder: a pilot randomized controlled study. Journal of EMDR Practice and Research. 2023;17(3):159-70. doi: 10.1891/EMDR-2023-0014.","1630652","2024"
"wakusawa2023_B","wakusawa2023","Other mixed","2023","PTSD","Inactive Control",,"22","B","11",,"Waitlist","Waitlist","Waitlist","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"8",,,,,,,,,,,,,,"Not reported","Community","90.9%","Mixed","Other (""childhood abuse"" not further specified); Other (not specified)","High","Wakusawa K, Sugiyama T, Hotta H, et al. Triadic therapy based on somatic eye movement desensitization and reprocessing for complex posttraumatic stress disorder: a pilot randomized controlled study. Journal of EMDR Practice and Research. 2023;17(3):159-70. doi: 10.1891/EMDR-2023-0014.","1630652","2024"
"wallace2022_A","wallace2022","Other Mixed","2022","PTSD","PTSD",,"30","A","15","study completers; overall study n=30 allocated out of 32 ""randomized"" by alternation","diaphragmatic breathing with  BreatheWell Wear + TAU","Relaxation","Diaphragmatic breathing with BreatheWell Wear: twice daily during slow, calm periods and are encouraged to use DB when they experience stress or anxiety, with help from the BreatheWell Wear smartwatch App.

TAU: intensive outpatient rehabilitation program, SHARE, with individual and group therapies, including physical, occupational, recreational, speech-language/cognitive and behavioral health, targeted to support patient goal attainment, as well as instruction in diaphragmatic breathing  by their behavioral health provider; participants are instructed to practice diaphragmatic breathing","No",,"No",,"Yes","Relaxation","No","No","No","Yes","No","Mixed","In Person",,,,"4",,"See Detail",,"treatment completion not defined, reports study (assessment) completion (n=15); also reports app usability metrics",,,,"31.13","18.25","Number of breathing sessions",,,,"Race and Ethnicity data reported","Veteran","6.7%",,,"High","Wallace T, Morris JT, Glickstein R, et al. Implementation of a Mobile Technology-Supported Diaphragmatic Breathing Intervention in Military mTBI With PTSD. J Head Trauma Rehabil. 2022 May-Jun;37(3):152-61. doi: 10.1097/HTR.0000000000000774. PMID: 35703895.","1620172","2023"
"wallace2022_B","wallace2022","Other Mixed","2022","PTSD","PTSD",,"30","B","15","study completers; overall study n=30 allocated out of 32 ""randomized"" by alternation","diaphragmatic breathing + TAU","Relaxation","Diaphragmatic breathing: instruction in diaphragmatic breathing by their behavioral health provider using alarm on their personal smartphone

TAU: intensive outpatient rehabilitation program, SHARE, with individual and group therapies, including physical, occupational, recreational, speech-language/cognitive and behavioral health, targeted to support patient goal attainment, as well as education on diaphragmatic breathing by their behavioral health provider","No",,"No",,"Yes","Relaxation","No","No","No","Yes","No","Mixed","In Person",,,,"4",,"See Detail",,"treatment completion not defined, reports study (assessment) completion (n=15)",,,,"14.73","14.27","Number of breathing sessions",,,,"Race and Ethnicity data reported","Veteran","6.7%",,,"High","Wallace T, Morris JT, Glickstein R, et al. Implementation of a Mobile Technology-Supported Diaphragmatic Breathing Intervention in Military mTBI With PTSD. J Head Trauma Rehabil. 2022 May-Jun;37(3):152-61. doi: 10.1097/HTR.0000000000000774. PMID: 35703895.","1620172","2023"
"walter2023_A","walter2023","Psychotherapy","2023","PTSD","PTSD",,"94","A","47",,"Behavioral activation (BA) + cognitive processing therapy (CPT)","Behavioral activation (BA) + Cognitive Processing Therapy (CPT)","Behavioral activation integrated with CPT: Manualized individual therapy; ""selected content from the BATD-R (Brief Behavioral Activation Treatment for Depression: Revised) manual was incorporated into the CPT protocol. Specifically, BA content was the sole focus of the first two sessions and integrated into the CPT sessions thereafter."" Session contents included psychoeducation, activity tracking, value and activity assessment, behavioral goals, and CPT content.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","14","14 weekly sessions, goal to complete all within 20 weeks","Completed all 14 sessions (completed protocol)",,,,,,"10.9","4.8","12.8% of participants received extra sessions",,,,"Race and Ethnicity data reported","Active Duty Military","55.3%","Mixed","Combat-related; Rape/sexual assault; Other (not specified)","Low","Walter KH, Hunt WM, Otis NP, et al. Comparison of behavioral activation-enhanced cognitive processing therapy and cognitive processing therapy among U.S. service members: a randomized clinical trial. Psychiatry Res. 2023;326 doi: 10.1016/j.psychres.2023.115330. PMID: 37418778.","1622357","2024"
"walter2023_B","walter2023","Psychotherapy","2023","PTSD","Active Control",,"94","B","47",,"Cognitive processing therapy (CPT)","Cognitive Processing Therapy (CPT)","Manualized individual therapy; used the 12-session CPT Veteran/Military Version manual including the written trauma account. CPT treatment aims to ""encourage examination and modification of
trauma-related beliefs, with the goal of adopting more realistic beliefs
and subsequent emotions"". CPT did not include behavioral activation or psychoeducation about depression.","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"60 minutes","Weekly","12","12 weekly sessions, goal to complete all within 20 weeks; some participants received additional sessions","Completed all 12 sessions (completed protocol)",,,,,,"9.7","5","21.3% of participants received extra sessions",,,,"Race and Ethnicity data reported","Active Duty Military","55.3%","Mixed","Combat-related; Rape/sexual assault; Other (not specified)","Low","Walter KH, Hunt WM, Otis NP, et al. Comparison of behavioral activation-enhanced cognitive processing therapy and cognitive processing therapy among U.S. service members: a randomized clinical trial. Psychiatry Res. 2023;326 doi: 10.1016/j.psychres.2023.115330. PMID: 37418778.","1622357","2024"
"walters2020_A","walters2020","Psychotherapy","2020","PTSD","PTSD",,"23","A","12",,"IRT + CBT-I","Cognitive Behavioral Therapy for Insomnia (CBT-I) + Imagery Rehearsal Training (IRT)","IRT: manualized therapy for nightmares; did not include exposure to the nightmare



CBT-I: comprised of ""psychoeducation on chronic insomnia, sleep restriction, stimulus control, sleep hygiene, stress reduction and relaxation, decatastrophization of consequences through cognitive restructuring, and relapse prevention""","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","12","5 weeks IRT and 7 weeks CBT-I","completed treatment",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","17.39%","Combat-related",,"High","Walters EM, Jenkins MM, Nappi CM, et al. The impact of prolonged exposure on sleep and enhancing treatment outcomes with evidence-based sleep interventions: a pilot study. Psychol Trauma. 2020 Feb;12(2):175-85. doi: 10.1037/tra0000478. PMID: 31246050.","52102","2020"
"walters2020_B","walters2020","Psychotherapy","2020","PTSD","Active Control",,"23","B","11",,"Supportive care therapy","Supportive counseling","Nondirective Rogerian therapy, strictly avoided components of IRT and CBT-I. Uses empathetic listening, clarification of goals, and nondirective questioning to help participants ""better understand their emotional response to PTSD symptoms and provide supportive, unconditional positive regard to managing their own PTSD symptoms"".","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"60 minutes","Weekly","12",,"completed treatment",,,,,,,,,,,,"Race and Ethnicity data reported","Mixed","17.39%","Combat-related",,"High","Walters EM, Jenkins MM, Nappi CM, et al. The impact of prolonged exposure on sleep and enhancing treatment outcomes with evidence-based sleep interventions: a pilot study. Psychol Trauma. 2020 Feb;12(2):175-85. doi: 10.1037/tra0000478. PMID: 31246050.","52102","2020"
"wang2012_A","wang2012","Other mixed","2012","PTSD","PTSD",,"138","A","69",,"Electroacupuncture","Acupuncture","Scalp electroacupuncture on Sishencong, Baihui, Shenting, and Fengchi points using continuous wave of 100 Hz.","No",,"No",,"Yes","Acupuncture","No","No","No","No","No","Individual","In Person","30 minutes",,"Every other day","12",,"completed treatment",,,,,,,,,,,,"Not reported","Community","58.14%","Natural or manmade disasters",,"High","Wang Y, Hu YP, Wang WC, et al. Clinical studies on treatment of earthquake-caused posttraumatic stress disorder using electroacupuncture. Evid Based Complement Alternat Med. 2012;2012:431279. doi: 10.1155/2012/431279. PMID: 23049609.","40245","2019"
"wang2012_B","wang2012","Other mixed","2012","PTSD","PTSD",,"138","B","69",,"Paroxetine","Paroxetine","SSRI","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","20 mg",,"Daily","12",,"completed treatment",,,,,,,,,,,,"Not reported","Community","58.14%","Natural or manmade disasters",,"High","Wang Y, Hu YP, Wang WC, et al. Clinical studies on treatment of earthquake-caused posttraumatic stress disorder using electroacupuncture. Evid Based Complement Alternat Med. 2012;2012:431279. doi: 10.1155/2012/431279. PMID: 23049609.","40245","2019"
"watkins2023_A","watkins2023","Psychotherapy","2023","PTSD","PTSD",,"112","A","78",,"Cognitive processing therapy","Cognitive Processing Therapy (CPT)","Trauma-focused cognitive processing therapy","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"1 hour","Twice weekly","6","total 12 sessions","Attended 8 or more sessions",,"72% completed all sessions",,,,"9.7","4.1",,,,,"Race data reported","Mixed","56%","Mixed","Combat-related; Child physical abuse; Child sexual abuse; Rape/Sexual assault; Other (""adult physical abuse"")","Low","Watkins LL, LoSavio ST, Calhoun P, et al. Effect of cognitive processing therapy on markers of cardiovascular risk in posttraumatic stress disorder patients: a randomized clinical trial. J Psychosom Res. 2023;170:111351. doi: 10.1016/j.jpsychores.2023.111351. PMID: 37178469.","1620764","2024"
"watkins2023_B","watkins2023","Psychotherapy","2023","PTSD","Inactive Control",,"112","B","34",,"Waitlist","Attention control","Waitlist with minimal attention provided in the form of weekly telephone calls to assess current emotional state; if participant reported experiencing a crisis then provided supportive, nondirective, brief counseling.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Phone",,,"Weekly","6","total 6 phone calls","Completed all 6 phone sessions",,,,,,"5.9","1",,,,,"Race data reported","Mixed","56%","Mixed","Combat-related; Child physical abuse; Child sexual abuse; Rape/Sexual assault; Other (""adult physical abuse"")","Low","Watkins LL, LoSavio ST, Calhoun P, et al. Effect of cognitive processing therapy on markers of cardiovascular risk in posttraumatic stress disorder patients: a randomized clinical trial. J Psychosom Res. 2023;170:111351. doi: 10.1016/j.jpsychores.2023.111351. PMID: 37178469.","1620764","2024"
"watson1997_A","watson1997","CIH","1997","PTSD","PTSD",,"90","A","30",,"Relaxation Instruction","Relaxation","Participants seated in a comfortable reclining chair and instructed to relax as much as possible","No",,"No",,"Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"30 minutes",,,"10 sessions total","Participated in at least 9 or the 10 sessions",,"""Only subjects who participated in at least 9 of the 10 scheduled sessions were included in the analyses. Those who did not complete at least nine sessions were dropped from the study and replaced by other volunteers.""",,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%",,,"High","Watson CG, Tuorila JR, Vickers KS, et al. The efficacies of three relaxation regimens in the treatment of PTSD in Vietnam War veterans. J Clin Psychol. 1997 Dec;53(8):917-23. doi: 10.1002/(SICI)1097-4679(199712)53:8<917::AID-JCLP17>3.0.CO;2-N. PMID: 9403395.","09969","2019"
"watson1997_B","watson1997","CIH","1997","PTSD","PTSD",,"90","B","30",,"Relaxation Instruction with deep breathing exercise","Relaxation with deep breathing exercise","Participants seated in a comfortable reclining chair and instructed to relax and practice deep breathing","No",,"No",,"Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"30 minutes",,,"10 sessions total","Participated in at least 9 or the 10 sessions",,"""Only subjects who participated in at least 9 of the 10 scheduled sessions were included in the analyses. Those who did not complete at least nine sessions were dropped from the study and replaced by other volunteers.""",,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%",,,"High","Watson CG, Tuorila JR, Vickers KS, et al. The efficacies of three relaxation regimens in the treatment of PTSD in Vietnam War veterans. J Clin Psychol. 1997 Dec;53(8):917-23. doi: 10.1002/(SICI)1097-4679(199712)53:8<917::AID-JCLP17>3.0.CO;2-N. PMID: 9403395.","09969","2019"
"watson1997_C","watson1997","CIH","1997","PTSD","PTSD",,"90","C","30",,"Relaxation instruction with deep breathing and biofeedback","Relaxation with deep breathing and biofeedback","Participants seated in a comfortable reclining chair and instructed to relax and practice deep breathing. In addition, a tone indicating level of relaxation by change one tone for every tenth of a degree Fahrenheit was played","No",,"No",,"Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"30 minutes",,,"10 sessions total","Participated in at least 9 or the 10 sessions",,"""Only subjects who participated in at least 9 of the 10 scheduled sessions were included in the analyses. Those who did not complete at least nine sessions were dropped from the study and replaced by other volunteers.""",,,,,,,,,,"Race and Ethnicity data reported","Veteran","0%",,,"High","Watson CG, Tuorila JR, Vickers KS, et al. The efficacies of three relaxation regimens in the treatment of PTSD in Vietnam War veterans. J Clin Psychol. 1997 Dec;53(8):917-23. doi: 10.1002/(SICI)1097-4679(199712)53:8<917::AID-JCLP17>3.0.CO;2-N. PMID: 9403395.","09969","2019"
"watts2012_A","watts2012","Nonpharmacologic biological","2012","PTSD","PTSD",,"20","A","10",,"rTMS","Transcranial magnetic stimulation (TMS)","Neuronetic 2100 (Neuronetics, LLC, Marietta, GA) used. Before the first session, the right motor threshold was determined by increasing the intensity of stimulation by 2.5% increments over the right motor cortex until there is any movement of the digits of the left hand. For subsequent treatments the coil was placed 4 cm anterior parasagittally and 2 cm laterally of the motor strip location that caused hand movement. This placement approximated the location of the right dorsolateral prefrontal cortex. Active rTMS was delivered to the right dorsolateral prefrontal cortex at 90% of motor threshold","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person","Cycles were 1 Hz for a total of 20 minutes per day. Each 1 minute cycle consisted of a 20-second stimulation train with a 40-second intertrain interval.","Cycles were 1 Hz for a total of 20 minutes per day. Each 1 minute cycle consisted of a 20-second stimulation train with a 40-second intertrain interval.","Daily","1.43",,"See Detail",,"does not report any study or treatment dropouts",,,,,,,,,,"Race data reported","Veteran","10%","Mixed","combat-related, rape/sexual assault, community/school violence, other (multiple trauma)","High","Watts BV, Landon B, Groft A, et al. A sham controlled study of repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Brain Stimul. 2012 Jan;5(1):38-43. doi: 10.1016/j.brs.2011.02.002. PMID: 22264669.","38446","2019"
"watts2012_B","watts2012","Nonpharmacologic biological","2012","PTSD","Inactive Control",,"20","B","10",,"Sham rTMS","Sham","Motor threshold determined by increasing the intensity of stimulation by 2.5% increments over the right motor cortex until left-hand digit movement. Subsequent treatments given using a sham magnetic coil that looks and sounds identical to the active coil, but prevents magnetic energy from leaving the device.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","Cycles were 1 Hz for a total of 20 minutes per day. Each 1 minute cycle consisted of a 20-second stimulation train with a 40-second intertrain interval.","Cycles were 1 Hz for a total of 20 minutes per day. Each 1 minute cycle consisted of a 20-second stimulation train with a 40-second intertrain interval.","Daily","1.43",,"See Detail",,"does not report any study or treatment dropouts",,,,,,,,,,"Race data reported","Veteran","10%","Mixed","combat-related, rape/sexual assault, community/school violence, other (multiple trauma)","High","Watts BV, Landon B, Groft A, et al. A sham controlled study of repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Brain Stimul. 2012 Jan;5(1):38-43. doi: 10.1016/j.brs.2011.02.002. PMID: 22264669.","38446","2019"
"wells2012_A","wells2012","Psychotherapy","2012","PTSD","PTSD",,"20","A","10",,"Metacognitive therapy","Metacognitive Therapy","Manualized Intervention (Wells, 2009; Wells & Sembi, 2004) intends to modify metacognitive beliefs about rumination, worry, attention, and symptoms, and generate generic plans for coping with threat","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,,,"8 sessions total","completed therapy",,"""Nine participants completed therapy. Not all participants required the full eight sessions.""",,,,"6.4",,,,,,"Not reported","Community","55%","Mixed","rape/sexual assault, community/school violence, accidents","High","Wells A, Colbear JS. Treating posttraumatic stress disorder with metacognitive therapy: a preliminary controlled trial. J Clin Psychol. 2012 Apr;68(4):373-81. doi: 10.1002/jclp.20871. PMID: 24469928.","38376","2019"
"wells2012_B","wells2012","Psychotherapy","2012","PTSD","Inactive Control",,"20","B","10",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,,,,,,,,,,,,,,,"Not reported","Community","55%","Mixed","rape/sexual assault, community/school violence, accidents","High","Wells A, Colbear JS. Treating posttraumatic stress disorder with metacognitive therapy: a preliminary controlled trial. J Clin Psychol. 2012 Apr;68(4):373-81. doi: 10.1002/jclp.20871. PMID: 24469928.","38376","2019"
"wells2015_A","wells2015","Psychotherapy","2015","PTSD","PTSD",,"32","A","11",,"Metacognitive therapy","Metacognitive Therapy","Manualized intervention according to Wells & Sembi 2004 that teaches participant to postpone worry, rumination, and going over memories in response to trigger thoughts. Intervention also includes attention modification to shift individual out of threat-modes of processing","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","8",,"completed treatment",,"n=2 completed 7 sessions, n=8 completed 8 sessions, all considered treatment completers",,,,,,,,,,"Not reported","Community","37.5%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (fire)","High","Wells A, Walton D, Lovell K, et al. Metacognitive therapy versus prolonged exposure in adults with chronic post-traumatic stress disorder. Cognit Ther Res. 2015 February;39(1):70-80. doi: 10.1007/s10608-014-9636-6.","50330","2019"
"wells2015_B","wells2015","Psychotherapy","2015","PTSD","PTSD",,"32","B","11",,"PE","Prolonged Exposure (PE)","Trauma-focused CBT according to manual by Marks et al. (1998)","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 minutes","Weekly","8",,"completed treatment",,"text suggests all n=10 completed all 8 sessions",,,,,,,,,,"Not reported","Community","37.5%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (fire)","High","Wells A, Walton D, Lovell K, et al. Metacognitive therapy versus prolonged exposure in adults with chronic post-traumatic stress disorder. Cognit Ther Res. 2015 February;39(1):70-80. doi: 10.1007/s10608-014-9636-6.","50330","2019"
"wells2015_C","wells2015","Psychotherapy","2015","PTSD","Inactive Control",,"32","C","10",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"8",,,,"n=10 attended post-waitlist assessment",,,,,,,,,,"Not reported","Community","37.5%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence, other (fire)","High","Wells A, Walton D, Lovell K, et al. Metacognitive therapy versus prolonged exposure in adults with chronic post-traumatic stress disorder. Cognit Ther Res. 2015 February;39(1):70-80. doi: 10.1007/s10608-014-9636-6.","50330","2019"
"wheeler2020a_A","wheeler2020a","Other study class","2020","PTSD","PTSD",,"30","A","11",,"Angling","Recreational therapy","Day-long outdoor angling in a peer group led by qualified coaches; qualified mental health profession on site but no formal psychological therapy was offered or delivered during the intervention and there was no deliberate initiation of discussions relating to trauma","No",,"No",,"No",,"No","No","No","Yes","No","Group","In Person",,"1 day","Once","0.14","One day-long session","Completed intervention",,"""received intervention"" in flow diagram, single day intervention",,,,,,,,,,"Not reported","Veteran","17%",,,"High","Wheeler M, Cooper NR, Andrews L, et al. Outdoor recreational activity experiences improve psychological wellbeing of military veterans with post-traumatic stress disorder: Positive findings from a pilot study and a randomised controlled trial. PLoS One. 2020;15(11):e0241763. doi: 10.1371/journal.pone.0241763. PMID: 33237906.","1561810","2022"
"wheeler2020a_B","wheeler2020a","Other study class","2020","PTSD","PTSD",,"30","B","8",,"Equine","Animal Assisted","Day-long outdoor equine husbandry in a peer group led by qualified coaches; qualified mental health profession on site but no formal psychological therapy was offered or delivered during the intervention and there was no deliberate initiation of discussions relating to trauma","No",,"No",,"No",,"No","No","No","Yes","No","Group","In Person",,"1 day","Once","0.14","One day-long session","Completed intervention",,"""received intervention"" in flow diagram, single day intervention",,,,,,,,,,"Not reported","Veteran","17%",,,"High","Wheeler M, Cooper NR, Andrews L, et al. Outdoor recreational activity experiences improve psychological wellbeing of military veterans with post-traumatic stress disorder: Positive findings from a pilot study and a randomised controlled trial. PLoS One. 2020;15(11):e0241763. doi: 10.1371/journal.pone.0241763. PMID: 33237906.","1561810","2022"
"wheeler2020a_C","wheeler2020a","Other study class","2020","PTSD","PTSD",,"30","C","11",,"Falconry","Recreational therapy","Day-long outdoor falconry and archery in a peer group led by qualified coaches; qualified mental health profession on site but no formal psychological therapy was offered or delivered during the intervention and there was no deliberate initiation of discussions relating to trauma","No",,"No",,"No",,"No","No","No","Yes","No","Group","In Person",,"1 day","Once","0.14","One day-long session","Completed intervention",,"""received intervention"" in flow diagram, single day intervention",,,,,,,,,,"Not reported","Veteran","17%",,,"High","Wheeler M, Cooper NR, Andrews L, et al. Outdoor recreational activity experiences improve psychological wellbeing of military veterans with post-traumatic stress disorder: Positive findings from a pilot study and a randomised controlled trial. PLoS One. 2020;15(11):e0241763. doi: 10.1371/journal.pone.0241763. PMID: 33237906.","1561810","2022"
"wheeler2020b_A","wheeler2020b","Other study class","2020","PTSD","PTSD",,"25","A","13","9 analyzed; 13 randomized, 4 did not receive intervention","Angling","Recreational therapy","Day-long outdoor angling in a peer group led by qualified coaches; qualified mental health profession on site but no formal psychological therapy was offered or delivered during the intervention and there was no deliberate initiation of discussions relating to trauma","No",,"No",,"No",,"No","No","No","Yes","No","Group","In Person",,"1 day","Once","0.14","One day-long session","Completed intervention",,"""received intervention"" in flow diagram, single day intervention; n=4 did not show up for intervention",,,,,,,,,,"Not reported","Veteran","6%",,,"High","Wheeler M, Cooper NR, Andrews L, et al. Outdoor recreational activity experiences improve psychological wellbeing of military veterans with post-traumatic stress disorder: Positive findings from a pilot study and a randomised controlled trial. PLoS One. 2020;15(11):e0241763. doi: 10.1371/journal.pone.0241763. PMID: 33237906.","1561810","2022"
"wheeler2020b_B","wheeler2020b","Other study class","2020","PTSD","Inactive Control",,"25","B","12","9 analyzed; 12 randomized, 3 did not receive post-wait period intervention","Waitlist","Waitlist","Waitlist","No",,"No",,"No",,"No","No","Yes","No","No",,,,"2 weeks","Once","2","Waitlist",,,,,,,,,,,,,"Not reported","Veteran","6%",,,"High","Wheeler M, Cooper NR, Andrews L, et al. Outdoor recreational activity experiences improve psychological wellbeing of military veterans with post-traumatic stress disorder: Positive findings from a pilot study and a randomised controlled trial. PLoS One. 2020;15(11):e0241763. doi: 10.1371/journal.pone.0241763. PMID: 33237906.","1561810","2022"
"whitworth2019a_A","whitworth2019a","Other study class","2019","PTSD","PTSD",,"22","A","11",,"Resistance training","Exercise","Individual resistance training; each session comprised of: ""5-min warm up on a stationary bicycle, five resistance training exercises (i.e., squat, bench press, pulldown, overhead press, and biceps curl) done over the course of 20 min, and a 5-min cool down on a stationary bicycle.""","No",,"No",,"No",,"No","No","No","Yes","No","Individual","In Person",,"30 minutes","3 times per week","3",,"Attended all sessions",,"n=1 did not receive intervention, ""Of the participants who received the resistance training intervention all 10 completed the study with perfect attendance""",,,,"8.4","2.1",,,,,"Race data reported","Community","81.8%","Mixed","combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, other (unspecified type of child abuse, unspecified ""other"")","High","Whitworth JW, Nosrat S, SantaBarbara NJ, et al. High intensity resistance training improves sleep quality and anxiety in individuals who screen positive for posttraumatic stress disorder: a randomized controlled feasibility trial. Ment Health Phys Act. 2019b;16:43-9. doi: 10.1016/j.mhpa.2019.04.001.","52118","2020"
"whitworth2019a_B","whitworth2019a","Other study class","2019","PTSD","Inactive Control",,"22","B","11",,"Attention control","Attention control","Individual sessions in which ""participants learned about various topics unrelated to exercise, trauma, or PTSD (e.g., nutrition, human anatomy, the universe) through videos and handouts.""","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"30 minutes","3 times per week","3",,"Received intervention",,"n=1 did not receive intervention, does not report N completing all sessions or other definition of treatment completion",,,,"8.3","2.1",,,,,"Race data reported","Community","81.8%","Mixed","combat-related, rape/sexual assault, accidents, illness/medical procedure, community/school violence, natural or manmade disasters, other (unspecified type of child abuse, unspecified ""other"")","High","Whitworth JW, Nosrat S, SantaBarbara NJ, et al. High intensity resistance training improves sleep quality and anxiety in individuals who screen positive for posttraumatic stress disorder: a randomized controlled feasibility trial. Ment Health Phys Act. 2019b;16:43-9. doi: 10.1016/j.mhpa.2019.04.001.","52118","2020"
"whitworth2019b_A","whitworth2019b","Other study class","2019","PTSD","PTSD",,"30","A","15",,"High-intensity resistance exercise","Exercise","One-on-one sessions of resistance exercise; each 30-minute session included 5 minutes warm up on stationary bicycle, 5 resistance exercises over 20 minutes, and 5 minutes cool down on stationary bicycle, led by certified personal trainer.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","In Person",,"30 minutes","3 times per week","3",,"See Detail",,"treatment completion not defined, reports study (assessment) completion (n=12, 80%)",,,,"7.2","2.31",,,,,"Race data reported","Community","73.3%","Mixed","rape/sexual assault, community/school violence, other (""sudden or unexpected loss of a child or spouse"")","High","Whitworth JW, Nosrat S, SantaBarbara NJ, et al. Feasibility of resistance exercise for posttraumatic stress and anxiety symptoms: a randomized controlled pilot study. J Trauma Stress. 2019 Dec;32(6):977-84. doi: 10.1002/jts.22464. PMID: 31743507.","1548217","2020"
"whitworth2019b_B","whitworth2019b","Other study class","2019","PTSD","Inactive Control",,"30","B","15",,"Time-matched control","Attention control","One-on-one sessions by same interventionist and same site as for the exercise intervention (Intervention A); sessions included videos on educational topics, excluding exercise and mental health.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"30 minutes","3 times per week","3",,"See Detail",,"treatment completion not defined, reports study (assessment) completion (n=12, 80%)",,,,"6.6","2.44",,,,,"Race data reported","Community","73.3%","Mixed","rape/sexual assault, community/school violence, other (""sudden or unexpected loss of a child or spouse"")","High","Whitworth JW, Nosrat S, SantaBarbara NJ, et al. Feasibility of resistance exercise for posttraumatic stress and anxiety symptoms: a randomized controlled pilot study. J Trauma Stress. 2019 Dec;32(6):977-84. doi: 10.1002/jts.22464. PMID: 31743507.","1548217","2020"
"wielgosz2024_A","wielgosz2024","Other study class","2024","PTSD","PTSD",,"173","A","86",,"Mindfulness Coach application","Mindfulness","A self-guided mobile application developed by the NCPTSD to provide support in mindfulness training tailored for veterans. Core training features are practice exercises and psychoeducation, and includes progress-tracking features and a structured training plan. Participants were instructed to use the app in whatever way they found helpful.","No",,"No",,"No",,"No","No","No","Yes","No","Individual","Technology alone",,,"ad libitum","8",,"See Detail",,"treatment completion not defined; n=57 initiated use of mobile app, n=38 dropped (n=20 technical issues, n=18 lost to follow-up), n=19 study completers; study also reports on app usage in outcomes",,,"reports as app engagement -
nonengaged (single visit or no interaction with active content): n=13
higher-intensity (above the sample median for days of use, visits to the app, and number of practice exercises completed): n=12
lower-intensity (actively engaged, but not higher-intensity): n=32",,,"Publication provides additional information on app usage among participants who installed and logged in (n=57).
Engaged in guided mindfulness practices: 75.4%
Mean 76.27 (SD 22.76) minutes of practice across mean 10.00 sessions, and mean 3.03 (SD 3.15) distinct practice exercises.",,,,"Race and Ethnicity data reported","Veteran","39.31%","Mixed","Combat-related; Accidents; Other (""interpersonal event"", ""other event"")","High","Wielgosz J, Walser RD, Kuhn E, Chang A, Bantum EO, Pagano I, Jaworski BK, Taylor K, Ramsey KM, Owen JE. Clinical benefits of self-guided mindfulness coach mobile app use for veterans with posttraumatic stress disorder: A pilot randomized control trial. Psychol Trauma. 2024 Aug 26. doi: 10.1037/tra0001736. Epub ahead of print. PMID: 39190441.","1638072","2025"
"wielgosz2024_B","wielgosz2024","Other study class","2024","PTSD","Inactive Control",,"173","B","87",,"Waitlist","Waitlist","Waitlist participants provided with a link to information resources about PTSD on the NCPTSD website.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Technology alone",,,,"8",,,,"study completers n=37",,,,,,,,,,"Race and Ethnicity data reported","Veteran","39.31%","Mixed","Combat-related; Accidents; Other (""interpersonal event"", ""other event"")","High","Wielgosz J, Walser RD, Kuhn E, Chang A, Bantum EO, Pagano I, Jaworski BK, Taylor K, Ramsey KM, Owen JE. Clinical benefits of self-guided mindfulness coach mobile app use for veterans with posttraumatic stress disorder: A pilot randomized control trial. Psychol Trauma. 2024 Aug 26. doi: 10.1037/tra0001736. Epub ahead of print. PMID: 39190441.","1638072","2025"
"wigard2024_A","wigard2024","Psychotherapy","2024","PTSD","PTSD",,"68","A","34",,"Skills training in affective and interpersonal regulation (STAIR) + eye movement desensitization and reprocessing (EMDR)","Skills Training in Affect and Interpersonal Regulation (STAIR) + Eye Movement Desensitization and Reprocessing (EMDR)","STAIR followed by EMDR
STAIR: manualized therapy in which emotion dysregulation and interpersonal problems are targeted; first 4 sessions focus on enhancing emotion regulation skills, last 4 sessions on developing interpersonal skills.
EMDR: focuses on processing the memory of the trauma and/or its meaning; usedprotocol to process traumatic experiences (Dutch translation of Shapiro 1995) and advanced strategies 'Cognitive Interweaves' to facilitate trauma processing.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"STAIR: 60 minutes
EMDR: 90 minutes","Weekly","16 to 20","STAIR: 8 weeks
EMDR: 8-12 weeks","Completing the whole course of treatment",,,,,,"18.5",,"Mean sessions by treatment completers",,,,"Not Reported","Community","11.8%","Mixed","Child physical abuse; Child sexual abuse; Other (""interpersonal trauma before the age of 17 years"")","Some Concerns","Wigard I, Meyerbröker K, Ehring T, Topper M, Arntz A, Emmelkamp P. Skills training followed by either EMDR or narrative therapy for posttraumatic stress disorder in adult survivors of childhood abuse: a randomized controlled trial. Eur J Psychotraumatol. 2024;15(1):2332104. doi: 10.1080/20008066.2024.2332104. Epub 2024 Apr 17. PMID: 38629403; PMCID: PMC11025408.","1633294","2025"
"wigard2024_B","wigard2024","Psychotherapy","2024","PTSD","PTSD",,"68","B","34",,"Skills training in affective and interpersonal regulation (STAIR) + narrative therapy (NT)","Skills Training in Affect and Interpersonal Regulation (STAIR) + Narrative Exposure Therapy","STAIR followed by NT
STAIR: manualized therapy in which emotion dysregulation and interpersonal problems are targeted; first 4 sessions focus on enhancing emotion regulation skills, last 4 sessions on developing interpersonal skills.
NT: manualized exposure treatment based on Prolonged Exposure, modified by replacing in vivor exposure to trauma stimuli with interpersonal skills practice, and introducing meaning analysis after the exposure in which abuse-related schemas embedded in the trauma narrative were identified and evaluated.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"STAIR: 60 minutes
NT: 90 minutes","Weekly","16 to 20","STAIR: 8 weeks
NT: 8-12 weeks","Completing the whole course of treatment",,,,,,"18.3",,"Mean sessions by treatment completers",,,,"Not Reported","Community","11.8%","Mixed","Child physical abuse; Child sexual abuse; Other (""interpersonal trauma before the age of 17 years"")","Some Concerns","Wigard I, Meyerbröker K, Ehring T, Topper M, Arntz A, Emmelkamp P. Skills training followed by either EMDR or narrative therapy for posttraumatic stress disorder in adult survivors of childhood abuse: a randomized controlled trial. Eur J Psychotraumatol. 2024;15(1):2332104. doi: 10.1080/20008066.2024.2332104. Epub 2024 Apr 17. PMID: 38629403; PMCID: PMC11025408.","1633294","2025"
"woud2021_A","woud2021","Nonpharmacologic cognitive","2021","PTSD","PTSD",,"80","A","39",,"Cognitive Bias Modification - Appraisal (CBM-APP) + TAU","Cognitive Bias Modification (CBM)","CBM-APP: ""Computerized training procedure targeting dysfunctional appraisals about trauma."" PTCI (all subscales) used to generate functional appraisal training sentences. Participants instructed to read a sentence, after which a word fragment appeared on the screen which they completed by pressing its missing letter. Word fragments were positive, so that participants completed each sentence in a functional/positive way. Each session included 66 trauma-related and 15 neutral sentences. Participants began randomized treatment about 2 weeks after admission.
TAU: multimodal treatment for PTSD in specialized inpatient unit, includes individual CBT, trauma group therapy, trauma stabilization group therapy, kinesitherapy, art therapy, and physiotherapy.","No",,"No",,"No",,"No","Yes","No","No","No","Individual","Technology alone",,"20 minutes","Four times a week","2","2 weeks (8 sessions) of study intervention during an 8-week inpatient stay for PTSD treatment","Completed training",,"per flow diagram; also analyzed per protocol (n=29, completed at least 4 sessions and provided complete outcome data)",,,,"7.54","1.19","CBT-APP sessions",,,,"Not reported","Community","87.5%","Mixed","Rape/sexual assault; Accidents; Community/school violence; Other (captivity; war; witnessed violence [sexual or non-sexual] or sudden death; learned about murder)","Low","Woud ML, Blackwell SE, Shkreli L, et al. The effects of modifying dysfunctional appraisals in posttraumatic stress disorder using a form of cognitive bias modification: results of a randomized controlled trial in an inpatient setting. Psychother Psychosom. 2021 Oct;90(6):386-402. doi: 10.1159/000514166. PMID: 33621970.","1565955","2024"
"woud2021_B","woud2021","Nonpharmacologic cognitive","2021","PTSD","Inactive Control",,"80","B","41",,"Peripheral Vision Task  + TAU","Sham","Peripheral Vision Task used as a sham training control condition. Computer screen showed a central fixation cross surrounded by 15 small grey circles arranged in a large circle. Participants focused on the cross while also paying attention to the small circles. They then heard several beeps and were instructed to shift their peripheral vision one small circle with each beep. Small circles then changed from grey to different colors, and participants were asked to identify by color the circle where their attention had ended. Participants began randomized treatment about 2 weeks after admission.
TAU: multimodal treatment for PTSD in specialized inpatient unit, includes individual CBT, trauma group therapy, trauma stabilization group therapy, kinesitherapy, art therapy, and physiotherapy.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Technology alone",,"20 minutes","Four times a week","2","2 weeks (8 sessions) of study intervention during an 8-week inpatient stay for PTSD treatment","Completed training",,"per flow diagram; also analyzed per protocol (n=29, completed at least 4 sessions and provided complete outcome data)",,,,"7.44","1.16","PVT sessions",,,,"Not reported","Community","87.5%","Mixed","Rape/sexual assault; Accidents; Community/school violence; Other (captivity; war; witnessed violence [sexual or non-sexual] or sudden death; learned about murder)","Low","Woud ML, Blackwell SE, Shkreli L, et al. The effects of modifying dysfunctional appraisals in posttraumatic stress disorder using a form of cognitive bias modification: results of a randomized controlled trial in an inpatient setting. Psychother Psychosom. 2021 Oct;90(6):386-402. doi: 10.1159/000514166. PMID: 33621970.","1565955","2024"
"xue2025_A","xue2025","Psychotherapy","2025","PTSD","PTSD",,"92","A","46",,"Narrative therapy (NT) + psychological stress leaflet","Narrative Exposure Therapy (NET)","Manualized trauma-focused narrative psychotherapy, individual via video call. NT intervention developed for use with clinical nurses; ""drawing on techniques related to narrative psychotherapy theory and the appropriate application of problem externalization, deconstruction, reframing, external witnessing, and treatment documentation to effectively guide clinical nurses in narrating their stories."" Publication references supplemental material for specific intervention protocol, but this was not available through the journal website.
Psychological stress leaflet (same for both groups): consisted of 3 main parts: processes and outcomes of psychological stress development, coping with traumatic events, and negative emotions and stress management. Participants were asked to read these frequently, and expecially when they experienced trauma or felt anxious and stressed.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Video",,"45-60 minutes","Weekly","8",,"See Detail",,"""two members of the intervention group discontinued the intervention due to work-related reasons"" but shown as lost to follow-up in Figure 1, unclear if other participants completed treatment or completed assessments (or both)",,,,,,,,,,,"Community","96.7%","Mixed","Community/school violence; Other (occupation/work-related events in clinical nursing)","High","Xue M, Yu P, Gu Z, Sun Y. Online narrative therapy intervention improves post-traumatic stress disorder symptoms, perceived stress, anxiety, and depression in nurses: a randomized controlled trial. Braz J Psychiatry. 2025;47:e20243740. doi: 10.47626/1516-4446-2024-3740. Epub 2024 Sep 27. PMID: 39331491.","1647302","2025"
"xue2025_B","xue2025","Psychotherapy","2025","PTSD","Inactive Control",,"92","B","46",,"Psychological stress leaflet","Psychoeducation","Psychological stress leaflet (same for both groups): consisted of 3 main parts: processes and outcomes of psychological stress development, coping with traumatic events, and negative emotions and stress management. Participants were asked to read these frequently, and expecially when they experienced trauma or felt anxious and stressed.","No",,"No",,"No",,"No","No","Yes","No","No","Individual",,,,,"8",,,,,,,,,,,,,,,"Community","96.7%","Mixed","Community/school violence; Other (occupation/work-related events in clinical nursing)","High","Xue M, Yu P, Gu Z, Sun Y. Online narrative therapy intervention improves post-traumatic stress disorder symptoms, perceived stress, anxiety, and depression in nurses: a randomized controlled trial. Braz J Psychiatry. 2025;47:e20243740. doi: 10.47626/1516-4446-2024-3740. Epub 2024 Sep 27. PMID: 39331491.","1647302","2025"
"yeh2011_A","yeh2011","Pharmacotherapy","2011","PTSD","PTSD",,"35","A","17",,"Topiramate","Topiramate","Initiated at 25 mg/day, increased weekly by 25 mg/day up to 200 mg/day","No",,"Yes","Mood Stabilizer","No",,"No","No","No","No","No","Individual","In Person","25 to 200 mg",,"Once daily","12",,,,,"compliance monitored by pill count",,,,,,"102.94 mg/day",,,"Not reported","Community","67.74%",,,"High","Yeh MS, Mari JJ, Costa MC, et al. A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD. CNS Neurosci Ther. 2011 Oct;17(5):305-10. doi: 10.1111/j.1755-5949.2010.00188.x. PMID: 21554564.","35220","2019"
"yeh2011_B","yeh2011","Pharmacotherapy","2011","PTSD","Inactive Control",,"35","B","18",,"Placebo","Placebo","Placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Once daily","12",,,,,,,,,,,,,,"Not reported","Community","67.74%",,,"High","Yeh MS, Mari JJ, Costa MC, et al. A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD. CNS Neurosci Ther. 2011 Oct;17(5):305-10. doi: 10.1111/j.1755-5949.2010.00188.x. PMID: 21554564.","35220","2019"
"yehuda2014_A","yehuda2014","Psychotherapy","2014","PTSD","PTSD",,"52","A","37",,"PE","Prolonged Exposure (PE)","Administered according to manualized protocol (Foa et al, 2007); includes education about reactions to trauma, breathing retraining, exposure to trauma memories and situation the patient avoids, and discussion of thoughts and feelings related to exposure exercises.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12",,"completed, did not choose to discontinue treatment",,,,,,,,,,,,"Ethnicity data reported","Veteran","10.81%","Combat-related",,"High","Yehuda R, Pratchett LC, Elmes MW, et al. Glucocorticoid-related predictors and correlates of post-traumatic stress disorder treatment response in combat veterans. Interface Focus. 2014 Oct 6;4(5):20140048. doi: 10.1098/rsfs.2014.0048. PMID: 25285201.","42868","2019"
"yehuda2014_B","yehuda2014","Psychotherapy","2014","PTSD","Inactive Control",,"52","B","15",,"Minimal attention","Minimal attention","Delivered according to manualized protocol developed by Foa et al. 2007; phone calls by study therapist to the patient to monitor symptoms","No",,"No",,"No",,"No","No","Yes","No","No","Individual","Phone",,"30 minutes","Weekly","12",,"completed, did not discontinue treatment",,,,,,,,,,,,"Ethnicity data reported","Veteran","10.81%","Combat-related",,"High","Yehuda R, Pratchett LC, Elmes MW, et al. Glucocorticoid-related predictors and correlates of post-traumatic stress disorder treatment response in combat veterans. Interface Focus. 2014 Oct 6;4(5):20140048. doi: 10.1098/rsfs.2014.0048. PMID: 25285201.","42868","2019"
"yehuda2015_A","yehuda2015","Psychotherapy & pharmacotherapy","2015","PTSD","Active Control",,"24","A","12",,"Hydrocortisone + PE","Hydrocortisone prior to Prolonged Exposure (PE)","Synthetic glucocorticoid with anti-inflammatory effects administered 20 minutes prior to PE sessions 3 to 10 + manualized PE consisting of guided imaginal exposure.","Yes","Trauma-focused","Yes","Steroids","No",,"No","No","Yes","No","No","Individual","In Person","Session length: NR







Dose: 30 mg",,,,"10 sessions total","treatment completion",,"also referred to as treatment retention in Figure 1, otherwise not further described",,,,"9.42","2.02",,,,,"Race and Ethnicity data reported","Veteran",,"Mixed","combat-related, accidents, other (interpersonal violence)","High","Yehuda R, Bierer LM, Pratchett LC, et al. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome. Psychoneuroendocrinology. 2015 Jan;51:589-97. doi: 10.1016/j.psyneuen.2014.08.004. PMID: 25212409.","42838","2019"
"yehuda2015_B","yehuda2015","Psychotherapy & pharmacotherapy","2015","PTSD","PTSD",,"24","B","12",,"PE + placebo","Prolonged Exposure (PE) + placebo","Placebo plus manualized PE consisting of guided imaginal exposure.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person","Session length: NR







Dose: NA",,,,"10 sessions total","treatment completion",,"also referred to as treatment retention in Figure 1, otherwise not further described",,,,"6","3.74",,,,,"Race and Ethnicity data reported","Veteran",,"Mixed","combat-related, accidents, other (interpersonal violence)","High","Yehuda R, Bierer LM, Pratchett LC, et al. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome. Psychoneuroendocrinology. 2015 Jan;51:589-97. doi: 10.1016/j.psyneuen.2014.08.004. PMID: 25212409.","42838","2019"
"yi2022_A","yi2022","CIH","2022","PTSD","PTSD",,"94","A","47","completer sample n=37","Yoga","Yoga","Instructor-led Kripalu-style yoga including compassionate self-observation, acceptance, mind-body connection, and focus on the breath and the present moment.","No",,"No",,"Yes","Yoga","No","No","No","No","No","Group","In Person",,"45 minutes","Every two weeks","12","6 sessions over 12 weeks","Did not drop out during 12-week intervention",,"n=6 declined participation during intervention period (discussion section), used this for treatment completion; flow diagram shows n=7 declined participation or lost contact during intervention period",,,,,,,,,,"Not reported","Community","100%","Accidents",,"High","Yi L, Lian Y, Ma N, et al. A randomized controlled trial of the influence of yoga for women with symptoms of post-traumatic stress disorder. J. 2022 Apr 5;20(1):162. doi: 10.1186/s12967-022-03356-0. PMID: 35382845.","1591328","2023"
"yi2022_B","yi2022","CIH","2022","PTSD","Inactive Control",,"94","B","47","completer sample n=39","Control","Attention control","""yoga sessions were replaced by exchanging daily life experiences and playing board games""","No",,"No",,"No",,"No","No","Yes","No","No","Group","In Person",,,,"12",,"Did not drop out during 12-week intervention",,"flow diagram shows n=7 declined participation during intervention period, not otherwise defined",,,,,,,,,,"Not reported","Community","100%","Accidents",,"High","Yi L, Lian Y, Ma N, et al. A randomized controlled trial of the influence of yoga for women with symptoms of post-traumatic stress disorder. J. 2022 Apr 5;20(1):162. doi: 10.1186/s12967-022-03356-0. PMID: 35382845.","1591328","2023"
"youngstedt2021_A","youngstedt2021","CIH","2021","PTSD","PTSD",,"71","A","35","34 analyzed (1 excluded from analysis for initiation of other treatment during study)","Bright light exposure","Bright light exposure","Daily exposure to 30 min of 10,000 lux ultraviolet-filtered white light","No",,"No",,"Yes","Other CIH","No","No","No","No","No","Individual","In Person",,"30 minutes","Daily","4",,"See Detail",,"at home treatment, flow diagram reports study completion (97.14%, n=34) but treatment completion not defined; self-reported adherence also reported","Self-reported adherence",,"mean 26.5 (SD 2.1) days and mean 28.6 (SD 1.5) minutes per day of treatment",,,,,,,"Not reported","Veteran","23.19%","Combat-related",,"Some Concerns","Youngstedt SD, Kline CE, Reynolds AM, et al. Bright light treatment of combat-related PTSD: a randomized controlled trial. Mil Med. [Epub ahead of print 29 January 2021] doi: 10.1093/milmed/usab014. PMID: 33511988.","1564540","2022"
"youngstedt2021_B","youngstedt2021","CIH","2021","PTSD","Inactive Control",,"71","B","36","35 analyzed (1 excluded from analysis for initiation of other treatment during study)","Control treatment","Control","Daily 30-min exposure to an inactivated negative ion generator","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"30 minutes","Daily","4",,"See Detail",,"at home treatment, flow diagram reports study completion (94.44%, n=34) but treatment completion not defined; self-reported adherence also reported","Self-reported adherence",,"mean 26.2 (SD 2.2) days and mean 28.9 (SD 1.7) minutes per day of treatment",,,,,,,"Not reported","Veteran","23.19%","Combat-related",,"Some Concerns","Youngstedt SD, Kline CE, Reynolds AM, et al. Bright light treatment of combat-related PTSD: a randomized controlled trial. Mil Med. [Epub ahead of print 29 January 2021] doi: 10.1093/milmed/usab014. PMID: 33511988.","1564540","2022"
"youssef2022_A","youssef2022","CIH","2022","PTSD","PTSD",,"21","A","11","11 analyzed, N randomized NR (21 total randomized, 20 analyzed)","Adjunct ketone supplementation + TAU","Beta-hydroxybutyrate ketone","Usual care plus twice daily supplementation of beta-hydroxybutyrate (total 14 g/day).","No",,"No",,"Yes","Natural products","No","No","No","No","No","Individual","In Person","7 g",,"Twice a day","6",,,,,,,"""Phone calls, adherence logs, and text messages were used to monitor adherence."" No data provided on actual adherence by participants.",,,,,,,"Not reported","Community","80%",,,"High","Youssef NA, Holland-Winkler AM, Phung P, Waller JL, Ponkshe S. A randomized, double-blind, clinical pilot trial of adjunct ketone supplement compared to placebo for treating posttraumatic stress disorder. Ann Clin Psychiatry. 2022 Nov;34(4):240-244. doi: 10.12788/acp.0088. PMID: 36282607.","1605352","2023"
"youssef2022_B","youssef2022","CIH","2022","PTSD","Inactive Control",,"21","B","9","9 analyzed, N randomized NR (21 total randomized, 20 analyzed)","Placebo + TAU","Placebo","Usual care plus placebo","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Twice a day","6",,,,,,,"""Phone calls, adherence logs, and text messages were used to monitor adherence."" No data provided on actual adherence by participants.",,,,,,,"Not reported","Community","80%",,,"High","Youssef NA, Holland-Winkler AM, Phung P, Waller JL, Ponkshe S. A randomized, double-blind, clinical pilot trial of adjunct ketone supplement compared to placebo for treating posttraumatic stress disorder. Ann Clin Psychiatry. 2022 Nov;34(4):240-244. doi: 10.12788/acp.0088. PMID: 36282607.","1605352","2023"
"yuan2023_A","yuan2023","Nonpharmacologic biological","2023","PTSD","PTSD",,"75","A","25",,"Intermittent theta burst stimulation (iTBS)","Transcranial magnetic stimulation (TMS)","Intermittent theta burst stimulation with coil placed at 45 degree angle to sagittal plane above the right dorsolateral prefrontal cortex (selected target); treatment mode: series of intermittent 5 Hz stimuli, and 50 Hz stimuli burst in every 5 Hz stimulus, duration of treatment 9.5 minutes with total 1800 pulses.","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person","intermittent 5 Hz stimuli, and 50 Hz stimuli burst in every 5 Hz stimulus, duration of treatment 9.5 minutes with total 1800 pulses.","9.5 minutes","Daily for five days per week (weekdays)","3","15 sessions","Completed intervention",,"not further described",,,,,,,,,,"Not reported","Community","73.3%",,,"High","Yuan H, Liu B, Li F, et al. Effects of intermittent theta-burst transcranial magnetic stimulation on post-traumatic stress disorder symptoms: a randomized controlled trial. Psychiatry Res. 2023 11;329:115533. doi: 10.1016/j.psychres.2023.115533. PMID: 37826976.","30215","2024"
"yuan2023_B","yuan2023","Nonpharmacologic biological","2023","PTSD","PTSD",,"75","B","25",,"rTMS","Transcranial magnetic stimulation (TMS)","rTMS with coil placed at 45 degree angle to sagittal plane above the right dorsolateral prefrontal cortex (selected target); treatment mode: continuous 10 Hz stimulus, duration of treatment 33 minutes with total 1800 pulses.","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person","continuous 10 Hz stimulus, duration of treatment 33 minutes with total 1800 pulses.","33 minutes","Daily for five days per week (weekdays)","3","15 sessions","Completed intervention",,"not further described",,,,,,,,,,"Not reported","Community","73.3%",,,"High","Yuan H, Liu B, Li F, et al. Effects of intermittent theta-burst transcranial magnetic stimulation on post-traumatic stress disorder symptoms: a randomized controlled trial. Psychiatry Res. 2023 11;329:115533. doi: 10.1016/j.psychres.2023.115533. PMID: 37826976.","30215","2024"
"yuan2023_C","yuan2023","Nonpharmacologic biological","2023","PTSD","Inactive Control",,"75","C","25",,"Sham intermittent theta burst stimulation (iTBS)","Sham","Sham stimulation using methods and settings of intermittent theta burst stimulation but with coil placed perpendicularly on the scalp.","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person","intermittent 5 Hz stimuli, and 50 Hz stimuli burst in every 5 Hz stimulus, duration of treatment 9.5 minutes with total 1800 pulses.","9.5 minutes","Daily for five days per week (weekdays)","3","15 sessions","Completed intervention",,"not further described",,,,,,,,,,"Not reported","Community","73.3%",,,"High","Yuan H, Liu B, Li F, et al. Effects of intermittent theta-burst transcranial magnetic stimulation on post-traumatic stress disorder symptoms: a randomized controlled trial. Psychiatry Res. 2023 11;329:115533. doi: 10.1016/j.psychres.2023.115533. PMID: 37826976.","30215","2024"
"yurtsever2018_A","yurtsever2018","Psychotherapy","2018","PTSD","PTSD",,"63","A","28","data reported for n=18 participants who completed both sessions and met MINI criteria for PTSD","EMDR Group Traumatic Episode Protocol","Eye Movement Desensitization and Reprocessing (EMDR)","Manualized intervention (Shapiro 2013) based on Recent Traumatic Episode Protocol (Shapiro and Laub, 2008) that includes procedures and measures for containment and safety","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"4 hours","Daily","0.29","2 4-hour sessions total, over 3 consecutive days","completed all sessions",,"18/28; n=18 analyzed only participants who ""completed the two sessions"" and met MINI critera for PTSD",,,,,,,,,,"Not reported","Community","76.6%","Terrorism/political violence/forced displacement",,"High","Yurtsever A, Konuk E, Akyüz T, et al. An Eye Movement Desensitization and Reprocessing (EMDR) group intervention for Syrian refugees with post-traumatic stress symptoms: results of a randomized controlled trial. Front Psychol. 2018 Jun 12;9:493. doi: 10.3389/fpsyg.2018.00493. PMID: 29946275.","51112","2019"
"yurtsever2018_B","yurtsever2018","Psychotherapy","2018","PTSD","Inactive Control",,"63","B","29","n=32 randomized, n=3 did not meet MINI critieria for PTSD and were excluded","Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"1",,,,"n=29 completed posttreatment measures",,,,,,,,,,"Not reported","Community","76.6%","Terrorism/political violence/forced displacement",,"High","Yurtsever A, Konuk E, Akyüz T, et al. An Eye Movement Desensitization and Reprocessing (EMDR) group intervention for Syrian refugees with post-traumatic stress symptoms: results of a randomized controlled trial. Front Psychol. 2018 Jun 12;9:493. doi: 10.3389/fpsyg.2018.00493. PMID: 29946275.","51112","2019"
"zaccari2022a_A","zaccari2022a","Psychotherapy & CIH","2022","PTSD","PTSD",,"42","A","17",,"Trauma Center Trauma-Sensitive Yoga","Yoga","Hatha-style yoga (gentle, slower-paced practice) with modifications for differing abilitiies (e.g using a chair for balance) using manualized protocol. Developed for use by women with treatment-resistant, complex PTSD. Themes include establishing safety, individual choice, interoception (perceiving inner state), being in the present moment, and taking effective action. Co-facilitated by two teachers.","No",,"No",,"Yes","Yoga","No","No","No","No","No","Group","In Person",,"60 minutes","Weekly","10","10 sessions","≥7 sessions",,,,,,,,"sessions attended, median (IQR): 8.5 (1 to 10)",,,,"Race data reported","Veteran","100%","MST",,"High","Zaccari B, Sherman ADF, Febres-Cordero S, et al. Findings from a pilot study of Trauma Center Trauma-Sensitive Yoga versus cognitive processing therapy for PTSD related to military sexual trauma among women Veterans. Complementary therapies in medicine. 2022;70:102850. doi: 10.1016/j.ctim.2022.102850. PMID: 35820575.","1596480","2023"
"zaccari2022a_B","zaccari2022a","Psychotherapy & CIH","2022","PTSD","PTSD",,"42","B","25","1 withdrew before baseline assessment, excluded from ITT analysis","CPT","Cognitive Processing Therapy (CPT)","Manualized therapy focused on identifying how thoughts change as a result of trauma exposure, evaluating maladaptive, rigid thoughts, and substituting more accurate, flexible, alternative thoughts. Elements include Socratic questioning, prioritizing assimilation, attending to practice assignments, and encouraging affect. Group sessions led by two LCSW's.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"90 minutes","Weekly","12","12 sessions","≥8 sessions",,,,,,,,"sessions attended, median (IQR): 5 (1.8 to 11)",,,,"Race data reported","Veteran","100%","MST",,"High","Zaccari B, Sherman ADF, Febres-Cordero S, et al. Findings from a pilot study of Trauma Center Trauma-Sensitive Yoga versus cognitive processing therapy for PTSD related to military sexual trauma among women Veterans. Complementary therapies in medicine. 2022;70:102850. doi: 10.1016/j.ctim.2022.102850. PMID: 35820575.","1596480","2023"
"zalta2019_A","zalta2019","Nonpharmacologic biological","2019","PTSD","PTSD",,"15","A","9",,"Re-timer","Re-timer","Device emitting LED green light (~500 nm, 500 lux)","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person",,"1 hour","Daily","4",,"Completed intervention",,"""all participants that were randomized completed the 4-week intervention""","days initiated treatment",,"19.67 (5.81) days",,,,"32.45 minutes per day","5.30 minutes per day",,"Race and Ethnicity data reported","Community","53.33%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence","High","Zalta AK, Bravo K, Valdespino‐Hayden Z, et al. A placebo‐controlled pilot study of a wearable morning bright light treatment for probable PTSD. Depress Anxiety. 2019 Jul;36(7):617-24. doi: 10.1002/da.22897. PMID: 30995350.","52251","2020"
"zalta2019_B","zalta2019","Nonpharmacologic biological","2019","PTSD","Inactive Control",,"15","B","6",,"Placebo Re-timer","Sham","Same device with additional filter that reduces light intensity to a level that will not shift circadian timing (7 lux)","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"1 hour","Daily","4",,"Completed intervention",,"""all participants that were randomized completed the 4-week intervention""","days initiated treatment",,"24.17 (6.01) days",,,,"39.22 minutes per day","5.81 minutes per day",,"Race and Ethnicity data reported","Community","53.33%","Mixed","combat-related, rape/sexual assault, accidents, community/school violence","High","Zalta AK, Bravo K, Valdespino‐Hayden Z, et al. A placebo‐controlled pilot study of a wearable morning bright light treatment for probable PTSD. Depress Anxiety. 2019 Jul;36(7):617-24. doi: 10.1002/da.22897. PMID: 30995350.","52251","2020"
"zang2013_A","zang2013","Psychotherapy","2013","PTSD","PTSD",,"22","A","11",,"NET","Narrative Exposure Therapy (NET)","Treatment following Schauer et al. 2005 manual, includes patient constructing a detailed chronological report of his/her own biography with a special focus on traumatic experiences and encouraged to relive emotions.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Spaced 2-4 days apart","2","4 sessions","completed treatment",,"not further described",,,,,,,,,,"Not reported","Community","77.27%","Natural or manmade disasters",,"High","Zang Y, Hunt NC, Cox T. A randomised controlled pilot study: the effectiveness of narrative exposure therapy with adult survivors of the Sichuan earthquake. BMC Psychiatry. 2013 Jan 31;13:41. doi: 10.1186/1471-244X-13-41. PMID: 23363689.","46041","2020"
"zang2013_B","zang2013","Psychotherapy","2013","PTSD","Inactive Control",,"22","B","11",,"Waitlist","Waitlist",,"No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"2",,,,,,,,,,,,,,"Not reported","Community","77.27%","Natural or manmade disasters",,"High","Zang Y, Hunt NC, Cox T. A randomised controlled pilot study: the effectiveness of narrative exposure therapy with adult survivors of the Sichuan earthquake. BMC Psychiatry. 2013 Jan 31;13:41. doi: 10.1186/1471-244X-13-41. PMID: 23363689.","46041","2020"
"zang2014_A","zang2014","Psychotherapy","2014","PTSD","PTSD",,"30","A","10",,"NET","Narrative Exposure Therapy (NET)","Standard Narrative Exposure Therapy; patients constructed detailed autobiography with special focus on traumatic experiences; encouraged to relive emotions while reporting events; received written report of narrative","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 to 90 minutes","About twice weekly","2","flexible number of total sessions","completed entire course of treatment and followup",,,,,,"4",,,,,,"Not reported","Community","90%","Natural or manmade disasters",,"High","Zang Y, Hunt NC, Cox T. Adapting narrative exposure therapy for Chinese earthquake survivors: a pilot randomised controlled feasibility study. BMC Psychiatry. 2014 Oct 3;14:262. doi: 10.1186/s12888-014-0262-3. PMID: 25927297.","46042","2019"
"zang2014_B","zang2014","Psychotherapy","2014","PTSD","PTSD",,"30","B","10",,"NET-Revised","Narrative Exposure Therapy (NET)","Revised Narrative Exposure Therapy adapted to a single traumatic event; patient first constructed detailed earthquake narrative, then completed chronologic autobiography; encouraged to relive emotions while reporting events; final reading of autobiography without written report","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"60 to 120 minutes","Every 1 to 2 days","1","flexible total number of sessions","completed entire course of treatment and followup",,,,,,,,,,,,"Not reported","Community","90%","Natural or manmade disasters",,"High","Zang Y, Hunt NC, Cox T. Adapting narrative exposure therapy for Chinese earthquake survivors: a pilot randomised controlled feasibility study. BMC Psychiatry. 2014 Oct 3;14:262. doi: 10.1186/s12888-014-0262-3. PMID: 25927297.","46042","2019"
"zang2014_C","zang2014","Psychotherapy","2014","PTSD","Inactive Control",,"30","C","10",,"Waitlist","Waitlist","Received NET-Revised after 3-week waiting period; assessed at 2 weeks after trial entry, comparable to post-treatment assessment for immediate treatment groups (T2)","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"2",,,,,,,,,,,,,,"Not reported","Community","90%","Natural or manmade disasters",,"High","Zang Y, Hunt NC, Cox T. Adapting narrative exposure therapy for Chinese earthquake survivors: a pilot randomised controlled feasibility study. BMC Psychiatry. 2014 Oct 3;14:262. doi: 10.1186/s12888-014-0262-3. PMID: 25927297.","46042","2019"
"zemestani2022_A","zemestani2022","Psychotherapy","2022","PTSD","PTSD",,"48","A","24",,"Culturally adapted TF-CBT","Trauma-focused cognitive behavioral therapy (TF-CBT)","Trauma-focused CBT following an age and culturally adapted manual for Kurdish-speaking adult women; adaptations related to language and included use of local concepts to explain key components of the treatment. Sessions started with eliciting recent trauma recall, then practicing a trauma-processing protocol involving emotional regulation techniques. Delivered in 12 weekly 90-minute individual sessions.","Yes","Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,"90 minutes","Weekly","12",,"Completed treatment",,,,,,,,,,,,"Not reported","Community","100%","Mixed","Terrorism/political violence/forced displacement; Other (violent death of a relative; experienced or witnessed explosions; witnessed murder of nonfamily members; other life-threatening events)","High","Zemestani M, Mohammed AF, Ismail AA, et al. A Pilot Randomized Clinical Trial of a Novel, Culturally Adapted, Trauma-Focused Cognitive-Behavioral Intervention for War-Related PTSD in Iraqi Women. Behav Ther. 2022 Jul;53(4):656-72. doi: 10.1016/j.beth.2022.01.009. PMID: 35697429","1592753","2023"
"zemestani2022_B","zemestani2022","Psychotherapy","2022","PTSD","Inactive Control",,"48","B","24",,"Waitlist","Waitlist","Waitlist; participants asked to come to the clinic to review their mental health status and complete assessments at baseline, 12 weeks (post-treatment for arm A), and 16 weeks (1-month followup for arm A).","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"12",,,,,,,,,,,,,,"Not reported","Community","100%","Mixed","Terrorism/political violence/forced displacement; Other (violent death of a relative; experienced or witnessed explosions; witnessed murder of nonfamily members; other life-threatening events)","High","Zemestani M, Mohammed AF, Ismail AA, et al. A Pilot Randomized Clinical Trial of a Novel, Culturally Adapted, Trauma-Focused Cognitive-Behavioral Intervention for War-Related PTSD in Iraqi Women. Behav Ther. 2022 Jul;53(4):656-72. doi: 10.1016/j.beth.2022.01.009. PMID: 35697429","1592753","2023"
"zhang2024_A","zhang2024","Other Mixed","2024","PTSD","PTSD",,"86","A","43",,"Traditional Chinese medicine (Anshen Dingzhi Prescription [ADP]) + paroxetine","Traditional Chinese medicine + paroxetine","Anshen Dingzhi prescription + Paroxetine
Anshen Dingzhi prescription includes ginseng and other herbal medications decocted in water, which ""has the effect of tranquilizing the mind and calming the spirit, benefiting the vital energy and suppressing fright."" One dose per day of 200 ml each time, in the morning and in the evening. Specific ingredients: poria (10 g), poriae cum radicise pini (10 g), ginseng radix et rhizome (10 g), and polygalae radix (10 g), along with acori tatarinowii rhizoma (5 g) and dens draconis (5 g).
Paroxetine hydrochloride: SSRI, 10 to 40 mg/day. Initial dose 10 mg/day, increased by 10 mg each week based on patient response, up to a maximum daily dose of 40 mg, administered as 20 mg in the morning and 20 mg in the evening.","No",,"Yes","Antidepressant: SSRI","Yes","Natural products","No","No","No","No","No","Individual","In Person","Paroxetine: 10 to 40 mg/day; initial dose 10 mg/day, increased by 10 mg/day weekly increments based on response to maximum 40 mg/day.
Anshen Dingzhi prescription: 200 mL twice a day",,"Twice a day","4",,,,,,,,,,,,,,,"Community",,"Illness/medical procedure",,"Some Concerns","Zhang H, Zhu Y, Zhu G, et al. Clinical Efficacy and Mechanistic Insights of Anshen Dingzhi Prescription on Breast Cancer-Related PTSD Through Network Pharmacology and Molecular Docking. Integ Cancer Ther. 2024 Jan-Dec;23:15347354241285435. doi: 10.1177/15347354241285435. PMID: 39344020.","1639644","2025"
"zhang2024_B","zhang2024","Other Mixed","2024","PTSD","Active Control",,"86","B","43",,"Paroxetine","Paroxetine","Paroxetine hydrochloride: SSRI, 10 to 40 mg/day. Initial dose 10 mg/day, increased by 10 mg each week based on patient response, up to a maximum daily dose of 40 mg, administered as 20 mg in the morning and 20 mg in the evening.","No",,"Yes","Antidepressant: SSRI","No",,"No","No","Yes","No","No","Individual","In Person","10 to 40 mg/day; initial dose 10 mg/day, increased by 10 mg/day weekly increments based on response to maximum 40 mg/day.",,"Twice a day","4",,,,,,,,,,,,,,,"Community",,"Illness/medical procedure",,"Some Concerns","Zhang H, Zhu Y, Zhu G, et al. Clinical Efficacy and Mechanistic Insights of Anshen Dingzhi Prescription on Breast Cancer-Related PTSD Through Network Pharmacology and Molecular Docking. Integ Cancer Ther. 2024 Jan-Dec;23:15347354241285435. doi: 10.1177/15347354241285435. PMID: 39344020.","1639644","2025"
"zhao2023_A","zhao2023","Nonpharmacologic biological","2023","PTSD","PTSD",,"27","A","15",,"Personalized neurofeedback","Neurofeedback","fMRI neurofeedback focused on the region of the amygdala associated with trauma recall; personalized trauma scripts; provided personalized mental strategies (strategy use was optional)","No",,"No",,"No",,"Yes","No","No","No","No","Individual","In Person",,"6 5-minute runs per session",,,"No mention of time to complete neurofeedback; total 3 training sessions of 6 runs per session","Received intervention and did not discontinue",,,,,,,,,,,,"Race and Ethnicity data reported","Community","84%",,,"High","Zhao Z, Duek O, Seidemann R, et al. Amygdala downregulation training using fMRI neurofeedback in post-traumatic stress disorder: a randomized, double-blind trial. Transl Psychiatry. 2023;13(1):177. doi: 10.1038/s41398-023-02467-6. PMID: 37230984.","1621286","2024"
"zhao2023_B","zhao2023","Nonpharmacologic biological","2023","PTSD","Inactive Control",,"27","B","12",,"Sham neurofeedback","Sham","Sham neurofeedback using recorded feedback from a matched participant from active group (""yoked"" feedback); personalized trauma scripts; provided personalized mental strategies (strategy use was optional)","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,"6 5-minute runs per session",,,"No mention of time to complete neurofeedback; total 3 training sessions of 6 runs per session","Received intervention and did not discontinue",,,,,,,,,,,,"Race and Ethnicity data reported","Community","84%",,,"High","Zhao Z, Duek O, Seidemann R, et al. Amygdala downregulation training using fMRI neurofeedback in post-traumatic stress disorder: a randomized, double-blind trial. Transl Psychiatry. 2023;13(1):177. doi: 10.1038/s41398-023-02467-6. PMID: 37230984.","1621286","2024"
"ziemba2014_A","ziemba2014","Psychotherapy","2014","PTSD","PTSD",,"18","A","9","data provided for n=7 participants completing pre- and post-intervention assessments","Telemedicine-administered CBT","Cognitive behavioral therapy (CBT) without a trauma focus","CBT following Beck model","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","Video",,,"Weekly","10","10 sessions, allowed up to 15 weeks to complete sessions","completed all 10 sessions",,"Information in discussion, interpreted as all participants completed all 10 sessions of treatment prior to post-intervention assessment; ""A small number of enrolled subjects was unable to complete the 10 sessions within the 15-week time frame. However, these subjects did complete treatment and assessments, but it is possible that the greater time period had an impact on results.""",,,,,,,,,,"Race data reported","Mixed","90%",,,"High","Ziemba SJ, Bradley NS, Landry L-AP, et al. Posttraumatic stress disorder treatment for Operation Enduring Freedom/Operation Iraqi Freedom combat veterans through a civilian community-based telemedicine network. Telemed J E Health. 2014 May;20(5):446-50. doi: 10.1089/tmj.2013.0312. PMID: 24617961.","46063","2019"
"ziemba2014_B","ziemba2014","Psychotherapy","2014","PTSD","PTSD",,"18","B","9","data provided for n=6 participants completing pre- and post-intervention assessments","Face-to-face-administered CBT","Cognitive behavioral therapy (CBT) without a trauma focus","CBT following Beck model","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Individual","In Person",,,"Weekly","10","10 sessions, allowed up to 15 weeks to complete sessions","completed all 10 sessions",,"Information in discussion, interpreted as all participants completed all 10 sessions of treatment prior to post-intervention assessment; ""A small number of enrolled subjects was unable to complete the 10 sessions within the 15-week time frame. However, these subjects did complete treatment and assessments, but it is possible that the greater time period had an impact on results.""",,,,,,,,,,"Race data reported","Mixed","90%",,,"High","Ziemba SJ, Bradley NS, Landry L-AP, et al. Posttraumatic stress disorder treatment for Operation Enduring Freedom/Operation Iraqi Freedom combat veterans through a civilian community-based telemedicine network. Telemed J E Health. 2014 May;20(5):446-50. doi: 10.1089/tmj.2013.0312. PMID: 24617961.","46063","2019"
"zlotnick1997_A","zlotnick1997","Psychotherapy","1997","PTSD","PTSD",,"48","A","24",,"Group affect management therapy","Affect management therapy","Intervention based on Linehan's Dialectical Behavior Therapy (Linehan, 1993) and Matsakis's Treatment Guide for Post-Traumatic Stress Disorder (Matsakis, 1994). Intervention includes psychoeducation, skill building, and application skills. Materials covered include dissociation, flashbacks, ""safe"" sleep, identification of emotions, crisis planning, anger management, techniques for distraction, self-soothing, distress tolerance, and relaxation. Participants also received individual psychotherapy with medication management.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Group","In Person",,"2 hours","Weekly","15",,"completed treatment group",,"not further described, n=7 ""failed to complete treatment"" and n=16 ""completed the treatment group"" (this data entered for completed psychotherapy percent), unclear status for remaining n=1 participant",,,,,,,,,,"Race data reported","Community","100%","Child sexual abuse",,"High","Zlotnick C, Shea MT, Rosen KH, et al. An affect-management group for women with posttraumatic stress disorder and histories of childhood sexual abuse. J Trauma Stress. 1997 Jul;10(3):425-36. doi: 10.1023/A:1024841321156. PMID: 9246650.","13731","2019"
"zlotnick1997_B","zlotnick1997","Psychotherapy","1997","PTSD","Inactive Control",,"48","B","24",,"Waitlist","Waitlist","Participants continued to receive individual psychotherapy with medication management","No",,"No",,"No",,"No","No","Yes","No","No",,,,,,"15",,,,"n=17 completed posttreatment measures",,,,,,,,,,"Race data reported","Community","100%","Child sexual abuse",,"High","Zlotnick C, Shea MT, Rosen KH, et al. An affect-management group for women with posttraumatic stress disorder and histories of childhood sexual abuse. J Trauma Stress. 1997 Jul;10(3):425-36. doi: 10.1023/A:1024841321156. PMID: 9246650.","13731","2019"
"zlotnick2009_A","zlotnick2009","Psychotherapy","2009","PTSD+SUD","PTSD+SUD","Integrated","49","A","27",,"Seeking Safety + TAU","Seeking Safety","Seeking safety: group modality (3 to 5 women per group) while in prison, with optional individual ""booster"" sessions upon release from prison; ""primary goals of SS are psychoeducation and the development of coping skills to help clients attain safety from both PTSD and SUD; it is present-focused, abstinence-oriented, and emphasizes an empowering, compassionate approach.""



TAU: abstinence-oriented residential substance use treatment program following 12-step model in ""psychoeducation large-group format, with weekly individual case management and drug counseling""; participants required to attend all components of TAU treatment to remain in program.","Yes","Non-Trauma-focused","No",,"No",,"No","No","No","No","No","Mixed","In Person",,"Seeking Safety group sessions: 90 minutes; Seeking Safety individual sessions: 60 minutes; TAU: NR (total 30 hours per week)","Seeking Safety group sessions: three times a week; Seeking Safety individual sessions: weekly; TAU: NR (total 30 hours per week)",,"Seeking Safety group sessions: 6 to 8 plus; Seeking Safety individual sessions: 12 weekly sessions offered for all participants in the SS group after group sessions ended; TAU: 12",,,,,,,,,"Seeking Safety group sessions: 15.6 (6.2); Seeking Safety individual sessions: 3.3 (3.8)",,,,"Race and Ethnicity data reported","Community","100%","Mixed","rape/sexual assault, community/school violence","High","Zlotnick C, Johnson JE, Najavits LM. Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behav Ther. 2009 Dec;40(4):325-36. doi: 10.1016/j.beth.2008.09.004. PMID: 19892078.","32555","2020"
"zlotnick2009_B","zlotnick2009","Psychotherapy","2009","PTSD+SUD","Active Control","Not integrated","49","B","22",,"TAU for substance use","Treatment as usual (TAU) for substance use","Abstinence-oriented residential substance use treatment program following 12-step model in ""psychoeducation large-group format, with weekly individual case management and drug counseling""; participants required to attend all components of TAU treatment to remain in program.","Yes","Non-Trauma-focused","No",,"No",,"No","No","Yes","No","No","Mixed","In Person",,"NR (total 30 hours per week)","NR (total 30 hours per week)","12",,,,,,,,,,,,,,"Race and Ethnicity data reported","Community","100%","Mixed","rape/sexual assault, community/school violence","High","Zlotnick C, Johnson JE, Najavits LM. Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD. Behav Ther. 2009 Dec;40(4):325-36. doi: 10.1016/j.beth.2008.09.004. PMID: 19892078.","32555","2020"
"zoellner2017_A","zoellner2017","Psychotherapy & pharmacotherapy","2017","PTSD","PTSD",,"42","A","15",,"Methylene blue + imaginal exposure","Imaginal exposure (experimental paradigm) + methylene blue","Methylene blue (methylthioninium chloride) stimulates mitochondrial metabolism and cerebral oxygen consumption, and may enhance post extinction memory consolidation; given after sessions two through six of six 50-minute daily imaginal exposure sessions based on the PE manual","Yes","Trauma-focused","Yes","Other pharmacotherapy","No",,"No","No","No","No","No","Individual","In Person","Session length: 50 minutes







Dose: 260 mg",,"Daily","0.86",,"completed treatment",,"not further described",,,,,,,,,,"Race and Ethnicity data reported","Community","71.43%","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)","Low","Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.","48582","2019"
"zoellner2017_B","zoellner2017","Psychotherapy & pharmacotherapy","2017","PTSD","Active Control",,"42","B","16",,"Placebo + imaginal exposure","Imaginal exposure (experimental paradigm) + placebo","Placebo containing inert dye to allow blinding (methylene blue turns urine light green or blue); given after sessions two through six of six 50-minute daily imaginal exposure sessions based on the PE manual","Yes","Trauma-focused","No",,"No",,"No","No","Yes","No","No","Individual","In Person","Session length: 50 minutes







Dose: NA",,"Daily","0.86",,"completed treatment",,"not further described",,,,,,,,,,"Race and Ethnicity data reported","Community","71.43%","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)","Low","Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.","48582","2019"
"zoellner2017_C","zoellner2017","Psychotherapy & pharmacotherapy","2017","PTSD","Inactive Control",,"42","C","11",,"Waitlist","Waitlist","No intervention through 1 month follow-up","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,,"4","waiting period through 1 month post-treatment follow-up",,,,,,,,,,,,,"Race and Ethnicity data reported","Community","71.43%","Mixed","combat-related, child physical abuse, child sexual abuse, rape/sexual assault, accidents, community/school violence, natural or manmade disasters, other (not specified)","Low","Zoellner LA, Telch M, Foa EB, et al. Enhancing extinction learning in posttraumatic stress disorder with brief daily imaginal exposure and methylene blue: a randomized controlled trial. J Clin Psychiatry. 2017;78(7):e782-e9. doi: 10.4088/JCP.16m10936. PMID: 28686823.","48582","2019"
"zohar2002_A","zohar2002","Pharmacotherapy","2002","PTSD","PTSD",,"42","A","23",,"Sertraline","Sertraline","SSRI; dose adjustment in 50-mg increments allowed every 2 weeks based on response; randomized treatment followed 1-week placebo run-in with responders excluded (≥20% CAPS-2 decrease)","No",,"Yes","Antidepressant: SSRI","No",,"No","No","No","No","No","Individual","In Person","Initiated at 50 mg, titrated to maximum 200 mg",,"Daily","10",,,,,"monitored with pill counts",,,,,,"120 mg/day","60",,"Not reported","Veteran","88%","Mixed","combat-related, accidents, other (captivity)","Some Concerns","Zohar J, Amital D, Miodownik C, et al. Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol. 2002;22(2):190-5. doi: 10.1097/00004714-200204000-00013. PMID: 11910265.","24564","2019"
"zohar2002_B","zohar2002","Pharmacotherapy","2002","PTSD","Inactive Control",,"42","B","19",,"Placebo","Placebo","Placebo not further described; randomized treatment followed 1-week placebo run-in with responders excluded (≥20% CAPS-2 decrease)","No",,"No",,"No",,"No","No","Yes","No","No","Individual","In Person",,,"Daily","10",,,,,"monitored with pill counts",,,,,,"147 mg/day equivalent","56",,"Not reported","Veteran","88%","Mixed","combat-related, accidents, other (captivity)","Some Concerns","Zohar J, Amital D, Miodownik C, et al. Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol. 2002;22(2):190-5. doi: 10.1097/00004714-200204000-00013. PMID: 11910265.","24564","2019"
"zucker2009_A","zucker2009","CIH","2009","PTSD","PTSD",,"45","A","19","randomized NR by arm, reports on n=19 study completers","Respiratory sinus arrhythmia biofeedback","Biofeedback","Biofeedback training using portable StressEraser device (Helicor, New York) which non-invasively measures respiratory sinus arrhythmia of heart rate oscillations; optimal heart rate rhythm achieved at about 6 breaths-per-minute.","No",,"No",,"Yes","Relaxation","No","No","No","No","No","Individual","In Person",,"20 minutes","Daily","4",,,,"reports only study completers, attrition not given by arm",,,,,,,,,,"Race and Ethnicity data reported","Community","44.7%",,,"High","Zucker TL, Samuelson KW, Muench F, et al. The effects of respiratory sinus arrhythmia biofeedback on heart rate variability and posttraumatic stress disorder symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2009;34(2):135-43. doi: 10.1007/s10484-009-9085-2. PMID: 19396540.","33842","2019"
"zucker2009_B","zucker2009","CIH","2009","PTSD","Active Control",,"45","B","19","randomized NR by arm, reports on n=19 study completers","Progressive muscle relaxation","Relaxation","Recorded progressive muscle relaxation exercise instruction derived from Putting Your Worries on a Shelf (Linehan, 2005).","No",,"No",,"Yes","Relaxation","No","No","Yes","No","No","Individual","In Person",,"20 minutes","Daily","4",,,,"reports only study completers, attrition not given by arm",,,,,,,,,,"Race and Ethnicity data reported","Community","44.7%",,,"High","Zucker TL, Samuelson KW, Muench F, et al. The effects of respiratory sinus arrhythmia biofeedback on heart rate variability and posttraumatic stress disorder symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2009;34(2):135-43. doi: 10.1007/s10484-009-9085-2. PMID: 19396540.","33842","2019"
